data_1l3h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l3h _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.561 0.696 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -140.9 167.4 22.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 128.743 2.817 . . . . 0.0 108.637 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -52.75 -38.77 61.41 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.612 0.642 . . . . 0.0 112.169 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 t -58.52 -62.45 1.84 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.345 0.658 . . . . 0.0 111.416 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.52 -32.81 71.83 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.11 -58.99 6.07 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.432 1.493 . . . . 0.0 110.504 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.3 -39.87 84.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.771 0.714 . . . . 0.0 112.481 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.2 -32.26 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.939 0.896 . . . . 0.0 112.109 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -73.6 -45.26 54.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.915 0.886 . . . . 0.0 112.368 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -77.23 -34.06 56.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.045 1.338 . . . . 0.0 113.256 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.5 mt -92.58 102.76 7.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.45 167.56 25.0 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.111 1.874 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.24 -21.57 34.95 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.92 47.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.397 1.879 . . . . 0.0 111.075 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -88.8 -10.2 0.15 Allowed Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -42.31 114.11 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 124.373 3.382 . . . . 0.0 115.208 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.06 -11.25 22.51 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.698 2.094 . . . . 0.0 112.783 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.9 p -140.03 171.74 13.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.681 1.993 . . . . 0.0 112.364 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -81.67 152.2 27.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 111.233 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -142.42 127.55 10.28 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.387 1.475 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.39 176.35 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.296 1.997 . . . . 0.0 113.447 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -140.32 150.26 43.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.074 2.15 . . . . 0.0 110.005 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.59 157.94 43.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.718 0.807 . . . . 0.0 113.039 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -99.26 179.41 4.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.804 1.642 . . . . 0.0 114.125 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -2.1 0.88 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.934 2.094 . . . . 0.0 114.933 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -122.73 19.35 10.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.4 1.88 . . . . 0.0 111.158 173.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.29 5.4 28.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.055 1.312 . . . . 0.0 114.678 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.83 164.39 17.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.076 1.35 . . . . 0.0 108.495 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -62.14 127.55 31.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.26 125.55 50.96 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.867 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.25 -8.53 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.023 3.149 . . . . 0.0 118.088 -176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -119.46 127.31 52.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.539 2.335 . . . . 0.0 107.03 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -120.74 146.31 46.61 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.343 1.057 . . . . 0.0 109.394 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 90.2 m -135.39 124.12 23.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.694 0.798 . . . . 0.0 112.455 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.19 71.08 10.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.687 1.595 . . . . 0.0 108.034 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.62 -35.87 11.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.809 1.671 . . . . 0.0 114.603 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 m -54.61 -22.71 14.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.901 1.681 . . . . 0.0 115.11 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.67 -0.94 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.881 1.673 . . . . 0.0 112.351 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.07 69.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.104 1.811 . . . . 0.0 115.181 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -84.12 154.13 23.33 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.78 1.29 . . . . 0.0 110.896 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.3 m -137.86 165.31 26.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.719 0.808 . . . . 0.0 111.998 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -147.43 162.53 38.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.089 1.756 . . . . 0.0 109.378 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.8 m -86.05 153.64 21.98 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.37 156.77 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.741 0.816 . . . . 0.0 111.65 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.07 160.63 77.86 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 165.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.18 -26.48 26.59 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.374 2.716 . . . . 0.0 115.591 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -75.55 -8.27 56.32 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.752 2.021 . . . . 0.0 115.417 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.57 -3.08 59.17 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.386 1.469 . . . . 0.0 115.339 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 m -73.66 130.72 40.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.033 1.417 . . . . 0.0 109.727 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.75 139.7 57.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.864 0.865 . . . . 0.0 112.517 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.68 115.52 58.83 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.46 134.83 6.76 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.7 3.6 . . . . 0.0 116.062 -169.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 62.88 11.11 4.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.781 2.032 . . . . 0.0 114.755 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -77.7 -22.33 50.63 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.881 1.219 . . . . 0.0 111.724 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.69 103.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.466 1.107 . . . . 0.0 111.814 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -144.92 171.22 14.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.948 1.299 . . . . 0.0 113.018 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -3.93 2.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.199 3.4 . . . . 0.0 115.421 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.67 -172.87 42.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.422 1.487 . . . . 0.0 112.602 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -57.57 164.19 2.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.153 1.781 . . . . 0.0 114.281 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.5 167.1 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.105 1.362 . . . . 0.0 110.56 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.11 60.76 6.45 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 111.724 -168.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 121.251 0.548 . . . . 0.0 112.433 -178.706 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 120.681 0.277 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.5 p -84.92 166.1 17.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.335 1.054 . . . . 0.0 111.994 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -54.95 -35.87 64.7 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 t -59.74 -63.31 1.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.209 0.459 . . . . 0.0 110.591 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -56.55 -32.24 64.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.887 0.875 . . . . 0.0 113.151 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.34 -59.43 5.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.73 1.15 . . . . 0.0 110.665 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -56.96 -42.39 80.05 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -32.23 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.079 0.552 . . . . 0.0 111.896 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m -83.39 6.53 19.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.013 1.725 . . . . 0.0 114.379 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -125.31 -38.18 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 0.0 111.561 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.76 110.14 27.71 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.17 164.01 37.23 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.923 1.748 . . . . 0.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.64 -26.11 61.14 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.64 68.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.82 1.248 . . . . 0.0 109.002 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -102.46 8.76 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -41.86 111.54 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 123.871 3.047 . . . . 0.0 116.007 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.57 9.83 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.74 2.591 . . . . 0.0 112.435 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 t -111.48 165.69 11.77 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.481 1.913 . . . . 0.0 112.37 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -76.37 161.85 28.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.304 1.842 . . . . 0.0 107.354 164.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -147.9 125.46 5.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.428 1.491 . . . . 0.0 108.53 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.9 169.62 20.82 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.733 1.622 . . . . 0.0 113.289 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -135.94 143.66 45.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.757 3.223 . . . . 0.0 109.75 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -141.43 161.84 36.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.37 175.97 5.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.599 1.16 . . . . 0.0 112.896 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -63.84 -18.19 63.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.502 1.521 . . . . 0.0 114.429 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -84.48 11.0 9.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.344 1.057 . . . . 0.0 111.753 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.96 8.19 60.7 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.456 1.027 . . . . 0.0 114.12 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.1 157.43 16.75 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.88 1.272 . . . . 0.0 109.563 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -66.81 129.49 40.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mt -58.41 135.98 85.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.722 -1.132 . . . . 0.0 108.805 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.67 -17.98 11.07 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.443 2.762 . . . . 0.0 117.377 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.19 137.02 50.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.755 2.022 . . . . 0.0 109.157 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -131.1 152.53 50.3 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.596 1.158 . . . . 0.0 109.707 171.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -141.96 137.58 31.33 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.86 76.39 10.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.87 -28.05 38.46 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.265 1.412 . . . . 0.0 114.89 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -62.15 -21.7 65.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.908 1.283 . . . . 0.0 114.11 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -107.41 -26.86 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.224 1.81 . . . . 0.0 109.816 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.78 10.67 84.83 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.882 1.706 . . . . 0.0 112.918 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -84.53 135.67 34.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.685 1.594 . . . . 0.0 109.709 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -130.37 162.36 29.27 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -149.77 163.77 37.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.698 1.599 . . . . 0.0 109.436 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.2 m -86.94 152.42 22.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.75 151.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 110.654 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -71.94 156.51 90.85 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 166.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.2 -21.67 23.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.44 2.76 . . . . 0.0 116.429 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -76.87 -10.89 59.69 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.321 1.848 . . . . 0.0 114.703 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.56 -1.87 53.19 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.717 1.627 . . . . 0.0 115.363 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -74.39 122.08 22.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.873 1.836 . . . . 0.0 109.42 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.73 159.91 21.23 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.94 94.24 2.45 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 168.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.15 18.82 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 125.525 4.15 . . . . 0.0 117.823 -167.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.99 -5.1 10.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.954 2.101 . . . . 0.0 112.934 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 p -87.94 -17.51 31.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.385 1.074 . . . . 0.0 113.112 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -56.77 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.874 1.67 . . . . 0.0 112.455 -168.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -127.67 166.02 18.9 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.921 1.688 . . . . 0.0 114.203 -167.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 1.13 0.61 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.518 3.127 . . . . 0.0 115.517 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.33 -176.25 45.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.135 1.826 . . . . 0.0 112.745 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -60.23 165.07 3.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.567 1.947 . . . . 0.0 114.296 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 165.13 37.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.207 1.403 . . . . 0.0 110.848 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -82.26 58.19 3.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.993 2.117 . . . . 0.0 112.478 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -173.398 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.604 0.716 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -142.66 168.54 19.48 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 128.486 2.714 . . . . 0.0 108.936 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -56.99 -22.31 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 t -74.92 -61.32 1.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 110.66 169.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -30.72 67.48 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 112.991 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -59.66 5.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.604 1.562 . . . . 0.0 110.269 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.75 -35.87 81.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.89 -30.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.131 0.878 . . . . 0.0 112.092 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -74.27 -47.03 37.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 0.0 112.107 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -73.43 -30.61 63.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.257 1.423 . . . . 0.0 113.268 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.96 96.9 6.14 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.08 171.4 18.03 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.937 2.424 . . . . 0.0 112.243 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.17 -20.57 27.34 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.36 69.01 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.537 1.535 . . . . 0.0 109.274 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -127.67 -17.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.19 116.76 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 124.013 3.142 . . . . 0.0 115.003 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.28 -33.75 5.0 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.893 1.711 . . . . 0.0 111.091 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -111.15 170.66 7.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.171 2.189 . . . . 0.0 111.453 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -82.49 156.72 23.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.189 1.396 . . . . 0.0 111.647 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -144.81 130.82 9.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.521 1.928 . . . . 0.0 108.113 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.7 170.65 19.01 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.185 1.923 . . . . 0.0 113.929 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -137.89 151.73 48.32 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.21 2.204 . . . . 0.0 110.657 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -130.5 159.79 36.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 113.193 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -99.87 176.66 5.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.836 1.654 . . . . 0.0 113.552 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -14.62 36.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.984 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.39 13.89 28.15 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.584 1.554 . . . . 0.0 111.915 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.66 8.4 39.74 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.918 1.246 . . . . 0.0 114.226 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -89.99 164.67 14.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.809 1.243 . . . . 0.0 108.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.44 127.48 31.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mt -54.15 127.66 55.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.94 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -51.57 -21.73 11.33 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.237 2.624 . . . . 0.0 116.153 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.2 134.37 51.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.578 1.951 . . . . 0.0 108.952 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -126.71 149.73 49.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.456 1.103 . . . . 0.0 109.224 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.19 155.31 47.91 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.52 0.728 . . . . 0.0 112.059 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.21 75.92 1.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.063 2.145 . . . . 0.0 107.508 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.7 -44.01 47.38 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.537 1.541 . . . . 0.0 115.061 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 p -65.01 -9.39 21.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.38 -1.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.672 1.124 . . . . 0.0 112.488 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.91 62.26 5.39 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.216 0.912 . . . . 0.0 111.314 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -142.42 154.94 45.02 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.61 161.11 38.73 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.33 1.852 . . . . 0.0 110.458 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.37 163.77 36.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.198 170.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.3 m -89.93 152.29 21.3 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.48 155.2 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.903 1.281 . . . . 0.0 109.914 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -74.3 161.07 79.83 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 166.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.63 -24.22 22.16 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.899 3.066 . . . . 0.0 115.879 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -78.64 -6.28 55.25 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.686 1.994 . . . . 0.0 115.151 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.46 -2.86 59.25 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.596 1.57 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.7 m -73.08 117.93 15.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.903 1.352 . . . . 0.0 110.022 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.89 148.05 11.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.031 1.332 . . . . 0.0 113.579 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.22 92.48 1.22 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.15 23.2 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.827 1 C-N-CA 125.875 4.383 . . . . 0.0 117.795 -166.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -124.95 -2.17 7.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.971 1.708 . . . . 0.0 112.603 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 p -86.01 -19.61 30.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.152 0.981 . . . . 0.0 112.933 174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -45.54 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.835 2.054 . . . . 0.0 112.468 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 m -135.98 166.02 24.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 110.83 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.7 mmm-85 -76.36 6.51 5.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.8 -177.77 45.1 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.373 1.939 . . . . 0.0 112.105 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 114.65 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.04 167.2 31.17 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.825 1.65 . . . . 0.0 110.854 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.29 49.55 0.58 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.226 2.61 . . . . 0.0 114.181 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.787 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.0 p -140.21 179.6 6.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.712 1.205 . . . . 0.0 111.745 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -21.62 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 131.192 3.797 . . . . 0.0 118.407 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.6 t -65.63 -51.21 61.34 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.589 -0.694 . . . . 0.0 110.668 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.72 -31.77 69.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.865 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.13 -54.23 41.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.699 1.136 . . . . 0.0 111.102 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.9 -44.31 86.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.295 0.498 . . . . 0.0 112.007 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.34 -27.1 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.127 0.971 . . . . 0.0 111.786 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -78.82 1.94 21.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.228 1.411 . . . . 0.0 113.963 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -126.4 -35.04 2.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.73 1.212 . . . . 0.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -88.25 109.33 27.57 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.501 1.92 . . . . 0.0 106.304 169.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.78 169.76 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.506 2.137 . . . . 0.0 111.937 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.2 -21.52 34.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.43 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.03 74.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.211 1.405 . . . . 0.0 108.591 169.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -116.4 61.79 2.33 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 124.816 1.247 . . . . 0.0 112.35 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.2 139.36 77.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.76 2.306 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.57 7.46 0.95 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.49 1.519 . . . . 0.0 115.624 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -134.44 176.24 8.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -112.95 140.34 47.85 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.547 1.539 . . . . 0.0 111.665 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -125.12 121.38 25.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.631 1.972 . . . . 0.0 108.297 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 172.24 2.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.766 2.311 . . . . 0.0 114.569 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 146.29 47.44 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.983 1.713 . . . . 0.0 109.441 169.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.76 160.79 39.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -165.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -73.51 173.93 8.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.864 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -61.43 -23.33 65.76 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.41 -9.77 58.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.536 1.934 . . . . 0.0 111.86 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.77 12.68 74.2 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.977 1.275 . . . . 0.0 114.67 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.5 155.46 18.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.455 1.128 . . . . 0.0 108.932 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -67.61 133.25 49.06 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.076 0.55 . . . . 0.0 110.183 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.46 142.05 91.12 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.2 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.89 -26.68 18.71 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.506 2.804 . . . . 0.0 116.4 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.94 45.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 0.0 109.935 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -123.15 144.28 49.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.54 1.136 . . . . 0.0 109.381 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.1 m -137.3 121.09 17.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.673 0.789 . . . . 0.0 112.192 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.43 66.92 9.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.131 1.773 . . . . 0.0 107.308 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.58 40.0 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.53 1.538 . . . . 0.0 114.381 -171.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -57.01 -20.11 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.096 1.758 . . . . 0.0 114.486 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 pt -121.59 2.36 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.785 1.634 . . . . 0.0 112.203 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.13 -4.03 78.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.667 2.079 . . . . 0.0 115.352 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.07 152.73 26.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.881 1.341 . . . . 0.0 112.293 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -139.95 164.47 29.91 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 112.586 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.39 163.77 38.2 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.426 1.89 . . . . 0.0 109.855 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.93 152.25 21.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.76 156.68 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.46 1.104 . . . . 0.0 111.108 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.82 160.07 72.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.56 -24.37 28.75 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.442 2.761 . . . . 0.0 116.256 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -75.84 -12.41 60.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.798 1.639 . . . . 0.0 114.608 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.17 -1.33 47.23 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.01 1.767 . . . . 0.0 115.099 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.8 m -71.34 118.32 13.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.784 1.792 . . . . 0.0 109.962 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.41 136.74 53.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.566 1.146 . . . . 0.0 113.167 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -83.88 110.53 26.11 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.87 158.35 43.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 65.11 -5.02 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.425 2.29 . . . . 0.0 115.218 -173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -78.15 -20.34 52.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.307 1.412 . . . . 0.0 111.773 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.95 91.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.981 1.713 . . . . 0.0 111.069 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -121.53 161.2 22.75 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.396 1.878 . . . . 0.0 113.643 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -13.02 5.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.255 2.622 . . . . 0.0 113.827 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.62 -177.2 36.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.294 0.95 . . . . 0.0 114.532 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -56.62 156.44 6.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.743 2.417 . . . . 0.0 114.737 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -155.87 167.67 29.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 108.316 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -112.11 61.68 0.62 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.278 -0.889 . . . . 0.0 112.489 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.466 0.345 0 C-N-CA 125.824 1.65 . . . . 0.0 113.596 -177.221 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.9 p -127.91 169.14 14.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.979 2.111 . . . . 0.0 110.632 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -38.99 -59.49 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 -49.93 75.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.589 0.631 . . . . 0.0 110.718 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -57.17 -40.62 77.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.524 0.73 . . . . 0.0 112.679 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.69 -57.34 13.1 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.924 0.89 . . . . 0.0 110.306 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.43 -36.85 81.51 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.84 -29.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.417 1.087 . . . . 0.0 112.124 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -72.26 -36.28 68.99 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.569 -0.707 . . . . 0.0 112.035 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -72.98 -46.77 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.602 1.161 . . . . 0.0 112.641 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -76.33 111.53 15.97 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.564 1.146 . . . . 0.0 108.081 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.46 151.82 75.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.113 1.875 . . . . 0.0 111.564 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.54 63.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.21 60.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.526 1.13 . . . . 0.0 109.54 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -90.54 -11.28 0.17 Allowed Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -42.51 128.41 4.7 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.828 3.019 . . . . 0.0 114.821 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.79 -24.59 30.9 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.791 1.662 . . . . 0.0 111.606 -168.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.9 p -123.28 162.65 22.24 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.67 1.988 . . . . 0.0 112.373 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.92 141.32 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.945 0.898 . . . . 0.0 111.08 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -136.47 118.89 11.79 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.286 1.834 . . . . 0.0 108.149 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.73 166.55 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.046 1.831 . . . . 0.0 115.868 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -118.84 142.55 47.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.792 2.837 . . . . 0.0 108.64 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -135.66 158.41 44.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.74 0.816 . . . . 0.0 112.8 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -98.75 -179.8 4.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.979 1.312 . . . . 0.0 113.906 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -62.43 -16.52 55.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -91.93 8.1 39.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.069 1.748 . . . . 0.0 111.929 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.12 2.45 18.59 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.021 1.772 . . . . 0.0 115.145 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.65 167.81 14.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.08 1.752 . . . . 0.0 108.932 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -59.42 133.49 56.14 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.119 -0.363 . . . . 0.0 110.362 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.85 139.04 95.61 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -53.57 -24.26 28.38 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.316 2.678 . . . . 0.0 116.394 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.01 139.01 42.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.019 1.728 . . . . 0.0 110.048 170.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -129.6 153.62 47.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.275 1.43 . . . . 0.0 109.792 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.7 m -141.2 157.5 45.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.968 0.907 . . . . 0.0 111.711 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.8 80.12 1.8 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.37 1.868 . . . . 0.0 107.808 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.05 -35.77 54.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.388 0.994 . . . . 0.0 114.235 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -62.76 -14.12 41.08 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.88 4.46 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.112 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.84 38.37 95.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.521 1.058 . . . . 0.0 113.515 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -128.03 152.25 48.17 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.7 m -136.2 159.63 41.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.03 1.732 . . . . 0.0 109.854 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -152.66 161.06 43.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.48 1.512 . . . . 0.0 109.387 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.31 152.14 22.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.906 -0.496 . . . . 0.0 109.933 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.08 154.4 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.412 1.085 . . . . 0.0 111.309 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -77.88 159.73 75.6 Favored Pre-proline 0 CA--C 1.554 1.112 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 166.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.44 -23.64 19.48 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.92 3.08 . . . . 0.0 117.555 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -85.37 -2.96 58.66 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.68 56.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.538 1.542 . . . . 0.0 114.82 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.7 m -69.35 109.59 4.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.693 1.247 . . . . 0.0 109.537 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -57.93 143.27 43.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 113.655 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.21 90.59 0.62 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -60.93 -24.06 78.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.908 2.405 . . . . 0.0 117.706 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -66.72 -12.0 56.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.027 2.131 . . . . 0.0 113.272 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -94.04 -10.01 34.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 117.438 -1.268 . . . . 0.0 113.297 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -59.89 106.08 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.312 1.414 . . . . 0.0 111.436 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 t -145.06 172.55 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.694 0.798 . . . . 0.0 113.094 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -65.5 1.5 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.568 3.547 . . . . 0.0 116.023 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.12 -177.74 41.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.69 1.614 . . . . 0.0 112.882 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -55.97 157.14 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.544 1.938 . . . . 0.0 114.139 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 164.73 38.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 111.147 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -85.48 65.46 9.19 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.553 1.541 . . . . 0.0 111.603 -169.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 66.3 m . . . . . 0 CA--C 1.536 0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.291 -179.493 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.573 0.701 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.5 p -139.11 171.46 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 128.032 2.533 . . . . 0.0 108.73 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -53.89 -35.38 61.54 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.595 -0.691 . . . . 0.0 112.276 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.0 -62.32 1.86 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.535 0.734 . . . . 0.0 111.234 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -59.8 -33.16 71.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.397 0.544 . . . . 0.0 112.369 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.92 -60.36 3.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.868 1.267 . . . . 0.0 109.758 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.71 -29.19 70.44 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.28 -32.89 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.853 0.861 . . . . 0.0 111.337 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.5 p -80.03 -28.92 39.25 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.17 -48.69 64.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.184 0.902 . . . . 0.0 111.099 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.7 112.78 53.86 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.451 1.1 . . . . 0.0 108.523 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.19 164.8 34.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.019 1.813 . . . . 0.0 111.215 173.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.16 46.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 t -77.02 72.51 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.942 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -117.5 26.61 0.11 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 174.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.59 116.4 3.51 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.854 2.37 . . . . 0.0 112.148 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.75 -13.42 53.52 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.315 1.436 . . . . 0.0 113.147 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -119.62 176.85 5.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.444 1.898 . . . . 0.0 111.767 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -91.71 159.32 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.061 2.544 . . . . 0.0 110.633 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -143.16 130.91 11.03 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.588 1.555 . . . . 0.0 109.014 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.55 168.59 24.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.335 2.023 . . . . 0.0 112.37 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.575 1.95 . . . . 0.0 110.424 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -128.55 153.67 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.797 1.239 . . . . 0.0 112.97 -169.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -87.54 178.58 6.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.532 1.533 . . . . 0.0 113.264 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pm0 -62.98 -12.73 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -99.82 13.01 35.23 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.149 1.78 . . . . 0.0 111.834 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 3.87 22.36 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.631 1.586 . . . . 0.0 114.708 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.69 166.06 16.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.066 1.746 . . . . 0.0 108.606 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -58.88 130.91 49.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.76 0.709 . . . . 0.0 109.794 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.41 119.99 16.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.826 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.45 -9.09 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.759 2.972 . . . . 0.0 116.912 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.56 124.01 48.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.146 2.178 . . . . 0.0 107.218 167.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.2 145.19 48.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.789 0.836 . . . . 0.0 109.399 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.0 m -136.55 126.51 25.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.748 0.819 . . . . 0.0 112.276 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -83.74 70.31 10.33 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.46 -35.87 29.64 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.624 1.583 . . . . 0.0 114.222 -170.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.3 m -53.28 -22.89 7.75 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.45 1.5 . . . . 0.0 114.733 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.59 2.41 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.739 1.616 . . . . 0.0 112.814 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.75 80.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.34 1.448 . . . . 0.0 115.593 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -84.49 147.2 27.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.717 1.258 . . . . 0.0 112.312 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 m -133.69 163.47 29.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.735 1.214 . . . . 0.0 112.117 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -146.81 161.92 39.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.572 1.949 . . . . 0.0 108.384 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.0 m -86.22 153.18 22.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.82 153.57 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.529 1.132 . . . . 0.0 110.223 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -74.14 160.72 80.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.4 -25.73 25.57 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.44 2.76 . . . . 0.0 115.944 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -75.95 -10.15 59.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.059 1.743 . . . . 0.0 114.856 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.52 -1.78 57.2 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.582 1.563 . . . . 0.0 115.395 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.6 m -75.0 127.99 34.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.896 1.848 . . . . 0.0 109.755 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -57.47 139.84 52.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.35 111.48 31.53 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 168.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -49.88 148.91 11.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.884 3.056 . . . . 0.0 114.679 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.73 6.63 0.9 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.126 1.77 . . . . 0.0 115.412 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 p -74.38 -26.03 59.86 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.949 1.25 . . . . 0.0 111.36 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.601 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -42.42 109.21 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.382 1.873 . . . . 0.0 111.213 -177.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -142.53 164.7 29.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.923 1.289 . . . . 0.0 111.653 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.601 ' NH1' HH22 ' A' ' 55' ' ' ARG . 4.7 mpt_? -77.97 16.28 0.75 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.919 2.488 . . . . 0.0 112.958 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -178.71 47.59 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.27 1.891 . . . . 0.0 112.293 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -65.27 167.53 8.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.131 1.772 . . . . 0.0 114.128 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 166.03 34.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.036 1.334 . . . . 0.0 111.258 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -84.97 63.48 8.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.082 2.153 . . . . 0.0 112.039 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -175.243 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 123.176 1.465 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -143.54 163.97 31.69 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 130.684 3.593 . . . . 0.0 109.584 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -52.59 -42.2 64.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.629 0.649 . . . . 0.0 112.38 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 t -56.53 -61.33 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.498 0.719 . . . . 0.0 111.18 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.92 -34.0 74.01 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.34 -56.18 23.36 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.373 1.469 . . . . 0.0 111.021 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -58.61 -41.88 86.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.312 0.505 . . . . 0.0 112.011 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -62.83 -31.89 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.002 0.921 . . . . 0.0 111.896 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -83.35 4.49 27.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.99 1.716 . . . . 0.0 114.099 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -126.01 -34.78 2.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 0.0 112.057 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -96.9 105.48 24.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.38 171.08 18.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.651 2.234 . . . . 0.0 112.117 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.58 -23.74 42.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.223 1.009 . . . . 0.0 113.502 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.06 76.46 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 108.095 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -115.53 47.93 0.53 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.74 130.08 28.4 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.701 2.267 . . . . 0.0 111.067 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.28 -9.05 50.28 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.383 1.468 . . . . 0.0 114.337 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -120.78 160.53 23.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.482 1.641 . . . . 0.0 113.208 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -77.52 162.99 26.71 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 165.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -147.88 129.75 7.46 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.358 2.263 . . . . 0.0 107.035 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.91 170.84 15.81 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.685 1.59 . . . . 0.0 113.067 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -141.38 148.24 39.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.87 2.068 . . . . 0.0 109.559 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.9 m -135.13 157.58 46.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -101.83 177.37 4.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.683 1.593 . . . . 0.0 113.611 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.77 -14.51 33.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.748 1.619 . . . . 0.0 115.034 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -98.1 13.27 31.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.505 1.522 . . . . 0.0 111.906 171.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.51 37.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.968 1.27 . . . . 0.0 114.334 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -88.33 164.68 15.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.166 1.387 . . . . 0.0 108.918 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.79 126.67 28.34 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.84 131.11 57.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.09 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -48.21 -18.76 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.971 3.781 . . . . 0.0 117.355 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.8 131.68 56.87 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.045 2.138 . . . . 0.0 108.439 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -121.87 146.52 47.02 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 109.289 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.1 m -136.13 119.94 17.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 68.21 9.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.814 1.646 . . . . 0.0 106.823 168.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.66 54.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.227 -1.351 . . . . 0.0 114.149 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.32 -10.53 16.74 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.0 pt -124.34 8.47 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.356 1.462 . . . . 0.0 111.764 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.43 5.45 72.74 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.308 1.432 . . . . 0.0 115.041 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HH ' ' NH2' ' A' ' 55' ' ' ARG . 3.9 m-85 -84.82 146.69 27.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.195 1.498 . . . . 0.0 112.776 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.08 157.24 47.15 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.11 1.364 . . . . 0.0 109.943 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -144.52 163.15 34.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.456 1.502 . . . . 0.0 109.406 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.1 m -86.03 150.75 24.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.159 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.8 157.01 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.92 0.888 . . . . 0.0 111.151 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -77.84 159.61 75.97 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 165.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.98 -24.29 24.25 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.585 2.857 . . . . 0.0 116.297 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -76.87 -10.36 59.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.14 1.776 . . . . 0.0 114.663 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.96 52.8 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.776 1.655 . . . . 0.0 115.334 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -71.83 116.19 11.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.962 1.881 . . . . 0.0 110.325 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.45 137.18 57.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.332 1.053 . . . . 0.0 113.694 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.22 109.07 16.74 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 168.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.86 158.77 45.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.569 2.18 . . . . 0.0 112.074 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 61.22 -0.47 0.34 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.695 1.998 . . . . 0.0 115.547 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -71.26 -29.17 64.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.431 1.468 . . . . 0.0 110.667 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.583 ' NH2' ' HH ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -43.57 95.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.199 2.2 . . . . 0.0 113.969 -174.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 58' ' ' GLY . 50.7 m -125.27 162.34 24.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.205 1.802 . . . . 0.0 111.863 -170.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.569 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -72.42 18.61 0.09 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.622 2.769 . . . . 0.0 112.597 175.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 56' ' ' SER . . . 178.33 -179.76 48.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.434 1.493 . . . . 0.0 113.249 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.25 163.24 13.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.093 1.757 . . . . 0.0 113.515 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 161.38 41.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.474 1.109 . . . . 0.0 111.818 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.13 67.96 9.92 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 111.242 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.309 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.465 0.174 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -84.38 168.19 15.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.954 0.902 . . . . 0.0 112.439 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -54.98 -39.94 69.53 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.622 -0.673 . . . . 0.0 112.031 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -59.64 -57.54 12.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.698 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -58.47 -38.47 77.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.262 0.625 . . . . 0.0 112.632 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -59.96 4.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.679 1.192 . . . . 0.0 110.5 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.64 -41.94 82.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.589 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.83 -33.02 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.252 0.621 . . . . 0.0 111.938 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -81.72 -0.88 44.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.504 1.522 . . . . 0.0 114.561 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -126.23 -31.64 2.79 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.544 1.065 . . . . 0.0 112.394 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.99 108.07 38.54 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.97 169.09 23.4 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.442 2.094 . . . . 0.0 111.746 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.28 27.05 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.347 1.059 . . . . 0.0 113.576 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 t -86.25 76.48 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 108.058 169.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -111.03 70.87 0.72 Allowed Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.078 1.351 . . . . 0.0 111.589 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.22 134.92 47.85 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.975 2.45 . . . . 0.0 110.973 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.84 8.5 0.6 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.184 1.849 . . . . 0.0 116.163 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 p -131.32 168.07 18.18 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.613 1.565 . . . . 0.0 112.913 -168.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.85 152.26 20.82 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.088 1.355 . . . . 0.0 111.763 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -138.53 129.82 15.49 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.59 1.956 . . . . 0.0 107.632 169.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.41 176.1 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.835 1.69 . . . . 0.0 113.015 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -139.68 150.34 44.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.849 2.059 . . . . 0.0 109.637 174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -135.23 158.73 43.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -97.37 -179.31 4.45 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.856 1.663 . . . . 0.0 113.981 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -3.17 0.99 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.622 1.969 . . . . 0.0 114.924 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -123.24 19.47 9.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.96 . . . . 0.0 111.193 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 7.62 29.24 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.277 1.417 . . . . 0.0 114.732 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -85.62 162.81 18.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.751 1.22 . . . . 0.0 108.629 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -63.29 126.84 28.76 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 122.009 -0.432 . . . . 0.0 109.9 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.08 132.28 68.34 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.179 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.34 -17.3 4.0 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.899 3.066 . . . . 0.0 116.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -113.14 131.24 55.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.639 1.976 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.32 147.62 45.43 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.493 1.117 . . . . 0.0 109.396 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.1 m -138.66 122.75 17.97 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.721 0.772 . . . . 0.0 112.482 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.8 69.87 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.666 1.586 . . . . 0.0 106.911 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.84 -35.3 47.04 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.437 1.494 . . . . 0.0 113.778 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -62.65 -11.9 19.93 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.42 -4.44 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.43 1.492 . . . . 0.0 111.553 167.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.14 58.18 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.32 1.914 . . . . 0.0 114.829 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -113.09 152.17 29.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.697 1.749 . . . . 0.0 111.751 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -135.95 165.1 26.44 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.935 0.894 . . . . 0.0 112.51 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -148.93 163.59 37.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 109.34 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 70.9 m -87.23 151.38 23.21 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.02 157.63 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.058 0.943 . . . . 0.0 111.108 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.11 160.69 72.97 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -22.08 23.4 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.508 2.806 . . . . 0.0 116.562 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -79.08 -9.9 59.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.054 1.741 . . . . 0.0 114.517 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.84 55.89 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.612 1.577 . . . . 0.0 115.221 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.2 m -73.17 122.59 22.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.978 1.889 . . . . 0.0 110.04 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.28 137.27 57.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.011 . . . . 0.0 113.52 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -84.1 109.56 19.97 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.24 158.21 41.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.797 2.332 . . . . 0.0 112.948 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 65.18 -0.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.488 2.315 . . . . 0.0 115.098 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.4 p -81.16 -19.11 44.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.102 1.319 . . . . 0.0 112.172 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.44 98.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.276 1.43 . . . . 0.0 110.408 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 t -140.72 170.96 14.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -168.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -63.2 -1.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.636 1 C-N-CA 132.273 4.229 . . . . 0.0 114.655 -171.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.43 -174.8 47.25 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.158 1.361 . . . . 0.0 112.595 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -55.78 157.36 4.29 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.084 1.754 . . . . 0.0 113.421 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.35 171.84 19.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.982 1.313 . . . . 0.0 110.485 175.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -105.98 82.4 1.77 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.017 1.327 . . . . 0.0 110.286 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 126.238 1.815 . . . . 0.0 112.637 174.023 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.903 0.382 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 p -83.83 166.25 18.1 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.522 1.129 . . . . 0.0 110.586 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.0 -39.89 66.48 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.369 -0.832 . . . . 0.0 112.291 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.6 t -58.38 -61.8 2.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.625 0.77 . . . . 0.0 111.265 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -62.01 -34.25 75.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.908 -0.568 . . . . 0.0 112.251 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.47 -59.55 4.98 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.746 1.218 . . . . 0.0 110.194 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -54.76 -47.84 73.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.755 0.422 . . . . 0.0 111.339 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.52 -28.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.868 0.867 . . . . 0.0 112.513 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.9 p -80.27 -2.29 44.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -131.42 -24.66 2.25 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -170.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.45 116.78 63.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.642 1.11 . . . . 0.0 109.542 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.31 163.05 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.929 1.753 . . . . 0.0 111.246 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.71 67.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.549 -0.72 . . . . 0.0 112.564 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.04 74.58 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.424 1.49 . . . . 0.0 108.498 170.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -111.41 63.68 0.53 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.73 1.212 . . . . 0.0 112.036 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.81 136.44 53.35 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.499 2.8 . . . . 0.0 110.949 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.28 13.79 0.77 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.274 1.416 . . . . 0.0 115.412 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -124.52 155.08 39.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.915 1.358 . . . . 0.0 113.173 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -75.97 157.45 33.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.545 1.538 . . . . 0.0 112.206 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -142.53 115.7 6.31 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 110.539 168.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.45 169.89 20.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.091 1.861 . . . . 0.0 113.422 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -136.81 143.18 43.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.155 2.982 . . . . 0.0 109.295 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.33 159.82 39.84 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.557 1.071 . . . . 0.0 113.02 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -95.81 174.93 6.71 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.653 1.581 . . . . 0.0 112.91 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -59.67 -20.93 59.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.463 1.105 . . . . 0.0 113.731 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.68 6.04 25.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.011 2.124 . . . . 0.0 111.636 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.5 7.09 38.28 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.628 1.585 . . . . 0.0 114.443 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.27 162.24 15.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.116 1.366 . . . . 0.0 109.32 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -61.71 126.8 28.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -55.64 138.2 69.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.854 -1.07 . . . . 0.0 108.652 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.85 -27.53 16.03 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.219 2.613 . . . . 0.0 115.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.49 135.47 45.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.533 1.533 . . . . 0.0 109.645 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -125.63 149.99 47.94 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.711 1.204 . . . . 0.0 109.018 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -137.78 153.49 49.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.662 1.22 . . . . 0.0 112.704 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.76 66.76 1.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.379 2.672 . . . . 0.0 106.096 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.78 -31.56 54.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.99 1.281 . . . . 0.0 113.598 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -60.13 -12.58 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.429 1.491 . . . . 0.0 114.791 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 pt -126.72 6.69 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 126.204 1.801 . . . . 0.0 111.693 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.69 7.95 87.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 0.0 115.556 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.99 156.96 16.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.667 1.733 . . . . 0.0 114.282 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.5 m -144.23 157.67 44.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.481 1.912 . . . . 0.0 109.93 166.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -148.49 164.62 33.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.79 1.636 . . . . 0.0 109.308 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.59 153.51 20.71 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.2 159.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.079 1.352 . . . . 0.0 110.66 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -79.33 161.28 68.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 165.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -52.04 -25.24 21.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.728 2.952 . . . . 0.0 116.32 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -78.22 -7.65 57.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.164 1.785 . . . . 0.0 115.301 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.63 -1.97 52.93 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.811 1.672 . . . . 0.0 114.984 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -71.12 113.77 8.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.963 1.382 . . . . 0.0 110.489 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -56.72 134.22 54.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.763 1.225 . . . . 0.0 113.709 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.63 111.37 31.49 Favored Pre-proline 0 C--O 1.241 0.61 0 C-N-CA 125.655 1.582 . . . . 0.0 107.131 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.49 161.41 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.64 2.227 . . . . 0.0 111.915 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.44 -2.55 0.12 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.359 1.864 . . . . 0.0 115.894 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.8 p -72.12 -31.51 66.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.46 1.482 . . . . 0.0 110.275 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -46.16 99.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.238 2.215 . . . . 0.0 112.834 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -129.77 165.91 20.97 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.741 1.616 . . . . 0.0 111.478 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 23.33 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.527 2.331 . . . . 0.0 111.927 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.56 -174.17 45.57 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.675 1.131 . . . . 0.0 114.438 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -61.43 152.51 29.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.886 2.474 . . . . 0.0 115.454 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 158.62 44.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.749 168.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -85.97 61.31 6.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.822 1.249 . . . . 0.0 112.607 -167.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.408 -174.493 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 121.519 0.675 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 p -138.6 172.69 12.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.208 2.603 . . . . 0.0 108.407 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -52.19 -38.1 56.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.194 0.598 . . . . 0.0 112.327 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.4 t -63.8 -58.18 7.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.357 0.663 . . . . 0.0 111.316 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -58.9 -35.05 72.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.3 -60.59 3.57 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.127 1.371 . . . . 0.0 110.398 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.43 -37.17 80.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.11 -31.26 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.78 0.832 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -72.16 -41.56 66.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.728 . . . . 0.0 112.387 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -74.73 -40.65 61.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.045 1.338 . . . . 0.0 112.986 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.1 mm -89.04 110.4 37.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.5 168.11 25.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.206 1.938 . . . . 0.0 111.452 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.51 -18.5 29.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.72 78.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.229 1.411 . . . . 0.0 107.666 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -114.86 53.62 0.75 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.764 1.225 . . . . 0.0 113.779 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -62.33 131.5 34.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 -5.47 3.83 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.613 -1.104 . . . . 0.0 115.673 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -113.93 156.4 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.737 1.768 . . . . 0.0 113.0 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -73.1 161.57 30.47 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -147.56 124.6 5.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 126.678 1.991 . . . . 0.0 108.404 168.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.64 172.03 16.59 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.749 1.632 . . . . 0.0 114.049 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -135.91 144.31 45.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.727 3.211 . . . . 0.0 110.102 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -137.81 160.32 39.6 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -103.69 178.7 4.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.901 1.681 . . . . 0.0 114.23 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.64 0.15 1.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.53 1.932 . . . . 0.0 114.656 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.93 19.27 10.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.6 8.65 40.65 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.026 1.298 . . . . 0.0 114.555 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.09 164.25 14.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.69 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.95 127.43 31.22 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.03 135.46 84.01 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 117.678 -1.153 . . . . 0.0 108.472 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -52.85 -10.21 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.49 2.793 . . . . 0.0 117.41 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.88 137.79 51.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.284 1.834 . . . . 0.0 109.227 167.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -129.79 145.58 51.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 109.056 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 98.0 m -137.15 119.02 15.19 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.635 0.731 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.3 66.09 9.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.453 1.501 . . . . 0.0 107.335 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.53 -32.16 45.46 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.195 1.379 . . . . 0.0 113.786 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 m -60.43 -12.52 9.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.325 1.45 . . . . 0.0 114.913 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.59 7.63 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.286 1.834 . . . . 0.0 111.697 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.69 -2.95 77.08 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.192 1.853 . . . . 0.0 115.41 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HH ' ' NH1' ' A' ' 57' ' ' ARG . 6.7 m-85 -83.06 151.66 25.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.133 1.466 . . . . 0.0 113.304 -169.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.74 160.72 39.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.043 0.937 . . . . 0.0 111.056 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -152.06 164.67 36.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.58 1.552 . . . . 0.0 108.817 169.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.44 154.5 17.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 110.571 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.36 157.96 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.768 0.827 . . . . 0.0 111.695 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.95 159.73 70.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.41 -21.23 17.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.067 3.178 . . . . 0.0 117.683 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -84.93 -4.44 59.12 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.79 1.636 . . . . 0.0 114.791 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.61 1.01 55.39 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.712 1.625 . . . . 0.0 114.641 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.1 m -71.75 115.75 11.31 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.902 1.351 . . . . 0.0 109.96 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -60.41 144.79 50.13 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.73 89.67 0.66 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.598 2.359 . . . . 0.0 104.818 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.54 -14.09 42.45 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.796 2.33 . . . . 0.0 117.583 -166.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -67.35 -10.86 55.17 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 127.107 2.163 . . . . 0.0 113.234 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -107.37 2.31 24.31 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.09 1.756 . . . . 0.0 112.545 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -62.83 94.17 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.403 1.001 . . . . 0.0 110.916 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -129.98 161.1 31.68 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -168.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.62 ' NH1' ' HH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -77.34 10.07 2.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.063 2.545 . . . . 0.0 113.146 -173.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.58 -179.22 48.31 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.406 1.955 . . . . 0.0 112.234 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.68 157.46 9.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.486 1.914 . . . . 0.0 114.484 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -155.17 168.91 25.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.564 2.745 . . . . 0.0 106.145 168.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -111.22 34.64 3.95 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -163.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m . . . . . 0 N--CA 1.467 0.399 0 O-C-N 121.627 -0.67 . . . . 0.0 112.029 175.561 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -82.89 166.86 18.57 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 111.314 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -53.51 -41.28 66.16 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.595 -0.691 . . . . 0.0 111.916 171.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.79 -60.21 4.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.309 0.644 . . . . 0.0 110.753 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.95 -39.09 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.351 0.66 . . . . 0.0 112.599 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.21 -56.82 16.86 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.878 1.271 . . . . 0.0 110.928 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -56.57 -43.76 80.32 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.42 0.554 . . . . 0.0 111.571 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.14 -34.97 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.537 0.735 . . . . 0.0 111.67 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -83.82 2.95 35.8 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.04 1.736 . . . . 0.0 114.318 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.58 -34.13 2.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.264 1.026 . . . . 0.0 112.392 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -89.13 113.69 57.25 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.32 163.82 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.237 1.958 . . . . 0.0 111.41 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -22.72 50.73 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.81 73.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.89 1.276 . . . . 0.0 108.66 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -110.9 35.51 0.12 Allowed Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.24 133.66 11.87 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.643 2.229 . . . . 0.0 113.546 169.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.75 -10.81 36.9 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.284 1.421 . . . . 0.0 114.617 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -130.08 173.29 10.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.733 1.767 . . . . 0.0 113.857 -170.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -94.17 152.87 18.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.524 2.329 . . . . 0.0 110.608 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -139.84 123.58 10.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.514 1.526 . . . . 0.0 108.606 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.99 175.95 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.3 2.0 . . . . 0.0 113.094 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 148.18 31.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.343 2.257 . . . . 0.0 109.519 173.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.7 158.42 44.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.83 0.852 . . . . 0.0 113.143 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -91.42 -175.96 4.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.652 1.581 . . . . 0.0 113.414 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -61.56 -16.8 51.23 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -91.48 -5.83 53.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.342 1.457 . . . . 0.0 112.103 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.79 81.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.11 0.862 . . . . 0.0 113.827 -169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -77.9 152.47 33.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.154 1.477 . . . . 0.0 109.478 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -55.41 125.39 20.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.966 0.506 . . . . 0.0 109.723 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.64 142.99 69.77 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.434 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -49.69 -22.89 7.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.567 3.512 . . . . 0.0 117.684 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.06 136.76 52.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.867 2.067 . . . . 0.0 109.406 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -130.03 152.57 49.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.233 1.013 . . . . 0.0 109.321 169.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.54 129.99 20.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.52 73.6 10.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.854 1.662 . . . . 0.0 106.528 168.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -46.59 -43.09 15.01 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.66 1.6 . . . . 0.0 114.258 -170.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 t -63.05 -8.83 8.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.3 pt -126.46 0.38 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.644 1.578 . . . . 0.0 112.44 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.6 7.19 85.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.538 1.066 . . . . 0.0 115.214 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -82.2 128.87 34.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.377 1.589 . . . . 0.0 110.532 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.02 158.77 25.15 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.903 0.881 . . . . 0.0 110.426 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -150.24 160.21 43.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.669 1.588 . . . . 0.0 108.676 171.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -86.18 155.06 20.89 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.28 154.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 122.016 0.912 . . . . 0.0 112.806 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.34 158.78 76.23 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 166.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 -8.36 17.09 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.693 2.262 . . . . 0.0 115.658 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -85.21 -12.14 53.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.306 1.843 . . . . 0.0 114.2 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.71 -2.07 52.68 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.907 1.717 . . . . 0.0 115.543 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.3 m -74.69 133.24 42.1 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.93 1.865 . . . . 0.0 109.068 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.35 155.22 40.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.73 111.53 35.76 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 125.822 1.649 . . . . 0.0 106.643 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.49 150.25 11.92 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.76 . . . . 0.0 113.646 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 61.84 1.5 0.63 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.508 1.923 . . . . 0.0 115.671 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 p -74.23 -28.5 61.27 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.398 1.454 . . . . 0.0 111.012 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -43.8 103.02 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.149 2.18 . . . . 0.0 112.136 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 58' ' ' GLY . 50.1 m -138.26 162.45 34.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.408 1.083 . . . . 0.0 112.453 -169.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.07 13.72 0.1 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.803 3.241 . . . . 0.0 114.314 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 56' ' ' SER . . . 165.73 -169.65 40.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.194 1.854 . . . . 0.0 113.46 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -57.49 152.39 14.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.444 2.298 . . . . 0.0 115.392 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.45 155.91 39.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.637 1.575 . . . . 0.0 108.987 168.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -94.43 70.64 3.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.52 1.128 . . . . 0.0 110.638 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 125.374 1.47 . . . . 0.0 112.913 -176.109 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.478 0.18 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 p -84.37 171.1 12.94 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -53.79 -41.76 67.6 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.978 1.311 . . . . 0.0 112.035 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.51 -57.74 11.64 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.289 0.636 . . . . 0.0 110.622 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -60.52 -35.45 76.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 112.634 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.94 -57.15 14.1 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.78 1.232 . . . . 0.0 110.624 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -57.4 -42.32 82.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.345 0.521 . . . . 0.0 111.875 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.96 -32.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 111.857 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -86.39 6.83 28.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.562 1.945 . . . . 0.0 114.187 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.04 -37.8 2.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.669 1.188 . . . . 0.0 111.55 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -92.44 107.68 25.53 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.73 171.16 18.71 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.536 2.158 . . . . 0.0 111.694 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.3 -21.97 38.59 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -84.71 76.84 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.284 1.434 . . . . 0.0 108.106 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -114.36 63.19 1.28 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.903 1.281 . . . . 0.0 112.69 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 138.55 68.46 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 111.594 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 55.35 10.85 3.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.708 1.623 . . . . 0.0 114.432 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -126.75 161.13 28.87 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.668 1.234 . . . . 0.0 113.242 -167.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -83.72 157.14 22.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.329 1.451 . . . . 0.0 111.294 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -143.48 129.67 10.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.954 1.702 . . . . 0.0 108.083 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.21 175.07 10.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.101 1.867 . . . . 0.0 112.747 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -142.99 149.31 38.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.386 1.875 . . . . 0.0 109.329 172.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.97 158.85 43.26 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.35 1.06 . . . . 0.0 111.563 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -98.76 -174.86 2.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.294 1.037 . . . . 0.0 113.495 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -22.45 56.03 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.15 -8.66 59.02 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.172 0.589 . . . . 0.0 111.807 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.41 4.27 84.02 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.354 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.76 160.46 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.047 1.924 . . . . 0.0 109.339 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -59.35 132.15 53.14 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -61.42 142.72 93.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.013 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.27 -28.61 20.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.914 3.076 . . . . 0.0 116.264 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -106.23 141.25 37.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.46 1.904 . . . . 0.0 109.533 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -131.64 150.59 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.323 1.449 . . . . 0.0 109.084 169.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.1 m -139.65 134.45 32.03 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.26 72.7 10.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.26 -39.4 20.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.617 1.58 . . . . 0.0 114.731 -169.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -64.5 -9.7 20.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 pt -123.38 -4.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 112.088 169.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.1 84.97 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.006 1.765 . . . . 0.0 115.571 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -84.05 151.22 25.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.295 1.548 . . . . 0.0 111.026 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -136.95 165.33 26.25 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.188 0.995 . . . . 0.0 112.667 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -149.05 165.08 32.77 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -88.18 151.87 22.38 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.45 149.43 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.6 0.76 . . . . 0.0 110.798 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -71.11 158.95 87.04 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -52.49 -21.65 14.57 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.626 2.884 . . . . 0.0 117.416 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -85.41 -3.68 58.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.53 1.532 . . . . 0.0 114.507 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.69 -0.48 52.58 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.376 1.465 . . . . 0.0 114.754 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m -70.71 113.8 8.16 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.071 1.435 . . . . 0.0 110.534 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.21 135.22 38.56 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -83.31 109.49 17.99 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.0 156.41 54.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.493 2.129 . . . . 0.0 112.004 -169.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 63.84 -1.51 0.64 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.066 2.146 . . . . 0.0 115.334 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 p -77.66 -23.25 49.69 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.464 1.484 . . . . 0.0 111.827 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.85 99.17 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.048 1.739 . . . . 0.0 110.984 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.2 t -140.5 171.24 14.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.759 1.224 . . . . 0.0 113.451 -168.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -6.65 3.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.019 3.328 . . . . 0.0 115.29 -173.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.39 -176.85 43.99 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.918 1.247 . . . . 0.0 112.957 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -55.64 157.74 3.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.78 2.032 . . . . 0.0 113.518 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.8 164.42 38.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 0.0 112.232 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -84.0 61.4 6.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.942 2.097 . . . . 0.0 111.849 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 123.848 0.859 . . . . 0.0 112.144 -175.172 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.7 p -82.95 167.45 17.96 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.952 0.901 . . . . 0.0 111.398 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -53.63 -37.67 63.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.643 0.777 . . . . 0.0 112.591 171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.0 t -60.36 -61.41 2.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -58.85 -37.27 76.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.422 0.689 . . . . 0.0 112.548 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.43 -59.17 5.88 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.196 1.398 . . . . 0.0 110.514 171.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -55.96 -46.63 78.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.416 0.553 . . . . 0.0 111.61 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.39 -33.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.056 0.542 . . . . 0.0 111.432 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -82.51 3.62 27.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.332 1.853 . . . . 0.0 114.509 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -126.03 -23.79 3.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.105 1.32 . . . . 0.0 113.506 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 mm -61.34 133.21 92.96 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 167.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.27 174.39 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.714 1.61 . . . . 0.0 112.986 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.43 -45.61 53.43 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.608 -0.682 . . . . 0.0 110.6 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.21 72.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.453 1.501 . . . . 0.0 108.799 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.93 -16.28 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -44.76 122.12 3.89 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 123.801 3.0 . . . . 0.0 114.29 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 -41.4 1.94 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.45 1.5 . . . . 0.0 110.517 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.1 p -74.74 163.5 27.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.366 1.467 . . . . 0.0 112.768 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -75.94 155.8 34.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.028 0.931 . . . . 0.0 111.323 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -144.77 128.5 8.74 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 125.503 1.521 . . . . 0.0 108.853 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.47 175.01 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.116 1.877 . . . . 0.0 112.289 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 153.69 40.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.631 1.572 . . . . 0.0 111.133 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.42 159.33 38.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.494 1.118 . . . . 0.0 113.071 -168.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -95.95 -179.69 4.78 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.983 1.713 . . . . 0.0 113.692 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -16.11 48.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.313 1.445 . . . . 0.0 114.866 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.72 13.76 31.1 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.788 1.635 . . . . 0.0 111.771 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 2.21 14.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.648 1.594 . . . . 0.0 114.71 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.34 164.14 20.19 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.811 1.306 . . . . 0.0 108.766 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -60.23 128.87 38.91 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.37 0.532 . . . . 0.0 109.827 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.79 128.23 62.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.15 -1.405 . . . . 0.0 108.675 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.62 -18.74 6.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.799 2.999 . . . . 0.0 116.761 -174.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.53 132.65 54.99 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.961 2.104 . . . . 0.0 108.551 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -124.84 151.87 44.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.254 1.022 . . . . 0.0 108.718 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -141.4 156.99 45.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.688 0.795 . . . . 0.0 112.07 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.03 93.45 3.19 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 110.742 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.76 -36.38 59.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.18 1.371 . . . . 0.0 115.091 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -57.76 -20.78 37.5 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.094 1.447 . . . . 0.0 114.503 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 pt -123.41 2.63 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.98 1.712 . . . . 0.0 112.207 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.44 12.22 69.33 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.293 1.425 . . . . 0.0 114.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -86.82 155.55 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.035 1.418 . . . . 0.0 113.339 -171.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.0 m -140.4 157.19 45.91 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.275 1.83 . . . . 0.0 109.57 166.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -149.5 162.7 39.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.628 1.571 . . . . 0.0 108.941 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.2 m -90.05 152.05 21.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.3 153.26 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.111 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -76.74 161.71 73.03 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 166.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -53.38 -23.85 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 116.361 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -80.8 -8.84 59.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.076 2.15 . . . . 0.0 114.924 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.27 59.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.34 1.447 . . . . 0.0 115.454 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.3 m -72.61 127.42 32.51 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.699 1.75 . . . . 0.0 108.863 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -71.83 165.92 23.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -99.83 92.8 2.11 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -68.85 23.2 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.863 1 C-N-CA 126.021 4.481 . . . . 0.0 117.907 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -124.77 -3.4 7.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.278 1.831 . . . . 0.0 112.465 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.9 p -84.95 -20.71 30.19 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.147 0.979 . . . . 0.0 113.067 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -57.25 97.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.076 1.351 . . . . 0.0 112.566 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -131.78 168.38 17.9 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.301 1.84 . . . . 0.0 111.992 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 21.8 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.108 2.563 . . . . 0.0 112.375 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 174.47 45.84 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.752 1.168 . . . . 0.0 113.219 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -62.82 164.08 8.5 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.059 1.744 . . . . 0.0 114.016 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 162.86 40.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.822 1.249 . . . . 0.0 111.212 175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.07 63.44 7.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.952 1.701 . . . . 0.0 111.812 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 113.335 -172.538 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 160.32 19.51 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.802 1.641 . . . . 0.0 111.137 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -46.39 -53.21 11.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -58.13 -55.92 28.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.496 0.318 . . . . 0.0 111.419 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.98 -41.7 71.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.005 0.922 . . . . 0.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.03 -60.58 3.37 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.889 1.276 . . . . 0.0 109.893 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.63 -46.23 77.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.172 0.442 . . . . 0.0 111.77 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.86 -30.82 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.342 0.657 . . . . 0.0 111.745 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p -79.72 -3.83 49.2 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.78 -21.96 4.3 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.698 1.136 . . . . 0.0 113.997 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.52 137.44 97.08 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 167.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.99 168.65 16.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 121.879 1.72 . . . . 0.0 112.511 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.43 -45.8 68.27 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.541 -0.724 . . . . 0.0 110.318 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 t -77.82 71.65 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.99 1.316 . . . . 0.0 108.784 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -113.95 -9.06 0.1 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -42.87 112.4 0.27 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.441 2.761 . . . . 0.0 114.242 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -46.17 1.1 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.211 1.862 . . . . 0.0 108.672 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -85.61 141.7 29.62 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.802 1.241 . . . . 0.0 111.732 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -64.18 163.98 11.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.789 1.236 . . . . 0.0 109.391 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -142.54 125.21 9.11 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 127.064 2.146 . . . . 0.0 108.947 173.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.73 170.29 7.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.615 2.21 . . . . 0.0 115.843 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -131.84 148.77 52.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.746 2.418 . . . . 0.0 109.146 169.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.87 155.34 46.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -86.14 175.46 8.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.254 1.421 . . . . 0.0 113.05 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.95 -18.18 43.49 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.19 7.66 36.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.329 1.852 . . . . 0.0 111.782 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.23 8.0 41.55 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.344 1.45 . . . . 0.0 114.632 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -91.19 167.65 12.18 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.749 1.62 . . . . 0.0 109.135 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -58.35 133.4 55.69 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.937 -0.477 . . . . 0.0 110.542 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -57.16 133.32 80.75 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.531 170.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -51.24 -30.21 32.26 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.519 2.813 . . . . 0.0 115.566 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.55 137.87 42.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.884 1.674 . . . . 0.0 109.262 169.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -123.74 147.2 47.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 0.0 108.358 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.68 155.49 48.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.109 0.964 . . . . 0.0 110.224 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.47 91.02 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.328 1.061 . . . . 0.0 111.157 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -13.19 34.99 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 117.564 1.785 . . . . 0.0 117.564 -169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.2 p -69.8 -23.65 63.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.159 1.98 . . . . 0.0 112.655 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.1 pt -120.44 -19.26 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.906 1.683 . . . . 0.0 112.492 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 10.27 84.6 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.547 1.546 . . . . 0.0 114.753 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -83.51 157.92 22.2 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.525 1.163 . . . . 0.0 110.755 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.6 m -135.11 163.63 29.47 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.826 1.25 . . . . 0.0 112.416 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -150.87 163.3 38.98 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.144 1.778 . . . . 0.0 109.755 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -89.76 151.85 21.61 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 169.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.2 154.42 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.232 1.013 . . . . 0.0 110.923 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -75.77 162.97 70.05 Favored Pre-proline 0 CA--C 1.552 1.047 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.26 -23.38 23.09 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.878 3.052 . . . . 0.0 116.508 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -82.79 -11.88 57.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.624 1.97 . . . . 0.0 114.691 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.42 49.19 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.457 1.503 . . . . 0.0 115.826 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 m -69.64 119.24 13.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.762 1.781 . . . . 0.0 109.575 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.01 138.5 54.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.914 0.886 . . . . 0.0 112.942 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.73 107.66 11.01 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.18 152.93 77.2 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -169.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 71.42 -3.62 2.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 128.438 2.695 . . . . 0.0 114.396 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.2 p -79.24 -19.98 49.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.222 1.374 . . . . 0.0 112.072 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.1 97.46 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.26 1.424 . . . . 0.0 110.293 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.9 t -137.66 168.78 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.129 1.372 . . . . 0.0 113.217 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -7.73 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 129.324 3.05 . . . . 0.0 115.084 -173.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.21 -169.18 40.3 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.654 1.121 . . . . 0.0 113.422 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.99 150.66 4.13 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.999 2.52 . . . . 0.0 114.777 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 164.63 38.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.794 1.238 . . . . 0.0 110.92 170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -95.54 66.61 2.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.871 1.268 . . . . 0.0 111.602 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.234 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.055 -179.8 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -83.26 167.7 17.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.39 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -52.94 -39.21 62.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.298 0.639 . . . . 0.0 112.099 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 t -59.57 -59.68 5.05 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.599 0.759 . . . . 0.0 110.9 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.75 -37.13 78.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.632 0.773 . . . . 0.0 112.537 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.11 -58.66 7.43 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.152 1.381 . . . . 0.0 110.841 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -56.94 -41.04 77.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.488 0.585 . . . . 0.0 112.108 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.04 -29.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.333 1.053 . . . . 0.0 112.365 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 m -72.59 -42.83 64.12 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.762 0.825 . . . . 0.0 112.274 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -78.85 -37.3 40.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.809 1.244 . . . . 0.0 113.265 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.4 mt -90.75 104.33 9.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.24 169.13 21.45 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.186 1.924 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.91 -24.55 38.25 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.44 68.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 0.0 108.873 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -104.34 8.81 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -41.96 136.67 3.4 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.452 2.768 . . . . 0.0 115.234 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.07 -18.56 35.41 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.888 1.708 . . . . 0.0 113.494 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.4 p -130.34 166.69 19.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.177 1.488 . . . . 0.0 114.362 -169.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -82.78 145.05 29.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.613 1.565 . . . . 0.0 110.733 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -133.7 123.95 17.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.944 1.698 . . . . 0.0 107.96 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.98 175.61 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.848 1.699 . . . . 0.0 114.569 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -136.83 146.36 45.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.826 2.05 . . . . 0.0 109.206 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 m -135.17 153.42 51.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.102 0.865 . . . . 0.0 112.301 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -95.48 -176.38 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.524 1.129 . . . . 0.0 114.03 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -61.14 -24.3 66.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -86.56 8.69 21.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.236 1.414 . . . . 0.0 112.667 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.15 2.08 12.38 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.472 1.511 . . . . 0.0 114.833 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -82.87 169.59 15.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.523 1.529 . . . . 0.0 108.553 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -61.29 133.63 56.09 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.651 -0.656 . . . . 0.0 109.6 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.14 145.59 72.94 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.75 -14.28 38.81 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.881 1.72 . . . . 0.0 114.144 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -110.63 135.51 51.15 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.172 2.189 . . . . 0.0 107.978 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -128.7 150.11 50.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.444 1.098 . . . . 0.0 109.491 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.9 m -140.68 134.83 30.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.269 0.628 . . . . 0.0 112.216 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.69 73.61 9.71 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.39 15.79 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.685 1.612 . . . . 0.0 114.598 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.68 -11.67 27.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.86 -5.28 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.481 1.513 . . . . 0.0 112.421 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.45 8.29 83.71 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.88 1.705 . . . . 0.0 115.629 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -83.91 148.1 27.13 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.093 1.447 . . . . 0.0 110.733 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.5 m -135.34 164.02 28.69 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.224 1.01 . . . . 0.0 113.037 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -149.35 163.58 37.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.689 1.996 . . . . 0.0 109.038 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -88.86 155.14 19.71 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.43 156.38 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.381 1.072 . . . . 0.0 111.796 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -76.46 164.81 57.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 166.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.83 -29.96 36.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.474 2.783 . . . . 0.0 115.893 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.61 -6.34 56.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.131 2.172 . . . . 0.0 114.643 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.12 0.93 65.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.626 1.108 . . . . 0.0 115.189 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.7 m -70.99 126.49 29.71 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.733 1.766 . . . . 0.0 108.588 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -68.82 161.86 27.65 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.25 95.13 3.15 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.16 23.62 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.916 1 C-N-CA 125.836 4.357 . . . . 0.0 117.82 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -125.04 -3.66 7.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.426 1.891 . . . . 0.0 112.398 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 p -86.4 -19.94 28.96 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.056 0.942 . . . . 0.0 113.192 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.93 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.511 1.525 . . . . 0.0 111.351 -169.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m -132.22 165.49 24.0 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.154 1.382 . . . . 0.0 113.177 -168.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -5.13 1.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.399 3.08 . . . . 0.0 115.02 176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.13 -173.1 39.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.093 1.806 . . . . 0.0 112.355 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -59.29 164.85 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.375 1.87 . . . . 0.0 114.41 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 167.98 28.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.454 1.501 . . . . 0.0 110.547 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.25 57.43 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.523 1.929 . . . . 0.0 112.458 -168.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.9 m . . . . . 0 CA--C 1.547 0.836 0 O-C-N 121.97 -0.456 . . . . 0.0 111.286 179.475 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.0 p -82.76 167.7 17.9 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.785 0.834 . . . . 0.0 111.32 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -54.28 -40.04 67.49 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.436 -0.79 . . . . 0.0 111.761 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -56.86 -60.28 3.8 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.737 0.815 . . . . 0.0 110.939 171.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.57 -36.66 76.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.252 0.621 . . . . 0.0 112.477 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.75 -57.56 11.41 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -52.69 -47.74 67.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.95 0.796 . . . . 0.0 111.459 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.95 -24.9 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.328 1.451 . . . . 0.0 112.426 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -91.01 3.93 53.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.235 1.814 . . . . 0.0 115.102 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -130.51 -33.16 1.67 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.187 1.358 . . . . 0.0 113.426 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.17 138.56 72.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.99 158.52 53.78 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 111.357 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.56 84.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.838 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.62 66.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.769 1.227 . . . . 0.0 109.135 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -85.54 -6.64 0.11 Allowed Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -43.72 107.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.881 3.054 . . . . 0.0 114.554 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.89 -20.48 6.0 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.619 2.057 . . . . 0.0 112.909 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -138.83 178.0 7.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.625 1.57 . . . . 0.0 112.215 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -80.68 159.07 25.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.245 1.818 . . . . 0.0 111.035 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -148.86 117.64 3.95 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.336 1.455 . . . . 0.0 109.34 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 174.68 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.17 1.913 . . . . 0.0 114.221 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -138.78 147.77 43.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.033 2.133 . . . . 0.0 108.905 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -132.75 157.67 44.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.254 0.934 . . . . 0.0 113.043 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -103.29 -178.27 3.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.751 1.621 . . . . 0.0 114.721 -169.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -15.56 27.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.968 1.707 . . . . 0.0 115.044 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -102.01 13.53 34.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.922 1.689 . . . . 0.0 111.886 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.19 3.94 20.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.328 1.442 . . . . 0.0 114.561 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -85.34 167.12 15.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.667 1.587 . . . . 0.0 109.343 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.0 124.1 19.51 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -53.83 128.71 55.13 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 117.394 -1.289 . . . . 0.0 108.697 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.39 -9.51 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.074 3.183 . . . . 0.0 117.915 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.43 127.85 54.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.772 2.429 . . . . 0.0 107.622 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.15 150.62 41.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.082 0.953 . . . . 0.0 109.721 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.3 m -138.12 153.83 49.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.893 0.854 . . . . 0.0 112.641 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.37 70.02 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.266 2.226 . . . . 0.0 107.668 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.84 -34.39 29.64 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.088 1.328 . . . . 0.0 113.991 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 m -53.13 -22.62 6.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.862 2.065 . . . . 0.0 115.191 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -121.39 -0.33 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 112.615 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.27 6.3 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.354 0.978 . . . . 0.0 111.339 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -143.3 158.62 43.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -141.23 161.57 37.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.177 2.191 . . . . 0.0 110.077 167.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.21 161.64 42.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.74 1.616 . . . . 0.0 109.366 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.1 m -85.98 153.73 21.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.85 159.28 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.38 1.072 . . . . 0.0 111.708 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -82.01 160.54 63.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.62 -26.21 22.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.785 2.99 . . . . 0.0 116.664 -172.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.1 -5.16 55.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.4 0.59 50.36 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.697 1.618 . . . . 0.0 114.806 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 m -67.9 108.62 3.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.165 1.482 . . . . 0.0 110.686 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -56.62 129.89 42.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.263 1.025 . . . . 0.0 112.979 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.48 110.69 26.17 Favored Pre-proline 0 C--O 1.241 0.617 0 C-N-CA 125.465 1.506 . . . . 0.0 107.97 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.8 161.2 33.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.595 2.197 . . . . 0.0 111.758 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 62.47 -5.23 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.948 2.099 . . . . 0.0 115.445 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 p -76.69 -24.89 53.17 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.345 1.429 . . . . 0.0 111.339 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -50.23 102.95 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.525 1.93 . . . . 0.0 111.106 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -144.33 167.74 21.74 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.448 1.099 . . . . 0.0 111.127 -170.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -74.79 4.56 6.18 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.79 43.82 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.684 1.611 . . . . 0.0 112.252 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -58.18 161.77 3.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.956 1.702 . . . . 0.0 114.439 -171.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.55 165.73 34.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 110.589 172.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -86.4 62.85 7.67 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.274 1.83 . . . . 0.0 111.223 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 179.013 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.3 p -82.88 166.98 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.882 0.873 . . . . 0.0 111.525 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -54.41 -37.99 65.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.406 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 t -60.84 -59.77 4.85 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 110.9 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.54 -39.11 79.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.286 0.634 . . . . 0.0 112.7 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.55 -56.2 24.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.293 1.437 . . . . 0.0 110.986 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -56.61 -44.04 80.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.766 0.426 . . . . 0.0 111.587 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.57 -28.11 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.235 1.014 . . . . 0.0 112.277 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 m -83.49 3.85 30.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.016 1.727 . . . . 0.0 114.03 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -124.78 -35.66 2.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.528 1.131 . . . . 0.0 111.805 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -94.08 105.95 19.98 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.51 171.33 18.44 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.614 2.209 . . . . 0.0 111.822 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.56 39.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.082 0.953 . . . . 0.0 113.403 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.98 76.7 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.983 1.313 . . . . 0.0 108.051 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.45 46.7 0.46 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.42 129.03 25.33 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.699 2.266 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.04 -7.51 66.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.158 1.361 . . . . 0.0 114.323 -173.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -123.28 161.26 24.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.629 1.714 . . . . 0.0 113.56 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -78.1 160.41 28.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.477 1.511 . . . . 0.0 107.708 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -147.79 127.32 6.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.497 2.319 . . . . 0.0 107.098 169.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.73 171.37 9.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.493 1.462 . . . . 0.0 114.111 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -135.28 137.44 42.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.595 2.358 . . . . 0.0 108.82 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.92 154.86 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.652 0.781 . . . . 0.0 111.216 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -79.86 173.56 12.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.937 0.895 . . . . 0.0 112.267 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -61.79 -16.74 52.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.76 -5.71 59.33 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.364 1.865 . . . . 0.0 111.523 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.43 2.07 89.14 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 125.532 1.539 . . . . 0.0 114.627 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -78.47 147.29 33.99 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.124 1.462 . . . . 0.0 109.106 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -54.84 123.77 14.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.915 0.886 . . . . 0.0 110.104 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.06 145.03 67.16 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.65 -18.58 59.11 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.508 2.138 . . . . 0.0 114.291 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -109.91 131.67 54.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.795 2.438 . . . . 0.0 108.541 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -119.64 146.94 45.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.871 1.269 . . . . 0.0 109.417 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.64 128.88 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.35 71.31 10.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.681 1.592 . . . . 0.0 106.991 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.63 -37.2 26.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.513 1.53 . . . . 0.0 114.401 -170.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -63.31 -10.41 16.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 pt -125.01 -0.47 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 112.453 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.7 -5.05 76.51 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.667 1.603 . . . . 0.0 115.498 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -81.83 151.23 27.46 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.028 1.414 . . . . 0.0 111.493 -172.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.2 m -137.38 164.99 27.28 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -148.4 163.96 35.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.8 2.04 . . . . 0.0 109.227 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.8 157.03 18.61 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 109.771 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.45 161.4 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.87 162.66 46.44 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.715 1.606 . . . . 0.0 108.697 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.81 -15.28 9.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.995 3.13 . . . . 0.0 118.027 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -95.55 0.78 53.39 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.103 1.361 . . . . 0.0 114.083 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 2.47 62.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.197 1.38 . . . . 0.0 114.804 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -71.23 130.38 41.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.122 1.461 . . . . 0.0 109.624 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.53 137.94 58.1 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.4 t -83.42 109.15 15.97 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.01 155.95 47.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.832 2.354 . . . . 0.0 113.141 -168.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 61.68 -0.24 0.43 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.135 2.174 . . . . 0.0 115.818 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 p -72.79 -32.01 65.27 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.106 1.321 . . . . 0.0 110.77 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.76 106.38 0.11 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 111.967 -169.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -137.21 165.82 25.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.013 1.325 . . . . 0.0 113.103 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -6.27 2.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.734 2.814 . . . . 0.0 114.216 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.89 -175.66 39.04 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.219 1.866 . . . . 0.0 112.559 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -58.04 161.97 3.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.823 2.049 . . . . 0.0 114.067 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.13 167.11 31.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.611 1.164 . . . . 0.0 111.771 172.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -82.61 61.53 5.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.448 2.299 . . . . 0.0 112.023 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.219 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 120.555 0.217 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -145.98 -178.83 6.32 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.149 1.38 . . . . 0.0 110.16 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -47.32 -33.02 5.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 112.369 169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.47 -68.5 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.235 0.614 . . . . 0.0 111.191 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -54.55 -39.77 68.06 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.44 1.096 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.94 -60.34 3.6 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.679 1.192 . . . . 0.0 110.282 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -54.32 -48.2 71.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.272 0.629 . . . . 0.0 111.908 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.06 -34.32 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.699 0.4 . . . . 0.0 111.261 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.6 p -80.97 -2.1 46.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -130.22 -23.58 2.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -67.33 137.74 93.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 165.15 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.007 1.805 . . . . 0.0 111.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.76 72.45 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.523 -0.736 . . . . 0.0 111.564 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -83.79 77.81 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.388 1.475 . . . . 0.0 107.927 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -118.68 53.2 1.83 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.383 1.073 . . . . 0.0 113.542 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -61.83 139.05 77.94 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.885 2.39 . . . . 0.0 110.853 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 11.51 0.78 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.266 1.412 . . . . 0.0 115.544 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -120.41 136.92 54.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.436 1.495 . . . . 0.0 110.928 -168.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.05 154.68 38.86 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -148.83 125.33 5.31 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.864 2.066 . . . . 0.0 108.523 168.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 178.3 7.04 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.274 1.983 . . . . 0.0 112.66 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -139.17 151.53 46.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.876 2.071 . . . . 0.0 109.764 170.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.77 154.46 51.22 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -86.25 175.36 8.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.442 . . . . 0.0 113.206 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.53 -21.06 59.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -84.9 6.31 25.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.348 1.859 . . . . 0.0 111.862 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.34 4.93 39.88 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.955 1.74 . . . . 0.0 114.889 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -90.5 164.73 14.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.831 2.052 . . . . 0.0 109.759 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.65 127.87 33.3 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.917 -0.489 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.35 141.2 62.96 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.826 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.5 -30.94 12.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.339 3.359 . . . . 0.0 116.251 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.2 tp -107.93 129.99 55.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.445 1.898 . . . . 0.0 108.855 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -112.52 140.09 47.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.681 1.193 . . . . 0.0 108.609 169.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.1 m -130.56 119.7 22.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 122.069 0.938 . . . . 0.0 110.669 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.25 66.59 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.24 1.816 . . . . 0.0 106.501 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.23 -27.12 64.78 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.564 1.554 . . . . 0.0 114.402 -169.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 p -61.97 -11.99 16.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.66 1.584 . . . . 0.0 114.267 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.48 -3.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.643 1.977 . . . . 0.0 111.705 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.69 20.32 79.56 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 126.412 1.958 . . . . 0.0 115.749 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -95.48 158.95 15.23 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.842 1.821 . . . . 0.0 111.28 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.37 164.88 29.03 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.746 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -149.51 164.18 35.78 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.785 2.034 . . . . 0.0 109.277 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.83 150.67 22.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.45 156.48 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.519 0.728 . . . . 0.0 111.737 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.5 158.59 81.05 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 165.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.55 -22.3 16.41 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.655 2.903 . . . . 0.0 117.091 -171.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -82.24 -5.46 58.53 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.421 1.489 . . . . 0.0 114.694 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.74 -0.47 48.88 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.679 1.609 . . . . 0.0 114.968 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -69.88 114.54 8.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.124 1.462 . . . . 0.0 110.539 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.92 136.81 55.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.729 0.812 . . . . 0.0 112.676 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.01 114.3 51.7 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -45.14 137.45 10.05 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.487 3.458 . . . . 0.0 115.58 -169.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.25 9.66 4.13 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.756 2.023 . . . . 0.0 114.843 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -78.11 -22.38 48.99 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.01 1.277 . . . . 0.0 111.604 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 105.17 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.197 0.999 . . . . 0.0 111.724 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -144.74 171.1 14.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.086 1.354 . . . . 0.0 112.999 -169.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -0.06 2.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 129.87 3.268 . . . . 0.0 114.922 -174.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.64 -176.58 48.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.218 1.389 . . . . 0.0 113.01 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.54 159.06 3.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.216 2.207 . . . . 0.0 114.174 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.51 166.29 33.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.479 1.111 . . . . 0.0 111.906 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.75 67.44 9.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.028 1.731 . . . . 0.0 111.535 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.272 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 p -83.72 167.92 16.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.32 1.048 . . . . 0.0 110.754 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -55.15 -39.24 69.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.443 -0.786 . . . . 0.0 112.239 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.1 t -62.18 -59.81 4.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.67 0.788 . . . . 0.0 111.03 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -58.0 -36.54 72.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.58 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.47 -59.23 5.74 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.366 1.066 . . . . 0.0 110.631 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.29 -42.1 81.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.414 0.552 . . . . 0.0 112.079 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.65 -32.27 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.262 1.025 . . . . 0.0 111.908 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 m -86.51 7.93 24.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.178 1.791 . . . . 0.0 114.063 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -124.94 -38.77 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.376 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.41 108.03 20.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 168.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -70.4 160.08 50.75 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.148 1.899 . . . . 0.0 111.47 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.63 61.08 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.89 67.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 108.927 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -99.11 5.31 0.07 OUTLIER Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -41.91 112.69 0.24 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.506 2.804 . . . . 0.0 115.609 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.99 28.44 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.118 1.818 . . . . 0.0 113.318 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -117.44 159.16 23.25 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.214 1.806 . . . . 0.0 111.972 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.38 157.87 37.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -148.54 130.14 7.35 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.499 1.919 . . . . 0.0 107.597 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.91 170.99 17.5 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.19 1.927 . . . . 0.0 112.509 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -144.14 150.5 38.17 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.18 1.792 . . . . 0.0 110.073 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -133.11 158.39 42.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.95 1.3 . . . . 0.0 111.208 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.38 179.64 6.04 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.282 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -16.82 49.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -173.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -84.64 -3.28 58.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.167 0.987 . . . . 0.0 112.61 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 8.93 82.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.215 0.912 . . . . 0.0 113.74 -171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -80.34 147.97 30.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.72 1.208 . . . . 0.0 109.008 172.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -51.98 126.97 19.89 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.089 0.956 . . . . 0.0 111.403 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.86 131.63 82.99 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.08 -30.05 30.35 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.24 2.627 . . . . 0.0 115.543 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.4 140.37 34.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.604 1.961 . . . . 0.0 109.482 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -131.72 149.82 52.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.087 1.355 . . . . 0.0 109.004 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 79.4 m -142.28 132.33 24.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.92 72.0 9.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 168.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.14 17.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.215 1.388 . . . . 0.0 114.784 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -60.9 -16.11 38.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.66 1.88 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.191 1.396 . . . . 0.0 112.435 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.94 69.26 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.811 1.672 . . . . 0.0 115.224 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -83.31 143.4 30.4 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.71 1.255 . . . . 0.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.7 m -131.18 164.81 24.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.645 1.178 . . . . 0.0 112.12 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -153.15 165.4 35.75 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.233 1.813 . . . . 0.0 109.376 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.9 m -89.66 154.16 20.17 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 122.027 -0.421 . . . . 0.0 110.241 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.81 160.29 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.874 0.87 . . . . 0.0 113.122 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.47 167.22 17.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.675 1.59 . . . . 0.0 110.714 167.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.82 -2.21 1.03 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 124.845 3.696 . . . . 0.0 118.614 -170.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -111.31 2.32 17.6 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.45 1.9 . . . . 0.0 113.562 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.69 2.34 61.48 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.227 1.394 . . . . 0.0 114.352 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.5 m -67.13 111.62 4.0 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.183 1.491 . . . . 0.0 110.108 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -56.09 138.34 49.73 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.705 1.602 . . . . 0.0 113.06 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.68 100.1 1.01 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.946 1.698 . . . . 0.0 106.826 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.17 19.32 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.506 4.137 . . . . 0.0 117.127 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -123.73 -1.28 8.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.847 2.059 . . . . 0.0 112.875 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 p -96.3 -15.08 22.13 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.359 1.064 . . . . 0.0 112.843 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.61 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.24 111.46 0.78 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.416 1.086 . . . . 0.0 109.877 -173.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 t -148.23 167.39 25.23 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.61 ' NH1' HH22 ' A' ' 55' ' ' ARG . 5.4 mpt_? -77.2 12.06 1.62 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.626 2.77 . . . . 0.0 113.598 -173.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.65 176.99 47.54 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.904 1.24 . . . . 0.0 112.747 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -57.6 157.98 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.61 1.964 . . . . 0.0 113.28 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.1 168.11 28.12 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.124 0.97 . . . . 0.0 111.821 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -87.76 65.74 8.53 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.771 1.628 . . . . 0.0 111.795 -168.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.4 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.89 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.4 p -83.42 168.24 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.403 0.681 . . . . 0.0 111.661 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -51.06 -42.64 60.68 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 0.0 112.207 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -58.91 6.49 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.954 0.343 . . . . 0.0 111.45 171.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.27 -34.41 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.97 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.74 -61.83 2.23 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.579 1.152 . . . . 0.0 110.359 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -51.41 -49.66 61.2 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.182 0.993 . . . . 0.0 111.59 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.57 -27.39 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.067 0.947 . . . . 0.0 111.357 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -86.2 2.77 45.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.224 1.81 . . . . 0.0 114.602 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -128.86 -25.62 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.192 1.36 . . . . 0.0 113.838 -174.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.65 136.15 92.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 169.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.4 169.39 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.947 1.765 . . . . 0.0 112.074 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.18 72.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.609 -0.682 . . . . 0.0 110.868 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.15 74.36 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.07 1.348 . . . . 0.0 108.498 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.47 15.85 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.49 110.36 1.22 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 CA-C-N 123.636 2.334 . . . . 0.0 110.734 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.96 -15.37 8.92 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.567 1.556 . . . . 0.0 113.134 -169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.0 t -124.87 148.81 48.08 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.474 1.509 . . . . 0.0 110.756 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -77.27 165.25 24.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.961 0.904 . . . . 0.0 112.624 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -138.85 106.97 7.51 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.122 1.769 . . . . 0.0 109.864 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -55.51 155.67 20.33 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.29 2.66 . . . . 0.0 115.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.27 128.81 51.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 127.995 2.518 . . . . 0.0 108.809 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 29' ' ' TYR . 76.0 m -143.19 157.74 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.012 0.91 . . . . 0.0 111.885 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -79.24 176.93 9.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.326 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.2 -24.64 63.29 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -84.61 7.98 18.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.977 1.711 . . . . 0.0 111.668 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.27 15.4 51.26 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.044 1.783 . . . . 0.0 114.634 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.86 149.77 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.728 1.211 . . . . 0.0 109.252 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.439 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 66.1 m-85 -69.0 120.69 15.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.715 0.806 . . . . 0.0 110.01 -170.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.31 128.87 83.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.638 -1.172 . . . . 0.0 108.898 -175.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.77 -22.45 9.8 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.773 2.982 . . . . 0.0 116.594 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.59 136.11 50.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.431 1.893 . . . . 0.0 109.228 169.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -123.69 148.92 46.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.475 1.51 . . . . 0.0 109.073 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -140.82 152.85 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.335 1.054 . . . . 0.0 110.1 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -127.09 88.2 2.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.325 1.06 . . . . 0.0 110.688 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.66 -12.93 36.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.841 1.686 . . . . 0.0 116.84 -169.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.2 p -66.25 -25.68 67.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.263 1.532 . . . . 0.0 112.833 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 pt -119.89 -17.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 112.515 173.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.29 9.25 85.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.515 1.531 . . . . 0.0 114.683 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -83.2 158.06 22.47 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.571 1.185 . . . . 0.0 110.95 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.1 m -133.82 164.97 26.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.618 1.167 . . . . 0.0 112.067 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.42 163.87 39.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.904 1.681 . . . . 0.0 109.498 169.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.4 m -90.64 150.42 21.7 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.693 0.797 . . . . 0.0 109.639 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.46 151.29 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.575 1.15 . . . . 0.0 110.208 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.3 155.4 91.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.9 -16.89 12.62 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.737 2.958 . . . . 0.0 117.372 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -83.23 -4.7 58.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.125 2.17 . . . . 0.0 114.996 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.29 -3.26 54.54 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.733 1.635 . . . . 0.0 114.873 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 m -73.83 111.6 9.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.628 1.214 . . . . 0.0 110.067 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -55.52 143.08 30.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.773 1.229 . . . . 0.0 113.804 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.94 89.04 0.7 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 168.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.18 -15.23 48.3 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.761 2.308 . . . . 0.0 117.435 -166.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.43 -12.96 59.92 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 127.217 2.207 . . . . 0.0 113.134 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.7 p -102.9 -2.62 27.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.923 1.689 . . . . 0.0 112.65 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 104.83 0.6 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.572 1.078 . . . . 0.0 109.447 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 t -141.39 162.04 36.45 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -7.84 3.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.847 3.259 . . . . 0.0 114.945 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.39 -174.53 42.96 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.107 0.86 . . . . 0.0 114.165 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -55.72 149.92 13.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.346 2.258 . . . . 0.0 113.982 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -155.46 -176.51 5.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.833 1.653 . . . . 0.0 110.024 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -130.88 91.03 2.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.527 1.531 . . . . 0.0 110.201 -170.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.542 0.657 0 C-N-CA 127.625 2.37 . . . . 0.0 112.916 177.232 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -83.09 167.19 18.07 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.706 0.803 . . . . 0.0 111.498 171.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -52.25 -39.66 60.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 112.382 171.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -59.59 -60.74 3.36 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.581 0.752 . . . . 0.0 110.949 171.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -58.88 -36.53 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.498 0.719 . . . . 0.0 112.458 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.86 -58.03 10.34 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.876 1.271 . . . . 0.0 110.749 171.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -57.81 -43.17 85.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.233 0.47 . . . . 0.0 112.016 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.55 -34.55 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.309 0.643 . . . . 0.0 111.628 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -82.46 3.19 29.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.736 1.615 . . . . 0.0 114.338 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -127.59 -34.02 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.439 1.018 . . . . 0.0 112.416 -177.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.8 mt -87.27 114.25 57.7 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.2 161.28 40.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.33 2.02 . . . . 0.0 111.705 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -18.43 42.87 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 175.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.02 78.9 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.302 1.441 . . . . 0.0 107.775 169.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -113.52 63.2 0.98 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.025 1.33 . . . . 0.0 112.763 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.16 136.65 57.13 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.366 2.71 . . . . 0.0 111.255 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.96 11.76 1.05 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.376 1.465 . . . . 0.0 115.183 -173.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -125.97 162.89 24.21 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.661 1.585 . . . . 0.0 112.007 -168.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -88.79 155.02 19.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.781 1.632 . . . . 0.0 111.675 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.61 126.34 8.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.796 1.639 . . . . 0.0 108.65 168.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.54 174.03 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.191 1.928 . . . . 0.0 113.507 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 151.34 44.86 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.822 2.049 . . . . 0.0 110.015 173.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.63 157.38 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.625 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.41 -175.64 3.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.564 1.146 . . . . 0.0 113.946 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -60.63 -24.97 65.94 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.14 8.65 20.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.238 1.415 . . . . 0.0 112.71 171.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.35 3.05 17.18 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.49 1.519 . . . . 0.0 114.794 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.19 170.68 11.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.682 1.593 . . . . 0.0 109.118 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -60.31 129.93 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 177.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.92 137.49 79.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.776 -1.106 . . . . 0.0 108.635 173.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.75 -22.78 10.27 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.495 2.796 . . . . 0.0 116.369 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.91 132.09 53.83 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.737 2.015 . . . . 0.0 109.319 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.8 147.78 46.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.628 1.171 . . . . 0.0 109.684 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -139.24 116.84 11.4 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -170.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 63.25 7.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.942 2.097 . . . . 0.0 106.531 168.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.63 -21.74 63.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.936 1.255 . . . . 0.0 114.945 -169.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.0 p -62.15 -15.0 42.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.87 1.268 . . . . 0.0 114.12 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -123.5 8.9 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 127.139 2.176 . . . . 0.0 111.724 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.18 5.05 89.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.963 1.744 . . . . 0.0 115.218 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -84.73 150.64 24.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.202 1.501 . . . . 0.0 114.142 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -143.77 163.37 33.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.897 1.679 . . . . 0.0 111.16 168.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -150.84 163.38 38.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.484 1.914 . . . . 0.0 108.731 169.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.88 154.31 20.95 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.29 157.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.203 1.001 . . . . 0.0 111.645 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -75.66 158.81 82.6 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 165.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.98 -13.68 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.386 2.057 . . . . 0.0 114.949 -169.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -79.8 -7.33 58.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.136 2.174 . . . . 0.0 115.103 169.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.69 -2.65 49.12 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.073 1.797 . . . . 0.0 115.132 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.9 m -73.33 116.78 14.28 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 1.408 . . . . 0.0 110.701 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.32 133.38 55.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.025 1.33 . . . . 0.0 113.635 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.17 111.7 35.48 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 126.718 2.007 . . . . 0.0 108.557 172.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.14 156.62 4.99 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.875 3.05 . . . . 0.0 114.285 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 59.99 -2.88 0.13 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.864 2.066 . . . . 0.0 116.04 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 p -76.01 -26.43 56.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.115 1.325 . . . . 0.0 111.524 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -46.94 106.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.941 2.097 . . . . 0.0 111.783 -174.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 t -148.08 161.29 41.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.729 0.812 . . . . 0.0 111.714 -172.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -89.69 36.23 0.84 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.214 1.405 . . . . 0.0 113.087 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.68 170.74 41.33 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.028 2.251 . . . . 0.0 112.218 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -67.71 167.89 12.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.052 1.341 . . . . 0.0 112.85 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 166.9 32.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.724 1.21 . . . . 0.0 110.981 174.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -83.99 61.3 6.35 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.795 2.038 . . . . 0.0 111.627 -168.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.545 0.763 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.496 179.448 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 p -130.96 176.14 8.49 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.756 1.222 . . . . 0.0 112.777 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -48.57 -35.98 14.57 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.202 1.401 . . . . 0.0 112.446 169.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.22 -57.69 10.51 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.453 0.57 . . . . 0.0 110.884 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -57.46 -40.41 78.45 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.279 0.632 . . . . 0.0 112.637 177.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.96 -57.59 12.21 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.044 0.937 . . . . 0.0 110.578 174.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.53 -46.79 73.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.703 0.801 . . . . 0.0 111.672 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -67.34 -29.58 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 0.0 112.014 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -76.95 -36.04 56.82 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.266 1.026 . . . . 0.0 113.167 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -80.08 -32.66 39.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.311 1.044 . . . . 0.0 113.365 -175.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.48 131.4 95.07 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 167.84 24.17 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.276 1.984 . . . . 0.0 112.678 -176.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.41 78.22 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.582 -0.699 . . . . 0.0 110.682 169.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -79.68 70.93 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.736 1.215 . . . . 0.0 108.914 171.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -114.29 -3.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.23 112.49 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 124.458 2.628 . . . . 0.0 113.904 174.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.82 6.67 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.154 1.835 . . . . 0.0 111.667 -169.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 t -125.32 162.54 24.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.397 1.879 . . . . 0.0 112.729 178.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.0 159.16 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.169 2.188 . . . . 0.0 112.938 -176.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -142.0 113.99 6.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.589 2.355 . . . . 0.0 107.723 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -62.46 168.81 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.367 2.044 . . . . 0.0 114.245 176.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.96 142.04 51.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.849 2.46 . . . . 0.0 108.442 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -136.13 156.77 48.21 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.289 0.95 . . . . 0.0 112.071 -176.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.08 -177.28 3.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.12 -32.34 64.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.035 1.334 . . . . 0.0 113.462 176.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -84.5 11.39 8.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 0.0 112.404 176.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.44 4.47 24.45 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.184 1.374 . . . . 0.0 114.371 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.22 169.88 11.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.814 1.307 . . . . 0.0 109.071 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -62.56 130.67 46.11 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -57.89 134.07 83.41 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 117.77 -1.109 . . . . 0.0 108.546 174.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.33 -26.07 15.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.037 2.492 . . . . 0.0 115.893 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.35 133.94 48.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.06 1.744 . . . . 0.0 109.142 168.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -121.76 149.28 43.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.632 169.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.27 148.43 43.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.496 0.665 . . . . 0.0 112.332 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.22 77.51 1.05 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.643 1.977 . . . . 0.0 107.81 -178.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -37.1 -54.54 1.53 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 127.6 2.524 . . . . 0.0 115.619 -169.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.6 p -63.79 -12.35 34.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -116.76 -5.6 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.343 1.057 . . . . 0.0 112.278 169.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.55 10.43 70.92 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.286 1.898 . . . . 0.0 115.246 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -83.41 155.7 23.34 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.621 1.21 . . . . 0.0 111.293 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.1 m -138.25 164.84 28.22 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.033 0.933 . . . . 0.0 112.423 170.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -148.94 164.03 35.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.595 1.958 . . . . 0.0 109.229 169.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.06 153.62 20.85 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.49 157.83 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 124.33 1.052 . . . . 0.0 111.595 173.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -77.81 160.77 73.56 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.28 -21.25 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.844 3.029 . . . . 0.0 117.358 -170.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.65 -3.0 58.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.792 1.637 . . . . 0.0 114.716 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.97 1.36 56.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.301 1.429 . . . . 0.0 114.899 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -71.31 117.45 12.86 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.134 1.467 . . . . 0.0 110.146 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -56.15 137.16 52.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.7 110.38 24.62 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.27 150.26 11.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.863 3.042 . . . . 0.0 114.408 -171.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.93 3.6 0.5 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.283 1.833 . . . . 0.0 115.585 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -73.71 -28.04 61.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.171 1.351 . . . . 0.0 110.926 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.88 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.695 1.998 . . . . 0.0 111.774 -176.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.5 m -136.13 164.22 28.55 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.079 1.352 . . . . 0.0 112.999 -168.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -4.75 0.81 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 130.03 3.332 . . . . 0.0 115.295 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.07 -175.77 41.12 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.592 1.567 . . . . 0.0 112.986 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -56.19 161.15 2.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.091 2.156 . . . . 0.0 113.698 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 171.03 20.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.751 1.221 . . . . 0.0 111.294 174.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -89.31 68.78 8.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.396 1.878 . . . . 0.0 110.488 -168.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.546 0.827 0 CA-C-O 121.803 0.811 . . . . 0.0 112.003 174.752 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.556 0.694 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -142.31 168.11 20.51 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.844 2.858 . . . . 0.0 108.695 177.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -52.17 -39.53 60.19 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 0.0 112.734 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -59.62 -61.46 2.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.603 0.761 . . . . 0.0 111.518 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.45 -31.22 71.16 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -61.24 -58.58 7.69 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.701 1.6 . . . . 0.0 110.517 170.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.79 -43.87 81.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.45 0.568 . . . . 0.0 111.954 177.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.29 -36.39 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.617 0.644 . . . . 0.0 111.712 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -68.68 -45.35 71.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.884 0.874 . . . . 0.0 112.353 173.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -77.81 -26.24 49.42 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.581 1.152 . . . . 0.0 113.47 -176.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.98 94.98 19.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.975 1.71 . . . . 0.0 108.06 179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.89 154.06 58.38 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.055 1.836 . . . . 0.0 109.994 169.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.51 -36.04 66.26 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.45 73.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 109.059 178.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.604 ' CE1' ' H ' ' A' ' 19' ' ' PHE . 7.0 p80 -132.67 151.09 77.51 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 112.826 175.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.9 155.19 69.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.382 2.721 . . . . 0.0 110.94 171.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.8 40.66 72.73 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -169.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 107.99 0.17 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.2 2.6 . . . . 0.0 114.487 -168.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.604 ' H ' ' CE1' ' A' ' 15' ' ' HIS . 2.4 t80 -152.64 89.1 1.38 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 130.654 3.582 . . . . 0.0 108.084 172.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -84.56 124.52 73.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.04 175.0 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.578 1.518 . . . . 0.0 111.118 169.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.08 153.67 36.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.688 1.195 . . . . 0.0 111.759 177.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.8 m -132.84 158.59 42.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 113.021 -169.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -95.76 -178.93 4.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.263 1.425 . . . . 0.0 113.698 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -62.43 -10.38 11.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -100.68 8.24 43.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.408 1.883 . . . . 0.0 111.619 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.62 6.07 27.14 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.963 1.268 . . . . 0.0 114.434 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -90.23 164.75 14.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.543 1.537 . . . . 0.0 108.876 178.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -61.35 132.62 54.11 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.851 -0.53 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.43 139.36 85.0 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.873 175.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.45 -21.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.292 3.328 . . . . 0.0 117.374 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.98 135.63 53.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.656 1.982 . . . . 0.0 109.37 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.81 151.74 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.654 1.181 . . . . 0.0 109.11 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 76.2 m -140.65 120.42 13.45 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.342 1.057 . . . . 0.0 113.238 -172.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.38 72.92 9.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.427 1.108 . . . . 0.0 108.416 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -42.49 -47.95 5.79 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.708 2.099 . . . . 0.0 115.133 -169.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 p -60.95 -14.44 22.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.7 pt -118.7 -6.91 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 120.016 1.28 . . . . 0.0 113.083 170.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.8 -3.74 86.74 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.194 1.854 . . . . 0.0 115.342 176.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.646 ' HH ' ' NH2' ' A' ' 57' ' ' ARG . 74.0 m-85 -83.55 117.66 23.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.363 1.581 . . . . 0.0 112.083 -173.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -102.18 158.54 16.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.424 1.089 . . . . 0.0 110.262 168.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.19 162.37 39.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.513 1.525 . . . . 0.0 109.499 171.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.1 m -86.39 154.38 21.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.3 157.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.118 0.961 . . . . 0.0 113.298 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.12 163.29 58.27 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.97 -24.13 46.77 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.495 2.797 . . . . 0.0 115.829 -169.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -81.45 -7.84 59.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.266 2.226 . . . . 0.0 114.766 176.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.22 59.45 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.2 1.381 . . . . 0.0 115.438 -178.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.0 m -70.91 132.31 45.04 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.907 1.854 . . . . 0.0 109.937 177.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.1 141.93 57.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.274 1.029 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -82.34 115.37 57.53 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -44.08 133.44 8.63 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.779 3.652 . . . . 0.0 116.262 -169.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 59.5 15.15 4.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.731 2.013 . . . . 0.0 115.719 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.4 p -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.197 170.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.363 0.0 OUTLIER -57.99 110.73 0.98 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.027 1.285 . . . . 0.0 113.232 -170.503 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLY . 27.3 t -148.65 153.54 38.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.792 1.637 . . . . 0.0 110.398 -170.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.646 ' NH2' ' HH ' ' A' ' 40' ' ' TYR . 14.8 ttm-85 -80.31 28.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.166 1.386 . . . . 0.0 114.333 -171.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' SER . . . -159.35 169.05 35.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.387 1.946 . . . . 0.0 112.598 171.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -63.92 165.3 8.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.734 1.214 . . . . 0.0 112.781 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 164.12 38.65 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.017 0.927 . . . . 0.0 111.333 172.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -83.45 62.88 7.01 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.159 1.784 . . . . 0.0 111.976 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.206 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.543 0.673 0 CA-C-O 120.607 0.241 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.8 p -144.89 167.69 22.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.516 1.927 . . . . 0.0 110.971 -174.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -50.23 -42.39 51.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.785 1.234 . . . . 0.0 113.418 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.08 -61.77 2.16 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.201 0.6 . . . . 0.0 111.127 173.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -58.66 -40.39 83.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.716 1.606 . . . . 0.0 112.265 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.24 -55.86 26.57 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 125.793 1.637 . . . . 0.0 110.344 172.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.68 -44.61 81.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.557 0.617 . . . . 0.0 111.432 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.85 -34.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.629 0.65 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -84.97 3.94 36.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.016 1.726 . . . . 0.0 115.231 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.8 -24.96 1.9 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.276 1.398 . . . . 0.0 114.265 -174.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.14 122.49 75.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.31 0.959 . . . . 0.0 109.166 176.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.54 172.48 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.302 2.002 . . . . 0.0 111.657 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -22.14 66.69 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.653 -0.654 . . . . 0.0 112.278 169.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.09 67.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.164 1.386 . . . . 0.0 109.184 169.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.5 92.65 44.13 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.102 1.361 . . . . 0.0 110.28 175.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.58 115.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.771 3.647 . . . . 0.0 114.994 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.9 51.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.174 1.368 . . . . 0.0 114.86 -177.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.261 92.0 p 69.16 107.08 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.274 3.029 . . . . 0.0 116.097 -176.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -138.44 136.21 35.99 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.968 1.707 . . . . 0.0 109.392 168.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -144.47 135.35 12.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 126.406 1.882 . . . . 0.0 106.086 169.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.9 163.57 38.72 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 120.63 1.261 . . . . 0.0 111.224 177.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -122.82 147.05 46.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.954 1.702 . . . . 0.0 109.469 177.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.4 m -136.61 156.53 48.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 111.848 -171.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -102.8 179.25 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.732 1.213 . . . . 0.0 114.162 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.21 -12.04 17.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 177.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -97.04 8.27 44.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.239 1.816 . . . . 0.0 111.696 175.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 8.81 35.38 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.706 1.146 . . . . 0.0 114.034 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.33 165.6 13.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.582 1.553 . . . . 0.0 108.85 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -62.17 132.52 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.09 135.74 87.88 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.8 -1.095 . . . . 0.0 108.258 174.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.07 -15.44 7.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.332 2.688 . . . . 0.0 116.887 -176.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.26 137.59 51.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.951 2.1 . . . . 0.0 109.891 171.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -131.9 152.42 51.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.853 1.261 . . . . 0.0 109.471 170.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.2 m -143.59 158.12 43.9 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.39 1.076 . . . . 0.0 112.353 -178.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 113.46 12.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.997 2.119 . . . . 0.0 108.93 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.04 -80.91 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 127.562 2.506 . . . . 0.0 117.274 -168.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 m -64.43 -18.73 65.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -168.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 pt -92.61 -3.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 10.83 59.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.597 1.57 . . . . 0.0 114.948 174.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -94.78 146.6 24.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.231 1.015 . . . . 0.0 113.445 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.9 m -130.86 156.45 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.509 1.523 . . . . 0.0 108.53 165.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.39 161.33 41.24 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.49 1.516 . . . . 0.0 108.781 172.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.8 m -86.8 152.69 22.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.82 156.66 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 110.019 170.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -73.68 161.19 79.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 166.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.54 -26.55 22.47 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.329 2.686 . . . . 0.0 115.389 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -76.46 -8.12 56.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.296 1.839 . . . . 0.0 115.374 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.69 -3.86 56.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.745 1.641 . . . . 0.0 115.266 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 m -73.56 119.79 18.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.059 1.43 . . . . 0.0 110.439 -177.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -56.82 132.14 51.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.719 1.207 . . . . 0.0 113.758 176.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.39 109.33 18.84 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.92 1.688 . . . . 0.0 107.639 169.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.44 163.51 26.6 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.556 2.171 . . . . 0.0 111.871 -175.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 61.2 -3.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.772 2.029 . . . . 0.0 115.74 -175.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.2 p -72.38 -28.84 63.27 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.994 1.27 . . . . 0.0 110.989 169.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -40.35 102.91 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.603 2.361 . . . . 0.0 113.103 -173.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 58' ' ' GLY . 50.7 m -133.51 161.79 33.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.118 0.967 . . . . 0.0 111.627 -172.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -71.95 17.55 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 130.17 3.388 . . . . 0.0 113.777 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 56' ' ' SER . . . 166.31 -178.82 40.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.669 2.081 . . . . 0.0 112.178 -171.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -61.21 162.45 7.5 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.654 1.581 . . . . 0.0 114.193 -172.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 163.75 36.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.066 1.346 . . . . 0.0 110.827 171.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.06 57.69 3.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.17 2.188 . . . . 0.0 112.496 -168.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 122.845 1.307 . . . . 0.0 112.078 -173.346 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 p -129.77 175.07 9.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.778 1.231 . . . . 0.0 112.717 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -51.02 -33.44 25.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.661 1.184 . . . . 0.0 112.31 172.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.1 t -61.33 -60.2 4.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.307 0.503 . . . . 0.0 110.653 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -55.68 -38.7 69.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.53 -58.22 9.42 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.087 0.955 . . . . 0.0 110.654 173.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.59 -40.84 88.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.385 0.539 . . . . 0.0 112.41 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -69.03 -28.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.036 0.934 . . . . 0.0 112.243 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -73.43 -48.44 33.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.69 0.796 . . . . 0.0 111.955 169.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -73.62 -33.75 64.7 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.846 1.259 . . . . 0.0 113.251 -175.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.8 mt -97.43 101.06 9.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.42 173.54 14.07 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.698 2.265 . . . . 0.0 111.902 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.22 -20.26 17.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.408 1.083 . . . . 0.0 113.808 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.41 76.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.124 1.37 . . . . 0.0 107.987 169.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -111.67 71.87 0.98 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.135 1.374 . . . . 0.0 111.354 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.78 119.44 6.7 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.833 3.022 . . . . 0.0 112.391 -169.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 53.37 8.62 0.81 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.444 1.974 . . . . 0.0 115.313 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -108.57 159.89 16.35 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.649 1.579 . . . . 0.0 112.39 -167.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -77.61 148.39 35.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.842 0.457 . . . . 0.0 110.751 173.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -138.28 125.03 13.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.318 1.847 . . . . 0.0 107.723 169.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -70.33 174.34 10.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.103 1.868 . . . . 0.0 113.427 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -135.41 143.88 46.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.016 2.126 . . . . 0.0 110.236 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.77 164.24 29.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.433 1.893 . . . . 0.0 110.643 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -120.99 178.38 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.041 0.936 . . . . 0.0 113.068 169.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -62.93 -11.95 22.07 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.571 1.548 . . . . 0.0 114.682 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -87.49 1.3 53.89 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.231 0.469 . . . . 0.0 111.901 173.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.45 -1.01 88.55 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.857 1.694 . . . . 0.0 114.353 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -86.71 165.18 16.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.481 1.113 . . . . 0.0 110.629 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -64.85 130.31 42.98 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 167.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -55.2 135.35 68.59 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.63 -7.01 16.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.153 1.902 . . . . 0.0 114.854 -168.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.12 135.97 53.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.555 1.942 . . . . 0.0 108.135 168.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -130.8 153.11 49.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.469 1.107 . . . . 0.0 108.977 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.7 m -140.53 156.88 46.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.145 0.978 . . . . 0.0 112.008 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.02 102.38 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.383 1.073 . . . . 0.0 111.24 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.44 -41.0 62.7 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.99 1.281 . . . . 0.0 114.946 -175.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 m -62.32 -17.88 59.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.004 1.402 . . . . 0.0 114.652 -176.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -112.83 -2.47 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.389 . . . . 0.0 112.313 171.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.58 20.72 74.13 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.9 1.238 . . . . 0.0 114.438 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -118.54 161.41 20.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.939 1.369 . . . . 0.0 113.724 -170.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.2 m -132.36 159.15 40.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.993 2.117 . . . . 0.0 109.742 167.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -145.71 160.93 41.01 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.169 1.387 . . . . 0.0 109.248 171.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.6 m -88.34 152.9 21.61 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.65 154.59 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.752 1.221 . . . . 0.0 110.942 172.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -74.82 164.82 58.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 167.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -50.86 -28.54 23.84 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.473 2.782 . . . . 0.0 115.758 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -78.59 -6.93 56.93 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.236 2.215 . . . . 0.0 115.459 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.28 -3.27 63.85 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.914 1.245 . . . . 0.0 115.458 177.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.2 m -73.4 131.73 42.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.929 1.365 . . . . 0.0 109.402 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -59.18 142.54 51.41 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.03 110.1 21.25 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -47.67 142.96 13.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.011 3.141 . . . . 0.0 115.334 -169.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 61.09 8.65 2.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.56 1.944 . . . . 0.0 115.225 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -27.58 63.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.037 1.29 . . . . 0.0 110.919 172.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.605 HH21 ' NH2' ' A' ' 57' ' ' ARG . 1.7 ptm180 -41.17 93.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.343 2.257 . . . . 0.0 114.363 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -127.78 163.44 24.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.17 1.788 . . . . 0.0 112.083 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.605 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -69.2 9.05 0.48 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.577 2.751 . . . . 0.0 113.318 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.37 -179.83 47.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.979 1.752 . . . . 0.0 112.658 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -65.19 167.31 8.37 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.156 1.782 . . . . 0.0 114.008 -174.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 167.08 31.54 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.074 1.35 . . . . 0.0 111.359 176.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -78.63 53.63 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.129 2.571 . . . . 0.0 113.196 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 122.916 1.341 . . . . 0.0 114.576 -169.315 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.29 0.09 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 p -83.53 170.08 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -173.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.9 -39.26 62.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.705 1.202 . . . . 0.0 112.684 170.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.9 t -61.22 -59.2 5.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.722 0.809 . . . . 0.0 110.677 171.231 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -59.95 -34.82 73.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.6 0.76 . . . . 0.0 112.595 -176.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.26 -59.29 5.64 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.765 1.626 . . . . 0.0 110.774 170.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.36 -44.99 76.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.183 0.447 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.63 -28.85 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.134 0.974 . . . . 0.0 112.136 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -83.0 3.02 31.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.664 1.586 . . . . 0.0 114.231 169.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -124.17 -33.66 3.05 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.689 1.131 . . . . 0.0 111.976 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.73 102.78 8.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 168.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.34 166.38 29.47 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.545 2.164 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.0 56.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.21 63.57 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.512 1.125 . . . . 0.0 109.272 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -93.52 -5.94 0.11 Allowed Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -178.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -42.39 126.8 4.05 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.726 2.951 . . . . 0.0 115.305 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.99 -23.75 33.57 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.106 1.813 . . . . 0.0 112.401 -169.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.0 p -123.02 159.44 28.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.594 1.558 . . . . 0.0 113.086 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -87.72 106.27 17.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.277 1.031 . . . . 0.0 111.291 175.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -91.76 118.39 68.27 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.97 174.75 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.356 2.037 . . . . 0.0 114.032 175.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -134.55 142.38 46.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.252 1.821 . . . . 0.0 109.94 175.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -137.54 157.67 46.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.802 1.641 . . . . 0.0 109.668 -177.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.24 -177.4 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 171.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -58.03 -22.94 52.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.478 1.511 . . . . 0.0 113.704 -174.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -84.96 -1.14 56.36 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.473 0.579 . . . . 0.0 111.916 176.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.87 86.6 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.892 1.711 . . . . 0.0 114.521 178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.85 160.74 28.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.628 1.714 . . . . 0.0 109.538 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.67 130.42 46.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.83 143.07 77.69 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.75 -17.3 52.18 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.814 . . . . 0.0 113.575 -169.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.07 137.63 44.77 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.705 2.002 . . . . 0.0 108.63 169.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -128.4 150.36 50.14 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.667 1.187 . . . . 0.0 109.414 169.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.4 m -140.99 151.98 44.56 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.972 0.909 . . . . 0.0 111.959 -177.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.36 78.46 1.81 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.795 2.038 . . . . 0.0 107.865 177.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.96 -34.86 58.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.228 0.918 . . . . 0.0 114.334 -170.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -63.72 -15.23 57.97 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -114.31 -0.25 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.646 1.178 . . . . 0.0 111.974 169.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.4 58.23 13.33 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.585 1.088 . . . . 0.0 111.351 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -140.7 154.31 46.3 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.6 m -142.28 160.19 40.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.4 1.88 . . . . 0.0 110.166 167.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -150.08 163.13 38.98 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.881 1.672 . . . . 0.0 109.113 173.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.8 m -89.28 153.09 21.17 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.54 152.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.307 1.043 . . . . 0.0 110.543 171.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.86 162.52 73.71 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 166.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.14 -20.1 29.73 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.586 2.857 . . . . 0.0 116.167 -170.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -83.57 -8.79 59.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.485 2.314 . . . . 0.0 114.67 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.06 -0.93 54.8 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.471 1.51 . . . . 0.0 115.269 -177.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -70.88 115.79 10.42 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.856 1.828 . . . . 0.0 110.342 178.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -54.83 135.3 47.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.836 1.254 . . . . 0.0 112.863 175.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.49 111.7 33.65 Favored Pre-proline 0 C--O 1.242 0.709 0 C-N-CA 125.509 1.524 . . . . 0.0 108.075 172.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -50.97 150.58 12.94 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.647 2.898 . . . . 0.0 113.653 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 59.86 2.24 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.404 1.882 . . . . 0.0 115.933 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p -72.85 -32.4 65.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.297 1.408 . . . . 0.0 110.565 169.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -45.27 103.86 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.335 1.854 . . . . 0.0 112.41 -172.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m -135.48 167.86 20.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.553 1.541 . . . . 0.0 110.14 -171.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -79.67 13.35 2.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.98 -178.16 47.27 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.744 2.116 . . . . 0.0 112.476 -172.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -62.69 162.94 9.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.466 1.506 . . . . 0.0 114.227 -172.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 169.12 22.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.135 1.774 . . . . 0.0 110.332 171.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -74.0 39.88 0.12 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.776 2.83 . . . . 0.0 114.747 -168.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.534 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.746 0.307 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -82.73 167.15 18.46 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.976 0.91 . . . . 0.0 111.235 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -53.47 -42.38 67.18 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.721 -0.612 . . . . 0.0 112.168 171.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -55.88 -61.4 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.444 0.697 . . . . 0.0 110.688 172.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -56.42 -43.19 79.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.682 1.193 . . . . 0.0 112.744 -178.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -56.43 -53.92 51.75 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.63 1.172 . . . . 0.0 110.706 172.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.15 -41.49 83.85 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.616 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -63.84 -35.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.563 1.074 . . . . 0.0 111.365 175.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -83.28 6.3 20.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.362 1.865 . . . . 0.0 114.733 176.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.44 -37.39 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.704 1.202 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.61 118.72 67.53 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.691 1.596 . . . . 0.0 106.76 172.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.54 168.02 23.34 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.672 2.248 . . . . 0.0 111.849 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.78 -23.63 53.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.277 1.031 . . . . 0.0 113.723 173.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.97 75.39 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.037 1.335 . . . . 0.0 108.549 172.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -118.73 62.04 5.16 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.333 1.053 . . . . 0.0 113.737 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.28 119.42 6.4 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.068 2.512 . . . . 0.0 110.575 172.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.91 88.07 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.389 -0.673 . . . . 0.0 114.465 -177.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -138.38 -179.4 5.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.376 1.47 . . . . 0.0 110.275 174.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -131.39 145.72 51.95 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.102 -0.999 . . . . 0.0 113.008 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -123.92 113.59 28.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.234 2.214 . . . . 0.0 108.295 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.65 161.33 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.694 1.596 . . . . 0.0 112.629 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -118.67 152.72 35.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.894 1.678 . . . . 0.0 109.747 169.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -131.27 151.57 51.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.762 1.225 . . . . 0.0 111.681 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.92 179.59 7.77 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.047 1.339 . . . . 0.0 112.362 173.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -61.37 -17.51 54.34 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -173.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.01 -2.03 58.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.51 1.124 . . . . 0.0 112.464 174.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.87 1.66 84.85 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.608 1.099 . . . . 0.0 113.853 -171.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.57 151.52 34.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.132 1.466 . . . . 0.0 109.072 175.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -51.28 129.92 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 111.281 175.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.62 131.18 77.64 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 117.888 -1.053 . . . . 0.0 108.368 171.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.43 -35.75 36.92 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.677 2.918 . . . . 0.0 114.53 -177.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.91 140.45 33.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.769 1.628 . . . . 0.0 109.898 169.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -126.52 143.52 51.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.226 1.41 . . . . 0.0 108.695 169.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.3 m -139.35 144.98 38.47 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.923 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -113.07 93.27 4.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 110.712 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.97 -9.22 26.89 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.2 p -68.65 -26.33 65.27 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.77 1.785 . . . . 0.0 112.538 169.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -125.56 -16.07 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.948 1.699 . . . . 0.0 112.853 -178.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.12 89.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.497 1.046 . . . . 0.0 114.578 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -81.93 154.4 25.79 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.21 1.005 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.4 m -134.55 165.34 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.018 1.327 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -153.26 165.0 37.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.125 1.77 . . . . 0.0 109.415 169.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 83.3 m -91.86 152.38 20.12 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 169.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.38 159.62 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.142 0.977 . . . . 0.0 113.377 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -92.68 164.85 20.68 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.059 2.143 . . . . 0.0 110.389 168.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -57.72 -5.83 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.749 3.633 . . . . 0.0 118.545 -172.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -103.59 -5.48 22.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.129 1.371 . . . . 0.0 113.865 172.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.46 0.58 55.59 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.797 1.665 . . . . 0.0 114.663 -177.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 m -69.77 128.08 35.18 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.886 1.343 . . . . 0.0 108.497 178.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.84 163.4 27.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.48 100.49 2.76 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 167.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.31 22.57 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.858 1 C-N-CA 125.895 4.396 . . . . 0.0 118.054 -166.436 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.85 -3.21 7.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.409 1.884 . . . . 0.0 112.398 168.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.5 p -92.98 -10.98 34.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.441 1.096 . . . . 0.0 113.246 178.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.51 96.5 0.08 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.157 0.983 . . . . 0.0 110.224 -173.424 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.647 ' HG ' ' CZ ' ' A' ' 57' ' ' ARG . 9.0 t -134.57 163.07 30.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -168.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.647 ' CZ ' ' HG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -69.04 -1.9 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.727 2.811 . . . . 0.0 114.017 -169.889 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.82 -171.04 40.04 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.071 1.796 . . . . 0.0 112.75 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.91 152.22 13.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.494 1.917 . . . . 0.0 114.505 -170.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.43 171.76 19.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.012 1.725 . . . . 0.0 109.502 169.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -116.43 78.12 1.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 0.0 110.824 -168.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 126.25 1.82 . . . . 0.0 113.066 -179.474 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.648 0.737 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -142.13 169.15 18.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.576 2.75 . . . . 0.0 108.823 176.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -51.59 -40.14 59.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 112.87 179.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.1 -62.36 1.94 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.598 0.759 . . . . 0.0 111.517 170.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -59.93 -31.03 69.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.673 0.789 . . . . 0.0 113.006 -176.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -62.11 -58.17 8.82 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.264 1.426 . . . . 0.0 110.509 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -58.31 -38.94 78.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.875 0.762 . . . . 0.0 112.623 177.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.97 -31.22 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.772 0.829 . . . . 0.0 112.223 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 m -72.55 -43.99 62.73 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.926 0.89 . . . . 0.0 112.233 171.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.05 -33.71 57.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 113.413 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.9 mt -99.55 101.56 13.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.75 1.62 . . . . 0.0 106.889 172.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.16 172.59 16.06 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.742 2.295 . . . . 0.0 112.148 -177.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.07 -23.15 31.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.309 1.043 . . . . 0.0 113.355 171.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -76.19 70.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.198 1.399 . . . . 0.0 109.29 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -122.36 24.93 0.11 Allowed Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -62.22 114.69 2.44 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.754 2.303 . . . . 0.0 112.13 -173.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.64 -17.2 30.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.013 1.768 . . . . 0.0 112.956 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.1 t -119.71 177.98 4.75 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.635 1.974 . . . . 0.0 111.646 177.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -94.24 157.69 15.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.252 2.621 . . . . 0.0 110.865 176.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -143.24 129.95 10.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 0.0 108.378 169.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.67 170.53 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.9 1.734 . . . . 0.0 113.221 177.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -137.7 145.63 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.477 3.111 . . . . 0.0 110.368 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -134.07 157.62 45.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.962 0.905 . . . . 0.0 112.504 -174.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -95.52 173.22 7.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.446 1.499 . . . . 0.0 112.798 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -62.43 -13.99 35.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.21 6.41 40.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.105 2.162 . . . . 0.0 111.379 175.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.55 5.78 38.69 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.643 1.592 . . . . 0.0 114.416 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -91.18 164.68 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.431 1.492 . . . . 0.0 109.289 178.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -64.7 130.74 44.71 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.7 138.61 77.25 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.988 176.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -48.12 -31.88 17.49 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.158 3.239 . . . . 0.0 116.13 -177.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.67 139.6 39.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 171.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -129.36 147.26 51.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.218 1.407 . . . . 0.0 108.871 169.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -139.15 125.48 20.28 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.4 68.17 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.3 168.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.21 -30.21 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.312 1.434 . . . . 0.0 114.409 -172.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 m -53.34 -24.87 13.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 173.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -122.03 10.16 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.963 1.705 . . . . 0.0 111.934 173.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.78 3.64 68.39 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.505 1.526 . . . . 0.0 115.006 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -81.59 149.51 28.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.206 1.503 . . . . 0.0 112.128 -169.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.2 m -138.42 160.6 39.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 111.43 168.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -150.71 163.5 38.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.154 1.782 . . . . 0.0 108.831 169.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.1 m -90.45 154.78 19.39 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 169.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.28 159.82 42.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.129 0.972 . . . . 0.0 111.363 175.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.77 159.98 72.81 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 165.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -24.32 31.7 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.627 2.884 . . . . 0.0 115.824 -173.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -78.22 -6.74 55.8 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.182 2.193 . . . . 0.0 115.289 174.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.92 56.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.594 1.569 . . . . 0.0 115.237 178.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -72.25 119.3 16.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.893 1.346 . . . . 0.0 109.984 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -59.28 144.88 45.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.739 1.215 . . . . 0.0 113.662 177.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.25 96.55 0.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.73 2.012 . . . . 0.0 106.239 168.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.81 24.01 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.853 1 C-N-CA 125.789 4.326 . . . . 0.0 117.26 -166.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -125.04 -1.25 7.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.149 1.78 . . . . 0.0 112.594 169.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -92.96 -14.41 27.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.047 0.939 . . . . 0.0 113.171 176.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -57.1 107.88 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.069 0.948 . . . . 0.0 112.102 -171.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 t -132.81 158.94 41.2 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.83 1.252 . . . . 0.0 112.374 -171.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 7.72 0.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 128.339 2.656 . . . . 0.0 113.408 169.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.65 -172.42 43.72 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.817 1.199 . . . . 0.0 114.099 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -58.11 154.11 13.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.67 2.388 . . . . 0.0 115.353 -169.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.87 158.39 37.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.063 1.345 . . . . 0.0 110.494 168.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.45 69.65 3.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.592 1.157 . . . . 0.0 110.577 -169.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.928 1.691 . . . . 0.0 113.938 -173.653 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 123.245 1.498 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.6 p -142.76 172.19 13.03 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 130.675 3.59 . . . . 0.0 112.483 -172.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.33 -39.71 32.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 0.0 111.991 169.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -58.71 -62.97 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.434 0.561 . . . . 0.0 110.949 175.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -62.45 -30.54 71.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.62 -58.59 7.49 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.118 1.367 . . . . 0.0 110.764 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -53.31 -48.14 68.67 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.639 0.775 . . . . 0.0 111.136 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.86 -26.3 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.412 1.085 . . . . 0.0 112.639 177.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -89.32 3.22 52.83 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.417 1.487 . . . . 0.0 114.652 171.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -130.93 -29.95 1.84 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.888 1.222 . . . . 0.0 113.905 -173.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.78 116.85 64.0 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.632 0.773 . . . . 0.0 109.105 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -70.16 162.92 40.5 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.877 1.718 . . . . 0.0 111.147 176.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.13 67.67 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.675 -0.641 . . . . 0.0 112.248 170.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -76.81 71.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.277 1.431 . . . . 0.0 109.15 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -114.73 30.19 0.12 Allowed Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 170.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.13 113.48 2.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.491 2.794 . . . . 0.0 112.173 -170.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.99 -16.34 27.92 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.093 1.806 . . . . 0.0 112.765 -174.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -115.93 171.93 7.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.67 1.588 . . . . 0.0 112.443 178.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -88.42 160.33 17.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.86 2.864 . . . . 0.0 111.611 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -141.96 123.16 8.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.08 0.952 . . . . 0.0 110.638 169.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.97 174.83 12.21 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.96 2.44 . . . . 0.0 113.525 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -140.2 149.46 42.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.335 2.254 . . . . 0.0 109.835 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -144.25 160.76 40.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.563 0.745 . . . . 0.0 112.437 -175.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -85.22 176.06 8.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.552 168.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.52 -29.49 66.33 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.319 1.047 . . . . 0.0 112.469 174.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -83.58 14.15 4.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.265 2.226 . . . . 0.0 111.92 -175.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.94 8.53 49.43 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.309 1.433 . . . . 0.0 114.43 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -91.42 146.65 23.63 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.562 1.181 . . . . 0.0 109.214 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -62.43 126.13 26.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.056 0.942 . . . . 0.0 108.919 177.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.3 143.73 79.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.386 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -50.22 -22.5 8.37 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.2 3.267 . . . . 0.0 117.489 -174.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.26 137.24 52.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.47 1.908 . . . . 0.0 109.598 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -130.68 147.2 52.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.846 1.259 . . . . 0.0 109.63 173.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -135.77 122.43 20.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -172.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.13 70.56 10.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.749 1.619 . . . . 0.0 108.057 169.034 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.31 -33.35 31.41 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.343 1.449 . . . . 0.0 114.562 -172.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m -54.73 -24.61 23.0 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 175.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -118.62 6.46 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.301 1.44 . . . . 0.0 112.022 174.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.94 67.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.299 1.428 . . . . 0.0 114.665 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -90.6 150.22 21.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.124 1.462 . . . . 0.0 112.121 -174.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.9 m -134.44 160.51 37.76 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.427 1.491 . . . . 0.0 110.078 168.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -144.45 163.21 34.47 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.169 1.787 . . . . 0.0 109.284 169.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.75 151.71 23.63 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 169.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.25 155.43 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.061 0.945 . . . . 0.0 111.307 172.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.57 159.91 76.01 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.3 -24.44 15.69 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.935 3.09 . . . . 0.0 117.102 -172.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -82.68 -4.77 58.29 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 175.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.77 -0.08 52.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.632 1.587 . . . . 0.0 114.772 -178.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.6 m -70.66 113.93 8.25 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.152 1.476 . . . . 0.0 110.222 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -55.61 136.7 50.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.06 109.76 19.21 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.3 156.48 50.73 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.729 2.286 . . . . 0.0 112.109 -169.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 m120 59.5 2.0 0.3 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.114 1.765 . . . . 0.0 115.52 -175.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -71.35 -30.95 66.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.639 1.563 . . . . 0.0 110.699 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.659 ' NH2' HH12 ' A' ' 57' ' ' ARG 0.279 0.0 OUTLIER -46.65 120.62 3.04 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 123.524 0.729 . . . . 0.0 111.98 -172.506 . . . . . . . . 4 4 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.9 m -151.87 164.73 36.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.784 1.233 . . . . 0.0 111.134 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.659 HH12 ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.98 17.29 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.337 2.655 . . . . 0.0 112.717 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.91 179.78 45.98 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.756 1.646 . . . . 0.0 112.745 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -67.0 167.04 12.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.759 1.623 . . . . 0.0 113.417 -176.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 166.69 32.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.789 1.236 . . . . 0.0 111.353 174.188 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.36 61.25 4.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.831 2.452 . . . . 0.0 112.289 -168.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.905 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.4 p -84.69 165.73 17.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.359 1.064 . . . . 0.0 112.71 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -51.6 -40.66 60.25 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.726 1.211 . . . . 0.0 113.029 172.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.01 -56.49 16.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.041 -0.412 . . . . 0.0 111.142 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.66 -31.24 69.36 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.41 -61.79 2.29 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.016 1.326 . . . . 0.0 110.082 169.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.67 -37.77 82.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.416 0.553 . . . . 0.0 112.461 -176.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.54 -27.44 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.568 1.147 . . . . 0.0 112.296 175.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -74.43 -41.39 60.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.587 -0.696 . . . . 0.0 111.47 168.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -69.29 -41.92 76.16 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.977 1.311 . . . . 0.0 112.8 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.71 108.95 18.55 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.61 167.29 27.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.915 1.744 . . . . 0.0 111.716 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.55 35.57 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.17 74.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.347 1.459 . . . . 0.0 108.272 169.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -112.98 65.53 0.92 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.965 1.306 . . . . 0.0 111.774 176.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -60.23 121.11 9.27 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.702 2.934 . . . . 0.0 111.734 -171.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.95 13.51 2.25 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.623 1.583 . . . . 0.0 114.98 -174.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.1 m -115.43 161.57 18.37 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.677 1.991 . . . . 0.0 112.373 -167.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -79.55 149.2 31.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.315 0.646 . . . . 0.0 111.513 179.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -144.79 127.64 8.39 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 108.624 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.45 168.52 17.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.581 1.52 . . . . 0.0 113.928 178.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -130.85 150.62 51.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.076 2.55 . . . . 0.0 110.867 173.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -128.93 155.54 45.15 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.552 1.141 . . . . 0.0 112.238 -175.202 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -90.76 176.84 6.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.59 1.556 . . . . 0.0 113.272 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.33 -16.13 31.97 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.86 9.56 38.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.186 1.795 . . . . 0.0 111.697 175.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 5.57 33.0 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.475 1.512 . . . . 0.0 114.432 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.63 166.17 13.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.839 1.256 . . . . 0.0 108.88 178.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -59.81 130.58 47.48 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.817 -0.552 . . . . 0.0 109.976 178.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.3 125.87 59.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.555 173.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.62 -18.57 6.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.641 2.894 . . . . 0.0 116.982 -175.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -111.48 135.31 52.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.655 1.982 . . . . 0.0 108.976 169.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -129.69 154.02 47.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.531 1.133 . . . . 0.0 109.127 169.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.6 m -141.22 159.35 42.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.939 0.895 . . . . 0.0 111.528 178.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.68 90.17 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.789 1.236 . . . . 0.0 109.904 175.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.11 -48.02 26.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.286 1.898 . . . . 0.0 116.052 -169.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -64.91 -13.41 56.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.095 1.447 . . . . 0.0 114.616 -175.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 pt -116.36 -0.45 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 112.812 170.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.01 4.43 55.4 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.867 1.699 . . . . 0.0 115.399 175.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -84.76 148.56 26.29 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.227 1.013 . . . . 0.0 112.811 -176.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -132.13 159.27 39.41 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.03 1.332 . . . . 0.0 109.75 166.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.1 p90 -151.76 160.92 43.41 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.318 1.447 . . . . 0.0 109.228 173.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.2 m -88.86 153.13 21.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 169.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.76 149.6 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.669 1.188 . . . . 0.0 110.587 175.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -70.22 155.96 92.6 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 165.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -14.56 38.27 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.796 2.331 . . . . 0.0 115.743 -169.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -78.34 -10.97 59.9 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.9 1.68 . . . . 0.0 114.204 171.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.21 -1.35 47.09 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.049 1.785 . . . . 0.0 115.183 -177.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.3 m -73.85 116.16 14.14 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.556 1.678 . . . . 0.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -57.11 145.02 32.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.699 1.2 . . . . 0.0 113.652 175.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.72 87.52 0.71 Allowed Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -64.27 -17.32 59.25 Favored 'Trans proline' 0 C--N 1.351 0.704 0 N-CA-C 118.169 2.334 . . . . 0.0 118.169 -165.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -68.23 -11.44 59.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.455 1.502 . . . . 0.0 113.184 172.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -90.83 -14.0 32.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.215 172.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -55.64 105.08 0.15 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.32 1.418 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m -133.63 166.19 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.79 1.236 . . . . 0.0 112.96 -168.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -70.12 12.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.105 3.362 . . . . 0.0 114.547 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.68 -176.64 41.14 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.38 1.943 . . . . 0.0 112.625 -172.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -61.27 163.13 6.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.338 1.855 . . . . 0.0 114.425 -171.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.19 165.21 37.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.256 1.422 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.11 63.76 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.084 2.154 . . . . 0.0 111.667 -168.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.237 0.396 0 CA-C-O 122.903 1.335 . . . . 0.0 112.129 -174.732 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.561 0.696 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -140.9 167.4 22.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 128.743 2.817 . . . . 0.0 108.637 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -52.75 -38.77 61.41 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.612 0.642 . . . . 0.0 112.169 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 t -58.52 -62.45 1.84 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.345 0.658 . . . . 0.0 111.416 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.52 -32.81 71.83 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.11 -58.99 6.07 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.432 1.493 . . . . 0.0 110.504 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.3 -39.87 84.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.771 0.714 . . . . 0.0 112.481 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.2 -32.26 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.939 0.896 . . . . 0.0 112.109 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -73.6 -45.26 54.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.915 0.886 . . . . 0.0 112.368 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -77.23 -34.06 56.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.045 1.338 . . . . 0.0 113.256 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.5 mt -92.58 102.76 7.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.45 167.56 25.0 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.111 1.874 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.24 -21.57 34.95 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.92 47.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.397 1.879 . . . . 0.0 111.075 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -88.8 -10.2 0.15 Allowed Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -42.31 114.11 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 124.373 3.382 . . . . 0.0 115.208 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.06 -11.25 22.51 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.698 2.094 . . . . 0.0 112.783 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.9 p -140.03 171.74 13.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.681 1.993 . . . . 0.0 112.364 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -81.67 152.2 27.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 111.233 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -142.42 127.55 10.28 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.387 1.475 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.39 176.35 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.296 1.997 . . . . 0.0 113.447 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -140.32 150.26 43.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.074 2.15 . . . . 0.0 110.005 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.59 157.94 43.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.718 0.807 . . . . 0.0 113.039 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -99.26 179.41 4.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.804 1.642 . . . . 0.0 114.125 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -2.1 0.88 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.934 2.094 . . . . 0.0 114.933 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -122.73 19.35 10.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.4 1.88 . . . . 0.0 111.158 173.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.29 5.4 28.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.055 1.312 . . . . 0.0 114.678 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.83 164.39 17.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.076 1.35 . . . . 0.0 108.495 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -62.14 127.55 31.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.26 125.55 50.96 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.867 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.25 -8.53 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.023 3.149 . . . . 0.0 118.088 -176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -119.46 127.31 52.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.539 2.335 . . . . 0.0 107.03 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -120.74 146.31 46.61 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.343 1.057 . . . . 0.0 109.394 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 90.2 m -135.39 124.12 23.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.694 0.798 . . . . 0.0 112.455 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.19 71.08 10.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.687 1.595 . . . . 0.0 108.034 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.62 -35.87 11.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.809 1.671 . . . . 0.0 114.603 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 m -54.61 -22.71 14.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.901 1.681 . . . . 0.0 115.11 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.67 -0.94 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.881 1.673 . . . . 0.0 112.351 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.07 69.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.104 1.811 . . . . 0.0 115.181 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -84.12 154.13 23.33 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.78 1.29 . . . . 0.0 110.896 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.3 m -137.86 165.31 26.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.719 0.808 . . . . 0.0 111.998 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -147.43 162.53 38.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.089 1.756 . . . . 0.0 109.378 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.8 m -86.05 153.64 21.98 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.37 156.77 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.741 0.816 . . . . 0.0 111.65 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.07 160.63 77.86 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 165.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.18 -26.48 26.59 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.374 2.716 . . . . 0.0 115.591 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -75.55 -8.27 56.32 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.752 2.021 . . . . 0.0 115.417 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.57 -3.08 59.17 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.386 1.469 . . . . 0.0 115.339 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 m -73.66 130.72 40.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.033 1.417 . . . . 0.0 109.727 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.75 139.7 57.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.864 0.865 . . . . 0.0 112.517 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.68 115.52 58.83 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.46 134.83 6.76 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.7 3.6 . . . . 0.0 116.062 -169.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 62.88 11.11 4.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.781 2.032 . . . . 0.0 114.755 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -77.7 -22.33 50.63 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.881 1.219 . . . . 0.0 111.724 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.69 103.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.466 1.107 . . . . 0.0 111.814 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -144.92 171.22 14.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.948 1.299 . . . . 0.0 113.018 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -3.93 2.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.199 3.4 . . . . 0.0 115.421 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.67 -172.87 42.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.422 1.487 . . . . 0.0 112.602 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -57.57 164.19 2.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.153 1.781 . . . . 0.0 114.281 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.5 167.1 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.105 1.362 . . . . 0.0 110.56 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.11 60.76 6.45 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 111.724 -168.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -68.89 170.79 9.02 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.251 0.548 . . . . 0.0 112.433 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 65' ' ' SER . 5.7 m -65.81 33.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 128.269 2.627 . . . . 0.0 116.34 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.64 4.08 0.12 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.652 2.781 . . . . 0.0 117.221 -169.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 63' ' ' SER . 36.6 m . . . . . 0 C--N 1.327 -0.399 0 C-N-CA 130.282 3.433 . . . . 0.0 114.038 167.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 120.681 0.277 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.5 p -84.92 166.1 17.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.335 1.054 . . . . 0.0 111.994 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -54.95 -35.87 64.7 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 t -59.74 -63.31 1.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.209 0.459 . . . . 0.0 110.591 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -56.55 -32.24 64.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.887 0.875 . . . . 0.0 113.151 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.34 -59.43 5.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.73 1.15 . . . . 0.0 110.665 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -56.96 -42.39 80.05 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -32.23 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.079 0.552 . . . . 0.0 111.896 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m -83.39 6.53 19.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.013 1.725 . . . . 0.0 114.379 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -125.31 -38.18 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 0.0 111.561 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.76 110.14 27.71 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.17 164.01 37.23 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.923 1.748 . . . . 0.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.64 -26.11 61.14 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.64 68.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.82 1.248 . . . . 0.0 109.002 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -102.46 8.76 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -41.86 111.54 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 123.871 3.047 . . . . 0.0 116.007 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.57 9.83 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.74 2.591 . . . . 0.0 112.435 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 t -111.48 165.69 11.77 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.481 1.913 . . . . 0.0 112.37 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -76.37 161.85 28.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.304 1.842 . . . . 0.0 107.354 164.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -147.9 125.46 5.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.428 1.491 . . . . 0.0 108.53 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.9 169.62 20.82 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.733 1.622 . . . . 0.0 113.289 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -135.94 143.66 45.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.757 3.223 . . . . 0.0 109.75 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -141.43 161.84 36.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.37 175.97 5.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.599 1.16 . . . . 0.0 112.896 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -63.84 -18.19 63.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.502 1.521 . . . . 0.0 114.429 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -84.48 11.0 9.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.344 1.057 . . . . 0.0 111.753 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.96 8.19 60.7 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.456 1.027 . . . . 0.0 114.12 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.1 157.43 16.75 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.88 1.272 . . . . 0.0 109.563 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -66.81 129.49 40.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mt -58.41 135.98 85.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.722 -1.132 . . . . 0.0 108.805 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.67 -17.98 11.07 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.443 2.762 . . . . 0.0 117.377 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.19 137.02 50.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.755 2.022 . . . . 0.0 109.157 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -131.1 152.53 50.3 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.596 1.158 . . . . 0.0 109.707 171.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -141.96 137.58 31.33 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.86 76.39 10.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.87 -28.05 38.46 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.265 1.412 . . . . 0.0 114.89 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -62.15 -21.7 65.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.908 1.283 . . . . 0.0 114.11 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -107.41 -26.86 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.224 1.81 . . . . 0.0 109.816 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.78 10.67 84.83 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.882 1.706 . . . . 0.0 112.918 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -84.53 135.67 34.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.685 1.594 . . . . 0.0 109.709 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -130.37 162.36 29.27 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -149.77 163.77 37.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.698 1.599 . . . . 0.0 109.436 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.2 m -86.94 152.42 22.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.75 151.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 110.654 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -71.94 156.51 90.85 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 166.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.2 -21.67 23.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.44 2.76 . . . . 0.0 116.429 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -76.87 -10.89 59.69 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.321 1.848 . . . . 0.0 114.703 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.56 -1.87 53.19 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.717 1.627 . . . . 0.0 115.363 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -74.39 122.08 22.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.873 1.836 . . . . 0.0 109.42 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.73 159.91 21.23 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.94 94.24 2.45 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 168.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.15 18.82 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 125.525 4.15 . . . . 0.0 117.823 -167.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.99 -5.1 10.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.954 2.101 . . . . 0.0 112.934 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 p -87.94 -17.51 31.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.385 1.074 . . . . 0.0 113.112 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -56.77 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.874 1.67 . . . . 0.0 112.455 -168.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -127.67 166.02 18.9 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.921 1.688 . . . . 0.0 114.203 -167.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 1.13 0.61 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.518 3.127 . . . . 0.0 115.517 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.33 -176.25 45.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.135 1.826 . . . . 0.0 112.745 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -60.23 165.07 3.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.567 1.947 . . . . 0.0 114.296 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 165.13 37.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.207 1.403 . . . . 0.0 110.848 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -82.26 58.19 3.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.993 2.117 . . . . 0.0 112.478 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -63.93 150.04 45.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.4 m -167.58 62.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.411 1.884 . . . . 0.0 109.303 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -78.17 50.95 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.003 1.321 . . . . 0.0 113.716 -169.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 124.897 1.279 . . . . 0.0 111.384 179.057 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.604 0.716 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -142.66 168.54 19.48 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 128.486 2.714 . . . . 0.0 108.936 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -56.99 -22.31 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 t -74.92 -61.32 1.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 110.66 169.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -30.72 67.48 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 112.991 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -59.66 5.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.604 1.562 . . . . 0.0 110.269 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.75 -35.87 81.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.89 -30.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.131 0.878 . . . . 0.0 112.092 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -74.27 -47.03 37.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 0.0 112.107 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -73.43 -30.61 63.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.257 1.423 . . . . 0.0 113.268 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.96 96.9 6.14 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.08 171.4 18.03 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.937 2.424 . . . . 0.0 112.243 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.17 -20.57 27.34 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.36 69.01 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.537 1.535 . . . . 0.0 109.274 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -127.67 -17.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -42.19 116.76 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 124.013 3.142 . . . . 0.0 115.003 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.28 -33.75 5.0 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.893 1.711 . . . . 0.0 111.091 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -111.15 170.66 7.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.171 2.189 . . . . 0.0 111.453 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -82.49 156.72 23.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.189 1.396 . . . . 0.0 111.647 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -144.81 130.82 9.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.521 1.928 . . . . 0.0 108.113 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.7 170.65 19.01 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.185 1.923 . . . . 0.0 113.929 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -137.89 151.73 48.32 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.21 2.204 . . . . 0.0 110.657 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -130.5 159.79 36.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 113.193 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -99.87 176.66 5.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.836 1.654 . . . . 0.0 113.552 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -14.62 36.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.984 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.39 13.89 28.15 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.584 1.554 . . . . 0.0 111.915 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.66 8.4 39.74 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.918 1.246 . . . . 0.0 114.226 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -89.99 164.67 14.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.809 1.243 . . . . 0.0 108.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.44 127.48 31.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mt -54.15 127.66 55.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.94 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -51.57 -21.73 11.33 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.237 2.624 . . . . 0.0 116.153 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.2 134.37 51.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.578 1.951 . . . . 0.0 108.952 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -126.71 149.73 49.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.456 1.103 . . . . 0.0 109.224 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.19 155.31 47.91 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.52 0.728 . . . . 0.0 112.059 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.21 75.92 1.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.063 2.145 . . . . 0.0 107.508 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.7 -44.01 47.38 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.537 1.541 . . . . 0.0 115.061 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 p -65.01 -9.39 21.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.38 -1.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.672 1.124 . . . . 0.0 112.488 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.91 62.26 5.39 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.216 0.912 . . . . 0.0 111.314 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -142.42 154.94 45.02 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.61 161.11 38.73 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.33 1.852 . . . . 0.0 110.458 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.37 163.77 36.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.198 170.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.3 m -89.93 152.29 21.3 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.48 155.2 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.903 1.281 . . . . 0.0 109.914 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -74.3 161.07 79.83 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 166.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.63 -24.22 22.16 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.899 3.066 . . . . 0.0 115.879 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -78.64 -6.28 55.25 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.686 1.994 . . . . 0.0 115.151 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.46 -2.86 59.25 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.596 1.57 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.7 m -73.08 117.93 15.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.903 1.352 . . . . 0.0 110.022 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.89 148.05 11.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.031 1.332 . . . . 0.0 113.579 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.22 92.48 1.22 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.15 23.2 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.827 1 C-N-CA 125.875 4.383 . . . . 0.0 117.795 -166.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -124.95 -2.17 7.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.971 1.708 . . . . 0.0 112.603 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 p -86.01 -19.61 30.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.152 0.981 . . . . 0.0 112.933 174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -45.54 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.835 2.054 . . . . 0.0 112.468 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 m -135.98 166.02 24.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 110.83 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.7 mmm-85 -76.36 6.51 5.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.8 -177.77 45.1 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.373 1.939 . . . . 0.0 112.105 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 114.65 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.04 167.2 31.17 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.825 1.65 . . . . 0.0 110.854 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.29 49.55 0.58 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.226 2.61 . . . . 0.0 114.181 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -56.1 107.87 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -118.77 25.2 10.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.524 1.93 . . . . 0.0 111.489 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.63 23.69 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.402 2.681 . . . . 0.0 116.048 -168.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 125.948 1.699 . . . . 0.0 111.762 -173.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.0 p -140.21 179.6 6.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.712 1.205 . . . . 0.0 111.745 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -21.62 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 131.192 3.797 . . . . 0.0 118.407 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.6 t -65.63 -51.21 61.34 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.589 -0.694 . . . . 0.0 110.668 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.72 -31.77 69.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.865 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.13 -54.23 41.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.699 1.136 . . . . 0.0 111.102 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.9 -44.31 86.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.295 0.498 . . . . 0.0 112.007 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.34 -27.1 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.127 0.971 . . . . 0.0 111.786 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -78.82 1.94 21.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.228 1.411 . . . . 0.0 113.963 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -126.4 -35.04 2.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.73 1.212 . . . . 0.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -88.25 109.33 27.57 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.501 1.92 . . . . 0.0 106.304 169.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.78 169.76 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.506 2.137 . . . . 0.0 111.937 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.2 -21.52 34.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.43 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.03 74.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.211 1.405 . . . . 0.0 108.591 169.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -116.4 61.79 2.33 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 124.816 1.247 . . . . 0.0 112.35 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.2 139.36 77.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.76 2.306 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.57 7.46 0.95 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.49 1.519 . . . . 0.0 115.624 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -134.44 176.24 8.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -112.95 140.34 47.85 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.547 1.539 . . . . 0.0 111.665 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -125.12 121.38 25.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.631 1.972 . . . . 0.0 108.297 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 172.24 2.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.766 2.311 . . . . 0.0 114.569 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 146.29 47.44 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.983 1.713 . . . . 0.0 109.441 169.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.76 160.79 39.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -165.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -73.51 173.93 8.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.864 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -61.43 -23.33 65.76 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.41 -9.77 58.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.536 1.934 . . . . 0.0 111.86 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.77 12.68 74.2 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.977 1.275 . . . . 0.0 114.67 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.5 155.46 18.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.455 1.128 . . . . 0.0 108.932 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -67.61 133.25 49.06 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.076 0.55 . . . . 0.0 110.183 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.46 142.05 91.12 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.2 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.89 -26.68 18.71 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.506 2.804 . . . . 0.0 116.4 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.94 45.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 0.0 109.935 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -123.15 144.28 49.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.54 1.136 . . . . 0.0 109.381 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.1 m -137.3 121.09 17.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.673 0.789 . . . . 0.0 112.192 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.43 66.92 9.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.131 1.773 . . . . 0.0 107.308 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.58 40.0 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.53 1.538 . . . . 0.0 114.381 -171.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -57.01 -20.11 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.096 1.758 . . . . 0.0 114.486 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 pt -121.59 2.36 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.785 1.634 . . . . 0.0 112.203 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.13 -4.03 78.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.667 2.079 . . . . 0.0 115.352 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.07 152.73 26.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.881 1.341 . . . . 0.0 112.293 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -139.95 164.47 29.91 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 112.586 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.39 163.77 38.2 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.426 1.89 . . . . 0.0 109.855 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.93 152.25 21.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.76 156.68 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.46 1.104 . . . . 0.0 111.108 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.82 160.07 72.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.56 -24.37 28.75 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.442 2.761 . . . . 0.0 116.256 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -75.84 -12.41 60.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.798 1.639 . . . . 0.0 114.608 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.17 -1.33 47.23 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.01 1.767 . . . . 0.0 115.099 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.8 m -71.34 118.32 13.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.784 1.792 . . . . 0.0 109.962 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.41 136.74 53.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.566 1.146 . . . . 0.0 113.167 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -83.88 110.53 26.11 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.87 158.35 43.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 65.11 -5.02 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.425 2.29 . . . . 0.0 115.218 -173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -78.15 -20.34 52.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.307 1.412 . . . . 0.0 111.773 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.95 91.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.981 1.713 . . . . 0.0 111.069 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -121.53 161.2 22.75 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.396 1.878 . . . . 0.0 113.643 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -13.02 5.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.255 2.622 . . . . 0.0 113.827 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.62 -177.2 36.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.294 0.95 . . . . 0.0 114.532 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -56.62 156.44 6.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.743 2.417 . . . . 0.0 114.737 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -155.87 167.67 29.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 108.316 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -112.11 61.68 0.62 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.278 -0.889 . . . . 0.0 112.489 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.3 m -52.24 106.66 0.16 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.824 1.65 . . . . 0.0 113.596 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 t 47.22 25.39 0.54 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.3 26.56 12.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.073 2.149 . . . . 0.0 113.682 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 126.918 2.087 . . . . 0.0 109.445 173.368 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.9 p -127.91 169.14 14.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.979 2.111 . . . . 0.0 110.632 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -38.99 -59.49 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 -49.93 75.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.589 0.631 . . . . 0.0 110.718 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -57.17 -40.62 77.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.524 0.73 . . . . 0.0 112.679 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.69 -57.34 13.1 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.924 0.89 . . . . 0.0 110.306 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.43 -36.85 81.51 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.84 -29.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.417 1.087 . . . . 0.0 112.124 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -72.26 -36.28 68.99 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.569 -0.707 . . . . 0.0 112.035 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -72.98 -46.77 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.602 1.161 . . . . 0.0 112.641 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -76.33 111.53 15.97 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.564 1.146 . . . . 0.0 108.081 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.46 151.82 75.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.113 1.875 . . . . 0.0 111.564 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.54 63.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.21 60.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.526 1.13 . . . . 0.0 109.54 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -90.54 -11.28 0.17 Allowed Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -42.51 128.41 4.7 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.828 3.019 . . . . 0.0 114.821 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.79 -24.59 30.9 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.791 1.662 . . . . 0.0 111.606 -168.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.9 p -123.28 162.65 22.24 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.67 1.988 . . . . 0.0 112.373 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.92 141.32 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.945 0.898 . . . . 0.0 111.08 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -136.47 118.89 11.79 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.286 1.834 . . . . 0.0 108.149 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.73 166.55 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.046 1.831 . . . . 0.0 115.868 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -118.84 142.55 47.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.792 2.837 . . . . 0.0 108.64 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -135.66 158.41 44.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.74 0.816 . . . . 0.0 112.8 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -98.75 -179.8 4.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.979 1.312 . . . . 0.0 113.906 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -62.43 -16.52 55.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -91.93 8.1 39.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.069 1.748 . . . . 0.0 111.929 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.12 2.45 18.59 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.021 1.772 . . . . 0.0 115.145 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.65 167.81 14.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.08 1.752 . . . . 0.0 108.932 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -59.42 133.49 56.14 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.119 -0.363 . . . . 0.0 110.362 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.85 139.04 95.61 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -53.57 -24.26 28.38 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.316 2.678 . . . . 0.0 116.394 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.01 139.01 42.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.019 1.728 . . . . 0.0 110.048 170.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -129.6 153.62 47.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.275 1.43 . . . . 0.0 109.792 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.7 m -141.2 157.5 45.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.968 0.907 . . . . 0.0 111.711 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.8 80.12 1.8 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.37 1.868 . . . . 0.0 107.808 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.05 -35.77 54.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.388 0.994 . . . . 0.0 114.235 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -62.76 -14.12 41.08 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.88 4.46 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.112 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.84 38.37 95.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.521 1.058 . . . . 0.0 113.515 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -128.03 152.25 48.17 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.7 m -136.2 159.63 41.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.03 1.732 . . . . 0.0 109.854 166.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -152.66 161.06 43.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.48 1.512 . . . . 0.0 109.387 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.31 152.14 22.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.906 -0.496 . . . . 0.0 109.933 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.08 154.4 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.412 1.085 . . . . 0.0 111.309 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -77.88 159.73 75.6 Favored Pre-proline 0 CA--C 1.554 1.112 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 166.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.44 -23.64 19.48 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.92 3.08 . . . . 0.0 117.555 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -85.37 -2.96 58.66 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.68 56.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.538 1.542 . . . . 0.0 114.82 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.7 m -69.35 109.59 4.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.693 1.247 . . . . 0.0 109.537 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -57.93 143.27 43.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 113.655 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.21 90.59 0.62 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -60.93 -24.06 78.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.908 2.405 . . . . 0.0 117.706 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -66.72 -12.0 56.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.027 2.131 . . . . 0.0 113.272 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -94.04 -10.01 34.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 117.438 -1.268 . . . . 0.0 113.297 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -59.89 106.08 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.312 1.414 . . . . 0.0 111.436 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 t -145.06 172.55 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.694 0.798 . . . . 0.0 113.094 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -65.5 1.5 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.568 3.547 . . . . 0.0 116.023 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.12 -177.74 41.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.69 1.614 . . . . 0.0 112.882 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -55.97 157.14 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.544 1.938 . . . . 0.0 114.139 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 164.73 38.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 111.147 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -85.48 65.46 9.19 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.553 1.541 . . . . 0.0 111.603 -169.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 66.3 m -58.8 157.35 9.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.291 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.4 p 52.71 27.09 4.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 55.3 29.99 13.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.003 2.121 . . . . 0.0 113.678 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.467 0.414 0 C-N-CA 125.028 1.331 . . . . 0.0 110.769 175.325 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.573 0.701 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.5 p -139.11 171.46 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 128.032 2.533 . . . . 0.0 108.73 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -53.89 -35.38 61.54 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.595 -0.691 . . . . 0.0 112.276 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.0 -62.32 1.86 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.535 0.734 . . . . 0.0 111.234 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -59.8 -33.16 71.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.397 0.544 . . . . 0.0 112.369 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.92 -60.36 3.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.868 1.267 . . . . 0.0 109.758 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.71 -29.19 70.44 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.28 -32.89 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.853 0.861 . . . . 0.0 111.337 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.5 p -80.03 -28.92 39.25 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.17 -48.69 64.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.184 0.902 . . . . 0.0 111.099 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.7 112.78 53.86 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.451 1.1 . . . . 0.0 108.523 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.19 164.8 34.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.019 1.813 . . . . 0.0 111.215 173.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.16 46.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 t -77.02 72.51 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.942 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -117.5 26.61 0.11 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 174.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.59 116.4 3.51 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.854 2.37 . . . . 0.0 112.148 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.75 -13.42 53.52 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.315 1.436 . . . . 0.0 113.147 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -119.62 176.85 5.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.444 1.898 . . . . 0.0 111.767 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -91.71 159.32 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.061 2.544 . . . . 0.0 110.633 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -143.16 130.91 11.03 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.588 1.555 . . . . 0.0 109.014 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.55 168.59 24.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.335 2.023 . . . . 0.0 112.37 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.575 1.95 . . . . 0.0 110.424 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -128.55 153.67 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.797 1.239 . . . . 0.0 112.97 -169.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -87.54 178.58 6.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.532 1.533 . . . . 0.0 113.264 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pm0 -62.98 -12.73 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -99.82 13.01 35.23 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.149 1.78 . . . . 0.0 111.834 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 3.87 22.36 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.631 1.586 . . . . 0.0 114.708 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.69 166.06 16.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.066 1.746 . . . . 0.0 108.606 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -58.88 130.91 49.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.76 0.709 . . . . 0.0 109.794 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.41 119.99 16.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.826 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.45 -9.09 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.759 2.972 . . . . 0.0 116.912 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.56 124.01 48.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.146 2.178 . . . . 0.0 107.218 167.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.2 145.19 48.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.789 0.836 . . . . 0.0 109.399 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.0 m -136.55 126.51 25.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.748 0.819 . . . . 0.0 112.276 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -83.74 70.31 10.33 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.46 -35.87 29.64 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.624 1.583 . . . . 0.0 114.222 -170.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.3 m -53.28 -22.89 7.75 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.45 1.5 . . . . 0.0 114.733 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.59 2.41 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.739 1.616 . . . . 0.0 112.814 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.75 80.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.34 1.448 . . . . 0.0 115.593 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -84.49 147.2 27.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.717 1.258 . . . . 0.0 112.312 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 m -133.69 163.47 29.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.735 1.214 . . . . 0.0 112.117 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -146.81 161.92 39.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.572 1.949 . . . . 0.0 108.384 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.0 m -86.22 153.18 22.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.82 153.57 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.529 1.132 . . . . 0.0 110.223 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -74.14 160.72 80.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.4 -25.73 25.57 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.44 2.76 . . . . 0.0 115.944 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -75.95 -10.15 59.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.059 1.743 . . . . 0.0 114.856 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.52 -1.78 57.2 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.582 1.563 . . . . 0.0 115.395 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.6 m -75.0 127.99 34.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.896 1.848 . . . . 0.0 109.755 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -57.47 139.84 52.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.35 111.48 31.53 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 168.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -49.88 148.91 11.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.884 3.056 . . . . 0.0 114.679 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.73 6.63 0.9 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.126 1.77 . . . . 0.0 115.412 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 p -74.38 -26.03 59.86 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.949 1.25 . . . . 0.0 111.36 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.601 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -42.42 109.21 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.382 1.873 . . . . 0.0 111.213 -177.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -142.53 164.7 29.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.923 1.289 . . . . 0.0 111.653 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.601 ' NH1' HH22 ' A' ' 55' ' ' ARG . 4.7 mpt_? -77.97 16.28 0.75 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.919 2.488 . . . . 0.0 112.958 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -178.71 47.59 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.27 1.891 . . . . 0.0 112.293 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -65.27 167.53 8.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.131 1.772 . . . . 0.0 114.128 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 166.03 34.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.036 1.334 . . . . 0.0 111.258 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -84.97 63.48 8.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.082 2.153 . . . . 0.0 112.039 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.0 m -66.65 164.35 17.02 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.5 p -70.38 72.75 0.49 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.251 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.63 68.9 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 130.021 3.328 . . . . 0.0 115.913 -169.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.468 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 110.63 168.249 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 123.176 1.465 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -143.54 163.97 31.69 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 130.684 3.593 . . . . 0.0 109.584 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -52.59 -42.2 64.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.629 0.649 . . . . 0.0 112.38 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 t -56.53 -61.33 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.498 0.719 . . . . 0.0 111.18 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.92 -34.0 74.01 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.34 -56.18 23.36 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.373 1.469 . . . . 0.0 111.021 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -58.61 -41.88 86.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.312 0.505 . . . . 0.0 112.011 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -62.83 -31.89 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.002 0.921 . . . . 0.0 111.896 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -83.35 4.49 27.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.99 1.716 . . . . 0.0 114.099 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -126.01 -34.78 2.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 0.0 112.057 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -96.9 105.48 24.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.38 171.08 18.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.651 2.234 . . . . 0.0 112.117 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.58 -23.74 42.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.223 1.009 . . . . 0.0 113.502 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.06 76.46 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 108.095 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -115.53 47.93 0.53 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.74 130.08 28.4 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.701 2.267 . . . . 0.0 111.067 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.28 -9.05 50.28 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.383 1.468 . . . . 0.0 114.337 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -120.78 160.53 23.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.482 1.641 . . . . 0.0 113.208 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -77.52 162.99 26.71 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 165.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -147.88 129.75 7.46 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.358 2.263 . . . . 0.0 107.035 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.91 170.84 15.81 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.685 1.59 . . . . 0.0 113.067 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -141.38 148.24 39.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.87 2.068 . . . . 0.0 109.559 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.9 m -135.13 157.58 46.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -101.83 177.37 4.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.683 1.593 . . . . 0.0 113.611 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.77 -14.51 33.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.748 1.619 . . . . 0.0 115.034 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -98.1 13.27 31.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.505 1.522 . . . . 0.0 111.906 171.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.51 37.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.968 1.27 . . . . 0.0 114.334 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -88.33 164.68 15.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.166 1.387 . . . . 0.0 108.918 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.79 126.67 28.34 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.84 131.11 57.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.09 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -48.21 -18.76 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.971 3.781 . . . . 0.0 117.355 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.8 131.68 56.87 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.045 2.138 . . . . 0.0 108.439 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -121.87 146.52 47.02 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 109.289 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.1 m -136.13 119.94 17.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 68.21 9.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.814 1.646 . . . . 0.0 106.823 168.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.66 54.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.227 -1.351 . . . . 0.0 114.149 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.32 -10.53 16.74 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.0 pt -124.34 8.47 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.356 1.462 . . . . 0.0 111.764 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.43 5.45 72.74 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.308 1.432 . . . . 0.0 115.041 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HH ' ' NH2' ' A' ' 55' ' ' ARG . 3.9 m-85 -84.82 146.69 27.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.195 1.498 . . . . 0.0 112.776 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.08 157.24 47.15 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.11 1.364 . . . . 0.0 109.943 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -144.52 163.15 34.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.456 1.502 . . . . 0.0 109.406 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.1 m -86.03 150.75 24.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.159 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.8 157.01 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.92 0.888 . . . . 0.0 111.151 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -77.84 159.61 75.97 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 165.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.98 -24.29 24.25 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.585 2.857 . . . . 0.0 116.297 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -76.87 -10.36 59.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.14 1.776 . . . . 0.0 114.663 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.96 52.8 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.776 1.655 . . . . 0.0 115.334 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -71.83 116.19 11.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.962 1.881 . . . . 0.0 110.325 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.45 137.18 57.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.332 1.053 . . . . 0.0 113.694 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.22 109.07 16.74 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 168.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.86 158.77 45.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.569 2.18 . . . . 0.0 112.074 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 61.22 -0.47 0.34 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.695 1.998 . . . . 0.0 115.547 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -71.26 -29.17 64.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.431 1.468 . . . . 0.0 110.667 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.583 ' NH2' ' HH ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -43.57 95.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.199 2.2 . . . . 0.0 113.969 -174.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 58' ' ' GLY . 50.7 m -125.27 162.34 24.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.205 1.802 . . . . 0.0 111.863 -170.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.569 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -72.42 18.61 0.09 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.622 2.769 . . . . 0.0 112.597 175.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 56' ' ' SER . . . 178.33 -179.76 48.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.434 1.493 . . . . 0.0 113.249 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.25 163.24 13.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.093 1.757 . . . . 0.0 113.515 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 161.38 41.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.474 1.109 . . . . 0.0 111.818 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.13 67.96 9.92 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 111.242 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.438 ' C ' ' H ' ' A' ' 64' ' ' GLU . 72.6 m -53.17 122.54 9.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 p -64.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 128.555 2.742 . . . . 0.0 116.151 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 62' ' ' CYS . 15.1 mp0 -123.81 10.04 8.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 127.249 2.22 . . . . 0.0 112.066 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.463 0.208 0 C-N-CA 127.441 2.297 . . . . 0.0 111.018 -176.421 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.465 0.174 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -84.38 168.19 15.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.954 0.902 . . . . 0.0 112.439 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -54.98 -39.94 69.53 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.622 -0.673 . . . . 0.0 112.031 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -59.64 -57.54 12.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.698 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -58.47 -38.47 77.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.262 0.625 . . . . 0.0 112.632 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -59.96 4.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.679 1.192 . . . . 0.0 110.5 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.64 -41.94 82.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.589 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.83 -33.02 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.252 0.621 . . . . 0.0 111.938 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -81.72 -0.88 44.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.504 1.522 . . . . 0.0 114.561 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -126.23 -31.64 2.79 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.544 1.065 . . . . 0.0 112.394 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.99 108.07 38.54 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.97 169.09 23.4 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.442 2.094 . . . . 0.0 111.746 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.28 27.05 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.347 1.059 . . . . 0.0 113.576 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 t -86.25 76.48 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 108.058 169.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -111.03 70.87 0.72 Allowed Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.078 1.351 . . . . 0.0 111.589 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.22 134.92 47.85 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.975 2.45 . . . . 0.0 110.973 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.84 8.5 0.6 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.184 1.849 . . . . 0.0 116.163 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 p -131.32 168.07 18.18 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.613 1.565 . . . . 0.0 112.913 -168.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.85 152.26 20.82 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.088 1.355 . . . . 0.0 111.763 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -138.53 129.82 15.49 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.59 1.956 . . . . 0.0 107.632 169.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.41 176.1 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.835 1.69 . . . . 0.0 113.015 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -139.68 150.34 44.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.849 2.059 . . . . 0.0 109.637 174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -135.23 158.73 43.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -97.37 -179.31 4.45 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.856 1.663 . . . . 0.0 113.981 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -3.17 0.99 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.622 1.969 . . . . 0.0 114.924 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -123.24 19.47 9.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.96 . . . . 0.0 111.193 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 7.62 29.24 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.277 1.417 . . . . 0.0 114.732 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -85.62 162.81 18.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.751 1.22 . . . . 0.0 108.629 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -63.29 126.84 28.76 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 122.009 -0.432 . . . . 0.0 109.9 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.08 132.28 68.34 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.179 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.34 -17.3 4.0 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.899 3.066 . . . . 0.0 116.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -113.14 131.24 55.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.639 1.976 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.32 147.62 45.43 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.493 1.117 . . . . 0.0 109.396 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.1 m -138.66 122.75 17.97 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.721 0.772 . . . . 0.0 112.482 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.8 69.87 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.666 1.586 . . . . 0.0 106.911 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.84 -35.3 47.04 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.437 1.494 . . . . 0.0 113.778 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -62.65 -11.9 19.93 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.42 -4.44 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.43 1.492 . . . . 0.0 111.553 167.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.14 58.18 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.32 1.914 . . . . 0.0 114.829 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -113.09 152.17 29.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.697 1.749 . . . . 0.0 111.751 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -135.95 165.1 26.44 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.935 0.894 . . . . 0.0 112.51 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -148.93 163.59 37.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 109.34 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 70.9 m -87.23 151.38 23.21 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.02 157.63 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.058 0.943 . . . . 0.0 111.108 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.11 160.69 72.97 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -22.08 23.4 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.508 2.806 . . . . 0.0 116.562 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -79.08 -9.9 59.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.054 1.741 . . . . 0.0 114.517 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.84 55.89 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.612 1.577 . . . . 0.0 115.221 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.2 m -73.17 122.59 22.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.978 1.889 . . . . 0.0 110.04 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.28 137.27 57.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.011 . . . . 0.0 113.52 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -84.1 109.56 19.97 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.24 158.21 41.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.797 2.332 . . . . 0.0 112.948 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 65.18 -0.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.488 2.315 . . . . 0.0 115.098 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.4 p -81.16 -19.11 44.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.102 1.319 . . . . 0.0 112.172 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.44 98.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.276 1.43 . . . . 0.0 110.408 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 t -140.72 170.96 14.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -168.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -63.2 -1.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.636 1 C-N-CA 132.273 4.229 . . . . 0.0 114.655 -171.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.43 -174.8 47.25 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.158 1.361 . . . . 0.0 112.595 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -55.78 157.36 4.29 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.084 1.754 . . . . 0.0 113.421 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.35 171.84 19.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.982 1.313 . . . . 0.0 110.485 175.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -105.98 82.4 1.77 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.017 1.327 . . . . 0.0 110.286 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.4 m -65.32 -172.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.238 1.815 . . . . 0.0 112.637 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -64.7 51.63 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.819 2.048 . . . . 0.0 113.623 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.65 32.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.895 2.878 . . . . 0.0 114.514 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.1 p . . . . . 0 C--O 1.235 0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 110.959 178.262 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.903 0.382 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 p -83.83 166.25 18.1 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.522 1.129 . . . . 0.0 110.586 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.0 -39.89 66.48 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.369 -0.832 . . . . 0.0 112.291 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.6 t -58.38 -61.8 2.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.625 0.77 . . . . 0.0 111.265 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -62.01 -34.25 75.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.908 -0.568 . . . . 0.0 112.251 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.47 -59.55 4.98 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.746 1.218 . . . . 0.0 110.194 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -54.76 -47.84 73.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.755 0.422 . . . . 0.0 111.339 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.52 -28.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.868 0.867 . . . . 0.0 112.513 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.9 p -80.27 -2.29 44.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -131.42 -24.66 2.25 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -170.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.45 116.78 63.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.642 1.11 . . . . 0.0 109.542 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.31 163.05 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.929 1.753 . . . . 0.0 111.246 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.71 67.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.549 -0.72 . . . . 0.0 112.564 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.04 74.58 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.424 1.49 . . . . 0.0 108.498 170.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -111.41 63.68 0.53 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.73 1.212 . . . . 0.0 112.036 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.81 136.44 53.35 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.499 2.8 . . . . 0.0 110.949 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.28 13.79 0.77 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.274 1.416 . . . . 0.0 115.412 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -124.52 155.08 39.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.915 1.358 . . . . 0.0 113.173 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -75.97 157.45 33.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.545 1.538 . . . . 0.0 112.206 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -142.53 115.7 6.31 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 110.539 168.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.45 169.89 20.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.091 1.861 . . . . 0.0 113.422 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -136.81 143.18 43.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.155 2.982 . . . . 0.0 109.295 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.33 159.82 39.84 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.557 1.071 . . . . 0.0 113.02 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -95.81 174.93 6.71 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.653 1.581 . . . . 0.0 112.91 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -59.67 -20.93 59.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.463 1.105 . . . . 0.0 113.731 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.68 6.04 25.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.011 2.124 . . . . 0.0 111.636 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.5 7.09 38.28 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.628 1.585 . . . . 0.0 114.443 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.27 162.24 15.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.116 1.366 . . . . 0.0 109.32 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -61.71 126.8 28.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -55.64 138.2 69.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.854 -1.07 . . . . 0.0 108.652 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.85 -27.53 16.03 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.219 2.613 . . . . 0.0 115.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.49 135.47 45.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.533 1.533 . . . . 0.0 109.645 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -125.63 149.99 47.94 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.711 1.204 . . . . 0.0 109.018 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -137.78 153.49 49.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.662 1.22 . . . . 0.0 112.704 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.76 66.76 1.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.379 2.672 . . . . 0.0 106.096 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.78 -31.56 54.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.99 1.281 . . . . 0.0 113.598 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -60.13 -12.58 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.429 1.491 . . . . 0.0 114.791 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 pt -126.72 6.69 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 126.204 1.801 . . . . 0.0 111.693 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.69 7.95 87.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 0.0 115.556 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.99 156.96 16.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.667 1.733 . . . . 0.0 114.282 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.5 m -144.23 157.67 44.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.481 1.912 . . . . 0.0 109.93 166.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -148.49 164.62 33.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.79 1.636 . . . . 0.0 109.308 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.59 153.51 20.71 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.2 159.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.079 1.352 . . . . 0.0 110.66 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -79.33 161.28 68.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 165.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -52.04 -25.24 21.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.728 2.952 . . . . 0.0 116.32 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -78.22 -7.65 57.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.164 1.785 . . . . 0.0 115.301 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.63 -1.97 52.93 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.811 1.672 . . . . 0.0 114.984 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -71.12 113.77 8.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.963 1.382 . . . . 0.0 110.489 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -56.72 134.22 54.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.763 1.225 . . . . 0.0 113.709 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.63 111.37 31.49 Favored Pre-proline 0 C--O 1.241 0.61 0 C-N-CA 125.655 1.582 . . . . 0.0 107.131 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.49 161.41 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.64 2.227 . . . . 0.0 111.915 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.44 -2.55 0.12 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.359 1.864 . . . . 0.0 115.894 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.8 p -72.12 -31.51 66.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.46 1.482 . . . . 0.0 110.275 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -46.16 99.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.238 2.215 . . . . 0.0 112.834 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -129.77 165.91 20.97 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.741 1.616 . . . . 0.0 111.478 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 23.33 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.527 2.331 . . . . 0.0 111.927 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.56 -174.17 45.57 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.675 1.131 . . . . 0.0 114.438 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -61.43 152.51 29.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.886 2.474 . . . . 0.0 115.454 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 158.62 44.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.749 168.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -85.97 61.31 6.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.822 1.249 . . . . 0.0 112.607 -167.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.6 m -56.44 110.5 0.78 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.408 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.5 m -108.85 18.7 20.46 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 113.667 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -75.34 26.1 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.415 2.286 . . . . 0.0 113.472 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 126.878 2.071 . . . . 0.0 111.665 -171.29 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 121.519 0.675 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 p -138.6 172.69 12.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.208 2.603 . . . . 0.0 108.407 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -52.19 -38.1 56.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.194 0.598 . . . . 0.0 112.327 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.4 t -63.8 -58.18 7.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.357 0.663 . . . . 0.0 111.316 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -58.9 -35.05 72.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.3 -60.59 3.57 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.127 1.371 . . . . 0.0 110.398 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.43 -37.17 80.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.11 -31.26 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.78 0.832 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -72.16 -41.56 66.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.728 . . . . 0.0 112.387 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -74.73 -40.65 61.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.045 1.338 . . . . 0.0 112.986 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.1 mm -89.04 110.4 37.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.5 168.11 25.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.206 1.938 . . . . 0.0 111.452 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.51 -18.5 29.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.72 78.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.229 1.411 . . . . 0.0 107.666 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -114.86 53.62 0.75 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.764 1.225 . . . . 0.0 113.779 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -62.33 131.5 34.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 -5.47 3.83 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.613 -1.104 . . . . 0.0 115.673 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -113.93 156.4 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.737 1.768 . . . . 0.0 113.0 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -73.1 161.57 30.47 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -147.56 124.6 5.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 126.678 1.991 . . . . 0.0 108.404 168.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.64 172.03 16.59 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.749 1.632 . . . . 0.0 114.049 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -135.91 144.31 45.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.727 3.211 . . . . 0.0 110.102 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -137.81 160.32 39.6 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -103.69 178.7 4.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.901 1.681 . . . . 0.0 114.23 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.64 0.15 1.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.53 1.932 . . . . 0.0 114.656 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.93 19.27 10.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.6 8.65 40.65 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.026 1.298 . . . . 0.0 114.555 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.09 164.25 14.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.69 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.95 127.43 31.22 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.03 135.46 84.01 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 117.678 -1.153 . . . . 0.0 108.472 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -52.85 -10.21 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.49 2.793 . . . . 0.0 117.41 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.88 137.79 51.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.284 1.834 . . . . 0.0 109.227 167.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -129.79 145.58 51.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 109.056 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 98.0 m -137.15 119.02 15.19 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.635 0.731 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.3 66.09 9.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.453 1.501 . . . . 0.0 107.335 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.53 -32.16 45.46 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.195 1.379 . . . . 0.0 113.786 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 m -60.43 -12.52 9.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.325 1.45 . . . . 0.0 114.913 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.59 7.63 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.286 1.834 . . . . 0.0 111.697 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.69 -2.95 77.08 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.192 1.853 . . . . 0.0 115.41 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HH ' ' NH1' ' A' ' 57' ' ' ARG . 6.7 m-85 -83.06 151.66 25.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.133 1.466 . . . . 0.0 113.304 -169.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.74 160.72 39.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.043 0.937 . . . . 0.0 111.056 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -152.06 164.67 36.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.58 1.552 . . . . 0.0 108.817 169.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.44 154.5 17.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 110.571 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.36 157.96 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.768 0.827 . . . . 0.0 111.695 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.95 159.73 70.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.41 -21.23 17.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.067 3.178 . . . . 0.0 117.683 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -84.93 -4.44 59.12 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.79 1.636 . . . . 0.0 114.791 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.61 1.01 55.39 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.712 1.625 . . . . 0.0 114.641 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.1 m -71.75 115.75 11.31 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.902 1.351 . . . . 0.0 109.96 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -60.41 144.79 50.13 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.73 89.67 0.66 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.598 2.359 . . . . 0.0 104.818 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.54 -14.09 42.45 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.796 2.33 . . . . 0.0 117.583 -166.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -67.35 -10.86 55.17 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 127.107 2.163 . . . . 0.0 113.234 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -107.37 2.31 24.31 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.09 1.756 . . . . 0.0 112.545 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -62.83 94.17 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.403 1.001 . . . . 0.0 110.916 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -129.98 161.1 31.68 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -168.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.62 ' NH1' ' HH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -77.34 10.07 2.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.063 2.545 . . . . 0.0 113.146 -173.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.58 -179.22 48.31 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.406 1.955 . . . . 0.0 112.234 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.68 157.46 9.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.486 1.914 . . . . 0.0 114.484 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -155.17 168.91 25.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.564 2.745 . . . . 0.0 106.145 168.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -111.22 34.64 3.95 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -163.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m -57.16 105.73 0.25 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.627 -0.67 . . . . 0.0 112.029 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t 54.29 19.31 2.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -106.7 12.34 29.31 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.47 0.54 0 C-N-CA 128.394 2.678 . . . . 0.0 114.056 177.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -82.89 166.86 18.57 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 111.314 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -53.51 -41.28 66.16 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.595 -0.691 . . . . 0.0 111.916 171.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.79 -60.21 4.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.309 0.644 . . . . 0.0 110.753 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.95 -39.09 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.351 0.66 . . . . 0.0 112.599 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.21 -56.82 16.86 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.878 1.271 . . . . 0.0 110.928 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -56.57 -43.76 80.32 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.42 0.554 . . . . 0.0 111.571 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.14 -34.97 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.537 0.735 . . . . 0.0 111.67 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -83.82 2.95 35.8 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.04 1.736 . . . . 0.0 114.318 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.58 -34.13 2.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.264 1.026 . . . . 0.0 112.392 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -89.13 113.69 57.25 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.32 163.82 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.237 1.958 . . . . 0.0 111.41 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -22.72 50.73 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.81 73.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.89 1.276 . . . . 0.0 108.66 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -110.9 35.51 0.12 Allowed Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.24 133.66 11.87 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.643 2.229 . . . . 0.0 113.546 169.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.75 -10.81 36.9 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.284 1.421 . . . . 0.0 114.617 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -130.08 173.29 10.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.733 1.767 . . . . 0.0 113.857 -170.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -94.17 152.87 18.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.524 2.329 . . . . 0.0 110.608 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -139.84 123.58 10.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.514 1.526 . . . . 0.0 108.606 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.99 175.95 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.3 2.0 . . . . 0.0 113.094 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 148.18 31.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.343 2.257 . . . . 0.0 109.519 173.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.7 158.42 44.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.83 0.852 . . . . 0.0 113.143 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -91.42 -175.96 4.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.652 1.581 . . . . 0.0 113.414 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -61.56 -16.8 51.23 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -91.48 -5.83 53.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.342 1.457 . . . . 0.0 112.103 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.79 81.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.11 0.862 . . . . 0.0 113.827 -169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -77.9 152.47 33.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.154 1.477 . . . . 0.0 109.478 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -55.41 125.39 20.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.966 0.506 . . . . 0.0 109.723 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.64 142.99 69.77 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.434 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -49.69 -22.89 7.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.567 3.512 . . . . 0.0 117.684 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.06 136.76 52.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.867 2.067 . . . . 0.0 109.406 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -130.03 152.57 49.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.233 1.013 . . . . 0.0 109.321 169.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.54 129.99 20.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.52 73.6 10.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.854 1.662 . . . . 0.0 106.528 168.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -46.59 -43.09 15.01 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.66 1.6 . . . . 0.0 114.258 -170.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 t -63.05 -8.83 8.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.3 pt -126.46 0.38 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.644 1.578 . . . . 0.0 112.44 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.6 7.19 85.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.538 1.066 . . . . 0.0 115.214 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -82.2 128.87 34.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.377 1.589 . . . . 0.0 110.532 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.02 158.77 25.15 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.903 0.881 . . . . 0.0 110.426 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -150.24 160.21 43.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.669 1.588 . . . . 0.0 108.676 171.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -86.18 155.06 20.89 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.28 154.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 122.016 0.912 . . . . 0.0 112.806 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.34 158.78 76.23 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 166.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 -8.36 17.09 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.693 2.262 . . . . 0.0 115.658 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -85.21 -12.14 53.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.306 1.843 . . . . 0.0 114.2 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.71 -2.07 52.68 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.907 1.717 . . . . 0.0 115.543 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.3 m -74.69 133.24 42.1 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.93 1.865 . . . . 0.0 109.068 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.35 155.22 40.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.73 111.53 35.76 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 125.822 1.649 . . . . 0.0 106.643 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.49 150.25 11.92 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.76 . . . . 0.0 113.646 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 61.84 1.5 0.63 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.508 1.923 . . . . 0.0 115.671 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 p -74.23 -28.5 61.27 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.398 1.454 . . . . 0.0 111.012 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -43.8 103.02 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.149 2.18 . . . . 0.0 112.136 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 58' ' ' GLY . 50.1 m -138.26 162.45 34.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.408 1.083 . . . . 0.0 112.453 -169.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.07 13.72 0.1 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.803 3.241 . . . . 0.0 114.314 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 56' ' ' SER . . . 165.73 -169.65 40.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.194 1.854 . . . . 0.0 113.46 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -57.49 152.39 14.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.444 2.298 . . . . 0.0 115.392 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.45 155.91 39.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.637 1.575 . . . . 0.0 108.987 168.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -94.43 70.64 3.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.52 1.128 . . . . 0.0 110.638 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.18 111.81 0.85 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.374 1.47 . . . . 0.0 112.913 -176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.7 p -71.32 70.94 0.61 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.982 1.713 . . . . 0.0 112.425 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 54.78 24.15 5.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.68 1.992 . . . . 0.0 114.406 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 128.163 2.585 . . . . 0.0 113.549 -170.272 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.478 0.18 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 p -84.37 171.1 12.94 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -53.79 -41.76 67.6 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.978 1.311 . . . . 0.0 112.035 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.51 -57.74 11.64 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.289 0.636 . . . . 0.0 110.622 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -60.52 -35.45 76.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 112.634 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.94 -57.15 14.1 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.78 1.232 . . . . 0.0 110.624 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -57.4 -42.32 82.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.345 0.521 . . . . 0.0 111.875 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.96 -32.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 111.857 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -86.39 6.83 28.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.562 1.945 . . . . 0.0 114.187 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.04 -37.8 2.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.669 1.188 . . . . 0.0 111.55 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -92.44 107.68 25.53 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.73 171.16 18.71 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.536 2.158 . . . . 0.0 111.694 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.3 -21.97 38.59 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -84.71 76.84 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.284 1.434 . . . . 0.0 108.106 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -114.36 63.19 1.28 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.903 1.281 . . . . 0.0 112.69 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 138.55 68.46 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 111.594 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 55.35 10.85 3.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.708 1.623 . . . . 0.0 114.432 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -126.75 161.13 28.87 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.668 1.234 . . . . 0.0 113.242 -167.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -83.72 157.14 22.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.329 1.451 . . . . 0.0 111.294 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -143.48 129.67 10.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.954 1.702 . . . . 0.0 108.083 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.21 175.07 10.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.101 1.867 . . . . 0.0 112.747 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -142.99 149.31 38.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.386 1.875 . . . . 0.0 109.329 172.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.97 158.85 43.26 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.35 1.06 . . . . 0.0 111.563 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -98.76 -174.86 2.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.294 1.037 . . . . 0.0 113.495 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -22.45 56.03 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.15 -8.66 59.02 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.172 0.589 . . . . 0.0 111.807 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.41 4.27 84.02 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.354 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.76 160.46 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.047 1.924 . . . . 0.0 109.339 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -59.35 132.15 53.14 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -61.42 142.72 93.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.013 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.27 -28.61 20.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.914 3.076 . . . . 0.0 116.264 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -106.23 141.25 37.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.46 1.904 . . . . 0.0 109.533 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -131.64 150.59 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.323 1.449 . . . . 0.0 109.084 169.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.1 m -139.65 134.45 32.03 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.26 72.7 10.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.26 -39.4 20.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.617 1.58 . . . . 0.0 114.731 -169.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -64.5 -9.7 20.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 pt -123.38 -4.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 112.088 169.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.1 84.97 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.006 1.765 . . . . 0.0 115.571 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -84.05 151.22 25.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.295 1.548 . . . . 0.0 111.026 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -136.95 165.33 26.25 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.188 0.995 . . . . 0.0 112.667 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -149.05 165.08 32.77 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -88.18 151.87 22.38 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.45 149.43 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.6 0.76 . . . . 0.0 110.798 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -71.11 158.95 87.04 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -52.49 -21.65 14.57 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.626 2.884 . . . . 0.0 117.416 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -85.41 -3.68 58.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.53 1.532 . . . . 0.0 114.507 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.69 -0.48 52.58 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.376 1.465 . . . . 0.0 114.754 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m -70.71 113.8 8.16 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.071 1.435 . . . . 0.0 110.534 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.21 135.22 38.56 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -83.31 109.49 17.99 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.0 156.41 54.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.493 2.129 . . . . 0.0 112.004 -169.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 63.84 -1.51 0.64 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.066 2.146 . . . . 0.0 115.334 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 p -77.66 -23.25 49.69 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.464 1.484 . . . . 0.0 111.827 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.85 99.17 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.048 1.739 . . . . 0.0 110.984 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.2 t -140.5 171.24 14.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.759 1.224 . . . . 0.0 113.451 -168.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -6.65 3.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.019 3.328 . . . . 0.0 115.29 -173.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.39 -176.85 43.99 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.918 1.247 . . . . 0.0 112.957 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -55.64 157.74 3.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.78 2.032 . . . . 0.0 113.518 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.8 164.42 38.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 0.0 112.232 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -84.0 61.4 6.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.942 2.097 . . . . 0.0 111.849 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.74 107.54 0.23 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.848 0.859 . . . . 0.0 112.144 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -123.65 27.2 7.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.323 1.849 . . . . 0.0 113.071 -168.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.54 17.95 2.54 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.097 1.759 . . . . 0.0 113.057 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.233 0.214 0 C-N-CA 126.619 1.968 . . . . 0.0 111.009 -169.88 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.7 p -82.95 167.45 17.96 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.952 0.901 . . . . 0.0 111.398 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -53.63 -37.67 63.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.643 0.777 . . . . 0.0 112.591 171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.0 t -60.36 -61.41 2.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -58.85 -37.27 76.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.422 0.689 . . . . 0.0 112.548 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.43 -59.17 5.88 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.196 1.398 . . . . 0.0 110.514 171.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -55.96 -46.63 78.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.416 0.553 . . . . 0.0 111.61 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.39 -33.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.056 0.542 . . . . 0.0 111.432 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -82.51 3.62 27.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.332 1.853 . . . . 0.0 114.509 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -126.03 -23.79 3.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.105 1.32 . . . . 0.0 113.506 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 mm -61.34 133.21 92.96 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 167.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.27 174.39 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.714 1.61 . . . . 0.0 112.986 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.43 -45.61 53.43 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.608 -0.682 . . . . 0.0 110.6 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.21 72.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.453 1.501 . . . . 0.0 108.799 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.93 -16.28 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -44.76 122.12 3.89 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 123.801 3.0 . . . . 0.0 114.29 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 -41.4 1.94 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.45 1.5 . . . . 0.0 110.517 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.1 p -74.74 163.5 27.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.366 1.467 . . . . 0.0 112.768 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -75.94 155.8 34.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.028 0.931 . . . . 0.0 111.323 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -144.77 128.5 8.74 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 125.503 1.521 . . . . 0.0 108.853 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.47 175.01 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.116 1.877 . . . . 0.0 112.289 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 153.69 40.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.631 1.572 . . . . 0.0 111.133 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.42 159.33 38.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.494 1.118 . . . . 0.0 113.071 -168.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -95.95 -179.69 4.78 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.983 1.713 . . . . 0.0 113.692 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -16.11 48.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.313 1.445 . . . . 0.0 114.866 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.72 13.76 31.1 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.788 1.635 . . . . 0.0 111.771 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 2.21 14.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.648 1.594 . . . . 0.0 114.71 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.34 164.14 20.19 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.811 1.306 . . . . 0.0 108.766 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -60.23 128.87 38.91 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.37 0.532 . . . . 0.0 109.827 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.79 128.23 62.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.15 -1.405 . . . . 0.0 108.675 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.62 -18.74 6.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.799 2.999 . . . . 0.0 116.761 -174.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.53 132.65 54.99 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.961 2.104 . . . . 0.0 108.551 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -124.84 151.87 44.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.254 1.022 . . . . 0.0 108.718 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.9 m -141.4 156.99 45.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.688 0.795 . . . . 0.0 112.07 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.03 93.45 3.19 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 110.742 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.76 -36.38 59.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.18 1.371 . . . . 0.0 115.091 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -57.76 -20.78 37.5 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.094 1.447 . . . . 0.0 114.503 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 pt -123.41 2.63 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.98 1.712 . . . . 0.0 112.207 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.44 12.22 69.33 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.293 1.425 . . . . 0.0 114.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -86.82 155.55 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.035 1.418 . . . . 0.0 113.339 -171.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.0 m -140.4 157.19 45.91 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.275 1.83 . . . . 0.0 109.57 166.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -149.5 162.7 39.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.628 1.571 . . . . 0.0 108.941 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.2 m -90.05 152.05 21.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.3 153.26 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.111 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -76.74 161.71 73.03 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 166.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -53.38 -23.85 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 116.361 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -80.8 -8.84 59.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.076 2.15 . . . . 0.0 114.924 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.27 59.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.34 1.447 . . . . 0.0 115.454 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.3 m -72.61 127.42 32.51 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.699 1.75 . . . . 0.0 108.863 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -71.83 165.92 23.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -99.83 92.8 2.11 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -68.85 23.2 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.863 1 C-N-CA 126.021 4.481 . . . . 0.0 117.907 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -124.77 -3.4 7.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.278 1.831 . . . . 0.0 112.465 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.9 p -84.95 -20.71 30.19 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.147 0.979 . . . . 0.0 113.067 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -57.25 97.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.076 1.351 . . . . 0.0 112.566 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -131.78 168.38 17.9 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.301 1.84 . . . . 0.0 111.992 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 21.8 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.108 2.563 . . . . 0.0 112.375 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 174.47 45.84 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.752 1.168 . . . . 0.0 113.219 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -62.82 164.08 8.5 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.059 1.744 . . . . 0.0 114.016 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 162.86 40.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.822 1.249 . . . . 0.0 111.212 175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.07 63.44 7.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.952 1.701 . . . . 0.0 111.812 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m -53.45 105.83 0.15 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 113.335 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 65' ' ' SER . 16.5 p -150.05 13.89 0.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.8 1.64 . . . . 0.0 114.77 -169.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.46 7.28 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.33 2.252 . . . . 0.0 115.755 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 63' ' ' SER . 34.8 m . . . . . 0 C--N 1.33 -0.282 0 C-N-CA 130.541 3.536 . . . . 0.0 114.112 168.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 160.32 19.51 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.802 1.641 . . . . 0.0 111.137 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -46.39 -53.21 11.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -58.13 -55.92 28.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.496 0.318 . . . . 0.0 111.419 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.98 -41.7 71.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.005 0.922 . . . . 0.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.03 -60.58 3.37 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.889 1.276 . . . . 0.0 109.893 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.63 -46.23 77.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.172 0.442 . . . . 0.0 111.77 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.86 -30.82 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.342 0.657 . . . . 0.0 111.745 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p -79.72 -3.83 49.2 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.78 -21.96 4.3 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.698 1.136 . . . . 0.0 113.997 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.52 137.44 97.08 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 167.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.99 168.65 16.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 121.879 1.72 . . . . 0.0 112.511 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.43 -45.8 68.27 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.541 -0.724 . . . . 0.0 110.318 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 t -77.82 71.65 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.99 1.316 . . . . 0.0 108.784 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -113.95 -9.06 0.1 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -42.87 112.4 0.27 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.441 2.761 . . . . 0.0 114.242 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -46.17 1.1 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.211 1.862 . . . . 0.0 108.672 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -85.61 141.7 29.62 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.802 1.241 . . . . 0.0 111.732 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -64.18 163.98 11.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.789 1.236 . . . . 0.0 109.391 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -142.54 125.21 9.11 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 127.064 2.146 . . . . 0.0 108.947 173.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.73 170.29 7.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.615 2.21 . . . . 0.0 115.843 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -131.84 148.77 52.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.746 2.418 . . . . 0.0 109.146 169.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.87 155.34 46.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -86.14 175.46 8.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.254 1.421 . . . . 0.0 113.05 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.95 -18.18 43.49 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.19 7.66 36.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.329 1.852 . . . . 0.0 111.782 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.23 8.0 41.55 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.344 1.45 . . . . 0.0 114.632 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -91.19 167.65 12.18 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.749 1.62 . . . . 0.0 109.135 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -58.35 133.4 55.69 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.937 -0.477 . . . . 0.0 110.542 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -57.16 133.32 80.75 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.531 170.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -51.24 -30.21 32.26 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.519 2.813 . . . . 0.0 115.566 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.55 137.87 42.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.884 1.674 . . . . 0.0 109.262 169.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -123.74 147.2 47.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 0.0 108.358 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.68 155.49 48.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.109 0.964 . . . . 0.0 110.224 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.47 91.02 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.328 1.061 . . . . 0.0 111.157 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -13.19 34.99 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 117.564 1.785 . . . . 0.0 117.564 -169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.2 p -69.8 -23.65 63.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.159 1.98 . . . . 0.0 112.655 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.1 pt -120.44 -19.26 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.906 1.683 . . . . 0.0 112.492 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 10.27 84.6 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.547 1.546 . . . . 0.0 114.753 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -83.51 157.92 22.2 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.525 1.163 . . . . 0.0 110.755 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.6 m -135.11 163.63 29.47 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.826 1.25 . . . . 0.0 112.416 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -150.87 163.3 38.98 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.144 1.778 . . . . 0.0 109.755 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -89.76 151.85 21.61 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 169.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.2 154.42 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.232 1.013 . . . . 0.0 110.923 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -75.77 162.97 70.05 Favored Pre-proline 0 CA--C 1.552 1.047 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.26 -23.38 23.09 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.878 3.052 . . . . 0.0 116.508 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -82.79 -11.88 57.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.624 1.97 . . . . 0.0 114.691 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.42 49.19 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.457 1.503 . . . . 0.0 115.826 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 m -69.64 119.24 13.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.762 1.781 . . . . 0.0 109.575 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.01 138.5 54.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.914 0.886 . . . . 0.0 112.942 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.73 107.66 11.01 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.18 152.93 77.2 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -169.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 71.42 -3.62 2.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 128.438 2.695 . . . . 0.0 114.396 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.2 p -79.24 -19.98 49.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.222 1.374 . . . . 0.0 112.072 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.1 97.46 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.26 1.424 . . . . 0.0 110.293 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.9 t -137.66 168.78 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.129 1.372 . . . . 0.0 113.217 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -7.73 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 129.324 3.05 . . . . 0.0 115.084 -173.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.21 -169.18 40.3 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.654 1.121 . . . . 0.0 113.422 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.99 150.66 4.13 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.999 2.52 . . . . 0.0 114.777 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 164.63 38.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.794 1.238 . . . . 0.0 110.92 170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -95.54 66.61 2.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.871 1.268 . . . . 0.0 111.602 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.5 m -60.12 134.86 57.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.055 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.6 m 49.81 27.09 2.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.312 1.045 . . . . 0.0 113.406 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 62.97 20.54 12.33 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.748 2.419 . . . . 0.0 114.462 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 125.9 1.68 . . . . 0.0 112.549 177.259 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -83.26 167.7 17.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.39 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -52.94 -39.21 62.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.298 0.639 . . . . 0.0 112.099 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 t -59.57 -59.68 5.05 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.599 0.759 . . . . 0.0 110.9 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.75 -37.13 78.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.632 0.773 . . . . 0.0 112.537 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.11 -58.66 7.43 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.152 1.381 . . . . 0.0 110.841 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -56.94 -41.04 77.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.488 0.585 . . . . 0.0 112.108 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.04 -29.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.333 1.053 . . . . 0.0 112.365 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 m -72.59 -42.83 64.12 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.762 0.825 . . . . 0.0 112.274 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -78.85 -37.3 40.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.809 1.244 . . . . 0.0 113.265 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.4 mt -90.75 104.33 9.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.24 169.13 21.45 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.186 1.924 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.91 -24.55 38.25 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.44 68.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 0.0 108.873 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -104.34 8.81 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -41.96 136.67 3.4 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.452 2.768 . . . . 0.0 115.234 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.07 -18.56 35.41 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.888 1.708 . . . . 0.0 113.494 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.4 p -130.34 166.69 19.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.177 1.488 . . . . 0.0 114.362 -169.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -82.78 145.05 29.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.613 1.565 . . . . 0.0 110.733 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -133.7 123.95 17.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.944 1.698 . . . . 0.0 107.96 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.98 175.61 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.848 1.699 . . . . 0.0 114.569 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -136.83 146.36 45.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.826 2.05 . . . . 0.0 109.206 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 m -135.17 153.42 51.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.102 0.865 . . . . 0.0 112.301 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -95.48 -176.38 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.524 1.129 . . . . 0.0 114.03 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -61.14 -24.3 66.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -86.56 8.69 21.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.236 1.414 . . . . 0.0 112.667 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.15 2.08 12.38 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.472 1.511 . . . . 0.0 114.833 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -82.87 169.59 15.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.523 1.529 . . . . 0.0 108.553 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -61.29 133.63 56.09 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.651 -0.656 . . . . 0.0 109.6 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.14 145.59 72.94 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.75 -14.28 38.81 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.881 1.72 . . . . 0.0 114.144 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -110.63 135.51 51.15 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.172 2.189 . . . . 0.0 107.978 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -128.7 150.11 50.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.444 1.098 . . . . 0.0 109.491 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.9 m -140.68 134.83 30.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.269 0.628 . . . . 0.0 112.216 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.69 73.61 9.71 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.39 15.79 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.685 1.612 . . . . 0.0 114.598 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.68 -11.67 27.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.86 -5.28 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.481 1.513 . . . . 0.0 112.421 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.45 8.29 83.71 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.88 1.705 . . . . 0.0 115.629 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -83.91 148.1 27.13 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.093 1.447 . . . . 0.0 110.733 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.5 m -135.34 164.02 28.69 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.224 1.01 . . . . 0.0 113.037 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -149.35 163.58 37.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.689 1.996 . . . . 0.0 109.038 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -88.86 155.14 19.71 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.43 156.38 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.381 1.072 . . . . 0.0 111.796 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -76.46 164.81 57.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 166.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.83 -29.96 36.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.474 2.783 . . . . 0.0 115.893 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.61 -6.34 56.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.131 2.172 . . . . 0.0 114.643 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.12 0.93 65.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.626 1.108 . . . . 0.0 115.189 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.7 m -70.99 126.49 29.71 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.733 1.766 . . . . 0.0 108.588 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -68.82 161.86 27.65 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.25 95.13 3.15 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.16 23.62 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.916 1 C-N-CA 125.836 4.357 . . . . 0.0 117.82 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -125.04 -3.66 7.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.426 1.891 . . . . 0.0 112.398 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 p -86.4 -19.94 28.96 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.056 0.942 . . . . 0.0 113.192 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.93 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.511 1.525 . . . . 0.0 111.351 -169.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m -132.22 165.49 24.0 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.154 1.382 . . . . 0.0 113.177 -168.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -5.13 1.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.399 3.08 . . . . 0.0 115.02 176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.13 -173.1 39.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.093 1.806 . . . . 0.0 112.355 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -59.29 164.85 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.375 1.87 . . . . 0.0 114.41 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 167.98 28.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.454 1.501 . . . . 0.0 110.547 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.25 57.43 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.523 1.929 . . . . 0.0 112.458 -168.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.9 m -66.92 159.34 28.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.97 -0.456 . . . . 0.0 111.286 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 m -154.98 20.76 0.44 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.23 -1.544 . . . . 0.0 114.991 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.52 21.44 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.811 2.445 . . . . 0.0 115.11 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 128.219 2.608 . . . . 0.0 110.328 -178.25 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.0 p -82.76 167.7 17.9 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.785 0.834 . . . . 0.0 111.32 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -54.28 -40.04 67.49 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.436 -0.79 . . . . 0.0 111.761 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -56.86 -60.28 3.8 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.737 0.815 . . . . 0.0 110.939 171.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.57 -36.66 76.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.252 0.621 . . . . 0.0 112.477 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.75 -57.56 11.41 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -52.69 -47.74 67.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.95 0.796 . . . . 0.0 111.459 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.95 -24.9 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.328 1.451 . . . . 0.0 112.426 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -91.01 3.93 53.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.235 1.814 . . . . 0.0 115.102 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -130.51 -33.16 1.67 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.187 1.358 . . . . 0.0 113.426 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.17 138.56 72.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.99 158.52 53.78 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 111.357 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.56 84.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.838 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.62 66.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.769 1.227 . . . . 0.0 109.135 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -85.54 -6.64 0.11 Allowed Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -43.72 107.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.881 3.054 . . . . 0.0 114.554 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.89 -20.48 6.0 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.619 2.057 . . . . 0.0 112.909 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -138.83 178.0 7.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.625 1.57 . . . . 0.0 112.215 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -80.68 159.07 25.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.245 1.818 . . . . 0.0 111.035 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -148.86 117.64 3.95 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.336 1.455 . . . . 0.0 109.34 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 174.68 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.17 1.913 . . . . 0.0 114.221 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -138.78 147.77 43.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.033 2.133 . . . . 0.0 108.905 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -132.75 157.67 44.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.254 0.934 . . . . 0.0 113.043 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -103.29 -178.27 3.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.751 1.621 . . . . 0.0 114.721 -169.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -15.56 27.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.968 1.707 . . . . 0.0 115.044 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -102.01 13.53 34.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.922 1.689 . . . . 0.0 111.886 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.19 3.94 20.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.328 1.442 . . . . 0.0 114.561 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -85.34 167.12 15.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.667 1.587 . . . . 0.0 109.343 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.0 124.1 19.51 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -53.83 128.71 55.13 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 117.394 -1.289 . . . . 0.0 108.697 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.39 -9.51 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.074 3.183 . . . . 0.0 117.915 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.43 127.85 54.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.772 2.429 . . . . 0.0 107.622 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.15 150.62 41.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.082 0.953 . . . . 0.0 109.721 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.3 m -138.12 153.83 49.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.893 0.854 . . . . 0.0 112.641 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.37 70.02 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.266 2.226 . . . . 0.0 107.668 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.84 -34.39 29.64 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.088 1.328 . . . . 0.0 113.991 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 m -53.13 -22.62 6.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.862 2.065 . . . . 0.0 115.191 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -121.39 -0.33 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 112.615 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.27 6.3 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.354 0.978 . . . . 0.0 111.339 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -143.3 158.62 43.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -141.23 161.57 37.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.177 2.191 . . . . 0.0 110.077 167.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.21 161.64 42.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.74 1.616 . . . . 0.0 109.366 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.1 m -85.98 153.73 21.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.85 159.28 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.38 1.072 . . . . 0.0 111.708 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -82.01 160.54 63.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.62 -26.21 22.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.785 2.99 . . . . 0.0 116.664 -172.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.1 -5.16 55.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.4 0.59 50.36 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.697 1.618 . . . . 0.0 114.806 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 m -67.9 108.62 3.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.165 1.482 . . . . 0.0 110.686 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -56.62 129.89 42.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.263 1.025 . . . . 0.0 112.979 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.48 110.69 26.17 Favored Pre-proline 0 C--O 1.241 0.617 0 C-N-CA 125.465 1.506 . . . . 0.0 107.97 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.8 161.2 33.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.595 2.197 . . . . 0.0 111.758 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 62.47 -5.23 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.948 2.099 . . . . 0.0 115.445 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 p -76.69 -24.89 53.17 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.345 1.429 . . . . 0.0 111.339 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -50.23 102.95 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.525 1.93 . . . . 0.0 111.106 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -144.33 167.74 21.74 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.448 1.099 . . . . 0.0 111.127 -170.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -74.79 4.56 6.18 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.79 43.82 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.684 1.611 . . . . 0.0 112.252 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -58.18 161.77 3.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.956 1.702 . . . . 0.0 114.439 -171.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.55 165.73 34.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 110.589 172.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -86.4 62.85 7.67 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.274 1.83 . . . . 0.0 111.223 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.6 m -65.14 164.1 13.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.5 m -70.25 63.53 0.24 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.828 1.651 . . . . 0.0 111.852 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.07 22.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.438 4.295 . . . . 0.0 121.375 -167.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.8 p . . . . . 0 N--CA 1.474 0.738 0 O-C-N 119.9 -1.75 . . . . 0.0 113.649 170.002 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.3 p -82.88 166.98 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.882 0.873 . . . . 0.0 111.525 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -54.41 -37.99 65.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.406 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 t -60.84 -59.77 4.85 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 110.9 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.54 -39.11 79.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.286 0.634 . . . . 0.0 112.7 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.55 -56.2 24.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.293 1.437 . . . . 0.0 110.986 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -56.61 -44.04 80.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.766 0.426 . . . . 0.0 111.587 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.57 -28.11 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.235 1.014 . . . . 0.0 112.277 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 m -83.49 3.85 30.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.016 1.727 . . . . 0.0 114.03 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -124.78 -35.66 2.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.528 1.131 . . . . 0.0 111.805 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -94.08 105.95 19.98 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.51 171.33 18.44 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.614 2.209 . . . . 0.0 111.822 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.56 39.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.082 0.953 . . . . 0.0 113.403 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.98 76.7 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.983 1.313 . . . . 0.0 108.051 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.45 46.7 0.46 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.42 129.03 25.33 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.699 2.266 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.04 -7.51 66.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.158 1.361 . . . . 0.0 114.323 -173.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -123.28 161.26 24.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.629 1.714 . . . . 0.0 113.56 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -78.1 160.41 28.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.477 1.511 . . . . 0.0 107.708 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -147.79 127.32 6.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.497 2.319 . . . . 0.0 107.098 169.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.73 171.37 9.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.493 1.462 . . . . 0.0 114.111 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -135.28 137.44 42.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.595 2.358 . . . . 0.0 108.82 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.92 154.86 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.652 0.781 . . . . 0.0 111.216 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -79.86 173.56 12.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.937 0.895 . . . . 0.0 112.267 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -61.79 -16.74 52.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.76 -5.71 59.33 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.364 1.865 . . . . 0.0 111.523 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.43 2.07 89.14 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 125.532 1.539 . . . . 0.0 114.627 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -78.47 147.29 33.99 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.124 1.462 . . . . 0.0 109.106 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -54.84 123.77 14.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.915 0.886 . . . . 0.0 110.104 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.06 145.03 67.16 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.65 -18.58 59.11 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.508 2.138 . . . . 0.0 114.291 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -109.91 131.67 54.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.795 2.438 . . . . 0.0 108.541 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -119.64 146.94 45.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.871 1.269 . . . . 0.0 109.417 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.64 128.88 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.35 71.31 10.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.681 1.592 . . . . 0.0 106.991 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.63 -37.2 26.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.513 1.53 . . . . 0.0 114.401 -170.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -63.31 -10.41 16.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 pt -125.01 -0.47 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 112.453 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.7 -5.05 76.51 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.667 1.603 . . . . 0.0 115.498 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -81.83 151.23 27.46 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.028 1.414 . . . . 0.0 111.493 -172.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.2 m -137.38 164.99 27.28 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -148.4 163.96 35.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.8 2.04 . . . . 0.0 109.227 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.8 157.03 18.61 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 109.771 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.45 161.4 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.87 162.66 46.44 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.715 1.606 . . . . 0.0 108.697 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.81 -15.28 9.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.995 3.13 . . . . 0.0 118.027 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -95.55 0.78 53.39 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.103 1.361 . . . . 0.0 114.083 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 2.47 62.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.197 1.38 . . . . 0.0 114.804 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -71.23 130.38 41.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.122 1.461 . . . . 0.0 109.624 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.53 137.94 58.1 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.4 t -83.42 109.15 15.97 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.01 155.95 47.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.832 2.354 . . . . 0.0 113.141 -168.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 61.68 -0.24 0.43 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.135 2.174 . . . . 0.0 115.818 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 p -72.79 -32.01 65.27 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.106 1.321 . . . . 0.0 110.77 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.76 106.38 0.11 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 111.967 -169.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -137.21 165.82 25.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.013 1.325 . . . . 0.0 113.103 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -6.27 2.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.734 2.814 . . . . 0.0 114.216 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.89 -175.66 39.04 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.219 1.866 . . . . 0.0 112.559 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -58.04 161.97 3.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.823 2.049 . . . . 0.0 114.067 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.13 167.11 31.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.611 1.164 . . . . 0.0 111.771 172.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -82.61 61.53 5.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.448 2.299 . . . . 0.0 112.023 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.7 m -58.4 111.28 1.17 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -72.69 69.94 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 112.281 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 57.44 11.11 1.09 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.645 2.378 . . . . 0.0 115.783 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 C--N 1.329 -0.286 0 C-N-CA 128.128 2.571 . . . . 0.0 110.32 169.678 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 120.555 0.217 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -145.98 -178.83 6.32 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.149 1.38 . . . . 0.0 110.16 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -47.32 -33.02 5.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 112.369 169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.47 -68.5 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.235 0.614 . . . . 0.0 111.191 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -54.55 -39.77 68.06 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.44 1.096 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.94 -60.34 3.6 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.679 1.192 . . . . 0.0 110.282 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -54.32 -48.2 71.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.272 0.629 . . . . 0.0 111.908 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.06 -34.32 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.699 0.4 . . . . 0.0 111.261 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.6 p -80.97 -2.1 46.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -130.22 -23.58 2.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -67.33 137.74 93.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 165.15 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.007 1.805 . . . . 0.0 111.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.76 72.45 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.523 -0.736 . . . . 0.0 111.564 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -83.79 77.81 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.388 1.475 . . . . 0.0 107.927 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -118.68 53.2 1.83 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.383 1.073 . . . . 0.0 113.542 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -61.83 139.05 77.94 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.885 2.39 . . . . 0.0 110.853 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 11.51 0.78 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.266 1.412 . . . . 0.0 115.544 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -120.41 136.92 54.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.436 1.495 . . . . 0.0 110.928 -168.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.05 154.68 38.86 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -148.83 125.33 5.31 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.864 2.066 . . . . 0.0 108.523 168.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 178.3 7.04 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.274 1.983 . . . . 0.0 112.66 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -139.17 151.53 46.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.876 2.071 . . . . 0.0 109.764 170.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.77 154.46 51.22 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -86.25 175.36 8.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.442 . . . . 0.0 113.206 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.53 -21.06 59.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -84.9 6.31 25.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.348 1.859 . . . . 0.0 111.862 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.34 4.93 39.88 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.955 1.74 . . . . 0.0 114.889 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -90.5 164.73 14.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.831 2.052 . . . . 0.0 109.759 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.65 127.87 33.3 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.917 -0.489 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.35 141.2 62.96 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.826 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.5 -30.94 12.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.339 3.359 . . . . 0.0 116.251 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.2 tp -107.93 129.99 55.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.445 1.898 . . . . 0.0 108.855 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -112.52 140.09 47.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.681 1.193 . . . . 0.0 108.609 169.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.1 m -130.56 119.7 22.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 122.069 0.938 . . . . 0.0 110.669 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.25 66.59 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.24 1.816 . . . . 0.0 106.501 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.23 -27.12 64.78 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.564 1.554 . . . . 0.0 114.402 -169.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 p -61.97 -11.99 16.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.66 1.584 . . . . 0.0 114.267 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.48 -3.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.643 1.977 . . . . 0.0 111.705 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.69 20.32 79.56 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 126.412 1.958 . . . . 0.0 115.749 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -95.48 158.95 15.23 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.842 1.821 . . . . 0.0 111.28 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.37 164.88 29.03 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.746 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -149.51 164.18 35.78 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.785 2.034 . . . . 0.0 109.277 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.83 150.67 22.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.45 156.48 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.519 0.728 . . . . 0.0 111.737 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.5 158.59 81.05 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 165.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.55 -22.3 16.41 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.655 2.903 . . . . 0.0 117.091 -171.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -82.24 -5.46 58.53 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.421 1.489 . . . . 0.0 114.694 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.74 -0.47 48.88 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.679 1.609 . . . . 0.0 114.968 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -69.88 114.54 8.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.124 1.462 . . . . 0.0 110.539 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.92 136.81 55.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.729 0.812 . . . . 0.0 112.676 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.01 114.3 51.7 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -45.14 137.45 10.05 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.487 3.458 . . . . 0.0 115.58 -169.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.25 9.66 4.13 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.756 2.023 . . . . 0.0 114.843 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -78.11 -22.38 48.99 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.01 1.277 . . . . 0.0 111.604 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 105.17 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.197 0.999 . . . . 0.0 111.724 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -144.74 171.1 14.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.086 1.354 . . . . 0.0 112.999 -169.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -0.06 2.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 129.87 3.268 . . . . 0.0 114.922 -174.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.64 -176.58 48.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.218 1.389 . . . . 0.0 113.01 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.54 159.06 3.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.216 2.207 . . . . 0.0 114.174 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.51 166.29 33.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.479 1.111 . . . . 0.0 111.906 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.75 67.44 9.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.028 1.731 . . . . 0.0 111.535 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m -59.05 111.48 1.33 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.9 p -70.36 76.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 112.079 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 10.5 pt-20 48.91 19.15 0.24 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 128.511 2.724 . . . . 0.0 116.413 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 127.345 2.258 . . . . 0.0 110.374 169.931 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 p -83.72 167.92 16.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.32 1.048 . . . . 0.0 110.754 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -55.15 -39.24 69.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.443 -0.786 . . . . 0.0 112.239 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.1 t -62.18 -59.81 4.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.67 0.788 . . . . 0.0 111.03 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -58.0 -36.54 72.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.58 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.47 -59.23 5.74 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.366 1.066 . . . . 0.0 110.631 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.29 -42.1 81.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.414 0.552 . . . . 0.0 112.079 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.65 -32.27 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.262 1.025 . . . . 0.0 111.908 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 m -86.51 7.93 24.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.178 1.791 . . . . 0.0 114.063 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -124.94 -38.77 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.376 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.41 108.03 20.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 168.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -70.4 160.08 50.75 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.148 1.899 . . . . 0.0 111.47 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.63 61.08 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.89 67.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 108.927 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -99.11 5.31 0.07 OUTLIER Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -41.91 112.69 0.24 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.506 2.804 . . . . 0.0 115.609 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.99 28.44 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.118 1.818 . . . . 0.0 113.318 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -117.44 159.16 23.25 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.214 1.806 . . . . 0.0 111.972 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.38 157.87 37.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -148.54 130.14 7.35 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.499 1.919 . . . . 0.0 107.597 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.91 170.99 17.5 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.19 1.927 . . . . 0.0 112.509 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -144.14 150.5 38.17 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.18 1.792 . . . . 0.0 110.073 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -133.11 158.39 42.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.95 1.3 . . . . 0.0 111.208 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.38 179.64 6.04 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.282 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -16.82 49.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -173.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -84.64 -3.28 58.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.167 0.987 . . . . 0.0 112.61 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 8.93 82.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.215 0.912 . . . . 0.0 113.74 -171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -80.34 147.97 30.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.72 1.208 . . . . 0.0 109.008 172.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -51.98 126.97 19.89 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.089 0.956 . . . . 0.0 111.403 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.86 131.63 82.99 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.08 -30.05 30.35 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.24 2.627 . . . . 0.0 115.543 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.4 140.37 34.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.604 1.961 . . . . 0.0 109.482 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -131.72 149.82 52.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.087 1.355 . . . . 0.0 109.004 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 79.4 m -142.28 132.33 24.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.92 72.0 9.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 168.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.14 17.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.215 1.388 . . . . 0.0 114.784 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -60.9 -16.11 38.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.66 1.88 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.191 1.396 . . . . 0.0 112.435 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.94 69.26 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.811 1.672 . . . . 0.0 115.224 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -83.31 143.4 30.4 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.71 1.255 . . . . 0.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.7 m -131.18 164.81 24.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.645 1.178 . . . . 0.0 112.12 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -153.15 165.4 35.75 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.233 1.813 . . . . 0.0 109.376 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.9 m -89.66 154.16 20.17 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 122.027 -0.421 . . . . 0.0 110.241 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.81 160.29 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.874 0.87 . . . . 0.0 113.122 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.47 167.22 17.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.675 1.59 . . . . 0.0 110.714 167.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.82 -2.21 1.03 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 124.845 3.696 . . . . 0.0 118.614 -170.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -111.31 2.32 17.6 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.45 1.9 . . . . 0.0 113.562 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.69 2.34 61.48 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.227 1.394 . . . . 0.0 114.352 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.5 m -67.13 111.62 4.0 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.183 1.491 . . . . 0.0 110.108 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -56.09 138.34 49.73 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.705 1.602 . . . . 0.0 113.06 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.68 100.1 1.01 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.946 1.698 . . . . 0.0 106.826 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.17 19.32 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.506 4.137 . . . . 0.0 117.127 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -123.73 -1.28 8.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.847 2.059 . . . . 0.0 112.875 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 p -96.3 -15.08 22.13 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.359 1.064 . . . . 0.0 112.843 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.61 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.24 111.46 0.78 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.416 1.086 . . . . 0.0 109.877 -173.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 t -148.23 167.39 25.23 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.61 ' NH1' HH22 ' A' ' 55' ' ' ARG . 5.4 mpt_? -77.2 12.06 1.62 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.626 2.77 . . . . 0.0 113.598 -173.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.65 176.99 47.54 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.904 1.24 . . . . 0.0 112.747 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -57.6 157.98 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.61 1.964 . . . . 0.0 113.28 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.1 168.11 28.12 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.124 0.97 . . . . 0.0 111.821 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -87.76 65.74 8.53 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.771 1.628 . . . . 0.0 111.795 -168.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.4 m -66.69 161.11 24.14 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -157.72 19.01 0.26 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.833 1.253 . . . . 0.0 114.171 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.51 25.18 0.19 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.303 1.841 . . . . 0.0 113.812 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.481 1.512 . . . . 0.0 111.565 177.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.4 p -83.42 168.24 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.403 0.681 . . . . 0.0 111.661 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -51.06 -42.64 60.68 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 0.0 112.207 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -58.91 6.49 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.954 0.343 . . . . 0.0 111.45 171.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.27 -34.41 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.97 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.74 -61.83 2.23 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.579 1.152 . . . . 0.0 110.359 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -51.41 -49.66 61.2 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.182 0.993 . . . . 0.0 111.59 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.57 -27.39 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.067 0.947 . . . . 0.0 111.357 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -86.2 2.77 45.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.224 1.81 . . . . 0.0 114.602 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -128.86 -25.62 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.192 1.36 . . . . 0.0 113.838 -174.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.65 136.15 92.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 169.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.4 169.39 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.947 1.765 . . . . 0.0 112.074 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.18 72.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.609 -0.682 . . . . 0.0 110.868 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.15 74.36 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.07 1.348 . . . . 0.0 108.498 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.47 15.85 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.49 110.36 1.22 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 CA-C-N 123.636 2.334 . . . . 0.0 110.734 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.96 -15.37 8.92 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.567 1.556 . . . . 0.0 113.134 -169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.0 t -124.87 148.81 48.08 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.474 1.509 . . . . 0.0 110.756 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -77.27 165.25 24.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.961 0.904 . . . . 0.0 112.624 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -138.85 106.97 7.51 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.122 1.769 . . . . 0.0 109.864 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -55.51 155.67 20.33 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.29 2.66 . . . . 0.0 115.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.27 128.81 51.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 127.995 2.518 . . . . 0.0 108.809 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 29' ' ' TYR . 76.0 m -143.19 157.74 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.012 0.91 . . . . 0.0 111.885 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -79.24 176.93 9.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.326 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.2 -24.64 63.29 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -84.61 7.98 18.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.977 1.711 . . . . 0.0 111.668 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.27 15.4 51.26 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.044 1.783 . . . . 0.0 114.634 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.86 149.77 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.728 1.211 . . . . 0.0 109.252 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.439 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 66.1 m-85 -69.0 120.69 15.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.715 0.806 . . . . 0.0 110.01 -170.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.31 128.87 83.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.638 -1.172 . . . . 0.0 108.898 -175.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.77 -22.45 9.8 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.773 2.982 . . . . 0.0 116.594 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.59 136.11 50.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.431 1.893 . . . . 0.0 109.228 169.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -123.69 148.92 46.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.475 1.51 . . . . 0.0 109.073 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -140.82 152.85 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.335 1.054 . . . . 0.0 110.1 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -127.09 88.2 2.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.325 1.06 . . . . 0.0 110.688 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.66 -12.93 36.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.841 1.686 . . . . 0.0 116.84 -169.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.2 p -66.25 -25.68 67.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.263 1.532 . . . . 0.0 112.833 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 pt -119.89 -17.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 112.515 173.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.29 9.25 85.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.515 1.531 . . . . 0.0 114.683 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -83.2 158.06 22.47 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.571 1.185 . . . . 0.0 110.95 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.1 m -133.82 164.97 26.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.618 1.167 . . . . 0.0 112.067 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.42 163.87 39.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.904 1.681 . . . . 0.0 109.498 169.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.4 m -90.64 150.42 21.7 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.693 0.797 . . . . 0.0 109.639 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.46 151.29 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.575 1.15 . . . . 0.0 110.208 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.3 155.4 91.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.9 -16.89 12.62 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.737 2.958 . . . . 0.0 117.372 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -83.23 -4.7 58.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.125 2.17 . . . . 0.0 114.996 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.29 -3.26 54.54 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.733 1.635 . . . . 0.0 114.873 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 m -73.83 111.6 9.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.628 1.214 . . . . 0.0 110.067 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -55.52 143.08 30.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.773 1.229 . . . . 0.0 113.804 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.94 89.04 0.7 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 168.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.18 -15.23 48.3 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.761 2.308 . . . . 0.0 117.435 -166.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.43 -12.96 59.92 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 127.217 2.207 . . . . 0.0 113.134 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.7 p -102.9 -2.62 27.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.923 1.689 . . . . 0.0 112.65 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 104.83 0.6 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.572 1.078 . . . . 0.0 109.447 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 t -141.39 162.04 36.45 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -7.84 3.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.847 3.259 . . . . 0.0 114.945 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.39 -174.53 42.96 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.107 0.86 . . . . 0.0 114.165 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -55.72 149.92 13.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.346 2.258 . . . . 0.0 113.982 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -155.46 -176.51 5.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.833 1.653 . . . . 0.0 110.024 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -130.88 91.03 2.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.527 1.531 . . . . 0.0 110.201 -170.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.3 m -68.12 -176.2 0.68 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.625 2.37 . . . . 0.0 112.916 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -65.64 74.19 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.35 1.46 . . . . 0.0 111.126 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -122.51 18.64 10.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.13 1.772 . . . . 0.0 114.285 -168.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 126.101 1.76 . . . . 0.0 111.709 -177.321 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -83.09 167.19 18.07 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.706 0.803 . . . . 0.0 111.498 171.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -52.25 -39.66 60.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 112.382 171.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -59.59 -60.74 3.36 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.581 0.752 . . . . 0.0 110.949 171.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -58.88 -36.53 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.498 0.719 . . . . 0.0 112.458 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.86 -58.03 10.34 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.876 1.271 . . . . 0.0 110.749 171.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -57.81 -43.17 85.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.233 0.47 . . . . 0.0 112.016 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.55 -34.55 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.309 0.643 . . . . 0.0 111.628 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -82.46 3.19 29.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.736 1.615 . . . . 0.0 114.338 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -127.59 -34.02 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.439 1.018 . . . . 0.0 112.416 -177.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.8 mt -87.27 114.25 57.7 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.2 161.28 40.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.33 2.02 . . . . 0.0 111.705 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -18.43 42.87 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 175.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.02 78.9 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.302 1.441 . . . . 0.0 107.775 169.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -113.52 63.2 0.98 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.025 1.33 . . . . 0.0 112.763 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.16 136.65 57.13 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.366 2.71 . . . . 0.0 111.255 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.96 11.76 1.05 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.376 1.465 . . . . 0.0 115.183 -173.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -125.97 162.89 24.21 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.661 1.585 . . . . 0.0 112.007 -168.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -88.79 155.02 19.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.781 1.632 . . . . 0.0 111.675 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.61 126.34 8.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.796 1.639 . . . . 0.0 108.65 168.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.54 174.03 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.191 1.928 . . . . 0.0 113.507 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 151.34 44.86 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.822 2.049 . . . . 0.0 110.015 173.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.63 157.38 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.625 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.41 -175.64 3.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.564 1.146 . . . . 0.0 113.946 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -60.63 -24.97 65.94 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.14 8.65 20.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.238 1.415 . . . . 0.0 112.71 171.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.35 3.05 17.18 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.49 1.519 . . . . 0.0 114.794 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.19 170.68 11.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.682 1.593 . . . . 0.0 109.118 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -60.31 129.93 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 177.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.92 137.49 79.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.776 -1.106 . . . . 0.0 108.635 173.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.75 -22.78 10.27 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.495 2.796 . . . . 0.0 116.369 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.91 132.09 53.83 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.737 2.015 . . . . 0.0 109.319 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.8 147.78 46.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.628 1.171 . . . . 0.0 109.684 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -139.24 116.84 11.4 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -170.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 63.25 7.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.942 2.097 . . . . 0.0 106.531 168.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.63 -21.74 63.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.936 1.255 . . . . 0.0 114.945 -169.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.0 p -62.15 -15.0 42.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.87 1.268 . . . . 0.0 114.12 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -123.5 8.9 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 127.139 2.176 . . . . 0.0 111.724 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.18 5.05 89.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.963 1.744 . . . . 0.0 115.218 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -84.73 150.64 24.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.202 1.501 . . . . 0.0 114.142 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -143.77 163.37 33.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.897 1.679 . . . . 0.0 111.16 168.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -150.84 163.38 38.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.484 1.914 . . . . 0.0 108.731 169.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.88 154.31 20.95 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.29 157.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.203 1.001 . . . . 0.0 111.645 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -75.66 158.81 82.6 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 165.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.98 -13.68 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.386 2.057 . . . . 0.0 114.949 -169.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -79.8 -7.33 58.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.136 2.174 . . . . 0.0 115.103 169.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.69 -2.65 49.12 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.073 1.797 . . . . 0.0 115.132 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.9 m -73.33 116.78 14.28 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 1.408 . . . . 0.0 110.701 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.32 133.38 55.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.025 1.33 . . . . 0.0 113.635 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.17 111.7 35.48 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 126.718 2.007 . . . . 0.0 108.557 172.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.14 156.62 4.99 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.875 3.05 . . . . 0.0 114.285 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 59.99 -2.88 0.13 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.864 2.066 . . . . 0.0 116.04 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 p -76.01 -26.43 56.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.115 1.325 . . . . 0.0 111.524 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -46.94 106.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.941 2.097 . . . . 0.0 111.783 -174.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 t -148.08 161.29 41.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.729 0.812 . . . . 0.0 111.714 -172.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -89.69 36.23 0.84 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.214 1.405 . . . . 0.0 113.087 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.68 170.74 41.33 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.028 2.251 . . . . 0.0 112.218 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -67.71 167.89 12.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.052 1.341 . . . . 0.0 112.85 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 166.9 32.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.724 1.21 . . . . 0.0 110.981 174.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -83.99 61.3 6.35 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.795 2.038 . . . . 0.0 111.627 -168.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.7 m -64.36 158.89 22.38 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.496 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.1 m -159.62 24.63 0.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -70.97 34.9 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.309 2.244 . . . . 0.0 113.412 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 126.313 1.845 . . . . 0.0 110.145 174.721 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 p -130.96 176.14 8.49 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.756 1.222 . . . . 0.0 112.777 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -48.57 -35.98 14.57 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.202 1.401 . . . . 0.0 112.446 169.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.22 -57.69 10.51 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.453 0.57 . . . . 0.0 110.884 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -57.46 -40.41 78.45 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.279 0.632 . . . . 0.0 112.637 177.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.96 -57.59 12.21 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.044 0.937 . . . . 0.0 110.578 174.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.53 -46.79 73.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.703 0.801 . . . . 0.0 111.672 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -67.34 -29.58 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 0.0 112.014 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -76.95 -36.04 56.82 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.266 1.026 . . . . 0.0 113.167 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -80.08 -32.66 39.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.311 1.044 . . . . 0.0 113.365 -175.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.48 131.4 95.07 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 167.84 24.17 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.276 1.984 . . . . 0.0 112.678 -176.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.41 78.22 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.582 -0.699 . . . . 0.0 110.682 169.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -79.68 70.93 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.736 1.215 . . . . 0.0 108.914 171.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -114.29 -3.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.23 112.49 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 124.458 2.628 . . . . 0.0 113.904 174.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.82 6.67 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.154 1.835 . . . . 0.0 111.667 -169.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 t -125.32 162.54 24.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.397 1.879 . . . . 0.0 112.729 178.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.0 159.16 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.169 2.188 . . . . 0.0 112.938 -176.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -142.0 113.99 6.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.589 2.355 . . . . 0.0 107.723 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -62.46 168.81 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.367 2.044 . . . . 0.0 114.245 176.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.96 142.04 51.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.849 2.46 . . . . 0.0 108.442 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -136.13 156.77 48.21 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.289 0.95 . . . . 0.0 112.071 -176.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.08 -177.28 3.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.12 -32.34 64.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.035 1.334 . . . . 0.0 113.462 176.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -84.5 11.39 8.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 0.0 112.404 176.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.44 4.47 24.45 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.184 1.374 . . . . 0.0 114.371 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.22 169.88 11.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.814 1.307 . . . . 0.0 109.071 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -62.56 130.67 46.11 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -57.89 134.07 83.41 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 117.77 -1.109 . . . . 0.0 108.546 174.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.33 -26.07 15.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.037 2.492 . . . . 0.0 115.893 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.35 133.94 48.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.06 1.744 . . . . 0.0 109.142 168.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -121.76 149.28 43.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.632 169.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.27 148.43 43.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.496 0.665 . . . . 0.0 112.332 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.22 77.51 1.05 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.643 1.977 . . . . 0.0 107.81 -178.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -37.1 -54.54 1.53 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 127.6 2.524 . . . . 0.0 115.619 -169.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.6 p -63.79 -12.35 34.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -116.76 -5.6 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.343 1.057 . . . . 0.0 112.278 169.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.55 10.43 70.92 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.286 1.898 . . . . 0.0 115.246 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -83.41 155.7 23.34 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.621 1.21 . . . . 0.0 111.293 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.1 m -138.25 164.84 28.22 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.033 0.933 . . . . 0.0 112.423 170.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -148.94 164.03 35.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.595 1.958 . . . . 0.0 109.229 169.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.06 153.62 20.85 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.49 157.83 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 124.33 1.052 . . . . 0.0 111.595 173.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -77.81 160.77 73.56 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.28 -21.25 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.844 3.029 . . . . 0.0 117.358 -170.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.65 -3.0 58.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.792 1.637 . . . . 0.0 114.716 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.97 1.36 56.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.301 1.429 . . . . 0.0 114.899 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -71.31 117.45 12.86 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.134 1.467 . . . . 0.0 110.146 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -56.15 137.16 52.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.7 110.38 24.62 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.27 150.26 11.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.863 3.042 . . . . 0.0 114.408 -171.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.93 3.6 0.5 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.283 1.833 . . . . 0.0 115.585 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -73.71 -28.04 61.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.171 1.351 . . . . 0.0 110.926 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.88 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.695 1.998 . . . . 0.0 111.774 -176.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.5 m -136.13 164.22 28.55 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.079 1.352 . . . . 0.0 112.999 -168.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -4.75 0.81 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 130.03 3.332 . . . . 0.0 115.295 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.07 -175.77 41.12 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.592 1.567 . . . . 0.0 112.986 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -56.19 161.15 2.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.091 2.156 . . . . 0.0 113.698 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 171.03 20.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.751 1.221 . . . . 0.0 111.294 174.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -89.31 68.78 8.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.396 1.878 . . . . 0.0 110.488 -168.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m -68.92 -178.66 1.27 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.803 0.811 . . . . 0.0 112.003 174.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.1 m -66.95 35.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.162 2.185 . . . . 0.0 116.682 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -69.51 66.17 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 110.514 169.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 126.063 1.745 . . . . 0.0 112.477 -172.344 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.556 0.694 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -142.31 168.11 20.51 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.844 2.858 . . . . 0.0 108.695 177.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -52.17 -39.53 60.19 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 0.0 112.734 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -59.62 -61.46 2.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.603 0.761 . . . . 0.0 111.518 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.45 -31.22 71.16 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -61.24 -58.58 7.69 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.701 1.6 . . . . 0.0 110.517 170.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.79 -43.87 81.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.45 0.568 . . . . 0.0 111.954 177.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.29 -36.39 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.617 0.644 . . . . 0.0 111.712 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -68.68 -45.35 71.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.884 0.874 . . . . 0.0 112.353 173.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -77.81 -26.24 49.42 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.581 1.152 . . . . 0.0 113.47 -176.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.98 94.98 19.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.975 1.71 . . . . 0.0 108.06 179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.89 154.06 58.38 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.055 1.836 . . . . 0.0 109.994 169.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.51 -36.04 66.26 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.45 73.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 109.059 178.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.604 ' CE1' ' H ' ' A' ' 19' ' ' PHE . 7.0 p80 -132.67 151.09 77.51 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 112.826 175.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.9 155.19 69.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.382 2.721 . . . . 0.0 110.94 171.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.8 40.66 72.73 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -169.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 107.99 0.17 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.2 2.6 . . . . 0.0 114.487 -168.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.604 ' H ' ' CE1' ' A' ' 15' ' ' HIS . 2.4 t80 -152.64 89.1 1.38 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 130.654 3.582 . . . . 0.0 108.084 172.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -84.56 124.52 73.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.04 175.0 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.578 1.518 . . . . 0.0 111.118 169.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.08 153.67 36.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.688 1.195 . . . . 0.0 111.759 177.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.8 m -132.84 158.59 42.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 113.021 -169.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -95.76 -178.93 4.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.263 1.425 . . . . 0.0 113.698 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -62.43 -10.38 11.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -100.68 8.24 43.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.408 1.883 . . . . 0.0 111.619 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.62 6.07 27.14 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.963 1.268 . . . . 0.0 114.434 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -90.23 164.75 14.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.543 1.537 . . . . 0.0 108.876 178.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -61.35 132.62 54.11 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.851 -0.53 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.43 139.36 85.0 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.873 175.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.45 -21.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.292 3.328 . . . . 0.0 117.374 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.98 135.63 53.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.656 1.982 . . . . 0.0 109.37 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.81 151.74 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.654 1.181 . . . . 0.0 109.11 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 76.2 m -140.65 120.42 13.45 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.342 1.057 . . . . 0.0 113.238 -172.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.38 72.92 9.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.427 1.108 . . . . 0.0 108.416 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -42.49 -47.95 5.79 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.708 2.099 . . . . 0.0 115.133 -169.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 p -60.95 -14.44 22.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.7 pt -118.7 -6.91 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 120.016 1.28 . . . . 0.0 113.083 170.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.8 -3.74 86.74 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.194 1.854 . . . . 0.0 115.342 176.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.646 ' HH ' ' NH2' ' A' ' 57' ' ' ARG . 74.0 m-85 -83.55 117.66 23.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.363 1.581 . . . . 0.0 112.083 -173.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -102.18 158.54 16.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.424 1.089 . . . . 0.0 110.262 168.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.19 162.37 39.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.513 1.525 . . . . 0.0 109.499 171.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.1 m -86.39 154.38 21.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.3 157.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.118 0.961 . . . . 0.0 113.298 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.12 163.29 58.27 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.97 -24.13 46.77 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.495 2.797 . . . . 0.0 115.829 -169.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -81.45 -7.84 59.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.266 2.226 . . . . 0.0 114.766 176.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.22 59.45 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.2 1.381 . . . . 0.0 115.438 -178.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.0 m -70.91 132.31 45.04 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.907 1.854 . . . . 0.0 109.937 177.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.1 141.93 57.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.274 1.029 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -82.34 115.37 57.53 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -44.08 133.44 8.63 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.779 3.652 . . . . 0.0 116.262 -169.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 59.5 15.15 4.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.731 2.013 . . . . 0.0 115.719 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.4 p -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.197 170.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.363 0.0 OUTLIER -57.99 110.73 0.98 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.027 1.285 . . . . 0.0 113.232 -170.503 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLY . 27.3 t -148.65 153.54 38.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.792 1.637 . . . . 0.0 110.398 -170.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.646 ' NH2' ' HH ' ' A' ' 40' ' ' TYR . 14.8 ttm-85 -80.31 28.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.166 1.386 . . . . 0.0 114.333 -171.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' SER . . . -159.35 169.05 35.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.387 1.946 . . . . 0.0 112.598 171.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -63.92 165.3 8.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.734 1.214 . . . . 0.0 112.781 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 164.12 38.65 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.017 0.927 . . . . 0.0 111.333 172.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -83.45 62.88 7.01 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.159 1.784 . . . . 0.0 111.976 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.45 108.4 0.94 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.7 t -139.45 27.92 2.26 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.214 1.806 . . . . 0.0 112.56 -177.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.02 15.9 3.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.347 1.459 . . . . 0.0 114.606 -169.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.331 -0.235 0 C-N-CA 125.426 1.49 . . . . 0.0 109.559 175.493 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.543 0.673 0 CA-C-O 120.607 0.241 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.8 p -144.89 167.69 22.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.516 1.927 . . . . 0.0 110.971 -174.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -50.23 -42.39 51.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.785 1.234 . . . . 0.0 113.418 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.08 -61.77 2.16 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.201 0.6 . . . . 0.0 111.127 173.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -58.66 -40.39 83.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.716 1.606 . . . . 0.0 112.265 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.24 -55.86 26.57 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 125.793 1.637 . . . . 0.0 110.344 172.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.68 -44.61 81.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.557 0.617 . . . . 0.0 111.432 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.85 -34.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.629 0.65 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -84.97 3.94 36.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.016 1.726 . . . . 0.0 115.231 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.8 -24.96 1.9 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.276 1.398 . . . . 0.0 114.265 -174.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.14 122.49 75.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.31 0.959 . . . . 0.0 109.166 176.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.54 172.48 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.302 2.002 . . . . 0.0 111.657 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -22.14 66.69 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.653 -0.654 . . . . 0.0 112.278 169.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.09 67.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.164 1.386 . . . . 0.0 109.184 169.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.5 92.65 44.13 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.102 1.361 . . . . 0.0 110.28 175.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.58 115.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.771 3.647 . . . . 0.0 114.994 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.9 51.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.174 1.368 . . . . 0.0 114.86 -177.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.261 92.0 p 69.16 107.08 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.274 3.029 . . . . 0.0 116.097 -176.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -138.44 136.21 35.99 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.968 1.707 . . . . 0.0 109.392 168.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -144.47 135.35 12.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 126.406 1.882 . . . . 0.0 106.086 169.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.9 163.57 38.72 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 120.63 1.261 . . . . 0.0 111.224 177.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -122.82 147.05 46.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.954 1.702 . . . . 0.0 109.469 177.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.4 m -136.61 156.53 48.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 111.848 -171.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -102.8 179.25 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.732 1.213 . . . . 0.0 114.162 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.21 -12.04 17.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 177.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -97.04 8.27 44.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.239 1.816 . . . . 0.0 111.696 175.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 8.81 35.38 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.706 1.146 . . . . 0.0 114.034 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.33 165.6 13.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.582 1.553 . . . . 0.0 108.85 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -62.17 132.52 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.09 135.74 87.88 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.8 -1.095 . . . . 0.0 108.258 174.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.07 -15.44 7.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.332 2.688 . . . . 0.0 116.887 -176.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.26 137.59 51.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.951 2.1 . . . . 0.0 109.891 171.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -131.9 152.42 51.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.853 1.261 . . . . 0.0 109.471 170.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.2 m -143.59 158.12 43.9 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.39 1.076 . . . . 0.0 112.353 -178.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 113.46 12.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.997 2.119 . . . . 0.0 108.93 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.04 -80.91 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 127.562 2.506 . . . . 0.0 117.274 -168.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 m -64.43 -18.73 65.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -168.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 pt -92.61 -3.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 10.83 59.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.597 1.57 . . . . 0.0 114.948 174.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -94.78 146.6 24.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.231 1.015 . . . . 0.0 113.445 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.9 m -130.86 156.45 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.509 1.523 . . . . 0.0 108.53 165.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.39 161.33 41.24 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.49 1.516 . . . . 0.0 108.781 172.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.8 m -86.8 152.69 22.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.82 156.66 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 110.019 170.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -73.68 161.19 79.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 166.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.54 -26.55 22.47 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.329 2.686 . . . . 0.0 115.389 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -76.46 -8.12 56.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.296 1.839 . . . . 0.0 115.374 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.69 -3.86 56.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.745 1.641 . . . . 0.0 115.266 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 m -73.56 119.79 18.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.059 1.43 . . . . 0.0 110.439 -177.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -56.82 132.14 51.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.719 1.207 . . . . 0.0 113.758 176.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.39 109.33 18.84 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.92 1.688 . . . . 0.0 107.639 169.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.44 163.51 26.6 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.556 2.171 . . . . 0.0 111.871 -175.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 61.2 -3.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.772 2.029 . . . . 0.0 115.74 -175.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.2 p -72.38 -28.84 63.27 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.994 1.27 . . . . 0.0 110.989 169.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -40.35 102.91 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.603 2.361 . . . . 0.0 113.103 -173.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 58' ' ' GLY . 50.7 m -133.51 161.79 33.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.118 0.967 . . . . 0.0 111.627 -172.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -71.95 17.55 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 130.17 3.388 . . . . 0.0 113.777 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 56' ' ' SER . . . 166.31 -178.82 40.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.669 2.081 . . . . 0.0 112.178 -171.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -61.21 162.45 7.5 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.654 1.581 . . . . 0.0 114.193 -172.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 163.75 36.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.066 1.346 . . . . 0.0 110.827 171.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.06 57.69 3.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.17 2.188 . . . . 0.0 112.496 -168.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.7 m -60.41 95.39 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.845 1.307 . . . . 0.0 112.078 -173.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.8 m -83.65 63.29 7.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.053 1.741 . . . . 0.0 111.571 -167.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 56.44 19.58 4.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 114.509 -171.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 127.368 2.267 . . . . 0.0 112.512 179.35 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 p -129.77 175.07 9.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.778 1.231 . . . . 0.0 112.717 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -51.02 -33.44 25.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.661 1.184 . . . . 0.0 112.31 172.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.1 t -61.33 -60.2 4.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.307 0.503 . . . . 0.0 110.653 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -55.68 -38.7 69.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.53 -58.22 9.42 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.087 0.955 . . . . 0.0 110.654 173.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.59 -40.84 88.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.385 0.539 . . . . 0.0 112.41 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -69.03 -28.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.036 0.934 . . . . 0.0 112.243 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -73.43 -48.44 33.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.69 0.796 . . . . 0.0 111.955 169.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -73.62 -33.75 64.7 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.846 1.259 . . . . 0.0 113.251 -175.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.8 mt -97.43 101.06 9.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.42 173.54 14.07 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.698 2.265 . . . . 0.0 111.902 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.22 -20.26 17.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.408 1.083 . . . . 0.0 113.808 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.41 76.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.124 1.37 . . . . 0.0 107.987 169.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -111.67 71.87 0.98 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.135 1.374 . . . . 0.0 111.354 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.78 119.44 6.7 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.833 3.022 . . . . 0.0 112.391 -169.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 53.37 8.62 0.81 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.444 1.974 . . . . 0.0 115.313 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -108.57 159.89 16.35 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.649 1.579 . . . . 0.0 112.39 -167.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -77.61 148.39 35.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.842 0.457 . . . . 0.0 110.751 173.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -138.28 125.03 13.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.318 1.847 . . . . 0.0 107.723 169.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -70.33 174.34 10.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.103 1.868 . . . . 0.0 113.427 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -135.41 143.88 46.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.016 2.126 . . . . 0.0 110.236 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.77 164.24 29.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.433 1.893 . . . . 0.0 110.643 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -120.99 178.38 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.041 0.936 . . . . 0.0 113.068 169.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -62.93 -11.95 22.07 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.571 1.548 . . . . 0.0 114.682 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -87.49 1.3 53.89 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.231 0.469 . . . . 0.0 111.901 173.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.45 -1.01 88.55 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.857 1.694 . . . . 0.0 114.353 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -86.71 165.18 16.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.481 1.113 . . . . 0.0 110.629 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -64.85 130.31 42.98 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 167.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -55.2 135.35 68.59 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.63 -7.01 16.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.153 1.902 . . . . 0.0 114.854 -168.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.12 135.97 53.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.555 1.942 . . . . 0.0 108.135 168.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -130.8 153.11 49.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.469 1.107 . . . . 0.0 108.977 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.7 m -140.53 156.88 46.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.145 0.978 . . . . 0.0 112.008 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.02 102.38 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.383 1.073 . . . . 0.0 111.24 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.44 -41.0 62.7 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.99 1.281 . . . . 0.0 114.946 -175.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 m -62.32 -17.88 59.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.004 1.402 . . . . 0.0 114.652 -176.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -112.83 -2.47 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.389 . . . . 0.0 112.313 171.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.58 20.72 74.13 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.9 1.238 . . . . 0.0 114.438 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -118.54 161.41 20.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.939 1.369 . . . . 0.0 113.724 -170.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.2 m -132.36 159.15 40.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.993 2.117 . . . . 0.0 109.742 167.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -145.71 160.93 41.01 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.169 1.387 . . . . 0.0 109.248 171.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.6 m -88.34 152.9 21.61 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.65 154.59 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.752 1.221 . . . . 0.0 110.942 172.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -74.82 164.82 58.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 167.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -50.86 -28.54 23.84 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.473 2.782 . . . . 0.0 115.758 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -78.59 -6.93 56.93 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.236 2.215 . . . . 0.0 115.459 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.28 -3.27 63.85 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.914 1.245 . . . . 0.0 115.458 177.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.2 m -73.4 131.73 42.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.929 1.365 . . . . 0.0 109.402 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -59.18 142.54 51.41 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.03 110.1 21.25 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -47.67 142.96 13.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.011 3.141 . . . . 0.0 115.334 -169.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 61.09 8.65 2.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.56 1.944 . . . . 0.0 115.225 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -27.58 63.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.037 1.29 . . . . 0.0 110.919 172.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.605 HH21 ' NH2' ' A' ' 57' ' ' ARG . 1.7 ptm180 -41.17 93.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.343 2.257 . . . . 0.0 114.363 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -127.78 163.44 24.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.17 1.788 . . . . 0.0 112.083 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.605 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -69.2 9.05 0.48 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.577 2.751 . . . . 0.0 113.318 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.37 -179.83 47.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.979 1.752 . . . . 0.0 112.658 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -65.19 167.31 8.37 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.156 1.782 . . . . 0.0 114.008 -174.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 167.08 31.54 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.074 1.35 . . . . 0.0 111.359 176.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -78.63 53.63 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.129 2.571 . . . . 0.0 113.196 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.9 m -60.68 95.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.916 1.341 . . . . 0.0 114.576 -169.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 m -89.05 34.43 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.248 2.219 . . . . 0.0 112.033 -169.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -119.88 23.7 10.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.615 1.566 . . . . 0.0 112.962 -169.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 125.285 1.434 . . . . 0.0 111.451 -179.603 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.29 0.09 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 p -83.53 170.08 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -173.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.9 -39.26 62.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.705 1.202 . . . . 0.0 112.684 170.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.9 t -61.22 -59.2 5.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.722 0.809 . . . . 0.0 110.677 171.231 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -59.95 -34.82 73.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.6 0.76 . . . . 0.0 112.595 -176.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.26 -59.29 5.64 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.765 1.626 . . . . 0.0 110.774 170.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.36 -44.99 76.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.183 0.447 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.63 -28.85 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.134 0.974 . . . . 0.0 112.136 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -83.0 3.02 31.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.664 1.586 . . . . 0.0 114.231 169.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -124.17 -33.66 3.05 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.689 1.131 . . . . 0.0 111.976 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.73 102.78 8.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 168.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.34 166.38 29.47 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.545 2.164 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.0 56.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.21 63.57 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.512 1.125 . . . . 0.0 109.272 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -93.52 -5.94 0.11 Allowed Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -178.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -42.39 126.8 4.05 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.726 2.951 . . . . 0.0 115.305 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.99 -23.75 33.57 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.106 1.813 . . . . 0.0 112.401 -169.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.0 p -123.02 159.44 28.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.594 1.558 . . . . 0.0 113.086 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -87.72 106.27 17.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.277 1.031 . . . . 0.0 111.291 175.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -91.76 118.39 68.27 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.97 174.75 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.356 2.037 . . . . 0.0 114.032 175.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -134.55 142.38 46.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.252 1.821 . . . . 0.0 109.94 175.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -137.54 157.67 46.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.802 1.641 . . . . 0.0 109.668 -177.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.24 -177.4 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 171.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -58.03 -22.94 52.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.478 1.511 . . . . 0.0 113.704 -174.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -84.96 -1.14 56.36 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.473 0.579 . . . . 0.0 111.916 176.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.87 86.6 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.892 1.711 . . . . 0.0 114.521 178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.85 160.74 28.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.628 1.714 . . . . 0.0 109.538 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.67 130.42 46.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.83 143.07 77.69 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.75 -17.3 52.18 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.814 . . . . 0.0 113.575 -169.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.07 137.63 44.77 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.705 2.002 . . . . 0.0 108.63 169.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -128.4 150.36 50.14 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.667 1.187 . . . . 0.0 109.414 169.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.4 m -140.99 151.98 44.56 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.972 0.909 . . . . 0.0 111.959 -177.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.36 78.46 1.81 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.795 2.038 . . . . 0.0 107.865 177.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.96 -34.86 58.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.228 0.918 . . . . 0.0 114.334 -170.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -63.72 -15.23 57.97 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -114.31 -0.25 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.646 1.178 . . . . 0.0 111.974 169.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.4 58.23 13.33 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.585 1.088 . . . . 0.0 111.351 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -140.7 154.31 46.3 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.6 m -142.28 160.19 40.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.4 1.88 . . . . 0.0 110.166 167.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -150.08 163.13 38.98 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.881 1.672 . . . . 0.0 109.113 173.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.8 m -89.28 153.09 21.17 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.54 152.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.307 1.043 . . . . 0.0 110.543 171.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.86 162.52 73.71 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 166.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.14 -20.1 29.73 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.586 2.857 . . . . 0.0 116.167 -170.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -83.57 -8.79 59.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.485 2.314 . . . . 0.0 114.67 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.06 -0.93 54.8 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.471 1.51 . . . . 0.0 115.269 -177.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -70.88 115.79 10.42 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.856 1.828 . . . . 0.0 110.342 178.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -54.83 135.3 47.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.836 1.254 . . . . 0.0 112.863 175.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.49 111.7 33.65 Favored Pre-proline 0 C--O 1.242 0.709 0 C-N-CA 125.509 1.524 . . . . 0.0 108.075 172.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -50.97 150.58 12.94 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.647 2.898 . . . . 0.0 113.653 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 59.86 2.24 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.404 1.882 . . . . 0.0 115.933 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p -72.85 -32.4 65.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.297 1.408 . . . . 0.0 110.565 169.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -45.27 103.86 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.335 1.854 . . . . 0.0 112.41 -172.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m -135.48 167.86 20.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.553 1.541 . . . . 0.0 110.14 -171.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -79.67 13.35 2.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.98 -178.16 47.27 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.744 2.116 . . . . 0.0 112.476 -172.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -62.69 162.94 9.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.466 1.506 . . . . 0.0 114.227 -172.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 169.12 22.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.135 1.774 . . . . 0.0 110.332 171.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -74.0 39.88 0.12 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.776 2.83 . . . . 0.0 114.747 -168.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -55.8 110.93 0.8 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -116.96 22.58 12.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.774 1.63 . . . . 0.0 111.658 -171.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.79 14.83 0.33 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.431 2.292 . . . . 0.0 115.539 -168.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 C--N 1.328 -0.326 0 C-N-CA 125.768 1.627 . . . . 0.0 110.75 -171.853 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.746 0.307 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -82.73 167.15 18.46 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.976 0.91 . . . . 0.0 111.235 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -53.47 -42.38 67.18 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.721 -0.612 . . . . 0.0 112.168 171.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.8 t -55.88 -61.4 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.444 0.697 . . . . 0.0 110.688 172.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -56.42 -43.19 79.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.682 1.193 . . . . 0.0 112.744 -178.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -56.43 -53.92 51.75 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.63 1.172 . . . . 0.0 110.706 172.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.15 -41.49 83.85 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.616 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -63.84 -35.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.563 1.074 . . . . 0.0 111.365 175.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -83.28 6.3 20.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.362 1.865 . . . . 0.0 114.733 176.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.44 -37.39 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.704 1.202 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.61 118.72 67.53 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.691 1.596 . . . . 0.0 106.76 172.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.54 168.02 23.34 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.672 2.248 . . . . 0.0 111.849 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.78 -23.63 53.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.277 1.031 . . . . 0.0 113.723 173.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.97 75.39 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.037 1.335 . . . . 0.0 108.549 172.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -118.73 62.04 5.16 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.333 1.053 . . . . 0.0 113.737 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.28 119.42 6.4 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.068 2.512 . . . . 0.0 110.575 172.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.91 88.07 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.389 -0.673 . . . . 0.0 114.465 -177.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -138.38 -179.4 5.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.376 1.47 . . . . 0.0 110.275 174.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -131.39 145.72 51.95 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.102 -0.999 . . . . 0.0 113.008 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -123.92 113.59 28.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.234 2.214 . . . . 0.0 108.295 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.65 161.33 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.694 1.596 . . . . 0.0 112.629 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -118.67 152.72 35.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.894 1.678 . . . . 0.0 109.747 169.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -131.27 151.57 51.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.762 1.225 . . . . 0.0 111.681 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.92 179.59 7.77 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.047 1.339 . . . . 0.0 112.362 173.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -61.37 -17.51 54.34 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -173.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.01 -2.03 58.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.51 1.124 . . . . 0.0 112.464 174.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.87 1.66 84.85 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.608 1.099 . . . . 0.0 113.853 -171.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.57 151.52 34.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.132 1.466 . . . . 0.0 109.072 175.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -51.28 129.92 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 111.281 175.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.62 131.18 77.64 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 117.888 -1.053 . . . . 0.0 108.368 171.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.43 -35.75 36.92 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.677 2.918 . . . . 0.0 114.53 -177.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.91 140.45 33.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.769 1.628 . . . . 0.0 109.898 169.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -126.52 143.52 51.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.226 1.41 . . . . 0.0 108.695 169.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.3 m -139.35 144.98 38.47 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.923 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -113.07 93.27 4.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 110.712 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.97 -9.22 26.89 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.2 p -68.65 -26.33 65.27 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.77 1.785 . . . . 0.0 112.538 169.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -125.56 -16.07 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.948 1.699 . . . . 0.0 112.853 -178.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.12 89.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.497 1.046 . . . . 0.0 114.578 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -81.93 154.4 25.79 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.21 1.005 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.4 m -134.55 165.34 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.018 1.327 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -153.26 165.0 37.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.125 1.77 . . . . 0.0 109.415 169.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 83.3 m -91.86 152.38 20.12 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 169.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.38 159.62 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.142 0.977 . . . . 0.0 113.377 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -92.68 164.85 20.68 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.059 2.143 . . . . 0.0 110.389 168.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -57.72 -5.83 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.749 3.633 . . . . 0.0 118.545 -172.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -103.59 -5.48 22.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.129 1.371 . . . . 0.0 113.865 172.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.46 0.58 55.59 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.797 1.665 . . . . 0.0 114.663 -177.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 m -69.77 128.08 35.18 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.886 1.343 . . . . 0.0 108.497 178.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.84 163.4 27.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.48 100.49 2.76 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 167.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.31 22.57 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.858 1 C-N-CA 125.895 4.396 . . . . 0.0 118.054 -166.436 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.85 -3.21 7.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.409 1.884 . . . . 0.0 112.398 168.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.5 p -92.98 -10.98 34.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.441 1.096 . . . . 0.0 113.246 178.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.51 96.5 0.08 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.157 0.983 . . . . 0.0 110.224 -173.424 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.647 ' HG ' ' CZ ' ' A' ' 57' ' ' ARG . 9.0 t -134.57 163.07 30.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -168.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.647 ' CZ ' ' HG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -69.04 -1.9 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.727 2.811 . . . . 0.0 114.017 -169.889 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.82 -171.04 40.04 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.071 1.796 . . . . 0.0 112.75 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.91 152.22 13.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.494 1.917 . . . . 0.0 114.505 -170.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.43 171.76 19.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.012 1.725 . . . . 0.0 109.502 169.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -116.43 78.12 1.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 0.0 110.824 -168.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.97 119.3 6.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.25 1.82 . . . . 0.0 113.066 -179.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.5 m -67.87 60.41 0.07 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.887 2.075 . . . . 0.0 113.64 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 53.98 29.47 10.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.613 1.965 . . . . 0.0 114.785 177.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.468 0.433 0 C-N-CA 126.202 1.801 . . . . 0.0 112.954 -175.639 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.648 0.737 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -142.13 169.15 18.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.576 2.75 . . . . 0.0 108.823 176.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -51.59 -40.14 59.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 112.87 179.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.1 -62.36 1.94 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.598 0.759 . . . . 0.0 111.517 170.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -59.93 -31.03 69.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.673 0.789 . . . . 0.0 113.006 -176.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -62.11 -58.17 8.82 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.264 1.426 . . . . 0.0 110.509 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -58.31 -38.94 78.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.875 0.762 . . . . 0.0 112.623 177.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.97 -31.22 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.772 0.829 . . . . 0.0 112.223 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 m -72.55 -43.99 62.73 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.926 0.89 . . . . 0.0 112.233 171.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.05 -33.71 57.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 113.413 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.9 mt -99.55 101.56 13.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.75 1.62 . . . . 0.0 106.889 172.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.16 172.59 16.06 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.742 2.295 . . . . 0.0 112.148 -177.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.07 -23.15 31.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.309 1.043 . . . . 0.0 113.355 171.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -76.19 70.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.198 1.399 . . . . 0.0 109.29 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -122.36 24.93 0.11 Allowed Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -62.22 114.69 2.44 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.754 2.303 . . . . 0.0 112.13 -173.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.64 -17.2 30.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.013 1.768 . . . . 0.0 112.956 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.1 t -119.71 177.98 4.75 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.635 1.974 . . . . 0.0 111.646 177.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -94.24 157.69 15.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.252 2.621 . . . . 0.0 110.865 176.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -143.24 129.95 10.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 0.0 108.378 169.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.67 170.53 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.9 1.734 . . . . 0.0 113.221 177.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -137.7 145.63 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.477 3.111 . . . . 0.0 110.368 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -134.07 157.62 45.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.962 0.905 . . . . 0.0 112.504 -174.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -95.52 173.22 7.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.446 1.499 . . . . 0.0 112.798 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -62.43 -13.99 35.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.21 6.41 40.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.105 2.162 . . . . 0.0 111.379 175.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.55 5.78 38.69 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.643 1.592 . . . . 0.0 114.416 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -91.18 164.68 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.431 1.492 . . . . 0.0 109.289 178.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -64.7 130.74 44.71 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.7 138.61 77.25 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.988 176.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -48.12 -31.88 17.49 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.158 3.239 . . . . 0.0 116.13 -177.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.67 139.6 39.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 171.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -129.36 147.26 51.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.218 1.407 . . . . 0.0 108.871 169.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -139.15 125.48 20.28 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.4 68.17 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.3 168.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.21 -30.21 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.312 1.434 . . . . 0.0 114.409 -172.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 m -53.34 -24.87 13.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 173.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -122.03 10.16 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.963 1.705 . . . . 0.0 111.934 173.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.78 3.64 68.39 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.505 1.526 . . . . 0.0 115.006 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -81.59 149.51 28.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.206 1.503 . . . . 0.0 112.128 -169.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.2 m -138.42 160.6 39.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 111.43 168.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -150.71 163.5 38.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.154 1.782 . . . . 0.0 108.831 169.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.1 m -90.45 154.78 19.39 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 169.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.28 159.82 42.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.129 0.972 . . . . 0.0 111.363 175.366 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.77 159.98 72.81 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 165.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -24.32 31.7 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.627 2.884 . . . . 0.0 115.824 -173.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -78.22 -6.74 55.8 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.182 2.193 . . . . 0.0 115.289 174.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.92 56.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.594 1.569 . . . . 0.0 115.237 178.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -72.25 119.3 16.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.893 1.346 . . . . 0.0 109.984 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -59.28 144.88 45.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.739 1.215 . . . . 0.0 113.662 177.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.25 96.55 0.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.73 2.012 . . . . 0.0 106.239 168.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.81 24.01 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.853 1 C-N-CA 125.789 4.326 . . . . 0.0 117.26 -166.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -125.04 -1.25 7.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.149 1.78 . . . . 0.0 112.594 169.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -92.96 -14.41 27.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.047 0.939 . . . . 0.0 113.171 176.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -57.1 107.88 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.069 0.948 . . . . 0.0 112.102 -171.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 t -132.81 158.94 41.2 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.83 1.252 . . . . 0.0 112.374 -171.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 7.72 0.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 128.339 2.656 . . . . 0.0 113.408 169.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.65 -172.42 43.72 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.817 1.199 . . . . 0.0 114.099 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -58.11 154.11 13.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.67 2.388 . . . . 0.0 115.353 -169.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.87 158.39 37.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.063 1.345 . . . . 0.0 110.494 168.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.45 69.65 3.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.592 1.157 . . . . 0.0 110.577 -169.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.2 m -46.3 106.95 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.928 1.691 . . . . 0.0 113.938 -173.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.3 m -130.28 24.23 5.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.477 1.911 . . . . 0.0 112.15 -170.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.09 10.93 2.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 115.066 -169.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.328 -0.368 0 C-N-CA 125.518 1.527 . . . . 0.0 109.439 177.349 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 123.245 1.498 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.6 p -142.76 172.19 13.03 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 130.675 3.59 . . . . 0.0 112.483 -172.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.33 -39.71 32.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 0.0 111.991 169.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -58.71 -62.97 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.434 0.561 . . . . 0.0 110.949 175.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -62.45 -30.54 71.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.62 -58.59 7.49 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.118 1.367 . . . . 0.0 110.764 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -53.31 -48.14 68.67 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.639 0.775 . . . . 0.0 111.136 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.86 -26.3 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.412 1.085 . . . . 0.0 112.639 177.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -89.32 3.22 52.83 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.417 1.487 . . . . 0.0 114.652 171.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -130.93 -29.95 1.84 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.888 1.222 . . . . 0.0 113.905 -173.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.78 116.85 64.0 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.632 0.773 . . . . 0.0 109.105 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -70.16 162.92 40.5 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.877 1.718 . . . . 0.0 111.147 176.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.13 67.67 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.675 -0.641 . . . . 0.0 112.248 170.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -76.81 71.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.277 1.431 . . . . 0.0 109.15 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -114.73 30.19 0.12 Allowed Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 170.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.13 113.48 2.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.491 2.794 . . . . 0.0 112.173 -170.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.99 -16.34 27.92 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.093 1.806 . . . . 0.0 112.765 -174.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -115.93 171.93 7.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.67 1.588 . . . . 0.0 112.443 178.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -88.42 160.33 17.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.86 2.864 . . . . 0.0 111.611 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -141.96 123.16 8.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.08 0.952 . . . . 0.0 110.638 169.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.97 174.83 12.21 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.96 2.44 . . . . 0.0 113.525 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -140.2 149.46 42.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.335 2.254 . . . . 0.0 109.835 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -144.25 160.76 40.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.563 0.745 . . . . 0.0 112.437 -175.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -85.22 176.06 8.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.552 168.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.52 -29.49 66.33 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.319 1.047 . . . . 0.0 112.469 174.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -83.58 14.15 4.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.265 2.226 . . . . 0.0 111.92 -175.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.94 8.53 49.43 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.309 1.433 . . . . 0.0 114.43 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -91.42 146.65 23.63 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.562 1.181 . . . . 0.0 109.214 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -62.43 126.13 26.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.056 0.942 . . . . 0.0 108.919 177.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.3 143.73 79.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.386 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -50.22 -22.5 8.37 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.2 3.267 . . . . 0.0 117.489 -174.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.26 137.24 52.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.47 1.908 . . . . 0.0 109.598 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -130.68 147.2 52.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.846 1.259 . . . . 0.0 109.63 173.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -135.77 122.43 20.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -172.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.13 70.56 10.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.749 1.619 . . . . 0.0 108.057 169.034 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.31 -33.35 31.41 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.343 1.449 . . . . 0.0 114.562 -172.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m -54.73 -24.61 23.0 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 175.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -118.62 6.46 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.301 1.44 . . . . 0.0 112.022 174.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.94 67.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.299 1.428 . . . . 0.0 114.665 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -90.6 150.22 21.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.124 1.462 . . . . 0.0 112.121 -174.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.9 m -134.44 160.51 37.76 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.427 1.491 . . . . 0.0 110.078 168.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -144.45 163.21 34.47 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.169 1.787 . . . . 0.0 109.284 169.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.75 151.71 23.63 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 169.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.25 155.43 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.061 0.945 . . . . 0.0 111.307 172.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.57 159.91 76.01 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.3 -24.44 15.69 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.935 3.09 . . . . 0.0 117.102 -172.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -82.68 -4.77 58.29 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 175.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.77 -0.08 52.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.632 1.587 . . . . 0.0 114.772 -178.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.6 m -70.66 113.93 8.25 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.152 1.476 . . . . 0.0 110.222 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -55.61 136.7 50.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.06 109.76 19.21 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.3 156.48 50.73 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.729 2.286 . . . . 0.0 112.109 -169.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 m120 59.5 2.0 0.3 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.114 1.765 . . . . 0.0 115.52 -175.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -71.35 -30.95 66.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.639 1.563 . . . . 0.0 110.699 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.659 ' NH2' HH12 ' A' ' 57' ' ' ARG 0.279 0.0 OUTLIER -46.65 120.62 3.04 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 123.524 0.729 . . . . 0.0 111.98 -172.506 . . . . . . . . 4 4 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.9 m -151.87 164.73 36.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.784 1.233 . . . . 0.0 111.134 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.659 HH12 ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.98 17.29 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.337 2.655 . . . . 0.0 112.717 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.91 179.78 45.98 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.756 1.646 . . . . 0.0 112.745 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -67.0 167.04 12.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.759 1.623 . . . . 0.0 113.417 -176.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 166.69 32.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.789 1.236 . . . . 0.0 111.353 174.188 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.36 61.25 4.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.831 2.452 . . . . 0.0 112.289 -168.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -65.85 98.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -77.13 23.81 0.18 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.868 2.067 . . . . 0.0 114.895 -175.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.21 25.67 3.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.008 1.323 . . . . 0.0 113.47 -169.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.469 0.512 0 C-N-CA 126.432 1.893 . . . . 0.0 110.543 169.759 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.4 p -84.69 165.73 17.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.359 1.064 . . . . 0.0 112.71 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -51.6 -40.66 60.25 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.726 1.211 . . . . 0.0 113.029 172.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.01 -56.49 16.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.041 -0.412 . . . . 0.0 111.142 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.66 -31.24 69.36 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.41 -61.79 2.29 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.016 1.326 . . . . 0.0 110.082 169.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.67 -37.77 82.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.416 0.553 . . . . 0.0 112.461 -176.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.54 -27.44 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.568 1.147 . . . . 0.0 112.296 175.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -74.43 -41.39 60.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.587 -0.696 . . . . 0.0 111.47 168.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -69.29 -41.92 76.16 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.977 1.311 . . . . 0.0 112.8 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.71 108.95 18.55 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.61 167.29 27.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.915 1.744 . . . . 0.0 111.716 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.55 35.57 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.17 74.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.347 1.459 . . . . 0.0 108.272 169.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -112.98 65.53 0.92 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.965 1.306 . . . . 0.0 111.774 176.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -60.23 121.11 9.27 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.702 2.934 . . . . 0.0 111.734 -171.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.95 13.51 2.25 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.623 1.583 . . . . 0.0 114.98 -174.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.1 m -115.43 161.57 18.37 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.677 1.991 . . . . 0.0 112.373 -167.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -79.55 149.2 31.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.315 0.646 . . . . 0.0 111.513 179.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -144.79 127.64 8.39 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 108.624 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.45 168.52 17.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.581 1.52 . . . . 0.0 113.928 178.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -130.85 150.62 51.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.076 2.55 . . . . 0.0 110.867 173.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -128.93 155.54 45.15 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.552 1.141 . . . . 0.0 112.238 -175.202 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -90.76 176.84 6.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.59 1.556 . . . . 0.0 113.272 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.33 -16.13 31.97 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.86 9.56 38.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.186 1.795 . . . . 0.0 111.697 175.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 5.57 33.0 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.475 1.512 . . . . 0.0 114.432 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.63 166.17 13.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.839 1.256 . . . . 0.0 108.88 178.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -59.81 130.58 47.48 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.817 -0.552 . . . . 0.0 109.976 178.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.3 125.87 59.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.555 173.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.62 -18.57 6.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.641 2.894 . . . . 0.0 116.982 -175.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -111.48 135.31 52.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.655 1.982 . . . . 0.0 108.976 169.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -129.69 154.02 47.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.531 1.133 . . . . 0.0 109.127 169.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.6 m -141.22 159.35 42.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.939 0.895 . . . . 0.0 111.528 178.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.68 90.17 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.789 1.236 . . . . 0.0 109.904 175.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.11 -48.02 26.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.286 1.898 . . . . 0.0 116.052 -169.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -64.91 -13.41 56.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.095 1.447 . . . . 0.0 114.616 -175.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 pt -116.36 -0.45 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 112.812 170.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.01 4.43 55.4 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.867 1.699 . . . . 0.0 115.399 175.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -84.76 148.56 26.29 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.227 1.013 . . . . 0.0 112.811 -176.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.6 m -132.13 159.27 39.41 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.03 1.332 . . . . 0.0 109.75 166.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.1 p90 -151.76 160.92 43.41 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.318 1.447 . . . . 0.0 109.228 173.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.2 m -88.86 153.13 21.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 169.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.76 149.6 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.669 1.188 . . . . 0.0 110.587 175.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -70.22 155.96 92.6 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 165.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -14.56 38.27 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.796 2.331 . . . . 0.0 115.743 -169.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -78.34 -10.97 59.9 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.9 1.68 . . . . 0.0 114.204 171.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.21 -1.35 47.09 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.049 1.785 . . . . 0.0 115.183 -177.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.3 m -73.85 116.16 14.14 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.556 1.678 . . . . 0.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -57.11 145.02 32.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.699 1.2 . . . . 0.0 113.652 175.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.72 87.52 0.71 Allowed Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -64.27 -17.32 59.25 Favored 'Trans proline' 0 C--N 1.351 0.704 0 N-CA-C 118.169 2.334 . . . . 0.0 118.169 -165.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -68.23 -11.44 59.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.455 1.502 . . . . 0.0 113.184 172.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -90.83 -14.0 32.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.215 172.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -55.64 105.08 0.15 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.32 1.418 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m -133.63 166.19 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.79 1.236 . . . . 0.0 112.96 -168.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -70.12 12.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.105 3.362 . . . . 0.0 114.547 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.68 -176.64 41.14 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.38 1.943 . . . . 0.0 112.625 -172.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -61.27 163.13 6.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.338 1.855 . . . . 0.0 114.425 -171.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.19 165.21 37.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.256 1.422 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.11 63.76 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.084 2.154 . . . . 0.0 111.667 -168.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m -57.14 98.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.903 1.335 . . . . 0.0 112.129 -174.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.9 m -76.6 31.62 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.857 2.463 . . . . 0.0 115.168 -167.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.67 13.2 14.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.311 1.844 . . . . 0.0 111.068 169.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 CA--C 1.53 0.177 0 C-N-CA 127.61 2.364 . . . . 0.0 110.734 -175.723 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.561 0.696 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -140.9 167.4 22.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 128.743 2.817 . . . . 0.0 108.637 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -52.75 -38.77 61.41 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.612 0.642 . . . . 0.0 112.169 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 t -58.52 -62.45 1.84 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.345 0.658 . . . . 0.0 111.416 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.52 -32.81 71.83 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.11 -58.99 6.07 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.432 1.493 . . . . 0.0 110.504 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.3 -39.87 84.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.771 0.714 . . . . 0.0 112.481 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.2 -32.26 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.939 0.896 . . . . 0.0 112.109 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -73.6 -45.26 54.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.915 0.886 . . . . 0.0 112.368 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -77.23 -34.06 56.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.045 1.338 . . . . 0.0 113.256 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.5 mt -92.58 102.76 7.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.45 167.56 25.0 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.111 1.874 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.24 -21.57 34.95 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.92 47.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.397 1.879 . . . . 0.0 111.075 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -88.8 -10.2 0.15 Allowed Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -42.31 114.11 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 124.373 3.382 . . . . 0.0 115.208 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.06 -11.25 22.51 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.698 2.094 . . . . 0.0 112.783 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.9 p -140.03 171.74 13.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.681 1.993 . . . . 0.0 112.364 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -81.67 152.2 27.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 111.233 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -142.42 127.55 10.28 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.387 1.475 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.39 176.35 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.296 1.997 . . . . 0.0 113.447 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -140.32 150.26 43.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.074 2.15 . . . . 0.0 110.005 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.59 157.94 43.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.718 0.807 . . . . 0.0 113.039 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -99.26 179.41 4.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.804 1.642 . . . . 0.0 114.125 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -2.1 0.88 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.934 2.094 . . . . 0.0 114.933 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -122.73 19.35 10.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.4 1.88 . . . . 0.0 111.158 173.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.29 5.4 28.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.055 1.312 . . . . 0.0 114.678 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.83 164.39 17.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.076 1.35 . . . . 0.0 108.495 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -62.14 127.55 31.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.26 125.55 50.96 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.867 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.25 -8.53 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.023 3.149 . . . . 0.0 118.088 -176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -119.46 127.31 52.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.539 2.335 . . . . 0.0 107.03 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -120.74 146.31 46.61 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.343 1.057 . . . . 0.0 109.394 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 90.2 m -135.39 124.12 23.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.694 0.798 . . . . 0.0 112.455 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.19 71.08 10.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.687 1.595 . . . . 0.0 108.034 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.62 -35.87 11.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.809 1.671 . . . . 0.0 114.603 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 m -54.61 -22.71 14.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.901 1.681 . . . . 0.0 115.11 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.67 -0.94 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.881 1.673 . . . . 0.0 112.351 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.07 69.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.104 1.811 . . . . 0.0 115.181 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -84.12 154.13 23.33 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.78 1.29 . . . . 0.0 110.896 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.3 m -137.86 165.31 26.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.719 0.808 . . . . 0.0 111.998 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -147.43 162.53 38.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.089 1.756 . . . . 0.0 109.378 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.8 m -86.05 153.64 21.98 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.37 156.77 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.741 0.816 . . . . 0.0 111.65 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.07 160.63 77.86 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 165.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.18 -26.48 26.59 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.374 2.716 . . . . 0.0 115.591 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -75.55 -8.27 56.32 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.752 2.021 . . . . 0.0 115.417 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.57 -3.08 59.17 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.386 1.469 . . . . 0.0 115.339 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 m -73.66 130.72 40.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.033 1.417 . . . . 0.0 109.727 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.75 139.7 57.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.864 0.865 . . . . 0.0 112.517 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.68 115.52 58.83 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.46 134.83 6.76 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.7 3.6 . . . . 0.0 116.062 -169.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 62.88 11.11 4.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.781 2.032 . . . . 0.0 114.755 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -77.7 -22.33 50.63 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.881 1.219 . . . . 0.0 111.724 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.69 103.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.466 1.107 . . . . 0.0 111.814 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -144.92 171.22 14.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.948 1.299 . . . . 0.0 113.018 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -3.93 2.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.199 3.4 . . . . 0.0 115.421 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.67 -172.87 42.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.422 1.487 . . . . 0.0 112.602 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -57.57 164.19 2.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.153 1.781 . . . . 0.0 114.281 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.5 167.1 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.105 1.362 . . . . 0.0 110.56 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.11 60.76 6.45 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 111.724 -168.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 121.251 0.548 . . . . 0.0 112.433 -178.706 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 120.681 0.277 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.5 p -84.92 166.1 17.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.335 1.054 . . . . 0.0 111.994 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -54.95 -35.87 64.7 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 t -59.74 -63.31 1.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.209 0.459 . . . . 0.0 110.591 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -56.55 -32.24 64.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.887 0.875 . . . . 0.0 113.151 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.34 -59.43 5.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.73 1.15 . . . . 0.0 110.665 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -56.96 -42.39 80.05 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -32.23 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.079 0.552 . . . . 0.0 111.896 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m -83.39 6.53 19.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.013 1.725 . . . . 0.0 114.379 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -125.31 -38.18 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 0.0 111.561 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.76 110.14 27.71 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.17 164.01 37.23 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.923 1.748 . . . . 0.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.64 -26.11 61.14 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.64 68.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.82 1.248 . . . . 0.0 109.002 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -102.46 8.76 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -41.86 111.54 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 123.871 3.047 . . . . 0.0 116.007 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.57 9.83 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.74 2.591 . . . . 0.0 112.435 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 t -111.48 165.69 11.77 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.481 1.913 . . . . 0.0 112.37 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -76.37 161.85 28.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.304 1.842 . . . . 0.0 107.354 164.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -147.9 125.46 5.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.428 1.491 . . . . 0.0 108.53 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.9 169.62 20.82 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.733 1.622 . . . . 0.0 113.289 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -135.94 143.66 45.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.757 3.223 . . . . 0.0 109.75 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -141.43 161.84 36.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.37 175.97 5.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.599 1.16 . . . . 0.0 112.896 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -63.84 -18.19 63.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.502 1.521 . . . . 0.0 114.429 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -84.48 11.0 9.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.344 1.057 . . . . 0.0 111.753 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.96 8.19 60.7 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.456 1.027 . . . . 0.0 114.12 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.1 157.43 16.75 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.88 1.272 . . . . 0.0 109.563 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -66.81 129.49 40.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mt -58.41 135.98 85.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.722 -1.132 . . . . 0.0 108.805 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.67 -17.98 11.07 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.443 2.762 . . . . 0.0 117.377 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.19 137.02 50.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.755 2.022 . . . . 0.0 109.157 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -131.1 152.53 50.3 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.596 1.158 . . . . 0.0 109.707 171.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -141.96 137.58 31.33 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.86 76.39 10.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.87 -28.05 38.46 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.265 1.412 . . . . 0.0 114.89 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -62.15 -21.7 65.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.908 1.283 . . . . 0.0 114.11 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -107.41 -26.86 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.224 1.81 . . . . 0.0 109.816 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.78 10.67 84.83 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.882 1.706 . . . . 0.0 112.918 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -84.53 135.67 34.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.685 1.594 . . . . 0.0 109.709 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -130.37 162.36 29.27 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -149.77 163.77 37.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.698 1.599 . . . . 0.0 109.436 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.2 m -86.94 152.42 22.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.75 151.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 110.654 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -71.94 156.51 90.85 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 166.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.2 -21.67 23.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.44 2.76 . . . . 0.0 116.429 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -76.87 -10.89 59.69 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.321 1.848 . . . . 0.0 114.703 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.56 -1.87 53.19 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.717 1.627 . . . . 0.0 115.363 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -74.39 122.08 22.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.873 1.836 . . . . 0.0 109.42 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.73 159.91 21.23 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.94 94.24 2.45 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 168.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.15 18.82 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 125.525 4.15 . . . . 0.0 117.823 -167.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.99 -5.1 10.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.954 2.101 . . . . 0.0 112.934 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 p -87.94 -17.51 31.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.385 1.074 . . . . 0.0 113.112 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -56.77 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.874 1.67 . . . . 0.0 112.455 -168.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -127.67 166.02 18.9 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.921 1.688 . . . . 0.0 114.203 -167.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 1.13 0.61 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.518 3.127 . . . . 0.0 115.517 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.33 -176.25 45.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.135 1.826 . . . . 0.0 112.745 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -60.23 165.07 3.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.567 1.947 . . . . 0.0 114.296 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 165.13 37.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.207 1.403 . . . . 0.0 110.848 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -82.26 58.19 3.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.993 2.117 . . . . 0.0 112.478 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -173.398 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.604 0.716 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -142.66 168.54 19.48 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 128.486 2.714 . . . . 0.0 108.936 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -56.99 -22.31 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 t -74.92 -61.32 1.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 110.66 169.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -30.72 67.48 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 112.991 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -59.66 5.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.604 1.562 . . . . 0.0 110.269 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.75 -35.87 81.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.89 -30.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.131 0.878 . . . . 0.0 112.092 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -74.27 -47.03 37.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 0.0 112.107 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -73.43 -30.61 63.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.257 1.423 . . . . 0.0 113.268 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.96 96.9 6.14 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.08 171.4 18.03 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.937 2.424 . . . . 0.0 112.243 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.17 -20.57 27.34 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.36 69.01 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.537 1.535 . . . . 0.0 109.274 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.423 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 7.9 p80 -127.67 -17.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 31.4 Cg_exo -42.19 116.76 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 124.013 3.142 . . . . 0.0 115.003 -176.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.28 -33.75 5.0 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.893 1.711 . . . . 0.0 111.091 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -111.15 170.66 7.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.171 2.189 . . . . 0.0 111.453 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -82.49 156.72 23.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.189 1.396 . . . . 0.0 111.647 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -144.81 130.82 9.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.521 1.928 . . . . 0.0 108.113 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.7 170.65 19.01 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.185 1.923 . . . . 0.0 113.929 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -137.89 151.73 48.32 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.21 2.204 . . . . 0.0 110.657 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -130.5 159.79 36.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 113.193 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -99.87 176.66 5.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.836 1.654 . . . . 0.0 113.552 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -14.62 36.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.984 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.39 13.89 28.15 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.584 1.554 . . . . 0.0 111.915 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.66 8.4 39.74 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.918 1.246 . . . . 0.0 114.226 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -89.99 164.67 14.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.809 1.243 . . . . 0.0 108.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.44 127.48 31.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mt -54.15 127.66 55.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.94 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -51.57 -21.73 11.33 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.237 2.624 . . . . 0.0 116.153 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.2 134.37 51.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.578 1.951 . . . . 0.0 108.952 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -126.71 149.73 49.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.456 1.103 . . . . 0.0 109.224 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.19 155.31 47.91 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.52 0.728 . . . . 0.0 112.059 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.21 75.92 1.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.063 2.145 . . . . 0.0 107.508 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.7 -44.01 47.38 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.537 1.541 . . . . 0.0 115.061 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 p -65.01 -9.39 21.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.38 -1.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.672 1.124 . . . . 0.0 112.488 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.91 62.26 5.39 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.216 0.912 . . . . 0.0 111.314 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -142.42 154.94 45.02 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.61 161.11 38.73 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.33 1.852 . . . . 0.0 110.458 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.37 163.77 36.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.198 170.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.3 m -89.93 152.29 21.3 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.48 155.2 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.903 1.281 . . . . 0.0 109.914 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -74.3 161.07 79.83 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 166.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.63 -24.22 22.16 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.899 3.066 . . . . 0.0 115.879 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -78.64 -6.28 55.25 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.686 1.994 . . . . 0.0 115.151 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.46 -2.86 59.25 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.596 1.57 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.7 m -73.08 117.93 15.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.903 1.352 . . . . 0.0 110.022 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.89 148.05 11.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.031 1.332 . . . . 0.0 113.579 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.22 92.48 1.22 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.15 23.2 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.827 1 C-N-CA 125.875 4.383 . . . . 0.0 117.795 -166.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -124.95 -2.17 7.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.971 1.708 . . . . 0.0 112.603 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 p -86.01 -19.61 30.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.152 0.981 . . . . 0.0 112.933 174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -45.54 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.835 2.054 . . . . 0.0 112.468 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 m -135.98 166.02 24.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 110.83 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.7 mmm-85 -76.36 6.51 5.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.8 -177.77 45.1 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.373 1.939 . . . . 0.0 112.105 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 114.65 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.04 167.2 31.17 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.825 1.65 . . . . 0.0 110.854 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.29 49.55 0.58 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.226 2.61 . . . . 0.0 114.181 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.787 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.0 p -140.21 179.6 6.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.712 1.205 . . . . 0.0 111.745 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -21.62 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 131.192 3.797 . . . . 0.0 118.407 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.6 t -65.63 -51.21 61.34 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.589 -0.694 . . . . 0.0 110.668 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.72 -31.77 69.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.865 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.13 -54.23 41.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.699 1.136 . . . . 0.0 111.102 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.9 -44.31 86.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.295 0.498 . . . . 0.0 112.007 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.34 -27.1 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.127 0.971 . . . . 0.0 111.786 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -78.82 1.94 21.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.228 1.411 . . . . 0.0 113.963 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -126.4 -35.04 2.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.73 1.212 . . . . 0.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -88.25 109.33 27.57 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.501 1.92 . . . . 0.0 106.304 169.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.78 169.76 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.506 2.137 . . . . 0.0 111.937 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.2 -21.52 34.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.43 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.03 74.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.211 1.405 . . . . 0.0 108.591 169.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -116.4 61.79 2.33 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 124.816 1.247 . . . . 0.0 112.35 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.2 139.36 77.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.76 2.306 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.57 7.46 0.95 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.49 1.519 . . . . 0.0 115.624 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -134.44 176.24 8.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -112.95 140.34 47.85 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.547 1.539 . . . . 0.0 111.665 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -125.12 121.38 25.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.631 1.972 . . . . 0.0 108.297 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 172.24 2.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.766 2.311 . . . . 0.0 114.569 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 146.29 47.44 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.983 1.713 . . . . 0.0 109.441 169.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.76 160.79 39.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -165.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -73.51 173.93 8.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.864 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -61.43 -23.33 65.76 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.41 -9.77 58.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.536 1.934 . . . . 0.0 111.86 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.77 12.68 74.2 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.977 1.275 . . . . 0.0 114.67 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.5 155.46 18.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.455 1.128 . . . . 0.0 108.932 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -67.61 133.25 49.06 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.076 0.55 . . . . 0.0 110.183 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.46 142.05 91.12 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.2 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.89 -26.68 18.71 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.506 2.804 . . . . 0.0 116.4 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.94 45.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 0.0 109.935 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -123.15 144.28 49.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.54 1.136 . . . . 0.0 109.381 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.1 m -137.3 121.09 17.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.673 0.789 . . . . 0.0 112.192 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.43 66.92 9.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.131 1.773 . . . . 0.0 107.308 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.58 40.0 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.53 1.538 . . . . 0.0 114.381 -171.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -57.01 -20.11 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.096 1.758 . . . . 0.0 114.486 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 pt -121.59 2.36 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.785 1.634 . . . . 0.0 112.203 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.13 -4.03 78.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.667 2.079 . . . . 0.0 115.352 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.07 152.73 26.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.881 1.341 . . . . 0.0 112.293 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -139.95 164.47 29.91 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 112.586 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.39 163.77 38.2 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.426 1.89 . . . . 0.0 109.855 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.93 152.25 21.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.76 156.68 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.46 1.104 . . . . 0.0 111.108 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.82 160.07 72.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.56 -24.37 28.75 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.442 2.761 . . . . 0.0 116.256 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -75.84 -12.41 60.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.798 1.639 . . . . 0.0 114.608 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.17 -1.33 47.23 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.01 1.767 . . . . 0.0 115.099 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.8 m -71.34 118.32 13.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.784 1.792 . . . . 0.0 109.962 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.41 136.74 53.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.566 1.146 . . . . 0.0 113.167 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -83.88 110.53 26.11 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.87 158.35 43.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 65.11 -5.02 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.425 2.29 . . . . 0.0 115.218 -173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -78.15 -20.34 52.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.307 1.412 . . . . 0.0 111.773 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.95 91.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.981 1.713 . . . . 0.0 111.069 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -121.53 161.2 22.75 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.396 1.878 . . . . 0.0 113.643 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -13.02 5.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.255 2.622 . . . . 0.0 113.827 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.62 -177.2 36.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.294 0.95 . . . . 0.0 114.532 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -56.62 156.44 6.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.743 2.417 . . . . 0.0 114.737 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -155.87 167.67 29.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 108.316 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -112.11 61.68 0.62 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.278 -0.889 . . . . 0.0 112.489 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.466 0.345 0 C-N-CA 125.824 1.65 . . . . 0.0 113.596 -177.221 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.9 p -127.91 169.14 14.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.979 2.111 . . . . 0.0 110.632 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -38.99 -59.49 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 -49.93 75.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.589 0.631 . . . . 0.0 110.718 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -57.17 -40.62 77.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.524 0.73 . . . . 0.0 112.679 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.69 -57.34 13.1 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.924 0.89 . . . . 0.0 110.306 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.43 -36.85 81.51 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.84 -29.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.417 1.087 . . . . 0.0 112.124 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -72.26 -36.28 68.99 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.569 -0.707 . . . . 0.0 112.035 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -72.98 -46.77 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.602 1.161 . . . . 0.0 112.641 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -76.33 111.53 15.97 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.564 1.146 . . . . 0.0 108.081 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.46 151.82 75.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.113 1.875 . . . . 0.0 111.564 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.54 63.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.21 60.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.526 1.13 . . . . 0.0 109.54 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -90.54 -11.28 0.17 Allowed Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -42.51 128.41 4.7 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.828 3.019 . . . . 0.0 114.821 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.79 -24.59 30.9 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.791 1.662 . . . . 0.0 111.606 -168.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.9 p -123.28 162.65 22.24 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.67 1.988 . . . . 0.0 112.373 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.92 141.32 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.945 0.898 . . . . 0.0 111.08 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -136.47 118.89 11.79 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.286 1.834 . . . . 0.0 108.149 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.73 166.55 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.046 1.831 . . . . 0.0 115.868 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -118.84 142.55 47.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.792 2.837 . . . . 0.0 108.64 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -135.66 158.41 44.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.74 0.816 . . . . 0.0 112.8 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -98.75 -179.8 4.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.979 1.312 . . . . 0.0 113.906 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -62.43 -16.52 55.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -91.93 8.1 39.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.069 1.748 . . . . 0.0 111.929 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.12 2.45 18.59 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.021 1.772 . . . . 0.0 115.145 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.65 167.81 14.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.08 1.752 . . . . 0.0 108.932 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -59.42 133.49 56.14 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.119 -0.363 . . . . 0.0 110.362 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.85 139.04 95.61 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -53.57 -24.26 28.38 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.316 2.678 . . . . 0.0 116.394 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.01 139.01 42.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.019 1.728 . . . . 0.0 110.048 170.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -129.6 153.62 47.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.275 1.43 . . . . 0.0 109.792 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -141.2 157.5 45.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.968 0.907 . . . . 0.0 111.711 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.8 80.12 1.8 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.37 1.868 . . . . 0.0 107.808 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.05 -35.77 54.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.388 0.994 . . . . 0.0 114.235 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -62.76 -14.12 41.08 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.88 4.46 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.112 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.84 38.37 95.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.521 1.058 . . . . 0.0 113.515 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -128.03 152.25 48.17 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.7 m -136.2 159.63 41.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.03 1.732 . . . . 0.0 109.854 166.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -152.66 161.06 43.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.48 1.512 . . . . 0.0 109.387 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.31 152.14 22.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.906 -0.496 . . . . 0.0 109.933 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.08 154.4 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.412 1.085 . . . . 0.0 111.309 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -77.88 159.73 75.6 Favored Pre-proline 0 CA--C 1.554 1.112 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 166.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.44 -23.64 19.48 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.92 3.08 . . . . 0.0 117.555 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -85.37 -2.96 58.66 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.68 56.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.538 1.542 . . . . 0.0 114.82 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.7 m -69.35 109.59 4.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.693 1.247 . . . . 0.0 109.537 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -57.93 143.27 43.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 113.655 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.21 90.59 0.62 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -60.93 -24.06 78.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.908 2.405 . . . . 0.0 117.706 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -66.72 -12.0 56.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.027 2.131 . . . . 0.0 113.272 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -94.04 -10.01 34.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 117.438 -1.268 . . . . 0.0 113.297 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -59.89 106.08 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.312 1.414 . . . . 0.0 111.436 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 t -145.06 172.55 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.694 0.798 . . . . 0.0 113.094 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -65.5 1.5 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.568 3.547 . . . . 0.0 116.023 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.12 -177.74 41.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.69 1.614 . . . . 0.0 112.882 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -55.97 157.14 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.544 1.938 . . . . 0.0 114.139 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 164.73 38.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 111.147 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -85.48 65.46 9.19 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.553 1.541 . . . . 0.0 111.603 -169.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 66.3 m . . . . . 0 CA--C 1.536 0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.291 -179.493 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.573 0.701 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 45.5 p -139.11 171.46 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 128.032 2.533 . . . . 0.0 108.73 173.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -53.89 -35.38 61.54 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.595 -0.691 . . . . 0.0 112.276 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.0 -62.32 1.86 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.535 0.734 . . . . 0.0 111.234 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' THR . 17.6 mm-40 -59.8 -33.16 71.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.397 0.544 . . . . 0.0 112.369 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.92 -60.36 3.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.868 1.267 . . . . 0.0 109.758 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.71 -29.19 70.44 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.28 -32.89 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.853 0.861 . . . . 0.0 111.337 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.5 p -80.03 -28.92 39.25 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.17 -48.69 64.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.184 0.902 . . . . 0.0 111.099 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.7 112.78 53.86 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.451 1.1 . . . . 0.0 108.523 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.19 164.8 34.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.019 1.813 . . . . 0.0 111.215 173.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.16 46.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 t -77.02 72.51 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.942 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -117.5 26.61 0.11 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 174.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.59 116.4 3.51 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.854 2.37 . . . . 0.0 112.148 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.75 -13.42 53.52 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.315 1.436 . . . . 0.0 113.147 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -119.62 176.85 5.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.444 1.898 . . . . 0.0 111.767 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -91.71 159.32 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.061 2.544 . . . . 0.0 110.633 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -143.16 130.91 11.03 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.588 1.555 . . . . 0.0 109.014 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.55 168.59 24.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.335 2.023 . . . . 0.0 112.37 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.575 1.95 . . . . 0.0 110.424 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -128.55 153.67 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.797 1.239 . . . . 0.0 112.97 -169.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -87.54 178.58 6.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.532 1.533 . . . . 0.0 113.264 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pm0 -62.98 -12.73 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -99.82 13.01 35.23 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.149 1.78 . . . . 0.0 111.834 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 3.87 22.36 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.631 1.586 . . . . 0.0 114.708 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.69 166.06 16.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.066 1.746 . . . . 0.0 108.606 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -58.88 130.91 49.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.76 0.709 . . . . 0.0 109.794 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.41 119.99 16.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.826 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.45 -9.09 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.759 2.972 . . . . 0.0 116.912 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.56 124.01 48.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.146 2.178 . . . . 0.0 107.218 167.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.2 145.19 48.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.789 0.836 . . . . 0.0 109.399 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.0 m -136.55 126.51 25.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.748 0.819 . . . . 0.0 112.276 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -83.74 70.31 10.33 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.46 -35.87 29.64 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.624 1.583 . . . . 0.0 114.222 -170.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.3 m -53.28 -22.89 7.75 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.45 1.5 . . . . 0.0 114.733 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.59 2.41 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.739 1.616 . . . . 0.0 112.814 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.75 80.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.34 1.448 . . . . 0.0 115.593 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -84.49 147.2 27.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.717 1.258 . . . . 0.0 112.312 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 m -133.69 163.47 29.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.735 1.214 . . . . 0.0 112.117 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -146.81 161.92 39.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.572 1.949 . . . . 0.0 108.384 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.0 m -86.22 153.18 22.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.82 153.57 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.529 1.132 . . . . 0.0 110.223 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -74.14 160.72 80.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.4 -25.73 25.57 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.44 2.76 . . . . 0.0 115.944 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -75.95 -10.15 59.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.059 1.743 . . . . 0.0 114.856 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.52 -1.78 57.2 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.582 1.563 . . . . 0.0 115.395 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.6 m -75.0 127.99 34.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.896 1.848 . . . . 0.0 109.755 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -57.47 139.84 52.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.35 111.48 31.53 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 168.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -49.88 148.91 11.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.884 3.056 . . . . 0.0 114.679 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.73 6.63 0.9 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.126 1.77 . . . . 0.0 115.412 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 p -74.38 -26.03 59.86 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.949 1.25 . . . . 0.0 111.36 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.605 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -42.42 109.21 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.382 1.873 . . . . 0.0 111.213 -177.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -142.53 164.7 29.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.923 1.289 . . . . 0.0 111.653 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.605 ' NH1' HH22 ' A' ' 55' ' ' ARG . 4.7 mpt_? -77.97 16.28 0.75 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.919 2.488 . . . . 0.0 112.958 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -178.71 47.59 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.27 1.891 . . . . 0.0 112.293 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -65.27 167.53 8.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.131 1.772 . . . . 0.0 114.128 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 166.03 34.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.036 1.334 . . . . 0.0 111.258 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -84.97 63.48 8.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.082 2.153 . . . . 0.0 112.039 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -175.243 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 123.176 1.465 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -143.54 163.97 31.69 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 130.684 3.593 . . . . 0.0 109.584 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -52.59 -42.2 64.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.629 0.649 . . . . 0.0 112.38 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 t -56.53 -61.33 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.498 0.719 . . . . 0.0 111.18 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.92 -34.0 74.01 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.34 -56.18 23.36 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.373 1.469 . . . . 0.0 111.021 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -58.61 -41.88 86.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.312 0.505 . . . . 0.0 112.011 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -62.83 -31.89 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.002 0.921 . . . . 0.0 111.896 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -83.35 4.49 27.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.99 1.716 . . . . 0.0 114.099 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -126.01 -34.78 2.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 0.0 112.057 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -96.9 105.48 24.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.38 171.08 18.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.651 2.234 . . . . 0.0 112.117 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.58 -23.74 42.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.223 1.009 . . . . 0.0 113.502 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.06 76.46 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 108.095 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -115.53 47.93 0.53 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.74 130.08 28.4 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.701 2.267 . . . . 0.0 111.067 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.28 -9.05 50.28 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.383 1.468 . . . . 0.0 114.337 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -120.78 160.53 23.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.482 1.641 . . . . 0.0 113.208 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -77.52 162.99 26.71 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 165.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -147.88 129.75 7.46 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.358 2.263 . . . . 0.0 107.035 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.91 170.84 15.81 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.685 1.59 . . . . 0.0 113.067 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -141.38 148.24 39.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.87 2.068 . . . . 0.0 109.559 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.9 m -135.13 157.58 46.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -101.83 177.37 4.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.683 1.593 . . . . 0.0 113.611 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.77 -14.51 33.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.748 1.619 . . . . 0.0 115.034 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -98.1 13.27 31.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.505 1.522 . . . . 0.0 111.906 171.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.51 37.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.968 1.27 . . . . 0.0 114.334 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -88.33 164.68 15.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.166 1.387 . . . . 0.0 108.918 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.79 126.67 28.34 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.84 131.11 57.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.09 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -48.21 -18.76 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.971 3.781 . . . . 0.0 117.355 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.8 131.68 56.87 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.045 2.138 . . . . 0.0 108.439 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -121.87 146.52 47.02 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 109.289 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.1 m -136.13 119.94 17.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 68.21 9.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.814 1.646 . . . . 0.0 106.823 168.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.66 54.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.227 -1.351 . . . . 0.0 114.149 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.32 -10.53 16.74 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.0 pt -124.34 8.47 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.356 1.462 . . . . 0.0 111.764 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.43 5.45 72.74 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.308 1.432 . . . . 0.0 115.041 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.82 146.69 27.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.195 1.498 . . . . 0.0 112.776 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.08 157.24 47.15 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.11 1.364 . . . . 0.0 109.943 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -144.52 163.15 34.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.456 1.502 . . . . 0.0 109.406 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.1 m -86.03 150.75 24.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.159 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.8 157.01 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.92 0.888 . . . . 0.0 111.151 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -77.84 159.61 75.97 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 165.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.98 -24.29 24.25 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.585 2.857 . . . . 0.0 116.297 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -76.87 -10.36 59.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.14 1.776 . . . . 0.0 114.663 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.96 52.8 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.776 1.655 . . . . 0.0 115.334 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -71.83 116.19 11.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.962 1.881 . . . . 0.0 110.325 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.45 137.18 57.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.332 1.053 . . . . 0.0 113.694 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.22 109.07 16.74 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 168.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.86 158.77 45.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.569 2.18 . . . . 0.0 112.074 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 61.22 -0.47 0.34 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.695 1.998 . . . . 0.0 115.547 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -71.26 -29.17 64.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.431 1.468 . . . . 0.0 110.667 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.532 HH21 ' NH2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -43.57 95.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.199 2.2 . . . . 0.0 113.969 -174.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -125.27 162.34 24.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.205 1.802 . . . . 0.0 111.863 -170.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -72.42 18.61 0.09 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.622 2.769 . . . . 0.0 112.597 175.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.33 -179.76 48.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.434 1.493 . . . . 0.0 113.249 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.25 163.24 13.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.093 1.757 . . . . 0.0 113.515 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 161.38 41.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.474 1.109 . . . . 0.0 111.818 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.13 67.96 9.92 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 111.242 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.309 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.465 0.174 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -84.38 168.19 15.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.954 0.902 . . . . 0.0 112.439 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -54.98 -39.94 69.53 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.622 -0.673 . . . . 0.0 112.031 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -59.64 -57.54 12.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.698 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -58.47 -38.47 77.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.262 0.625 . . . . 0.0 112.632 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -59.96 4.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.679 1.192 . . . . 0.0 110.5 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.64 -41.94 82.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.589 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.83 -33.02 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.252 0.621 . . . . 0.0 111.938 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -81.72 -0.88 44.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.504 1.522 . . . . 0.0 114.561 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -126.23 -31.64 2.79 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.544 1.065 . . . . 0.0 112.394 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.99 108.07 38.54 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.97 169.09 23.4 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.442 2.094 . . . . 0.0 111.746 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.28 27.05 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.347 1.059 . . . . 0.0 113.576 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 t -86.25 76.48 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 108.058 169.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -111.03 70.87 0.72 Allowed Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.078 1.351 . . . . 0.0 111.589 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.22 134.92 47.85 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.975 2.45 . . . . 0.0 110.973 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.84 8.5 0.6 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.184 1.849 . . . . 0.0 116.163 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 p -131.32 168.07 18.18 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.613 1.565 . . . . 0.0 112.913 -168.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.85 152.26 20.82 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.088 1.355 . . . . 0.0 111.763 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -138.53 129.82 15.49 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.59 1.956 . . . . 0.0 107.632 169.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.41 176.1 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.835 1.69 . . . . 0.0 113.015 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -139.68 150.34 44.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.849 2.059 . . . . 0.0 109.637 174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -135.23 158.73 43.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -97.37 -179.31 4.45 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.856 1.663 . . . . 0.0 113.981 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -3.17 0.99 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.622 1.969 . . . . 0.0 114.924 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -123.24 19.47 9.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.96 . . . . 0.0 111.193 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 7.62 29.24 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.277 1.417 . . . . 0.0 114.732 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -85.62 162.81 18.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.751 1.22 . . . . 0.0 108.629 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -63.29 126.84 28.76 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 122.009 -0.432 . . . . 0.0 109.9 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.08 132.28 68.34 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.179 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.34 -17.3 4.0 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.899 3.066 . . . . 0.0 116.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -113.14 131.24 55.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.639 1.976 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.32 147.62 45.43 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.493 1.117 . . . . 0.0 109.396 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.1 m -138.66 122.75 17.97 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.721 0.772 . . . . 0.0 112.482 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.8 69.87 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.666 1.586 . . . . 0.0 106.911 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.84 -35.3 47.04 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.437 1.494 . . . . 0.0 113.778 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -62.65 -11.9 19.93 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.42 -4.44 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.43 1.492 . . . . 0.0 111.553 167.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.14 58.18 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.32 1.914 . . . . 0.0 114.829 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -113.09 152.17 29.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.697 1.749 . . . . 0.0 111.751 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -135.95 165.1 26.44 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.935 0.894 . . . . 0.0 112.51 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -148.93 163.59 37.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 109.34 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 70.9 m -87.23 151.38 23.21 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.02 157.63 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.058 0.943 . . . . 0.0 111.108 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.11 160.69 72.97 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -22.08 23.4 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.508 2.806 . . . . 0.0 116.562 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -79.08 -9.9 59.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.054 1.741 . . . . 0.0 114.517 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.84 55.89 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.612 1.577 . . . . 0.0 115.221 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.2 m -73.17 122.59 22.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.978 1.889 . . . . 0.0 110.04 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.28 137.27 57.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.011 . . . . 0.0 113.52 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -84.1 109.56 19.97 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.24 158.21 41.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.797 2.332 . . . . 0.0 112.948 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 65.18 -0.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.488 2.315 . . . . 0.0 115.098 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.4 p -81.16 -19.11 44.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.102 1.319 . . . . 0.0 112.172 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.44 98.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.276 1.43 . . . . 0.0 110.408 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 t -140.72 170.96 14.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -168.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -63.2 -1.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.636 1 C-N-CA 132.273 4.229 . . . . 0.0 114.655 -171.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.43 -174.8 47.25 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.158 1.361 . . . . 0.0 112.595 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -55.78 157.36 4.29 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.084 1.754 . . . . 0.0 113.421 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.35 171.84 19.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.982 1.313 . . . . 0.0 110.485 175.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -105.98 82.4 1.77 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.017 1.327 . . . . 0.0 110.286 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 126.238 1.815 . . . . 0.0 112.637 174.023 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.903 0.382 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 p -83.83 166.25 18.1 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.522 1.129 . . . . 0.0 110.586 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.0 -39.89 66.48 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.369 -0.832 . . . . 0.0 112.291 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.6 t -58.38 -61.8 2.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.625 0.77 . . . . 0.0 111.265 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -62.01 -34.25 75.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.908 -0.568 . . . . 0.0 112.251 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.47 -59.55 4.98 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.746 1.218 . . . . 0.0 110.194 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -54.76 -47.84 73.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.755 0.422 . . . . 0.0 111.339 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 ' SG ' ' A' ' 23' ' ' CYS . 64.2 t -62.52 -28.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.868 0.867 . . . . 0.0 112.513 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.9 p -80.27 -2.29 44.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -131.42 -24.66 2.25 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -170.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.45 116.78 63.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.642 1.11 . . . . 0.0 109.542 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.31 163.05 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.929 1.753 . . . . 0.0 111.246 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.71 67.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.549 -0.72 . . . . 0.0 112.564 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.04 74.58 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.424 1.49 . . . . 0.0 108.498 170.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -111.41 63.68 0.53 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.73 1.212 . . . . 0.0 112.036 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.81 136.44 53.35 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.499 2.8 . . . . 0.0 110.949 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.28 13.79 0.77 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.274 1.416 . . . . 0.0 115.412 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -124.52 155.08 39.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.915 1.358 . . . . 0.0 113.173 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -75.97 157.45 33.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.545 1.538 . . . . 0.0 112.206 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -142.53 115.7 6.31 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 110.539 168.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.45 169.89 20.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.091 1.861 . . . . 0.0 113.422 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -136.81 143.18 43.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.155 2.982 . . . . 0.0 109.295 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' SG ' HG21 ' A' ' 8' ' ' VAL . 3.8 m -134.33 159.82 39.84 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.557 1.071 . . . . 0.0 113.02 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -95.81 174.93 6.71 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.653 1.581 . . . . 0.0 112.91 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -59.67 -20.93 59.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.463 1.105 . . . . 0.0 113.731 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.68 6.04 25.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.011 2.124 . . . . 0.0 111.636 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.5 7.09 38.28 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.628 1.585 . . . . 0.0 114.443 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.27 162.24 15.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.116 1.366 . . . . 0.0 109.32 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -61.71 126.8 28.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -55.64 138.2 69.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.854 -1.07 . . . . 0.0 108.652 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.85 -27.53 16.03 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.219 2.613 . . . . 0.0 115.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.49 135.47 45.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.533 1.533 . . . . 0.0 109.645 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -125.63 149.99 47.94 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.711 1.204 . . . . 0.0 109.018 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.0 m -137.78 153.49 49.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.662 1.22 . . . . 0.0 112.704 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.76 66.76 1.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.379 2.672 . . . . 0.0 106.096 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.78 -31.56 54.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.99 1.281 . . . . 0.0 113.598 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -60.13 -12.58 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.429 1.491 . . . . 0.0 114.791 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 pt -126.72 6.69 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 126.204 1.801 . . . . 0.0 111.693 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.69 7.95 87.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 0.0 115.556 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.99 156.96 16.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.667 1.733 . . . . 0.0 114.282 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.5 m -144.23 157.67 44.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.481 1.912 . . . . 0.0 109.93 166.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -148.49 164.62 33.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.79 1.636 . . . . 0.0 109.308 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.59 153.51 20.71 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.2 159.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.079 1.352 . . . . 0.0 110.66 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -79.33 161.28 68.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 165.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -52.04 -25.24 21.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.728 2.952 . . . . 0.0 116.32 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -78.22 -7.65 57.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.164 1.785 . . . . 0.0 115.301 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.63 -1.97 52.93 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.811 1.672 . . . . 0.0 114.984 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -71.12 113.77 8.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.963 1.382 . . . . 0.0 110.489 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -56.72 134.22 54.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.763 1.225 . . . . 0.0 113.709 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.63 111.37 31.49 Favored Pre-proline 0 C--O 1.241 0.61 0 C-N-CA 125.655 1.582 . . . . 0.0 107.131 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.49 161.41 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.64 2.227 . . . . 0.0 111.915 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.44 -2.55 0.12 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.359 1.864 . . . . 0.0 115.894 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.8 p -72.12 -31.51 66.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.46 1.482 . . . . 0.0 110.275 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -46.16 99.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.238 2.215 . . . . 0.0 112.834 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -129.77 165.91 20.97 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.741 1.616 . . . . 0.0 111.478 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 23.33 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.527 2.331 . . . . 0.0 111.927 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.56 -174.17 45.57 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.675 1.131 . . . . 0.0 114.438 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -61.43 152.51 29.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.886 2.474 . . . . 0.0 115.454 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 158.62 44.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.749 168.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -85.97 61.31 6.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.822 1.249 . . . . 0.0 112.607 -167.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.408 -174.493 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 121.519 0.675 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.433 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 27.6 p -138.6 172.69 12.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.208 2.603 . . . . 0.0 108.407 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -52.19 -38.1 56.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.194 0.598 . . . . 0.0 112.327 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.4 t -63.8 -58.18 7.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.357 0.663 . . . . 0.0 111.316 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' THR . 29.2 mm100 -58.9 -35.05 72.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.3 -60.59 3.57 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.127 1.371 . . . . 0.0 110.398 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.43 -37.17 80.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.11 -31.26 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.78 0.832 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -72.16 -41.56 66.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.728 . . . . 0.0 112.387 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -74.73 -40.65 61.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.045 1.338 . . . . 0.0 112.986 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.1 mm -89.04 110.4 37.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.5 168.11 25.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.206 1.938 . . . . 0.0 111.452 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.51 -18.5 29.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.72 78.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.229 1.411 . . . . 0.0 107.666 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -114.86 53.62 0.75 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.764 1.225 . . . . 0.0 113.779 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -62.33 131.5 34.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 -5.47 3.83 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.613 -1.104 . . . . 0.0 115.673 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -113.93 156.4 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.737 1.768 . . . . 0.0 113.0 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -73.1 161.57 30.47 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -147.56 124.6 5.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 126.678 1.991 . . . . 0.0 108.404 168.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.64 172.03 16.59 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.749 1.632 . . . . 0.0 114.049 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -135.91 144.31 45.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.727 3.211 . . . . 0.0 110.102 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -137.81 160.32 39.6 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -103.69 178.7 4.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.901 1.681 . . . . 0.0 114.23 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.64 0.15 1.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.53 1.932 . . . . 0.0 114.656 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.93 19.27 10.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.6 8.65 40.65 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.026 1.298 . . . . 0.0 114.555 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.09 164.25 14.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.69 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.95 127.43 31.22 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.03 135.46 84.01 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 117.678 -1.153 . . . . 0.0 108.472 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -52.85 -10.21 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.49 2.793 . . . . 0.0 117.41 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.88 137.79 51.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.284 1.834 . . . . 0.0 109.227 167.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -129.79 145.58 51.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 109.056 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 98.0 m -137.15 119.02 15.19 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.635 0.731 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.3 66.09 9.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.453 1.501 . . . . 0.0 107.335 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.53 -32.16 45.46 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.195 1.379 . . . . 0.0 113.786 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 m -60.43 -12.52 9.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.325 1.45 . . . . 0.0 114.913 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.59 7.63 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.286 1.834 . . . . 0.0 111.697 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.69 -2.95 77.08 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.192 1.853 . . . . 0.0 115.41 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -83.06 151.66 25.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.133 1.466 . . . . 0.0 113.304 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.74 160.72 39.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.043 0.937 . . . . 0.0 111.056 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -152.06 164.67 36.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.58 1.552 . . . . 0.0 108.817 169.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.44 154.5 17.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 110.571 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.36 157.96 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.768 0.827 . . . . 0.0 111.695 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.95 159.73 70.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.41 -21.23 17.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.067 3.178 . . . . 0.0 117.683 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -84.93 -4.44 59.12 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.79 1.636 . . . . 0.0 114.791 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.61 1.01 55.39 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.712 1.625 . . . . 0.0 114.641 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.1 m -71.75 115.75 11.31 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.902 1.351 . . . . 0.0 109.96 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -60.41 144.79 50.13 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.73 89.67 0.66 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.598 2.359 . . . . 0.0 104.818 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.54 -14.09 42.45 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.796 2.33 . . . . 0.0 117.583 -166.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -67.35 -10.86 55.17 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 127.107 2.163 . . . . 0.0 113.234 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -107.37 2.31 24.31 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.09 1.756 . . . . 0.0 112.545 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -62.83 94.17 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.403 1.001 . . . . 0.0 110.916 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -129.98 161.1 31.68 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -168.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.34 10.07 2.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.063 2.545 . . . . 0.0 113.146 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.58 -179.22 48.31 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.406 1.955 . . . . 0.0 112.234 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.68 157.46 9.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.486 1.914 . . . . 0.0 114.484 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -155.17 168.91 25.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.564 2.745 . . . . 0.0 106.145 168.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -111.22 34.64 3.95 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -163.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m . . . . . 0 N--CA 1.467 0.399 0 O-C-N 121.627 -0.67 . . . . 0.0 112.029 175.561 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -82.89 166.86 18.57 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 111.314 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -53.51 -41.28 66.16 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.595 -0.691 . . . . 0.0 111.916 171.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.79 -60.21 4.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.309 0.644 . . . . 0.0 110.753 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.95 -39.09 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.351 0.66 . . . . 0.0 112.599 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.21 -56.82 16.86 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.878 1.271 . . . . 0.0 110.928 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -56.57 -43.76 80.32 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.42 0.554 . . . . 0.0 111.571 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.14 -34.97 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.537 0.735 . . . . 0.0 111.67 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -83.82 2.95 35.8 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.04 1.736 . . . . 0.0 114.318 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.58 -34.13 2.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.264 1.026 . . . . 0.0 112.392 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -89.13 113.69 57.25 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.32 163.82 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.237 1.958 . . . . 0.0 111.41 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -22.72 50.73 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.81 73.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.89 1.276 . . . . 0.0 108.66 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -110.9 35.51 0.12 Allowed Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.24 133.66 11.87 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.643 2.229 . . . . 0.0 113.546 169.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.75 -10.81 36.9 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.284 1.421 . . . . 0.0 114.617 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -130.08 173.29 10.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.733 1.767 . . . . 0.0 113.857 -170.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -94.17 152.87 18.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.524 2.329 . . . . 0.0 110.608 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -139.84 123.58 10.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.514 1.526 . . . . 0.0 108.606 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.99 175.95 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.3 2.0 . . . . 0.0 113.094 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 148.18 31.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.343 2.257 . . . . 0.0 109.519 173.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.7 158.42 44.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.83 0.852 . . . . 0.0 113.143 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -91.42 -175.96 4.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.652 1.581 . . . . 0.0 113.414 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -61.56 -16.8 51.23 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -91.48 -5.83 53.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.342 1.457 . . . . 0.0 112.103 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.79 81.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.11 0.862 . . . . 0.0 113.827 -169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -77.9 152.47 33.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.154 1.477 . . . . 0.0 109.478 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -55.41 125.39 20.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.966 0.506 . . . . 0.0 109.723 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.64 142.99 69.77 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.434 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -49.69 -22.89 7.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.567 3.512 . . . . 0.0 117.684 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.06 136.76 52.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.867 2.067 . . . . 0.0 109.406 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -130.03 152.57 49.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.233 1.013 . . . . 0.0 109.321 169.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.54 129.99 20.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.52 73.6 10.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.854 1.662 . . . . 0.0 106.528 168.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -46.59 -43.09 15.01 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.66 1.6 . . . . 0.0 114.258 -170.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 t -63.05 -8.83 8.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.3 pt -126.46 0.38 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.644 1.578 . . . . 0.0 112.44 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.6 7.19 85.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.538 1.066 . . . . 0.0 115.214 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -82.2 128.87 34.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.377 1.589 . . . . 0.0 110.532 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.02 158.77 25.15 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.903 0.881 . . . . 0.0 110.426 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -150.24 160.21 43.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.669 1.588 . . . . 0.0 108.676 171.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -86.18 155.06 20.89 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.28 154.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 122.016 0.912 . . . . 0.0 112.806 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.34 158.78 76.23 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 166.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 -8.36 17.09 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.693 2.262 . . . . 0.0 115.658 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -85.21 -12.14 53.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.306 1.843 . . . . 0.0 114.2 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.71 -2.07 52.68 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.907 1.717 . . . . 0.0 115.543 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.3 m -74.69 133.24 42.1 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.93 1.865 . . . . 0.0 109.068 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.35 155.22 40.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.73 111.53 35.76 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 125.822 1.649 . . . . 0.0 106.643 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.49 150.25 11.92 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.76 . . . . 0.0 113.646 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 61.84 1.5 0.63 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.508 1.923 . . . . 0.0 115.671 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 p -74.23 -28.5 61.27 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.398 1.454 . . . . 0.0 111.012 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -43.8 103.02 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.149 2.18 . . . . 0.0 112.136 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -138.26 162.45 34.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.408 1.083 . . . . 0.0 112.453 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.07 13.72 0.1 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.803 3.241 . . . . 0.0 114.314 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.73 -169.65 40.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.194 1.854 . . . . 0.0 113.46 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -57.49 152.39 14.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.444 2.298 . . . . 0.0 115.392 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.45 155.91 39.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.637 1.575 . . . . 0.0 108.987 168.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -94.43 70.64 3.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.52 1.128 . . . . 0.0 110.638 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 125.374 1.47 . . . . 0.0 112.913 -176.109 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.478 0.18 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 p -84.37 171.1 12.94 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -53.79 -41.76 67.6 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.978 1.311 . . . . 0.0 112.035 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.51 -57.74 11.64 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.289 0.636 . . . . 0.0 110.622 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -60.52 -35.45 76.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 112.634 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.94 -57.15 14.1 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.78 1.232 . . . . 0.0 110.624 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -57.4 -42.32 82.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.345 0.521 . . . . 0.0 111.875 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.96 -32.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 111.857 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -86.39 6.83 28.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.562 1.945 . . . . 0.0 114.187 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.04 -37.8 2.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.669 1.188 . . . . 0.0 111.55 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -92.44 107.68 25.53 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.73 171.16 18.71 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.536 2.158 . . . . 0.0 111.694 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.3 -21.97 38.59 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -84.71 76.84 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.284 1.434 . . . . 0.0 108.106 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -114.36 63.19 1.28 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.903 1.281 . . . . 0.0 112.69 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 138.55 68.46 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 111.594 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 55.35 10.85 3.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.708 1.623 . . . . 0.0 114.432 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -126.75 161.13 28.87 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.668 1.234 . . . . 0.0 113.242 -167.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -83.72 157.14 22.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.329 1.451 . . . . 0.0 111.294 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -143.48 129.67 10.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.954 1.702 . . . . 0.0 108.083 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.21 175.07 10.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.101 1.867 . . . . 0.0 112.747 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -142.99 149.31 38.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.386 1.875 . . . . 0.0 109.329 172.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.97 158.85 43.26 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.35 1.06 . . . . 0.0 111.563 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -98.76 -174.86 2.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.294 1.037 . . . . 0.0 113.495 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -22.45 56.03 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.15 -8.66 59.02 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.172 0.589 . . . . 0.0 111.807 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.41 4.27 84.02 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.354 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.76 160.46 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.047 1.924 . . . . 0.0 109.339 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -59.35 132.15 53.14 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -61.42 142.72 93.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.013 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.27 -28.61 20.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.914 3.076 . . . . 0.0 116.264 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -106.23 141.25 37.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.46 1.904 . . . . 0.0 109.533 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -131.64 150.59 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.323 1.449 . . . . 0.0 109.084 169.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.1 m -139.65 134.45 32.03 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.26 72.7 10.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.26 -39.4 20.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.617 1.58 . . . . 0.0 114.731 -169.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -64.5 -9.7 20.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 pt -123.38 -4.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 112.088 169.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.1 84.97 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.006 1.765 . . . . 0.0 115.571 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -84.05 151.22 25.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.295 1.548 . . . . 0.0 111.026 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -136.95 165.33 26.25 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.188 0.995 . . . . 0.0 112.667 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -149.05 165.08 32.77 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -88.18 151.87 22.38 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.45 149.43 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.6 0.76 . . . . 0.0 110.798 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -71.11 158.95 87.04 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -52.49 -21.65 14.57 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.626 2.884 . . . . 0.0 117.416 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -85.41 -3.68 58.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.53 1.532 . . . . 0.0 114.507 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.69 -0.48 52.58 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.376 1.465 . . . . 0.0 114.754 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m -70.71 113.8 8.16 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.071 1.435 . . . . 0.0 110.534 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.21 135.22 38.56 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -83.31 109.49 17.99 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.0 156.41 54.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.493 2.129 . . . . 0.0 112.004 -169.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 63.84 -1.51 0.64 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.066 2.146 . . . . 0.0 115.334 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 p -77.66 -23.25 49.69 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.464 1.484 . . . . 0.0 111.827 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.85 99.17 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.048 1.739 . . . . 0.0 110.984 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.2 t -140.5 171.24 14.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.759 1.224 . . . . 0.0 113.451 -168.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -6.65 3.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.019 3.328 . . . . 0.0 115.29 -173.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.39 -176.85 43.99 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.918 1.247 . . . . 0.0 112.957 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -55.64 157.74 3.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.78 2.032 . . . . 0.0 113.518 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.8 164.42 38.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 0.0 112.232 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -84.0 61.4 6.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.942 2.097 . . . . 0.0 111.849 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 123.848 0.859 . . . . 0.0 112.144 -175.172 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.7 p -82.95 167.45 17.96 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.952 0.901 . . . . 0.0 111.398 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -53.63 -37.67 63.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.643 0.777 . . . . 0.0 112.591 171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.0 t -60.36 -61.41 2.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -58.85 -37.27 76.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.422 0.689 . . . . 0.0 112.548 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.43 -59.17 5.88 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.196 1.398 . . . . 0.0 110.514 171.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -55.96 -46.63 78.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.416 0.553 . . . . 0.0 111.61 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.39 -33.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.056 0.542 . . . . 0.0 111.432 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -82.51 3.62 27.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.332 1.853 . . . . 0.0 114.509 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -126.03 -23.79 3.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.105 1.32 . . . . 0.0 113.506 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 mm -61.34 133.21 92.96 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 167.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.27 174.39 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.714 1.61 . . . . 0.0 112.986 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.43 -45.61 53.43 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.608 -0.682 . . . . 0.0 110.6 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.21 72.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.453 1.501 . . . . 0.0 108.799 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.521 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 0.9 OUTLIER -133.93 -16.28 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -179.044 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 44.0 Cg_exo -44.76 122.12 3.89 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 123.801 3.0 . . . . 0.0 114.29 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 -41.4 1.94 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.45 1.5 . . . . 0.0 110.517 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.1 p -74.74 163.5 27.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.366 1.467 . . . . 0.0 112.768 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -75.94 155.8 34.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.028 0.931 . . . . 0.0 111.323 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -144.77 128.5 8.74 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 125.503 1.521 . . . . 0.0 108.853 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.47 175.01 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.116 1.877 . . . . 0.0 112.289 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 153.69 40.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.631 1.572 . . . . 0.0 111.133 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.42 159.33 38.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.494 1.118 . . . . 0.0 113.071 -168.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -95.95 -179.69 4.78 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.983 1.713 . . . . 0.0 113.692 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -16.11 48.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.313 1.445 . . . . 0.0 114.866 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.72 13.76 31.1 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.788 1.635 . . . . 0.0 111.771 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 2.21 14.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.648 1.594 . . . . 0.0 114.71 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.34 164.14 20.19 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.811 1.306 . . . . 0.0 108.766 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -60.23 128.87 38.91 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.37 0.532 . . . . 0.0 109.827 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.79 128.23 62.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.15 -1.405 . . . . 0.0 108.675 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.62 -18.74 6.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.799 2.999 . . . . 0.0 116.761 -174.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.53 132.65 54.99 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.961 2.104 . . . . 0.0 108.551 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -124.84 151.87 44.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.254 1.022 . . . . 0.0 108.718 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 83.9 m -141.4 156.99 45.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.688 0.795 . . . . 0.0 112.07 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.03 93.45 3.19 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 110.742 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.76 -36.38 59.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.18 1.371 . . . . 0.0 115.091 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -57.76 -20.78 37.5 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.094 1.447 . . . . 0.0 114.503 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 pt -123.41 2.63 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.98 1.712 . . . . 0.0 112.207 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.44 12.22 69.33 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.293 1.425 . . . . 0.0 114.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -86.82 155.55 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.035 1.418 . . . . 0.0 113.339 -171.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.0 m -140.4 157.19 45.91 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.275 1.83 . . . . 0.0 109.57 166.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -149.5 162.7 39.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.628 1.571 . . . . 0.0 108.941 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.2 m -90.05 152.05 21.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.3 153.26 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.111 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -76.74 161.71 73.03 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 166.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -53.38 -23.85 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 116.361 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -80.8 -8.84 59.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.076 2.15 . . . . 0.0 114.924 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.27 59.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.34 1.447 . . . . 0.0 115.454 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.3 m -72.61 127.42 32.51 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.699 1.75 . . . . 0.0 108.863 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -71.83 165.92 23.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -99.83 92.8 2.11 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -68.85 23.2 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.863 1 C-N-CA 126.021 4.481 . . . . 0.0 117.907 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -124.77 -3.4 7.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.278 1.831 . . . . 0.0 112.465 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.9 p -84.95 -20.71 30.19 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.147 0.979 . . . . 0.0 113.067 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -57.25 97.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.076 1.351 . . . . 0.0 112.566 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -131.78 168.38 17.9 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.301 1.84 . . . . 0.0 111.992 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 21.8 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.108 2.563 . . . . 0.0 112.375 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 174.47 45.84 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.752 1.168 . . . . 0.0 113.219 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -62.82 164.08 8.5 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.059 1.744 . . . . 0.0 114.016 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 162.86 40.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.822 1.249 . . . . 0.0 111.212 175.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.07 63.44 7.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.952 1.701 . . . . 0.0 111.812 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 113.335 -172.538 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 160.32 19.51 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.802 1.641 . . . . 0.0 111.137 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -46.39 -53.21 11.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -58.13 -55.92 28.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.496 0.318 . . . . 0.0 111.419 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.98 -41.7 71.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.005 0.922 . . . . 0.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.03 -60.58 3.37 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.889 1.276 . . . . 0.0 109.893 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.63 -46.23 77.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.172 0.442 . . . . 0.0 111.77 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.86 -30.82 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.342 0.657 . . . . 0.0 111.745 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p -79.72 -3.83 49.2 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.78 -21.96 4.3 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.698 1.136 . . . . 0.0 113.997 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.52 137.44 97.08 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 167.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.99 168.65 16.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 121.879 1.72 . . . . 0.0 112.511 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.43 -45.8 68.27 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.541 -0.724 . . . . 0.0 110.318 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 t -77.82 71.65 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.99 1.316 . . . . 0.0 108.784 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -113.95 -9.06 0.1 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -42.87 112.4 0.27 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.441 2.761 . . . . 0.0 114.242 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -46.17 1.1 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.211 1.862 . . . . 0.0 108.672 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -85.61 141.7 29.62 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.802 1.241 . . . . 0.0 111.732 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -64.18 163.98 11.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.789 1.236 . . . . 0.0 109.391 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -142.54 125.21 9.11 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 127.064 2.146 . . . . 0.0 108.947 173.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.73 170.29 7.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.615 2.21 . . . . 0.0 115.843 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -131.84 148.77 52.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.746 2.418 . . . . 0.0 109.146 169.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.87 155.34 46.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -86.14 175.46 8.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.254 1.421 . . . . 0.0 113.05 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.95 -18.18 43.49 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.19 7.66 36.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.329 1.852 . . . . 0.0 111.782 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.23 8.0 41.55 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.344 1.45 . . . . 0.0 114.632 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -91.19 167.65 12.18 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.749 1.62 . . . . 0.0 109.135 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -58.35 133.4 55.69 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.937 -0.477 . . . . 0.0 110.542 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -57.16 133.32 80.75 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.531 170.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -51.24 -30.21 32.26 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.519 2.813 . . . . 0.0 115.566 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.55 137.87 42.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.884 1.674 . . . . 0.0 109.262 169.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -123.74 147.2 47.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 0.0 108.358 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.68 155.49 48.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.109 0.964 . . . . 0.0 110.224 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.47 91.02 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.328 1.061 . . . . 0.0 111.157 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -13.19 34.99 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 117.564 1.785 . . . . 0.0 117.564 -169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.2 p -69.8 -23.65 63.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.159 1.98 . . . . 0.0 112.655 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.1 pt -120.44 -19.26 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.906 1.683 . . . . 0.0 112.492 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 10.27 84.6 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.547 1.546 . . . . 0.0 114.753 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -83.51 157.92 22.2 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.525 1.163 . . . . 0.0 110.755 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.6 m -135.11 163.63 29.47 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.826 1.25 . . . . 0.0 112.416 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -150.87 163.3 38.98 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.144 1.778 . . . . 0.0 109.755 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -89.76 151.85 21.61 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 169.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.2 154.42 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.232 1.013 . . . . 0.0 110.923 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -75.77 162.97 70.05 Favored Pre-proline 0 CA--C 1.552 1.047 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.26 -23.38 23.09 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.878 3.052 . . . . 0.0 116.508 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -82.79 -11.88 57.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.624 1.97 . . . . 0.0 114.691 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.42 49.19 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.457 1.503 . . . . 0.0 115.826 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 m -69.64 119.24 13.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.762 1.781 . . . . 0.0 109.575 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.01 138.5 54.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.914 0.886 . . . . 0.0 112.942 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.73 107.66 11.01 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.18 152.93 77.2 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -169.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 71.42 -3.62 2.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 128.438 2.695 . . . . 0.0 114.396 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.2 p -79.24 -19.98 49.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.222 1.374 . . . . 0.0 112.072 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.1 97.46 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.26 1.424 . . . . 0.0 110.293 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.9 t -137.66 168.78 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.129 1.372 . . . . 0.0 113.217 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -7.73 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 129.324 3.05 . . . . 0.0 115.084 -173.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.21 -169.18 40.3 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.654 1.121 . . . . 0.0 113.422 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.99 150.66 4.13 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.999 2.52 . . . . 0.0 114.777 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 164.63 38.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.794 1.238 . . . . 0.0 110.92 170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -95.54 66.61 2.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.871 1.268 . . . . 0.0 111.602 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.234 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.055 -179.8 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -83.26 167.7 17.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.39 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -52.94 -39.21 62.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.298 0.639 . . . . 0.0 112.099 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 t -59.57 -59.68 5.05 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.599 0.759 . . . . 0.0 110.9 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.75 -37.13 78.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.632 0.773 . . . . 0.0 112.537 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.11 -58.66 7.43 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.152 1.381 . . . . 0.0 110.841 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -56.94 -41.04 77.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.488 0.585 . . . . 0.0 112.108 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.04 -29.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.333 1.053 . . . . 0.0 112.365 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 m -72.59 -42.83 64.12 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.762 0.825 . . . . 0.0 112.274 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -78.85 -37.3 40.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.809 1.244 . . . . 0.0 113.265 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.4 mt -90.75 104.33 9.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.24 169.13 21.45 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.186 1.924 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.91 -24.55 38.25 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.44 68.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 0.0 108.873 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -104.34 8.81 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -41.96 136.67 3.4 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.452 2.768 . . . . 0.0 115.234 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.07 -18.56 35.41 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.888 1.708 . . . . 0.0 113.494 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.4 p -130.34 166.69 19.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.177 1.488 . . . . 0.0 114.362 -169.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -82.78 145.05 29.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.613 1.565 . . . . 0.0 110.733 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -133.7 123.95 17.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.944 1.698 . . . . 0.0 107.96 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.98 175.61 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.848 1.699 . . . . 0.0 114.569 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -136.83 146.36 45.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.826 2.05 . . . . 0.0 109.206 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 m -135.17 153.42 51.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.102 0.865 . . . . 0.0 112.301 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -95.48 -176.38 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.524 1.129 . . . . 0.0 114.03 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -61.14 -24.3 66.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -86.56 8.69 21.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.236 1.414 . . . . 0.0 112.667 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.15 2.08 12.38 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.472 1.511 . . . . 0.0 114.833 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -82.87 169.59 15.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.523 1.529 . . . . 0.0 108.553 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -61.29 133.63 56.09 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.651 -0.656 . . . . 0.0 109.6 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.14 145.59 72.94 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.75 -14.28 38.81 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.881 1.72 . . . . 0.0 114.144 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -110.63 135.51 51.15 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.172 2.189 . . . . 0.0 107.978 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -128.7 150.11 50.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.444 1.098 . . . . 0.0 109.491 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.9 m -140.68 134.83 30.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.269 0.628 . . . . 0.0 112.216 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.69 73.61 9.71 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.39 15.79 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.685 1.612 . . . . 0.0 114.598 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.68 -11.67 27.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.86 -5.28 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.481 1.513 . . . . 0.0 112.421 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.45 8.29 83.71 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.88 1.705 . . . . 0.0 115.629 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -83.91 148.1 27.13 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.093 1.447 . . . . 0.0 110.733 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.5 m -135.34 164.02 28.69 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.224 1.01 . . . . 0.0 113.037 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -149.35 163.58 37.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.689 1.996 . . . . 0.0 109.038 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -88.86 155.14 19.71 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.43 156.38 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.381 1.072 . . . . 0.0 111.796 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -76.46 164.81 57.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 166.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.83 -29.96 36.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.474 2.783 . . . . 0.0 115.893 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.61 -6.34 56.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.131 2.172 . . . . 0.0 114.643 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.12 0.93 65.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.626 1.108 . . . . 0.0 115.189 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.7 m -70.99 126.49 29.71 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.733 1.766 . . . . 0.0 108.588 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -68.82 161.86 27.65 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.25 95.13 3.15 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.16 23.62 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.916 1 C-N-CA 125.836 4.357 . . . . 0.0 117.82 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -125.04 -3.66 7.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.426 1.891 . . . . 0.0 112.398 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 p -86.4 -19.94 28.96 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.056 0.942 . . . . 0.0 113.192 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.93 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.511 1.525 . . . . 0.0 111.351 -169.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m -132.22 165.49 24.0 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.154 1.382 . . . . 0.0 113.177 -168.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -5.13 1.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.399 3.08 . . . . 0.0 115.02 176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.13 -173.1 39.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.093 1.806 . . . . 0.0 112.355 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -59.29 164.85 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.375 1.87 . . . . 0.0 114.41 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 167.98 28.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.454 1.501 . . . . 0.0 110.547 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.25 57.43 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.523 1.929 . . . . 0.0 112.458 -168.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.9 m . . . . . 0 CA--C 1.547 0.836 0 O-C-N 121.97 -0.456 . . . . 0.0 111.286 179.475 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.0 p -82.76 167.7 17.9 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.785 0.834 . . . . 0.0 111.32 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -54.28 -40.04 67.49 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.436 -0.79 . . . . 0.0 111.761 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -56.86 -60.28 3.8 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.737 0.815 . . . . 0.0 110.939 171.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.57 -36.66 76.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.252 0.621 . . . . 0.0 112.477 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.75 -57.56 11.41 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -52.69 -47.74 67.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.95 0.796 . . . . 0.0 111.459 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.95 -24.9 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.328 1.451 . . . . 0.0 112.426 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -91.01 3.93 53.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.235 1.814 . . . . 0.0 115.102 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -130.51 -33.16 1.67 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.187 1.358 . . . . 0.0 113.426 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.17 138.56 72.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.99 158.52 53.78 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 111.357 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.56 84.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.838 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.62 66.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.769 1.227 . . . . 0.0 109.135 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -85.54 -6.64 0.11 Allowed Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -43.72 107.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.881 3.054 . . . . 0.0 114.554 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.89 -20.48 6.0 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.619 2.057 . . . . 0.0 112.909 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -138.83 178.0 7.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.625 1.57 . . . . 0.0 112.215 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -80.68 159.07 25.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.245 1.818 . . . . 0.0 111.035 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -148.86 117.64 3.95 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.336 1.455 . . . . 0.0 109.34 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 174.68 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.17 1.913 . . . . 0.0 114.221 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -138.78 147.77 43.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.033 2.133 . . . . 0.0 108.905 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -132.75 157.67 44.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.254 0.934 . . . . 0.0 113.043 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -103.29 -178.27 3.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.751 1.621 . . . . 0.0 114.721 -169.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -15.56 27.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.968 1.707 . . . . 0.0 115.044 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -102.01 13.53 34.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.922 1.689 . . . . 0.0 111.886 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.19 3.94 20.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.328 1.442 . . . . 0.0 114.561 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -85.34 167.12 15.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.667 1.587 . . . . 0.0 109.343 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.0 124.1 19.51 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -53.83 128.71 55.13 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 117.394 -1.289 . . . . 0.0 108.697 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.39 -9.51 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.074 3.183 . . . . 0.0 117.915 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.43 127.85 54.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.772 2.429 . . . . 0.0 107.622 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.15 150.62 41.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.082 0.953 . . . . 0.0 109.721 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.3 m -138.12 153.83 49.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.893 0.854 . . . . 0.0 112.641 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.37 70.02 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.266 2.226 . . . . 0.0 107.668 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.84 -34.39 29.64 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.088 1.328 . . . . 0.0 113.991 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 m -53.13 -22.62 6.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.862 2.065 . . . . 0.0 115.191 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -121.39 -0.33 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 112.615 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.27 6.3 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.354 0.978 . . . . 0.0 111.339 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -143.3 158.62 43.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -141.23 161.57 37.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.177 2.191 . . . . 0.0 110.077 167.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.21 161.64 42.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.74 1.616 . . . . 0.0 109.366 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.1 m -85.98 153.73 21.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.85 159.28 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.38 1.072 . . . . 0.0 111.708 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -82.01 160.54 63.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.62 -26.21 22.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.785 2.99 . . . . 0.0 116.664 -172.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.1 -5.16 55.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.4 0.59 50.36 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.697 1.618 . . . . 0.0 114.806 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 m -67.9 108.62 3.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.165 1.482 . . . . 0.0 110.686 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -56.62 129.89 42.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.263 1.025 . . . . 0.0 112.979 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.48 110.69 26.17 Favored Pre-proline 0 C--O 1.241 0.617 0 C-N-CA 125.465 1.506 . . . . 0.0 107.97 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.8 161.2 33.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.595 2.197 . . . . 0.0 111.758 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 62.47 -5.23 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.948 2.099 . . . . 0.0 115.445 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 p -76.69 -24.89 53.17 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.345 1.429 . . . . 0.0 111.339 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -50.23 102.95 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.525 1.93 . . . . 0.0 111.106 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -144.33 167.74 21.74 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.448 1.099 . . . . 0.0 111.127 -170.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -74.79 4.56 6.18 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.79 43.82 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.684 1.611 . . . . 0.0 112.252 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -58.18 161.77 3.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.956 1.702 . . . . 0.0 114.439 -171.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.55 165.73 34.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 110.589 172.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -86.4 62.85 7.67 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.274 1.83 . . . . 0.0 111.223 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 179.013 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.3 p -82.88 166.98 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.882 0.873 . . . . 0.0 111.525 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -54.41 -37.99 65.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.406 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 t -60.84 -59.77 4.85 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 110.9 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.54 -39.11 79.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.286 0.634 . . . . 0.0 112.7 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.55 -56.2 24.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.293 1.437 . . . . 0.0 110.986 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -56.61 -44.04 80.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.766 0.426 . . . . 0.0 111.587 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.57 -28.11 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.235 1.014 . . . . 0.0 112.277 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 m -83.49 3.85 30.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.016 1.727 . . . . 0.0 114.03 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -124.78 -35.66 2.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.528 1.131 . . . . 0.0 111.805 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -94.08 105.95 19.98 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.51 171.33 18.44 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.614 2.209 . . . . 0.0 111.822 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.56 39.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.082 0.953 . . . . 0.0 113.403 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.98 76.7 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.983 1.313 . . . . 0.0 108.051 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.45 46.7 0.46 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.42 129.03 25.33 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.699 2.266 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.04 -7.51 66.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.158 1.361 . . . . 0.0 114.323 -173.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -123.28 161.26 24.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.629 1.714 . . . . 0.0 113.56 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -78.1 160.41 28.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.477 1.511 . . . . 0.0 107.708 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -147.79 127.32 6.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.497 2.319 . . . . 0.0 107.098 169.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.73 171.37 9.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.493 1.462 . . . . 0.0 114.111 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -135.28 137.44 42.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.595 2.358 . . . . 0.0 108.82 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.92 154.86 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.652 0.781 . . . . 0.0 111.216 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -79.86 173.56 12.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.937 0.895 . . . . 0.0 112.267 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -61.79 -16.74 52.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.76 -5.71 59.33 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.364 1.865 . . . . 0.0 111.523 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.43 2.07 89.14 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 125.532 1.539 . . . . 0.0 114.627 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -78.47 147.29 33.99 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.124 1.462 . . . . 0.0 109.106 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -54.84 123.77 14.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.915 0.886 . . . . 0.0 110.104 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.06 145.03 67.16 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.65 -18.58 59.11 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.508 2.138 . . . . 0.0 114.291 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -109.91 131.67 54.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.795 2.438 . . . . 0.0 108.541 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -119.64 146.94 45.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.871 1.269 . . . . 0.0 109.417 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.64 128.88 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.35 71.31 10.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.681 1.592 . . . . 0.0 106.991 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.63 -37.2 26.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.513 1.53 . . . . 0.0 114.401 -170.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -63.31 -10.41 16.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 pt -125.01 -0.47 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 112.453 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.7 -5.05 76.51 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.667 1.603 . . . . 0.0 115.498 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -81.83 151.23 27.46 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.028 1.414 . . . . 0.0 111.493 -172.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.2 m -137.38 164.99 27.28 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -148.4 163.96 35.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.8 2.04 . . . . 0.0 109.227 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.8 157.03 18.61 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 109.771 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.45 161.4 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.87 162.66 46.44 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.715 1.606 . . . . 0.0 108.697 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.81 -15.28 9.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.995 3.13 . . . . 0.0 118.027 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -95.55 0.78 53.39 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.103 1.361 . . . . 0.0 114.083 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 2.47 62.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.197 1.38 . . . . 0.0 114.804 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -71.23 130.38 41.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.122 1.461 . . . . 0.0 109.624 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.53 137.94 58.1 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.4 t -83.42 109.15 15.97 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.01 155.95 47.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.832 2.354 . . . . 0.0 113.141 -168.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 61.68 -0.24 0.43 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.135 2.174 . . . . 0.0 115.818 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 p -72.79 -32.01 65.27 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.106 1.321 . . . . 0.0 110.77 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.76 106.38 0.11 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 111.967 -169.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -137.21 165.82 25.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.013 1.325 . . . . 0.0 113.103 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' NE ' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.84 -6.27 2.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.734 2.814 . . . . 0.0 114.216 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.89 -175.66 39.04 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.219 1.866 . . . . 0.0 112.559 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -58.04 161.97 3.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.823 2.049 . . . . 0.0 114.067 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.13 167.11 31.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.611 1.164 . . . . 0.0 111.771 172.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -82.61 61.53 5.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.448 2.299 . . . . 0.0 112.023 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.219 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 120.555 0.217 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -145.98 -178.83 6.32 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.149 1.38 . . . . 0.0 110.16 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -47.32 -33.02 5.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 112.369 169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.47 -68.5 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.235 0.614 . . . . 0.0 111.191 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -54.55 -39.77 68.06 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.44 1.096 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.94 -60.34 3.6 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.679 1.192 . . . . 0.0 110.282 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -54.32 -48.2 71.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.272 0.629 . . . . 0.0 111.908 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.06 -34.32 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.699 0.4 . . . . 0.0 111.261 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.6 p -80.97 -2.1 46.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -130.22 -23.58 2.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -67.33 137.74 93.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 165.15 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.007 1.805 . . . . 0.0 111.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.76 72.45 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.523 -0.736 . . . . 0.0 111.564 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -83.79 77.81 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.388 1.475 . . . . 0.0 107.927 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -118.68 53.2 1.83 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.383 1.073 . . . . 0.0 113.542 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -61.83 139.05 77.94 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.885 2.39 . . . . 0.0 110.853 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 11.51 0.78 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.266 1.412 . . . . 0.0 115.544 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -120.41 136.92 54.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.436 1.495 . . . . 0.0 110.928 -168.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.05 154.68 38.86 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -148.83 125.33 5.31 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.864 2.066 . . . . 0.0 108.523 168.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 178.3 7.04 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.274 1.983 . . . . 0.0 112.66 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -139.17 151.53 46.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.876 2.071 . . . . 0.0 109.764 170.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.77 154.46 51.22 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -86.25 175.36 8.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.442 . . . . 0.0 113.206 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.53 -21.06 59.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -84.9 6.31 25.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.348 1.859 . . . . 0.0 111.862 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.34 4.93 39.88 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.955 1.74 . . . . 0.0 114.889 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -90.5 164.73 14.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.831 2.052 . . . . 0.0 109.759 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.65 127.87 33.3 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.917 -0.489 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.35 141.2 62.96 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.826 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.5 -30.94 12.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.339 3.359 . . . . 0.0 116.251 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.2 tp -107.93 129.99 55.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.445 1.898 . . . . 0.0 108.855 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -112.52 140.09 47.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.681 1.193 . . . . 0.0 108.609 169.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.1 m -130.56 119.7 22.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 122.069 0.938 . . . . 0.0 110.669 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.25 66.59 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.24 1.816 . . . . 0.0 106.501 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.23 -27.12 64.78 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.564 1.554 . . . . 0.0 114.402 -169.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 p -61.97 -11.99 16.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.66 1.584 . . . . 0.0 114.267 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.48 -3.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.643 1.977 . . . . 0.0 111.705 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.69 20.32 79.56 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 126.412 1.958 . . . . 0.0 115.749 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -95.48 158.95 15.23 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.842 1.821 . . . . 0.0 111.28 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.37 164.88 29.03 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.746 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -149.51 164.18 35.78 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.785 2.034 . . . . 0.0 109.277 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.83 150.67 22.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.45 156.48 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.519 0.728 . . . . 0.0 111.737 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.5 158.59 81.05 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 165.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.55 -22.3 16.41 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.655 2.903 . . . . 0.0 117.091 -171.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -82.24 -5.46 58.53 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.421 1.489 . . . . 0.0 114.694 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.74 -0.47 48.88 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.679 1.609 . . . . 0.0 114.968 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -69.88 114.54 8.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.124 1.462 . . . . 0.0 110.539 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.92 136.81 55.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.729 0.812 . . . . 0.0 112.676 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.01 114.3 51.7 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -45.14 137.45 10.05 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.487 3.458 . . . . 0.0 115.58 -169.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.25 9.66 4.13 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.756 2.023 . . . . 0.0 114.843 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -78.11 -22.38 48.99 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.01 1.277 . . . . 0.0 111.604 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 105.17 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.197 0.999 . . . . 0.0 111.724 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -144.74 171.1 14.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.086 1.354 . . . . 0.0 112.999 -169.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -0.06 2.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 129.87 3.268 . . . . 0.0 114.922 -174.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.64 -176.58 48.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.218 1.389 . . . . 0.0 113.01 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.54 159.06 3.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.216 2.207 . . . . 0.0 114.174 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.51 166.29 33.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.479 1.111 . . . . 0.0 111.906 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.75 67.44 9.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.028 1.731 . . . . 0.0 111.535 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.272 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 p -83.72 167.92 16.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.32 1.048 . . . . 0.0 110.754 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -55.15 -39.24 69.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.443 -0.786 . . . . 0.0 112.239 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.1 t -62.18 -59.81 4.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.67 0.788 . . . . 0.0 111.03 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -58.0 -36.54 72.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.58 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.47 -59.23 5.74 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.366 1.066 . . . . 0.0 110.631 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.29 -42.1 81.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.414 0.552 . . . . 0.0 112.079 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.65 -32.27 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.262 1.025 . . . . 0.0 111.908 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 m -86.51 7.93 24.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.178 1.791 . . . . 0.0 114.063 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -124.94 -38.77 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.376 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.41 108.03 20.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 168.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -70.4 160.08 50.75 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.148 1.899 . . . . 0.0 111.47 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.63 61.08 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.89 67.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 108.927 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -99.11 5.31 0.07 OUTLIER Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -41.91 112.69 0.24 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.506 2.804 . . . . 0.0 115.609 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.99 28.44 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.118 1.818 . . . . 0.0 113.318 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -117.44 159.16 23.25 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.214 1.806 . . . . 0.0 111.972 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.38 157.87 37.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -148.54 130.14 7.35 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.499 1.919 . . . . 0.0 107.597 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.91 170.99 17.5 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.19 1.927 . . . . 0.0 112.509 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -144.14 150.5 38.17 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.18 1.792 . . . . 0.0 110.073 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -133.11 158.39 42.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.95 1.3 . . . . 0.0 111.208 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.38 179.64 6.04 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.282 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -16.82 49.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -173.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -84.64 -3.28 58.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.167 0.987 . . . . 0.0 112.61 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 8.93 82.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.215 0.912 . . . . 0.0 113.74 -171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -80.34 147.97 30.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.72 1.208 . . . . 0.0 109.008 172.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -51.98 126.97 19.89 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.089 0.956 . . . . 0.0 111.403 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.86 131.63 82.99 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.08 -30.05 30.35 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.24 2.627 . . . . 0.0 115.543 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.4 140.37 34.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.604 1.961 . . . . 0.0 109.482 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -131.72 149.82 52.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.087 1.355 . . . . 0.0 109.004 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 79.4 m -142.28 132.33 24.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.92 72.0 9.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 168.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.14 17.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.215 1.388 . . . . 0.0 114.784 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -60.9 -16.11 38.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.66 1.88 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.191 1.396 . . . . 0.0 112.435 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.94 69.26 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.811 1.672 . . . . 0.0 115.224 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -83.31 143.4 30.4 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.71 1.255 . . . . 0.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.7 m -131.18 164.81 24.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.645 1.178 . . . . 0.0 112.12 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -153.15 165.4 35.75 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.233 1.813 . . . . 0.0 109.376 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.9 m -89.66 154.16 20.17 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 122.027 -0.421 . . . . 0.0 110.241 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.81 160.29 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.874 0.87 . . . . 0.0 113.122 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.47 167.22 17.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.675 1.59 . . . . 0.0 110.714 167.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.82 -2.21 1.03 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 124.845 3.696 . . . . 0.0 118.614 -170.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -111.31 2.32 17.6 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.45 1.9 . . . . 0.0 113.562 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.69 2.34 61.48 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.227 1.394 . . . . 0.0 114.352 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.5 m -67.13 111.62 4.0 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.183 1.491 . . . . 0.0 110.108 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -56.09 138.34 49.73 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.705 1.602 . . . . 0.0 113.06 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.68 100.1 1.01 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.946 1.698 . . . . 0.0 106.826 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.17 19.32 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.506 4.137 . . . . 0.0 117.127 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -123.73 -1.28 8.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.847 2.059 . . . . 0.0 112.875 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 p -96.3 -15.08 22.13 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.359 1.064 . . . . 0.0 112.843 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.616 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.24 111.46 0.78 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.416 1.086 . . . . 0.0 109.877 -173.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 t -148.23 167.39 25.23 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.616 ' NH1' HH22 ' A' ' 55' ' ' ARG . 5.4 mpt_? -77.2 12.06 1.62 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.626 2.77 . . . . 0.0 113.598 -173.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.65 176.99 47.54 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.904 1.24 . . . . 0.0 112.747 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -57.6 157.98 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.61 1.964 . . . . 0.0 113.28 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.1 168.11 28.12 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.124 0.97 . . . . 0.0 111.821 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -87.76 65.74 8.53 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.771 1.628 . . . . 0.0 111.795 -168.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.4 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.89 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.4 p -83.42 168.24 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.403 0.681 . . . . 0.0 111.661 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -51.06 -42.64 60.68 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 0.0 112.207 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -58.91 6.49 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.954 0.343 . . . . 0.0 111.45 171.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.27 -34.41 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.97 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.74 -61.83 2.23 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.579 1.152 . . . . 0.0 110.359 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -51.41 -49.66 61.2 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.182 0.993 . . . . 0.0 111.59 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.57 -27.39 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.067 0.947 . . . . 0.0 111.357 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -86.2 2.77 45.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.224 1.81 . . . . 0.0 114.602 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -128.86 -25.62 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.192 1.36 . . . . 0.0 113.838 -174.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.65 136.15 92.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 169.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.4 169.39 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.947 1.765 . . . . 0.0 112.074 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.18 72.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.609 -0.682 . . . . 0.0 110.868 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.15 74.36 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.07 1.348 . . . . 0.0 108.498 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.47 15.85 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.49 110.36 1.22 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 CA-C-N 123.636 2.334 . . . . 0.0 110.734 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.96 -15.37 8.92 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.567 1.556 . . . . 0.0 113.134 -169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.0 t -124.87 148.81 48.08 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.474 1.509 . . . . 0.0 110.756 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -77.27 165.25 24.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.961 0.904 . . . . 0.0 112.624 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -138.85 106.97 7.51 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.122 1.769 . . . . 0.0 109.864 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -55.51 155.67 20.33 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.29 2.66 . . . . 0.0 115.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.27 128.81 51.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 127.995 2.518 . . . . 0.0 108.809 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 29' ' ' TYR . 76.0 m -143.19 157.74 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.012 0.91 . . . . 0.0 111.885 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -79.24 176.93 9.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.326 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.2 -24.64 63.29 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -84.61 7.98 18.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.977 1.711 . . . . 0.0 111.668 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.27 15.4 51.26 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.044 1.783 . . . . 0.0 114.634 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.86 149.77 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.728 1.211 . . . . 0.0 109.252 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 66.1 m-85 -69.0 120.69 15.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.715 0.806 . . . . 0.0 110.01 -170.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.31 128.87 83.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.638 -1.172 . . . . 0.0 108.898 -175.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.77 -22.45 9.8 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.773 2.982 . . . . 0.0 116.594 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.59 136.11 50.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.431 1.893 . . . . 0.0 109.228 169.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -123.69 148.92 46.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.475 1.51 . . . . 0.0 109.073 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -140.82 152.85 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.335 1.054 . . . . 0.0 110.1 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -127.09 88.2 2.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.325 1.06 . . . . 0.0 110.688 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.66 -12.93 36.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.841 1.686 . . . . 0.0 116.84 -169.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.2 p -66.25 -25.68 67.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.263 1.532 . . . . 0.0 112.833 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 pt -119.89 -17.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 112.515 173.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.29 9.25 85.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.515 1.531 . . . . 0.0 114.683 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -83.2 158.06 22.47 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.571 1.185 . . . . 0.0 110.95 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.1 m -133.82 164.97 26.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.618 1.167 . . . . 0.0 112.067 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.42 163.87 39.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.904 1.681 . . . . 0.0 109.498 169.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.4 m -90.64 150.42 21.7 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.693 0.797 . . . . 0.0 109.639 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.46 151.29 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.575 1.15 . . . . 0.0 110.208 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.3 155.4 91.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.9 -16.89 12.62 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.737 2.958 . . . . 0.0 117.372 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -83.23 -4.7 58.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.125 2.17 . . . . 0.0 114.996 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.29 -3.26 54.54 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.733 1.635 . . . . 0.0 114.873 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 m -73.83 111.6 9.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.628 1.214 . . . . 0.0 110.067 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -55.52 143.08 30.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.773 1.229 . . . . 0.0 113.804 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.94 89.04 0.7 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 168.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.18 -15.23 48.3 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.761 2.308 . . . . 0.0 117.435 -166.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.43 -12.96 59.92 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 127.217 2.207 . . . . 0.0 113.134 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.7 p -102.9 -2.62 27.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.923 1.689 . . . . 0.0 112.65 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 104.83 0.6 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.572 1.078 . . . . 0.0 109.447 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 t -141.39 162.04 36.45 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -7.84 3.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.847 3.259 . . . . 0.0 114.945 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.39 -174.53 42.96 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.107 0.86 . . . . 0.0 114.165 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -55.72 149.92 13.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.346 2.258 . . . . 0.0 113.982 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -155.46 -176.51 5.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.833 1.653 . . . . 0.0 110.024 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -130.88 91.03 2.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.527 1.531 . . . . 0.0 110.201 -170.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.542 0.657 0 C-N-CA 127.625 2.37 . . . . 0.0 112.916 177.232 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -83.09 167.19 18.07 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.706 0.803 . . . . 0.0 111.498 171.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -52.25 -39.66 60.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 112.382 171.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -59.59 -60.74 3.36 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.581 0.752 . . . . 0.0 110.949 171.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -58.88 -36.53 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.498 0.719 . . . . 0.0 112.458 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.86 -58.03 10.34 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.876 1.271 . . . . 0.0 110.749 171.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -57.81 -43.17 85.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.233 0.47 . . . . 0.0 112.016 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.55 -34.55 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.309 0.643 . . . . 0.0 111.628 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -82.46 3.19 29.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.736 1.615 . . . . 0.0 114.338 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -127.59 -34.02 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.439 1.018 . . . . 0.0 112.416 -177.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.8 mt -87.27 114.25 57.7 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.2 161.28 40.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.33 2.02 . . . . 0.0 111.705 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -18.43 42.87 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 175.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.02 78.9 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.302 1.441 . . . . 0.0 107.775 169.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -113.52 63.2 0.98 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.025 1.33 . . . . 0.0 112.763 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.16 136.65 57.13 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.366 2.71 . . . . 0.0 111.255 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.96 11.76 1.05 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.376 1.465 . . . . 0.0 115.183 -173.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -125.97 162.89 24.21 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.661 1.585 . . . . 0.0 112.007 -168.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -88.79 155.02 19.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.781 1.632 . . . . 0.0 111.675 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.61 126.34 8.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.796 1.639 . . . . 0.0 108.65 168.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.54 174.03 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.191 1.928 . . . . 0.0 113.507 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 151.34 44.86 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.822 2.049 . . . . 0.0 110.015 173.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.63 157.38 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.625 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.41 -175.64 3.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.564 1.146 . . . . 0.0 113.946 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -60.63 -24.97 65.94 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.14 8.65 20.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.238 1.415 . . . . 0.0 112.71 171.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.35 3.05 17.18 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.49 1.519 . . . . 0.0 114.794 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.19 170.68 11.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.682 1.593 . . . . 0.0 109.118 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -60.31 129.93 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 177.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.92 137.49 79.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.776 -1.106 . . . . 0.0 108.635 173.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.75 -22.78 10.27 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.495 2.796 . . . . 0.0 116.369 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.91 132.09 53.83 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.737 2.015 . . . . 0.0 109.319 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.8 147.78 46.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.628 1.171 . . . . 0.0 109.684 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -139.24 116.84 11.4 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -170.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 63.25 7.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.942 2.097 . . . . 0.0 106.531 168.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.63 -21.74 63.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.936 1.255 . . . . 0.0 114.945 -169.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.0 p -62.15 -15.0 42.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.87 1.268 . . . . 0.0 114.12 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -123.5 8.9 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 127.139 2.176 . . . . 0.0 111.724 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.18 5.05 89.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.963 1.744 . . . . 0.0 115.218 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -84.73 150.64 24.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.202 1.501 . . . . 0.0 114.142 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -143.77 163.37 33.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.897 1.679 . . . . 0.0 111.16 168.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -150.84 163.38 38.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.484 1.914 . . . . 0.0 108.731 169.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.88 154.31 20.95 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.29 157.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.203 1.001 . . . . 0.0 111.645 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -75.66 158.81 82.6 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 165.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.98 -13.68 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.386 2.057 . . . . 0.0 114.949 -169.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -79.8 -7.33 58.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.136 2.174 . . . . 0.0 115.103 169.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.69 -2.65 49.12 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.073 1.797 . . . . 0.0 115.132 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.9 m -73.33 116.78 14.28 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 1.408 . . . . 0.0 110.701 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.32 133.38 55.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.025 1.33 . . . . 0.0 113.635 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.17 111.7 35.48 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 126.718 2.007 . . . . 0.0 108.557 172.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.14 156.62 4.99 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.875 3.05 . . . . 0.0 114.285 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 59.99 -2.88 0.13 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.864 2.066 . . . . 0.0 116.04 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 p -76.01 -26.43 56.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.115 1.325 . . . . 0.0 111.524 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -46.94 106.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.941 2.097 . . . . 0.0 111.783 -174.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 t -148.08 161.29 41.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.729 0.812 . . . . 0.0 111.714 -172.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -89.69 36.23 0.84 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.214 1.405 . . . . 0.0 113.087 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.68 170.74 41.33 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.028 2.251 . . . . 0.0 112.218 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -67.71 167.89 12.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.052 1.341 . . . . 0.0 112.85 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 166.9 32.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.724 1.21 . . . . 0.0 110.981 174.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -83.99 61.3 6.35 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.795 2.038 . . . . 0.0 111.627 -168.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.545 0.763 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.496 179.448 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 p -130.96 176.14 8.49 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.756 1.222 . . . . 0.0 112.777 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -48.57 -35.98 14.57 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.202 1.401 . . . . 0.0 112.446 169.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.22 -57.69 10.51 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.453 0.57 . . . . 0.0 110.884 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -57.46 -40.41 78.45 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.279 0.632 . . . . 0.0 112.637 177.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.96 -57.59 12.21 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.044 0.937 . . . . 0.0 110.578 174.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.53 -46.79 73.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.703 0.801 . . . . 0.0 111.672 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -67.34 -29.58 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 0.0 112.014 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -76.95 -36.04 56.82 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.266 1.026 . . . . 0.0 113.167 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -80.08 -32.66 39.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.311 1.044 . . . . 0.0 113.365 -175.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.48 131.4 95.07 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 167.84 24.17 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.276 1.984 . . . . 0.0 112.678 -176.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.41 78.22 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.582 -0.699 . . . . 0.0 110.682 169.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -79.68 70.93 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.736 1.215 . . . . 0.0 108.914 171.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -114.29 -3.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.23 112.49 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 124.458 2.628 . . . . 0.0 113.904 174.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.82 6.67 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.154 1.835 . . . . 0.0 111.667 -169.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 t -125.32 162.54 24.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.397 1.879 . . . . 0.0 112.729 178.225 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.0 159.16 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.169 2.188 . . . . 0.0 112.938 -176.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -142.0 113.99 6.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.589 2.355 . . . . 0.0 107.723 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -62.46 168.81 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.367 2.044 . . . . 0.0 114.245 176.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.96 142.04 51.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.849 2.46 . . . . 0.0 108.442 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -136.13 156.77 48.21 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.289 0.95 . . . . 0.0 112.071 -176.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.08 -177.28 3.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.12 -32.34 64.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.035 1.334 . . . . 0.0 113.462 176.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -84.5 11.39 8.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 0.0 112.404 176.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.44 4.47 24.45 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.184 1.374 . . . . 0.0 114.371 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.22 169.88 11.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.814 1.307 . . . . 0.0 109.071 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -62.56 130.67 46.11 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -57.89 134.07 83.41 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 117.77 -1.109 . . . . 0.0 108.546 174.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.33 -26.07 15.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.037 2.492 . . . . 0.0 115.893 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.35 133.94 48.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.06 1.744 . . . . 0.0 109.142 168.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -121.76 149.28 43.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.632 169.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.27 148.43 43.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.496 0.665 . . . . 0.0 112.332 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.22 77.51 1.05 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.643 1.977 . . . . 0.0 107.81 -178.041 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -37.1 -54.54 1.53 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 127.6 2.524 . . . . 0.0 115.619 -169.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.6 p -63.79 -12.35 34.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -116.76 -5.6 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.343 1.057 . . . . 0.0 112.278 169.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.55 10.43 70.92 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.286 1.898 . . . . 0.0 115.246 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -83.41 155.7 23.34 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.621 1.21 . . . . 0.0 111.293 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.1 m -138.25 164.84 28.22 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.033 0.933 . . . . 0.0 112.423 170.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -148.94 164.03 35.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.595 1.958 . . . . 0.0 109.229 169.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.06 153.62 20.85 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.49 157.83 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 124.33 1.052 . . . . 0.0 111.595 173.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -77.81 160.77 73.56 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.28 -21.25 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.844 3.029 . . . . 0.0 117.358 -170.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.65 -3.0 58.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.792 1.637 . . . . 0.0 114.716 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.97 1.36 56.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.301 1.429 . . . . 0.0 114.899 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -71.31 117.45 12.86 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.134 1.467 . . . . 0.0 110.146 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -56.15 137.16 52.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.7 110.38 24.62 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.27 150.26 11.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.863 3.042 . . . . 0.0 114.408 -171.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.93 3.6 0.5 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.283 1.833 . . . . 0.0 115.585 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -73.71 -28.04 61.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.171 1.351 . . . . 0.0 110.926 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.88 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.695 1.998 . . . . 0.0 111.774 -176.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.5 m -136.13 164.22 28.55 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.079 1.352 . . . . 0.0 112.999 -168.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -4.75 0.81 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 130.03 3.332 . . . . 0.0 115.295 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.07 -175.77 41.12 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.592 1.567 . . . . 0.0 112.986 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -56.19 161.15 2.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.091 2.156 . . . . 0.0 113.698 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 171.03 20.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.751 1.221 . . . . 0.0 111.294 174.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -89.31 68.78 8.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.396 1.878 . . . . 0.0 110.488 -168.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.546 0.827 0 CA-C-O 121.803 0.811 . . . . 0.0 112.003 174.752 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.556 0.694 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -142.31 168.11 20.51 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.844 2.858 . . . . 0.0 108.695 177.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -52.17 -39.53 60.19 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 0.0 112.734 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -59.62 -61.46 2.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.603 0.761 . . . . 0.0 111.518 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.45 -31.22 71.16 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -61.24 -58.58 7.69 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.701 1.6 . . . . 0.0 110.517 170.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.79 -43.87 81.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.45 0.568 . . . . 0.0 111.954 177.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.29 -36.39 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.617 0.644 . . . . 0.0 111.712 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -68.68 -45.35 71.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.884 0.874 . . . . 0.0 112.353 173.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -77.81 -26.24 49.42 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.581 1.152 . . . . 0.0 113.47 -176.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.98 94.98 19.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.975 1.71 . . . . 0.0 108.06 179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.89 154.06 58.38 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.055 1.836 . . . . 0.0 109.994 169.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.51 -36.04 66.26 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.45 73.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 109.059 178.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.633 ' CE1' ' H ' ' A' ' 19' ' ' PHE . 7.0 p80 -132.67 151.09 77.51 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 112.826 175.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.9 155.19 69.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.382 2.721 . . . . 0.0 110.94 171.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.8 40.66 72.73 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -169.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 107.99 0.17 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.2 2.6 . . . . 0.0 114.487 -168.075 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.633 ' H ' ' CE1' ' A' ' 15' ' ' HIS . 2.4 t80 -152.64 89.1 1.38 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 130.654 3.582 . . . . 0.0 108.084 172.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -84.56 124.52 73.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.04 175.0 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.578 1.518 . . . . 0.0 111.118 169.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.08 153.67 36.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.688 1.195 . . . . 0.0 111.759 177.457 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.8 m -132.84 158.59 42.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 113.021 -169.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -95.76 -178.93 4.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.263 1.425 . . . . 0.0 113.698 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -62.43 -10.38 11.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -100.68 8.24 43.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.408 1.883 . . . . 0.0 111.619 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.62 6.07 27.14 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.963 1.268 . . . . 0.0 114.434 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -90.23 164.75 14.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.543 1.537 . . . . 0.0 108.876 178.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -61.35 132.62 54.11 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.851 -0.53 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.43 139.36 85.0 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.873 175.215 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.45 -21.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.292 3.328 . . . . 0.0 117.374 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.98 135.63 53.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.656 1.982 . . . . 0.0 109.37 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.81 151.74 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.654 1.181 . . . . 0.0 109.11 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 76.2 m -140.65 120.42 13.45 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.342 1.057 . . . . 0.0 113.238 -172.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.38 72.92 9.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.427 1.108 . . . . 0.0 108.416 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -42.49 -47.95 5.79 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.708 2.099 . . . . 0.0 115.133 -169.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 p -60.95 -14.44 22.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.7 pt -118.7 -6.91 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 120.016 1.28 . . . . 0.0 113.083 170.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.8 -3.74 86.74 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.194 1.854 . . . . 0.0 115.342 176.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -83.55 117.66 23.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.363 1.581 . . . . 0.0 112.083 -173.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.9 m -102.18 158.54 16.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.424 1.089 . . . . 0.0 110.262 168.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.19 162.37 39.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.513 1.525 . . . . 0.0 109.499 171.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.1 m -86.39 154.38 21.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.3 157.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.118 0.961 . . . . 0.0 113.298 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.12 163.29 58.27 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.97 -24.13 46.77 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.495 2.797 . . . . 0.0 115.829 -169.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -81.45 -7.84 59.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.266 2.226 . . . . 0.0 114.766 176.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.22 59.45 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.2 1.381 . . . . 0.0 115.438 -178.125 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.0 m -70.91 132.31 45.04 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.907 1.854 . . . . 0.0 109.937 177.195 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.1 141.93 57.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.274 1.029 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -82.34 115.37 57.53 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -44.08 133.44 8.63 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.779 3.652 . . . . 0.0 116.262 -169.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 59.5 15.15 4.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.731 2.013 . . . . 0.0 115.719 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.4 p -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.197 170.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.363 0.0 OUTLIER -57.99 110.73 0.98 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.027 1.285 . . . . 0.0 113.232 -170.503 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.3 t -148.65 153.54 38.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.792 1.637 . . . . 0.0 110.398 -170.157 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -80.31 28.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.166 1.386 . . . . 0.0 114.333 -171.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.35 169.05 35.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.387 1.946 . . . . 0.0 112.598 171.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -63.92 165.3 8.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.734 1.214 . . . . 0.0 112.781 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 164.12 38.65 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.017 0.927 . . . . 0.0 111.333 172.054 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -83.45 62.88 7.01 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.159 1.784 . . . . 0.0 111.976 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.206 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.543 0.673 0 CA-C-O 120.607 0.241 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.8 p -144.89 167.69 22.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.516 1.927 . . . . 0.0 110.971 -174.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -50.23 -42.39 51.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.785 1.234 . . . . 0.0 113.418 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.08 -61.77 2.16 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.201 0.6 . . . . 0.0 111.127 173.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -58.66 -40.39 83.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.716 1.606 . . . . 0.0 112.265 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.24 -55.86 26.57 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 125.793 1.637 . . . . 0.0 110.344 172.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.68 -44.61 81.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.557 0.617 . . . . 0.0 111.432 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.85 -34.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.629 0.65 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -84.97 3.94 36.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.016 1.726 . . . . 0.0 115.231 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.8 -24.96 1.9 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.276 1.398 . . . . 0.0 114.265 -174.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.14 122.49 75.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.31 0.959 . . . . 0.0 109.166 176.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.54 172.48 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.302 2.002 . . . . 0.0 111.657 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -22.14 66.69 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.653 -0.654 . . . . 0.0 112.278 169.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.09 67.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.164 1.386 . . . . 0.0 109.184 169.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.5 92.65 44.13 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.102 1.361 . . . . 0.0 110.28 175.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.58 115.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.771 3.647 . . . . 0.0 114.994 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.9 51.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.174 1.368 . . . . 0.0 114.86 -177.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.261 92.0 p 69.16 107.08 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.274 3.029 . . . . 0.0 116.097 -176.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -138.44 136.21 35.99 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.968 1.707 . . . . 0.0 109.392 168.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -144.47 135.35 12.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 126.406 1.882 . . . . 0.0 106.086 169.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.9 163.57 38.72 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 120.63 1.261 . . . . 0.0 111.224 177.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -122.82 147.05 46.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.954 1.702 . . . . 0.0 109.469 177.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.4 m -136.61 156.53 48.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 111.848 -171.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -102.8 179.25 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.732 1.213 . . . . 0.0 114.162 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.21 -12.04 17.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 177.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -97.04 8.27 44.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.239 1.816 . . . . 0.0 111.696 175.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 8.81 35.38 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.706 1.146 . . . . 0.0 114.034 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.33 165.6 13.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.582 1.553 . . . . 0.0 108.85 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -62.17 132.52 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.09 135.74 87.88 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.8 -1.095 . . . . 0.0 108.258 174.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.07 -15.44 7.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.332 2.688 . . . . 0.0 116.887 -176.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.26 137.59 51.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.951 2.1 . . . . 0.0 109.891 171.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -131.9 152.42 51.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.853 1.261 . . . . 0.0 109.471 170.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.2 m -143.59 158.12 43.9 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.39 1.076 . . . . 0.0 112.353 -178.343 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 113.46 12.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.997 2.119 . . . . 0.0 108.93 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.04 -80.91 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 127.562 2.506 . . . . 0.0 117.274 -168.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 m -64.43 -18.73 65.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -168.34 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 pt -92.61 -3.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 10.83 59.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.597 1.57 . . . . 0.0 114.948 174.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -94.78 146.6 24.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.231 1.015 . . . . 0.0 113.445 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.9 m -130.86 156.45 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.509 1.523 . . . . 0.0 108.53 165.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.39 161.33 41.24 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.49 1.516 . . . . 0.0 108.781 172.517 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.8 m -86.8 152.69 22.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.2 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.82 156.66 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 110.019 170.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -73.68 161.19 79.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 166.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.54 -26.55 22.47 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.329 2.686 . . . . 0.0 115.389 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -76.46 -8.12 56.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.296 1.839 . . . . 0.0 115.374 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.69 -3.86 56.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.745 1.641 . . . . 0.0 115.266 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 m -73.56 119.79 18.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.059 1.43 . . . . 0.0 110.439 -177.523 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -56.82 132.14 51.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.719 1.207 . . . . 0.0 113.758 176.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.39 109.33 18.84 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.92 1.688 . . . . 0.0 107.639 169.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.44 163.51 26.6 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.556 2.171 . . . . 0.0 111.871 -175.015 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 61.2 -3.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.772 2.029 . . . . 0.0 115.74 -175.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.2 p -72.38 -28.84 63.27 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.994 1.27 . . . . 0.0 110.989 169.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -40.35 102.91 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.603 2.361 . . . . 0.0 113.103 -173.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -133.51 161.79 33.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.118 0.967 . . . . 0.0 111.627 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -71.95 17.55 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 130.17 3.388 . . . . 0.0 113.777 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.82 40.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.669 2.081 . . . . 0.0 112.178 -171.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -61.21 162.45 7.5 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.654 1.581 . . . . 0.0 114.193 -172.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 163.75 36.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.066 1.346 . . . . 0.0 110.827 171.025 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.06 57.69 3.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.17 2.188 . . . . 0.0 112.496 -168.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 122.845 1.307 . . . . 0.0 112.078 -173.346 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 p -129.77 175.07 9.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.778 1.231 . . . . 0.0 112.717 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -51.02 -33.44 25.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.661 1.184 . . . . 0.0 112.31 172.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.1 t -61.33 -60.2 4.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.307 0.503 . . . . 0.0 110.653 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -55.68 -38.7 69.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.53 -58.22 9.42 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.087 0.955 . . . . 0.0 110.654 173.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.59 -40.84 88.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.385 0.539 . . . . 0.0 112.41 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -69.03 -28.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.036 0.934 . . . . 0.0 112.243 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -73.43 -48.44 33.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.69 0.796 . . . . 0.0 111.955 169.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -73.62 -33.75 64.7 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.846 1.259 . . . . 0.0 113.251 -175.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.8 mt -97.43 101.06 9.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.42 173.54 14.07 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.698 2.265 . . . . 0.0 111.902 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.22 -20.26 17.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.408 1.083 . . . . 0.0 113.808 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.41 76.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.124 1.37 . . . . 0.0 107.987 169.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -111.67 71.87 0.98 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.135 1.374 . . . . 0.0 111.354 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.78 119.44 6.7 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.833 3.022 . . . . 0.0 112.391 -169.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 53.37 8.62 0.81 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.444 1.974 . . . . 0.0 115.313 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -108.57 159.89 16.35 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.649 1.579 . . . . 0.0 112.39 -167.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -77.61 148.39 35.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.842 0.457 . . . . 0.0 110.751 173.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -138.28 125.03 13.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.318 1.847 . . . . 0.0 107.723 169.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -70.33 174.34 10.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.103 1.868 . . . . 0.0 113.427 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -135.41 143.88 46.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.016 2.126 . . . . 0.0 110.236 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.77 164.24 29.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.433 1.893 . . . . 0.0 110.643 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -120.99 178.38 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.041 0.936 . . . . 0.0 113.068 169.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -62.93 -11.95 22.07 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.571 1.548 . . . . 0.0 114.682 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -87.49 1.3 53.89 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.231 0.469 . . . . 0.0 111.901 173.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.45 -1.01 88.55 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.857 1.694 . . . . 0.0 114.353 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -86.71 165.18 16.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.481 1.113 . . . . 0.0 110.629 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -64.85 130.31 42.98 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 167.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -55.2 135.35 68.59 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.63 -7.01 16.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.153 1.902 . . . . 0.0 114.854 -168.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.12 135.97 53.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.555 1.942 . . . . 0.0 108.135 168.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -130.8 153.11 49.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.469 1.107 . . . . 0.0 108.977 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -140.53 156.88 46.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.145 0.978 . . . . 0.0 112.008 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.02 102.38 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.383 1.073 . . . . 0.0 111.24 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.44 -41.0 62.7 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.99 1.281 . . . . 0.0 114.946 -175.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 m -62.32 -17.88 59.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.004 1.402 . . . . 0.0 114.652 -176.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -112.83 -2.47 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.389 . . . . 0.0 112.313 171.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.58 20.72 74.13 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.9 1.238 . . . . 0.0 114.438 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -118.54 161.41 20.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.939 1.369 . . . . 0.0 113.724 -170.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.2 m -132.36 159.15 40.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.993 2.117 . . . . 0.0 109.742 167.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -145.71 160.93 41.01 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.169 1.387 . . . . 0.0 109.248 171.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.6 m -88.34 152.9 21.61 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.361 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.65 154.59 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.752 1.221 . . . . 0.0 110.942 172.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -74.82 164.82 58.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 167.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -50.86 -28.54 23.84 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.473 2.782 . . . . 0.0 115.758 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -78.59 -6.93 56.93 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.236 2.215 . . . . 0.0 115.459 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.28 -3.27 63.85 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.914 1.245 . . . . 0.0 115.458 177.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.2 m -73.4 131.73 42.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.929 1.365 . . . . 0.0 109.402 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -59.18 142.54 51.41 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.03 110.1 21.25 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -47.67 142.96 13.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.011 3.141 . . . . 0.0 115.334 -169.086 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 61.09 8.65 2.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.56 1.944 . . . . 0.0 115.225 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -27.58 63.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.037 1.29 . . . . 0.0 110.919 172.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.549 HH21 ' NH2' ' A' ' 57' ' ' ARG . 1.7 ptm180 -41.17 93.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.343 2.257 . . . . 0.0 114.363 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -127.78 163.44 24.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.17 1.788 . . . . 0.0 112.083 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -69.2 9.05 0.48 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.577 2.751 . . . . 0.0 113.318 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.37 -179.83 47.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.979 1.752 . . . . 0.0 112.658 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -65.19 167.31 8.37 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.156 1.782 . . . . 0.0 114.008 -174.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 167.08 31.54 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.074 1.35 . . . . 0.0 111.359 176.355 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -78.63 53.63 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.129 2.571 . . . . 0.0 113.196 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 122.916 1.341 . . . . 0.0 114.576 -169.315 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.29 0.09 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 p -83.53 170.08 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -173.131 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.9 -39.26 62.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.705 1.202 . . . . 0.0 112.684 170.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.9 t -61.22 -59.2 5.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.722 0.809 . . . . 0.0 110.677 171.231 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -59.95 -34.82 73.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.6 0.76 . . . . 0.0 112.595 -176.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.26 -59.29 5.64 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.765 1.626 . . . . 0.0 110.774 170.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.36 -44.99 76.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.183 0.447 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.63 -28.85 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.134 0.974 . . . . 0.0 112.136 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -83.0 3.02 31.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.664 1.586 . . . . 0.0 114.231 169.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -124.17 -33.66 3.05 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.689 1.131 . . . . 0.0 111.976 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.73 102.78 8.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 168.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.34 166.38 29.47 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.545 2.164 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.0 56.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.21 63.57 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.512 1.125 . . . . 0.0 109.272 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -93.52 -5.94 0.11 Allowed Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -178.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -42.39 126.8 4.05 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.726 2.951 . . . . 0.0 115.305 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.99 -23.75 33.57 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.106 1.813 . . . . 0.0 112.401 -169.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.0 p -123.02 159.44 28.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.594 1.558 . . . . 0.0 113.086 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -87.72 106.27 17.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.277 1.031 . . . . 0.0 111.291 175.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -91.76 118.39 68.27 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.97 174.75 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.356 2.037 . . . . 0.0 114.032 175.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -134.55 142.38 46.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.252 1.821 . . . . 0.0 109.94 175.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -137.54 157.67 46.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.802 1.641 . . . . 0.0 109.668 -177.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.24 -177.4 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 171.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -58.03 -22.94 52.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.478 1.511 . . . . 0.0 113.704 -174.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -84.96 -1.14 56.36 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.473 0.579 . . . . 0.0 111.916 176.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.87 86.6 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.892 1.711 . . . . 0.0 114.521 178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.85 160.74 28.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.628 1.714 . . . . 0.0 109.538 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.67 130.42 46.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.83 143.07 77.69 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.75 -17.3 52.18 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.814 . . . . 0.0 113.575 -169.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.07 137.63 44.77 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.705 2.002 . . . . 0.0 108.63 169.065 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -128.4 150.36 50.14 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.667 1.187 . . . . 0.0 109.414 169.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.4 m -140.99 151.98 44.56 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.972 0.909 . . . . 0.0 111.959 -177.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.36 78.46 1.81 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.795 2.038 . . . . 0.0 107.865 177.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.96 -34.86 58.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.228 0.918 . . . . 0.0 114.334 -170.553 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -63.72 -15.23 57.97 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -114.31 -0.25 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.646 1.178 . . . . 0.0 111.974 169.288 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.4 58.23 13.33 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.585 1.088 . . . . 0.0 111.351 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -140.7 154.31 46.3 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.6 m -142.28 160.19 40.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.4 1.88 . . . . 0.0 110.166 167.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -150.08 163.13 38.98 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.881 1.672 . . . . 0.0 109.113 173.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.8 m -89.28 153.09 21.17 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.54 152.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.307 1.043 . . . . 0.0 110.543 171.136 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.86 162.52 73.71 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 166.426 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.14 -20.1 29.73 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.586 2.857 . . . . 0.0 116.167 -170.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -83.57 -8.79 59.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.485 2.314 . . . . 0.0 114.67 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.06 -0.93 54.8 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.471 1.51 . . . . 0.0 115.269 -177.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -70.88 115.79 10.42 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.856 1.828 . . . . 0.0 110.342 178.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -54.83 135.3 47.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.836 1.254 . . . . 0.0 112.863 175.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.49 111.7 33.65 Favored Pre-proline 0 C--O 1.242 0.709 0 C-N-CA 125.509 1.524 . . . . 0.0 108.075 172.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -50.97 150.58 12.94 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.647 2.898 . . . . 0.0 113.653 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 59.86 2.24 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.404 1.882 . . . . 0.0 115.933 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p -72.85 -32.4 65.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.297 1.408 . . . . 0.0 110.565 169.51 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -45.27 103.86 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.335 1.854 . . . . 0.0 112.41 -172.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m -135.48 167.86 20.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.553 1.541 . . . . 0.0 110.14 -171.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -79.67 13.35 2.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -178.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.98 -178.16 47.27 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.744 2.116 . . . . 0.0 112.476 -172.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -62.69 162.94 9.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.466 1.506 . . . . 0.0 114.227 -172.002 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 169.12 22.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.135 1.774 . . . . 0.0 110.332 171.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -74.0 39.88 0.12 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.776 2.83 . . . . 0.0 114.747 -168.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.534 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.746 0.307 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -82.73 167.15 18.46 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.976 0.91 . . . . 0.0 111.235 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -53.47 -42.38 67.18 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.721 -0.612 . . . . 0.0 112.168 171.213 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.8 t -55.88 -61.4 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.444 0.697 . . . . 0.0 110.688 172.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -56.42 -43.19 79.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.682 1.193 . . . . 0.0 112.744 -178.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -56.43 -53.92 51.75 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.63 1.172 . . . . 0.0 110.706 172.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.15 -41.49 83.85 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.616 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 4' ' ' CYS . 1.6 t -63.84 -35.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.563 1.074 . . . . 0.0 111.365 175.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -83.28 6.3 20.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.362 1.865 . . . . 0.0 114.733 176.402 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.44 -37.39 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.704 1.202 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.61 118.72 67.53 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.691 1.596 . . . . 0.0 106.76 172.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.54 168.02 23.34 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.672 2.248 . . . . 0.0 111.849 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.78 -23.63 53.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.277 1.031 . . . . 0.0 113.723 173.502 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.97 75.39 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.037 1.335 . . . . 0.0 108.549 172.068 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -118.73 62.04 5.16 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.333 1.053 . . . . 0.0 113.737 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.28 119.42 6.4 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.068 2.512 . . . . 0.0 110.575 172.53 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.91 88.07 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.389 -0.673 . . . . 0.0 114.465 -177.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -138.38 -179.4 5.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.376 1.47 . . . . 0.0 110.275 174.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -131.39 145.72 51.95 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.102 -0.999 . . . . 0.0 113.008 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -123.92 113.59 28.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.234 2.214 . . . . 0.0 108.295 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.65 161.33 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.694 1.596 . . . . 0.0 112.629 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -118.67 152.72 35.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.894 1.678 . . . . 0.0 109.747 169.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -131.27 151.57 51.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.762 1.225 . . . . 0.0 111.681 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.92 179.59 7.77 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.047 1.339 . . . . 0.0 112.362 173.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -61.37 -17.51 54.34 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -173.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.01 -2.03 58.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.51 1.124 . . . . 0.0 112.464 174.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.87 1.66 84.85 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.608 1.099 . . . . 0.0 113.853 -171.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.57 151.52 34.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.132 1.466 . . . . 0.0 109.072 175.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -51.28 129.92 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 111.281 175.417 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.62 131.18 77.64 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 117.888 -1.053 . . . . 0.0 108.368 171.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.43 -35.75 36.92 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.677 2.918 . . . . 0.0 114.53 -177.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.91 140.45 33.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.769 1.628 . . . . 0.0 109.898 169.451 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -126.52 143.52 51.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.226 1.41 . . . . 0.0 108.695 169.405 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.3 m -139.35 144.98 38.47 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.923 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -113.07 93.27 4.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 110.712 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.97 -9.22 26.89 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.2 p -68.65 -26.33 65.27 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.77 1.785 . . . . 0.0 112.538 169.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -125.56 -16.07 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.948 1.699 . . . . 0.0 112.853 -178.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.12 89.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.497 1.046 . . . . 0.0 114.578 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -81.93 154.4 25.79 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.21 1.005 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.4 m -134.55 165.34 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.018 1.327 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -153.26 165.0 37.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.125 1.77 . . . . 0.0 109.415 169.413 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 83.3 m -91.86 152.38 20.12 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 169.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.38 159.62 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.142 0.977 . . . . 0.0 113.377 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -92.68 164.85 20.68 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.059 2.143 . . . . 0.0 110.389 168.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -57.72 -5.83 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.749 3.633 . . . . 0.0 118.545 -172.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -103.59 -5.48 22.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.129 1.371 . . . . 0.0 113.865 172.084 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.46 0.58 55.59 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.797 1.665 . . . . 0.0 114.663 -177.408 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 m -69.77 128.08 35.18 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.886 1.343 . . . . 0.0 108.497 178.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.84 163.4 27.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.48 100.49 2.76 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 167.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.31 22.57 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.858 1 C-N-CA 125.895 4.396 . . . . 0.0 118.054 -166.436 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.85 -3.21 7.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.409 1.884 . . . . 0.0 112.398 168.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.5 p -92.98 -10.98 34.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.441 1.096 . . . . 0.0 113.246 178.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.51 96.5 0.08 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.157 0.983 . . . . 0.0 110.224 -173.424 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.0 t -134.57 163.07 30.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -168.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -1.9 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.727 2.811 . . . . 0.0 114.017 -169.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.82 -171.04 40.04 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.071 1.796 . . . . 0.0 112.75 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.91 152.22 13.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.494 1.917 . . . . 0.0 114.505 -170.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.43 171.76 19.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.012 1.725 . . . . 0.0 109.502 169.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -116.43 78.12 1.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 0.0 110.824 -168.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 126.25 1.82 . . . . 0.0 113.066 -179.474 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.648 0.737 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -142.13 169.15 18.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.576 2.75 . . . . 0.0 108.823 176.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -51.59 -40.14 59.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 112.87 179.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.1 -62.36 1.94 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.598 0.759 . . . . 0.0 111.517 170.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -59.93 -31.03 69.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.673 0.789 . . . . 0.0 113.006 -176.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -62.11 -58.17 8.82 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.264 1.426 . . . . 0.0 110.509 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -58.31 -38.94 78.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.875 0.762 . . . . 0.0 112.623 177.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.97 -31.22 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.772 0.829 . . . . 0.0 112.223 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 m -72.55 -43.99 62.73 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.926 0.89 . . . . 0.0 112.233 171.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.05 -33.71 57.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 113.413 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.9 mt -99.55 101.56 13.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.75 1.62 . . . . 0.0 106.889 172.506 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.16 172.59 16.06 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.742 2.295 . . . . 0.0 112.148 -177.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.07 -23.15 31.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.309 1.043 . . . . 0.0 113.355 171.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -76.19 70.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.198 1.399 . . . . 0.0 109.29 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -122.36 24.93 0.11 Allowed Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.725 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -62.22 114.69 2.44 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.754 2.303 . . . . 0.0 112.13 -173.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.64 -17.2 30.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.013 1.768 . . . . 0.0 112.956 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.1 t -119.71 177.98 4.75 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.635 1.974 . . . . 0.0 111.646 177.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -94.24 157.69 15.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.252 2.621 . . . . 0.0 110.865 176.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -143.24 129.95 10.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 0.0 108.378 169.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.67 170.53 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.9 1.734 . . . . 0.0 113.221 177.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -137.7 145.63 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.477 3.111 . . . . 0.0 110.368 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -134.07 157.62 45.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.962 0.905 . . . . 0.0 112.504 -174.296 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -95.52 173.22 7.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.446 1.499 . . . . 0.0 112.798 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -62.43 -13.99 35.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.21 6.41 40.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.105 2.162 . . . . 0.0 111.379 175.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.55 5.78 38.69 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.643 1.592 . . . . 0.0 114.416 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -91.18 164.68 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.431 1.492 . . . . 0.0 109.289 178.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -64.7 130.74 44.71 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.7 138.61 77.25 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.988 176.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -48.12 -31.88 17.49 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.158 3.239 . . . . 0.0 116.13 -177.156 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.67 139.6 39.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 171.271 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -129.36 147.26 51.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.218 1.407 . . . . 0.0 108.871 169.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -139.15 125.48 20.28 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.4 68.17 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.3 168.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.21 -30.21 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.312 1.434 . . . . 0.0 114.409 -172.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 m -53.34 -24.87 13.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 173.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -122.03 10.16 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.963 1.705 . . . . 0.0 111.934 173.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.78 3.64 68.39 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.505 1.526 . . . . 0.0 115.006 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -81.59 149.51 28.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.206 1.503 . . . . 0.0 112.128 -169.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.2 m -138.42 160.6 39.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 111.43 168.296 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -150.71 163.5 38.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.154 1.782 . . . . 0.0 108.831 169.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.1 m -90.45 154.78 19.39 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 169.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.28 159.82 42.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.129 0.972 . . . . 0.0 111.363 175.366 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.77 159.98 72.81 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 165.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -24.32 31.7 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.627 2.884 . . . . 0.0 115.824 -173.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -78.22 -6.74 55.8 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.182 2.193 . . . . 0.0 115.289 174.381 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.92 56.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.594 1.569 . . . . 0.0 115.237 178.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -72.25 119.3 16.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.893 1.346 . . . . 0.0 109.984 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -59.28 144.88 45.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.739 1.215 . . . . 0.0 113.662 177.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.25 96.55 0.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.73 2.012 . . . . 0.0 106.239 168.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.81 24.01 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.853 1 C-N-CA 125.789 4.326 . . . . 0.0 117.26 -166.74 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -125.04 -1.25 7.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.149 1.78 . . . . 0.0 112.594 169.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -92.96 -14.41 27.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.047 0.939 . . . . 0.0 113.171 176.615 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -57.1 107.88 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.069 0.948 . . . . 0.0 112.102 -171.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 t -132.81 158.94 41.2 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.83 1.252 . . . . 0.0 112.374 -171.7 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 7.72 0.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 128.339 2.656 . . . . 0.0 113.408 169.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.65 -172.42 43.72 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.817 1.199 . . . . 0.0 114.099 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -58.11 154.11 13.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.67 2.388 . . . . 0.0 115.353 -169.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.87 158.39 37.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.063 1.345 . . . . 0.0 110.494 168.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.45 69.65 3.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.592 1.157 . . . . 0.0 110.577 -169.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.928 1.691 . . . . 0.0 113.938 -173.653 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 123.245 1.498 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.6 p -142.76 172.19 13.03 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 130.675 3.59 . . . . 0.0 112.483 -172.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.33 -39.71 32.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 0.0 111.991 169.426 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -58.71 -62.97 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.434 0.561 . . . . 0.0 110.949 175.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -62.45 -30.54 71.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.62 -58.59 7.49 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.118 1.367 . . . . 0.0 110.764 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -53.31 -48.14 68.67 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.639 0.775 . . . . 0.0 111.136 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.86 -26.3 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.412 1.085 . . . . 0.0 112.639 177.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -89.32 3.22 52.83 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.417 1.487 . . . . 0.0 114.652 171.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -130.93 -29.95 1.84 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.888 1.222 . . . . 0.0 113.905 -173.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.78 116.85 64.0 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.632 0.773 . . . . 0.0 109.105 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -70.16 162.92 40.5 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.877 1.718 . . . . 0.0 111.147 176.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.13 67.67 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.675 -0.641 . . . . 0.0 112.248 170.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -76.81 71.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.277 1.431 . . . . 0.0 109.15 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -114.73 30.19 0.12 Allowed Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 170.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.13 113.48 2.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.491 2.794 . . . . 0.0 112.173 -170.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.99 -16.34 27.92 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.093 1.806 . . . . 0.0 112.765 -174.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -115.93 171.93 7.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.67 1.588 . . . . 0.0 112.443 178.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -88.42 160.33 17.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.86 2.864 . . . . 0.0 111.611 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -141.96 123.16 8.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.08 0.952 . . . . 0.0 110.638 169.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.97 174.83 12.21 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.96 2.44 . . . . 0.0 113.525 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -140.2 149.46 42.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.335 2.254 . . . . 0.0 109.835 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -144.25 160.76 40.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.563 0.745 . . . . 0.0 112.437 -175.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -85.22 176.06 8.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.552 168.055 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.52 -29.49 66.33 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.319 1.047 . . . . 0.0 112.469 174.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -83.58 14.15 4.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.265 2.226 . . . . 0.0 111.92 -175.046 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.94 8.53 49.43 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.309 1.433 . . . . 0.0 114.43 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -91.42 146.65 23.63 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.562 1.181 . . . . 0.0 109.214 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -62.43 126.13 26.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.056 0.942 . . . . 0.0 108.919 177.359 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.3 143.73 79.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.386 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -50.22 -22.5 8.37 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.2 3.267 . . . . 0.0 117.489 -174.755 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.26 137.24 52.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.47 1.908 . . . . 0.0 109.598 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -130.68 147.2 52.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.846 1.259 . . . . 0.0 109.63 173.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -135.77 122.43 20.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -172.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.13 70.56 10.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.749 1.619 . . . . 0.0 108.057 169.034 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.31 -33.35 31.41 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.343 1.449 . . . . 0.0 114.562 -172.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m -54.73 -24.61 23.0 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 175.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -118.62 6.46 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.301 1.44 . . . . 0.0 112.022 174.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.94 67.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.299 1.428 . . . . 0.0 114.665 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -90.6 150.22 21.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.124 1.462 . . . . 0.0 112.121 -174.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.9 m -134.44 160.51 37.76 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.427 1.491 . . . . 0.0 110.078 168.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -144.45 163.21 34.47 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.169 1.787 . . . . 0.0 109.284 169.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.75 151.71 23.63 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 169.554 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.25 155.43 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.061 0.945 . . . . 0.0 111.307 172.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.57 159.91 76.01 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.3 -24.44 15.69 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.935 3.09 . . . . 0.0 117.102 -172.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -82.68 -4.77 58.29 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 175.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.77 -0.08 52.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.632 1.587 . . . . 0.0 114.772 -178.341 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.6 m -70.66 113.93 8.25 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.152 1.476 . . . . 0.0 110.222 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -55.61 136.7 50.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.06 109.76 19.21 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.3 156.48 50.73 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.729 2.286 . . . . 0.0 112.109 -169.446 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 m120 59.5 2.0 0.3 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.114 1.765 . . . . 0.0 115.52 -175.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -71.35 -30.95 66.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.639 1.563 . . . . 0.0 110.699 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.664 ' NH2' HH12 ' A' ' 57' ' ' ARG 0.279 0.0 OUTLIER -46.65 120.62 3.04 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 123.524 0.729 . . . . 0.0 111.98 -172.506 . . . . . . . . 4 4 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.9 m -151.87 164.73 36.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.784 1.233 . . . . 0.0 111.134 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.664 HH12 ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.98 17.29 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.337 2.655 . . . . 0.0 112.717 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.91 179.78 45.98 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.756 1.646 . . . . 0.0 112.745 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -67.0 167.04 12.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.759 1.623 . . . . 0.0 113.417 -176.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 166.69 32.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.789 1.236 . . . . 0.0 111.353 174.188 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.36 61.25 4.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.831 2.452 . . . . 0.0 112.289 -168.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.905 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.4 p -84.69 165.73 17.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.359 1.064 . . . . 0.0 112.71 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -51.6 -40.66 60.25 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.726 1.211 . . . . 0.0 113.029 172.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.01 -56.49 16.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.041 -0.412 . . . . 0.0 111.142 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.66 -31.24 69.36 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.41 -61.79 2.29 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.016 1.326 . . . . 0.0 110.082 169.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.67 -37.77 82.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.416 0.553 . . . . 0.0 112.461 -176.723 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.54 -27.44 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.568 1.147 . . . . 0.0 112.296 175.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -74.43 -41.39 60.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.587 -0.696 . . . . 0.0 111.47 168.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -69.29 -41.92 76.16 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.977 1.311 . . . . 0.0 112.8 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.71 108.95 18.55 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.46 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.61 167.29 27.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.915 1.744 . . . . 0.0 111.716 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.55 35.57 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.17 74.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.347 1.459 . . . . 0.0 108.272 169.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -112.98 65.53 0.92 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.965 1.306 . . . . 0.0 111.774 176.145 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -60.23 121.11 9.27 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.702 2.934 . . . . 0.0 111.734 -171.09 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.95 13.51 2.25 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.623 1.583 . . . . 0.0 114.98 -174.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.1 m -115.43 161.57 18.37 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.677 1.991 . . . . 0.0 112.373 -167.615 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -79.55 149.2 31.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.315 0.646 . . . . 0.0 111.513 179.047 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -144.79 127.64 8.39 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 108.624 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.45 168.52 17.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.581 1.52 . . . . 0.0 113.928 178.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -130.85 150.62 51.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.076 2.55 . . . . 0.0 110.867 173.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -128.93 155.54 45.15 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.552 1.141 . . . . 0.0 112.238 -175.202 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -90.76 176.84 6.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.59 1.556 . . . . 0.0 113.272 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.33 -16.13 31.97 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.86 9.56 38.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.186 1.795 . . . . 0.0 111.697 175.17 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 5.57 33.0 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.475 1.512 . . . . 0.0 114.432 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.63 166.17 13.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.839 1.256 . . . . 0.0 108.88 178.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -59.81 130.58 47.48 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.817 -0.552 . . . . 0.0 109.976 178.407 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.3 125.87 59.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.555 173.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.62 -18.57 6.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.641 2.894 . . . . 0.0 116.982 -175.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -111.48 135.31 52.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.655 1.982 . . . . 0.0 108.976 169.222 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -129.69 154.02 47.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.531 1.133 . . . . 0.0 109.127 169.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.6 m -141.22 159.35 42.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.939 0.895 . . . . 0.0 111.528 178.702 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.68 90.17 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.789 1.236 . . . . 0.0 109.904 175.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.11 -48.02 26.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.286 1.898 . . . . 0.0 116.052 -169.743 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -64.91 -13.41 56.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.095 1.447 . . . . 0.0 114.616 -175.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 pt -116.36 -0.45 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 112.812 170.11 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.01 4.43 55.4 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.867 1.699 . . . . 0.0 115.399 175.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -84.76 148.56 26.29 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.227 1.013 . . . . 0.0 112.811 -176.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.6 m -132.13 159.27 39.41 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.03 1.332 . . . . 0.0 109.75 166.629 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.1 p90 -151.76 160.92 43.41 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.318 1.447 . . . . 0.0 109.228 173.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.2 m -88.86 153.13 21.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 169.165 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.76 149.6 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.669 1.188 . . . . 0.0 110.587 175.042 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -70.22 155.96 92.6 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 165.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -14.56 38.27 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.796 2.331 . . . . 0.0 115.743 -169.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -78.34 -10.97 59.9 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.9 1.68 . . . . 0.0 114.204 171.098 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.21 -1.35 47.09 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.049 1.785 . . . . 0.0 115.183 -177.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.3 m -73.85 116.16 14.14 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.556 1.678 . . . . 0.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -57.11 145.02 32.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.699 1.2 . . . . 0.0 113.652 175.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.72 87.52 0.71 Allowed Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.002 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -64.27 -17.32 59.25 Favored 'Trans proline' 0 C--N 1.351 0.704 0 N-CA-C 118.169 2.334 . . . . 0.0 118.169 -165.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -68.23 -11.44 59.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.455 1.502 . . . . 0.0 113.184 172.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -90.83 -14.0 32.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.215 172.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -55.64 105.08 0.15 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.32 1.418 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m -133.63 166.19 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.79 1.236 . . . . 0.0 112.96 -168.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -70.12 12.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.105 3.362 . . . . 0.0 114.547 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.68 -176.64 41.14 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.38 1.943 . . . . 0.0 112.625 -172.075 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -61.27 163.13 6.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.338 1.855 . . . . 0.0 114.425 -171.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.19 165.21 37.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.256 1.422 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.11 63.76 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.084 2.154 . . . . 0.0 111.667 -168.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.237 0.396 0 CA-C-O 122.903 1.335 . . . . 0.0 112.129 -174.732 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.561 0.696 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -140.9 167.4 22.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 128.743 2.817 . . . . 0.0 108.637 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -52.75 -38.77 61.41 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.612 0.642 . . . . 0.0 112.169 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 t -58.52 -62.45 1.84 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.345 0.658 . . . . 0.0 111.416 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.52 -32.81 71.83 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.11 -58.99 6.07 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.432 1.493 . . . . 0.0 110.504 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.3 -39.87 84.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.771 0.714 . . . . 0.0 112.481 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.2 -32.26 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.939 0.896 . . . . 0.0 112.109 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -73.6 -45.26 54.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.915 0.886 . . . . 0.0 112.368 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -77.23 -34.06 56.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.045 1.338 . . . . 0.0 113.256 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.5 mt -92.58 102.76 7.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.45 167.56 25.0 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.111 1.874 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.24 -21.57 34.95 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.92 47.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.397 1.879 . . . . 0.0 111.075 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -88.8 -10.2 0.15 Allowed Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -42.31 114.11 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 124.373 3.382 . . . . 0.0 115.208 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.06 -11.25 22.51 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.698 2.094 . . . . 0.0 112.783 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.9 p -140.03 171.74 13.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.681 1.993 . . . . 0.0 112.364 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -81.67 152.2 27.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 111.233 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -142.42 127.55 10.28 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.387 1.475 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.39 176.35 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.296 1.997 . . . . 0.0 113.447 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -140.32 150.26 43.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.074 2.15 . . . . 0.0 110.005 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.59 157.94 43.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.718 0.807 . . . . 0.0 113.039 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -99.26 179.41 4.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.804 1.642 . . . . 0.0 114.125 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -2.1 0.88 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.934 2.094 . . . . 0.0 114.933 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -122.73 19.35 10.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.4 1.88 . . . . 0.0 111.158 173.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.29 5.4 28.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.055 1.312 . . . . 0.0 114.678 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.83 164.39 17.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.076 1.35 . . . . 0.0 108.495 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -62.14 127.55 31.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.26 125.55 50.96 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.867 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.25 -8.53 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.023 3.149 . . . . 0.0 118.088 -176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -119.46 127.31 52.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.539 2.335 . . . . 0.0 107.03 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -120.74 146.31 46.61 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.343 1.057 . . . . 0.0 109.394 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 90.2 m -135.39 124.12 23.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.694 0.798 . . . . 0.0 112.455 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.19 71.08 10.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.687 1.595 . . . . 0.0 108.034 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.62 -35.87 11.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.809 1.671 . . . . 0.0 114.603 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 m -54.61 -22.71 14.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.901 1.681 . . . . 0.0 115.11 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.67 -0.94 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.881 1.673 . . . . 0.0 112.351 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.07 69.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.104 1.811 . . . . 0.0 115.181 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -84.12 154.13 23.33 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.78 1.29 . . . . 0.0 110.896 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.3 m -137.86 165.31 26.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.719 0.808 . . . . 0.0 111.998 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -147.43 162.53 38.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.089 1.756 . . . . 0.0 109.378 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.8 m -86.05 153.64 21.98 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.37 156.77 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.741 0.816 . . . . 0.0 111.65 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.07 160.63 77.86 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 165.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.18 -26.48 26.59 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.374 2.716 . . . . 0.0 115.591 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -75.55 -8.27 56.32 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.752 2.021 . . . . 0.0 115.417 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.57 -3.08 59.17 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.386 1.469 . . . . 0.0 115.339 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 m -73.66 130.72 40.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.033 1.417 . . . . 0.0 109.727 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.75 139.7 57.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.864 0.865 . . . . 0.0 112.517 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.68 115.52 58.83 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.46 134.83 6.76 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.7 3.6 . . . . 0.0 116.062 -169.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 62.88 11.11 4.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.781 2.032 . . . . 0.0 114.755 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -77.7 -22.33 50.63 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.881 1.219 . . . . 0.0 111.724 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.69 103.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.466 1.107 . . . . 0.0 111.814 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -144.92 171.22 14.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.948 1.299 . . . . 0.0 113.018 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -3.93 2.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.199 3.4 . . . . 0.0 115.421 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.67 -172.87 42.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.422 1.487 . . . . 0.0 112.602 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -57.57 164.19 2.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.153 1.781 . . . . 0.0 114.281 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.5 167.1 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.105 1.362 . . . . 0.0 110.56 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.11 60.76 6.45 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 111.724 -168.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -68.89 170.79 9.02 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.251 0.548 . . . . 0.0 112.433 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 m -65.81 33.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 128.269 2.627 . . . . 0.0 116.34 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.64 4.08 0.12 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.652 2.781 . . . . 0.0 117.221 -169.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 C--N 1.327 -0.399 0 C-N-CA 130.282 3.433 . . . . 0.0 114.038 167.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 120.681 0.277 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.5 p -84.92 166.1 17.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.335 1.054 . . . . 0.0 111.994 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -54.95 -35.87 64.7 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 t -59.74 -63.31 1.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.209 0.459 . . . . 0.0 110.591 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -56.55 -32.24 64.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.887 0.875 . . . . 0.0 113.151 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.34 -59.43 5.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.73 1.15 . . . . 0.0 110.665 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -56.96 -42.39 80.05 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -32.23 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.079 0.552 . . . . 0.0 111.896 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m -83.39 6.53 19.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.013 1.725 . . . . 0.0 114.379 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -125.31 -38.18 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 0.0 111.561 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.76 110.14 27.71 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.17 164.01 37.23 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.923 1.748 . . . . 0.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.64 -26.11 61.14 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.64 68.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.82 1.248 . . . . 0.0 109.002 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -102.46 8.76 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -41.86 111.54 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 123.871 3.047 . . . . 0.0 116.007 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.57 9.83 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.74 2.591 . . . . 0.0 112.435 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 t -111.48 165.69 11.77 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.481 1.913 . . . . 0.0 112.37 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -76.37 161.85 28.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.304 1.842 . . . . 0.0 107.354 164.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -147.9 125.46 5.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.428 1.491 . . . . 0.0 108.53 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.9 169.62 20.82 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.733 1.622 . . . . 0.0 113.289 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -135.94 143.66 45.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.757 3.223 . . . . 0.0 109.75 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -141.43 161.84 36.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.37 175.97 5.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.599 1.16 . . . . 0.0 112.896 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -63.84 -18.19 63.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.502 1.521 . . . . 0.0 114.429 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -84.48 11.0 9.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.344 1.057 . . . . 0.0 111.753 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.96 8.19 60.7 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.456 1.027 . . . . 0.0 114.12 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.1 157.43 16.75 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.88 1.272 . . . . 0.0 109.563 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -66.81 129.49 40.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mt -58.41 135.98 85.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.722 -1.132 . . . . 0.0 108.805 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.67 -17.98 11.07 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.443 2.762 . . . . 0.0 117.377 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.19 137.02 50.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.755 2.022 . . . . 0.0 109.157 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -131.1 152.53 50.3 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.596 1.158 . . . . 0.0 109.707 171.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -141.96 137.58 31.33 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.86 76.39 10.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.87 -28.05 38.46 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.265 1.412 . . . . 0.0 114.89 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -62.15 -21.7 65.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.908 1.283 . . . . 0.0 114.11 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -107.41 -26.86 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.224 1.81 . . . . 0.0 109.816 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.78 10.67 84.83 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.882 1.706 . . . . 0.0 112.918 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -84.53 135.67 34.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.685 1.594 . . . . 0.0 109.709 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -130.37 162.36 29.27 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -149.77 163.77 37.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.698 1.599 . . . . 0.0 109.436 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.2 m -86.94 152.42 22.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.75 151.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 110.654 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -71.94 156.51 90.85 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 166.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.2 -21.67 23.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.44 2.76 . . . . 0.0 116.429 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -76.87 -10.89 59.69 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.321 1.848 . . . . 0.0 114.703 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.56 -1.87 53.19 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.717 1.627 . . . . 0.0 115.363 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -74.39 122.08 22.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.873 1.836 . . . . 0.0 109.42 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.73 159.91 21.23 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.94 94.24 2.45 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 168.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.15 18.82 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 125.525 4.15 . . . . 0.0 117.823 -167.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.99 -5.1 10.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.954 2.101 . . . . 0.0 112.934 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 p -87.94 -17.51 31.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.385 1.074 . . . . 0.0 113.112 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -56.77 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.874 1.67 . . . . 0.0 112.455 -168.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -127.67 166.02 18.9 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.921 1.688 . . . . 0.0 114.203 -167.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 1.13 0.61 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.518 3.127 . . . . 0.0 115.517 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.33 -176.25 45.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.135 1.826 . . . . 0.0 112.745 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -60.23 165.07 3.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.567 1.947 . . . . 0.0 114.296 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 165.13 37.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.207 1.403 . . . . 0.0 110.848 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -82.26 58.19 3.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.993 2.117 . . . . 0.0 112.478 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -63.93 150.04 45.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.4 m -167.58 62.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.411 1.884 . . . . 0.0 109.303 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -78.17 50.95 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.003 1.321 . . . . 0.0 113.716 -169.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 124.897 1.279 . . . . 0.0 111.384 179.057 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.604 0.716 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -142.66 168.54 19.48 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 128.486 2.714 . . . . 0.0 108.936 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -56.99 -22.31 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 t -74.92 -61.32 1.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 110.66 169.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -30.72 67.48 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 112.991 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -59.66 5.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.604 1.562 . . . . 0.0 110.269 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.75 -35.87 81.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.89 -30.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.131 0.878 . . . . 0.0 112.092 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -74.27 -47.03 37.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 0.0 112.107 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -73.43 -30.61 63.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.257 1.423 . . . . 0.0 113.268 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.96 96.9 6.14 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.08 171.4 18.03 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.937 2.424 . . . . 0.0 112.243 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.17 -20.57 27.34 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.36 69.01 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.537 1.535 . . . . 0.0 109.274 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.423 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 7.9 p80 -127.67 -17.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 31.4 Cg_exo -42.19 116.76 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 124.013 3.142 . . . . 0.0 115.003 -176.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.28 -33.75 5.0 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.893 1.711 . . . . 0.0 111.091 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -111.15 170.66 7.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.171 2.189 . . . . 0.0 111.453 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -82.49 156.72 23.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.189 1.396 . . . . 0.0 111.647 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -144.81 130.82 9.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.521 1.928 . . . . 0.0 108.113 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.7 170.65 19.01 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.185 1.923 . . . . 0.0 113.929 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -137.89 151.73 48.32 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.21 2.204 . . . . 0.0 110.657 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -130.5 159.79 36.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 113.193 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -99.87 176.66 5.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.836 1.654 . . . . 0.0 113.552 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -14.62 36.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.984 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.39 13.89 28.15 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.584 1.554 . . . . 0.0 111.915 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.66 8.4 39.74 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.918 1.246 . . . . 0.0 114.226 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -89.99 164.67 14.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.809 1.243 . . . . 0.0 108.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.44 127.48 31.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mt -54.15 127.66 55.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.94 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -51.57 -21.73 11.33 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.237 2.624 . . . . 0.0 116.153 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.2 134.37 51.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.578 1.951 . . . . 0.0 108.952 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -126.71 149.73 49.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.456 1.103 . . . . 0.0 109.224 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.19 155.31 47.91 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.52 0.728 . . . . 0.0 112.059 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.21 75.92 1.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.063 2.145 . . . . 0.0 107.508 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.7 -44.01 47.38 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.537 1.541 . . . . 0.0 115.061 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 p -65.01 -9.39 21.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.38 -1.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.672 1.124 . . . . 0.0 112.488 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.91 62.26 5.39 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.216 0.912 . . . . 0.0 111.314 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -142.42 154.94 45.02 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.61 161.11 38.73 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.33 1.852 . . . . 0.0 110.458 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.37 163.77 36.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.198 170.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.3 m -89.93 152.29 21.3 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.48 155.2 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.903 1.281 . . . . 0.0 109.914 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -74.3 161.07 79.83 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 166.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.63 -24.22 22.16 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.899 3.066 . . . . 0.0 115.879 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -78.64 -6.28 55.25 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.686 1.994 . . . . 0.0 115.151 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.46 -2.86 59.25 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.596 1.57 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.7 m -73.08 117.93 15.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.903 1.352 . . . . 0.0 110.022 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.89 148.05 11.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.031 1.332 . . . . 0.0 113.579 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.22 92.48 1.22 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.15 23.2 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.827 1 C-N-CA 125.875 4.383 . . . . 0.0 117.795 -166.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -124.95 -2.17 7.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.971 1.708 . . . . 0.0 112.603 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 p -86.01 -19.61 30.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.152 0.981 . . . . 0.0 112.933 174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -45.54 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.835 2.054 . . . . 0.0 112.468 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 m -135.98 166.02 24.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 110.83 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.7 mmm-85 -76.36 6.51 5.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.8 -177.77 45.1 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.373 1.939 . . . . 0.0 112.105 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 114.65 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.04 167.2 31.17 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.825 1.65 . . . . 0.0 110.854 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.29 49.55 0.58 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.226 2.61 . . . . 0.0 114.181 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -56.1 107.87 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -118.77 25.2 10.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.524 1.93 . . . . 0.0 111.489 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.63 23.69 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.402 2.681 . . . . 0.0 116.048 -168.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 125.948 1.699 . . . . 0.0 111.762 -173.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.0 p -140.21 179.6 6.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.712 1.205 . . . . 0.0 111.745 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -21.62 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 131.192 3.797 . . . . 0.0 118.407 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.6 t -65.63 -51.21 61.34 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.589 -0.694 . . . . 0.0 110.668 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.72 -31.77 69.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.865 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.13 -54.23 41.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.699 1.136 . . . . 0.0 111.102 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.9 -44.31 86.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.295 0.498 . . . . 0.0 112.007 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.34 -27.1 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.127 0.971 . . . . 0.0 111.786 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -78.82 1.94 21.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.228 1.411 . . . . 0.0 113.963 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -126.4 -35.04 2.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.73 1.212 . . . . 0.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -88.25 109.33 27.57 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.501 1.92 . . . . 0.0 106.304 169.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.78 169.76 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.506 2.137 . . . . 0.0 111.937 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.2 -21.52 34.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.43 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.03 74.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.211 1.405 . . . . 0.0 108.591 169.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -116.4 61.79 2.33 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 124.816 1.247 . . . . 0.0 112.35 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.2 139.36 77.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.76 2.306 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.57 7.46 0.95 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.49 1.519 . . . . 0.0 115.624 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -134.44 176.24 8.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -112.95 140.34 47.85 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.547 1.539 . . . . 0.0 111.665 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -125.12 121.38 25.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.631 1.972 . . . . 0.0 108.297 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 172.24 2.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.766 2.311 . . . . 0.0 114.569 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 146.29 47.44 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.983 1.713 . . . . 0.0 109.441 169.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.76 160.79 39.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -165.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -73.51 173.93 8.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.864 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -61.43 -23.33 65.76 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.41 -9.77 58.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.536 1.934 . . . . 0.0 111.86 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.77 12.68 74.2 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.977 1.275 . . . . 0.0 114.67 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.5 155.46 18.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.455 1.128 . . . . 0.0 108.932 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -67.61 133.25 49.06 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.076 0.55 . . . . 0.0 110.183 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.46 142.05 91.12 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.2 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.89 -26.68 18.71 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.506 2.804 . . . . 0.0 116.4 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.94 45.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 0.0 109.935 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -123.15 144.28 49.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.54 1.136 . . . . 0.0 109.381 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.1 m -137.3 121.09 17.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.673 0.789 . . . . 0.0 112.192 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.43 66.92 9.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.131 1.773 . . . . 0.0 107.308 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.58 40.0 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.53 1.538 . . . . 0.0 114.381 -171.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -57.01 -20.11 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.096 1.758 . . . . 0.0 114.486 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 pt -121.59 2.36 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.785 1.634 . . . . 0.0 112.203 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.13 -4.03 78.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.667 2.079 . . . . 0.0 115.352 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.07 152.73 26.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.881 1.341 . . . . 0.0 112.293 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -139.95 164.47 29.91 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 112.586 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.39 163.77 38.2 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.426 1.89 . . . . 0.0 109.855 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.93 152.25 21.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.76 156.68 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.46 1.104 . . . . 0.0 111.108 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.82 160.07 72.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.56 -24.37 28.75 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.442 2.761 . . . . 0.0 116.256 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -75.84 -12.41 60.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.798 1.639 . . . . 0.0 114.608 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.17 -1.33 47.23 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.01 1.767 . . . . 0.0 115.099 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.8 m -71.34 118.32 13.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.784 1.792 . . . . 0.0 109.962 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.41 136.74 53.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.566 1.146 . . . . 0.0 113.167 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -83.88 110.53 26.11 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.87 158.35 43.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 65.11 -5.02 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.425 2.29 . . . . 0.0 115.218 -173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -78.15 -20.34 52.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.307 1.412 . . . . 0.0 111.773 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.95 91.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.981 1.713 . . . . 0.0 111.069 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -121.53 161.2 22.75 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.396 1.878 . . . . 0.0 113.643 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -13.02 5.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.255 2.622 . . . . 0.0 113.827 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.62 -177.2 36.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.294 0.95 . . . . 0.0 114.532 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -56.62 156.44 6.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.743 2.417 . . . . 0.0 114.737 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -155.87 167.67 29.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 108.316 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -112.11 61.68 0.62 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.278 -0.889 . . . . 0.0 112.489 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.3 m -52.24 106.66 0.16 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.824 1.65 . . . . 0.0 113.596 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 t 47.22 25.39 0.54 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.3 26.56 12.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.073 2.149 . . . . 0.0 113.682 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 126.918 2.087 . . . . 0.0 109.445 173.368 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.9 p -127.91 169.14 14.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.979 2.111 . . . . 0.0 110.632 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -38.99 -59.49 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 -49.93 75.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.589 0.631 . . . . 0.0 110.718 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -57.17 -40.62 77.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.524 0.73 . . . . 0.0 112.679 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.69 -57.34 13.1 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.924 0.89 . . . . 0.0 110.306 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.43 -36.85 81.51 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.84 -29.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.417 1.087 . . . . 0.0 112.124 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -72.26 -36.28 68.99 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.569 -0.707 . . . . 0.0 112.035 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -72.98 -46.77 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.602 1.161 . . . . 0.0 112.641 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -76.33 111.53 15.97 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.564 1.146 . . . . 0.0 108.081 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.46 151.82 75.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.113 1.875 . . . . 0.0 111.564 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.54 63.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.21 60.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.526 1.13 . . . . 0.0 109.54 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -90.54 -11.28 0.17 Allowed Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -42.51 128.41 4.7 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.828 3.019 . . . . 0.0 114.821 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.79 -24.59 30.9 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.791 1.662 . . . . 0.0 111.606 -168.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.9 p -123.28 162.65 22.24 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.67 1.988 . . . . 0.0 112.373 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.92 141.32 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.945 0.898 . . . . 0.0 111.08 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -136.47 118.89 11.79 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.286 1.834 . . . . 0.0 108.149 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.73 166.55 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.046 1.831 . . . . 0.0 115.868 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -118.84 142.55 47.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.792 2.837 . . . . 0.0 108.64 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -135.66 158.41 44.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.74 0.816 . . . . 0.0 112.8 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -98.75 -179.8 4.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.979 1.312 . . . . 0.0 113.906 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -62.43 -16.52 55.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -91.93 8.1 39.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.069 1.748 . . . . 0.0 111.929 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.12 2.45 18.59 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.021 1.772 . . . . 0.0 115.145 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.65 167.81 14.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.08 1.752 . . . . 0.0 108.932 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -59.42 133.49 56.14 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.119 -0.363 . . . . 0.0 110.362 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.85 139.04 95.61 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -53.57 -24.26 28.38 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.316 2.678 . . . . 0.0 116.394 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.01 139.01 42.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.019 1.728 . . . . 0.0 110.048 170.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -129.6 153.62 47.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.275 1.43 . . . . 0.0 109.792 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -141.2 157.5 45.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.968 0.907 . . . . 0.0 111.711 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.8 80.12 1.8 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.37 1.868 . . . . 0.0 107.808 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.05 -35.77 54.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.388 0.994 . . . . 0.0 114.235 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -62.76 -14.12 41.08 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.88 4.46 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.112 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.84 38.37 95.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.521 1.058 . . . . 0.0 113.515 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -128.03 152.25 48.17 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.7 m -136.2 159.63 41.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.03 1.732 . . . . 0.0 109.854 166.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -152.66 161.06 43.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.48 1.512 . . . . 0.0 109.387 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.31 152.14 22.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.906 -0.496 . . . . 0.0 109.933 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.08 154.4 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.412 1.085 . . . . 0.0 111.309 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -77.88 159.73 75.6 Favored Pre-proline 0 CA--C 1.554 1.112 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 166.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.44 -23.64 19.48 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.92 3.08 . . . . 0.0 117.555 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -85.37 -2.96 58.66 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.68 56.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.538 1.542 . . . . 0.0 114.82 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.7 m -69.35 109.59 4.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.693 1.247 . . . . 0.0 109.537 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -57.93 143.27 43.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 113.655 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.21 90.59 0.62 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -60.93 -24.06 78.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.908 2.405 . . . . 0.0 117.706 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -66.72 -12.0 56.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.027 2.131 . . . . 0.0 113.272 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -94.04 -10.01 34.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 117.438 -1.268 . . . . 0.0 113.297 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -59.89 106.08 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.312 1.414 . . . . 0.0 111.436 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 t -145.06 172.55 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.694 0.798 . . . . 0.0 113.094 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -65.5 1.5 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.568 3.547 . . . . 0.0 116.023 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.12 -177.74 41.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.69 1.614 . . . . 0.0 112.882 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -55.97 157.14 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.544 1.938 . . . . 0.0 114.139 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 164.73 38.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 111.147 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -85.48 65.46 9.19 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.553 1.541 . . . . 0.0 111.603 -169.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 66.3 m -58.8 157.35 9.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.291 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.4 p 52.71 27.09 4.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 55.3 29.99 13.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.003 2.121 . . . . 0.0 113.678 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.467 0.414 0 C-N-CA 125.028 1.331 . . . . 0.0 110.769 175.325 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.573 0.701 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 45.5 p -139.11 171.46 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 128.032 2.533 . . . . 0.0 108.73 173.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -53.89 -35.38 61.54 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.595 -0.691 . . . . 0.0 112.276 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.0 -62.32 1.86 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.535 0.734 . . . . 0.0 111.234 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' THR . 17.6 mm-40 -59.8 -33.16 71.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.397 0.544 . . . . 0.0 112.369 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.92 -60.36 3.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.868 1.267 . . . . 0.0 109.758 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.71 -29.19 70.44 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.28 -32.89 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.853 0.861 . . . . 0.0 111.337 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.5 p -80.03 -28.92 39.25 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.17 -48.69 64.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.184 0.902 . . . . 0.0 111.099 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.7 112.78 53.86 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.451 1.1 . . . . 0.0 108.523 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.19 164.8 34.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.019 1.813 . . . . 0.0 111.215 173.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.16 46.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 t -77.02 72.51 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.942 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -117.5 26.61 0.11 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 174.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.59 116.4 3.51 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.854 2.37 . . . . 0.0 112.148 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.75 -13.42 53.52 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.315 1.436 . . . . 0.0 113.147 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -119.62 176.85 5.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.444 1.898 . . . . 0.0 111.767 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -91.71 159.32 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.061 2.544 . . . . 0.0 110.633 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -143.16 130.91 11.03 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.588 1.555 . . . . 0.0 109.014 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.55 168.59 24.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.335 2.023 . . . . 0.0 112.37 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.575 1.95 . . . . 0.0 110.424 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -128.55 153.67 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.797 1.239 . . . . 0.0 112.97 -169.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -87.54 178.58 6.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.532 1.533 . . . . 0.0 113.264 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pm0 -62.98 -12.73 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -99.82 13.01 35.23 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.149 1.78 . . . . 0.0 111.834 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 3.87 22.36 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.631 1.586 . . . . 0.0 114.708 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.69 166.06 16.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.066 1.746 . . . . 0.0 108.606 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -58.88 130.91 49.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.76 0.709 . . . . 0.0 109.794 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.41 119.99 16.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.826 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.45 -9.09 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.759 2.972 . . . . 0.0 116.912 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.56 124.01 48.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.146 2.178 . . . . 0.0 107.218 167.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.2 145.19 48.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.789 0.836 . . . . 0.0 109.399 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.0 m -136.55 126.51 25.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.748 0.819 . . . . 0.0 112.276 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -83.74 70.31 10.33 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.46 -35.87 29.64 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.624 1.583 . . . . 0.0 114.222 -170.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.3 m -53.28 -22.89 7.75 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.45 1.5 . . . . 0.0 114.733 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.59 2.41 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.739 1.616 . . . . 0.0 112.814 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.75 80.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.34 1.448 . . . . 0.0 115.593 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -84.49 147.2 27.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.717 1.258 . . . . 0.0 112.312 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 m -133.69 163.47 29.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.735 1.214 . . . . 0.0 112.117 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -146.81 161.92 39.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.572 1.949 . . . . 0.0 108.384 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.0 m -86.22 153.18 22.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.82 153.57 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.529 1.132 . . . . 0.0 110.223 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -74.14 160.72 80.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.4 -25.73 25.57 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.44 2.76 . . . . 0.0 115.944 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -75.95 -10.15 59.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.059 1.743 . . . . 0.0 114.856 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.52 -1.78 57.2 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.582 1.563 . . . . 0.0 115.395 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.6 m -75.0 127.99 34.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.896 1.848 . . . . 0.0 109.755 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -57.47 139.84 52.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.35 111.48 31.53 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 168.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -49.88 148.91 11.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.884 3.056 . . . . 0.0 114.679 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.73 6.63 0.9 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.126 1.77 . . . . 0.0 115.412 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 p -74.38 -26.03 59.86 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.949 1.25 . . . . 0.0 111.36 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.605 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -42.42 109.21 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.382 1.873 . . . . 0.0 111.213 -177.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -142.53 164.7 29.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.923 1.289 . . . . 0.0 111.653 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.605 ' NH1' HH22 ' A' ' 55' ' ' ARG . 4.7 mpt_? -77.97 16.28 0.75 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.919 2.488 . . . . 0.0 112.958 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -178.71 47.59 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.27 1.891 . . . . 0.0 112.293 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -65.27 167.53 8.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.131 1.772 . . . . 0.0 114.128 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 166.03 34.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.036 1.334 . . . . 0.0 111.258 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -84.97 63.48 8.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.082 2.153 . . . . 0.0 112.039 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.0 m -66.65 164.35 17.02 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.5 p -70.38 72.75 0.49 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.251 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.63 68.9 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 130.021 3.328 . . . . 0.0 115.913 -169.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.468 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 110.63 168.249 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 123.176 1.465 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -143.54 163.97 31.69 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 130.684 3.593 . . . . 0.0 109.584 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -52.59 -42.2 64.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.629 0.649 . . . . 0.0 112.38 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 t -56.53 -61.33 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.498 0.719 . . . . 0.0 111.18 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.92 -34.0 74.01 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.34 -56.18 23.36 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.373 1.469 . . . . 0.0 111.021 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -58.61 -41.88 86.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.312 0.505 . . . . 0.0 112.011 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -62.83 -31.89 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.002 0.921 . . . . 0.0 111.896 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -83.35 4.49 27.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.99 1.716 . . . . 0.0 114.099 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -126.01 -34.78 2.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 0.0 112.057 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -96.9 105.48 24.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.38 171.08 18.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.651 2.234 . . . . 0.0 112.117 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.58 -23.74 42.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.223 1.009 . . . . 0.0 113.502 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.06 76.46 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 108.095 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -115.53 47.93 0.53 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.74 130.08 28.4 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.701 2.267 . . . . 0.0 111.067 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.28 -9.05 50.28 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.383 1.468 . . . . 0.0 114.337 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -120.78 160.53 23.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.482 1.641 . . . . 0.0 113.208 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -77.52 162.99 26.71 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 165.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -147.88 129.75 7.46 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.358 2.263 . . . . 0.0 107.035 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.91 170.84 15.81 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.685 1.59 . . . . 0.0 113.067 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -141.38 148.24 39.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.87 2.068 . . . . 0.0 109.559 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.9 m -135.13 157.58 46.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -101.83 177.37 4.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.683 1.593 . . . . 0.0 113.611 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.77 -14.51 33.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.748 1.619 . . . . 0.0 115.034 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -98.1 13.27 31.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.505 1.522 . . . . 0.0 111.906 171.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.51 37.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.968 1.27 . . . . 0.0 114.334 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -88.33 164.68 15.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.166 1.387 . . . . 0.0 108.918 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.79 126.67 28.34 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.84 131.11 57.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.09 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -48.21 -18.76 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.971 3.781 . . . . 0.0 117.355 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.8 131.68 56.87 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.045 2.138 . . . . 0.0 108.439 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -121.87 146.52 47.02 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 109.289 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.1 m -136.13 119.94 17.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 68.21 9.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.814 1.646 . . . . 0.0 106.823 168.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.66 54.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.227 -1.351 . . . . 0.0 114.149 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.32 -10.53 16.74 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.0 pt -124.34 8.47 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.356 1.462 . . . . 0.0 111.764 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.43 5.45 72.74 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.308 1.432 . . . . 0.0 115.041 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.82 146.69 27.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.195 1.498 . . . . 0.0 112.776 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.08 157.24 47.15 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.11 1.364 . . . . 0.0 109.943 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -144.52 163.15 34.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.456 1.502 . . . . 0.0 109.406 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.1 m -86.03 150.75 24.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.159 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.8 157.01 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.92 0.888 . . . . 0.0 111.151 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -77.84 159.61 75.97 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 165.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.98 -24.29 24.25 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.585 2.857 . . . . 0.0 116.297 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -76.87 -10.36 59.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.14 1.776 . . . . 0.0 114.663 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.96 52.8 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.776 1.655 . . . . 0.0 115.334 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -71.83 116.19 11.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.962 1.881 . . . . 0.0 110.325 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.45 137.18 57.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.332 1.053 . . . . 0.0 113.694 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.22 109.07 16.74 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 168.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.86 158.77 45.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.569 2.18 . . . . 0.0 112.074 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 61.22 -0.47 0.34 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.695 1.998 . . . . 0.0 115.547 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -71.26 -29.17 64.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.431 1.468 . . . . 0.0 110.667 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.532 HH21 ' NH2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -43.57 95.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.199 2.2 . . . . 0.0 113.969 -174.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -125.27 162.34 24.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.205 1.802 . . . . 0.0 111.863 -170.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -72.42 18.61 0.09 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.622 2.769 . . . . 0.0 112.597 175.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.33 -179.76 48.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.434 1.493 . . . . 0.0 113.249 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.25 163.24 13.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.093 1.757 . . . . 0.0 113.515 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 161.38 41.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.474 1.109 . . . . 0.0 111.818 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.13 67.96 9.92 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 111.242 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 72.6 m -53.17 122.54 9.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 p -64.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 128.555 2.742 . . . . 0.0 116.151 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -123.81 10.04 8.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 127.249 2.22 . . . . 0.0 112.066 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.463 0.208 0 C-N-CA 127.441 2.297 . . . . 0.0 111.018 -176.421 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.465 0.174 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -84.38 168.19 15.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.954 0.902 . . . . 0.0 112.439 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -54.98 -39.94 69.53 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.622 -0.673 . . . . 0.0 112.031 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -59.64 -57.54 12.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.698 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -58.47 -38.47 77.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.262 0.625 . . . . 0.0 112.632 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -59.96 4.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.679 1.192 . . . . 0.0 110.5 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.64 -41.94 82.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.589 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.83 -33.02 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.252 0.621 . . . . 0.0 111.938 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -81.72 -0.88 44.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.504 1.522 . . . . 0.0 114.561 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -126.23 -31.64 2.79 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.544 1.065 . . . . 0.0 112.394 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.99 108.07 38.54 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.97 169.09 23.4 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.442 2.094 . . . . 0.0 111.746 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.28 27.05 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.347 1.059 . . . . 0.0 113.576 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 t -86.25 76.48 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 108.058 169.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -111.03 70.87 0.72 Allowed Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.078 1.351 . . . . 0.0 111.589 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.22 134.92 47.85 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.975 2.45 . . . . 0.0 110.973 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.84 8.5 0.6 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.184 1.849 . . . . 0.0 116.163 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 p -131.32 168.07 18.18 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.613 1.565 . . . . 0.0 112.913 -168.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.85 152.26 20.82 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.088 1.355 . . . . 0.0 111.763 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -138.53 129.82 15.49 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.59 1.956 . . . . 0.0 107.632 169.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.41 176.1 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.835 1.69 . . . . 0.0 113.015 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -139.68 150.34 44.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.849 2.059 . . . . 0.0 109.637 174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -135.23 158.73 43.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -97.37 -179.31 4.45 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.856 1.663 . . . . 0.0 113.981 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -3.17 0.99 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.622 1.969 . . . . 0.0 114.924 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -123.24 19.47 9.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.96 . . . . 0.0 111.193 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 7.62 29.24 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.277 1.417 . . . . 0.0 114.732 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -85.62 162.81 18.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.751 1.22 . . . . 0.0 108.629 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -63.29 126.84 28.76 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 122.009 -0.432 . . . . 0.0 109.9 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.08 132.28 68.34 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.179 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.34 -17.3 4.0 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.899 3.066 . . . . 0.0 116.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -113.14 131.24 55.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.639 1.976 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.32 147.62 45.43 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.493 1.117 . . . . 0.0 109.396 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.1 m -138.66 122.75 17.97 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.721 0.772 . . . . 0.0 112.482 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.8 69.87 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.666 1.586 . . . . 0.0 106.911 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.84 -35.3 47.04 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.437 1.494 . . . . 0.0 113.778 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -62.65 -11.9 19.93 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.42 -4.44 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.43 1.492 . . . . 0.0 111.553 167.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.14 58.18 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.32 1.914 . . . . 0.0 114.829 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -113.09 152.17 29.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.697 1.749 . . . . 0.0 111.751 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -135.95 165.1 26.44 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.935 0.894 . . . . 0.0 112.51 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -148.93 163.59 37.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 109.34 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 70.9 m -87.23 151.38 23.21 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.02 157.63 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.058 0.943 . . . . 0.0 111.108 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.11 160.69 72.97 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -22.08 23.4 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.508 2.806 . . . . 0.0 116.562 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -79.08 -9.9 59.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.054 1.741 . . . . 0.0 114.517 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.84 55.89 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.612 1.577 . . . . 0.0 115.221 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.2 m -73.17 122.59 22.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.978 1.889 . . . . 0.0 110.04 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.28 137.27 57.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.011 . . . . 0.0 113.52 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -84.1 109.56 19.97 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.24 158.21 41.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.797 2.332 . . . . 0.0 112.948 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 65.18 -0.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.488 2.315 . . . . 0.0 115.098 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.4 p -81.16 -19.11 44.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.102 1.319 . . . . 0.0 112.172 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.44 98.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.276 1.43 . . . . 0.0 110.408 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 t -140.72 170.96 14.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -168.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -63.2 -1.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.636 1 C-N-CA 132.273 4.229 . . . . 0.0 114.655 -171.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.43 -174.8 47.25 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.158 1.361 . . . . 0.0 112.595 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -55.78 157.36 4.29 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.084 1.754 . . . . 0.0 113.421 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.35 171.84 19.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.982 1.313 . . . . 0.0 110.485 175.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -105.98 82.4 1.77 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.017 1.327 . . . . 0.0 110.286 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.4 m -65.32 -172.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.238 1.815 . . . . 0.0 112.637 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -64.7 51.63 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.819 2.048 . . . . 0.0 113.623 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.65 32.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.895 2.878 . . . . 0.0 114.514 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.1 p . . . . . 0 C--O 1.235 0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 110.959 178.262 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.903 0.382 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 p -83.83 166.25 18.1 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.522 1.129 . . . . 0.0 110.586 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.0 -39.89 66.48 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.369 -0.832 . . . . 0.0 112.291 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.6 t -58.38 -61.8 2.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.625 0.77 . . . . 0.0 111.265 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -62.01 -34.25 75.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.908 -0.568 . . . . 0.0 112.251 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.47 -59.55 4.98 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.746 1.218 . . . . 0.0 110.194 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -54.76 -47.84 73.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.755 0.422 . . . . 0.0 111.339 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 ' SG ' ' A' ' 23' ' ' CYS . 64.2 t -62.52 -28.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.868 0.867 . . . . 0.0 112.513 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.9 p -80.27 -2.29 44.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -131.42 -24.66 2.25 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -170.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.45 116.78 63.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.642 1.11 . . . . 0.0 109.542 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.31 163.05 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.929 1.753 . . . . 0.0 111.246 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.71 67.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.549 -0.72 . . . . 0.0 112.564 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.04 74.58 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.424 1.49 . . . . 0.0 108.498 170.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -111.41 63.68 0.53 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.73 1.212 . . . . 0.0 112.036 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.81 136.44 53.35 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.499 2.8 . . . . 0.0 110.949 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.28 13.79 0.77 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.274 1.416 . . . . 0.0 115.412 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -124.52 155.08 39.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.915 1.358 . . . . 0.0 113.173 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -75.97 157.45 33.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.545 1.538 . . . . 0.0 112.206 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -142.53 115.7 6.31 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 110.539 168.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.45 169.89 20.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.091 1.861 . . . . 0.0 113.422 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -136.81 143.18 43.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.155 2.982 . . . . 0.0 109.295 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' SG ' HG21 ' A' ' 8' ' ' VAL . 3.8 m -134.33 159.82 39.84 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.557 1.071 . . . . 0.0 113.02 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -95.81 174.93 6.71 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.653 1.581 . . . . 0.0 112.91 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -59.67 -20.93 59.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.463 1.105 . . . . 0.0 113.731 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.68 6.04 25.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.011 2.124 . . . . 0.0 111.636 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.5 7.09 38.28 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.628 1.585 . . . . 0.0 114.443 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.27 162.24 15.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.116 1.366 . . . . 0.0 109.32 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -61.71 126.8 28.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -55.64 138.2 69.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.854 -1.07 . . . . 0.0 108.652 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.85 -27.53 16.03 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.219 2.613 . . . . 0.0 115.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.49 135.47 45.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.533 1.533 . . . . 0.0 109.645 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -125.63 149.99 47.94 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.711 1.204 . . . . 0.0 109.018 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.0 m -137.78 153.49 49.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.662 1.22 . . . . 0.0 112.704 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.76 66.76 1.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.379 2.672 . . . . 0.0 106.096 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.78 -31.56 54.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.99 1.281 . . . . 0.0 113.598 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -60.13 -12.58 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.429 1.491 . . . . 0.0 114.791 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 pt -126.72 6.69 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 126.204 1.801 . . . . 0.0 111.693 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.69 7.95 87.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 0.0 115.556 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.99 156.96 16.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.667 1.733 . . . . 0.0 114.282 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.5 m -144.23 157.67 44.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.481 1.912 . . . . 0.0 109.93 166.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -148.49 164.62 33.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.79 1.636 . . . . 0.0 109.308 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.59 153.51 20.71 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.2 159.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.079 1.352 . . . . 0.0 110.66 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -79.33 161.28 68.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 165.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -52.04 -25.24 21.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.728 2.952 . . . . 0.0 116.32 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -78.22 -7.65 57.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.164 1.785 . . . . 0.0 115.301 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.63 -1.97 52.93 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.811 1.672 . . . . 0.0 114.984 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -71.12 113.77 8.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.963 1.382 . . . . 0.0 110.489 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -56.72 134.22 54.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.763 1.225 . . . . 0.0 113.709 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.63 111.37 31.49 Favored Pre-proline 0 C--O 1.241 0.61 0 C-N-CA 125.655 1.582 . . . . 0.0 107.131 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.49 161.41 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.64 2.227 . . . . 0.0 111.915 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.44 -2.55 0.12 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.359 1.864 . . . . 0.0 115.894 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.8 p -72.12 -31.51 66.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.46 1.482 . . . . 0.0 110.275 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -46.16 99.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.238 2.215 . . . . 0.0 112.834 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -129.77 165.91 20.97 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.741 1.616 . . . . 0.0 111.478 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 23.33 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.527 2.331 . . . . 0.0 111.927 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.56 -174.17 45.57 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.675 1.131 . . . . 0.0 114.438 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -61.43 152.51 29.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.886 2.474 . . . . 0.0 115.454 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 158.62 44.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.749 168.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -85.97 61.31 6.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.822 1.249 . . . . 0.0 112.607 -167.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.6 m -56.44 110.5 0.78 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.408 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.5 m -108.85 18.7 20.46 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 113.667 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -75.34 26.1 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.415 2.286 . . . . 0.0 113.472 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 126.878 2.071 . . . . 0.0 111.665 -171.29 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 121.519 0.675 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.433 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 27.6 p -138.6 172.69 12.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.208 2.603 . . . . 0.0 108.407 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -52.19 -38.1 56.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.194 0.598 . . . . 0.0 112.327 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.4 t -63.8 -58.18 7.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.357 0.663 . . . . 0.0 111.316 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' THR . 29.2 mm100 -58.9 -35.05 72.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.3 -60.59 3.57 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.127 1.371 . . . . 0.0 110.398 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.43 -37.17 80.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.11 -31.26 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.78 0.832 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -72.16 -41.56 66.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.728 . . . . 0.0 112.387 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -74.73 -40.65 61.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.045 1.338 . . . . 0.0 112.986 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.1 mm -89.04 110.4 37.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.5 168.11 25.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.206 1.938 . . . . 0.0 111.452 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.51 -18.5 29.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.72 78.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.229 1.411 . . . . 0.0 107.666 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -114.86 53.62 0.75 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.764 1.225 . . . . 0.0 113.779 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -62.33 131.5 34.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 -5.47 3.83 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.613 -1.104 . . . . 0.0 115.673 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -113.93 156.4 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.737 1.768 . . . . 0.0 113.0 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -73.1 161.57 30.47 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -147.56 124.6 5.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 126.678 1.991 . . . . 0.0 108.404 168.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.64 172.03 16.59 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.749 1.632 . . . . 0.0 114.049 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -135.91 144.31 45.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.727 3.211 . . . . 0.0 110.102 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -137.81 160.32 39.6 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -103.69 178.7 4.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.901 1.681 . . . . 0.0 114.23 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.64 0.15 1.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.53 1.932 . . . . 0.0 114.656 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.93 19.27 10.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.6 8.65 40.65 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.026 1.298 . . . . 0.0 114.555 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.09 164.25 14.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.69 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.95 127.43 31.22 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.03 135.46 84.01 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 117.678 -1.153 . . . . 0.0 108.472 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -52.85 -10.21 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.49 2.793 . . . . 0.0 117.41 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.88 137.79 51.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.284 1.834 . . . . 0.0 109.227 167.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -129.79 145.58 51.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 109.056 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 98.0 m -137.15 119.02 15.19 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.635 0.731 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.3 66.09 9.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.453 1.501 . . . . 0.0 107.335 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.53 -32.16 45.46 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.195 1.379 . . . . 0.0 113.786 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 m -60.43 -12.52 9.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.325 1.45 . . . . 0.0 114.913 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.59 7.63 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.286 1.834 . . . . 0.0 111.697 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.69 -2.95 77.08 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.192 1.853 . . . . 0.0 115.41 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -83.06 151.66 25.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.133 1.466 . . . . 0.0 113.304 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.74 160.72 39.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.043 0.937 . . . . 0.0 111.056 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -152.06 164.67 36.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.58 1.552 . . . . 0.0 108.817 169.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.44 154.5 17.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 110.571 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.36 157.96 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.768 0.827 . . . . 0.0 111.695 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.95 159.73 70.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.41 -21.23 17.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.067 3.178 . . . . 0.0 117.683 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -84.93 -4.44 59.12 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.79 1.636 . . . . 0.0 114.791 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.61 1.01 55.39 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.712 1.625 . . . . 0.0 114.641 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.1 m -71.75 115.75 11.31 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.902 1.351 . . . . 0.0 109.96 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -60.41 144.79 50.13 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.73 89.67 0.66 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.598 2.359 . . . . 0.0 104.818 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.54 -14.09 42.45 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.796 2.33 . . . . 0.0 117.583 -166.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -67.35 -10.86 55.17 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 127.107 2.163 . . . . 0.0 113.234 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -107.37 2.31 24.31 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.09 1.756 . . . . 0.0 112.545 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -62.83 94.17 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.403 1.001 . . . . 0.0 110.916 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -129.98 161.1 31.68 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -168.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.34 10.07 2.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.063 2.545 . . . . 0.0 113.146 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.58 -179.22 48.31 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.406 1.955 . . . . 0.0 112.234 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.68 157.46 9.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.486 1.914 . . . . 0.0 114.484 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -155.17 168.91 25.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.564 2.745 . . . . 0.0 106.145 168.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -111.22 34.64 3.95 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -163.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m -57.16 105.73 0.25 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.627 -0.67 . . . . 0.0 112.029 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t 54.29 19.31 2.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -106.7 12.34 29.31 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.47 0.54 0 C-N-CA 128.394 2.678 . . . . 0.0 114.056 177.834 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -82.89 166.86 18.57 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 111.314 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -53.51 -41.28 66.16 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.595 -0.691 . . . . 0.0 111.916 171.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.79 -60.21 4.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.309 0.644 . . . . 0.0 110.753 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.95 -39.09 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.351 0.66 . . . . 0.0 112.599 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.21 -56.82 16.86 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.878 1.271 . . . . 0.0 110.928 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -56.57 -43.76 80.32 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.42 0.554 . . . . 0.0 111.571 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.14 -34.97 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.537 0.735 . . . . 0.0 111.67 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -83.82 2.95 35.8 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.04 1.736 . . . . 0.0 114.318 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.58 -34.13 2.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.264 1.026 . . . . 0.0 112.392 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -89.13 113.69 57.25 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.32 163.82 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.237 1.958 . . . . 0.0 111.41 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -22.72 50.73 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.81 73.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.89 1.276 . . . . 0.0 108.66 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -110.9 35.51 0.12 Allowed Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.24 133.66 11.87 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.643 2.229 . . . . 0.0 113.546 169.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.75 -10.81 36.9 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.284 1.421 . . . . 0.0 114.617 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -130.08 173.29 10.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.733 1.767 . . . . 0.0 113.857 -170.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -94.17 152.87 18.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.524 2.329 . . . . 0.0 110.608 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -139.84 123.58 10.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.514 1.526 . . . . 0.0 108.606 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.99 175.95 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.3 2.0 . . . . 0.0 113.094 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 148.18 31.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.343 2.257 . . . . 0.0 109.519 173.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.7 158.42 44.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.83 0.852 . . . . 0.0 113.143 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -91.42 -175.96 4.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.652 1.581 . . . . 0.0 113.414 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -61.56 -16.8 51.23 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -91.48 -5.83 53.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.342 1.457 . . . . 0.0 112.103 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.79 81.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.11 0.862 . . . . 0.0 113.827 -169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -77.9 152.47 33.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.154 1.477 . . . . 0.0 109.478 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -55.41 125.39 20.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.966 0.506 . . . . 0.0 109.723 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.64 142.99 69.77 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.434 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -49.69 -22.89 7.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.567 3.512 . . . . 0.0 117.684 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.06 136.76 52.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.867 2.067 . . . . 0.0 109.406 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -130.03 152.57 49.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.233 1.013 . . . . 0.0 109.321 169.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.54 129.99 20.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.52 73.6 10.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.854 1.662 . . . . 0.0 106.528 168.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -46.59 -43.09 15.01 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.66 1.6 . . . . 0.0 114.258 -170.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 t -63.05 -8.83 8.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.3 pt -126.46 0.38 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.644 1.578 . . . . 0.0 112.44 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.6 7.19 85.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.538 1.066 . . . . 0.0 115.214 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -82.2 128.87 34.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.377 1.589 . . . . 0.0 110.532 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.02 158.77 25.15 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.903 0.881 . . . . 0.0 110.426 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -150.24 160.21 43.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.669 1.588 . . . . 0.0 108.676 171.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -86.18 155.06 20.89 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.28 154.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 122.016 0.912 . . . . 0.0 112.806 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.34 158.78 76.23 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 166.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 -8.36 17.09 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.693 2.262 . . . . 0.0 115.658 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -85.21 -12.14 53.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.306 1.843 . . . . 0.0 114.2 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.71 -2.07 52.68 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.907 1.717 . . . . 0.0 115.543 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.3 m -74.69 133.24 42.1 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.93 1.865 . . . . 0.0 109.068 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.35 155.22 40.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.73 111.53 35.76 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 125.822 1.649 . . . . 0.0 106.643 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.49 150.25 11.92 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.76 . . . . 0.0 113.646 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 61.84 1.5 0.63 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.508 1.923 . . . . 0.0 115.671 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 p -74.23 -28.5 61.27 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.398 1.454 . . . . 0.0 111.012 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -43.8 103.02 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.149 2.18 . . . . 0.0 112.136 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -138.26 162.45 34.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.408 1.083 . . . . 0.0 112.453 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.07 13.72 0.1 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.803 3.241 . . . . 0.0 114.314 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.73 -169.65 40.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.194 1.854 . . . . 0.0 113.46 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -57.49 152.39 14.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.444 2.298 . . . . 0.0 115.392 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.45 155.91 39.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.637 1.575 . . . . 0.0 108.987 168.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -94.43 70.64 3.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.52 1.128 . . . . 0.0 110.638 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.18 111.81 0.85 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.374 1.47 . . . . 0.0 112.913 -176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.7 p -71.32 70.94 0.61 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.982 1.713 . . . . 0.0 112.425 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 54.78 24.15 5.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.68 1.992 . . . . 0.0 114.406 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 128.163 2.585 . . . . 0.0 113.549 -170.272 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.478 0.18 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 p -84.37 171.1 12.94 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -53.79 -41.76 67.6 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.978 1.311 . . . . 0.0 112.035 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.51 -57.74 11.64 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.289 0.636 . . . . 0.0 110.622 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -60.52 -35.45 76.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 112.634 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.94 -57.15 14.1 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.78 1.232 . . . . 0.0 110.624 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -57.4 -42.32 82.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.345 0.521 . . . . 0.0 111.875 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.96 -32.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 111.857 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -86.39 6.83 28.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.562 1.945 . . . . 0.0 114.187 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.04 -37.8 2.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.669 1.188 . . . . 0.0 111.55 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -92.44 107.68 25.53 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.73 171.16 18.71 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.536 2.158 . . . . 0.0 111.694 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.3 -21.97 38.59 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -84.71 76.84 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.284 1.434 . . . . 0.0 108.106 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -114.36 63.19 1.28 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.903 1.281 . . . . 0.0 112.69 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 138.55 68.46 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 111.594 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 55.35 10.85 3.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.708 1.623 . . . . 0.0 114.432 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -126.75 161.13 28.87 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.668 1.234 . . . . 0.0 113.242 -167.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -83.72 157.14 22.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.329 1.451 . . . . 0.0 111.294 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -143.48 129.67 10.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.954 1.702 . . . . 0.0 108.083 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.21 175.07 10.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.101 1.867 . . . . 0.0 112.747 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -142.99 149.31 38.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.386 1.875 . . . . 0.0 109.329 172.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.97 158.85 43.26 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.35 1.06 . . . . 0.0 111.563 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -98.76 -174.86 2.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.294 1.037 . . . . 0.0 113.495 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -22.45 56.03 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.15 -8.66 59.02 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.172 0.589 . . . . 0.0 111.807 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.41 4.27 84.02 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.354 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.76 160.46 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.047 1.924 . . . . 0.0 109.339 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -59.35 132.15 53.14 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -61.42 142.72 93.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.013 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.27 -28.61 20.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.914 3.076 . . . . 0.0 116.264 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -106.23 141.25 37.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.46 1.904 . . . . 0.0 109.533 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -131.64 150.59 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.323 1.449 . . . . 0.0 109.084 169.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.1 m -139.65 134.45 32.03 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.26 72.7 10.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.26 -39.4 20.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.617 1.58 . . . . 0.0 114.731 -169.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -64.5 -9.7 20.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 pt -123.38 -4.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 112.088 169.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.1 84.97 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.006 1.765 . . . . 0.0 115.571 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -84.05 151.22 25.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.295 1.548 . . . . 0.0 111.026 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -136.95 165.33 26.25 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.188 0.995 . . . . 0.0 112.667 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -149.05 165.08 32.77 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -88.18 151.87 22.38 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.45 149.43 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.6 0.76 . . . . 0.0 110.798 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -71.11 158.95 87.04 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -52.49 -21.65 14.57 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.626 2.884 . . . . 0.0 117.416 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -85.41 -3.68 58.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.53 1.532 . . . . 0.0 114.507 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.69 -0.48 52.58 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.376 1.465 . . . . 0.0 114.754 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m -70.71 113.8 8.16 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.071 1.435 . . . . 0.0 110.534 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.21 135.22 38.56 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -83.31 109.49 17.99 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.0 156.41 54.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.493 2.129 . . . . 0.0 112.004 -169.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 63.84 -1.51 0.64 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.066 2.146 . . . . 0.0 115.334 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 p -77.66 -23.25 49.69 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.464 1.484 . . . . 0.0 111.827 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.85 99.17 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.048 1.739 . . . . 0.0 110.984 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.2 t -140.5 171.24 14.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.759 1.224 . . . . 0.0 113.451 -168.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -6.65 3.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.019 3.328 . . . . 0.0 115.29 -173.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.39 -176.85 43.99 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.918 1.247 . . . . 0.0 112.957 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -55.64 157.74 3.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.78 2.032 . . . . 0.0 113.518 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.8 164.42 38.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 0.0 112.232 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -84.0 61.4 6.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.942 2.097 . . . . 0.0 111.849 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.74 107.54 0.23 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.848 0.859 . . . . 0.0 112.144 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -123.65 27.2 7.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.323 1.849 . . . . 0.0 113.071 -168.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.54 17.95 2.54 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.097 1.759 . . . . 0.0 113.057 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.233 0.214 0 C-N-CA 126.619 1.968 . . . . 0.0 111.009 -169.88 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.7 p -82.95 167.45 17.96 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.952 0.901 . . . . 0.0 111.398 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -53.63 -37.67 63.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.643 0.777 . . . . 0.0 112.591 171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.0 t -60.36 -61.41 2.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -58.85 -37.27 76.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.422 0.689 . . . . 0.0 112.548 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.43 -59.17 5.88 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.196 1.398 . . . . 0.0 110.514 171.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -55.96 -46.63 78.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.416 0.553 . . . . 0.0 111.61 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.39 -33.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.056 0.542 . . . . 0.0 111.432 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -82.51 3.62 27.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.332 1.853 . . . . 0.0 114.509 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -126.03 -23.79 3.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.105 1.32 . . . . 0.0 113.506 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 mm -61.34 133.21 92.96 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 167.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.27 174.39 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.714 1.61 . . . . 0.0 112.986 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.43 -45.61 53.43 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.608 -0.682 . . . . 0.0 110.6 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.21 72.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.453 1.501 . . . . 0.0 108.799 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.521 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 0.9 OUTLIER -133.93 -16.28 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -179.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 44.0 Cg_exo -44.76 122.12 3.89 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 123.801 3.0 . . . . 0.0 114.29 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 -41.4 1.94 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.45 1.5 . . . . 0.0 110.517 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.1 p -74.74 163.5 27.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.366 1.467 . . . . 0.0 112.768 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -75.94 155.8 34.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.028 0.931 . . . . 0.0 111.323 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -144.77 128.5 8.74 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 125.503 1.521 . . . . 0.0 108.853 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.47 175.01 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.116 1.877 . . . . 0.0 112.289 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 153.69 40.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.631 1.572 . . . . 0.0 111.133 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.42 159.33 38.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.494 1.118 . . . . 0.0 113.071 -168.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -95.95 -179.69 4.78 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.983 1.713 . . . . 0.0 113.692 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -16.11 48.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.313 1.445 . . . . 0.0 114.866 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.72 13.76 31.1 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.788 1.635 . . . . 0.0 111.771 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 2.21 14.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.648 1.594 . . . . 0.0 114.71 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.34 164.14 20.19 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.811 1.306 . . . . 0.0 108.766 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -60.23 128.87 38.91 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.37 0.532 . . . . 0.0 109.827 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.79 128.23 62.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.15 -1.405 . . . . 0.0 108.675 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.62 -18.74 6.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.799 2.999 . . . . 0.0 116.761 -174.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.53 132.65 54.99 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.961 2.104 . . . . 0.0 108.551 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -124.84 151.87 44.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.254 1.022 . . . . 0.0 108.718 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 83.9 m -141.4 156.99 45.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.688 0.795 . . . . 0.0 112.07 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.03 93.45 3.19 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 110.742 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.76 -36.38 59.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.18 1.371 . . . . 0.0 115.091 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -57.76 -20.78 37.5 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.094 1.447 . . . . 0.0 114.503 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 pt -123.41 2.63 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.98 1.712 . . . . 0.0 112.207 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.44 12.22 69.33 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.293 1.425 . . . . 0.0 114.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -86.82 155.55 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.035 1.418 . . . . 0.0 113.339 -171.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.0 m -140.4 157.19 45.91 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.275 1.83 . . . . 0.0 109.57 166.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -149.5 162.7 39.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.628 1.571 . . . . 0.0 108.941 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.2 m -90.05 152.05 21.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.3 153.26 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.111 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -76.74 161.71 73.03 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 166.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -53.38 -23.85 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 116.361 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -80.8 -8.84 59.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.076 2.15 . . . . 0.0 114.924 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.27 59.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.34 1.447 . . . . 0.0 115.454 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.3 m -72.61 127.42 32.51 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.699 1.75 . . . . 0.0 108.863 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -71.83 165.92 23.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -99.83 92.8 2.11 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -68.85 23.2 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.863 1 C-N-CA 126.021 4.481 . . . . 0.0 117.907 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -124.77 -3.4 7.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.278 1.831 . . . . 0.0 112.465 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.9 p -84.95 -20.71 30.19 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.147 0.979 . . . . 0.0 113.067 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -57.25 97.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.076 1.351 . . . . 0.0 112.566 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -131.78 168.38 17.9 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.301 1.84 . . . . 0.0 111.992 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 21.8 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.108 2.563 . . . . 0.0 112.375 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 174.47 45.84 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.752 1.168 . . . . 0.0 113.219 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -62.82 164.08 8.5 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.059 1.744 . . . . 0.0 114.016 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 162.86 40.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.822 1.249 . . . . 0.0 111.212 175.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.07 63.44 7.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.952 1.701 . . . . 0.0 111.812 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m -53.45 105.83 0.15 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 113.335 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 p -150.05 13.89 0.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.8 1.64 . . . . 0.0 114.77 -169.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.46 7.28 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.33 2.252 . . . . 0.0 115.755 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--N 1.33 -0.282 0 C-N-CA 130.541 3.536 . . . . 0.0 114.112 168.048 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 160.32 19.51 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.802 1.641 . . . . 0.0 111.137 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -46.39 -53.21 11.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -58.13 -55.92 28.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.496 0.318 . . . . 0.0 111.419 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.98 -41.7 71.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.005 0.922 . . . . 0.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.03 -60.58 3.37 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.889 1.276 . . . . 0.0 109.893 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.63 -46.23 77.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.172 0.442 . . . . 0.0 111.77 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.86 -30.82 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.342 0.657 . . . . 0.0 111.745 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p -79.72 -3.83 49.2 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.78 -21.96 4.3 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.698 1.136 . . . . 0.0 113.997 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.52 137.44 97.08 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 167.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.99 168.65 16.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 121.879 1.72 . . . . 0.0 112.511 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.43 -45.8 68.27 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.541 -0.724 . . . . 0.0 110.318 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 t -77.82 71.65 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.99 1.316 . . . . 0.0 108.784 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -113.95 -9.06 0.1 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -42.87 112.4 0.27 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.441 2.761 . . . . 0.0 114.242 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -46.17 1.1 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.211 1.862 . . . . 0.0 108.672 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -85.61 141.7 29.62 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.802 1.241 . . . . 0.0 111.732 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -64.18 163.98 11.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.789 1.236 . . . . 0.0 109.391 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -142.54 125.21 9.11 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 127.064 2.146 . . . . 0.0 108.947 173.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.73 170.29 7.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.615 2.21 . . . . 0.0 115.843 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -131.84 148.77 52.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.746 2.418 . . . . 0.0 109.146 169.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.87 155.34 46.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -86.14 175.46 8.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.254 1.421 . . . . 0.0 113.05 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.95 -18.18 43.49 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.19 7.66 36.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.329 1.852 . . . . 0.0 111.782 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.23 8.0 41.55 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.344 1.45 . . . . 0.0 114.632 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -91.19 167.65 12.18 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.749 1.62 . . . . 0.0 109.135 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -58.35 133.4 55.69 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.937 -0.477 . . . . 0.0 110.542 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -57.16 133.32 80.75 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.531 170.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -51.24 -30.21 32.26 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.519 2.813 . . . . 0.0 115.566 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.55 137.87 42.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.884 1.674 . . . . 0.0 109.262 169.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -123.74 147.2 47.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 0.0 108.358 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.68 155.49 48.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.109 0.964 . . . . 0.0 110.224 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.47 91.02 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.328 1.061 . . . . 0.0 111.157 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -13.19 34.99 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 117.564 1.785 . . . . 0.0 117.564 -169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.2 p -69.8 -23.65 63.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.159 1.98 . . . . 0.0 112.655 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.1 pt -120.44 -19.26 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.906 1.683 . . . . 0.0 112.492 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 10.27 84.6 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.547 1.546 . . . . 0.0 114.753 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -83.51 157.92 22.2 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.525 1.163 . . . . 0.0 110.755 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.6 m -135.11 163.63 29.47 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.826 1.25 . . . . 0.0 112.416 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -150.87 163.3 38.98 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.144 1.778 . . . . 0.0 109.755 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -89.76 151.85 21.61 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 169.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.2 154.42 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.232 1.013 . . . . 0.0 110.923 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -75.77 162.97 70.05 Favored Pre-proline 0 CA--C 1.552 1.047 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.26 -23.38 23.09 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.878 3.052 . . . . 0.0 116.508 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -82.79 -11.88 57.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.624 1.97 . . . . 0.0 114.691 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.42 49.19 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.457 1.503 . . . . 0.0 115.826 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 m -69.64 119.24 13.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.762 1.781 . . . . 0.0 109.575 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.01 138.5 54.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.914 0.886 . . . . 0.0 112.942 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.73 107.66 11.01 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.18 152.93 77.2 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -169.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 71.42 -3.62 2.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 128.438 2.695 . . . . 0.0 114.396 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.2 p -79.24 -19.98 49.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.222 1.374 . . . . 0.0 112.072 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.1 97.46 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.26 1.424 . . . . 0.0 110.293 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.9 t -137.66 168.78 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.129 1.372 . . . . 0.0 113.217 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -7.73 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 129.324 3.05 . . . . 0.0 115.084 -173.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.21 -169.18 40.3 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.654 1.121 . . . . 0.0 113.422 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.99 150.66 4.13 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.999 2.52 . . . . 0.0 114.777 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 164.63 38.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.794 1.238 . . . . 0.0 110.92 170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -95.54 66.61 2.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.871 1.268 . . . . 0.0 111.602 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.5 m -60.12 134.86 57.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.055 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.6 m 49.81 27.09 2.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.312 1.045 . . . . 0.0 113.406 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 62.97 20.54 12.33 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.748 2.419 . . . . 0.0 114.462 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 125.9 1.68 . . . . 0.0 112.549 177.259 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -83.26 167.7 17.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.39 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -52.94 -39.21 62.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.298 0.639 . . . . 0.0 112.099 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 t -59.57 -59.68 5.05 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.599 0.759 . . . . 0.0 110.9 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.75 -37.13 78.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.632 0.773 . . . . 0.0 112.537 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.11 -58.66 7.43 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.152 1.381 . . . . 0.0 110.841 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -56.94 -41.04 77.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.488 0.585 . . . . 0.0 112.108 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.04 -29.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.333 1.053 . . . . 0.0 112.365 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 m -72.59 -42.83 64.12 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.762 0.825 . . . . 0.0 112.274 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -78.85 -37.3 40.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.809 1.244 . . . . 0.0 113.265 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.4 mt -90.75 104.33 9.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.24 169.13 21.45 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.186 1.924 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.91 -24.55 38.25 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.44 68.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 0.0 108.873 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -104.34 8.81 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -41.96 136.67 3.4 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.452 2.768 . . . . 0.0 115.234 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.07 -18.56 35.41 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.888 1.708 . . . . 0.0 113.494 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.4 p -130.34 166.69 19.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.177 1.488 . . . . 0.0 114.362 -169.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -82.78 145.05 29.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.613 1.565 . . . . 0.0 110.733 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -133.7 123.95 17.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.944 1.698 . . . . 0.0 107.96 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.98 175.61 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.848 1.699 . . . . 0.0 114.569 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -136.83 146.36 45.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.826 2.05 . . . . 0.0 109.206 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 m -135.17 153.42 51.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.102 0.865 . . . . 0.0 112.301 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -95.48 -176.38 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.524 1.129 . . . . 0.0 114.03 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -61.14 -24.3 66.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -86.56 8.69 21.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.236 1.414 . . . . 0.0 112.667 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.15 2.08 12.38 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.472 1.511 . . . . 0.0 114.833 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -82.87 169.59 15.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.523 1.529 . . . . 0.0 108.553 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -61.29 133.63 56.09 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.651 -0.656 . . . . 0.0 109.6 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.14 145.59 72.94 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.75 -14.28 38.81 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.881 1.72 . . . . 0.0 114.144 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -110.63 135.51 51.15 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.172 2.189 . . . . 0.0 107.978 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -128.7 150.11 50.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.444 1.098 . . . . 0.0 109.491 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.9 m -140.68 134.83 30.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.269 0.628 . . . . 0.0 112.216 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.69 73.61 9.71 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.39 15.79 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.685 1.612 . . . . 0.0 114.598 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.68 -11.67 27.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.86 -5.28 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.481 1.513 . . . . 0.0 112.421 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.45 8.29 83.71 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.88 1.705 . . . . 0.0 115.629 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -83.91 148.1 27.13 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.093 1.447 . . . . 0.0 110.733 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.5 m -135.34 164.02 28.69 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.224 1.01 . . . . 0.0 113.037 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -149.35 163.58 37.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.689 1.996 . . . . 0.0 109.038 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -88.86 155.14 19.71 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.43 156.38 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.381 1.072 . . . . 0.0 111.796 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -76.46 164.81 57.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 166.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.83 -29.96 36.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.474 2.783 . . . . 0.0 115.893 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.61 -6.34 56.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.131 2.172 . . . . 0.0 114.643 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.12 0.93 65.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.626 1.108 . . . . 0.0 115.189 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.7 m -70.99 126.49 29.71 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.733 1.766 . . . . 0.0 108.588 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -68.82 161.86 27.65 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.25 95.13 3.15 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.16 23.62 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.916 1 C-N-CA 125.836 4.357 . . . . 0.0 117.82 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -125.04 -3.66 7.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.426 1.891 . . . . 0.0 112.398 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 p -86.4 -19.94 28.96 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.056 0.942 . . . . 0.0 113.192 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.93 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.511 1.525 . . . . 0.0 111.351 -169.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m -132.22 165.49 24.0 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.154 1.382 . . . . 0.0 113.177 -168.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -5.13 1.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.399 3.08 . . . . 0.0 115.02 176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.13 -173.1 39.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.093 1.806 . . . . 0.0 112.355 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -59.29 164.85 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.375 1.87 . . . . 0.0 114.41 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 167.98 28.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.454 1.501 . . . . 0.0 110.547 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.25 57.43 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.523 1.929 . . . . 0.0 112.458 -168.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.9 m -66.92 159.34 28.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.97 -0.456 . . . . 0.0 111.286 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 m -154.98 20.76 0.44 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.23 -1.544 . . . . 0.0 114.991 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.52 21.44 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.811 2.445 . . . . 0.0 115.11 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 128.219 2.608 . . . . 0.0 110.328 -178.25 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.0 p -82.76 167.7 17.9 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.785 0.834 . . . . 0.0 111.32 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -54.28 -40.04 67.49 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.436 -0.79 . . . . 0.0 111.761 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -56.86 -60.28 3.8 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.737 0.815 . . . . 0.0 110.939 171.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.57 -36.66 76.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.252 0.621 . . . . 0.0 112.477 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.75 -57.56 11.41 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -52.69 -47.74 67.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.95 0.796 . . . . 0.0 111.459 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.95 -24.9 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.328 1.451 . . . . 0.0 112.426 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -91.01 3.93 53.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.235 1.814 . . . . 0.0 115.102 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -130.51 -33.16 1.67 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.187 1.358 . . . . 0.0 113.426 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.17 138.56 72.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.99 158.52 53.78 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 111.357 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.56 84.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.838 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.62 66.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.769 1.227 . . . . 0.0 109.135 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -85.54 -6.64 0.11 Allowed Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -43.72 107.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.881 3.054 . . . . 0.0 114.554 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.89 -20.48 6.0 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.619 2.057 . . . . 0.0 112.909 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -138.83 178.0 7.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.625 1.57 . . . . 0.0 112.215 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -80.68 159.07 25.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.245 1.818 . . . . 0.0 111.035 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -148.86 117.64 3.95 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.336 1.455 . . . . 0.0 109.34 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 174.68 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.17 1.913 . . . . 0.0 114.221 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -138.78 147.77 43.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.033 2.133 . . . . 0.0 108.905 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -132.75 157.67 44.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.254 0.934 . . . . 0.0 113.043 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -103.29 -178.27 3.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.751 1.621 . . . . 0.0 114.721 -169.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -15.56 27.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.968 1.707 . . . . 0.0 115.044 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -102.01 13.53 34.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.922 1.689 . . . . 0.0 111.886 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.19 3.94 20.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.328 1.442 . . . . 0.0 114.561 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -85.34 167.12 15.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.667 1.587 . . . . 0.0 109.343 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.0 124.1 19.51 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -53.83 128.71 55.13 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 117.394 -1.289 . . . . 0.0 108.697 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.39 -9.51 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.074 3.183 . . . . 0.0 117.915 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.43 127.85 54.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.772 2.429 . . . . 0.0 107.622 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.15 150.62 41.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.082 0.953 . . . . 0.0 109.721 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.3 m -138.12 153.83 49.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.893 0.854 . . . . 0.0 112.641 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.37 70.02 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.266 2.226 . . . . 0.0 107.668 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.84 -34.39 29.64 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.088 1.328 . . . . 0.0 113.991 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 m -53.13 -22.62 6.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.862 2.065 . . . . 0.0 115.191 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -121.39 -0.33 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 112.615 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.27 6.3 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.354 0.978 . . . . 0.0 111.339 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -143.3 158.62 43.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -141.23 161.57 37.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.177 2.191 . . . . 0.0 110.077 167.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.21 161.64 42.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.74 1.616 . . . . 0.0 109.366 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.1 m -85.98 153.73 21.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.85 159.28 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.38 1.072 . . . . 0.0 111.708 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -82.01 160.54 63.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.62 -26.21 22.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.785 2.99 . . . . 0.0 116.664 -172.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.1 -5.16 55.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.4 0.59 50.36 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.697 1.618 . . . . 0.0 114.806 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 m -67.9 108.62 3.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.165 1.482 . . . . 0.0 110.686 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -56.62 129.89 42.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.263 1.025 . . . . 0.0 112.979 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.48 110.69 26.17 Favored Pre-proline 0 C--O 1.241 0.617 0 C-N-CA 125.465 1.506 . . . . 0.0 107.97 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.8 161.2 33.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.595 2.197 . . . . 0.0 111.758 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 62.47 -5.23 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.948 2.099 . . . . 0.0 115.445 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 p -76.69 -24.89 53.17 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.345 1.429 . . . . 0.0 111.339 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -50.23 102.95 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.525 1.93 . . . . 0.0 111.106 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -144.33 167.74 21.74 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.448 1.099 . . . . 0.0 111.127 -170.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -74.79 4.56 6.18 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.79 43.82 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.684 1.611 . . . . 0.0 112.252 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -58.18 161.77 3.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.956 1.702 . . . . 0.0 114.439 -171.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.55 165.73 34.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 110.589 172.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -86.4 62.85 7.67 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.274 1.83 . . . . 0.0 111.223 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.6 m -65.14 164.1 13.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.5 m -70.25 63.53 0.24 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.828 1.651 . . . . 0.0 111.852 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.07 22.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.438 4.295 . . . . 0.0 121.375 -167.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.8 p . . . . . 0 N--CA 1.474 0.738 0 O-C-N 119.9 -1.75 . . . . 0.0 113.649 170.002 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.3 p -82.88 166.98 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.882 0.873 . . . . 0.0 111.525 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -54.41 -37.99 65.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.406 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 t -60.84 -59.77 4.85 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 110.9 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.54 -39.11 79.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.286 0.634 . . . . 0.0 112.7 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.55 -56.2 24.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.293 1.437 . . . . 0.0 110.986 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -56.61 -44.04 80.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.766 0.426 . . . . 0.0 111.587 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.57 -28.11 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.235 1.014 . . . . 0.0 112.277 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 m -83.49 3.85 30.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.016 1.727 . . . . 0.0 114.03 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -124.78 -35.66 2.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.528 1.131 . . . . 0.0 111.805 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -94.08 105.95 19.98 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.51 171.33 18.44 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.614 2.209 . . . . 0.0 111.822 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.56 39.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.082 0.953 . . . . 0.0 113.403 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.98 76.7 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.983 1.313 . . . . 0.0 108.051 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.45 46.7 0.46 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.42 129.03 25.33 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.699 2.266 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.04 -7.51 66.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.158 1.361 . . . . 0.0 114.323 -173.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -123.28 161.26 24.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.629 1.714 . . . . 0.0 113.56 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -78.1 160.41 28.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.477 1.511 . . . . 0.0 107.708 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -147.79 127.32 6.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.497 2.319 . . . . 0.0 107.098 169.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.73 171.37 9.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.493 1.462 . . . . 0.0 114.111 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -135.28 137.44 42.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.595 2.358 . . . . 0.0 108.82 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.92 154.86 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.652 0.781 . . . . 0.0 111.216 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -79.86 173.56 12.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.937 0.895 . . . . 0.0 112.267 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -61.79 -16.74 52.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.76 -5.71 59.33 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.364 1.865 . . . . 0.0 111.523 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.43 2.07 89.14 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 125.532 1.539 . . . . 0.0 114.627 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -78.47 147.29 33.99 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.124 1.462 . . . . 0.0 109.106 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -54.84 123.77 14.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.915 0.886 . . . . 0.0 110.104 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.06 145.03 67.16 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.65 -18.58 59.11 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.508 2.138 . . . . 0.0 114.291 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -109.91 131.67 54.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.795 2.438 . . . . 0.0 108.541 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -119.64 146.94 45.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.871 1.269 . . . . 0.0 109.417 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.64 128.88 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.35 71.31 10.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.681 1.592 . . . . 0.0 106.991 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.63 -37.2 26.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.513 1.53 . . . . 0.0 114.401 -170.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -63.31 -10.41 16.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 pt -125.01 -0.47 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 112.453 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.7 -5.05 76.51 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.667 1.603 . . . . 0.0 115.498 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -81.83 151.23 27.46 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.028 1.414 . . . . 0.0 111.493 -172.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.2 m -137.38 164.99 27.28 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -148.4 163.96 35.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.8 2.04 . . . . 0.0 109.227 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.8 157.03 18.61 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 109.771 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.45 161.4 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.87 162.66 46.44 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.715 1.606 . . . . 0.0 108.697 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.81 -15.28 9.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.995 3.13 . . . . 0.0 118.027 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -95.55 0.78 53.39 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.103 1.361 . . . . 0.0 114.083 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 2.47 62.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.197 1.38 . . . . 0.0 114.804 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -71.23 130.38 41.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.122 1.461 . . . . 0.0 109.624 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.53 137.94 58.1 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.4 t -83.42 109.15 15.97 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.01 155.95 47.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.832 2.354 . . . . 0.0 113.141 -168.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 61.68 -0.24 0.43 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.135 2.174 . . . . 0.0 115.818 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 p -72.79 -32.01 65.27 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.106 1.321 . . . . 0.0 110.77 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.76 106.38 0.11 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 111.967 -169.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -137.21 165.82 25.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.013 1.325 . . . . 0.0 113.103 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' NE ' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.84 -6.27 2.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.734 2.814 . . . . 0.0 114.216 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.89 -175.66 39.04 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.219 1.866 . . . . 0.0 112.559 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -58.04 161.97 3.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.823 2.049 . . . . 0.0 114.067 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.13 167.11 31.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.611 1.164 . . . . 0.0 111.771 172.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -82.61 61.53 5.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.448 2.299 . . . . 0.0 112.023 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.7 m -58.4 111.28 1.17 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -72.69 69.94 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 112.281 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 57.44 11.11 1.09 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.645 2.378 . . . . 0.0 115.783 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 C--N 1.329 -0.286 0 C-N-CA 128.128 2.571 . . . . 0.0 110.32 169.678 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 120.555 0.217 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -145.98 -178.83 6.32 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.149 1.38 . . . . 0.0 110.16 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -47.32 -33.02 5.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 112.369 169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.47 -68.5 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.235 0.614 . . . . 0.0 111.191 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -54.55 -39.77 68.06 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.44 1.096 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.94 -60.34 3.6 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.679 1.192 . . . . 0.0 110.282 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -54.32 -48.2 71.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.272 0.629 . . . . 0.0 111.908 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.06 -34.32 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.699 0.4 . . . . 0.0 111.261 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.6 p -80.97 -2.1 46.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -130.22 -23.58 2.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -67.33 137.74 93.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 165.15 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.007 1.805 . . . . 0.0 111.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.76 72.45 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.523 -0.736 . . . . 0.0 111.564 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -83.79 77.81 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.388 1.475 . . . . 0.0 107.927 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -118.68 53.2 1.83 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.383 1.073 . . . . 0.0 113.542 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -61.83 139.05 77.94 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.885 2.39 . . . . 0.0 110.853 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 11.51 0.78 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.266 1.412 . . . . 0.0 115.544 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -120.41 136.92 54.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.436 1.495 . . . . 0.0 110.928 -168.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.05 154.68 38.86 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -148.83 125.33 5.31 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.864 2.066 . . . . 0.0 108.523 168.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 178.3 7.04 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.274 1.983 . . . . 0.0 112.66 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -139.17 151.53 46.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.876 2.071 . . . . 0.0 109.764 170.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.77 154.46 51.22 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -86.25 175.36 8.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.442 . . . . 0.0 113.206 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.53 -21.06 59.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -84.9 6.31 25.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.348 1.859 . . . . 0.0 111.862 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.34 4.93 39.88 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.955 1.74 . . . . 0.0 114.889 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -90.5 164.73 14.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.831 2.052 . . . . 0.0 109.759 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.65 127.87 33.3 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.917 -0.489 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.35 141.2 62.96 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.826 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.5 -30.94 12.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.339 3.359 . . . . 0.0 116.251 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.2 tp -107.93 129.99 55.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.445 1.898 . . . . 0.0 108.855 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -112.52 140.09 47.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.681 1.193 . . . . 0.0 108.609 169.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.1 m -130.56 119.7 22.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 122.069 0.938 . . . . 0.0 110.669 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.25 66.59 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.24 1.816 . . . . 0.0 106.501 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.23 -27.12 64.78 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.564 1.554 . . . . 0.0 114.402 -169.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 p -61.97 -11.99 16.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.66 1.584 . . . . 0.0 114.267 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.48 -3.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.643 1.977 . . . . 0.0 111.705 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.69 20.32 79.56 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 126.412 1.958 . . . . 0.0 115.749 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -95.48 158.95 15.23 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.842 1.821 . . . . 0.0 111.28 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.37 164.88 29.03 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.746 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -149.51 164.18 35.78 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.785 2.034 . . . . 0.0 109.277 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.83 150.67 22.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.45 156.48 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.519 0.728 . . . . 0.0 111.737 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.5 158.59 81.05 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 165.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.55 -22.3 16.41 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.655 2.903 . . . . 0.0 117.091 -171.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -82.24 -5.46 58.53 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.421 1.489 . . . . 0.0 114.694 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.74 -0.47 48.88 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.679 1.609 . . . . 0.0 114.968 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -69.88 114.54 8.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.124 1.462 . . . . 0.0 110.539 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.92 136.81 55.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.729 0.812 . . . . 0.0 112.676 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.01 114.3 51.7 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -45.14 137.45 10.05 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.487 3.458 . . . . 0.0 115.58 -169.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.25 9.66 4.13 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.756 2.023 . . . . 0.0 114.843 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -78.11 -22.38 48.99 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.01 1.277 . . . . 0.0 111.604 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 105.17 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.197 0.999 . . . . 0.0 111.724 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -144.74 171.1 14.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.086 1.354 . . . . 0.0 112.999 -169.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -0.06 2.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 129.87 3.268 . . . . 0.0 114.922 -174.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.64 -176.58 48.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.218 1.389 . . . . 0.0 113.01 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.54 159.06 3.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.216 2.207 . . . . 0.0 114.174 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.51 166.29 33.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.479 1.111 . . . . 0.0 111.906 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.75 67.44 9.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.028 1.731 . . . . 0.0 111.535 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m -59.05 111.48 1.33 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.9 p -70.36 76.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 112.079 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 10.5 pt-20 48.91 19.15 0.24 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 128.511 2.724 . . . . 0.0 116.413 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 127.345 2.258 . . . . 0.0 110.374 169.931 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 p -83.72 167.92 16.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.32 1.048 . . . . 0.0 110.754 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -55.15 -39.24 69.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.443 -0.786 . . . . 0.0 112.239 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.1 t -62.18 -59.81 4.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.67 0.788 . . . . 0.0 111.03 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -58.0 -36.54 72.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.58 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.47 -59.23 5.74 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.366 1.066 . . . . 0.0 110.631 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.29 -42.1 81.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.414 0.552 . . . . 0.0 112.079 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.65 -32.27 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.262 1.025 . . . . 0.0 111.908 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 m -86.51 7.93 24.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.178 1.791 . . . . 0.0 114.063 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -124.94 -38.77 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.376 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.41 108.03 20.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 168.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -70.4 160.08 50.75 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.148 1.899 . . . . 0.0 111.47 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.63 61.08 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.89 67.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 108.927 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -99.11 5.31 0.07 OUTLIER Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -41.91 112.69 0.24 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.506 2.804 . . . . 0.0 115.609 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.99 28.44 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.118 1.818 . . . . 0.0 113.318 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -117.44 159.16 23.25 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.214 1.806 . . . . 0.0 111.972 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.38 157.87 37.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -148.54 130.14 7.35 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.499 1.919 . . . . 0.0 107.597 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.91 170.99 17.5 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.19 1.927 . . . . 0.0 112.509 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -144.14 150.5 38.17 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.18 1.792 . . . . 0.0 110.073 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -133.11 158.39 42.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.95 1.3 . . . . 0.0 111.208 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.38 179.64 6.04 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.282 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -16.82 49.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -173.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -84.64 -3.28 58.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.167 0.987 . . . . 0.0 112.61 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 8.93 82.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.215 0.912 . . . . 0.0 113.74 -171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -80.34 147.97 30.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.72 1.208 . . . . 0.0 109.008 172.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -51.98 126.97 19.89 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.089 0.956 . . . . 0.0 111.403 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.86 131.63 82.99 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.08 -30.05 30.35 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.24 2.627 . . . . 0.0 115.543 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.4 140.37 34.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.604 1.961 . . . . 0.0 109.482 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -131.72 149.82 52.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.087 1.355 . . . . 0.0 109.004 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 79.4 m -142.28 132.33 24.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.92 72.0 9.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 168.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.14 17.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.215 1.388 . . . . 0.0 114.784 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -60.9 -16.11 38.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.66 1.88 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.191 1.396 . . . . 0.0 112.435 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.94 69.26 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.811 1.672 . . . . 0.0 115.224 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -83.31 143.4 30.4 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.71 1.255 . . . . 0.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.7 m -131.18 164.81 24.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.645 1.178 . . . . 0.0 112.12 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -153.15 165.4 35.75 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.233 1.813 . . . . 0.0 109.376 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.9 m -89.66 154.16 20.17 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 122.027 -0.421 . . . . 0.0 110.241 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.81 160.29 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.874 0.87 . . . . 0.0 113.122 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.47 167.22 17.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.675 1.59 . . . . 0.0 110.714 167.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.82 -2.21 1.03 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 124.845 3.696 . . . . 0.0 118.614 -170.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -111.31 2.32 17.6 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.45 1.9 . . . . 0.0 113.562 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.69 2.34 61.48 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.227 1.394 . . . . 0.0 114.352 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.5 m -67.13 111.62 4.0 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.183 1.491 . . . . 0.0 110.108 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -56.09 138.34 49.73 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.705 1.602 . . . . 0.0 113.06 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.68 100.1 1.01 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.946 1.698 . . . . 0.0 106.826 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.17 19.32 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.506 4.137 . . . . 0.0 117.127 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -123.73 -1.28 8.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.847 2.059 . . . . 0.0 112.875 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 p -96.3 -15.08 22.13 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.359 1.064 . . . . 0.0 112.843 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.616 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.24 111.46 0.78 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.416 1.086 . . . . 0.0 109.877 -173.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 t -148.23 167.39 25.23 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.616 ' NH1' HH22 ' A' ' 55' ' ' ARG . 5.4 mpt_? -77.2 12.06 1.62 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.626 2.77 . . . . 0.0 113.598 -173.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.65 176.99 47.54 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.904 1.24 . . . . 0.0 112.747 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -57.6 157.98 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.61 1.964 . . . . 0.0 113.28 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.1 168.11 28.12 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.124 0.97 . . . . 0.0 111.821 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -87.76 65.74 8.53 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.771 1.628 . . . . 0.0 111.795 -168.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.4 m -66.69 161.11 24.14 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -157.72 19.01 0.26 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.833 1.253 . . . . 0.0 114.171 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.51 25.18 0.19 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.303 1.841 . . . . 0.0 113.812 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.481 1.512 . . . . 0.0 111.565 177.762 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.4 p -83.42 168.24 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.403 0.681 . . . . 0.0 111.661 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -51.06 -42.64 60.68 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 0.0 112.207 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -58.91 6.49 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.954 0.343 . . . . 0.0 111.45 171.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.27 -34.41 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.97 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.74 -61.83 2.23 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.579 1.152 . . . . 0.0 110.359 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -51.41 -49.66 61.2 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.182 0.993 . . . . 0.0 111.59 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.57 -27.39 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.067 0.947 . . . . 0.0 111.357 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -86.2 2.77 45.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.224 1.81 . . . . 0.0 114.602 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -128.86 -25.62 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.192 1.36 . . . . 0.0 113.838 -174.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.65 136.15 92.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 169.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.4 169.39 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.947 1.765 . . . . 0.0 112.074 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.18 72.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.609 -0.682 . . . . 0.0 110.868 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.15 74.36 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.07 1.348 . . . . 0.0 108.498 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.47 15.85 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.49 110.36 1.22 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 CA-C-N 123.636 2.334 . . . . 0.0 110.734 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.96 -15.37 8.92 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.567 1.556 . . . . 0.0 113.134 -169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.0 t -124.87 148.81 48.08 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.474 1.509 . . . . 0.0 110.756 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -77.27 165.25 24.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.961 0.904 . . . . 0.0 112.624 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -138.85 106.97 7.51 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.122 1.769 . . . . 0.0 109.864 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -55.51 155.67 20.33 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.29 2.66 . . . . 0.0 115.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.27 128.81 51.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 127.995 2.518 . . . . 0.0 108.809 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 29' ' ' TYR . 76.0 m -143.19 157.74 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.012 0.91 . . . . 0.0 111.885 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -79.24 176.93 9.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.326 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.2 -24.64 63.29 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -84.61 7.98 18.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.977 1.711 . . . . 0.0 111.668 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.27 15.4 51.26 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.044 1.783 . . . . 0.0 114.634 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.86 149.77 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.728 1.211 . . . . 0.0 109.252 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 66.1 m-85 -69.0 120.69 15.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.715 0.806 . . . . 0.0 110.01 -170.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.31 128.87 83.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.638 -1.172 . . . . 0.0 108.898 -175.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.77 -22.45 9.8 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.773 2.982 . . . . 0.0 116.594 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.59 136.11 50.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.431 1.893 . . . . 0.0 109.228 169.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -123.69 148.92 46.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.475 1.51 . . . . 0.0 109.073 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -140.82 152.85 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.335 1.054 . . . . 0.0 110.1 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -127.09 88.2 2.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.325 1.06 . . . . 0.0 110.688 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.66 -12.93 36.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.841 1.686 . . . . 0.0 116.84 -169.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.2 p -66.25 -25.68 67.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.263 1.532 . . . . 0.0 112.833 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 pt -119.89 -17.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 112.515 173.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.29 9.25 85.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.515 1.531 . . . . 0.0 114.683 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -83.2 158.06 22.47 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.571 1.185 . . . . 0.0 110.95 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.1 m -133.82 164.97 26.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.618 1.167 . . . . 0.0 112.067 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.42 163.87 39.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.904 1.681 . . . . 0.0 109.498 169.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.4 m -90.64 150.42 21.7 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.693 0.797 . . . . 0.0 109.639 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.46 151.29 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.575 1.15 . . . . 0.0 110.208 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.3 155.4 91.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.9 -16.89 12.62 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.737 2.958 . . . . 0.0 117.372 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -83.23 -4.7 58.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.125 2.17 . . . . 0.0 114.996 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.29 -3.26 54.54 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.733 1.635 . . . . 0.0 114.873 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 m -73.83 111.6 9.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.628 1.214 . . . . 0.0 110.067 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -55.52 143.08 30.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.773 1.229 . . . . 0.0 113.804 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.94 89.04 0.7 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 168.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.18 -15.23 48.3 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.761 2.308 . . . . 0.0 117.435 -166.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.43 -12.96 59.92 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 127.217 2.207 . . . . 0.0 113.134 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.7 p -102.9 -2.62 27.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.923 1.689 . . . . 0.0 112.65 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 104.83 0.6 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.572 1.078 . . . . 0.0 109.447 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 t -141.39 162.04 36.45 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -7.84 3.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.847 3.259 . . . . 0.0 114.945 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.39 -174.53 42.96 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.107 0.86 . . . . 0.0 114.165 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -55.72 149.92 13.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.346 2.258 . . . . 0.0 113.982 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -155.46 -176.51 5.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.833 1.653 . . . . 0.0 110.024 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -130.88 91.03 2.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.527 1.531 . . . . 0.0 110.201 -170.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.3 m -68.12 -176.2 0.68 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.625 2.37 . . . . 0.0 112.916 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -65.64 74.19 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.35 1.46 . . . . 0.0 111.126 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -122.51 18.64 10.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.13 1.772 . . . . 0.0 114.285 -168.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 126.101 1.76 . . . . 0.0 111.709 -177.321 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -83.09 167.19 18.07 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.706 0.803 . . . . 0.0 111.498 171.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -52.25 -39.66 60.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 112.382 171.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -59.59 -60.74 3.36 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.581 0.752 . . . . 0.0 110.949 171.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -58.88 -36.53 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.498 0.719 . . . . 0.0 112.458 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.86 -58.03 10.34 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.876 1.271 . . . . 0.0 110.749 171.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -57.81 -43.17 85.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.233 0.47 . . . . 0.0 112.016 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.55 -34.55 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.309 0.643 . . . . 0.0 111.628 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -82.46 3.19 29.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.736 1.615 . . . . 0.0 114.338 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -127.59 -34.02 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.439 1.018 . . . . 0.0 112.416 -177.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.8 mt -87.27 114.25 57.7 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.2 161.28 40.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.33 2.02 . . . . 0.0 111.705 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -18.43 42.87 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 175.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.02 78.9 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.302 1.441 . . . . 0.0 107.775 169.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -113.52 63.2 0.98 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.025 1.33 . . . . 0.0 112.763 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.16 136.65 57.13 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.366 2.71 . . . . 0.0 111.255 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.96 11.76 1.05 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.376 1.465 . . . . 0.0 115.183 -173.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -125.97 162.89 24.21 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.661 1.585 . . . . 0.0 112.007 -168.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -88.79 155.02 19.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.781 1.632 . . . . 0.0 111.675 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.61 126.34 8.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.796 1.639 . . . . 0.0 108.65 168.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.54 174.03 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.191 1.928 . . . . 0.0 113.507 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 151.34 44.86 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.822 2.049 . . . . 0.0 110.015 173.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.63 157.38 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.625 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.41 -175.64 3.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.564 1.146 . . . . 0.0 113.946 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -60.63 -24.97 65.94 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.14 8.65 20.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.238 1.415 . . . . 0.0 112.71 171.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.35 3.05 17.18 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.49 1.519 . . . . 0.0 114.794 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.19 170.68 11.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.682 1.593 . . . . 0.0 109.118 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -60.31 129.93 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 177.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.92 137.49 79.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.776 -1.106 . . . . 0.0 108.635 173.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.75 -22.78 10.27 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.495 2.796 . . . . 0.0 116.369 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.91 132.09 53.83 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.737 2.015 . . . . 0.0 109.319 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.8 147.78 46.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.628 1.171 . . . . 0.0 109.684 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -139.24 116.84 11.4 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -170.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 63.25 7.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.942 2.097 . . . . 0.0 106.531 168.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.63 -21.74 63.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.936 1.255 . . . . 0.0 114.945 -169.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.0 p -62.15 -15.0 42.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.87 1.268 . . . . 0.0 114.12 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -123.5 8.9 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 127.139 2.176 . . . . 0.0 111.724 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.18 5.05 89.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.963 1.744 . . . . 0.0 115.218 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -84.73 150.64 24.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.202 1.501 . . . . 0.0 114.142 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -143.77 163.37 33.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.897 1.679 . . . . 0.0 111.16 168.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -150.84 163.38 38.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.484 1.914 . . . . 0.0 108.731 169.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.88 154.31 20.95 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.29 157.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.203 1.001 . . . . 0.0 111.645 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -75.66 158.81 82.6 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 165.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.98 -13.68 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.386 2.057 . . . . 0.0 114.949 -169.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -79.8 -7.33 58.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.136 2.174 . . . . 0.0 115.103 169.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.69 -2.65 49.12 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.073 1.797 . . . . 0.0 115.132 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.9 m -73.33 116.78 14.28 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 1.408 . . . . 0.0 110.701 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.32 133.38 55.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.025 1.33 . . . . 0.0 113.635 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.17 111.7 35.48 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 126.718 2.007 . . . . 0.0 108.557 172.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.14 156.62 4.99 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.875 3.05 . . . . 0.0 114.285 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 59.99 -2.88 0.13 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.864 2.066 . . . . 0.0 116.04 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 p -76.01 -26.43 56.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.115 1.325 . . . . 0.0 111.524 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -46.94 106.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.941 2.097 . . . . 0.0 111.783 -174.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 t -148.08 161.29 41.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.729 0.812 . . . . 0.0 111.714 -172.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -89.69 36.23 0.84 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.214 1.405 . . . . 0.0 113.087 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.68 170.74 41.33 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.028 2.251 . . . . 0.0 112.218 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -67.71 167.89 12.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.052 1.341 . . . . 0.0 112.85 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 166.9 32.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.724 1.21 . . . . 0.0 110.981 174.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -83.99 61.3 6.35 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.795 2.038 . . . . 0.0 111.627 -168.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.7 m -64.36 158.89 22.38 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.496 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.1 m -159.62 24.63 0.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -70.97 34.9 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.309 2.244 . . . . 0.0 113.412 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 126.313 1.845 . . . . 0.0 110.145 174.721 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 p -130.96 176.14 8.49 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.756 1.222 . . . . 0.0 112.777 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -48.57 -35.98 14.57 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.202 1.401 . . . . 0.0 112.446 169.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.22 -57.69 10.51 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.453 0.57 . . . . 0.0 110.884 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -57.46 -40.41 78.45 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.279 0.632 . . . . 0.0 112.637 177.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.96 -57.59 12.21 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.044 0.937 . . . . 0.0 110.578 174.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.53 -46.79 73.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.703 0.801 . . . . 0.0 111.672 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -67.34 -29.58 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 0.0 112.014 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -76.95 -36.04 56.82 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.266 1.026 . . . . 0.0 113.167 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -80.08 -32.66 39.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.311 1.044 . . . . 0.0 113.365 -175.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.48 131.4 95.07 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 167.84 24.17 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.276 1.984 . . . . 0.0 112.678 -176.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.41 78.22 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.582 -0.699 . . . . 0.0 110.682 169.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -79.68 70.93 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.736 1.215 . . . . 0.0 108.914 171.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -114.29 -3.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.23 112.49 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 124.458 2.628 . . . . 0.0 113.904 174.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.82 6.67 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.154 1.835 . . . . 0.0 111.667 -169.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 t -125.32 162.54 24.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.397 1.879 . . . . 0.0 112.729 178.225 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.0 159.16 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.169 2.188 . . . . 0.0 112.938 -176.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -142.0 113.99 6.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.589 2.355 . . . . 0.0 107.723 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -62.46 168.81 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.367 2.044 . . . . 0.0 114.245 176.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.96 142.04 51.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.849 2.46 . . . . 0.0 108.442 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -136.13 156.77 48.21 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.289 0.95 . . . . 0.0 112.071 -176.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.08 -177.28 3.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.12 -32.34 64.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.035 1.334 . . . . 0.0 113.462 176.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -84.5 11.39 8.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 0.0 112.404 176.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.44 4.47 24.45 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.184 1.374 . . . . 0.0 114.371 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.22 169.88 11.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.814 1.307 . . . . 0.0 109.071 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -62.56 130.67 46.11 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -57.89 134.07 83.41 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 117.77 -1.109 . . . . 0.0 108.546 174.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.33 -26.07 15.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.037 2.492 . . . . 0.0 115.893 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.35 133.94 48.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.06 1.744 . . . . 0.0 109.142 168.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -121.76 149.28 43.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.632 169.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.27 148.43 43.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.496 0.665 . . . . 0.0 112.332 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.22 77.51 1.05 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.643 1.977 . . . . 0.0 107.81 -178.041 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -37.1 -54.54 1.53 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 127.6 2.524 . . . . 0.0 115.619 -169.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.6 p -63.79 -12.35 34.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -116.76 -5.6 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.343 1.057 . . . . 0.0 112.278 169.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.55 10.43 70.92 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.286 1.898 . . . . 0.0 115.246 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -83.41 155.7 23.34 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.621 1.21 . . . . 0.0 111.293 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.1 m -138.25 164.84 28.22 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.033 0.933 . . . . 0.0 112.423 170.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -148.94 164.03 35.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.595 1.958 . . . . 0.0 109.229 169.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.06 153.62 20.85 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.49 157.83 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 124.33 1.052 . . . . 0.0 111.595 173.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -77.81 160.77 73.56 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.28 -21.25 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.844 3.029 . . . . 0.0 117.358 -170.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.65 -3.0 58.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.792 1.637 . . . . 0.0 114.716 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.97 1.36 56.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.301 1.429 . . . . 0.0 114.899 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -71.31 117.45 12.86 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.134 1.467 . . . . 0.0 110.146 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -56.15 137.16 52.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.7 110.38 24.62 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.27 150.26 11.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.863 3.042 . . . . 0.0 114.408 -171.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.93 3.6 0.5 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.283 1.833 . . . . 0.0 115.585 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -73.71 -28.04 61.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.171 1.351 . . . . 0.0 110.926 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.88 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.695 1.998 . . . . 0.0 111.774 -176.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.5 m -136.13 164.22 28.55 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.079 1.352 . . . . 0.0 112.999 -168.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -4.75 0.81 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 130.03 3.332 . . . . 0.0 115.295 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.07 -175.77 41.12 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.592 1.567 . . . . 0.0 112.986 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -56.19 161.15 2.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.091 2.156 . . . . 0.0 113.698 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 171.03 20.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.751 1.221 . . . . 0.0 111.294 174.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -89.31 68.78 8.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.396 1.878 . . . . 0.0 110.488 -168.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m -68.92 -178.66 1.27 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.803 0.811 . . . . 0.0 112.003 174.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.1 m -66.95 35.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.162 2.185 . . . . 0.0 116.682 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -69.51 66.17 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 110.514 169.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 126.063 1.745 . . . . 0.0 112.477 -172.344 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.556 0.694 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -142.31 168.11 20.51 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.844 2.858 . . . . 0.0 108.695 177.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -52.17 -39.53 60.19 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 0.0 112.734 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -59.62 -61.46 2.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.603 0.761 . . . . 0.0 111.518 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.45 -31.22 71.16 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -61.24 -58.58 7.69 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.701 1.6 . . . . 0.0 110.517 170.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.79 -43.87 81.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.45 0.568 . . . . 0.0 111.954 177.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.29 -36.39 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.617 0.644 . . . . 0.0 111.712 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -68.68 -45.35 71.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.884 0.874 . . . . 0.0 112.353 173.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -77.81 -26.24 49.42 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.581 1.152 . . . . 0.0 113.47 -176.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.98 94.98 19.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.975 1.71 . . . . 0.0 108.06 179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.89 154.06 58.38 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.055 1.836 . . . . 0.0 109.994 169.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.51 -36.04 66.26 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.45 73.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 109.059 178.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.633 ' CE1' ' H ' ' A' ' 19' ' ' PHE . 7.0 p80 -132.67 151.09 77.51 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 112.826 175.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.9 155.19 69.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.382 2.721 . . . . 0.0 110.94 171.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.8 40.66 72.73 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -169.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 107.99 0.17 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.2 2.6 . . . . 0.0 114.487 -168.075 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.633 ' H ' ' CE1' ' A' ' 15' ' ' HIS . 2.4 t80 -152.64 89.1 1.38 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 130.654 3.582 . . . . 0.0 108.084 172.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -84.56 124.52 73.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.04 175.0 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.578 1.518 . . . . 0.0 111.118 169.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.08 153.67 36.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.688 1.195 . . . . 0.0 111.759 177.457 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.8 m -132.84 158.59 42.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 113.021 -169.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -95.76 -178.93 4.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.263 1.425 . . . . 0.0 113.698 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -62.43 -10.38 11.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -100.68 8.24 43.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.408 1.883 . . . . 0.0 111.619 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.62 6.07 27.14 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.963 1.268 . . . . 0.0 114.434 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -90.23 164.75 14.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.543 1.537 . . . . 0.0 108.876 178.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -61.35 132.62 54.11 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.851 -0.53 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.43 139.36 85.0 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.873 175.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.45 -21.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.292 3.328 . . . . 0.0 117.374 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.98 135.63 53.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.656 1.982 . . . . 0.0 109.37 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.81 151.74 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.654 1.181 . . . . 0.0 109.11 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 76.2 m -140.65 120.42 13.45 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.342 1.057 . . . . 0.0 113.238 -172.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.38 72.92 9.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.427 1.108 . . . . 0.0 108.416 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -42.49 -47.95 5.79 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.708 2.099 . . . . 0.0 115.133 -169.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 p -60.95 -14.44 22.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.7 pt -118.7 -6.91 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 120.016 1.28 . . . . 0.0 113.083 170.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.8 -3.74 86.74 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.194 1.854 . . . . 0.0 115.342 176.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -83.55 117.66 23.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.363 1.581 . . . . 0.0 112.083 -173.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.9 m -102.18 158.54 16.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.424 1.089 . . . . 0.0 110.262 168.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.19 162.37 39.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.513 1.525 . . . . 0.0 109.499 171.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.1 m -86.39 154.38 21.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.3 157.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.118 0.961 . . . . 0.0 113.298 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.12 163.29 58.27 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.97 -24.13 46.77 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.495 2.797 . . . . 0.0 115.829 -169.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -81.45 -7.84 59.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.266 2.226 . . . . 0.0 114.766 176.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.22 59.45 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.2 1.381 . . . . 0.0 115.438 -178.125 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.0 m -70.91 132.31 45.04 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.907 1.854 . . . . 0.0 109.937 177.195 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.1 141.93 57.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.274 1.029 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -82.34 115.37 57.53 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -44.08 133.44 8.63 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.779 3.652 . . . . 0.0 116.262 -169.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 59.5 15.15 4.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.731 2.013 . . . . 0.0 115.719 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.4 p -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.197 170.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.363 0.0 OUTLIER -57.99 110.73 0.98 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.027 1.285 . . . . 0.0 113.232 -170.503 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.3 t -148.65 153.54 38.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.792 1.637 . . . . 0.0 110.398 -170.157 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -80.31 28.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.166 1.386 . . . . 0.0 114.333 -171.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.35 169.05 35.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.387 1.946 . . . . 0.0 112.598 171.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -63.92 165.3 8.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.734 1.214 . . . . 0.0 112.781 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 164.12 38.65 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.017 0.927 . . . . 0.0 111.333 172.054 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -83.45 62.88 7.01 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.159 1.784 . . . . 0.0 111.976 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.45 108.4 0.94 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.7 t -139.45 27.92 2.26 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.214 1.806 . . . . 0.0 112.56 -177.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.02 15.9 3.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.347 1.459 . . . . 0.0 114.606 -169.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.331 -0.235 0 C-N-CA 125.426 1.49 . . . . 0.0 109.559 175.493 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.543 0.673 0 CA-C-O 120.607 0.241 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.8 p -144.89 167.69 22.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.516 1.927 . . . . 0.0 110.971 -174.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -50.23 -42.39 51.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.785 1.234 . . . . 0.0 113.418 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.08 -61.77 2.16 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.201 0.6 . . . . 0.0 111.127 173.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -58.66 -40.39 83.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.716 1.606 . . . . 0.0 112.265 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.24 -55.86 26.57 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 125.793 1.637 . . . . 0.0 110.344 172.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.68 -44.61 81.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.557 0.617 . . . . 0.0 111.432 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.85 -34.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.629 0.65 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -84.97 3.94 36.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.016 1.726 . . . . 0.0 115.231 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.8 -24.96 1.9 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.276 1.398 . . . . 0.0 114.265 -174.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.14 122.49 75.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.31 0.959 . . . . 0.0 109.166 176.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.54 172.48 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.302 2.002 . . . . 0.0 111.657 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -22.14 66.69 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.653 -0.654 . . . . 0.0 112.278 169.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.09 67.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.164 1.386 . . . . 0.0 109.184 169.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.5 92.65 44.13 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.102 1.361 . . . . 0.0 110.28 175.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.58 115.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.771 3.647 . . . . 0.0 114.994 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.9 51.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.174 1.368 . . . . 0.0 114.86 -177.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.261 92.0 p 69.16 107.08 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.274 3.029 . . . . 0.0 116.097 -176.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -138.44 136.21 35.99 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.968 1.707 . . . . 0.0 109.392 168.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -144.47 135.35 12.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 126.406 1.882 . . . . 0.0 106.086 169.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.9 163.57 38.72 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 120.63 1.261 . . . . 0.0 111.224 177.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -122.82 147.05 46.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.954 1.702 . . . . 0.0 109.469 177.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.4 m -136.61 156.53 48.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 111.848 -171.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -102.8 179.25 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.732 1.213 . . . . 0.0 114.162 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.21 -12.04 17.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 177.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -97.04 8.27 44.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.239 1.816 . . . . 0.0 111.696 175.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 8.81 35.38 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.706 1.146 . . . . 0.0 114.034 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.33 165.6 13.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.582 1.553 . . . . 0.0 108.85 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -62.17 132.52 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.09 135.74 87.88 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.8 -1.095 . . . . 0.0 108.258 174.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.07 -15.44 7.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.332 2.688 . . . . 0.0 116.887 -176.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.26 137.59 51.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.951 2.1 . . . . 0.0 109.891 171.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -131.9 152.42 51.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.853 1.261 . . . . 0.0 109.471 170.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.2 m -143.59 158.12 43.9 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.39 1.076 . . . . 0.0 112.353 -178.343 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 113.46 12.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.997 2.119 . . . . 0.0 108.93 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.04 -80.91 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 127.562 2.506 . . . . 0.0 117.274 -168.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 m -64.43 -18.73 65.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -168.34 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 pt -92.61 -3.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 10.83 59.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.597 1.57 . . . . 0.0 114.948 174.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -94.78 146.6 24.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.231 1.015 . . . . 0.0 113.445 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.9 m -130.86 156.45 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.509 1.523 . . . . 0.0 108.53 165.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.39 161.33 41.24 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.49 1.516 . . . . 0.0 108.781 172.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.8 m -86.8 152.69 22.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.82 156.66 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 110.019 170.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -73.68 161.19 79.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 166.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.54 -26.55 22.47 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.329 2.686 . . . . 0.0 115.389 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -76.46 -8.12 56.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.296 1.839 . . . . 0.0 115.374 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.69 -3.86 56.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.745 1.641 . . . . 0.0 115.266 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 m -73.56 119.79 18.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.059 1.43 . . . . 0.0 110.439 -177.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -56.82 132.14 51.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.719 1.207 . . . . 0.0 113.758 176.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.39 109.33 18.84 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.92 1.688 . . . . 0.0 107.639 169.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.44 163.51 26.6 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.556 2.171 . . . . 0.0 111.871 -175.015 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 61.2 -3.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.772 2.029 . . . . 0.0 115.74 -175.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.2 p -72.38 -28.84 63.27 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.994 1.27 . . . . 0.0 110.989 169.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -40.35 102.91 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.603 2.361 . . . . 0.0 113.103 -173.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -133.51 161.79 33.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.118 0.967 . . . . 0.0 111.627 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -71.95 17.55 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 130.17 3.388 . . . . 0.0 113.777 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.82 40.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.669 2.081 . . . . 0.0 112.178 -171.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -61.21 162.45 7.5 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.654 1.581 . . . . 0.0 114.193 -172.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 163.75 36.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.066 1.346 . . . . 0.0 110.827 171.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.06 57.69 3.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.17 2.188 . . . . 0.0 112.496 -168.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.7 m -60.41 95.39 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.845 1.307 . . . . 0.0 112.078 -173.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.8 m -83.65 63.29 7.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.053 1.741 . . . . 0.0 111.571 -167.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 56.44 19.58 4.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 114.509 -171.011 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 127.368 2.267 . . . . 0.0 112.512 179.35 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 p -129.77 175.07 9.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.778 1.231 . . . . 0.0 112.717 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -51.02 -33.44 25.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.661 1.184 . . . . 0.0 112.31 172.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.1 t -61.33 -60.2 4.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.307 0.503 . . . . 0.0 110.653 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -55.68 -38.7 69.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.53 -58.22 9.42 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.087 0.955 . . . . 0.0 110.654 173.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.59 -40.84 88.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.385 0.539 . . . . 0.0 112.41 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -69.03 -28.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.036 0.934 . . . . 0.0 112.243 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -73.43 -48.44 33.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.69 0.796 . . . . 0.0 111.955 169.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -73.62 -33.75 64.7 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.846 1.259 . . . . 0.0 113.251 -175.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.8 mt -97.43 101.06 9.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.42 173.54 14.07 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.698 2.265 . . . . 0.0 111.902 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.22 -20.26 17.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.408 1.083 . . . . 0.0 113.808 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.41 76.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.124 1.37 . . . . 0.0 107.987 169.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -111.67 71.87 0.98 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.135 1.374 . . . . 0.0 111.354 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.78 119.44 6.7 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.833 3.022 . . . . 0.0 112.391 -169.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 53.37 8.62 0.81 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.444 1.974 . . . . 0.0 115.313 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -108.57 159.89 16.35 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.649 1.579 . . . . 0.0 112.39 -167.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -77.61 148.39 35.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.842 0.457 . . . . 0.0 110.751 173.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -138.28 125.03 13.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.318 1.847 . . . . 0.0 107.723 169.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -70.33 174.34 10.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.103 1.868 . . . . 0.0 113.427 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -135.41 143.88 46.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.016 2.126 . . . . 0.0 110.236 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.77 164.24 29.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.433 1.893 . . . . 0.0 110.643 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -120.99 178.38 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.041 0.936 . . . . 0.0 113.068 169.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -62.93 -11.95 22.07 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.571 1.548 . . . . 0.0 114.682 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -87.49 1.3 53.89 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.231 0.469 . . . . 0.0 111.901 173.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.45 -1.01 88.55 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.857 1.694 . . . . 0.0 114.353 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -86.71 165.18 16.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.481 1.113 . . . . 0.0 110.629 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -64.85 130.31 42.98 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 167.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -55.2 135.35 68.59 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.63 -7.01 16.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.153 1.902 . . . . 0.0 114.854 -168.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.12 135.97 53.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.555 1.942 . . . . 0.0 108.135 168.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -130.8 153.11 49.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.469 1.107 . . . . 0.0 108.977 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -140.53 156.88 46.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.145 0.978 . . . . 0.0 112.008 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.02 102.38 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.383 1.073 . . . . 0.0 111.24 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.44 -41.0 62.7 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.99 1.281 . . . . 0.0 114.946 -175.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 m -62.32 -17.88 59.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.004 1.402 . . . . 0.0 114.652 -176.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -112.83 -2.47 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.389 . . . . 0.0 112.313 171.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.58 20.72 74.13 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.9 1.238 . . . . 0.0 114.438 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -118.54 161.41 20.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.939 1.369 . . . . 0.0 113.724 -170.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.2 m -132.36 159.15 40.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.993 2.117 . . . . 0.0 109.742 167.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -145.71 160.93 41.01 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.169 1.387 . . . . 0.0 109.248 171.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.6 m -88.34 152.9 21.61 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.65 154.59 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.752 1.221 . . . . 0.0 110.942 172.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -74.82 164.82 58.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 167.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -50.86 -28.54 23.84 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.473 2.782 . . . . 0.0 115.758 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -78.59 -6.93 56.93 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.236 2.215 . . . . 0.0 115.459 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.28 -3.27 63.85 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.914 1.245 . . . . 0.0 115.458 177.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.2 m -73.4 131.73 42.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.929 1.365 . . . . 0.0 109.402 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -59.18 142.54 51.41 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.03 110.1 21.25 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -47.67 142.96 13.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.011 3.141 . . . . 0.0 115.334 -169.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 61.09 8.65 2.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.56 1.944 . . . . 0.0 115.225 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -27.58 63.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.037 1.29 . . . . 0.0 110.919 172.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.549 HH21 ' NH2' ' A' ' 57' ' ' ARG . 1.7 ptm180 -41.17 93.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.343 2.257 . . . . 0.0 114.363 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -127.78 163.44 24.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.17 1.788 . . . . 0.0 112.083 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -69.2 9.05 0.48 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.577 2.751 . . . . 0.0 113.318 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.37 -179.83 47.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.979 1.752 . . . . 0.0 112.658 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -65.19 167.31 8.37 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.156 1.782 . . . . 0.0 114.008 -174.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 167.08 31.54 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.074 1.35 . . . . 0.0 111.359 176.355 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -78.63 53.63 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.129 2.571 . . . . 0.0 113.196 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.9 m -60.68 95.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.916 1.341 . . . . 0.0 114.576 -169.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 m -89.05 34.43 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.248 2.219 . . . . 0.0 112.033 -169.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -119.88 23.7 10.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.615 1.566 . . . . 0.0 112.962 -169.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 125.285 1.434 . . . . 0.0 111.451 -179.603 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.29 0.09 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 p -83.53 170.08 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -173.131 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.9 -39.26 62.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.705 1.202 . . . . 0.0 112.684 170.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.9 t -61.22 -59.2 5.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.722 0.809 . . . . 0.0 110.677 171.231 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -59.95 -34.82 73.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.6 0.76 . . . . 0.0 112.595 -176.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.26 -59.29 5.64 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.765 1.626 . . . . 0.0 110.774 170.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.36 -44.99 76.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.183 0.447 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.63 -28.85 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.134 0.974 . . . . 0.0 112.136 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -83.0 3.02 31.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.664 1.586 . . . . 0.0 114.231 169.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -124.17 -33.66 3.05 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.689 1.131 . . . . 0.0 111.976 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.73 102.78 8.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 168.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.34 166.38 29.47 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.545 2.164 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.0 56.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.21 63.57 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.512 1.125 . . . . 0.0 109.272 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -93.52 -5.94 0.11 Allowed Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -178.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -42.39 126.8 4.05 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.726 2.951 . . . . 0.0 115.305 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.99 -23.75 33.57 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.106 1.813 . . . . 0.0 112.401 -169.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.0 p -123.02 159.44 28.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.594 1.558 . . . . 0.0 113.086 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -87.72 106.27 17.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.277 1.031 . . . . 0.0 111.291 175.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -91.76 118.39 68.27 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.97 174.75 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.356 2.037 . . . . 0.0 114.032 175.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -134.55 142.38 46.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.252 1.821 . . . . 0.0 109.94 175.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -137.54 157.67 46.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.802 1.641 . . . . 0.0 109.668 -177.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.24 -177.4 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 171.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -58.03 -22.94 52.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.478 1.511 . . . . 0.0 113.704 -174.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -84.96 -1.14 56.36 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.473 0.579 . . . . 0.0 111.916 176.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.87 86.6 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.892 1.711 . . . . 0.0 114.521 178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.85 160.74 28.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.628 1.714 . . . . 0.0 109.538 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.67 130.42 46.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.83 143.07 77.69 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.75 -17.3 52.18 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.814 . . . . 0.0 113.575 -169.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.07 137.63 44.77 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.705 2.002 . . . . 0.0 108.63 169.065 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -128.4 150.36 50.14 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.667 1.187 . . . . 0.0 109.414 169.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.4 m -140.99 151.98 44.56 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.972 0.909 . . . . 0.0 111.959 -177.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.36 78.46 1.81 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.795 2.038 . . . . 0.0 107.865 177.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.96 -34.86 58.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.228 0.918 . . . . 0.0 114.334 -170.553 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -63.72 -15.23 57.97 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -114.31 -0.25 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.646 1.178 . . . . 0.0 111.974 169.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.4 58.23 13.33 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.585 1.088 . . . . 0.0 111.351 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -140.7 154.31 46.3 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.6 m -142.28 160.19 40.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.4 1.88 . . . . 0.0 110.166 167.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -150.08 163.13 38.98 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.881 1.672 . . . . 0.0 109.113 173.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.8 m -89.28 153.09 21.17 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.54 152.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.307 1.043 . . . . 0.0 110.543 171.136 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.86 162.52 73.71 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 166.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.14 -20.1 29.73 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.586 2.857 . . . . 0.0 116.167 -170.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -83.57 -8.79 59.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.485 2.314 . . . . 0.0 114.67 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.06 -0.93 54.8 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.471 1.51 . . . . 0.0 115.269 -177.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -70.88 115.79 10.42 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.856 1.828 . . . . 0.0 110.342 178.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -54.83 135.3 47.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.836 1.254 . . . . 0.0 112.863 175.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.49 111.7 33.65 Favored Pre-proline 0 C--O 1.242 0.709 0 C-N-CA 125.509 1.524 . . . . 0.0 108.075 172.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -50.97 150.58 12.94 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.647 2.898 . . . . 0.0 113.653 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 59.86 2.24 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.404 1.882 . . . . 0.0 115.933 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p -72.85 -32.4 65.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.297 1.408 . . . . 0.0 110.565 169.51 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -45.27 103.86 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.335 1.854 . . . . 0.0 112.41 -172.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m -135.48 167.86 20.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.553 1.541 . . . . 0.0 110.14 -171.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -79.67 13.35 2.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -178.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.98 -178.16 47.27 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.744 2.116 . . . . 0.0 112.476 -172.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -62.69 162.94 9.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.466 1.506 . . . . 0.0 114.227 -172.002 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 169.12 22.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.135 1.774 . . . . 0.0 110.332 171.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -74.0 39.88 0.12 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.776 2.83 . . . . 0.0 114.747 -168.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -55.8 110.93 0.8 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -116.96 22.58 12.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.774 1.63 . . . . 0.0 111.658 -171.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.79 14.83 0.33 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.431 2.292 . . . . 0.0 115.539 -168.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 C--N 1.328 -0.326 0 C-N-CA 125.768 1.627 . . . . 0.0 110.75 -171.853 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.746 0.307 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -82.73 167.15 18.46 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.976 0.91 . . . . 0.0 111.235 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -53.47 -42.38 67.18 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.721 -0.612 . . . . 0.0 112.168 171.213 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.8 t -55.88 -61.4 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.444 0.697 . . . . 0.0 110.688 172.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -56.42 -43.19 79.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.682 1.193 . . . . 0.0 112.744 -178.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -56.43 -53.92 51.75 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.63 1.172 . . . . 0.0 110.706 172.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.15 -41.49 83.85 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.616 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 4' ' ' CYS . 1.6 t -63.84 -35.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.563 1.074 . . . . 0.0 111.365 175.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -83.28 6.3 20.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.362 1.865 . . . . 0.0 114.733 176.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.44 -37.39 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.704 1.202 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.61 118.72 67.53 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.691 1.596 . . . . 0.0 106.76 172.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.54 168.02 23.34 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.672 2.248 . . . . 0.0 111.849 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.78 -23.63 53.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.277 1.031 . . . . 0.0 113.723 173.502 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.97 75.39 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.037 1.335 . . . . 0.0 108.549 172.068 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -118.73 62.04 5.16 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.333 1.053 . . . . 0.0 113.737 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.28 119.42 6.4 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.068 2.512 . . . . 0.0 110.575 172.53 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.91 88.07 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.389 -0.673 . . . . 0.0 114.465 -177.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -138.38 -179.4 5.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.376 1.47 . . . . 0.0 110.275 174.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -131.39 145.72 51.95 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.102 -0.999 . . . . 0.0 113.008 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -123.92 113.59 28.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.234 2.214 . . . . 0.0 108.295 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.65 161.33 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.694 1.596 . . . . 0.0 112.629 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -118.67 152.72 35.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.894 1.678 . . . . 0.0 109.747 169.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -131.27 151.57 51.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.762 1.225 . . . . 0.0 111.681 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.92 179.59 7.77 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.047 1.339 . . . . 0.0 112.362 173.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -61.37 -17.51 54.34 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -173.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.01 -2.03 58.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.51 1.124 . . . . 0.0 112.464 174.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.87 1.66 84.85 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.608 1.099 . . . . 0.0 113.853 -171.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.57 151.52 34.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.132 1.466 . . . . 0.0 109.072 175.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -51.28 129.92 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 111.281 175.417 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.62 131.18 77.64 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 117.888 -1.053 . . . . 0.0 108.368 171.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.43 -35.75 36.92 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.677 2.918 . . . . 0.0 114.53 -177.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.91 140.45 33.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.769 1.628 . . . . 0.0 109.898 169.451 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -126.52 143.52 51.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.226 1.41 . . . . 0.0 108.695 169.405 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.3 m -139.35 144.98 38.47 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.923 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -113.07 93.27 4.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 110.712 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.97 -9.22 26.89 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.2 p -68.65 -26.33 65.27 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.77 1.785 . . . . 0.0 112.538 169.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -125.56 -16.07 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.948 1.699 . . . . 0.0 112.853 -178.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.12 89.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.497 1.046 . . . . 0.0 114.578 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -81.93 154.4 25.79 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.21 1.005 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.4 m -134.55 165.34 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.018 1.327 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -153.26 165.0 37.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.125 1.77 . . . . 0.0 109.415 169.413 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 83.3 m -91.86 152.38 20.12 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 169.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.38 159.62 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.142 0.977 . . . . 0.0 113.377 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -92.68 164.85 20.68 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.059 2.143 . . . . 0.0 110.389 168.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -57.72 -5.83 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.749 3.633 . . . . 0.0 118.545 -172.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -103.59 -5.48 22.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.129 1.371 . . . . 0.0 113.865 172.084 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.46 0.58 55.59 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.797 1.665 . . . . 0.0 114.663 -177.408 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 m -69.77 128.08 35.18 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.886 1.343 . . . . 0.0 108.497 178.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.84 163.4 27.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.48 100.49 2.76 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 167.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.31 22.57 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.858 1 C-N-CA 125.895 4.396 . . . . 0.0 118.054 -166.436 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.85 -3.21 7.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.409 1.884 . . . . 0.0 112.398 168.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.5 p -92.98 -10.98 34.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.441 1.096 . . . . 0.0 113.246 178.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.51 96.5 0.08 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.157 0.983 . . . . 0.0 110.224 -173.424 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.0 t -134.57 163.07 30.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -168.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -1.9 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.727 2.811 . . . . 0.0 114.017 -169.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.82 -171.04 40.04 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.071 1.796 . . . . 0.0 112.75 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.91 152.22 13.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.494 1.917 . . . . 0.0 114.505 -170.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.43 171.76 19.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.012 1.725 . . . . 0.0 109.502 169.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -116.43 78.12 1.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 0.0 110.824 -168.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.97 119.3 6.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.25 1.82 . . . . 0.0 113.066 -179.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.5 m -67.87 60.41 0.07 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.887 2.075 . . . . 0.0 113.64 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 53.98 29.47 10.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.613 1.965 . . . . 0.0 114.785 177.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.468 0.433 0 C-N-CA 126.202 1.801 . . . . 0.0 112.954 -175.639 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.648 0.737 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -142.13 169.15 18.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.576 2.75 . . . . 0.0 108.823 176.386 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -51.59 -40.14 59.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 112.87 179.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.1 -62.36 1.94 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.598 0.759 . . . . 0.0 111.517 170.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -59.93 -31.03 69.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.673 0.789 . . . . 0.0 113.006 -176.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -62.11 -58.17 8.82 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.264 1.426 . . . . 0.0 110.509 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -58.31 -38.94 78.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.875 0.762 . . . . 0.0 112.623 177.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.97 -31.22 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.772 0.829 . . . . 0.0 112.223 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 m -72.55 -43.99 62.73 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.926 0.89 . . . . 0.0 112.233 171.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.05 -33.71 57.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 113.413 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.9 mt -99.55 101.56 13.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.75 1.62 . . . . 0.0 106.889 172.506 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.16 172.59 16.06 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.742 2.295 . . . . 0.0 112.148 -177.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.07 -23.15 31.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.309 1.043 . . . . 0.0 113.355 171.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -76.19 70.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.198 1.399 . . . . 0.0 109.29 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -122.36 24.93 0.11 Allowed Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -62.22 114.69 2.44 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.754 2.303 . . . . 0.0 112.13 -173.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.64 -17.2 30.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.013 1.768 . . . . 0.0 112.956 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.1 t -119.71 177.98 4.75 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.635 1.974 . . . . 0.0 111.646 177.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -94.24 157.69 15.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.252 2.621 . . . . 0.0 110.865 176.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -143.24 129.95 10.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 0.0 108.378 169.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.67 170.53 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.9 1.734 . . . . 0.0 113.221 177.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -137.7 145.63 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.477 3.111 . . . . 0.0 110.368 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -134.07 157.62 45.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.962 0.905 . . . . 0.0 112.504 -174.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -95.52 173.22 7.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.446 1.499 . . . . 0.0 112.798 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -62.43 -13.99 35.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.21 6.41 40.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.105 2.162 . . . . 0.0 111.379 175.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.55 5.78 38.69 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.643 1.592 . . . . 0.0 114.416 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -91.18 164.68 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.431 1.492 . . . . 0.0 109.289 178.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -64.7 130.74 44.71 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.7 138.61 77.25 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.988 176.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -48.12 -31.88 17.49 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.158 3.239 . . . . 0.0 116.13 -177.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.67 139.6 39.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 171.271 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -129.36 147.26 51.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.218 1.407 . . . . 0.0 108.871 169.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -139.15 125.48 20.28 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.4 68.17 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.3 168.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.21 -30.21 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.312 1.434 . . . . 0.0 114.409 -172.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 m -53.34 -24.87 13.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 173.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -122.03 10.16 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.963 1.705 . . . . 0.0 111.934 173.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.78 3.64 68.39 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.505 1.526 . . . . 0.0 115.006 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -81.59 149.51 28.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.206 1.503 . . . . 0.0 112.128 -169.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.2 m -138.42 160.6 39.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 111.43 168.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -150.71 163.5 38.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.154 1.782 . . . . 0.0 108.831 169.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.1 m -90.45 154.78 19.39 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 169.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.28 159.82 42.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.129 0.972 . . . . 0.0 111.363 175.366 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.77 159.98 72.81 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 165.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -24.32 31.7 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.627 2.884 . . . . 0.0 115.824 -173.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -78.22 -6.74 55.8 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.182 2.193 . . . . 0.0 115.289 174.381 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.92 56.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.594 1.569 . . . . 0.0 115.237 178.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -72.25 119.3 16.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.893 1.346 . . . . 0.0 109.984 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -59.28 144.88 45.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.739 1.215 . . . . 0.0 113.662 177.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.25 96.55 0.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.73 2.012 . . . . 0.0 106.239 168.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.81 24.01 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.853 1 C-N-CA 125.789 4.326 . . . . 0.0 117.26 -166.74 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -125.04 -1.25 7.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.149 1.78 . . . . 0.0 112.594 169.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -92.96 -14.41 27.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.047 0.939 . . . . 0.0 113.171 176.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -57.1 107.88 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.069 0.948 . . . . 0.0 112.102 -171.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 t -132.81 158.94 41.2 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.83 1.252 . . . . 0.0 112.374 -171.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 7.72 0.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 128.339 2.656 . . . . 0.0 113.408 169.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.65 -172.42 43.72 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.817 1.199 . . . . 0.0 114.099 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -58.11 154.11 13.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.67 2.388 . . . . 0.0 115.353 -169.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.87 158.39 37.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.063 1.345 . . . . 0.0 110.494 168.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.45 69.65 3.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.592 1.157 . . . . 0.0 110.577 -169.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.2 m -46.3 106.95 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.928 1.691 . . . . 0.0 113.938 -173.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.3 m -130.28 24.23 5.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.477 1.911 . . . . 0.0 112.15 -170.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.09 10.93 2.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 115.066 -169.322 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.328 -0.368 0 C-N-CA 125.518 1.527 . . . . 0.0 109.439 177.349 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 123.245 1.498 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.6 p -142.76 172.19 13.03 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 130.675 3.59 . . . . 0.0 112.483 -172.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.33 -39.71 32.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 0.0 111.991 169.426 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -58.71 -62.97 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.434 0.561 . . . . 0.0 110.949 175.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -62.45 -30.54 71.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.62 -58.59 7.49 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.118 1.367 . . . . 0.0 110.764 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -53.31 -48.14 68.67 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.639 0.775 . . . . 0.0 111.136 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.86 -26.3 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.412 1.085 . . . . 0.0 112.639 177.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -89.32 3.22 52.83 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.417 1.487 . . . . 0.0 114.652 171.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -130.93 -29.95 1.84 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.888 1.222 . . . . 0.0 113.905 -173.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.78 116.85 64.0 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.632 0.773 . . . . 0.0 109.105 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -70.16 162.92 40.5 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.877 1.718 . . . . 0.0 111.147 176.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.13 67.67 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.675 -0.641 . . . . 0.0 112.248 170.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -76.81 71.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.277 1.431 . . . . 0.0 109.15 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -114.73 30.19 0.12 Allowed Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 170.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.13 113.48 2.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.491 2.794 . . . . 0.0 112.173 -170.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.99 -16.34 27.92 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.093 1.806 . . . . 0.0 112.765 -174.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -115.93 171.93 7.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.67 1.588 . . . . 0.0 112.443 178.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -88.42 160.33 17.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.86 2.864 . . . . 0.0 111.611 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -141.96 123.16 8.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.08 0.952 . . . . 0.0 110.638 169.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.97 174.83 12.21 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.96 2.44 . . . . 0.0 113.525 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -140.2 149.46 42.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.335 2.254 . . . . 0.0 109.835 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -144.25 160.76 40.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.563 0.745 . . . . 0.0 112.437 -175.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -85.22 176.06 8.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.552 168.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.52 -29.49 66.33 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.319 1.047 . . . . 0.0 112.469 174.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -83.58 14.15 4.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.265 2.226 . . . . 0.0 111.92 -175.046 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.94 8.53 49.43 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.309 1.433 . . . . 0.0 114.43 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -91.42 146.65 23.63 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.562 1.181 . . . . 0.0 109.214 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -62.43 126.13 26.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.056 0.942 . . . . 0.0 108.919 177.359 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.3 143.73 79.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.386 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -50.22 -22.5 8.37 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.2 3.267 . . . . 0.0 117.489 -174.755 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.26 137.24 52.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.47 1.908 . . . . 0.0 109.598 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -130.68 147.2 52.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.846 1.259 . . . . 0.0 109.63 173.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -135.77 122.43 20.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -172.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.13 70.56 10.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.749 1.619 . . . . 0.0 108.057 169.034 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.31 -33.35 31.41 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.343 1.449 . . . . 0.0 114.562 -172.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m -54.73 -24.61 23.0 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 175.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -118.62 6.46 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.301 1.44 . . . . 0.0 112.022 174.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.94 67.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.299 1.428 . . . . 0.0 114.665 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -90.6 150.22 21.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.124 1.462 . . . . 0.0 112.121 -174.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.9 m -134.44 160.51 37.76 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.427 1.491 . . . . 0.0 110.078 168.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -144.45 163.21 34.47 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.169 1.787 . . . . 0.0 109.284 169.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.75 151.71 23.63 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 169.554 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.25 155.43 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.061 0.945 . . . . 0.0 111.307 172.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.57 159.91 76.01 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.3 -24.44 15.69 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.935 3.09 . . . . 0.0 117.102 -172.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -82.68 -4.77 58.29 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 175.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.77 -0.08 52.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.632 1.587 . . . . 0.0 114.772 -178.341 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.6 m -70.66 113.93 8.25 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.152 1.476 . . . . 0.0 110.222 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -55.61 136.7 50.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.06 109.76 19.21 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.3 156.48 50.73 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.729 2.286 . . . . 0.0 112.109 -169.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 m120 59.5 2.0 0.3 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.114 1.765 . . . . 0.0 115.52 -175.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -71.35 -30.95 66.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.639 1.563 . . . . 0.0 110.699 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.664 ' NH2' HH12 ' A' ' 57' ' ' ARG 0.279 0.0 OUTLIER -46.65 120.62 3.04 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 123.524 0.729 . . . . 0.0 111.98 -172.506 . . . . . . . . 4 4 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.9 m -151.87 164.73 36.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.784 1.233 . . . . 0.0 111.134 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.664 HH12 ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.98 17.29 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.337 2.655 . . . . 0.0 112.717 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.91 179.78 45.98 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.756 1.646 . . . . 0.0 112.745 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -67.0 167.04 12.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.759 1.623 . . . . 0.0 113.417 -176.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 166.69 32.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.789 1.236 . . . . 0.0 111.353 174.188 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.36 61.25 4.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.831 2.452 . . . . 0.0 112.289 -168.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -65.85 98.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -77.13 23.81 0.18 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.868 2.067 . . . . 0.0 114.895 -175.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.21 25.67 3.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.008 1.323 . . . . 0.0 113.47 -169.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.469 0.512 0 C-N-CA 126.432 1.893 . . . . 0.0 110.543 169.759 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.4 p -84.69 165.73 17.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.359 1.064 . . . . 0.0 112.71 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -51.6 -40.66 60.25 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.726 1.211 . . . . 0.0 113.029 172.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.01 -56.49 16.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.041 -0.412 . . . . 0.0 111.142 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.66 -31.24 69.36 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.41 -61.79 2.29 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.016 1.326 . . . . 0.0 110.082 169.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.67 -37.77 82.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.416 0.553 . . . . 0.0 112.461 -176.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.54 -27.44 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.568 1.147 . . . . 0.0 112.296 175.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -74.43 -41.39 60.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.587 -0.696 . . . . 0.0 111.47 168.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -69.29 -41.92 76.16 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.977 1.311 . . . . 0.0 112.8 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.71 108.95 18.55 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.46 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.61 167.29 27.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.915 1.744 . . . . 0.0 111.716 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.55 35.57 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.17 74.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.347 1.459 . . . . 0.0 108.272 169.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -112.98 65.53 0.92 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.965 1.306 . . . . 0.0 111.774 176.145 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -60.23 121.11 9.27 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.702 2.934 . . . . 0.0 111.734 -171.09 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.95 13.51 2.25 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.623 1.583 . . . . 0.0 114.98 -174.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.1 m -115.43 161.57 18.37 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.677 1.991 . . . . 0.0 112.373 -167.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -79.55 149.2 31.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.315 0.646 . . . . 0.0 111.513 179.047 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -144.79 127.64 8.39 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 108.624 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.45 168.52 17.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.581 1.52 . . . . 0.0 113.928 178.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -130.85 150.62 51.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.076 2.55 . . . . 0.0 110.867 173.565 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -128.93 155.54 45.15 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.552 1.141 . . . . 0.0 112.238 -175.202 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -90.76 176.84 6.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.59 1.556 . . . . 0.0 113.272 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.33 -16.13 31.97 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.86 9.56 38.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.186 1.795 . . . . 0.0 111.697 175.17 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 5.57 33.0 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.475 1.512 . . . . 0.0 114.432 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.63 166.17 13.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.839 1.256 . . . . 0.0 108.88 178.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -59.81 130.58 47.48 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.817 -0.552 . . . . 0.0 109.976 178.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.3 125.87 59.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.555 173.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.62 -18.57 6.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.641 2.894 . . . . 0.0 116.982 -175.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -111.48 135.31 52.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.655 1.982 . . . . 0.0 108.976 169.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -129.69 154.02 47.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.531 1.133 . . . . 0.0 109.127 169.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.6 m -141.22 159.35 42.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.939 0.895 . . . . 0.0 111.528 178.702 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.68 90.17 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.789 1.236 . . . . 0.0 109.904 175.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.11 -48.02 26.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.286 1.898 . . . . 0.0 116.052 -169.743 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -64.91 -13.41 56.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.095 1.447 . . . . 0.0 114.616 -175.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 pt -116.36 -0.45 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 112.812 170.11 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.01 4.43 55.4 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.867 1.699 . . . . 0.0 115.399 175.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -84.76 148.56 26.29 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.227 1.013 . . . . 0.0 112.811 -176.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.6 m -132.13 159.27 39.41 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.03 1.332 . . . . 0.0 109.75 166.629 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.1 p90 -151.76 160.92 43.41 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.318 1.447 . . . . 0.0 109.228 173.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.2 m -88.86 153.13 21.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 169.165 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.76 149.6 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.669 1.188 . . . . 0.0 110.587 175.042 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -70.22 155.96 92.6 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 165.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -14.56 38.27 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.796 2.331 . . . . 0.0 115.743 -169.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -78.34 -10.97 59.9 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.9 1.68 . . . . 0.0 114.204 171.098 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.21 -1.35 47.09 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.049 1.785 . . . . 0.0 115.183 -177.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.3 m -73.85 116.16 14.14 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.556 1.678 . . . . 0.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -57.11 145.02 32.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.699 1.2 . . . . 0.0 113.652 175.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.72 87.52 0.71 Allowed Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.002 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -64.27 -17.32 59.25 Favored 'Trans proline' 0 C--N 1.351 0.704 0 N-CA-C 118.169 2.334 . . . . 0.0 118.169 -165.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -68.23 -11.44 59.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.455 1.502 . . . . 0.0 113.184 172.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -90.83 -14.0 32.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.215 172.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -55.64 105.08 0.15 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.32 1.418 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m -133.63 166.19 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.79 1.236 . . . . 0.0 112.96 -168.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -70.12 12.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.105 3.362 . . . . 0.0 114.547 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.68 -176.64 41.14 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.38 1.943 . . . . 0.0 112.625 -172.075 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -61.27 163.13 6.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.338 1.855 . . . . 0.0 114.425 -171.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.19 165.21 37.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.256 1.422 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.11 63.76 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.084 2.154 . . . . 0.0 111.667 -168.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m -57.14 98.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.903 1.335 . . . . 0.0 112.129 -174.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.9 m -76.6 31.62 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.857 2.463 . . . . 0.0 115.168 -167.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.67 13.2 14.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.311 1.844 . . . . 0.0 111.068 169.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 CA--C 1.53 0.177 0 C-N-CA 127.61 2.364 . . . . 0.0 110.734 -175.723 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.561 0.696 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -140.9 167.4 22.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 128.743 2.817 . . . . 0.0 108.637 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -52.75 -38.77 61.41 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.612 0.642 . . . . 0.0 112.169 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 t -58.52 -62.45 1.84 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.345 0.658 . . . . 0.0 111.416 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.52 -32.81 71.83 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.11 -58.99 6.07 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.432 1.493 . . . . 0.0 110.504 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.3 -39.87 84.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.771 0.714 . . . . 0.0 112.481 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.2 -32.26 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.939 0.896 . . . . 0.0 112.109 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -73.6 -45.26 54.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.915 0.886 . . . . 0.0 112.368 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -77.23 -34.06 56.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.045 1.338 . . . . 0.0 113.256 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.5 mt -92.58 102.76 7.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.45 167.56 25.0 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.111 1.874 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.24 -21.57 34.95 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.92 47.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.397 1.879 . . . . 0.0 111.075 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -88.8 -10.2 0.15 Allowed Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -42.31 114.11 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 124.373 3.382 . . . . 0.0 115.208 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.06 -11.25 22.51 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.698 2.094 . . . . 0.0 112.783 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.9 p -140.03 171.74 13.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.681 1.993 . . . . 0.0 112.364 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -81.67 152.2 27.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 111.233 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -142.42 127.55 10.28 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.387 1.475 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.39 176.35 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.296 1.997 . . . . 0.0 113.447 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -140.32 150.26 43.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.074 2.15 . . . . 0.0 110.005 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.59 157.94 43.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.718 0.807 . . . . 0.0 113.039 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -99.26 179.41 4.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.804 1.642 . . . . 0.0 114.125 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -2.1 0.88 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.934 2.094 . . . . 0.0 114.933 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -122.73 19.35 10.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.4 1.88 . . . . 0.0 111.158 173.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.29 5.4 28.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.055 1.312 . . . . 0.0 114.678 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.83 164.39 17.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.076 1.35 . . . . 0.0 108.495 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -62.14 127.55 31.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.26 125.55 50.96 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.867 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.25 -8.53 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.023 3.149 . . . . 0.0 118.088 -176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -119.46 127.31 52.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.539 2.335 . . . . 0.0 107.03 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -120.74 146.31 46.61 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.343 1.057 . . . . 0.0 109.394 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 90.2 m -135.39 124.12 23.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.694 0.798 . . . . 0.0 112.455 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.19 71.08 10.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.687 1.595 . . . . 0.0 108.034 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.62 -35.87 11.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.809 1.671 . . . . 0.0 114.603 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 m -54.61 -22.71 14.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.901 1.681 . . . . 0.0 115.11 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.67 -0.94 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.881 1.673 . . . . 0.0 112.351 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.07 69.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.104 1.811 . . . . 0.0 115.181 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -84.12 154.13 23.33 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.78 1.29 . . . . 0.0 110.896 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.3 m -137.86 165.31 26.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.719 0.808 . . . . 0.0 111.998 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -147.43 162.53 38.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.089 1.756 . . . . 0.0 109.378 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.8 m -86.05 153.64 21.98 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.37 156.77 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.741 0.816 . . . . 0.0 111.65 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.07 160.63 77.86 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 165.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.18 -26.48 26.59 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.374 2.716 . . . . 0.0 115.591 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -75.55 -8.27 56.32 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.752 2.021 . . . . 0.0 115.417 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.57 -3.08 59.17 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.386 1.469 . . . . 0.0 115.339 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 m -73.66 130.72 40.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.033 1.417 . . . . 0.0 109.727 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.75 139.7 57.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.864 0.865 . . . . 0.0 112.517 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.68 115.52 58.83 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.46 134.83 6.76 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.7 3.6 . . . . 0.0 116.062 -169.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 62.88 11.11 4.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.781 2.032 . . . . 0.0 114.755 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -77.7 -22.33 50.63 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.881 1.219 . . . . 0.0 111.724 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.69 103.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.466 1.107 . . . . 0.0 111.814 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -144.92 171.22 14.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.948 1.299 . . . . 0.0 113.018 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -3.93 2.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.199 3.4 . . . . 0.0 115.421 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.67 -172.87 42.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.422 1.487 . . . . 0.0 112.602 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -57.57 164.19 2.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.153 1.781 . . . . 0.0 114.281 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.5 167.1 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.105 1.362 . . . . 0.0 110.56 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.11 60.76 6.45 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 111.724 -168.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 121.251 0.548 . . . . 0.0 112.433 -178.706 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 120.681 0.277 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.5 p -84.92 166.1 17.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.335 1.054 . . . . 0.0 111.994 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -54.95 -35.87 64.7 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 t -59.74 -63.31 1.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.209 0.459 . . . . 0.0 110.591 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -56.55 -32.24 64.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.887 0.875 . . . . 0.0 113.151 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.34 -59.43 5.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.73 1.15 . . . . 0.0 110.665 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -56.96 -42.39 80.05 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -32.23 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.079 0.552 . . . . 0.0 111.896 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m -83.39 6.53 19.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.013 1.725 . . . . 0.0 114.379 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -125.31 -38.18 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 0.0 111.561 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.76 110.14 27.71 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.17 164.01 37.23 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.923 1.748 . . . . 0.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.64 -26.11 61.14 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.64 68.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.82 1.248 . . . . 0.0 109.002 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -102.46 8.76 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -41.86 111.54 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 123.871 3.047 . . . . 0.0 116.007 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.57 9.83 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.74 2.591 . . . . 0.0 112.435 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 t -111.48 165.69 11.77 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.481 1.913 . . . . 0.0 112.37 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -76.37 161.85 28.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.304 1.842 . . . . 0.0 107.354 164.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -147.9 125.46 5.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.428 1.491 . . . . 0.0 108.53 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.9 169.62 20.82 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.733 1.622 . . . . 0.0 113.289 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -135.94 143.66 45.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.757 3.223 . . . . 0.0 109.75 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -141.43 161.84 36.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.37 175.97 5.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.599 1.16 . . . . 0.0 112.896 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -63.84 -18.19 63.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.502 1.521 . . . . 0.0 114.429 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -84.48 11.0 9.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.344 1.057 . . . . 0.0 111.753 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.96 8.19 60.7 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.456 1.027 . . . . 0.0 114.12 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.1 157.43 16.75 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.88 1.272 . . . . 0.0 109.563 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -66.81 129.49 40.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mt -58.41 135.98 85.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.722 -1.132 . . . . 0.0 108.805 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.67 -17.98 11.07 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.443 2.762 . . . . 0.0 117.377 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.19 137.02 50.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.755 2.022 . . . . 0.0 109.157 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -131.1 152.53 50.3 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.596 1.158 . . . . 0.0 109.707 171.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -141.96 137.58 31.33 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.86 76.39 10.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.87 -28.05 38.46 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.265 1.412 . . . . 0.0 114.89 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -62.15 -21.7 65.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.908 1.283 . . . . 0.0 114.11 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -107.41 -26.86 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.224 1.81 . . . . 0.0 109.816 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.78 10.67 84.83 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.882 1.706 . . . . 0.0 112.918 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -84.53 135.67 34.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.685 1.594 . . . . 0.0 109.709 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -130.37 162.36 29.27 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -149.77 163.77 37.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.698 1.599 . . . . 0.0 109.436 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.2 m -86.94 152.42 22.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.75 151.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 110.654 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -71.94 156.51 90.85 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 166.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.2 -21.67 23.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.44 2.76 . . . . 0.0 116.429 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -76.87 -10.89 59.69 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.321 1.848 . . . . 0.0 114.703 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.56 -1.87 53.19 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.717 1.627 . . . . 0.0 115.363 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -74.39 122.08 22.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.873 1.836 . . . . 0.0 109.42 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.73 159.91 21.23 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.94 94.24 2.45 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 168.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.15 18.82 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 125.525 4.15 . . . . 0.0 117.823 -167.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.99 -5.1 10.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.954 2.101 . . . . 0.0 112.934 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 p -87.94 -17.51 31.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.385 1.074 . . . . 0.0 113.112 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -56.77 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.874 1.67 . . . . 0.0 112.455 -168.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -127.67 166.02 18.9 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.921 1.688 . . . . 0.0 114.203 -167.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 1.13 0.61 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.518 3.127 . . . . 0.0 115.517 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.33 -176.25 45.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.135 1.826 . . . . 0.0 112.745 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -60.23 165.07 3.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.567 1.947 . . . . 0.0 114.296 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 165.13 37.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.207 1.403 . . . . 0.0 110.848 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -82.26 58.19 3.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.993 2.117 . . . . 0.0 112.478 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -173.398 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.604 0.716 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -142.66 168.54 19.48 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 128.486 2.714 . . . . 0.0 108.936 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -56.99 -22.31 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 t -74.92 -61.32 1.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 110.66 169.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -30.72 67.48 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 112.991 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -59.66 5.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.604 1.562 . . . . 0.0 110.269 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.75 -35.87 81.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.89 -30.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.131 0.878 . . . . 0.0 112.092 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -74.27 -47.03 37.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 0.0 112.107 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -73.43 -30.61 63.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.257 1.423 . . . . 0.0 113.268 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.96 96.9 6.14 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.08 171.4 18.03 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.937 2.424 . . . . 0.0 112.243 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.17 -20.57 27.34 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.36 69.01 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.537 1.535 . . . . 0.0 109.274 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.423 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 7.9 p80 -127.67 -17.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 31.4 Cg_exo -42.19 116.76 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 124.013 3.142 . . . . 0.0 115.003 -176.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.28 -33.75 5.0 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.893 1.711 . . . . 0.0 111.091 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -111.15 170.66 7.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.171 2.189 . . . . 0.0 111.453 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -82.49 156.72 23.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.189 1.396 . . . . 0.0 111.647 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -144.81 130.82 9.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.521 1.928 . . . . 0.0 108.113 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.7 170.65 19.01 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.185 1.923 . . . . 0.0 113.929 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -137.89 151.73 48.32 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.21 2.204 . . . . 0.0 110.657 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -130.5 159.79 36.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 113.193 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -99.87 176.66 5.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.836 1.654 . . . . 0.0 113.552 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -14.62 36.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.984 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.39 13.89 28.15 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.584 1.554 . . . . 0.0 111.915 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.66 8.4 39.74 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.918 1.246 . . . . 0.0 114.226 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -89.99 164.67 14.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.809 1.243 . . . . 0.0 108.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.44 127.48 31.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mt -54.15 127.66 55.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.94 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -51.57 -21.73 11.33 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.237 2.624 . . . . 0.0 116.153 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.2 134.37 51.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.578 1.951 . . . . 0.0 108.952 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -126.71 149.73 49.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.456 1.103 . . . . 0.0 109.224 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.19 155.31 47.91 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.52 0.728 . . . . 0.0 112.059 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.21 75.92 1.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.063 2.145 . . . . 0.0 107.508 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.7 -44.01 47.38 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.537 1.541 . . . . 0.0 115.061 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 p -65.01 -9.39 21.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.38 -1.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.672 1.124 . . . . 0.0 112.488 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.91 62.26 5.39 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.216 0.912 . . . . 0.0 111.314 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -142.42 154.94 45.02 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.61 161.11 38.73 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.33 1.852 . . . . 0.0 110.458 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.37 163.77 36.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.198 170.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.3 m -89.93 152.29 21.3 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.48 155.2 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.903 1.281 . . . . 0.0 109.914 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -74.3 161.07 79.83 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 166.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.63 -24.22 22.16 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.899 3.066 . . . . 0.0 115.879 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -78.64 -6.28 55.25 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.686 1.994 . . . . 0.0 115.151 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.46 -2.86 59.25 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.596 1.57 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.7 m -73.08 117.93 15.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.903 1.352 . . . . 0.0 110.022 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.89 148.05 11.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.031 1.332 . . . . 0.0 113.579 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.22 92.48 1.22 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.15 23.2 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.827 1 C-N-CA 125.875 4.383 . . . . 0.0 117.795 -166.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -124.95 -2.17 7.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.971 1.708 . . . . 0.0 112.603 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 p -86.01 -19.61 30.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.152 0.981 . . . . 0.0 112.933 174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -45.54 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.835 2.054 . . . . 0.0 112.468 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 m -135.98 166.02 24.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 110.83 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.7 mmm-85 -76.36 6.51 5.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.8 -177.77 45.1 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.373 1.939 . . . . 0.0 112.105 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 114.65 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.04 167.2 31.17 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.825 1.65 . . . . 0.0 110.854 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.29 49.55 0.58 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.226 2.61 . . . . 0.0 114.181 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.787 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.0 p -140.21 179.6 6.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.712 1.205 . . . . 0.0 111.745 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -21.62 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 131.192 3.797 . . . . 0.0 118.407 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.6 t -65.63 -51.21 61.34 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.589 -0.694 . . . . 0.0 110.668 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.72 -31.77 69.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.865 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.13 -54.23 41.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.699 1.136 . . . . 0.0 111.102 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.9 -44.31 86.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.295 0.498 . . . . 0.0 112.007 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.34 -27.1 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.127 0.971 . . . . 0.0 111.786 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -78.82 1.94 21.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.228 1.411 . . . . 0.0 113.963 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -126.4 -35.04 2.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.73 1.212 . . . . 0.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -88.25 109.33 27.57 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.501 1.92 . . . . 0.0 106.304 169.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.78 169.76 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.506 2.137 . . . . 0.0 111.937 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.2 -21.52 34.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.43 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.03 74.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.211 1.405 . . . . 0.0 108.591 169.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -116.4 61.79 2.33 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 124.816 1.247 . . . . 0.0 112.35 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.2 139.36 77.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.76 2.306 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.57 7.46 0.95 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.49 1.519 . . . . 0.0 115.624 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -134.44 176.24 8.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -112.95 140.34 47.85 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.547 1.539 . . . . 0.0 111.665 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -125.12 121.38 25.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.631 1.972 . . . . 0.0 108.297 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 172.24 2.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.766 2.311 . . . . 0.0 114.569 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 146.29 47.44 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.983 1.713 . . . . 0.0 109.441 169.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.76 160.79 39.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -165.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -73.51 173.93 8.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.864 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -61.43 -23.33 65.76 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.41 -9.77 58.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.536 1.934 . . . . 0.0 111.86 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.77 12.68 74.2 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.977 1.275 . . . . 0.0 114.67 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.5 155.46 18.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.455 1.128 . . . . 0.0 108.932 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -67.61 133.25 49.06 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.076 0.55 . . . . 0.0 110.183 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.46 142.05 91.12 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.2 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.89 -26.68 18.71 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.506 2.804 . . . . 0.0 116.4 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.94 45.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 0.0 109.935 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -123.15 144.28 49.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.54 1.136 . . . . 0.0 109.381 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.1 m -137.3 121.09 17.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.673 0.789 . . . . 0.0 112.192 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.43 66.92 9.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.131 1.773 . . . . 0.0 107.308 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.58 40.0 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.53 1.538 . . . . 0.0 114.381 -171.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -57.01 -20.11 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.096 1.758 . . . . 0.0 114.486 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 pt -121.59 2.36 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.785 1.634 . . . . 0.0 112.203 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.13 -4.03 78.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.667 2.079 . . . . 0.0 115.352 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.07 152.73 26.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.881 1.341 . . . . 0.0 112.293 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -139.95 164.47 29.91 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 112.586 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.39 163.77 38.2 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.426 1.89 . . . . 0.0 109.855 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.93 152.25 21.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.76 156.68 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.46 1.104 . . . . 0.0 111.108 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.82 160.07 72.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.56 -24.37 28.75 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.442 2.761 . . . . 0.0 116.256 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -75.84 -12.41 60.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.798 1.639 . . . . 0.0 114.608 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.17 -1.33 47.23 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.01 1.767 . . . . 0.0 115.099 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.8 m -71.34 118.32 13.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.784 1.792 . . . . 0.0 109.962 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.41 136.74 53.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.566 1.146 . . . . 0.0 113.167 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -83.88 110.53 26.11 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.87 158.35 43.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 65.11 -5.02 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.425 2.29 . . . . 0.0 115.218 -173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -78.15 -20.34 52.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.307 1.412 . . . . 0.0 111.773 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.95 91.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.981 1.713 . . . . 0.0 111.069 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -121.53 161.2 22.75 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.396 1.878 . . . . 0.0 113.643 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -13.02 5.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.255 2.622 . . . . 0.0 113.827 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.62 -177.2 36.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.294 0.95 . . . . 0.0 114.532 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -56.62 156.44 6.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.743 2.417 . . . . 0.0 114.737 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -155.87 167.67 29.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 108.316 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -112.11 61.68 0.62 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.278 -0.889 . . . . 0.0 112.489 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.466 0.345 0 C-N-CA 125.824 1.65 . . . . 0.0 113.596 -177.221 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.9 p -127.91 169.14 14.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.979 2.111 . . . . 0.0 110.632 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -38.99 -59.49 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 -49.93 75.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.589 0.631 . . . . 0.0 110.718 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -57.17 -40.62 77.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.524 0.73 . . . . 0.0 112.679 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.69 -57.34 13.1 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.924 0.89 . . . . 0.0 110.306 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.43 -36.85 81.51 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.84 -29.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.417 1.087 . . . . 0.0 112.124 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -72.26 -36.28 68.99 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.569 -0.707 . . . . 0.0 112.035 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -72.98 -46.77 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.602 1.161 . . . . 0.0 112.641 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -76.33 111.53 15.97 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.564 1.146 . . . . 0.0 108.081 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.46 151.82 75.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.113 1.875 . . . . 0.0 111.564 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.54 63.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.21 60.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.526 1.13 . . . . 0.0 109.54 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -90.54 -11.28 0.17 Allowed Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -42.51 128.41 4.7 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.828 3.019 . . . . 0.0 114.821 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.79 -24.59 30.9 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.791 1.662 . . . . 0.0 111.606 -168.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.9 p -123.28 162.65 22.24 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.67 1.988 . . . . 0.0 112.373 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.92 141.32 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.945 0.898 . . . . 0.0 111.08 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -136.47 118.89 11.79 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.286 1.834 . . . . 0.0 108.149 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.73 166.55 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.046 1.831 . . . . 0.0 115.868 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -118.84 142.55 47.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.792 2.837 . . . . 0.0 108.64 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -135.66 158.41 44.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.74 0.816 . . . . 0.0 112.8 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -98.75 -179.8 4.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.979 1.312 . . . . 0.0 113.906 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -62.43 -16.52 55.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -91.93 8.1 39.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.069 1.748 . . . . 0.0 111.929 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.12 2.45 18.59 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.021 1.772 . . . . 0.0 115.145 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.65 167.81 14.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.08 1.752 . . . . 0.0 108.932 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -59.42 133.49 56.14 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.119 -0.363 . . . . 0.0 110.362 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.85 139.04 95.61 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -53.57 -24.26 28.38 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.316 2.678 . . . . 0.0 116.394 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.01 139.01 42.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.019 1.728 . . . . 0.0 110.048 170.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -129.6 153.62 47.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.275 1.43 . . . . 0.0 109.792 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -141.2 157.5 45.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.968 0.907 . . . . 0.0 111.711 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.8 80.12 1.8 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.37 1.868 . . . . 0.0 107.808 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.05 -35.77 54.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.388 0.994 . . . . 0.0 114.235 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -62.76 -14.12 41.08 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.88 4.46 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.112 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.84 38.37 95.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.521 1.058 . . . . 0.0 113.515 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -128.03 152.25 48.17 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.7 m -136.2 159.63 41.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.03 1.732 . . . . 0.0 109.854 166.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -152.66 161.06 43.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.48 1.512 . . . . 0.0 109.387 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.31 152.14 22.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.906 -0.496 . . . . 0.0 109.933 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.08 154.4 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.412 1.085 . . . . 0.0 111.309 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -77.88 159.73 75.6 Favored Pre-proline 0 CA--C 1.554 1.112 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 166.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.44 -23.64 19.48 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.92 3.08 . . . . 0.0 117.555 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -85.37 -2.96 58.66 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.68 56.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.538 1.542 . . . . 0.0 114.82 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.7 m -69.35 109.59 4.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.693 1.247 . . . . 0.0 109.537 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -57.93 143.27 43.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 113.655 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.21 90.59 0.62 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -60.93 -24.06 78.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.908 2.405 . . . . 0.0 117.706 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -66.72 -12.0 56.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.027 2.131 . . . . 0.0 113.272 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -94.04 -10.01 34.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 117.438 -1.268 . . . . 0.0 113.297 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -59.89 106.08 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.312 1.414 . . . . 0.0 111.436 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 t -145.06 172.55 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.694 0.798 . . . . 0.0 113.094 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -65.5 1.5 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.568 3.547 . . . . 0.0 116.023 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.12 -177.74 41.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.69 1.614 . . . . 0.0 112.882 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -55.97 157.14 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.544 1.938 . . . . 0.0 114.139 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 164.73 38.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 111.147 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -85.48 65.46 9.19 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.553 1.541 . . . . 0.0 111.603 -169.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 66.3 m . . . . . 0 CA--C 1.536 0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.291 -179.493 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.573 0.701 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 45.5 p -139.11 171.46 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 128.032 2.533 . . . . 0.0 108.73 173.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -53.89 -35.38 61.54 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.595 -0.691 . . . . 0.0 112.276 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.0 -62.32 1.86 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.535 0.734 . . . . 0.0 111.234 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' THR . 17.6 mm-40 -59.8 -33.16 71.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.397 0.544 . . . . 0.0 112.369 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.92 -60.36 3.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.868 1.267 . . . . 0.0 109.758 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.71 -29.19 70.44 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.28 -32.89 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.853 0.861 . . . . 0.0 111.337 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.5 p -80.03 -28.92 39.25 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.17 -48.69 64.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.184 0.902 . . . . 0.0 111.099 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.7 112.78 53.86 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.451 1.1 . . . . 0.0 108.523 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.19 164.8 34.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.019 1.813 . . . . 0.0 111.215 173.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.16 46.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 t -77.02 72.51 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.942 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -117.5 26.61 0.11 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 174.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.59 116.4 3.51 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.854 2.37 . . . . 0.0 112.148 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.75 -13.42 53.52 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.315 1.436 . . . . 0.0 113.147 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -119.62 176.85 5.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.444 1.898 . . . . 0.0 111.767 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -91.71 159.32 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.061 2.544 . . . . 0.0 110.633 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -143.16 130.91 11.03 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.588 1.555 . . . . 0.0 109.014 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.55 168.59 24.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.335 2.023 . . . . 0.0 112.37 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.575 1.95 . . . . 0.0 110.424 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -128.55 153.67 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.797 1.239 . . . . 0.0 112.97 -169.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -87.54 178.58 6.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.532 1.533 . . . . 0.0 113.264 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pm0 -62.98 -12.73 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -99.82 13.01 35.23 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.149 1.78 . . . . 0.0 111.834 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 3.87 22.36 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.631 1.586 . . . . 0.0 114.708 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.69 166.06 16.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.066 1.746 . . . . 0.0 108.606 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -58.88 130.91 49.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.76 0.709 . . . . 0.0 109.794 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.41 119.99 16.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.826 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.45 -9.09 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.759 2.972 . . . . 0.0 116.912 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.56 124.01 48.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.146 2.178 . . . . 0.0 107.218 167.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.2 145.19 48.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.789 0.836 . . . . 0.0 109.399 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.0 m -136.55 126.51 25.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.748 0.819 . . . . 0.0 112.276 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -83.74 70.31 10.33 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.46 -35.87 29.64 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.624 1.583 . . . . 0.0 114.222 -170.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.3 m -53.28 -22.89 7.75 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.45 1.5 . . . . 0.0 114.733 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.59 2.41 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.739 1.616 . . . . 0.0 112.814 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.75 80.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.34 1.448 . . . . 0.0 115.593 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -84.49 147.2 27.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.717 1.258 . . . . 0.0 112.312 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 m -133.69 163.47 29.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.735 1.214 . . . . 0.0 112.117 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -146.81 161.92 39.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.572 1.949 . . . . 0.0 108.384 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.0 m -86.22 153.18 22.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.82 153.57 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.529 1.132 . . . . 0.0 110.223 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -74.14 160.72 80.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.4 -25.73 25.57 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.44 2.76 . . . . 0.0 115.944 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -75.95 -10.15 59.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.059 1.743 . . . . 0.0 114.856 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.52 -1.78 57.2 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.582 1.563 . . . . 0.0 115.395 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.6 m -75.0 127.99 34.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.896 1.848 . . . . 0.0 109.755 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -57.47 139.84 52.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.35 111.48 31.53 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 168.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -49.88 148.91 11.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.884 3.056 . . . . 0.0 114.679 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.73 6.63 0.9 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.126 1.77 . . . . 0.0 115.412 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 p -74.38 -26.03 59.86 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.949 1.25 . . . . 0.0 111.36 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.605 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -42.42 109.21 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.382 1.873 . . . . 0.0 111.213 -177.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -142.53 164.7 29.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.923 1.289 . . . . 0.0 111.653 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.605 ' NH1' HH22 ' A' ' 55' ' ' ARG . 4.7 mpt_? -77.97 16.28 0.75 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.919 2.488 . . . . 0.0 112.958 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -178.71 47.59 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.27 1.891 . . . . 0.0 112.293 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -65.27 167.53 8.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.131 1.772 . . . . 0.0 114.128 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 166.03 34.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.036 1.334 . . . . 0.0 111.258 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -84.97 63.48 8.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.082 2.153 . . . . 0.0 112.039 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -175.243 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 123.176 1.465 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -143.54 163.97 31.69 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 130.684 3.593 . . . . 0.0 109.584 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -52.59 -42.2 64.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.629 0.649 . . . . 0.0 112.38 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 t -56.53 -61.33 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.498 0.719 . . . . 0.0 111.18 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.92 -34.0 74.01 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.34 -56.18 23.36 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.373 1.469 . . . . 0.0 111.021 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -58.61 -41.88 86.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.312 0.505 . . . . 0.0 112.011 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -62.83 -31.89 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.002 0.921 . . . . 0.0 111.896 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -83.35 4.49 27.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.99 1.716 . . . . 0.0 114.099 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -126.01 -34.78 2.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 0.0 112.057 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -96.9 105.48 24.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.38 171.08 18.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.651 2.234 . . . . 0.0 112.117 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.58 -23.74 42.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.223 1.009 . . . . 0.0 113.502 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.06 76.46 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 108.095 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -115.53 47.93 0.53 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.74 130.08 28.4 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.701 2.267 . . . . 0.0 111.067 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.28 -9.05 50.28 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.383 1.468 . . . . 0.0 114.337 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -120.78 160.53 23.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.482 1.641 . . . . 0.0 113.208 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -77.52 162.99 26.71 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 165.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -147.88 129.75 7.46 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.358 2.263 . . . . 0.0 107.035 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.91 170.84 15.81 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.685 1.59 . . . . 0.0 113.067 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -141.38 148.24 39.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.87 2.068 . . . . 0.0 109.559 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.9 m -135.13 157.58 46.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -101.83 177.37 4.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.683 1.593 . . . . 0.0 113.611 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.77 -14.51 33.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.748 1.619 . . . . 0.0 115.034 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -98.1 13.27 31.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.505 1.522 . . . . 0.0 111.906 171.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.51 37.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.968 1.27 . . . . 0.0 114.334 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -88.33 164.68 15.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.166 1.387 . . . . 0.0 108.918 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.79 126.67 28.34 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.84 131.11 57.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.09 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -48.21 -18.76 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.971 3.781 . . . . 0.0 117.355 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.8 131.68 56.87 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.045 2.138 . . . . 0.0 108.439 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -121.87 146.52 47.02 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 109.289 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.1 m -136.13 119.94 17.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 68.21 9.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.814 1.646 . . . . 0.0 106.823 168.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.66 54.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.227 -1.351 . . . . 0.0 114.149 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.32 -10.53 16.74 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.0 pt -124.34 8.47 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.356 1.462 . . . . 0.0 111.764 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.43 5.45 72.74 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.308 1.432 . . . . 0.0 115.041 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.82 146.69 27.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.195 1.498 . . . . 0.0 112.776 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.08 157.24 47.15 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.11 1.364 . . . . 0.0 109.943 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -144.52 163.15 34.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.456 1.502 . . . . 0.0 109.406 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.1 m -86.03 150.75 24.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.159 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.8 157.01 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.92 0.888 . . . . 0.0 111.151 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -77.84 159.61 75.97 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 165.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.98 -24.29 24.25 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.585 2.857 . . . . 0.0 116.297 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -76.87 -10.36 59.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.14 1.776 . . . . 0.0 114.663 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.96 52.8 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.776 1.655 . . . . 0.0 115.334 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -71.83 116.19 11.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.962 1.881 . . . . 0.0 110.325 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.45 137.18 57.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.332 1.053 . . . . 0.0 113.694 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.22 109.07 16.74 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 168.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.86 158.77 45.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.569 2.18 . . . . 0.0 112.074 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 61.22 -0.47 0.34 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.695 1.998 . . . . 0.0 115.547 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -71.26 -29.17 64.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.431 1.468 . . . . 0.0 110.667 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.532 HH21 ' NH2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -43.57 95.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.199 2.2 . . . . 0.0 113.969 -174.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -125.27 162.34 24.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.205 1.802 . . . . 0.0 111.863 -170.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -72.42 18.61 0.09 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.622 2.769 . . . . 0.0 112.597 175.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.33 -179.76 48.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.434 1.493 . . . . 0.0 113.249 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.25 163.24 13.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.093 1.757 . . . . 0.0 113.515 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 161.38 41.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.474 1.109 . . . . 0.0 111.818 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.13 67.96 9.92 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 111.242 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.309 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.465 0.174 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -84.38 168.19 15.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.954 0.902 . . . . 0.0 112.439 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -54.98 -39.94 69.53 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.622 -0.673 . . . . 0.0 112.031 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -59.64 -57.54 12.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.698 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -58.47 -38.47 77.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.262 0.625 . . . . 0.0 112.632 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -59.96 4.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.679 1.192 . . . . 0.0 110.5 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.64 -41.94 82.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.589 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.83 -33.02 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.252 0.621 . . . . 0.0 111.938 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -81.72 -0.88 44.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.504 1.522 . . . . 0.0 114.561 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -126.23 -31.64 2.79 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.544 1.065 . . . . 0.0 112.394 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.99 108.07 38.54 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.97 169.09 23.4 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.442 2.094 . . . . 0.0 111.746 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.28 27.05 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.347 1.059 . . . . 0.0 113.576 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 t -86.25 76.48 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 108.058 169.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -111.03 70.87 0.72 Allowed Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.078 1.351 . . . . 0.0 111.589 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.22 134.92 47.85 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.975 2.45 . . . . 0.0 110.973 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.84 8.5 0.6 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.184 1.849 . . . . 0.0 116.163 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 p -131.32 168.07 18.18 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.613 1.565 . . . . 0.0 112.913 -168.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.85 152.26 20.82 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.088 1.355 . . . . 0.0 111.763 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -138.53 129.82 15.49 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.59 1.956 . . . . 0.0 107.632 169.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.41 176.1 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.835 1.69 . . . . 0.0 113.015 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -139.68 150.34 44.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.849 2.059 . . . . 0.0 109.637 174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -135.23 158.73 43.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -97.37 -179.31 4.45 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.856 1.663 . . . . 0.0 113.981 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -3.17 0.99 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.622 1.969 . . . . 0.0 114.924 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -123.24 19.47 9.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.96 . . . . 0.0 111.193 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 7.62 29.24 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.277 1.417 . . . . 0.0 114.732 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -85.62 162.81 18.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.751 1.22 . . . . 0.0 108.629 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -63.29 126.84 28.76 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 122.009 -0.432 . . . . 0.0 109.9 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.08 132.28 68.34 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.179 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.34 -17.3 4.0 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.899 3.066 . . . . 0.0 116.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -113.14 131.24 55.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.639 1.976 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.32 147.62 45.43 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.493 1.117 . . . . 0.0 109.396 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.1 m -138.66 122.75 17.97 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.721 0.772 . . . . 0.0 112.482 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.8 69.87 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.666 1.586 . . . . 0.0 106.911 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.84 -35.3 47.04 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.437 1.494 . . . . 0.0 113.778 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -62.65 -11.9 19.93 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.42 -4.44 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.43 1.492 . . . . 0.0 111.553 167.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.14 58.18 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.32 1.914 . . . . 0.0 114.829 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -113.09 152.17 29.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.697 1.749 . . . . 0.0 111.751 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -135.95 165.1 26.44 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.935 0.894 . . . . 0.0 112.51 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -148.93 163.59 37.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 109.34 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 70.9 m -87.23 151.38 23.21 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.02 157.63 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.058 0.943 . . . . 0.0 111.108 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.11 160.69 72.97 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -22.08 23.4 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.508 2.806 . . . . 0.0 116.562 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -79.08 -9.9 59.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.054 1.741 . . . . 0.0 114.517 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.84 55.89 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.612 1.577 . . . . 0.0 115.221 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.2 m -73.17 122.59 22.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.978 1.889 . . . . 0.0 110.04 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.28 137.27 57.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.011 . . . . 0.0 113.52 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -84.1 109.56 19.97 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.24 158.21 41.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.797 2.332 . . . . 0.0 112.948 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 65.18 -0.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.488 2.315 . . . . 0.0 115.098 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.4 p -81.16 -19.11 44.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.102 1.319 . . . . 0.0 112.172 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.44 98.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.276 1.43 . . . . 0.0 110.408 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 t -140.72 170.96 14.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -168.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -63.2 -1.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.636 1 C-N-CA 132.273 4.229 . . . . 0.0 114.655 -171.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.43 -174.8 47.25 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.158 1.361 . . . . 0.0 112.595 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -55.78 157.36 4.29 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.084 1.754 . . . . 0.0 113.421 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.35 171.84 19.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.982 1.313 . . . . 0.0 110.485 175.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -105.98 82.4 1.77 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.017 1.327 . . . . 0.0 110.286 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 126.238 1.815 . . . . 0.0 112.637 174.023 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.903 0.382 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 p -83.83 166.25 18.1 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.522 1.129 . . . . 0.0 110.586 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.0 -39.89 66.48 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.369 -0.832 . . . . 0.0 112.291 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.6 t -58.38 -61.8 2.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.625 0.77 . . . . 0.0 111.265 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -62.01 -34.25 75.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.908 -0.568 . . . . 0.0 112.251 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.47 -59.55 4.98 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.746 1.218 . . . . 0.0 110.194 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -54.76 -47.84 73.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.755 0.422 . . . . 0.0 111.339 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 ' SG ' ' A' ' 23' ' ' CYS . 64.2 t -62.52 -28.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.868 0.867 . . . . 0.0 112.513 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.9 p -80.27 -2.29 44.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -131.42 -24.66 2.25 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -170.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.45 116.78 63.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.642 1.11 . . . . 0.0 109.542 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.31 163.05 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.929 1.753 . . . . 0.0 111.246 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.71 67.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.549 -0.72 . . . . 0.0 112.564 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.04 74.58 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.424 1.49 . . . . 0.0 108.498 170.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -111.41 63.68 0.53 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.73 1.212 . . . . 0.0 112.036 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.81 136.44 53.35 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.499 2.8 . . . . 0.0 110.949 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.28 13.79 0.77 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.274 1.416 . . . . 0.0 115.412 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -124.52 155.08 39.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.915 1.358 . . . . 0.0 113.173 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -75.97 157.45 33.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.545 1.538 . . . . 0.0 112.206 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -142.53 115.7 6.31 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 110.539 168.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.45 169.89 20.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.091 1.861 . . . . 0.0 113.422 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -136.81 143.18 43.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.155 2.982 . . . . 0.0 109.295 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' SG ' HG21 ' A' ' 8' ' ' VAL . 3.8 m -134.33 159.82 39.84 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.557 1.071 . . . . 0.0 113.02 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -95.81 174.93 6.71 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.653 1.581 . . . . 0.0 112.91 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -59.67 -20.93 59.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.463 1.105 . . . . 0.0 113.731 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.68 6.04 25.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.011 2.124 . . . . 0.0 111.636 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.5 7.09 38.28 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.628 1.585 . . . . 0.0 114.443 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.27 162.24 15.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.116 1.366 . . . . 0.0 109.32 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -61.71 126.8 28.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -55.64 138.2 69.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.854 -1.07 . . . . 0.0 108.652 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.85 -27.53 16.03 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.219 2.613 . . . . 0.0 115.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.49 135.47 45.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.533 1.533 . . . . 0.0 109.645 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -125.63 149.99 47.94 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.711 1.204 . . . . 0.0 109.018 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.0 m -137.78 153.49 49.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.662 1.22 . . . . 0.0 112.704 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.76 66.76 1.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.379 2.672 . . . . 0.0 106.096 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.78 -31.56 54.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.99 1.281 . . . . 0.0 113.598 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -60.13 -12.58 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.429 1.491 . . . . 0.0 114.791 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 pt -126.72 6.69 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 126.204 1.801 . . . . 0.0 111.693 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.69 7.95 87.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 0.0 115.556 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.99 156.96 16.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.667 1.733 . . . . 0.0 114.282 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.5 m -144.23 157.67 44.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.481 1.912 . . . . 0.0 109.93 166.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -148.49 164.62 33.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.79 1.636 . . . . 0.0 109.308 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.59 153.51 20.71 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.2 159.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.079 1.352 . . . . 0.0 110.66 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -79.33 161.28 68.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 165.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -52.04 -25.24 21.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.728 2.952 . . . . 0.0 116.32 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -78.22 -7.65 57.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.164 1.785 . . . . 0.0 115.301 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.63 -1.97 52.93 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.811 1.672 . . . . 0.0 114.984 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -71.12 113.77 8.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.963 1.382 . . . . 0.0 110.489 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -56.72 134.22 54.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.763 1.225 . . . . 0.0 113.709 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.63 111.37 31.49 Favored Pre-proline 0 C--O 1.241 0.61 0 C-N-CA 125.655 1.582 . . . . 0.0 107.131 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.49 161.41 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.64 2.227 . . . . 0.0 111.915 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.44 -2.55 0.12 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.359 1.864 . . . . 0.0 115.894 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.8 p -72.12 -31.51 66.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.46 1.482 . . . . 0.0 110.275 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -46.16 99.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.238 2.215 . . . . 0.0 112.834 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -129.77 165.91 20.97 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.741 1.616 . . . . 0.0 111.478 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 23.33 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.527 2.331 . . . . 0.0 111.927 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.56 -174.17 45.57 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.675 1.131 . . . . 0.0 114.438 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -61.43 152.51 29.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.886 2.474 . . . . 0.0 115.454 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 158.62 44.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.749 168.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -85.97 61.31 6.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.822 1.249 . . . . 0.0 112.607 -167.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.408 -174.493 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 121.519 0.675 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.433 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 27.6 p -138.6 172.69 12.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.208 2.603 . . . . 0.0 108.407 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -52.19 -38.1 56.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.194 0.598 . . . . 0.0 112.327 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.4 t -63.8 -58.18 7.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.357 0.663 . . . . 0.0 111.316 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' THR . 29.2 mm100 -58.9 -35.05 72.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.3 -60.59 3.57 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.127 1.371 . . . . 0.0 110.398 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.43 -37.17 80.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.11 -31.26 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.78 0.832 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -72.16 -41.56 66.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.728 . . . . 0.0 112.387 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -74.73 -40.65 61.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.045 1.338 . . . . 0.0 112.986 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.1 mm -89.04 110.4 37.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.5 168.11 25.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.206 1.938 . . . . 0.0 111.452 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.51 -18.5 29.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.72 78.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.229 1.411 . . . . 0.0 107.666 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -114.86 53.62 0.75 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.764 1.225 . . . . 0.0 113.779 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -62.33 131.5 34.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 -5.47 3.83 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.613 -1.104 . . . . 0.0 115.673 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -113.93 156.4 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.737 1.768 . . . . 0.0 113.0 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -73.1 161.57 30.47 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -147.56 124.6 5.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 126.678 1.991 . . . . 0.0 108.404 168.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.64 172.03 16.59 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.749 1.632 . . . . 0.0 114.049 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -135.91 144.31 45.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.727 3.211 . . . . 0.0 110.102 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -137.81 160.32 39.6 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -103.69 178.7 4.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.901 1.681 . . . . 0.0 114.23 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.64 0.15 1.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.53 1.932 . . . . 0.0 114.656 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.93 19.27 10.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.6 8.65 40.65 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.026 1.298 . . . . 0.0 114.555 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.09 164.25 14.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.69 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.95 127.43 31.22 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.03 135.46 84.01 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 117.678 -1.153 . . . . 0.0 108.472 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -52.85 -10.21 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.49 2.793 . . . . 0.0 117.41 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.88 137.79 51.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.284 1.834 . . . . 0.0 109.227 167.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -129.79 145.58 51.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 109.056 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 98.0 m -137.15 119.02 15.19 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.635 0.731 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.3 66.09 9.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.453 1.501 . . . . 0.0 107.335 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.53 -32.16 45.46 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.195 1.379 . . . . 0.0 113.786 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 m -60.43 -12.52 9.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.325 1.45 . . . . 0.0 114.913 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.59 7.63 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.286 1.834 . . . . 0.0 111.697 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.69 -2.95 77.08 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.192 1.853 . . . . 0.0 115.41 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -83.06 151.66 25.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.133 1.466 . . . . 0.0 113.304 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.74 160.72 39.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.043 0.937 . . . . 0.0 111.056 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -152.06 164.67 36.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.58 1.552 . . . . 0.0 108.817 169.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.44 154.5 17.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 110.571 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.36 157.96 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.768 0.827 . . . . 0.0 111.695 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.95 159.73 70.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.41 -21.23 17.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.067 3.178 . . . . 0.0 117.683 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -84.93 -4.44 59.12 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.79 1.636 . . . . 0.0 114.791 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.61 1.01 55.39 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.712 1.625 . . . . 0.0 114.641 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.1 m -71.75 115.75 11.31 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.902 1.351 . . . . 0.0 109.96 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -60.41 144.79 50.13 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.73 89.67 0.66 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.598 2.359 . . . . 0.0 104.818 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.54 -14.09 42.45 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.796 2.33 . . . . 0.0 117.583 -166.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -67.35 -10.86 55.17 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 127.107 2.163 . . . . 0.0 113.234 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -107.37 2.31 24.31 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.09 1.756 . . . . 0.0 112.545 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -62.83 94.17 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.403 1.001 . . . . 0.0 110.916 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -129.98 161.1 31.68 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -168.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.34 10.07 2.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.063 2.545 . . . . 0.0 113.146 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.58 -179.22 48.31 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.406 1.955 . . . . 0.0 112.234 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.68 157.46 9.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.486 1.914 . . . . 0.0 114.484 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -155.17 168.91 25.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.564 2.745 . . . . 0.0 106.145 168.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -111.22 34.64 3.95 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -163.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m . . . . . 0 N--CA 1.467 0.399 0 O-C-N 121.627 -0.67 . . . . 0.0 112.029 175.561 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -82.89 166.86 18.57 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 111.314 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -53.51 -41.28 66.16 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.595 -0.691 . . . . 0.0 111.916 171.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.79 -60.21 4.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.309 0.644 . . . . 0.0 110.753 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.95 -39.09 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.351 0.66 . . . . 0.0 112.599 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.21 -56.82 16.86 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.878 1.271 . . . . 0.0 110.928 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -56.57 -43.76 80.32 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.42 0.554 . . . . 0.0 111.571 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.14 -34.97 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.537 0.735 . . . . 0.0 111.67 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -83.82 2.95 35.8 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.04 1.736 . . . . 0.0 114.318 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.58 -34.13 2.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.264 1.026 . . . . 0.0 112.392 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -89.13 113.69 57.25 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.32 163.82 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.237 1.958 . . . . 0.0 111.41 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -22.72 50.73 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.81 73.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.89 1.276 . . . . 0.0 108.66 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -110.9 35.51 0.12 Allowed Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.24 133.66 11.87 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.643 2.229 . . . . 0.0 113.546 169.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.75 -10.81 36.9 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.284 1.421 . . . . 0.0 114.617 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -130.08 173.29 10.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.733 1.767 . . . . 0.0 113.857 -170.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -94.17 152.87 18.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.524 2.329 . . . . 0.0 110.608 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -139.84 123.58 10.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.514 1.526 . . . . 0.0 108.606 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.99 175.95 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.3 2.0 . . . . 0.0 113.094 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 148.18 31.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.343 2.257 . . . . 0.0 109.519 173.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.7 158.42 44.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.83 0.852 . . . . 0.0 113.143 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -91.42 -175.96 4.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.652 1.581 . . . . 0.0 113.414 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -61.56 -16.8 51.23 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -91.48 -5.83 53.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.342 1.457 . . . . 0.0 112.103 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.79 81.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.11 0.862 . . . . 0.0 113.827 -169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -77.9 152.47 33.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.154 1.477 . . . . 0.0 109.478 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -55.41 125.39 20.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.966 0.506 . . . . 0.0 109.723 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.64 142.99 69.77 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.434 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -49.69 -22.89 7.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.567 3.512 . . . . 0.0 117.684 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.06 136.76 52.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.867 2.067 . . . . 0.0 109.406 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -130.03 152.57 49.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.233 1.013 . . . . 0.0 109.321 169.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.54 129.99 20.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.52 73.6 10.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.854 1.662 . . . . 0.0 106.528 168.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -46.59 -43.09 15.01 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.66 1.6 . . . . 0.0 114.258 -170.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 t -63.05 -8.83 8.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.3 pt -126.46 0.38 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.644 1.578 . . . . 0.0 112.44 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.6 7.19 85.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.538 1.066 . . . . 0.0 115.214 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -82.2 128.87 34.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.377 1.589 . . . . 0.0 110.532 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.02 158.77 25.15 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.903 0.881 . . . . 0.0 110.426 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -150.24 160.21 43.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.669 1.588 . . . . 0.0 108.676 171.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -86.18 155.06 20.89 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.28 154.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 122.016 0.912 . . . . 0.0 112.806 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.34 158.78 76.23 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 166.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 -8.36 17.09 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.693 2.262 . . . . 0.0 115.658 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -85.21 -12.14 53.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.306 1.843 . . . . 0.0 114.2 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.71 -2.07 52.68 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.907 1.717 . . . . 0.0 115.543 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.3 m -74.69 133.24 42.1 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.93 1.865 . . . . 0.0 109.068 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.35 155.22 40.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.73 111.53 35.76 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 125.822 1.649 . . . . 0.0 106.643 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.49 150.25 11.92 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.76 . . . . 0.0 113.646 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 61.84 1.5 0.63 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.508 1.923 . . . . 0.0 115.671 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 p -74.23 -28.5 61.27 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.398 1.454 . . . . 0.0 111.012 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -43.8 103.02 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.149 2.18 . . . . 0.0 112.136 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -138.26 162.45 34.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.408 1.083 . . . . 0.0 112.453 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.07 13.72 0.1 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.803 3.241 . . . . 0.0 114.314 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.73 -169.65 40.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.194 1.854 . . . . 0.0 113.46 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -57.49 152.39 14.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.444 2.298 . . . . 0.0 115.392 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.45 155.91 39.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.637 1.575 . . . . 0.0 108.987 168.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -94.43 70.64 3.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.52 1.128 . . . . 0.0 110.638 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 125.374 1.47 . . . . 0.0 112.913 -176.109 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.478 0.18 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 p -84.37 171.1 12.94 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -53.79 -41.76 67.6 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.978 1.311 . . . . 0.0 112.035 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.51 -57.74 11.64 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.289 0.636 . . . . 0.0 110.622 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -60.52 -35.45 76.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 112.634 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.94 -57.15 14.1 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.78 1.232 . . . . 0.0 110.624 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -57.4 -42.32 82.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.345 0.521 . . . . 0.0 111.875 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.96 -32.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 111.857 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -86.39 6.83 28.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.562 1.945 . . . . 0.0 114.187 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.04 -37.8 2.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.669 1.188 . . . . 0.0 111.55 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -92.44 107.68 25.53 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.73 171.16 18.71 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.536 2.158 . . . . 0.0 111.694 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.3 -21.97 38.59 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -84.71 76.84 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.284 1.434 . . . . 0.0 108.106 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -114.36 63.19 1.28 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.903 1.281 . . . . 0.0 112.69 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 138.55 68.46 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 111.594 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 55.35 10.85 3.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.708 1.623 . . . . 0.0 114.432 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -126.75 161.13 28.87 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.668 1.234 . . . . 0.0 113.242 -167.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -83.72 157.14 22.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.329 1.451 . . . . 0.0 111.294 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -143.48 129.67 10.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.954 1.702 . . . . 0.0 108.083 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.21 175.07 10.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.101 1.867 . . . . 0.0 112.747 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -142.99 149.31 38.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.386 1.875 . . . . 0.0 109.329 172.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.97 158.85 43.26 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.35 1.06 . . . . 0.0 111.563 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -98.76 -174.86 2.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.294 1.037 . . . . 0.0 113.495 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -22.45 56.03 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.15 -8.66 59.02 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.172 0.589 . . . . 0.0 111.807 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.41 4.27 84.02 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.354 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.76 160.46 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.047 1.924 . . . . 0.0 109.339 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -59.35 132.15 53.14 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -61.42 142.72 93.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.013 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.27 -28.61 20.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.914 3.076 . . . . 0.0 116.264 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -106.23 141.25 37.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.46 1.904 . . . . 0.0 109.533 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -131.64 150.59 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.323 1.449 . . . . 0.0 109.084 169.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.1 m -139.65 134.45 32.03 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.26 72.7 10.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.26 -39.4 20.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.617 1.58 . . . . 0.0 114.731 -169.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -64.5 -9.7 20.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 pt -123.38 -4.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 112.088 169.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.1 84.97 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.006 1.765 . . . . 0.0 115.571 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -84.05 151.22 25.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.295 1.548 . . . . 0.0 111.026 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -136.95 165.33 26.25 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.188 0.995 . . . . 0.0 112.667 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -149.05 165.08 32.77 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -88.18 151.87 22.38 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.45 149.43 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.6 0.76 . . . . 0.0 110.798 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -71.11 158.95 87.04 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -52.49 -21.65 14.57 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.626 2.884 . . . . 0.0 117.416 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -85.41 -3.68 58.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.53 1.532 . . . . 0.0 114.507 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.69 -0.48 52.58 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.376 1.465 . . . . 0.0 114.754 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m -70.71 113.8 8.16 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.071 1.435 . . . . 0.0 110.534 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.21 135.22 38.56 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -83.31 109.49 17.99 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.0 156.41 54.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.493 2.129 . . . . 0.0 112.004 -169.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 63.84 -1.51 0.64 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.066 2.146 . . . . 0.0 115.334 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 p -77.66 -23.25 49.69 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.464 1.484 . . . . 0.0 111.827 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.85 99.17 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.048 1.739 . . . . 0.0 110.984 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.2 t -140.5 171.24 14.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.759 1.224 . . . . 0.0 113.451 -168.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -6.65 3.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.019 3.328 . . . . 0.0 115.29 -173.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.39 -176.85 43.99 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.918 1.247 . . . . 0.0 112.957 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -55.64 157.74 3.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.78 2.032 . . . . 0.0 113.518 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.8 164.42 38.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 0.0 112.232 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -84.0 61.4 6.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.942 2.097 . . . . 0.0 111.849 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 123.848 0.859 . . . . 0.0 112.144 -175.172 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.7 p -82.95 167.45 17.96 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.952 0.901 . . . . 0.0 111.398 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -53.63 -37.67 63.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.643 0.777 . . . . 0.0 112.591 171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.0 t -60.36 -61.41 2.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -58.85 -37.27 76.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.422 0.689 . . . . 0.0 112.548 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.43 -59.17 5.88 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.196 1.398 . . . . 0.0 110.514 171.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -55.96 -46.63 78.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.416 0.553 . . . . 0.0 111.61 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.39 -33.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.056 0.542 . . . . 0.0 111.432 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -82.51 3.62 27.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.332 1.853 . . . . 0.0 114.509 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -126.03 -23.79 3.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.105 1.32 . . . . 0.0 113.506 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 mm -61.34 133.21 92.96 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 167.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.27 174.39 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.714 1.61 . . . . 0.0 112.986 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.43 -45.61 53.43 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.608 -0.682 . . . . 0.0 110.6 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.21 72.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.453 1.501 . . . . 0.0 108.799 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.521 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 0.9 OUTLIER -133.93 -16.28 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -179.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 44.0 Cg_exo -44.76 122.12 3.89 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 123.801 3.0 . . . . 0.0 114.29 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 -41.4 1.94 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.45 1.5 . . . . 0.0 110.517 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.1 p -74.74 163.5 27.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.366 1.467 . . . . 0.0 112.768 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -75.94 155.8 34.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.028 0.931 . . . . 0.0 111.323 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -144.77 128.5 8.74 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 125.503 1.521 . . . . 0.0 108.853 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.47 175.01 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.116 1.877 . . . . 0.0 112.289 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 153.69 40.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.631 1.572 . . . . 0.0 111.133 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.42 159.33 38.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.494 1.118 . . . . 0.0 113.071 -168.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -95.95 -179.69 4.78 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.983 1.713 . . . . 0.0 113.692 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -16.11 48.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.313 1.445 . . . . 0.0 114.866 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.72 13.76 31.1 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.788 1.635 . . . . 0.0 111.771 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 2.21 14.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.648 1.594 . . . . 0.0 114.71 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.34 164.14 20.19 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.811 1.306 . . . . 0.0 108.766 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -60.23 128.87 38.91 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.37 0.532 . . . . 0.0 109.827 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.79 128.23 62.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.15 -1.405 . . . . 0.0 108.675 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.62 -18.74 6.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.799 2.999 . . . . 0.0 116.761 -174.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.53 132.65 54.99 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.961 2.104 . . . . 0.0 108.551 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -124.84 151.87 44.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.254 1.022 . . . . 0.0 108.718 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 83.9 m -141.4 156.99 45.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.688 0.795 . . . . 0.0 112.07 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.03 93.45 3.19 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 110.742 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.76 -36.38 59.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.18 1.371 . . . . 0.0 115.091 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -57.76 -20.78 37.5 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.094 1.447 . . . . 0.0 114.503 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 pt -123.41 2.63 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.98 1.712 . . . . 0.0 112.207 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.44 12.22 69.33 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.293 1.425 . . . . 0.0 114.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -86.82 155.55 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.035 1.418 . . . . 0.0 113.339 -171.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.0 m -140.4 157.19 45.91 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.275 1.83 . . . . 0.0 109.57 166.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -149.5 162.7 39.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.628 1.571 . . . . 0.0 108.941 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.2 m -90.05 152.05 21.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.3 153.26 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.111 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -76.74 161.71 73.03 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 166.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -53.38 -23.85 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 116.361 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -80.8 -8.84 59.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.076 2.15 . . . . 0.0 114.924 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.27 59.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.34 1.447 . . . . 0.0 115.454 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.3 m -72.61 127.42 32.51 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.699 1.75 . . . . 0.0 108.863 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -71.83 165.92 23.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -99.83 92.8 2.11 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -68.85 23.2 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.863 1 C-N-CA 126.021 4.481 . . . . 0.0 117.907 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -124.77 -3.4 7.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.278 1.831 . . . . 0.0 112.465 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.9 p -84.95 -20.71 30.19 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.147 0.979 . . . . 0.0 113.067 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -57.25 97.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.076 1.351 . . . . 0.0 112.566 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -131.78 168.38 17.9 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.301 1.84 . . . . 0.0 111.992 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 21.8 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.108 2.563 . . . . 0.0 112.375 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 174.47 45.84 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.752 1.168 . . . . 0.0 113.219 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -62.82 164.08 8.5 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.059 1.744 . . . . 0.0 114.016 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 162.86 40.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.822 1.249 . . . . 0.0 111.212 175.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.07 63.44 7.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.952 1.701 . . . . 0.0 111.812 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 113.335 -172.538 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 160.32 19.51 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.802 1.641 . . . . 0.0 111.137 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -46.39 -53.21 11.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -58.13 -55.92 28.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.496 0.318 . . . . 0.0 111.419 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.98 -41.7 71.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.005 0.922 . . . . 0.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.03 -60.58 3.37 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.889 1.276 . . . . 0.0 109.893 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.63 -46.23 77.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.172 0.442 . . . . 0.0 111.77 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.86 -30.82 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.342 0.657 . . . . 0.0 111.745 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p -79.72 -3.83 49.2 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.78 -21.96 4.3 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.698 1.136 . . . . 0.0 113.997 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.52 137.44 97.08 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 167.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.99 168.65 16.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 121.879 1.72 . . . . 0.0 112.511 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.43 -45.8 68.27 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.541 -0.724 . . . . 0.0 110.318 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 t -77.82 71.65 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.99 1.316 . . . . 0.0 108.784 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -113.95 -9.06 0.1 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -42.87 112.4 0.27 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.441 2.761 . . . . 0.0 114.242 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -46.17 1.1 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.211 1.862 . . . . 0.0 108.672 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -85.61 141.7 29.62 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.802 1.241 . . . . 0.0 111.732 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -64.18 163.98 11.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.789 1.236 . . . . 0.0 109.391 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -142.54 125.21 9.11 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 127.064 2.146 . . . . 0.0 108.947 173.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.73 170.29 7.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.615 2.21 . . . . 0.0 115.843 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -131.84 148.77 52.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.746 2.418 . . . . 0.0 109.146 169.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.87 155.34 46.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -86.14 175.46 8.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.254 1.421 . . . . 0.0 113.05 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.95 -18.18 43.49 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.19 7.66 36.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.329 1.852 . . . . 0.0 111.782 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.23 8.0 41.55 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.344 1.45 . . . . 0.0 114.632 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -91.19 167.65 12.18 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.749 1.62 . . . . 0.0 109.135 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -58.35 133.4 55.69 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.937 -0.477 . . . . 0.0 110.542 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -57.16 133.32 80.75 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.531 170.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -51.24 -30.21 32.26 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.519 2.813 . . . . 0.0 115.566 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.55 137.87 42.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.884 1.674 . . . . 0.0 109.262 169.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -123.74 147.2 47.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 0.0 108.358 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.68 155.49 48.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.109 0.964 . . . . 0.0 110.224 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.47 91.02 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.328 1.061 . . . . 0.0 111.157 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -13.19 34.99 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 117.564 1.785 . . . . 0.0 117.564 -169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.2 p -69.8 -23.65 63.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.159 1.98 . . . . 0.0 112.655 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.1 pt -120.44 -19.26 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.906 1.683 . . . . 0.0 112.492 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 10.27 84.6 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.547 1.546 . . . . 0.0 114.753 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -83.51 157.92 22.2 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.525 1.163 . . . . 0.0 110.755 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.6 m -135.11 163.63 29.47 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.826 1.25 . . . . 0.0 112.416 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -150.87 163.3 38.98 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.144 1.778 . . . . 0.0 109.755 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -89.76 151.85 21.61 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 169.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.2 154.42 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.232 1.013 . . . . 0.0 110.923 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -75.77 162.97 70.05 Favored Pre-proline 0 CA--C 1.552 1.047 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.26 -23.38 23.09 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.878 3.052 . . . . 0.0 116.508 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -82.79 -11.88 57.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.624 1.97 . . . . 0.0 114.691 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.42 49.19 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.457 1.503 . . . . 0.0 115.826 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 m -69.64 119.24 13.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.762 1.781 . . . . 0.0 109.575 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.01 138.5 54.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.914 0.886 . . . . 0.0 112.942 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.73 107.66 11.01 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.18 152.93 77.2 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -169.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 71.42 -3.62 2.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 128.438 2.695 . . . . 0.0 114.396 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.2 p -79.24 -19.98 49.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.222 1.374 . . . . 0.0 112.072 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.1 97.46 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.26 1.424 . . . . 0.0 110.293 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.9 t -137.66 168.78 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.129 1.372 . . . . 0.0 113.217 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -7.73 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 129.324 3.05 . . . . 0.0 115.084 -173.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.21 -169.18 40.3 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.654 1.121 . . . . 0.0 113.422 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.99 150.66 4.13 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.999 2.52 . . . . 0.0 114.777 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 164.63 38.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.794 1.238 . . . . 0.0 110.92 170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -95.54 66.61 2.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.871 1.268 . . . . 0.0 111.602 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.234 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.055 -179.8 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -83.26 167.7 17.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.39 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -52.94 -39.21 62.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.298 0.639 . . . . 0.0 112.099 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 t -59.57 -59.68 5.05 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.599 0.759 . . . . 0.0 110.9 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.75 -37.13 78.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.632 0.773 . . . . 0.0 112.537 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.11 -58.66 7.43 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.152 1.381 . . . . 0.0 110.841 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -56.94 -41.04 77.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.488 0.585 . . . . 0.0 112.108 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.04 -29.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.333 1.053 . . . . 0.0 112.365 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 m -72.59 -42.83 64.12 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.762 0.825 . . . . 0.0 112.274 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -78.85 -37.3 40.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.809 1.244 . . . . 0.0 113.265 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.4 mt -90.75 104.33 9.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.24 169.13 21.45 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.186 1.924 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.91 -24.55 38.25 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.44 68.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 0.0 108.873 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -104.34 8.81 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -41.96 136.67 3.4 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.452 2.768 . . . . 0.0 115.234 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.07 -18.56 35.41 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.888 1.708 . . . . 0.0 113.494 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.4 p -130.34 166.69 19.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.177 1.488 . . . . 0.0 114.362 -169.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -82.78 145.05 29.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.613 1.565 . . . . 0.0 110.733 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -133.7 123.95 17.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.944 1.698 . . . . 0.0 107.96 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.98 175.61 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.848 1.699 . . . . 0.0 114.569 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -136.83 146.36 45.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.826 2.05 . . . . 0.0 109.206 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 m -135.17 153.42 51.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.102 0.865 . . . . 0.0 112.301 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -95.48 -176.38 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.524 1.129 . . . . 0.0 114.03 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -61.14 -24.3 66.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -86.56 8.69 21.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.236 1.414 . . . . 0.0 112.667 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.15 2.08 12.38 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.472 1.511 . . . . 0.0 114.833 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -82.87 169.59 15.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.523 1.529 . . . . 0.0 108.553 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -61.29 133.63 56.09 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.651 -0.656 . . . . 0.0 109.6 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.14 145.59 72.94 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.75 -14.28 38.81 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.881 1.72 . . . . 0.0 114.144 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -110.63 135.51 51.15 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.172 2.189 . . . . 0.0 107.978 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -128.7 150.11 50.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.444 1.098 . . . . 0.0 109.491 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.9 m -140.68 134.83 30.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.269 0.628 . . . . 0.0 112.216 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.69 73.61 9.71 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.39 15.79 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.685 1.612 . . . . 0.0 114.598 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.68 -11.67 27.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.86 -5.28 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.481 1.513 . . . . 0.0 112.421 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.45 8.29 83.71 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.88 1.705 . . . . 0.0 115.629 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -83.91 148.1 27.13 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.093 1.447 . . . . 0.0 110.733 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.5 m -135.34 164.02 28.69 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.224 1.01 . . . . 0.0 113.037 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -149.35 163.58 37.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.689 1.996 . . . . 0.0 109.038 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -88.86 155.14 19.71 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.43 156.38 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.381 1.072 . . . . 0.0 111.796 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -76.46 164.81 57.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 166.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.83 -29.96 36.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.474 2.783 . . . . 0.0 115.893 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.61 -6.34 56.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.131 2.172 . . . . 0.0 114.643 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.12 0.93 65.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.626 1.108 . . . . 0.0 115.189 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.7 m -70.99 126.49 29.71 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.733 1.766 . . . . 0.0 108.588 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -68.82 161.86 27.65 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.25 95.13 3.15 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.16 23.62 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.916 1 C-N-CA 125.836 4.357 . . . . 0.0 117.82 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -125.04 -3.66 7.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.426 1.891 . . . . 0.0 112.398 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 p -86.4 -19.94 28.96 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.056 0.942 . . . . 0.0 113.192 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.93 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.511 1.525 . . . . 0.0 111.351 -169.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m -132.22 165.49 24.0 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.154 1.382 . . . . 0.0 113.177 -168.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -5.13 1.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.399 3.08 . . . . 0.0 115.02 176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.13 -173.1 39.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.093 1.806 . . . . 0.0 112.355 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -59.29 164.85 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.375 1.87 . . . . 0.0 114.41 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 167.98 28.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.454 1.501 . . . . 0.0 110.547 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.25 57.43 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.523 1.929 . . . . 0.0 112.458 -168.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.9 m . . . . . 0 CA--C 1.547 0.836 0 O-C-N 121.97 -0.456 . . . . 0.0 111.286 179.475 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.0 p -82.76 167.7 17.9 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.785 0.834 . . . . 0.0 111.32 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -54.28 -40.04 67.49 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.436 -0.79 . . . . 0.0 111.761 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -56.86 -60.28 3.8 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.737 0.815 . . . . 0.0 110.939 171.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.57 -36.66 76.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.252 0.621 . . . . 0.0 112.477 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.75 -57.56 11.41 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -52.69 -47.74 67.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.95 0.796 . . . . 0.0 111.459 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.95 -24.9 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.328 1.451 . . . . 0.0 112.426 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -91.01 3.93 53.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.235 1.814 . . . . 0.0 115.102 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -130.51 -33.16 1.67 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.187 1.358 . . . . 0.0 113.426 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.17 138.56 72.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.99 158.52 53.78 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 111.357 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.56 84.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.838 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.62 66.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.769 1.227 . . . . 0.0 109.135 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -85.54 -6.64 0.11 Allowed Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -43.72 107.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.881 3.054 . . . . 0.0 114.554 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.89 -20.48 6.0 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.619 2.057 . . . . 0.0 112.909 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -138.83 178.0 7.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.625 1.57 . . . . 0.0 112.215 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -80.68 159.07 25.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.245 1.818 . . . . 0.0 111.035 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -148.86 117.64 3.95 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.336 1.455 . . . . 0.0 109.34 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 174.68 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.17 1.913 . . . . 0.0 114.221 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -138.78 147.77 43.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.033 2.133 . . . . 0.0 108.905 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -132.75 157.67 44.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.254 0.934 . . . . 0.0 113.043 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -103.29 -178.27 3.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.751 1.621 . . . . 0.0 114.721 -169.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -15.56 27.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.968 1.707 . . . . 0.0 115.044 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -102.01 13.53 34.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.922 1.689 . . . . 0.0 111.886 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.19 3.94 20.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.328 1.442 . . . . 0.0 114.561 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -85.34 167.12 15.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.667 1.587 . . . . 0.0 109.343 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.0 124.1 19.51 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -53.83 128.71 55.13 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 117.394 -1.289 . . . . 0.0 108.697 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.39 -9.51 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.074 3.183 . . . . 0.0 117.915 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.43 127.85 54.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.772 2.429 . . . . 0.0 107.622 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.15 150.62 41.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.082 0.953 . . . . 0.0 109.721 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.3 m -138.12 153.83 49.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.893 0.854 . . . . 0.0 112.641 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.37 70.02 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.266 2.226 . . . . 0.0 107.668 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.84 -34.39 29.64 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.088 1.328 . . . . 0.0 113.991 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 m -53.13 -22.62 6.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.862 2.065 . . . . 0.0 115.191 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -121.39 -0.33 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 112.615 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.27 6.3 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.354 0.978 . . . . 0.0 111.339 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -143.3 158.62 43.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -141.23 161.57 37.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.177 2.191 . . . . 0.0 110.077 167.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.21 161.64 42.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.74 1.616 . . . . 0.0 109.366 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.1 m -85.98 153.73 21.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.85 159.28 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.38 1.072 . . . . 0.0 111.708 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -82.01 160.54 63.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.62 -26.21 22.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.785 2.99 . . . . 0.0 116.664 -172.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.1 -5.16 55.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.4 0.59 50.36 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.697 1.618 . . . . 0.0 114.806 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 m -67.9 108.62 3.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.165 1.482 . . . . 0.0 110.686 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -56.62 129.89 42.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.263 1.025 . . . . 0.0 112.979 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.48 110.69 26.17 Favored Pre-proline 0 C--O 1.241 0.617 0 C-N-CA 125.465 1.506 . . . . 0.0 107.97 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.8 161.2 33.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.595 2.197 . . . . 0.0 111.758 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 62.47 -5.23 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.948 2.099 . . . . 0.0 115.445 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 p -76.69 -24.89 53.17 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.345 1.429 . . . . 0.0 111.339 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -50.23 102.95 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.525 1.93 . . . . 0.0 111.106 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -144.33 167.74 21.74 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.448 1.099 . . . . 0.0 111.127 -170.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -74.79 4.56 6.18 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.79 43.82 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.684 1.611 . . . . 0.0 112.252 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -58.18 161.77 3.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.956 1.702 . . . . 0.0 114.439 -171.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.55 165.73 34.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 110.589 172.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -86.4 62.85 7.67 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.274 1.83 . . . . 0.0 111.223 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 179.013 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.3 p -82.88 166.98 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.882 0.873 . . . . 0.0 111.525 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -54.41 -37.99 65.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.406 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 t -60.84 -59.77 4.85 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 110.9 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.54 -39.11 79.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.286 0.634 . . . . 0.0 112.7 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.55 -56.2 24.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.293 1.437 . . . . 0.0 110.986 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -56.61 -44.04 80.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.766 0.426 . . . . 0.0 111.587 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.57 -28.11 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.235 1.014 . . . . 0.0 112.277 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 m -83.49 3.85 30.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.016 1.727 . . . . 0.0 114.03 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -124.78 -35.66 2.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.528 1.131 . . . . 0.0 111.805 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -94.08 105.95 19.98 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.51 171.33 18.44 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.614 2.209 . . . . 0.0 111.822 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.56 39.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.082 0.953 . . . . 0.0 113.403 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.98 76.7 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.983 1.313 . . . . 0.0 108.051 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.45 46.7 0.46 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.42 129.03 25.33 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.699 2.266 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.04 -7.51 66.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.158 1.361 . . . . 0.0 114.323 -173.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -123.28 161.26 24.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.629 1.714 . . . . 0.0 113.56 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -78.1 160.41 28.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.477 1.511 . . . . 0.0 107.708 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -147.79 127.32 6.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.497 2.319 . . . . 0.0 107.098 169.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.73 171.37 9.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.493 1.462 . . . . 0.0 114.111 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -135.28 137.44 42.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.595 2.358 . . . . 0.0 108.82 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.92 154.86 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.652 0.781 . . . . 0.0 111.216 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -79.86 173.56 12.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.937 0.895 . . . . 0.0 112.267 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -61.79 -16.74 52.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.76 -5.71 59.33 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.364 1.865 . . . . 0.0 111.523 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.43 2.07 89.14 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 125.532 1.539 . . . . 0.0 114.627 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -78.47 147.29 33.99 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.124 1.462 . . . . 0.0 109.106 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -54.84 123.77 14.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.915 0.886 . . . . 0.0 110.104 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.06 145.03 67.16 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.65 -18.58 59.11 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.508 2.138 . . . . 0.0 114.291 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -109.91 131.67 54.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.795 2.438 . . . . 0.0 108.541 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -119.64 146.94 45.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.871 1.269 . . . . 0.0 109.417 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.64 128.88 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.35 71.31 10.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.681 1.592 . . . . 0.0 106.991 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.63 -37.2 26.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.513 1.53 . . . . 0.0 114.401 -170.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -63.31 -10.41 16.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 pt -125.01 -0.47 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 112.453 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.7 -5.05 76.51 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.667 1.603 . . . . 0.0 115.498 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -81.83 151.23 27.46 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.028 1.414 . . . . 0.0 111.493 -172.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.2 m -137.38 164.99 27.28 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -148.4 163.96 35.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.8 2.04 . . . . 0.0 109.227 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.8 157.03 18.61 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 109.771 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.45 161.4 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.87 162.66 46.44 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.715 1.606 . . . . 0.0 108.697 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.81 -15.28 9.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.995 3.13 . . . . 0.0 118.027 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -95.55 0.78 53.39 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.103 1.361 . . . . 0.0 114.083 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 2.47 62.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.197 1.38 . . . . 0.0 114.804 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -71.23 130.38 41.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.122 1.461 . . . . 0.0 109.624 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.53 137.94 58.1 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.4 t -83.42 109.15 15.97 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.01 155.95 47.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.832 2.354 . . . . 0.0 113.141 -168.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 61.68 -0.24 0.43 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.135 2.174 . . . . 0.0 115.818 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 p -72.79 -32.01 65.27 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.106 1.321 . . . . 0.0 110.77 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.76 106.38 0.11 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 111.967 -169.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -137.21 165.82 25.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.013 1.325 . . . . 0.0 113.103 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.84 -6.27 2.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.734 2.814 . . . . 0.0 114.216 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.89 -175.66 39.04 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.219 1.866 . . . . 0.0 112.559 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -58.04 161.97 3.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.823 2.049 . . . . 0.0 114.067 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.13 167.11 31.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.611 1.164 . . . . 0.0 111.771 172.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -82.61 61.53 5.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.448 2.299 . . . . 0.0 112.023 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.219 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 120.555 0.217 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -145.98 -178.83 6.32 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.149 1.38 . . . . 0.0 110.16 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -47.32 -33.02 5.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 112.369 169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.47 -68.5 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.235 0.614 . . . . 0.0 111.191 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -54.55 -39.77 68.06 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.44 1.096 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.94 -60.34 3.6 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.679 1.192 . . . . 0.0 110.282 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -54.32 -48.2 71.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.272 0.629 . . . . 0.0 111.908 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.06 -34.32 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.699 0.4 . . . . 0.0 111.261 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.6 p -80.97 -2.1 46.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -130.22 -23.58 2.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -67.33 137.74 93.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 165.15 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.007 1.805 . . . . 0.0 111.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.76 72.45 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.523 -0.736 . . . . 0.0 111.564 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -83.79 77.81 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.388 1.475 . . . . 0.0 107.927 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -118.68 53.2 1.83 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.383 1.073 . . . . 0.0 113.542 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -61.83 139.05 77.94 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.885 2.39 . . . . 0.0 110.853 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 11.51 0.78 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.266 1.412 . . . . 0.0 115.544 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -120.41 136.92 54.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.436 1.495 . . . . 0.0 110.928 -168.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.05 154.68 38.86 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -148.83 125.33 5.31 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.864 2.066 . . . . 0.0 108.523 168.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 178.3 7.04 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.274 1.983 . . . . 0.0 112.66 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -139.17 151.53 46.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.876 2.071 . . . . 0.0 109.764 170.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.77 154.46 51.22 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -86.25 175.36 8.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.442 . . . . 0.0 113.206 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.53 -21.06 59.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -84.9 6.31 25.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.348 1.859 . . . . 0.0 111.862 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.34 4.93 39.88 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.955 1.74 . . . . 0.0 114.889 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -90.5 164.73 14.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.831 2.052 . . . . 0.0 109.759 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.65 127.87 33.3 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.917 -0.489 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.35 141.2 62.96 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.826 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.5 -30.94 12.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.339 3.359 . . . . 0.0 116.251 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.2 tp -107.93 129.99 55.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.445 1.898 . . . . 0.0 108.855 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -112.52 140.09 47.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.681 1.193 . . . . 0.0 108.609 169.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.1 m -130.56 119.7 22.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 122.069 0.938 . . . . 0.0 110.669 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.25 66.59 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.24 1.816 . . . . 0.0 106.501 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.23 -27.12 64.78 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.564 1.554 . . . . 0.0 114.402 -169.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 p -61.97 -11.99 16.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.66 1.584 . . . . 0.0 114.267 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.48 -3.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.643 1.977 . . . . 0.0 111.705 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.69 20.32 79.56 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 126.412 1.958 . . . . 0.0 115.749 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -95.48 158.95 15.23 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.842 1.821 . . . . 0.0 111.28 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.37 164.88 29.03 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.746 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -149.51 164.18 35.78 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.785 2.034 . . . . 0.0 109.277 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.83 150.67 22.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.45 156.48 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.519 0.728 . . . . 0.0 111.737 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.5 158.59 81.05 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 165.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.55 -22.3 16.41 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.655 2.903 . . . . 0.0 117.091 -171.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -82.24 -5.46 58.53 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.421 1.489 . . . . 0.0 114.694 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.74 -0.47 48.88 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.679 1.609 . . . . 0.0 114.968 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -69.88 114.54 8.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.124 1.462 . . . . 0.0 110.539 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.92 136.81 55.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.729 0.812 . . . . 0.0 112.676 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.01 114.3 51.7 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -45.14 137.45 10.05 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.487 3.458 . . . . 0.0 115.58 -169.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.25 9.66 4.13 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.756 2.023 . . . . 0.0 114.843 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -78.11 -22.38 48.99 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.01 1.277 . . . . 0.0 111.604 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 105.17 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.197 0.999 . . . . 0.0 111.724 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -144.74 171.1 14.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.086 1.354 . . . . 0.0 112.999 -169.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -0.06 2.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 129.87 3.268 . . . . 0.0 114.922 -174.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.64 -176.58 48.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.218 1.389 . . . . 0.0 113.01 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.54 159.06 3.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.216 2.207 . . . . 0.0 114.174 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.51 166.29 33.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.479 1.111 . . . . 0.0 111.906 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.75 67.44 9.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.028 1.731 . . . . 0.0 111.535 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.272 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 p -83.72 167.92 16.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.32 1.048 . . . . 0.0 110.754 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -55.15 -39.24 69.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.443 -0.786 . . . . 0.0 112.239 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.1 t -62.18 -59.81 4.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.67 0.788 . . . . 0.0 111.03 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -58.0 -36.54 72.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.58 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.47 -59.23 5.74 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.366 1.066 . . . . 0.0 110.631 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.29 -42.1 81.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.414 0.552 . . . . 0.0 112.079 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.65 -32.27 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.262 1.025 . . . . 0.0 111.908 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 m -86.51 7.93 24.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.178 1.791 . . . . 0.0 114.063 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -124.94 -38.77 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.376 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.41 108.03 20.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 168.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -70.4 160.08 50.75 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.148 1.899 . . . . 0.0 111.47 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.63 61.08 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.89 67.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 108.927 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -99.11 5.31 0.07 OUTLIER Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -41.91 112.69 0.24 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.506 2.804 . . . . 0.0 115.609 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.99 28.44 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.118 1.818 . . . . 0.0 113.318 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -117.44 159.16 23.25 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.214 1.806 . . . . 0.0 111.972 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.38 157.87 37.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -148.54 130.14 7.35 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.499 1.919 . . . . 0.0 107.597 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.91 170.99 17.5 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.19 1.927 . . . . 0.0 112.509 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -144.14 150.5 38.17 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.18 1.792 . . . . 0.0 110.073 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -133.11 158.39 42.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.95 1.3 . . . . 0.0 111.208 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.38 179.64 6.04 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.282 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -16.82 49.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -173.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -84.64 -3.28 58.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.167 0.987 . . . . 0.0 112.61 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 8.93 82.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.215 0.912 . . . . 0.0 113.74 -171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -80.34 147.97 30.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.72 1.208 . . . . 0.0 109.008 172.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -51.98 126.97 19.89 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.089 0.956 . . . . 0.0 111.403 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.86 131.63 82.99 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.08 -30.05 30.35 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.24 2.627 . . . . 0.0 115.543 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.4 140.37 34.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.604 1.961 . . . . 0.0 109.482 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -131.72 149.82 52.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.087 1.355 . . . . 0.0 109.004 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 79.4 m -142.28 132.33 24.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.92 72.0 9.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 168.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.14 17.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.215 1.388 . . . . 0.0 114.784 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -60.9 -16.11 38.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.66 1.88 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.191 1.396 . . . . 0.0 112.435 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.94 69.26 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.811 1.672 . . . . 0.0 115.224 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -83.31 143.4 30.4 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.71 1.255 . . . . 0.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.7 m -131.18 164.81 24.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.645 1.178 . . . . 0.0 112.12 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -153.15 165.4 35.75 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.233 1.813 . . . . 0.0 109.376 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.9 m -89.66 154.16 20.17 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 122.027 -0.421 . . . . 0.0 110.241 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.81 160.29 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.874 0.87 . . . . 0.0 113.122 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.47 167.22 17.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.675 1.59 . . . . 0.0 110.714 167.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.82 -2.21 1.03 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 124.845 3.696 . . . . 0.0 118.614 -170.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -111.31 2.32 17.6 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.45 1.9 . . . . 0.0 113.562 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.69 2.34 61.48 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.227 1.394 . . . . 0.0 114.352 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.5 m -67.13 111.62 4.0 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.183 1.491 . . . . 0.0 110.108 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -56.09 138.34 49.73 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.705 1.602 . . . . 0.0 113.06 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.68 100.1 1.01 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.946 1.698 . . . . 0.0 106.826 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.17 19.32 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.506 4.137 . . . . 0.0 117.127 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -123.73 -1.28 8.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.847 2.059 . . . . 0.0 112.875 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 p -96.3 -15.08 22.13 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.359 1.064 . . . . 0.0 112.843 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.616 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.24 111.46 0.78 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.416 1.086 . . . . 0.0 109.877 -173.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 t -148.23 167.39 25.23 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.616 ' NH1' HH22 ' A' ' 55' ' ' ARG . 5.4 mpt_? -77.2 12.06 1.62 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.626 2.77 . . . . 0.0 113.598 -173.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.65 176.99 47.54 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.904 1.24 . . . . 0.0 112.747 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -57.6 157.98 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.61 1.964 . . . . 0.0 113.28 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.1 168.11 28.12 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.124 0.97 . . . . 0.0 111.821 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -87.76 65.74 8.53 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.771 1.628 . . . . 0.0 111.795 -168.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.4 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.89 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.4 p -83.42 168.24 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.403 0.681 . . . . 0.0 111.661 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -51.06 -42.64 60.68 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 0.0 112.207 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -58.91 6.49 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.954 0.343 . . . . 0.0 111.45 171.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.27 -34.41 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.97 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.74 -61.83 2.23 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.579 1.152 . . . . 0.0 110.359 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -51.41 -49.66 61.2 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.182 0.993 . . . . 0.0 111.59 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.57 -27.39 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.067 0.947 . . . . 0.0 111.357 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -86.2 2.77 45.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.224 1.81 . . . . 0.0 114.602 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -128.86 -25.62 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.192 1.36 . . . . 0.0 113.838 -174.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.65 136.15 92.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 169.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.4 169.39 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.947 1.765 . . . . 0.0 112.074 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.18 72.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.609 -0.682 . . . . 0.0 110.868 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.15 74.36 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.07 1.348 . . . . 0.0 108.498 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.47 15.85 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.49 110.36 1.22 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 CA-C-N 123.636 2.334 . . . . 0.0 110.734 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.96 -15.37 8.92 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.567 1.556 . . . . 0.0 113.134 -169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.0 t -124.87 148.81 48.08 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.474 1.509 . . . . 0.0 110.756 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -77.27 165.25 24.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.961 0.904 . . . . 0.0 112.624 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -138.85 106.97 7.51 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.122 1.769 . . . . 0.0 109.864 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -55.51 155.67 20.33 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.29 2.66 . . . . 0.0 115.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.27 128.81 51.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 127.995 2.518 . . . . 0.0 108.809 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 29' ' ' TYR . 76.0 m -143.19 157.74 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.012 0.91 . . . . 0.0 111.885 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -79.24 176.93 9.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.326 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.2 -24.64 63.29 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -84.61 7.98 18.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.977 1.711 . . . . 0.0 111.668 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.27 15.4 51.26 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.044 1.783 . . . . 0.0 114.634 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.86 149.77 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.728 1.211 . . . . 0.0 109.252 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 66.1 m-85 -69.0 120.69 15.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.715 0.806 . . . . 0.0 110.01 -170.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.31 128.87 83.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.638 -1.172 . . . . 0.0 108.898 -175.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.77 -22.45 9.8 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.773 2.982 . . . . 0.0 116.594 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.59 136.11 50.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.431 1.893 . . . . 0.0 109.228 169.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -123.69 148.92 46.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.475 1.51 . . . . 0.0 109.073 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -140.82 152.85 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.335 1.054 . . . . 0.0 110.1 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -127.09 88.2 2.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.325 1.06 . . . . 0.0 110.688 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.66 -12.93 36.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.841 1.686 . . . . 0.0 116.84 -169.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.2 p -66.25 -25.68 67.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.263 1.532 . . . . 0.0 112.833 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 pt -119.89 -17.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 112.515 173.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.29 9.25 85.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.515 1.531 . . . . 0.0 114.683 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -83.2 158.06 22.47 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.571 1.185 . . . . 0.0 110.95 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.1 m -133.82 164.97 26.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.618 1.167 . . . . 0.0 112.067 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.42 163.87 39.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.904 1.681 . . . . 0.0 109.498 169.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.4 m -90.64 150.42 21.7 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.693 0.797 . . . . 0.0 109.639 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.46 151.29 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.575 1.15 . . . . 0.0 110.208 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.3 155.4 91.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.9 -16.89 12.62 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.737 2.958 . . . . 0.0 117.372 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -83.23 -4.7 58.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.125 2.17 . . . . 0.0 114.996 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.29 -3.26 54.54 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.733 1.635 . . . . 0.0 114.873 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 m -73.83 111.6 9.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.628 1.214 . . . . 0.0 110.067 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -55.52 143.08 30.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.773 1.229 . . . . 0.0 113.804 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.94 89.04 0.7 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 168.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.18 -15.23 48.3 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.761 2.308 . . . . 0.0 117.435 -166.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.43 -12.96 59.92 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 127.217 2.207 . . . . 0.0 113.134 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.7 p -102.9 -2.62 27.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.923 1.689 . . . . 0.0 112.65 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 104.83 0.6 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.572 1.078 . . . . 0.0 109.447 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 t -141.39 162.04 36.45 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -7.84 3.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.847 3.259 . . . . 0.0 114.945 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.39 -174.53 42.96 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.107 0.86 . . . . 0.0 114.165 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -55.72 149.92 13.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.346 2.258 . . . . 0.0 113.982 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -155.46 -176.51 5.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.833 1.653 . . . . 0.0 110.024 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -130.88 91.03 2.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.527 1.531 . . . . 0.0 110.201 -170.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.542 0.657 0 C-N-CA 127.625 2.37 . . . . 0.0 112.916 177.232 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -83.09 167.19 18.07 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.706 0.803 . . . . 0.0 111.498 171.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -52.25 -39.66 60.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 112.382 171.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -59.59 -60.74 3.36 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.581 0.752 . . . . 0.0 110.949 171.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -58.88 -36.53 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.498 0.719 . . . . 0.0 112.458 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.86 -58.03 10.34 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.876 1.271 . . . . 0.0 110.749 171.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -57.81 -43.17 85.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.233 0.47 . . . . 0.0 112.016 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.55 -34.55 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.309 0.643 . . . . 0.0 111.628 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -82.46 3.19 29.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.736 1.615 . . . . 0.0 114.338 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -127.59 -34.02 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.439 1.018 . . . . 0.0 112.416 -177.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.8 mt -87.27 114.25 57.7 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.2 161.28 40.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.33 2.02 . . . . 0.0 111.705 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -18.43 42.87 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 175.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.02 78.9 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.302 1.441 . . . . 0.0 107.775 169.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -113.52 63.2 0.98 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.025 1.33 . . . . 0.0 112.763 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.16 136.65 57.13 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.366 2.71 . . . . 0.0 111.255 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.96 11.76 1.05 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.376 1.465 . . . . 0.0 115.183 -173.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -125.97 162.89 24.21 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.661 1.585 . . . . 0.0 112.007 -168.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -88.79 155.02 19.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.781 1.632 . . . . 0.0 111.675 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.61 126.34 8.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.796 1.639 . . . . 0.0 108.65 168.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.54 174.03 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.191 1.928 . . . . 0.0 113.507 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 151.34 44.86 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.822 2.049 . . . . 0.0 110.015 173.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.63 157.38 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.625 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.41 -175.64 3.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.564 1.146 . . . . 0.0 113.946 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -60.63 -24.97 65.94 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.14 8.65 20.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.238 1.415 . . . . 0.0 112.71 171.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.35 3.05 17.18 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.49 1.519 . . . . 0.0 114.794 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.19 170.68 11.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.682 1.593 . . . . 0.0 109.118 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -60.31 129.93 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 177.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.92 137.49 79.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.776 -1.106 . . . . 0.0 108.635 173.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.75 -22.78 10.27 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.495 2.796 . . . . 0.0 116.369 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.91 132.09 53.83 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.737 2.015 . . . . 0.0 109.319 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.8 147.78 46.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.628 1.171 . . . . 0.0 109.684 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -139.24 116.84 11.4 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -170.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 63.25 7.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.942 2.097 . . . . 0.0 106.531 168.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.63 -21.74 63.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.936 1.255 . . . . 0.0 114.945 -169.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.0 p -62.15 -15.0 42.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.87 1.268 . . . . 0.0 114.12 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -123.5 8.9 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 127.139 2.176 . . . . 0.0 111.724 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.18 5.05 89.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.963 1.744 . . . . 0.0 115.218 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -84.73 150.64 24.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.202 1.501 . . . . 0.0 114.142 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -143.77 163.37 33.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.897 1.679 . . . . 0.0 111.16 168.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -150.84 163.38 38.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.484 1.914 . . . . 0.0 108.731 169.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.88 154.31 20.95 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.29 157.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.203 1.001 . . . . 0.0 111.645 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -75.66 158.81 82.6 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 165.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.98 -13.68 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.386 2.057 . . . . 0.0 114.949 -169.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -79.8 -7.33 58.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.136 2.174 . . . . 0.0 115.103 169.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.69 -2.65 49.12 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.073 1.797 . . . . 0.0 115.132 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.9 m -73.33 116.78 14.28 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 1.408 . . . . 0.0 110.701 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.32 133.38 55.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.025 1.33 . . . . 0.0 113.635 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.17 111.7 35.48 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 126.718 2.007 . . . . 0.0 108.557 172.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.14 156.62 4.99 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.875 3.05 . . . . 0.0 114.285 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 59.99 -2.88 0.13 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.864 2.066 . . . . 0.0 116.04 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 p -76.01 -26.43 56.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.115 1.325 . . . . 0.0 111.524 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -46.94 106.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.941 2.097 . . . . 0.0 111.783 -174.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 t -148.08 161.29 41.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.729 0.812 . . . . 0.0 111.714 -172.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -89.69 36.23 0.84 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.214 1.405 . . . . 0.0 113.087 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.68 170.74 41.33 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.028 2.251 . . . . 0.0 112.218 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -67.71 167.89 12.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.052 1.341 . . . . 0.0 112.85 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 166.9 32.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.724 1.21 . . . . 0.0 110.981 174.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -83.99 61.3 6.35 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.795 2.038 . . . . 0.0 111.627 -168.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.545 0.763 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.496 179.448 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 p -130.96 176.14 8.49 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.756 1.222 . . . . 0.0 112.777 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -48.57 -35.98 14.57 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.202 1.401 . . . . 0.0 112.446 169.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.22 -57.69 10.51 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.453 0.57 . . . . 0.0 110.884 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -57.46 -40.41 78.45 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.279 0.632 . . . . 0.0 112.637 177.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.96 -57.59 12.21 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.044 0.937 . . . . 0.0 110.578 174.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.53 -46.79 73.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.703 0.801 . . . . 0.0 111.672 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -67.34 -29.58 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 0.0 112.014 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -76.95 -36.04 56.82 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.266 1.026 . . . . 0.0 113.167 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -80.08 -32.66 39.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.311 1.044 . . . . 0.0 113.365 -175.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.48 131.4 95.07 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 167.84 24.17 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.276 1.984 . . . . 0.0 112.678 -176.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.41 78.22 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.582 -0.699 . . . . 0.0 110.682 169.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -79.68 70.93 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.736 1.215 . . . . 0.0 108.914 171.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -114.29 -3.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.23 112.49 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 124.458 2.628 . . . . 0.0 113.904 174.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.82 6.67 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.154 1.835 . . . . 0.0 111.667 -169.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 t -125.32 162.54 24.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.397 1.879 . . . . 0.0 112.729 178.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.0 159.16 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.169 2.188 . . . . 0.0 112.938 -176.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -142.0 113.99 6.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.589 2.355 . . . . 0.0 107.723 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -62.46 168.81 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.367 2.044 . . . . 0.0 114.245 176.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.96 142.04 51.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.849 2.46 . . . . 0.0 108.442 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -136.13 156.77 48.21 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.289 0.95 . . . . 0.0 112.071 -176.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.08 -177.28 3.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.12 -32.34 64.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.035 1.334 . . . . 0.0 113.462 176.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -84.5 11.39 8.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 0.0 112.404 176.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.44 4.47 24.45 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.184 1.374 . . . . 0.0 114.371 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.22 169.88 11.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.814 1.307 . . . . 0.0 109.071 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -62.56 130.67 46.11 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -57.89 134.07 83.41 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 117.77 -1.109 . . . . 0.0 108.546 174.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.33 -26.07 15.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.037 2.492 . . . . 0.0 115.893 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.35 133.94 48.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.06 1.744 . . . . 0.0 109.142 168.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -121.76 149.28 43.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.632 169.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.27 148.43 43.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.496 0.665 . . . . 0.0 112.332 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.22 77.51 1.05 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.643 1.977 . . . . 0.0 107.81 -178.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -37.1 -54.54 1.53 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 127.6 2.524 . . . . 0.0 115.619 -169.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.6 p -63.79 -12.35 34.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -116.76 -5.6 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.343 1.057 . . . . 0.0 112.278 169.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.55 10.43 70.92 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.286 1.898 . . . . 0.0 115.246 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -83.41 155.7 23.34 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.621 1.21 . . . . 0.0 111.293 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.1 m -138.25 164.84 28.22 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.033 0.933 . . . . 0.0 112.423 170.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -148.94 164.03 35.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.595 1.958 . . . . 0.0 109.229 169.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.06 153.62 20.85 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.49 157.83 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 124.33 1.052 . . . . 0.0 111.595 173.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -77.81 160.77 73.56 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.28 -21.25 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.844 3.029 . . . . 0.0 117.358 -170.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.65 -3.0 58.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.792 1.637 . . . . 0.0 114.716 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.97 1.36 56.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.301 1.429 . . . . 0.0 114.899 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -71.31 117.45 12.86 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.134 1.467 . . . . 0.0 110.146 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -56.15 137.16 52.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.7 110.38 24.62 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.27 150.26 11.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.863 3.042 . . . . 0.0 114.408 -171.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.93 3.6 0.5 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.283 1.833 . . . . 0.0 115.585 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -73.71 -28.04 61.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.171 1.351 . . . . 0.0 110.926 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.88 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.695 1.998 . . . . 0.0 111.774 -176.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.5 m -136.13 164.22 28.55 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.079 1.352 . . . . 0.0 112.999 -168.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -4.75 0.81 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 130.03 3.332 . . . . 0.0 115.295 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.07 -175.77 41.12 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.592 1.567 . . . . 0.0 112.986 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -56.19 161.15 2.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.091 2.156 . . . . 0.0 113.698 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 171.03 20.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.751 1.221 . . . . 0.0 111.294 174.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -89.31 68.78 8.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.396 1.878 . . . . 0.0 110.488 -168.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.546 0.827 0 CA-C-O 121.803 0.811 . . . . 0.0 112.003 174.752 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.556 0.694 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -142.31 168.11 20.51 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.844 2.858 . . . . 0.0 108.695 177.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -52.17 -39.53 60.19 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 0.0 112.734 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -59.62 -61.46 2.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.603 0.761 . . . . 0.0 111.518 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.45 -31.22 71.16 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -61.24 -58.58 7.69 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.701 1.6 . . . . 0.0 110.517 170.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.79 -43.87 81.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.45 0.568 . . . . 0.0 111.954 177.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.29 -36.39 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.617 0.644 . . . . 0.0 111.712 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -68.68 -45.35 71.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.884 0.874 . . . . 0.0 112.353 173.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -77.81 -26.24 49.42 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.581 1.152 . . . . 0.0 113.47 -176.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.98 94.98 19.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.975 1.71 . . . . 0.0 108.06 179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.89 154.06 58.38 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.055 1.836 . . . . 0.0 109.994 169.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.51 -36.04 66.26 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.45 73.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 109.059 178.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.633 ' CE1' ' H ' ' A' ' 19' ' ' PHE . 7.0 p80 -132.67 151.09 77.51 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 112.826 175.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.9 155.19 69.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.382 2.721 . . . . 0.0 110.94 171.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.8 40.66 72.73 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -169.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 107.99 0.17 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.2 2.6 . . . . 0.0 114.487 -168.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.633 ' H ' ' CE1' ' A' ' 15' ' ' HIS . 2.4 t80 -152.64 89.1 1.38 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 130.654 3.582 . . . . 0.0 108.084 172.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -84.56 124.52 73.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.04 175.0 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.578 1.518 . . . . 0.0 111.118 169.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.08 153.67 36.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.688 1.195 . . . . 0.0 111.759 177.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.8 m -132.84 158.59 42.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 113.021 -169.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -95.76 -178.93 4.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.263 1.425 . . . . 0.0 113.698 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -62.43 -10.38 11.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -100.68 8.24 43.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.408 1.883 . . . . 0.0 111.619 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.62 6.07 27.14 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.963 1.268 . . . . 0.0 114.434 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -90.23 164.75 14.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.543 1.537 . . . . 0.0 108.876 178.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -61.35 132.62 54.11 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.851 -0.53 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.43 139.36 85.0 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.873 175.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.45 -21.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.292 3.328 . . . . 0.0 117.374 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.98 135.63 53.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.656 1.982 . . . . 0.0 109.37 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.81 151.74 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.654 1.181 . . . . 0.0 109.11 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 76.2 m -140.65 120.42 13.45 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.342 1.057 . . . . 0.0 113.238 -172.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.38 72.92 9.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.427 1.108 . . . . 0.0 108.416 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -42.49 -47.95 5.79 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.708 2.099 . . . . 0.0 115.133 -169.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 p -60.95 -14.44 22.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.7 pt -118.7 -6.91 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 120.016 1.28 . . . . 0.0 113.083 170.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.8 -3.74 86.74 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.194 1.854 . . . . 0.0 115.342 176.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -83.55 117.66 23.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.363 1.581 . . . . 0.0 112.083 -173.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.9 m -102.18 158.54 16.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.424 1.089 . . . . 0.0 110.262 168.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.19 162.37 39.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.513 1.525 . . . . 0.0 109.499 171.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.1 m -86.39 154.38 21.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.3 157.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.118 0.961 . . . . 0.0 113.298 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.12 163.29 58.27 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.97 -24.13 46.77 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.495 2.797 . . . . 0.0 115.829 -169.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -81.45 -7.84 59.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.266 2.226 . . . . 0.0 114.766 176.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.22 59.45 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.2 1.381 . . . . 0.0 115.438 -178.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.0 m -70.91 132.31 45.04 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.907 1.854 . . . . 0.0 109.937 177.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.1 141.93 57.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.274 1.029 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -82.34 115.37 57.53 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -44.08 133.44 8.63 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.779 3.652 . . . . 0.0 116.262 -169.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 59.5 15.15 4.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.731 2.013 . . . . 0.0 115.719 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.4 p -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.197 170.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.363 0.0 OUTLIER -57.99 110.73 0.98 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.027 1.285 . . . . 0.0 113.232 -170.503 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.3 t -148.65 153.54 38.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.792 1.637 . . . . 0.0 110.398 -170.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -80.31 28.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.166 1.386 . . . . 0.0 114.333 -171.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.35 169.05 35.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.387 1.946 . . . . 0.0 112.598 171.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -63.92 165.3 8.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.734 1.214 . . . . 0.0 112.781 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 164.12 38.65 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.017 0.927 . . . . 0.0 111.333 172.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -83.45 62.88 7.01 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.159 1.784 . . . . 0.0 111.976 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.206 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.543 0.673 0 CA-C-O 120.607 0.241 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.8 p -144.89 167.69 22.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.516 1.927 . . . . 0.0 110.971 -174.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -50.23 -42.39 51.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.785 1.234 . . . . 0.0 113.418 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.08 -61.77 2.16 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.201 0.6 . . . . 0.0 111.127 173.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -58.66 -40.39 83.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.716 1.606 . . . . 0.0 112.265 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.24 -55.86 26.57 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 125.793 1.637 . . . . 0.0 110.344 172.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.68 -44.61 81.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.557 0.617 . . . . 0.0 111.432 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.85 -34.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.629 0.65 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -84.97 3.94 36.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.016 1.726 . . . . 0.0 115.231 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.8 -24.96 1.9 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.276 1.398 . . . . 0.0 114.265 -174.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.14 122.49 75.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.31 0.959 . . . . 0.0 109.166 176.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.54 172.48 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.302 2.002 . . . . 0.0 111.657 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -22.14 66.69 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.653 -0.654 . . . . 0.0 112.278 169.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.09 67.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.164 1.386 . . . . 0.0 109.184 169.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.5 92.65 44.13 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.102 1.361 . . . . 0.0 110.28 175.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.58 115.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.771 3.647 . . . . 0.0 114.994 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.9 51.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.174 1.368 . . . . 0.0 114.86 -177.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.261 92.0 p 69.16 107.08 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.274 3.029 . . . . 0.0 116.097 -176.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -138.44 136.21 35.99 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.968 1.707 . . . . 0.0 109.392 168.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -144.47 135.35 12.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 126.406 1.882 . . . . 0.0 106.086 169.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.9 163.57 38.72 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 120.63 1.261 . . . . 0.0 111.224 177.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -122.82 147.05 46.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.954 1.702 . . . . 0.0 109.469 177.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.4 m -136.61 156.53 48.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 111.848 -171.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -102.8 179.25 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.732 1.213 . . . . 0.0 114.162 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.21 -12.04 17.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 177.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -97.04 8.27 44.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.239 1.816 . . . . 0.0 111.696 175.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 8.81 35.38 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.706 1.146 . . . . 0.0 114.034 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.33 165.6 13.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.582 1.553 . . . . 0.0 108.85 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -62.17 132.52 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.09 135.74 87.88 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.8 -1.095 . . . . 0.0 108.258 174.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.07 -15.44 7.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.332 2.688 . . . . 0.0 116.887 -176.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.26 137.59 51.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.951 2.1 . . . . 0.0 109.891 171.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -131.9 152.42 51.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.853 1.261 . . . . 0.0 109.471 170.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.2 m -143.59 158.12 43.9 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.39 1.076 . . . . 0.0 112.353 -178.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 113.46 12.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.997 2.119 . . . . 0.0 108.93 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.04 -80.91 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 127.562 2.506 . . . . 0.0 117.274 -168.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 m -64.43 -18.73 65.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -168.34 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 pt -92.61 -3.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 10.83 59.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.597 1.57 . . . . 0.0 114.948 174.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -94.78 146.6 24.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.231 1.015 . . . . 0.0 113.445 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.9 m -130.86 156.45 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.509 1.523 . . . . 0.0 108.53 165.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.39 161.33 41.24 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.49 1.516 . . . . 0.0 108.781 172.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.8 m -86.8 152.69 22.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.82 156.66 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 110.019 170.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -73.68 161.19 79.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 166.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.54 -26.55 22.47 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.329 2.686 . . . . 0.0 115.389 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -76.46 -8.12 56.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.296 1.839 . . . . 0.0 115.374 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.69 -3.86 56.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.745 1.641 . . . . 0.0 115.266 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 m -73.56 119.79 18.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.059 1.43 . . . . 0.0 110.439 -177.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -56.82 132.14 51.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.719 1.207 . . . . 0.0 113.758 176.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.39 109.33 18.84 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.92 1.688 . . . . 0.0 107.639 169.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.44 163.51 26.6 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.556 2.171 . . . . 0.0 111.871 -175.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 61.2 -3.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.772 2.029 . . . . 0.0 115.74 -175.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.2 p -72.38 -28.84 63.27 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.994 1.27 . . . . 0.0 110.989 169.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -40.35 102.91 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.603 2.361 . . . . 0.0 113.103 -173.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -133.51 161.79 33.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.118 0.967 . . . . 0.0 111.627 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -71.95 17.55 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 130.17 3.388 . . . . 0.0 113.777 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.82 40.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.669 2.081 . . . . 0.0 112.178 -171.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -61.21 162.45 7.5 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.654 1.581 . . . . 0.0 114.193 -172.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 163.75 36.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.066 1.346 . . . . 0.0 110.827 171.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.06 57.69 3.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.17 2.188 . . . . 0.0 112.496 -168.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 122.845 1.307 . . . . 0.0 112.078 -173.346 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 p -129.77 175.07 9.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.778 1.231 . . . . 0.0 112.717 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -51.02 -33.44 25.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.661 1.184 . . . . 0.0 112.31 172.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.1 t -61.33 -60.2 4.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.307 0.503 . . . . 0.0 110.653 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -55.68 -38.7 69.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.53 -58.22 9.42 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.087 0.955 . . . . 0.0 110.654 173.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.59 -40.84 88.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.385 0.539 . . . . 0.0 112.41 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -69.03 -28.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.036 0.934 . . . . 0.0 112.243 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -73.43 -48.44 33.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.69 0.796 . . . . 0.0 111.955 169.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -73.62 -33.75 64.7 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.846 1.259 . . . . 0.0 113.251 -175.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.8 mt -97.43 101.06 9.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.42 173.54 14.07 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.698 2.265 . . . . 0.0 111.902 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.22 -20.26 17.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.408 1.083 . . . . 0.0 113.808 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.41 76.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.124 1.37 . . . . 0.0 107.987 169.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -111.67 71.87 0.98 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.135 1.374 . . . . 0.0 111.354 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.78 119.44 6.7 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.833 3.022 . . . . 0.0 112.391 -169.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 53.37 8.62 0.81 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.444 1.974 . . . . 0.0 115.313 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -108.57 159.89 16.35 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.649 1.579 . . . . 0.0 112.39 -167.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -77.61 148.39 35.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.842 0.457 . . . . 0.0 110.751 173.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -138.28 125.03 13.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.318 1.847 . . . . 0.0 107.723 169.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -70.33 174.34 10.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.103 1.868 . . . . 0.0 113.427 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -135.41 143.88 46.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.016 2.126 . . . . 0.0 110.236 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.77 164.24 29.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.433 1.893 . . . . 0.0 110.643 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -120.99 178.38 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.041 0.936 . . . . 0.0 113.068 169.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -62.93 -11.95 22.07 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.571 1.548 . . . . 0.0 114.682 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -87.49 1.3 53.89 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.231 0.469 . . . . 0.0 111.901 173.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.45 -1.01 88.55 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.857 1.694 . . . . 0.0 114.353 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -86.71 165.18 16.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.481 1.113 . . . . 0.0 110.629 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -64.85 130.31 42.98 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 167.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -55.2 135.35 68.59 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.63 -7.01 16.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.153 1.902 . . . . 0.0 114.854 -168.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.12 135.97 53.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.555 1.942 . . . . 0.0 108.135 168.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -130.8 153.11 49.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.469 1.107 . . . . 0.0 108.977 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -140.53 156.88 46.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.145 0.978 . . . . 0.0 112.008 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.02 102.38 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.383 1.073 . . . . 0.0 111.24 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.44 -41.0 62.7 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.99 1.281 . . . . 0.0 114.946 -175.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 m -62.32 -17.88 59.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.004 1.402 . . . . 0.0 114.652 -176.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -112.83 -2.47 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.389 . . . . 0.0 112.313 171.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.58 20.72 74.13 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.9 1.238 . . . . 0.0 114.438 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -118.54 161.41 20.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.939 1.369 . . . . 0.0 113.724 -170.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.2 m -132.36 159.15 40.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.993 2.117 . . . . 0.0 109.742 167.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -145.71 160.93 41.01 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.169 1.387 . . . . 0.0 109.248 171.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.6 m -88.34 152.9 21.61 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.65 154.59 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.752 1.221 . . . . 0.0 110.942 172.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -74.82 164.82 58.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 167.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -50.86 -28.54 23.84 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.473 2.782 . . . . 0.0 115.758 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -78.59 -6.93 56.93 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.236 2.215 . . . . 0.0 115.459 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.28 -3.27 63.85 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.914 1.245 . . . . 0.0 115.458 177.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.2 m -73.4 131.73 42.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.929 1.365 . . . . 0.0 109.402 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -59.18 142.54 51.41 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.03 110.1 21.25 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -47.67 142.96 13.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.011 3.141 . . . . 0.0 115.334 -169.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 61.09 8.65 2.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.56 1.944 . . . . 0.0 115.225 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -27.58 63.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.037 1.29 . . . . 0.0 110.919 172.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.549 HH21 ' NH2' ' A' ' 57' ' ' ARG . 1.7 ptm180 -41.17 93.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.343 2.257 . . . . 0.0 114.363 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -127.78 163.44 24.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.17 1.788 . . . . 0.0 112.083 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -69.2 9.05 0.48 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.577 2.751 . . . . 0.0 113.318 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.37 -179.83 47.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.979 1.752 . . . . 0.0 112.658 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -65.19 167.31 8.37 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.156 1.782 . . . . 0.0 114.008 -174.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 167.08 31.54 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.074 1.35 . . . . 0.0 111.359 176.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -78.63 53.63 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.129 2.571 . . . . 0.0 113.196 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 122.916 1.341 . . . . 0.0 114.576 -169.315 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.29 0.09 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 p -83.53 170.08 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -173.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.9 -39.26 62.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.705 1.202 . . . . 0.0 112.684 170.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.9 t -61.22 -59.2 5.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.722 0.809 . . . . 0.0 110.677 171.231 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -59.95 -34.82 73.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.6 0.76 . . . . 0.0 112.595 -176.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.26 -59.29 5.64 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.765 1.626 . . . . 0.0 110.774 170.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.36 -44.99 76.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.183 0.447 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.63 -28.85 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.134 0.974 . . . . 0.0 112.136 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -83.0 3.02 31.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.664 1.586 . . . . 0.0 114.231 169.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -124.17 -33.66 3.05 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.689 1.131 . . . . 0.0 111.976 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.73 102.78 8.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 168.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.34 166.38 29.47 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.545 2.164 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.0 56.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.21 63.57 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.512 1.125 . . . . 0.0 109.272 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -93.52 -5.94 0.11 Allowed Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -178.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -42.39 126.8 4.05 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.726 2.951 . . . . 0.0 115.305 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.99 -23.75 33.57 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.106 1.813 . . . . 0.0 112.401 -169.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.0 p -123.02 159.44 28.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.594 1.558 . . . . 0.0 113.086 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -87.72 106.27 17.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.277 1.031 . . . . 0.0 111.291 175.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -91.76 118.39 68.27 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.97 174.75 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.356 2.037 . . . . 0.0 114.032 175.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -134.55 142.38 46.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.252 1.821 . . . . 0.0 109.94 175.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -137.54 157.67 46.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.802 1.641 . . . . 0.0 109.668 -177.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.24 -177.4 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 171.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -58.03 -22.94 52.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.478 1.511 . . . . 0.0 113.704 -174.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -84.96 -1.14 56.36 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.473 0.579 . . . . 0.0 111.916 176.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.87 86.6 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.892 1.711 . . . . 0.0 114.521 178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.85 160.74 28.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.628 1.714 . . . . 0.0 109.538 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.67 130.42 46.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.83 143.07 77.69 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.75 -17.3 52.18 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.814 . . . . 0.0 113.575 -169.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.07 137.63 44.77 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.705 2.002 . . . . 0.0 108.63 169.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -128.4 150.36 50.14 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.667 1.187 . . . . 0.0 109.414 169.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.4 m -140.99 151.98 44.56 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.972 0.909 . . . . 0.0 111.959 -177.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.36 78.46 1.81 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.795 2.038 . . . . 0.0 107.865 177.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.96 -34.86 58.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.228 0.918 . . . . 0.0 114.334 -170.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -63.72 -15.23 57.97 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -114.31 -0.25 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.646 1.178 . . . . 0.0 111.974 169.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.4 58.23 13.33 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.585 1.088 . . . . 0.0 111.351 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -140.7 154.31 46.3 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.6 m -142.28 160.19 40.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.4 1.88 . . . . 0.0 110.166 167.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -150.08 163.13 38.98 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.881 1.672 . . . . 0.0 109.113 173.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.8 m -89.28 153.09 21.17 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.54 152.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.307 1.043 . . . . 0.0 110.543 171.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.86 162.52 73.71 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 166.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.14 -20.1 29.73 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.586 2.857 . . . . 0.0 116.167 -170.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -83.57 -8.79 59.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.485 2.314 . . . . 0.0 114.67 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.06 -0.93 54.8 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.471 1.51 . . . . 0.0 115.269 -177.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -70.88 115.79 10.42 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.856 1.828 . . . . 0.0 110.342 178.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -54.83 135.3 47.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.836 1.254 . . . . 0.0 112.863 175.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.49 111.7 33.65 Favored Pre-proline 0 C--O 1.242 0.709 0 C-N-CA 125.509 1.524 . . . . 0.0 108.075 172.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -50.97 150.58 12.94 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.647 2.898 . . . . 0.0 113.653 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 59.86 2.24 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.404 1.882 . . . . 0.0 115.933 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p -72.85 -32.4 65.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.297 1.408 . . . . 0.0 110.565 169.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -45.27 103.86 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.335 1.854 . . . . 0.0 112.41 -172.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m -135.48 167.86 20.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.553 1.541 . . . . 0.0 110.14 -171.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -79.67 13.35 2.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -178.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.98 -178.16 47.27 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.744 2.116 . . . . 0.0 112.476 -172.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -62.69 162.94 9.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.466 1.506 . . . . 0.0 114.227 -172.002 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 169.12 22.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.135 1.774 . . . . 0.0 110.332 171.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -74.0 39.88 0.12 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.776 2.83 . . . . 0.0 114.747 -168.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.534 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.746 0.307 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -82.73 167.15 18.46 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.976 0.91 . . . . 0.0 111.235 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -53.47 -42.38 67.18 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.721 -0.612 . . . . 0.0 112.168 171.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.8 t -55.88 -61.4 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.444 0.697 . . . . 0.0 110.688 172.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -56.42 -43.19 79.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.682 1.193 . . . . 0.0 112.744 -178.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -56.43 -53.92 51.75 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.63 1.172 . . . . 0.0 110.706 172.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.15 -41.49 83.85 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.616 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 4' ' ' CYS . 1.6 t -63.84 -35.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.563 1.074 . . . . 0.0 111.365 175.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -83.28 6.3 20.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.362 1.865 . . . . 0.0 114.733 176.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.44 -37.39 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.704 1.202 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.61 118.72 67.53 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.691 1.596 . . . . 0.0 106.76 172.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.54 168.02 23.34 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.672 2.248 . . . . 0.0 111.849 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.78 -23.63 53.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.277 1.031 . . . . 0.0 113.723 173.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.97 75.39 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.037 1.335 . . . . 0.0 108.549 172.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -118.73 62.04 5.16 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.333 1.053 . . . . 0.0 113.737 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.28 119.42 6.4 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.068 2.512 . . . . 0.0 110.575 172.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.91 88.07 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.389 -0.673 . . . . 0.0 114.465 -177.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -138.38 -179.4 5.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.376 1.47 . . . . 0.0 110.275 174.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -131.39 145.72 51.95 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.102 -0.999 . . . . 0.0 113.008 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -123.92 113.59 28.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.234 2.214 . . . . 0.0 108.295 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.65 161.33 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.694 1.596 . . . . 0.0 112.629 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -118.67 152.72 35.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.894 1.678 . . . . 0.0 109.747 169.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -131.27 151.57 51.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.762 1.225 . . . . 0.0 111.681 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.92 179.59 7.77 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.047 1.339 . . . . 0.0 112.362 173.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -61.37 -17.51 54.34 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -173.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.01 -2.03 58.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.51 1.124 . . . . 0.0 112.464 174.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.87 1.66 84.85 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.608 1.099 . . . . 0.0 113.853 -171.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.57 151.52 34.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.132 1.466 . . . . 0.0 109.072 175.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -51.28 129.92 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 111.281 175.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.62 131.18 77.64 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 117.888 -1.053 . . . . 0.0 108.368 171.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.43 -35.75 36.92 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.677 2.918 . . . . 0.0 114.53 -177.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.91 140.45 33.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.769 1.628 . . . . 0.0 109.898 169.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -126.52 143.52 51.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.226 1.41 . . . . 0.0 108.695 169.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.3 m -139.35 144.98 38.47 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.923 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -113.07 93.27 4.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 110.712 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.97 -9.22 26.89 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.2 p -68.65 -26.33 65.27 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.77 1.785 . . . . 0.0 112.538 169.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -125.56 -16.07 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.948 1.699 . . . . 0.0 112.853 -178.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.12 89.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.497 1.046 . . . . 0.0 114.578 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -81.93 154.4 25.79 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.21 1.005 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.4 m -134.55 165.34 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.018 1.327 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -153.26 165.0 37.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.125 1.77 . . . . 0.0 109.415 169.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 83.3 m -91.86 152.38 20.12 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 169.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.38 159.62 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.142 0.977 . . . . 0.0 113.377 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -92.68 164.85 20.68 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.059 2.143 . . . . 0.0 110.389 168.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -57.72 -5.83 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.749 3.633 . . . . 0.0 118.545 -172.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -103.59 -5.48 22.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.129 1.371 . . . . 0.0 113.865 172.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.46 0.58 55.59 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.797 1.665 . . . . 0.0 114.663 -177.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 m -69.77 128.08 35.18 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.886 1.343 . . . . 0.0 108.497 178.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.84 163.4 27.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.48 100.49 2.76 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 167.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.31 22.57 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.858 1 C-N-CA 125.895 4.396 . . . . 0.0 118.054 -166.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.85 -3.21 7.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.409 1.884 . . . . 0.0 112.398 168.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.5 p -92.98 -10.98 34.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.441 1.096 . . . . 0.0 113.246 178.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.51 96.5 0.08 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.157 0.983 . . . . 0.0 110.224 -173.424 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.0 t -134.57 163.07 30.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -168.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -1.9 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.727 2.811 . . . . 0.0 114.017 -169.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.82 -171.04 40.04 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.071 1.796 . . . . 0.0 112.75 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.91 152.22 13.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.494 1.917 . . . . 0.0 114.505 -170.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.43 171.76 19.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.012 1.725 . . . . 0.0 109.502 169.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -116.43 78.12 1.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 0.0 110.824 -168.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 126.25 1.82 . . . . 0.0 113.066 -179.474 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.648 0.737 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -142.13 169.15 18.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.576 2.75 . . . . 0.0 108.823 176.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -51.59 -40.14 59.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 112.87 179.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.1 -62.36 1.94 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.598 0.759 . . . . 0.0 111.517 170.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -59.93 -31.03 69.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.673 0.789 . . . . 0.0 113.006 -176.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -62.11 -58.17 8.82 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.264 1.426 . . . . 0.0 110.509 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -58.31 -38.94 78.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.875 0.762 . . . . 0.0 112.623 177.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.97 -31.22 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.772 0.829 . . . . 0.0 112.223 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 m -72.55 -43.99 62.73 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.926 0.89 . . . . 0.0 112.233 171.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.05 -33.71 57.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 113.413 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.9 mt -99.55 101.56 13.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.75 1.62 . . . . 0.0 106.889 172.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.16 172.59 16.06 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.742 2.295 . . . . 0.0 112.148 -177.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.07 -23.15 31.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.309 1.043 . . . . 0.0 113.355 171.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -76.19 70.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.198 1.399 . . . . 0.0 109.29 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -122.36 24.93 0.11 Allowed Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -62.22 114.69 2.44 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.754 2.303 . . . . 0.0 112.13 -173.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.64 -17.2 30.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.013 1.768 . . . . 0.0 112.956 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.1 t -119.71 177.98 4.75 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.635 1.974 . . . . 0.0 111.646 177.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -94.24 157.69 15.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.252 2.621 . . . . 0.0 110.865 176.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -143.24 129.95 10.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 0.0 108.378 169.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.67 170.53 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.9 1.734 . . . . 0.0 113.221 177.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -137.7 145.63 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.477 3.111 . . . . 0.0 110.368 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -134.07 157.62 45.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.962 0.905 . . . . 0.0 112.504 -174.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -95.52 173.22 7.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.446 1.499 . . . . 0.0 112.798 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -62.43 -13.99 35.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.21 6.41 40.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.105 2.162 . . . . 0.0 111.379 175.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.55 5.78 38.69 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.643 1.592 . . . . 0.0 114.416 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -91.18 164.68 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.431 1.492 . . . . 0.0 109.289 178.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -64.7 130.74 44.71 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.7 138.61 77.25 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.988 176.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -48.12 -31.88 17.49 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.158 3.239 . . . . 0.0 116.13 -177.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.67 139.6 39.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 171.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -129.36 147.26 51.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.218 1.407 . . . . 0.0 108.871 169.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -139.15 125.48 20.28 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.4 68.17 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.3 168.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.21 -30.21 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.312 1.434 . . . . 0.0 114.409 -172.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 m -53.34 -24.87 13.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 173.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -122.03 10.16 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.963 1.705 . . . . 0.0 111.934 173.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.78 3.64 68.39 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.505 1.526 . . . . 0.0 115.006 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -81.59 149.51 28.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.206 1.503 . . . . 0.0 112.128 -169.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.2 m -138.42 160.6 39.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 111.43 168.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -150.71 163.5 38.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.154 1.782 . . . . 0.0 108.831 169.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.1 m -90.45 154.78 19.39 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 169.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.28 159.82 42.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.129 0.972 . . . . 0.0 111.363 175.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.77 159.98 72.81 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 165.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -24.32 31.7 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.627 2.884 . . . . 0.0 115.824 -173.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -78.22 -6.74 55.8 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.182 2.193 . . . . 0.0 115.289 174.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.92 56.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.594 1.569 . . . . 0.0 115.237 178.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -72.25 119.3 16.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.893 1.346 . . . . 0.0 109.984 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -59.28 144.88 45.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.739 1.215 . . . . 0.0 113.662 177.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.25 96.55 0.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.73 2.012 . . . . 0.0 106.239 168.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.81 24.01 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.853 1 C-N-CA 125.789 4.326 . . . . 0.0 117.26 -166.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -125.04 -1.25 7.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.149 1.78 . . . . 0.0 112.594 169.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -92.96 -14.41 27.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.047 0.939 . . . . 0.0 113.171 176.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -57.1 107.88 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.069 0.948 . . . . 0.0 112.102 -171.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 t -132.81 158.94 41.2 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.83 1.252 . . . . 0.0 112.374 -171.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 7.72 0.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 128.339 2.656 . . . . 0.0 113.408 169.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.65 -172.42 43.72 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.817 1.199 . . . . 0.0 114.099 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -58.11 154.11 13.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.67 2.388 . . . . 0.0 115.353 -169.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.87 158.39 37.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.063 1.345 . . . . 0.0 110.494 168.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.45 69.65 3.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.592 1.157 . . . . 0.0 110.577 -169.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.928 1.691 . . . . 0.0 113.938 -173.653 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 123.245 1.498 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.6 p -142.76 172.19 13.03 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 130.675 3.59 . . . . 0.0 112.483 -172.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.33 -39.71 32.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 0.0 111.991 169.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -58.71 -62.97 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.434 0.561 . . . . 0.0 110.949 175.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -62.45 -30.54 71.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.62 -58.59 7.49 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.118 1.367 . . . . 0.0 110.764 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -53.31 -48.14 68.67 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.639 0.775 . . . . 0.0 111.136 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.86 -26.3 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.412 1.085 . . . . 0.0 112.639 177.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -89.32 3.22 52.83 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.417 1.487 . . . . 0.0 114.652 171.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -130.93 -29.95 1.84 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.888 1.222 . . . . 0.0 113.905 -173.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.78 116.85 64.0 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.632 0.773 . . . . 0.0 109.105 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -70.16 162.92 40.5 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.877 1.718 . . . . 0.0 111.147 176.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.13 67.67 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.675 -0.641 . . . . 0.0 112.248 170.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -76.81 71.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.277 1.431 . . . . 0.0 109.15 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -114.73 30.19 0.12 Allowed Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 170.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.13 113.48 2.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.491 2.794 . . . . 0.0 112.173 -170.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.99 -16.34 27.92 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.093 1.806 . . . . 0.0 112.765 -174.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -115.93 171.93 7.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.67 1.588 . . . . 0.0 112.443 178.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -88.42 160.33 17.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.86 2.864 . . . . 0.0 111.611 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -141.96 123.16 8.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.08 0.952 . . . . 0.0 110.638 169.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.97 174.83 12.21 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.96 2.44 . . . . 0.0 113.525 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -140.2 149.46 42.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.335 2.254 . . . . 0.0 109.835 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -144.25 160.76 40.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.563 0.745 . . . . 0.0 112.437 -175.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -85.22 176.06 8.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.552 168.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.52 -29.49 66.33 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.319 1.047 . . . . 0.0 112.469 174.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -83.58 14.15 4.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.265 2.226 . . . . 0.0 111.92 -175.046 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.94 8.53 49.43 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.309 1.433 . . . . 0.0 114.43 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -91.42 146.65 23.63 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.562 1.181 . . . . 0.0 109.214 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -62.43 126.13 26.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.056 0.942 . . . . 0.0 108.919 177.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.3 143.73 79.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.386 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -50.22 -22.5 8.37 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.2 3.267 . . . . 0.0 117.489 -174.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.26 137.24 52.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.47 1.908 . . . . 0.0 109.598 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -130.68 147.2 52.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.846 1.259 . . . . 0.0 109.63 173.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -135.77 122.43 20.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -172.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.13 70.56 10.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.749 1.619 . . . . 0.0 108.057 169.034 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.31 -33.35 31.41 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.343 1.449 . . . . 0.0 114.562 -172.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m -54.73 -24.61 23.0 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 175.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -118.62 6.46 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.301 1.44 . . . . 0.0 112.022 174.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.94 67.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.299 1.428 . . . . 0.0 114.665 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -90.6 150.22 21.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.124 1.462 . . . . 0.0 112.121 -174.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.9 m -134.44 160.51 37.76 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.427 1.491 . . . . 0.0 110.078 168.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -144.45 163.21 34.47 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.169 1.787 . . . . 0.0 109.284 169.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.75 151.71 23.63 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 169.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.25 155.43 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.061 0.945 . . . . 0.0 111.307 172.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.57 159.91 76.01 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.3 -24.44 15.69 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.935 3.09 . . . . 0.0 117.102 -172.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -82.68 -4.77 58.29 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 175.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.77 -0.08 52.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.632 1.587 . . . . 0.0 114.772 -178.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.6 m -70.66 113.93 8.25 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.152 1.476 . . . . 0.0 110.222 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -55.61 136.7 50.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.06 109.76 19.21 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.3 156.48 50.73 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.729 2.286 . . . . 0.0 112.109 -169.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 m120 59.5 2.0 0.3 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.114 1.765 . . . . 0.0 115.52 -175.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -71.35 -30.95 66.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.639 1.563 . . . . 0.0 110.699 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.664 ' NH2' HH12 ' A' ' 57' ' ' ARG 0.279 0.0 OUTLIER -46.65 120.62 3.04 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 123.524 0.729 . . . . 0.0 111.98 -172.506 . . . . . . . . 4 4 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.9 m -151.87 164.73 36.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.784 1.233 . . . . 0.0 111.134 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.664 HH12 ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.98 17.29 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.337 2.655 . . . . 0.0 112.717 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.91 179.78 45.98 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.756 1.646 . . . . 0.0 112.745 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -67.0 167.04 12.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.759 1.623 . . . . 0.0 113.417 -176.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 166.69 32.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.789 1.236 . . . . 0.0 111.353 174.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.36 61.25 4.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.831 2.452 . . . . 0.0 112.289 -168.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.905 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.4 p -84.69 165.73 17.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.359 1.064 . . . . 0.0 112.71 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -51.6 -40.66 60.25 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.726 1.211 . . . . 0.0 113.029 172.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.01 -56.49 16.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.041 -0.412 . . . . 0.0 111.142 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.66 -31.24 69.36 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.41 -61.79 2.29 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.016 1.326 . . . . 0.0 110.082 169.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.67 -37.77 82.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.416 0.553 . . . . 0.0 112.461 -176.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.54 -27.44 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.568 1.147 . . . . 0.0 112.296 175.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -74.43 -41.39 60.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.587 -0.696 . . . . 0.0 111.47 168.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -69.29 -41.92 76.16 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.977 1.311 . . . . 0.0 112.8 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.71 108.95 18.55 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.61 167.29 27.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.915 1.744 . . . . 0.0 111.716 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.55 35.57 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.17 74.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.347 1.459 . . . . 0.0 108.272 169.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -112.98 65.53 0.92 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.965 1.306 . . . . 0.0 111.774 176.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -60.23 121.11 9.27 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.702 2.934 . . . . 0.0 111.734 -171.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.95 13.51 2.25 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.623 1.583 . . . . 0.0 114.98 -174.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.1 m -115.43 161.57 18.37 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.677 1.991 . . . . 0.0 112.373 -167.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -79.55 149.2 31.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.315 0.646 . . . . 0.0 111.513 179.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -144.79 127.64 8.39 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 108.624 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.45 168.52 17.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.581 1.52 . . . . 0.0 113.928 178.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -130.85 150.62 51.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.076 2.55 . . . . 0.0 110.867 173.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -128.93 155.54 45.15 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.552 1.141 . . . . 0.0 112.238 -175.202 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -90.76 176.84 6.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.59 1.556 . . . . 0.0 113.272 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.33 -16.13 31.97 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.86 9.56 38.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.186 1.795 . . . . 0.0 111.697 175.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 5.57 33.0 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.475 1.512 . . . . 0.0 114.432 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.63 166.17 13.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.839 1.256 . . . . 0.0 108.88 178.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -59.81 130.58 47.48 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.817 -0.552 . . . . 0.0 109.976 178.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.3 125.87 59.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.555 173.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.62 -18.57 6.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.641 2.894 . . . . 0.0 116.982 -175.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -111.48 135.31 52.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.655 1.982 . . . . 0.0 108.976 169.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -129.69 154.02 47.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.531 1.133 . . . . 0.0 109.127 169.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.6 m -141.22 159.35 42.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.939 0.895 . . . . 0.0 111.528 178.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.68 90.17 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.789 1.236 . . . . 0.0 109.904 175.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.11 -48.02 26.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.286 1.898 . . . . 0.0 116.052 -169.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -64.91 -13.41 56.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.095 1.447 . . . . 0.0 114.616 -175.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 pt -116.36 -0.45 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 112.812 170.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.01 4.43 55.4 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.867 1.699 . . . . 0.0 115.399 175.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -84.76 148.56 26.29 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.227 1.013 . . . . 0.0 112.811 -176.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.6 m -132.13 159.27 39.41 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.03 1.332 . . . . 0.0 109.75 166.629 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.1 p90 -151.76 160.92 43.41 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.318 1.447 . . . . 0.0 109.228 173.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.2 m -88.86 153.13 21.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 169.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.76 149.6 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.669 1.188 . . . . 0.0 110.587 175.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -70.22 155.96 92.6 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 165.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -14.56 38.27 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.796 2.331 . . . . 0.0 115.743 -169.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -78.34 -10.97 59.9 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.9 1.68 . . . . 0.0 114.204 171.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.21 -1.35 47.09 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.049 1.785 . . . . 0.0 115.183 -177.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.3 m -73.85 116.16 14.14 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.556 1.678 . . . . 0.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -57.11 145.02 32.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.699 1.2 . . . . 0.0 113.652 175.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.72 87.52 0.71 Allowed Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -64.27 -17.32 59.25 Favored 'Trans proline' 0 C--N 1.351 0.704 0 N-CA-C 118.169 2.334 . . . . 0.0 118.169 -165.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -68.23 -11.44 59.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.455 1.502 . . . . 0.0 113.184 172.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -90.83 -14.0 32.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.215 172.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -55.64 105.08 0.15 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.32 1.418 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m -133.63 166.19 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.79 1.236 . . . . 0.0 112.96 -168.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -70.12 12.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.105 3.362 . . . . 0.0 114.547 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.68 -176.64 41.14 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.38 1.943 . . . . 0.0 112.625 -172.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -61.27 163.13 6.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.338 1.855 . . . . 0.0 114.425 -171.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.19 165.21 37.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.256 1.422 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.11 63.76 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.084 2.154 . . . . 0.0 111.667 -168.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.237 0.396 0 CA-C-O 122.903 1.335 . . . . 0.0 112.129 -174.732 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.561 0.696 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.9 p -140.9 167.4 22.27 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 128.743 2.817 . . . . 0.0 108.637 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -52.75 -38.77 61.41 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 118.612 0.642 . . . . 0.0 112.169 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.1 t -58.52 -62.45 1.84 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.345 0.658 . . . . 0.0 111.416 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.52 -32.81 71.83 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -61.11 -58.99 6.07 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.432 1.493 . . . . 0.0 110.504 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.3 -39.87 84.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.771 0.714 . . . . 0.0 112.481 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.2 -32.26 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.939 0.896 . . . . 0.0 112.109 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -73.6 -45.26 54.18 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.915 0.886 . . . . 0.0 112.368 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -77.23 -34.06 56.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.045 1.338 . . . . 0.0 113.256 -174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.5 mt -92.58 102.76 7.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.45 167.56 25.0 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.111 1.874 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.24 -21.57 34.95 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.92 47.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 126.397 1.879 . . . . 0.0 111.075 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -88.8 -10.2 0.15 Allowed Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -42.31 114.11 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 124.373 3.382 . . . . 0.0 115.208 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.06 -11.25 22.51 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.698 2.094 . . . . 0.0 112.783 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.9 p -140.03 171.74 13.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.681 1.993 . . . . 0.0 112.364 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -81.67 152.2 27.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 111.233 172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -142.42 127.55 10.28 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.387 1.475 . . . . 0.0 108.685 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.39 176.35 9.36 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.296 1.997 . . . . 0.0 113.447 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -140.32 150.26 43.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.074 2.15 . . . . 0.0 110.005 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.59 157.94 43.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.718 0.807 . . . . 0.0 113.039 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -99.26 179.41 4.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.804 1.642 . . . . 0.0 114.125 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -2.1 0.88 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.934 2.094 . . . . 0.0 114.933 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -122.73 19.35 10.27 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.4 1.88 . . . . 0.0 111.158 173.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.29 5.4 28.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.055 1.312 . . . . 0.0 114.678 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.83 164.39 17.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.076 1.35 . . . . 0.0 108.495 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -62.14 127.55 31.89 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.26 125.55 50.96 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.867 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.25 -8.53 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.023 3.149 . . . . 0.0 118.088 -176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -119.46 127.31 52.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.539 2.335 . . . . 0.0 107.03 167.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -120.74 146.31 46.61 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.343 1.057 . . . . 0.0 109.394 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 90.2 m -135.39 124.12 23.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.694 0.798 . . . . 0.0 112.455 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.19 71.08 10.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.687 1.595 . . . . 0.0 108.034 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.62 -35.87 11.79 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.809 1.671 . . . . 0.0 114.603 -173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 m -54.61 -22.71 14.25 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.901 1.681 . . . . 0.0 115.11 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.67 -0.94 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.881 1.673 . . . . 0.0 112.351 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.07 69.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.104 1.811 . . . . 0.0 115.181 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -84.12 154.13 23.33 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.78 1.29 . . . . 0.0 110.896 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.3 m -137.86 165.31 26.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.719 0.808 . . . . 0.0 111.998 170.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -147.43 162.53 38.83 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.089 1.756 . . . . 0.0 109.378 169.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.8 m -86.05 153.64 21.98 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 168.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.37 156.77 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.741 0.816 . . . . 0.0 111.65 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.07 160.63 77.86 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 165.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.18 -26.48 26.59 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.374 2.716 . . . . 0.0 115.591 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -75.55 -8.27 56.32 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.752 2.021 . . . . 0.0 115.417 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.57 -3.08 59.17 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.386 1.469 . . . . 0.0 115.339 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.9 m -73.66 130.72 40.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.033 1.417 . . . . 0.0 109.727 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.75 139.7 57.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.864 0.865 . . . . 0.0 112.517 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.68 115.52 58.83 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -43.46 134.83 6.76 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.7 3.6 . . . . 0.0 116.062 -169.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 62.88 11.11 4.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.781 2.032 . . . . 0.0 114.755 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -77.7 -22.33 50.63 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.881 1.219 . . . . 0.0 111.724 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.69 103.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.466 1.107 . . . . 0.0 111.814 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -144.92 171.22 14.75 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.948 1.299 . . . . 0.0 113.018 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -3.93 2.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 130.199 3.4 . . . . 0.0 115.421 -173.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.67 -172.87 42.62 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.422 1.487 . . . . 0.0 112.602 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -57.57 164.19 2.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.153 1.781 . . . . 0.0 114.281 -176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.5 167.1 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.105 1.362 . . . . 0.0 110.56 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -85.11 60.76 6.45 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.445 1.898 . . . . 0.0 111.724 -168.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.6 m -68.89 170.79 9.02 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.251 0.548 . . . . 0.0 112.433 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.7 m -65.81 33.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 128.269 2.627 . . . . 0.0 116.34 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.64 4.08 0.12 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.652 2.781 . . . . 0.0 117.221 -169.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 C--N 1.327 -0.399 0 C-N-CA 130.282 3.433 . . . . 0.0 114.038 167.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 120.681 0.277 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.5 p -84.92 166.1 17.09 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.335 1.054 . . . . 0.0 111.994 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -54.95 -35.87 64.7 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.0 t -59.74 -63.31 1.35 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.209 0.459 . . . . 0.0 110.591 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -56.55 -32.24 64.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.887 0.875 . . . . 0.0 113.151 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.34 -59.43 5.29 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.73 1.15 . . . . 0.0 110.665 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -56.96 -42.39 80.05 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.26 0.482 . . . . 0.0 111.763 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.3 -32.23 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.079 0.552 . . . . 0.0 111.896 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m -83.39 6.53 19.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.013 1.725 . . . . 0.0 114.379 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -125.31 -38.18 2.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 0.0 111.561 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mm -85.76 110.14 27.71 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.17 164.01 37.23 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 121.923 1.748 . . . . 0.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.64 -26.11 61.14 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.64 68.44 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.82 1.248 . . . . 0.0 109.002 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -102.46 8.76 0.07 OUTLIER Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -41.86 111.54 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 123.871 3.047 . . . . 0.0 116.007 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.15 -25.57 9.83 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.74 2.591 . . . . 0.0 112.435 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 t -111.48 165.69 11.77 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.481 1.913 . . . . 0.0 112.37 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -76.37 161.85 28.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.304 1.842 . . . . 0.0 107.354 164.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -147.9 125.46 5.78 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 125.428 1.491 . . . . 0.0 108.53 168.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.9 169.62 20.82 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.733 1.622 . . . . 0.0 113.289 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -135.94 143.66 45.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 129.757 3.223 . . . . 0.0 109.75 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -141.43 161.84 36.92 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.37 175.97 5.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.599 1.16 . . . . 0.0 112.896 173.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -63.84 -18.19 63.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.502 1.521 . . . . 0.0 114.429 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -84.48 11.0 9.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.344 1.057 . . . . 0.0 111.753 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.96 8.19 60.7 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.456 1.027 . . . . 0.0 114.12 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -92.1 157.43 16.75 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.88 1.272 . . . . 0.0 109.563 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -66.81 129.49 40.04 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.6 mt -58.41 135.98 85.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.722 -1.132 . . . . 0.0 108.805 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -53.67 -17.98 11.07 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.443 2.762 . . . . 0.0 117.377 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.19 137.02 50.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.755 2.022 . . . . 0.0 109.157 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -131.1 152.53 50.3 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.596 1.158 . . . . 0.0 109.707 171.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.0 m -141.96 137.58 31.33 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.86 76.39 10.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 168.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.87 -28.05 38.46 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.265 1.412 . . . . 0.0 114.89 -169.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -62.15 -21.7 65.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.908 1.283 . . . . 0.0 114.11 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -107.41 -26.86 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.224 1.81 . . . . 0.0 109.816 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.78 10.67 84.83 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.882 1.706 . . . . 0.0 112.918 -169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -84.53 135.67 34.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.685 1.594 . . . . 0.0 109.709 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -130.37 162.36 29.27 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -149.77 163.77 37.08 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.698 1.599 . . . . 0.0 109.436 171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.2 m -86.94 152.42 22.44 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.75 151.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 110.654 171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -71.94 156.51 90.85 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 166.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -54.2 -21.67 23.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.44 2.76 . . . . 0.0 116.429 -171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -76.87 -10.89 59.69 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.321 1.848 . . . . 0.0 114.703 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.56 -1.87 53.19 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.717 1.627 . . . . 0.0 115.363 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.4 m -74.39 122.08 22.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.873 1.836 . . . . 0.0 109.42 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.73 159.91 21.23 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.94 94.24 2.45 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 168.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.15 18.82 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 125.525 4.15 . . . . 0.0 117.823 -167.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -119.99 -5.1 10.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.954 2.101 . . . . 0.0 112.934 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 p -87.94 -17.51 31.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.385 1.074 . . . . 0.0 113.112 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -56.77 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.874 1.67 . . . . 0.0 112.455 -168.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -127.67 166.02 18.9 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.921 1.688 . . . . 0.0 114.203 -167.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 1.13 0.61 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 129.518 3.127 . . . . 0.0 115.517 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.33 -176.25 45.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.135 1.826 . . . . 0.0 112.745 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -60.23 165.07 3.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.567 1.947 . . . . 0.0 114.296 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 165.13 37.67 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.207 1.403 . . . . 0.0 110.848 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -82.26 58.19 3.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.993 2.117 . . . . 0.0 112.478 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -63.93 150.04 45.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.4 m -167.58 62.99 0.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.411 1.884 . . . . 0.0 109.303 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -78.17 50.95 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.003 1.321 . . . . 0.0 113.716 -169.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 124.897 1.279 . . . . 0.0 111.384 179.057 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.604 0.716 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -142.66 168.54 19.48 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 128.486 2.714 . . . . 0.0 108.936 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -56.99 -22.31 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 t -74.92 -61.32 1.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.465 -0.772 . . . . 0.0 110.66 169.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -30.72 67.48 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.867 0.867 . . . . 0.0 112.991 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -59.66 5.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.604 1.562 . . . . 0.0 110.269 169.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.75 -35.87 81.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.89 -30.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 119.131 0.878 . . . . 0.0 112.092 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -74.27 -47.03 37.61 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.864 . . . . 0.0 112.107 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -73.43 -30.61 63.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.257 1.423 . . . . 0.0 113.268 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 59.8 mt -100.96 96.9 6.14 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 169.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.08 171.4 18.03 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.937 2.424 . . . . 0.0 112.243 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.17 -20.57 27.34 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.36 69.01 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.537 1.535 . . . . 0.0 109.274 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.423 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 7.9 p80 -127.67 -17.28 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 117.929 2.566 . . . . 0.0 117.929 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 31.4 Cg_exo -42.19 116.76 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 124.013 3.142 . . . . 0.0 115.003 -176.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.28 -33.75 5.0 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.893 1.711 . . . . 0.0 111.091 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 t -111.15 170.66 7.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.171 2.189 . . . . 0.0 111.453 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -82.49 156.72 23.91 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.189 1.396 . . . . 0.0 111.647 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -144.81 130.82 9.69 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 126.521 1.928 . . . . 0.0 108.113 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.7 170.65 19.01 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.185 1.923 . . . . 0.0 113.929 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -137.89 151.73 48.32 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.21 2.204 . . . . 0.0 110.657 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -130.5 159.79 36.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 113.193 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -99.87 176.66 5.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.836 1.654 . . . . 0.0 113.552 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -14.62 36.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.984 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.39 13.89 28.15 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.584 1.554 . . . . 0.0 111.915 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.66 8.4 39.74 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.918 1.246 . . . . 0.0 114.226 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -89.99 164.67 14.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.809 1.243 . . . . 0.0 108.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.44 127.48 31.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mt -54.15 127.66 55.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.256 -1.354 . . . . 0.0 108.94 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -51.57 -21.73 11.33 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.237 2.624 . . . . 0.0 116.153 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.2 134.37 51.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.578 1.951 . . . . 0.0 108.952 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -126.71 149.73 49.42 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.456 1.103 . . . . 0.0 109.224 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.19 155.31 47.91 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.52 0.728 . . . . 0.0 112.059 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.21 75.92 1.69 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.063 2.145 . . . . 0.0 107.508 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.7 -44.01 47.38 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.537 1.541 . . . . 0.0 115.061 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 p -65.01 -9.39 21.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 pt -116.38 -1.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.672 1.124 . . . . 0.0 112.488 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.91 62.26 5.39 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.216 0.912 . . . . 0.0 111.314 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -142.42 154.94 45.02 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.61 161.11 38.73 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.33 1.852 . . . . 0.0 110.458 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.37 163.77 36.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.739 1.616 . . . . 0.0 109.198 170.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.3 m -89.93 152.29 21.3 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.48 155.2 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.903 1.281 . . . . 0.0 109.914 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -74.3 161.07 79.83 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 166.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -52.63 -24.22 22.16 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.899 3.066 . . . . 0.0 115.879 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -78.64 -6.28 55.25 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.686 1.994 . . . . 0.0 115.151 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.46 -2.86 59.25 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.596 1.57 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.7 m -73.08 117.93 15.41 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.903 1.352 . . . . 0.0 110.022 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.89 148.05 11.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.031 1.332 . . . . 0.0 113.579 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.22 92.48 1.22 Allowed Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.15 23.2 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.827 1 C-N-CA 125.875 4.383 . . . . 0.0 117.795 -166.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -124.95 -2.17 7.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.971 1.708 . . . . 0.0 112.603 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 p -86.01 -19.61 30.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.152 0.981 . . . . 0.0 112.933 174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -45.54 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.835 2.054 . . . . 0.0 112.468 -173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.8 m -135.98 166.02 24.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 110.83 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.7 mmm-85 -76.36 6.51 5.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.8 -177.77 45.1 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.373 1.939 . . . . 0.0 112.105 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 114.65 -169.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.04 167.2 31.17 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.825 1.65 . . . . 0.0 110.854 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -76.29 49.55 0.58 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.226 2.61 . . . . 0.0 114.181 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -56.1 107.87 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -118.77 25.2 10.39 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.524 1.93 . . . . 0.0 111.489 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.63 23.69 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.402 2.681 . . . . 0.0 116.048 -168.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 125.948 1.699 . . . . 0.0 111.762 -173.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.0 p -140.21 179.6 6.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.712 1.205 . . . . 0.0 111.745 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -21.62 -62.14 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 131.192 3.797 . . . . 0.0 118.407 -170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.6 t -65.63 -51.21 61.34 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.589 -0.694 . . . . 0.0 110.668 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.72 -31.77 69.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.865 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.13 -54.23 41.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.699 1.136 . . . . 0.0 111.102 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.9 -44.31 86.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.295 0.498 . . . . 0.0 112.007 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.34 -27.1 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.127 0.971 . . . . 0.0 111.786 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -78.82 1.94 21.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.228 1.411 . . . . 0.0 113.963 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -126.4 -35.04 2.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.73 1.212 . . . . 0.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -88.25 109.33 27.57 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.501 1.92 . . . . 0.0 106.304 169.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.78 169.76 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.506 2.137 . . . . 0.0 111.937 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.2 -21.52 34.06 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.43 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.03 74.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.211 1.405 . . . . 0.0 108.591 169.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -116.4 61.79 2.33 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 124.816 1.247 . . . . 0.0 112.35 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.2 139.36 77.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.76 2.306 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.57 7.46 0.95 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.49 1.519 . . . . 0.0 115.624 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 p -134.44 176.24 8.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.136 1.774 . . . . 0.0 111.742 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -112.95 140.34 47.85 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.547 1.539 . . . . 0.0 111.665 -169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -125.12 121.38 25.28 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.631 1.972 . . . . 0.0 108.297 169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 172.24 2.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.766 2.311 . . . . 0.0 114.569 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 146.29 47.44 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.983 1.713 . . . . 0.0 109.441 169.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.76 160.79 39.27 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -165.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -73.51 173.93 8.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.864 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -61.43 -23.33 65.76 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.41 -9.77 58.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.536 1.934 . . . . 0.0 111.86 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.77 12.68 74.2 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 124.977 1.275 . . . . 0.0 114.67 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.5 155.46 18.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.455 1.128 . . . . 0.0 108.932 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -67.61 133.25 49.06 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.076 0.55 . . . . 0.0 110.183 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.46 142.05 91.12 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.2 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.89 -26.68 18.71 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.506 2.804 . . . . 0.0 116.4 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.94 45.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.072 1.349 . . . . 0.0 109.935 168.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -123.15 144.28 49.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.54 1.136 . . . . 0.0 109.381 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.1 m -137.3 121.09 17.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.673 0.789 . . . . 0.0 112.192 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.43 66.92 9.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.131 1.773 . . . . 0.0 107.308 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.24 -30.58 40.0 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.53 1.538 . . . . 0.0 114.381 -171.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -57.01 -20.11 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.096 1.758 . . . . 0.0 114.486 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.7 pt -121.59 2.36 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.785 1.634 . . . . 0.0 112.203 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.13 -4.03 78.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.667 2.079 . . . . 0.0 115.352 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.07 152.73 26.46 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.881 1.341 . . . . 0.0 112.293 -169.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -139.95 164.47 29.91 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 112.586 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -151.39 163.77 38.2 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.426 1.89 . . . . 0.0 109.855 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.93 152.25 21.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.76 156.68 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.46 1.104 . . . . 0.0 111.108 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.82 160.07 72.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 165.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.56 -24.37 28.75 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.442 2.761 . . . . 0.0 116.256 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -75.84 -12.41 60.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.798 1.639 . . . . 0.0 114.608 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.17 -1.33 47.23 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 126.01 1.767 . . . . 0.0 115.099 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.8 m -71.34 118.32 13.99 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.784 1.792 . . . . 0.0 109.962 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.41 136.74 53.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.566 1.146 . . . . 0.0 113.167 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -83.88 110.53 26.11 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -62.87 158.35 43.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.556 2.171 . . . . 0.0 112.288 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 65.11 -5.02 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.425 2.29 . . . . 0.0 115.218 -173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -78.15 -20.34 52.24 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.307 1.412 . . . . 0.0 111.773 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.95 91.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.981 1.713 . . . . 0.0 111.069 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -121.53 161.2 22.75 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.396 1.878 . . . . 0.0 113.643 -167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -13.02 5.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.255 2.622 . . . . 0.0 113.827 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.62 -177.2 36.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.294 0.95 . . . . 0.0 114.532 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -56.62 156.44 6.28 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.743 2.417 . . . . 0.0 114.737 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -155.87 167.67 29.67 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 108.316 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -112.11 61.68 0.62 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.278 -0.889 . . . . 0.0 112.489 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 48.3 m -52.24 106.66 0.16 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.824 1.65 . . . . 0.0 113.596 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.6 t 47.22 25.39 0.54 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 65.3 26.56 12.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.073 2.149 . . . . 0.0 113.682 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 126.918 2.087 . . . . 0.0 109.445 173.368 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.9 p -127.91 169.14 14.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.979 2.111 . . . . 0.0 110.632 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -38.99 -59.49 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.7 t -61.21 -49.93 75.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.589 0.631 . . . . 0.0 110.718 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -57.17 -40.62 77.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.524 0.73 . . . . 0.0 112.679 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.69 -57.34 13.1 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.924 0.89 . . . . 0.0 110.306 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.43 -36.85 81.51 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.84 -29.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.417 1.087 . . . . 0.0 112.124 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -72.26 -36.28 68.99 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.569 -0.707 . . . . 0.0 112.035 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -72.98 -46.77 50.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.602 1.161 . . . . 0.0 112.641 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -76.33 111.53 15.97 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.564 1.146 . . . . 0.0 108.081 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.46 151.82 75.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.113 1.875 . . . . 0.0 111.564 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -25.54 63.55 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.21 60.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.526 1.13 . . . . 0.0 109.54 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -90.54 -11.28 0.17 Allowed Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -42.51 128.41 4.7 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 123.828 3.019 . . . . 0.0 114.821 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.79 -24.59 30.9 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.791 1.662 . . . . 0.0 111.606 -168.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.9 p -123.28 162.65 22.24 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.67 1.988 . . . . 0.0 112.373 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.92 141.32 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.945 0.898 . . . . 0.0 111.08 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -136.47 118.89 11.79 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.286 1.834 . . . . 0.0 108.149 171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.73 166.55 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.046 1.831 . . . . 0.0 115.868 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -118.84 142.55 47.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.792 2.837 . . . . 0.0 108.64 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -135.66 158.41 44.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.74 0.816 . . . . 0.0 112.8 -171.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -98.75 -179.8 4.41 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.979 1.312 . . . . 0.0 113.906 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -62.43 -16.52 55.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -91.93 8.1 39.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.069 1.748 . . . . 0.0 111.929 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.12 2.45 18.59 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.021 1.772 . . . . 0.0 115.145 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -86.65 167.81 14.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.08 1.752 . . . . 0.0 108.932 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -59.42 133.49 56.14 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.119 -0.363 . . . . 0.0 110.362 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mt -61.85 139.04 95.61 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -53.57 -24.26 28.38 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.316 2.678 . . . . 0.0 116.394 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.01 139.01 42.09 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.019 1.728 . . . . 0.0 110.048 170.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -129.6 153.62 47.89 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.275 1.43 . . . . 0.0 109.792 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -141.2 157.5 45.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.968 0.907 . . . . 0.0 111.711 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.8 80.12 1.8 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.37 1.868 . . . . 0.0 107.808 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.05 -35.77 54.9 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.388 0.994 . . . . 0.0 114.235 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 m -62.76 -14.12 41.08 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.88 4.46 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.105 1.362 . . . . 0.0 112.112 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.84 38.37 95.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.521 1.058 . . . . 0.0 113.515 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -128.03 152.25 48.17 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.7 m -136.2 159.63 41.15 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.03 1.732 . . . . 0.0 109.854 166.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -152.66 161.06 43.08 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.48 1.512 . . . . 0.0 109.387 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.0 m -88.31 152.14 22.14 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.906 -0.496 . . . . 0.0 109.933 169.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.08 154.4 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.412 1.085 . . . . 0.0 111.309 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -77.88 159.73 75.6 Favored Pre-proline 0 CA--C 1.554 1.112 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 166.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -52.44 -23.64 19.48 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.92 3.08 . . . . 0.0 117.555 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -85.37 -2.96 58.66 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.68 56.39 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.538 1.542 . . . . 0.0 114.82 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.7 m -69.35 109.59 4.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.693 1.247 . . . . 0.0 109.537 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -57.93 143.27 43.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 113.655 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.21 90.59 0.62 Allowed Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 167.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -60.93 -24.06 78.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.908 2.405 . . . . 0.0 117.706 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -66.72 -12.0 56.78 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.027 2.131 . . . . 0.0 113.272 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -94.04 -10.01 34.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 117.438 -1.268 . . . . 0.0 113.297 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -59.89 106.08 0.45 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.312 1.414 . . . . 0.0 111.436 -171.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 t -145.06 172.55 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.694 0.798 . . . . 0.0 113.094 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -65.5 1.5 1.17 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.568 3.547 . . . . 0.0 116.023 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.12 -177.74 41.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.69 1.614 . . . . 0.0 112.882 -172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -55.97 157.14 4.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.544 1.938 . . . . 0.0 114.139 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.51 164.73 38.24 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 111.147 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -85.48 65.46 9.19 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.553 1.541 . . . . 0.0 111.603 -169.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 66.3 m -58.8 157.35 9.72 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.291 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.4 p 52.71 27.09 4.93 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 55.3 29.99 13.94 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.003 2.121 . . . . 0.0 113.678 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.467 0.414 0 C-N-CA 125.028 1.331 . . . . 0.0 110.769 175.325 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.573 0.701 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 45.5 p -139.11 171.46 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 128.032 2.533 . . . . 0.0 108.73 173.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -53.89 -35.38 61.54 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.595 -0.691 . . . . 0.0 112.276 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.0 -62.32 1.86 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.535 0.734 . . . . 0.0 111.234 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' THR . 17.6 mm-40 -59.8 -33.16 71.37 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.397 0.544 . . . . 0.0 112.369 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -58.92 -60.36 3.99 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.868 1.267 . . . . 0.0 109.758 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.71 -29.19 70.44 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.28 -32.89 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.853 0.861 . . . . 0.0 111.337 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.5 p -80.03 -28.92 39.25 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -68.17 -48.69 64.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.184 0.902 . . . . 0.0 111.099 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.7 112.78 53.86 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.451 1.1 . . . . 0.0 108.523 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.19 164.8 34.37 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.019 1.813 . . . . 0.0 111.215 173.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.73 -20.16 46.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 t -77.02 72.51 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.942 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -117.5 26.61 0.11 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 174.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -62.59 116.4 3.51 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.854 2.37 . . . . 0.0 112.148 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.75 -13.42 53.52 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.315 1.436 . . . . 0.0 113.147 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 t -119.62 176.85 5.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.444 1.898 . . . . 0.0 111.767 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -91.71 159.32 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.061 2.544 . . . . 0.0 110.633 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 -143.16 130.91 11.03 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.588 1.555 . . . . 0.0 109.014 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.55 168.59 24.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.335 2.023 . . . . 0.0 112.37 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.575 1.95 . . . . 0.0 110.424 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -128.55 153.67 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.797 1.239 . . . . 0.0 112.97 -169.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -87.54 178.58 6.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.532 1.533 . . . . 0.0 113.264 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pm0 -62.98 -12.73 27.71 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -99.82 13.01 35.23 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.149 1.78 . . . . 0.0 111.834 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 3.87 22.36 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.631 1.586 . . . . 0.0 114.708 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.69 166.06 16.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.066 1.746 . . . . 0.0 108.606 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -58.88 130.91 49.27 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.76 0.709 . . . . 0.0 109.794 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.41 119.99 16.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.826 173.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.45 -9.09 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.759 2.972 . . . . 0.0 116.912 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -116.56 124.01 48.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.146 2.178 . . . . 0.0 107.218 167.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.2 145.19 48.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.789 0.836 . . . . 0.0 109.399 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.0 m -136.55 126.51 25.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.748 0.819 . . . . 0.0 112.276 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -83.74 70.31 10.33 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.46 -35.87 29.64 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.624 1.583 . . . . 0.0 114.222 -170.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.3 m -53.28 -22.89 7.75 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.45 1.5 . . . . 0.0 114.733 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.59 2.41 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.739 1.616 . . . . 0.0 112.814 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.75 80.45 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.34 1.448 . . . . 0.0 115.593 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -84.49 147.2 27.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.717 1.258 . . . . 0.0 112.312 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 m -133.69 163.47 29.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.735 1.214 . . . . 0.0 112.117 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -146.81 161.92 39.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.572 1.949 . . . . 0.0 108.384 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.0 m -86.22 153.18 22.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.82 153.57 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.529 1.132 . . . . 0.0 110.223 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -74.14 160.72 80.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.4 -25.73 25.57 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.44 2.76 . . . . 0.0 115.944 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -75.95 -10.15 59.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.059 1.743 . . . . 0.0 114.856 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.52 -1.78 57.2 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.582 1.563 . . . . 0.0 115.395 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.6 m -75.0 127.99 34.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.896 1.848 . . . . 0.0 109.755 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -57.47 139.84 52.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.6 t -83.35 111.48 31.53 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 168.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -49.88 148.91 11.93 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.884 3.056 . . . . 0.0 114.679 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 59.73 6.63 0.9 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.126 1.77 . . . . 0.0 115.412 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 p -74.38 -26.03 59.86 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.949 1.25 . . . . 0.0 111.36 172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.605 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -42.42 109.21 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.382 1.873 . . . . 0.0 111.213 -177.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -142.53 164.7 29.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.923 1.289 . . . . 0.0 111.653 -171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.605 ' NH1' HH22 ' A' ' 55' ' ' ARG . 4.7 mpt_? -77.97 16.28 0.75 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.919 2.488 . . . . 0.0 112.958 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -178.71 47.59 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 126.27 1.891 . . . . 0.0 112.293 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -65.27 167.53 8.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.131 1.772 . . . . 0.0 114.128 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 166.03 34.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.036 1.334 . . . . 0.0 111.258 173.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -84.97 63.48 8.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.082 2.153 . . . . 0.0 112.039 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.0 m -66.65 164.35 17.02 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.5 p -70.38 72.75 0.49 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.994 1.717 . . . . 0.0 112.251 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.63 68.9 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 130.021 3.328 . . . . 0.0 115.913 -169.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.468 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 110.63 168.249 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 123.176 1.465 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.8 p -143.54 163.97 31.69 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 130.684 3.593 . . . . 0.0 109.584 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -52.59 -42.2 64.32 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.629 0.649 . . . . 0.0 112.38 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 t -56.53 -61.33 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.498 0.719 . . . . 0.0 111.18 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -60.92 -34.0 74.01 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.34 -56.18 23.36 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.373 1.469 . . . . 0.0 111.021 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -58.61 -41.88 86.9 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.312 0.505 . . . . 0.0 112.011 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.2 t -62.83 -31.89 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.002 0.921 . . . . 0.0 111.896 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -83.35 4.49 27.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.99 1.716 . . . . 0.0 114.099 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -126.01 -34.78 2.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 0.0 112.057 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -96.9 105.48 24.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.38 171.08 18.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.651 2.234 . . . . 0.0 112.117 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.58 -23.74 42.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.223 1.009 . . . . 0.0 113.502 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -81.06 76.46 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 108.095 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -115.53 47.93 0.53 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.74 130.08 28.4 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.701 2.267 . . . . 0.0 111.067 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.28 -9.05 50.28 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.383 1.468 . . . . 0.0 114.337 -173.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -120.78 160.53 23.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.482 1.641 . . . . 0.0 113.208 -170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -77.52 162.99 26.71 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 165.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -147.88 129.75 7.46 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.358 2.263 . . . . 0.0 107.035 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.91 170.84 15.81 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.685 1.59 . . . . 0.0 113.067 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -141.38 148.24 39.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.87 2.068 . . . . 0.0 109.559 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.9 m -135.13 157.58 46.57 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -101.83 177.37 4.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.683 1.593 . . . . 0.0 113.611 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.77 -14.51 33.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.748 1.619 . . . . 0.0 115.034 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -98.1 13.27 31.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.505 1.522 . . . . 0.0 111.906 171.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.09 7.51 37.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.968 1.27 . . . . 0.0 114.334 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -88.33 164.68 15.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.166 1.387 . . . . 0.0 108.918 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -63.79 126.67 28.34 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.84 131.11 57.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.09 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -48.21 -18.76 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.971 3.781 . . . . 0.0 117.355 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.8 131.68 56.87 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.045 2.138 . . . . 0.0 108.439 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -121.87 146.52 47.02 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.75 1.22 . . . . 0.0 109.289 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 96.1 m -136.13 119.94 17.35 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 68.21 9.94 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.814 1.646 . . . . 0.0 106.823 168.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.66 54.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.227 -1.351 . . . . 0.0 114.149 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.32 -10.53 16.74 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.0 pt -124.34 8.47 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.356 1.462 . . . . 0.0 111.764 169.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.43 5.45 72.74 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.308 1.432 . . . . 0.0 115.041 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -84.82 146.69 27.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.195 1.498 . . . . 0.0 112.776 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.08 157.24 47.15 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.11 1.364 . . . . 0.0 109.943 166.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -144.52 163.15 34.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.456 1.502 . . . . 0.0 109.406 169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.1 m -86.03 150.75 24.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.159 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.8 157.01 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.92 0.888 . . . . 0.0 111.151 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -77.84 159.61 75.97 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 165.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.98 -24.29 24.25 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.585 2.857 . . . . 0.0 116.297 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -76.87 -10.36 59.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.14 1.776 . . . . 0.0 114.663 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.96 52.8 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.776 1.655 . . . . 0.0 115.334 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -71.83 116.19 11.91 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.962 1.881 . . . . 0.0 110.325 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -58.45 137.18 57.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.332 1.053 . . . . 0.0 113.694 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.22 109.07 16.74 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 168.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.86 158.77 45.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.569 2.18 . . . . 0.0 112.074 -169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 61.22 -0.47 0.34 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.695 1.998 . . . . 0.0 115.547 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -71.26 -29.17 64.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.431 1.468 . . . . 0.0 110.667 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.532 HH21 ' NH2' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -43.57 95.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.199 2.2 . . . . 0.0 113.969 -174.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -125.27 162.34 24.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.205 1.802 . . . . 0.0 111.863 -170.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -72.42 18.61 0.09 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.622 2.769 . . . . 0.0 112.597 175.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.33 -179.76 48.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.434 1.493 . . . . 0.0 113.249 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.25 163.24 13.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.093 1.757 . . . . 0.0 113.515 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 161.38 41.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.474 1.109 . . . . 0.0 111.818 174.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.13 67.96 9.92 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 111.242 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 72.6 m -53.17 122.54 9.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.5 p -64.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 128.555 2.742 . . . . 0.0 116.151 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -123.81 10.04 8.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 127.249 2.22 . . . . 0.0 112.066 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.463 0.208 0 C-N-CA 127.441 2.297 . . . . 0.0 111.018 -176.421 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.465 0.174 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -84.38 168.19 15.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.954 0.902 . . . . 0.0 112.439 -174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -54.98 -39.94 69.53 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.622 -0.673 . . . . 0.0 112.031 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.5 t -59.64 -57.54 12.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.095 0.558 . . . . 0.0 110.698 172.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -58.47 -38.47 77.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.262 0.625 . . . . 0.0 112.632 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -59.96 4.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.679 1.192 . . . . 0.0 110.5 170.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -57.64 -41.94 82.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.589 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.83 -33.02 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.252 0.621 . . . . 0.0 111.938 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -81.72 -0.88 44.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.504 1.522 . . . . 0.0 114.561 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -126.23 -31.64 2.79 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.544 1.065 . . . . 0.0 112.394 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.99 108.07 38.54 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.97 169.09 23.4 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.442 2.094 . . . . 0.0 111.746 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.28 27.05 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.347 1.059 . . . . 0.0 113.576 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 t -86.25 76.48 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 108.058 169.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -111.03 70.87 0.72 Allowed Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.078 1.351 . . . . 0.0 111.589 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.22 134.92 47.85 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.975 2.45 . . . . 0.0 110.973 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.84 8.5 0.6 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.184 1.849 . . . . 0.0 116.163 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 p -131.32 168.07 18.18 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.613 1.565 . . . . 0.0 112.913 -168.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.85 152.26 20.82 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.088 1.355 . . . . 0.0 111.763 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -138.53 129.82 15.49 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 126.59 1.956 . . . . 0.0 107.632 169.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.41 176.1 9.14 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.835 1.69 . . . . 0.0 113.015 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -139.68 150.34 44.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.849 2.059 . . . . 0.0 109.637 174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -135.23 158.73 43.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -97.37 -179.31 4.45 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.856 1.663 . . . . 0.0 113.981 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.7 -3.17 0.99 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.622 1.969 . . . . 0.0 114.924 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -123.24 19.47 9.84 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.601 1.96 . . . . 0.0 111.193 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 7.62 29.24 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.277 1.417 . . . . 0.0 114.732 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -85.62 162.81 18.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.751 1.22 . . . . 0.0 108.629 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -63.29 126.84 28.76 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 122.009 -0.432 . . . . 0.0 109.9 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -55.08 132.28 68.34 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.179 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.34 -17.3 4.0 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.899 3.066 . . . . 0.0 116.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 tp -113.14 131.24 55.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.639 1.976 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -121.32 147.62 45.43 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.493 1.117 . . . . 0.0 109.396 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.1 m -138.66 122.75 17.97 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.721 0.772 . . . . 0.0 112.482 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.8 69.87 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.666 1.586 . . . . 0.0 106.911 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.84 -35.3 47.04 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.437 1.494 . . . . 0.0 113.778 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 m -62.65 -11.9 19.93 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.42 -4.44 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.43 1.492 . . . . 0.0 111.553 167.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.14 58.18 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.32 1.914 . . . . 0.0 114.829 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -113.09 152.17 29.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.697 1.749 . . . . 0.0 111.751 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.5 m -135.95 165.1 26.44 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.935 0.894 . . . . 0.0 112.51 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -148.93 163.59 37.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.211 1.804 . . . . 0.0 109.34 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 70.9 m -87.23 151.38 23.21 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.02 157.63 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.058 0.943 . . . . 0.0 111.108 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.11 160.69 72.97 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -22.08 23.4 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.508 2.806 . . . . 0.0 116.562 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -79.08 -9.9 59.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.054 1.741 . . . . 0.0 114.517 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.84 55.89 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.612 1.577 . . . . 0.0 115.221 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.2 m -73.17 122.59 22.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.978 1.889 . . . . 0.0 110.04 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.28 137.27 57.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.011 . . . . 0.0 113.52 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -84.1 109.56 19.97 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 167.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.24 158.21 41.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.797 2.332 . . . . 0.0 112.948 -168.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 65.18 -0.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.488 2.315 . . . . 0.0 115.098 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.4 p -81.16 -19.11 44.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.102 1.319 . . . . 0.0 112.172 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.44 98.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.276 1.43 . . . . 0.0 110.408 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 t -140.72 170.96 14.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -168.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -63.2 -1.45 1.04 Allowed 'General case' 0 N--CA 1.472 0.636 1 C-N-CA 132.273 4.229 . . . . 0.0 114.655 -171.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.43 -174.8 47.25 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.158 1.361 . . . . 0.0 112.595 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -55.78 157.36 4.29 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.084 1.754 . . . . 0.0 113.421 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.35 171.84 19.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.982 1.313 . . . . 0.0 110.485 175.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -105.98 82.4 1.77 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.017 1.327 . . . . 0.0 110.286 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.4 m -65.32 -172.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.238 1.815 . . . . 0.0 112.637 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -64.7 51.63 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.819 2.048 . . . . 0.0 113.623 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.65 32.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.895 2.878 . . . . 0.0 114.514 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.1 p . . . . . 0 C--O 1.235 0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 110.959 178.262 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.903 0.382 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 p -83.83 166.25 18.1 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.522 1.129 . . . . 0.0 110.586 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.0 -39.89 66.48 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.369 -0.832 . . . . 0.0 112.291 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.6 t -58.38 -61.8 2.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.625 0.77 . . . . 0.0 111.265 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -62.01 -34.25 75.85 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.908 -0.568 . . . . 0.0 112.251 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.47 -59.55 4.98 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.746 1.218 . . . . 0.0 110.194 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -54.76 -47.84 73.37 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.755 0.422 . . . . 0.0 111.339 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 ' SG ' ' A' ' 23' ' ' CYS . 64.2 t -62.52 -28.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.868 0.867 . . . . 0.0 112.513 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.9 p -80.27 -2.29 44.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -131.42 -24.66 2.25 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -170.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.7 mm -79.45 116.78 63.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.642 1.11 . . . . 0.0 109.542 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.31 163.05 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.929 1.753 . . . . 0.0 111.246 174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.71 67.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.549 -0.72 . . . . 0.0 112.564 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.04 74.58 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.424 1.49 . . . . 0.0 108.498 170.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -111.41 63.68 0.53 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.73 1.212 . . . . 0.0 112.036 173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -63.81 136.44 53.35 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.499 2.8 . . . . 0.0 110.949 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.28 13.79 0.77 Allowed Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.274 1.416 . . . . 0.0 115.412 -173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.2 m -124.52 155.08 39.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.915 1.358 . . . . 0.0 113.173 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -75.97 157.45 33.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.545 1.538 . . . . 0.0 112.206 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -142.53 115.7 6.31 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 110.539 168.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.45 169.89 20.65 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.091 1.861 . . . . 0.0 113.422 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -136.81 143.18 43.0 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.155 2.982 . . . . 0.0 109.295 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' SG ' HG21 ' A' ' 8' ' ' VAL . 3.8 m -134.33 159.82 39.84 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.557 1.071 . . . . 0.0 113.02 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -95.81 174.93 6.71 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.653 1.581 . . . . 0.0 112.91 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -59.67 -20.93 59.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.463 1.105 . . . . 0.0 113.731 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.68 6.04 25.77 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.011 2.124 . . . . 0.0 111.636 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.5 7.09 38.28 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.628 1.585 . . . . 0.0 114.443 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.27 162.24 15.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.116 1.366 . . . . 0.0 109.32 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -61.71 126.8 28.64 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -55.64 138.2 69.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.854 -1.07 . . . . 0.0 108.652 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -49.85 -27.53 16.03 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.219 2.613 . . . . 0.0 115.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.49 135.47 45.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.533 1.533 . . . . 0.0 109.645 169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -125.63 149.99 47.94 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.711 1.204 . . . . 0.0 109.018 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.0 m -137.78 153.49 49.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 122.662 1.22 . . . . 0.0 112.704 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.76 66.76 1.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.379 2.672 . . . . 0.0 106.096 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.78 -31.56 54.15 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.99 1.281 . . . . 0.0 113.598 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -60.13 -12.58 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.429 1.491 . . . . 0.0 114.791 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 37.8 pt -126.72 6.69 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 126.204 1.801 . . . . 0.0 111.693 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.69 7.95 87.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.879 1.704 . . . . 0.0 115.556 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.99 156.96 16.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.667 1.733 . . . . 0.0 114.282 -169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 67.5 m -144.23 157.67 44.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.481 1.912 . . . . 0.0 109.93 166.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -148.49 164.62 33.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.79 1.636 . . . . 0.0 109.308 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.59 153.51 20.71 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 169.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.2 159.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.079 1.352 . . . . 0.0 110.66 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -79.33 161.28 68.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 165.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -52.04 -25.24 21.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.728 2.952 . . . . 0.0 116.32 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -78.22 -7.65 57.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.164 1.785 . . . . 0.0 115.301 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.63 -1.97 52.93 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.811 1.672 . . . . 0.0 114.984 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.5 m -71.12 113.77 8.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.963 1.382 . . . . 0.0 110.489 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -56.72 134.22 54.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.763 1.225 . . . . 0.0 113.709 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.63 111.37 31.49 Favored Pre-proline 0 C--O 1.241 0.61 0 C-N-CA 125.655 1.582 . . . . 0.0 107.131 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.49 161.41 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.64 2.227 . . . . 0.0 111.915 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.44 -2.55 0.12 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.359 1.864 . . . . 0.0 115.894 -175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.8 p -72.12 -31.51 66.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.46 1.482 . . . . 0.0 110.275 169.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.3 ttm-85 -46.16 99.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.238 2.215 . . . . 0.0 112.834 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -129.77 165.91 20.97 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.741 1.616 . . . . 0.0 111.478 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 23.33 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.527 2.331 . . . . 0.0 111.927 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.56 -174.17 45.57 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.675 1.131 . . . . 0.0 114.438 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -61.43 152.51 29.64 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.886 2.474 . . . . 0.0 115.454 -169.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 158.62 44.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.882 1.273 . . . . 0.0 109.749 168.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -85.97 61.31 6.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.822 1.249 . . . . 0.0 112.607 -167.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.6 m -56.44 110.5 0.78 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.408 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.5 m -108.85 18.7 20.46 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.001 1.32 . . . . 0.0 113.667 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.7 mp0 -75.34 26.1 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.415 2.286 . . . . 0.0 113.472 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 126.878 2.071 . . . . 0.0 111.665 -171.29 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 121.519 0.675 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.433 ' H ' ' HB2' ' A' ' 5' ' ' GLN . 27.6 p -138.6 172.69 12.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.208 2.603 . . . . 0.0 108.407 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -52.19 -38.1 56.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.194 0.598 . . . . 0.0 112.327 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.4 t -63.8 -58.18 7.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.357 0.663 . . . . 0.0 111.316 172.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB2' ' H ' ' A' ' 2' ' ' THR . 29.2 mm100 -58.9 -35.05 72.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.3 -60.59 3.57 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.127 1.371 . . . . 0.0 110.398 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.43 -37.17 80.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.11 -31.26 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.78 0.832 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -72.16 -41.56 66.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.728 . . . . 0.0 112.387 170.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -74.73 -40.65 61.15 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.045 1.338 . . . . 0.0 112.986 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.1 mm -89.04 110.4 37.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.5 168.11 25.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.206 1.938 . . . . 0.0 111.452 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.51 -18.5 29.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -84.72 78.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.229 1.411 . . . . 0.0 107.666 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -114.86 53.62 0.75 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.764 1.225 . . . . 0.0 113.779 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -62.33 131.5 34.43 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.024 2.483 . . . . 0.0 110.735 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 -5.47 3.83 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-O 118.613 -1.104 . . . . 0.0 115.673 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -113.93 156.4 24.06 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.737 1.768 . . . . 0.0 113.0 -173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -73.1 161.57 30.47 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -147.56 124.6 5.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 126.678 1.991 . . . . 0.0 108.404 168.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.64 172.03 16.59 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.749 1.632 . . . . 0.0 114.049 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -135.91 144.31 45.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 129.727 3.211 . . . . 0.0 110.102 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 m -137.81 160.32 39.6 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -103.69 178.7 4.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.901 1.681 . . . . 0.0 114.23 -172.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.64 0.15 1.21 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.53 1.932 . . . . 0.0 114.656 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -121.93 19.27 10.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.092 1.757 . . . . 0.0 111.12 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.6 8.65 40.65 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.026 1.298 . . . . 0.0 114.555 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -90.09 164.25 14.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.85 1.26 . . . . 0.0 108.69 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -62.95 127.43 31.22 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.03 135.46 84.01 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 117.678 -1.153 . . . . 0.0 108.472 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -52.85 -10.21 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.49 2.793 . . . . 0.0 117.41 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.88 137.79 51.77 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.284 1.834 . . . . 0.0 109.227 167.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -129.79 145.58 51.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 109.056 169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 98.0 m -137.15 119.02 15.19 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.635 0.731 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.3 66.09 9.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.453 1.501 . . . . 0.0 107.335 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.53 -32.16 45.46 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.195 1.379 . . . . 0.0 113.786 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 m -60.43 -12.52 9.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.325 1.45 . . . . 0.0 114.913 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.59 7.63 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 126.286 1.834 . . . . 0.0 111.697 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.69 -2.95 77.08 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.192 1.853 . . . . 0.0 115.41 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -83.06 151.66 25.69 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.133 1.466 . . . . 0.0 113.304 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.74 160.72 39.23 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.043 0.937 . . . . 0.0 111.056 167.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -152.06 164.67 36.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.58 1.552 . . . . 0.0 108.817 169.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.6 m -93.44 154.5 17.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 110.571 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.36 157.96 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.768 0.827 . . . . 0.0 111.695 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -79.95 159.73 70.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.41 -21.23 17.51 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.067 3.178 . . . . 0.0 117.683 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -84.93 -4.44 59.12 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.79 1.636 . . . . 0.0 114.791 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.61 1.01 55.39 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.712 1.625 . . . . 0.0 114.641 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.1 m -71.75 115.75 11.31 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.902 1.351 . . . . 0.0 109.96 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -60.41 144.79 50.13 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.73 89.67 0.66 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.598 2.359 . . . . 0.0 104.818 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.54 -14.09 42.45 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.796 2.33 . . . . 0.0 117.583 -166.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -67.35 -10.86 55.17 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 127.107 2.163 . . . . 0.0 113.234 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -107.37 2.31 24.31 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.09 1.756 . . . . 0.0 112.545 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -62.83 94.17 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.403 1.001 . . . . 0.0 110.916 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -129.98 161.1 31.68 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -168.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.34 10.07 2.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.063 2.545 . . . . 0.0 113.146 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.58 -179.22 48.31 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.406 1.955 . . . . 0.0 112.234 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.68 157.46 9.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.486 1.914 . . . . 0.0 114.484 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -155.17 168.91 25.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.564 2.745 . . . . 0.0 106.145 168.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -111.22 34.64 3.95 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -163.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m -57.16 105.73 0.25 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.627 -0.67 . . . . 0.0 112.029 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t 54.29 19.31 2.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -106.7 12.34 29.31 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.47 0.54 0 C-N-CA 128.394 2.678 . . . . 0.0 114.056 177.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -82.89 166.86 18.57 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 111.314 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -53.51 -41.28 66.16 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.595 -0.691 . . . . 0.0 111.916 171.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.79 -60.21 4.05 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.309 0.644 . . . . 0.0 110.753 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.95 -39.09 77.23 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.351 0.66 . . . . 0.0 112.599 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.21 -56.82 16.86 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.878 1.271 . . . . 0.0 110.928 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -56.57 -43.76 80.32 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.42 0.554 . . . . 0.0 111.571 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.14 -34.97 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.537 0.735 . . . . 0.0 111.67 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -83.82 2.95 35.8 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.04 1.736 . . . . 0.0 114.318 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.58 -34.13 2.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.264 1.026 . . . . 0.0 112.392 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -89.13 113.69 57.25 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.32 163.82 35.5 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.237 1.958 . . . . 0.0 111.41 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -22.72 50.73 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -79.81 73.52 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.89 1.276 . . . . 0.0 108.66 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -110.9 35.51 0.12 Allowed Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.24 133.66 11.87 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.643 2.229 . . . . 0.0 113.546 169.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.75 -10.81 36.9 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.284 1.421 . . . . 0.0 114.617 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -130.08 173.29 10.88 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.733 1.767 . . . . 0.0 113.857 -170.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -94.17 152.87 18.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.524 2.329 . . . . 0.0 110.608 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -139.84 123.58 10.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.514 1.526 . . . . 0.0 108.606 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.99 175.95 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.3 2.0 . . . . 0.0 113.094 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 148.18 31.18 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.343 2.257 . . . . 0.0 109.519 173.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.7 158.42 44.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.83 0.852 . . . . 0.0 113.143 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -91.42 -175.96 4.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.652 1.581 . . . . 0.0 113.414 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -61.56 -16.8 51.23 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -91.48 -5.83 53.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.342 1.457 . . . . 0.0 112.103 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.79 81.08 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.11 0.862 . . . . 0.0 113.827 -169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -77.9 152.47 33.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.154 1.477 . . . . 0.0 109.478 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -55.41 125.39 20.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.966 0.506 . . . . 0.0 109.723 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.64 142.99 69.77 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.434 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -49.69 -22.89 7.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.567 3.512 . . . . 0.0 117.684 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.06 136.76 52.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.867 2.067 . . . . 0.0 109.406 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -130.03 152.57 49.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.233 1.013 . . . . 0.0 109.321 169.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.0 m -143.54 129.99 20.03 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.52 73.6 10.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.854 1.662 . . . . 0.0 106.528 168.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -46.59 -43.09 15.01 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.66 1.6 . . . . 0.0 114.258 -170.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 t -63.05 -8.83 8.3 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.3 pt -126.46 0.38 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 125.644 1.578 . . . . 0.0 112.44 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.6 7.19 85.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.538 1.066 . . . . 0.0 115.214 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -82.2 128.87 34.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.377 1.589 . . . . 0.0 110.532 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.02 158.77 25.15 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.903 0.881 . . . . 0.0 110.426 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -150.24 160.21 43.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.669 1.588 . . . . 0.0 108.676 171.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.5 m -86.18 155.06 20.89 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.28 154.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 122.016 0.912 . . . . 0.0 112.806 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.34 158.78 76.23 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 166.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 -8.36 17.09 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.693 2.262 . . . . 0.0 115.658 -170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -85.21 -12.14 53.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.306 1.843 . . . . 0.0 114.2 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.71 -2.07 52.68 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.907 1.717 . . . . 0.0 115.543 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.3 m -74.69 133.24 42.1 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.93 1.865 . . . . 0.0 109.068 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.35 155.22 40.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -84.73 111.53 35.76 Favored Pre-proline 0 C--O 1.242 0.662 0 C-N-CA 125.822 1.649 . . . . 0.0 106.643 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.49 150.25 11.92 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.439 2.76 . . . . 0.0 113.646 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 61.84 1.5 0.63 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.508 1.923 . . . . 0.0 115.671 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 p -74.23 -28.5 61.27 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.398 1.454 . . . . 0.0 111.012 169.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -43.8 103.02 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.149 2.18 . . . . 0.0 112.136 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -138.26 162.45 34.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.408 1.083 . . . . 0.0 112.453 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.07 13.72 0.1 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.803 3.241 . . . . 0.0 114.314 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.73 -169.65 40.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.194 1.854 . . . . 0.0 113.46 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -57.49 152.39 14.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.444 2.298 . . . . 0.0 115.392 -169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.45 155.91 39.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.637 1.575 . . . . 0.0 108.987 168.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -94.43 70.64 3.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.52 1.128 . . . . 0.0 110.638 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.18 111.81 0.85 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.374 1.47 . . . . 0.0 112.913 -176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.7 p -71.32 70.94 0.61 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.982 1.713 . . . . 0.0 112.425 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 54.78 24.15 5.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.68 1.992 . . . . 0.0 114.406 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 128.163 2.585 . . . . 0.0 113.549 -170.272 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.478 0.18 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 p -84.37 171.1 12.94 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -53.79 -41.76 67.6 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.978 1.311 . . . . 0.0 112.035 169.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.51 -57.74 11.64 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.289 0.636 . . . . 0.0 110.622 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -60.52 -35.45 76.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 112.634 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.94 -57.15 14.1 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.78 1.232 . . . . 0.0 110.624 169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -57.4 -42.32 82.01 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.345 0.521 . . . . 0.0 111.875 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.96 -32.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 111.857 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -86.39 6.83 28.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.562 1.945 . . . . 0.0 114.187 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.04 -37.8 2.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.669 1.188 . . . . 0.0 111.55 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.8 mt -92.44 107.68 25.53 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.73 171.16 18.71 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.536 2.158 . . . . 0.0 111.694 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.3 -21.97 38.59 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -84.71 76.84 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.284 1.434 . . . . 0.0 108.106 169.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -114.36 63.19 1.28 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.903 1.281 . . . . 0.0 112.69 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -63.01 138.55 68.46 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 111.594 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 55.35 10.85 3.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.708 1.623 . . . . 0.0 114.432 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -126.75 161.13 28.87 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.668 1.234 . . . . 0.0 113.242 -167.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -83.72 157.14 22.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.329 1.451 . . . . 0.0 111.294 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -143.48 129.67 10.25 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.954 1.702 . . . . 0.0 108.083 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.21 175.07 10.44 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.101 1.867 . . . . 0.0 112.747 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -142.99 149.31 38.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.386 1.875 . . . . 0.0 109.329 172.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.97 158.85 43.26 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.35 1.06 . . . . 0.0 111.563 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -98.76 -174.86 2.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.294 1.037 . . . . 0.0 113.495 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -22.45 56.03 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -84.15 -8.66 59.02 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.172 0.589 . . . . 0.0 111.807 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.41 4.27 84.02 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.266 -1.297 . . . . 0.0 114.354 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.76 160.46 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.047 1.924 . . . . 0.0 109.339 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -59.35 132.15 53.14 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -61.42 142.72 93.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.013 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -50.27 -28.61 20.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.914 3.076 . . . . 0.0 116.264 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -106.23 141.25 37.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.46 1.904 . . . . 0.0 109.533 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -131.64 150.59 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.323 1.449 . . . . 0.0 109.084 169.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.1 m -139.65 134.45 32.03 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.26 72.7 10.53 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.26 -39.4 20.62 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.617 1.58 . . . . 0.0 114.731 -169.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -64.5 -9.7 20.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.9 pt -123.38 -4.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.298 1.439 . . . . 0.0 112.088 169.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.14 8.1 84.97 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.006 1.765 . . . . 0.0 115.571 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -84.05 151.22 25.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.295 1.548 . . . . 0.0 111.026 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 55.9 m -136.95 165.33 26.25 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.188 0.995 . . . . 0.0 112.667 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -149.05 165.08 32.77 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.531 1.932 . . . . 0.0 108.785 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.4 m -88.18 151.87 22.38 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.45 149.43 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.6 0.76 . . . . 0.0 110.798 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -71.11 158.95 87.04 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -52.49 -21.65 14.57 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.626 2.884 . . . . 0.0 117.416 -169.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -85.41 -3.68 58.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.53 1.532 . . . . 0.0 114.507 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.69 -0.48 52.58 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.376 1.465 . . . . 0.0 114.754 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m -70.71 113.8 8.16 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.071 1.435 . . . . 0.0 110.534 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.21 135.22 38.56 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -83.31 109.49 17.99 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -63.0 156.41 54.85 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.493 2.129 . . . . 0.0 112.004 -169.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 63.84 -1.51 0.64 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.066 2.146 . . . . 0.0 115.334 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 p -77.66 -23.25 49.69 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.464 1.484 . . . . 0.0 111.827 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.85 99.17 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.048 1.739 . . . . 0.0 110.984 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.2 t -140.5 171.24 14.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.759 1.224 . . . . 0.0 113.451 -168.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -6.65 3.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.019 3.328 . . . . 0.0 115.29 -173.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.39 -176.85 43.99 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.918 1.247 . . . . 0.0 112.957 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -55.64 157.74 3.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.78 2.032 . . . . 0.0 113.518 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.8 164.42 38.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 0.0 112.232 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -84.0 61.4 6.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.942 2.097 . . . . 0.0 111.849 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -52.74 107.54 0.23 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.848 0.859 . . . . 0.0 112.144 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -123.65 27.2 7.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.323 1.849 . . . . 0.0 113.071 -168.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.54 17.95 2.54 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.097 1.759 . . . . 0.0 113.057 -170.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.233 0.214 0 C-N-CA 126.619 1.968 . . . . 0.0 111.009 -169.88 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.7 p -82.95 167.45 17.96 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.952 0.901 . . . . 0.0 111.398 171.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -53.63 -37.67 63.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.643 0.777 . . . . 0.0 112.591 171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.0 t -60.36 -61.41 2.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -58.85 -37.27 76.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.422 0.689 . . . . 0.0 112.548 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -59.43 -59.17 5.88 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.196 1.398 . . . . 0.0 110.514 171.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -55.96 -46.63 78.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.416 0.553 . . . . 0.0 111.61 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -60.39 -33.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.056 0.542 . . . . 0.0 111.432 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -82.51 3.62 27.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.332 1.853 . . . . 0.0 114.509 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -126.03 -23.79 3.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 120.105 1.32 . . . . 0.0 113.506 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 mm -61.34 133.21 92.96 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 167.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.27 174.39 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.714 1.61 . . . . 0.0 112.986 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.43 -45.61 53.43 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.608 -0.682 . . . . 0.0 110.6 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.21 72.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.453 1.501 . . . . 0.0 108.799 173.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.521 ' H ' ' CD ' ' A' ' 16' ' ' PRO . 0.9 OUTLIER -133.93 -16.28 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 -179.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' CD ' ' H ' ' A' ' 15' ' ' HIS . 44.0 Cg_exo -44.76 122.12 3.89 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 123.801 3.0 . . . . 0.0 114.29 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 -41.4 1.94 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.45 1.5 . . . . 0.0 110.517 -169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 95.1 p -74.74 163.5 27.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.366 1.467 . . . . 0.0 112.768 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -75.94 155.8 34.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.028 0.931 . . . . 0.0 111.323 170.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -144.77 128.5 8.74 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 125.503 1.521 . . . . 0.0 108.853 169.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.47 175.01 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.116 1.877 . . . . 0.0 112.289 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 153.69 40.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.631 1.572 . . . . 0.0 111.133 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.42 159.33 38.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.494 1.118 . . . . 0.0 113.071 -168.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -95.95 -179.69 4.78 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.983 1.713 . . . . 0.0 113.692 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.93 -16.11 48.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.313 1.445 . . . . 0.0 114.866 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.72 13.76 31.1 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.788 1.635 . . . . 0.0 111.771 170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.57 2.21 14.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.648 1.594 . . . . 0.0 114.71 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.34 164.14 20.19 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.811 1.306 . . . . 0.0 108.766 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -60.23 128.87 38.91 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.37 0.532 . . . . 0.0 109.827 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.79 128.23 62.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 117.15 -1.405 . . . . 0.0 108.675 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.62 -18.74 6.41 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.799 2.999 . . . . 0.0 116.761 -174.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.53 132.65 54.99 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.961 2.104 . . . . 0.0 108.551 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -124.84 151.87 44.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.254 1.022 . . . . 0.0 108.718 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 83.9 m -141.4 156.99 45.75 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.688 0.795 . . . . 0.0 112.07 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -133.03 93.45 3.19 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.72 1.608 . . . . 0.0 110.742 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.76 -36.38 59.53 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.18 1.371 . . . . 0.0 115.091 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -57.76 -20.78 37.5 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.094 1.447 . . . . 0.0 114.503 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 pt -123.41 2.63 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.98 1.712 . . . . 0.0 112.207 174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.44 12.22 69.33 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.293 1.425 . . . . 0.0 114.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -86.82 155.55 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.035 1.418 . . . . 0.0 113.339 -171.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 73.0 m -140.4 157.19 45.91 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.275 1.83 . . . . 0.0 109.57 166.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -149.5 162.7 39.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.628 1.571 . . . . 0.0 108.941 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.2 m -90.05 152.05 21.35 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.3 153.26 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.111 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -76.74 161.71 73.03 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 166.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -53.38 -23.85 25.57 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 116.361 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -80.8 -8.84 59.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.076 2.15 . . . . 0.0 114.924 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.85 -1.27 59.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.34 1.447 . . . . 0.0 115.454 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.3 m -72.61 127.42 32.51 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.699 1.75 . . . . 0.0 108.863 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -71.83 165.92 23.11 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -99.83 92.8 2.11 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -68.85 23.2 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.863 1 C-N-CA 126.021 4.481 . . . . 0.0 117.907 -166.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -124.77 -3.4 7.73 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.278 1.831 . . . . 0.0 112.465 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.9 p -84.95 -20.71 30.19 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.147 0.979 . . . . 0.0 113.067 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -57.25 97.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.076 1.351 . . . . 0.0 112.566 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -131.78 168.38 17.9 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.301 1.84 . . . . 0.0 111.992 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.44 21.8 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 128.108 2.563 . . . . 0.0 112.375 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 174.47 45.84 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.752 1.168 . . . . 0.0 113.219 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -62.82 164.08 8.5 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.059 1.744 . . . . 0.0 114.016 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 162.86 40.41 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.822 1.249 . . . . 0.0 111.212 175.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.07 63.44 7.64 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.952 1.701 . . . . 0.0 111.812 -169.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 78.6 m -53.45 105.83 0.15 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.55 1.14 . . . . 0.0 113.335 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 p -150.05 13.89 0.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.8 1.64 . . . . 0.0 114.77 -169.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.46 7.28 0.23 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.33 2.252 . . . . 0.0 115.755 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 C--N 1.33 -0.282 0 C-N-CA 130.541 3.536 . . . . 0.0 114.112 168.048 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 160.32 19.51 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.802 1.641 . . . . 0.0 111.137 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -46.39 -53.21 11.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 39.9 t -58.13 -55.92 28.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.496 0.318 . . . . 0.0 111.419 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.98 -41.7 71.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.005 0.922 . . . . 0.0 112.612 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.03 -60.58 3.37 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.889 1.276 . . . . 0.0 109.893 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.63 -46.23 77.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.172 0.442 . . . . 0.0 111.77 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.86 -30.82 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.342 0.657 . . . . 0.0 111.745 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 p -79.72 -3.83 49.2 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -125.78 -21.96 4.3 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.698 1.136 . . . . 0.0 113.997 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.52 137.44 97.08 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 167.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.99 168.65 16.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 121.879 1.72 . . . . 0.0 112.511 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.43 -45.8 68.27 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.541 -0.724 . . . . 0.0 110.318 169.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 t -77.82 71.65 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.99 1.316 . . . . 0.0 108.784 171.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -113.95 -9.06 0.1 Allowed Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -42.87 112.4 0.27 Allowed 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.441 2.761 . . . . 0.0 114.242 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -46.17 1.1 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.211 1.862 . . . . 0.0 108.672 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.6 t -85.61 141.7 29.62 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.802 1.241 . . . . 0.0 111.732 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -64.18 163.98 11.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.789 1.236 . . . . 0.0 109.391 166.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -142.54 125.21 9.11 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 127.064 2.146 . . . . 0.0 108.947 173.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -62.73 170.29 7.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.615 2.21 . . . . 0.0 115.843 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -131.84 148.77 52.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.746 2.418 . . . . 0.0 109.146 169.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.87 155.34 46.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p30 -86.14 175.46 8.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.254 1.421 . . . . 0.0 113.05 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.95 -18.18 43.49 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.19 7.66 36.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.329 1.852 . . . . 0.0 111.782 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.23 8.0 41.55 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.344 1.45 . . . . 0.0 114.632 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -91.19 167.65 12.18 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.749 1.62 . . . . 0.0 109.135 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -58.35 133.4 55.69 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.937 -0.477 . . . . 0.0 110.542 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -57.16 133.32 80.75 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.531 170.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -51.24 -30.21 32.26 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.519 2.813 . . . . 0.0 115.566 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.55 137.87 42.68 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.884 1.674 . . . . 0.0 109.262 169.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -123.74 147.2 47.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.708 1.203 . . . . 0.0 108.358 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.68 155.49 48.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.109 0.964 . . . . 0.0 110.224 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.47 91.02 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.328 1.061 . . . . 0.0 111.157 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -13.19 34.99 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 117.564 1.785 . . . . 0.0 117.564 -169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.2 p -69.8 -23.65 63.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.159 1.98 . . . . 0.0 112.655 171.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.1 pt -120.44 -19.26 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.906 1.683 . . . . 0.0 112.492 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.58 10.27 84.6 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.547 1.546 . . . . 0.0 114.753 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -83.51 157.92 22.2 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.525 1.163 . . . . 0.0 110.755 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.6 m -135.11 163.63 29.47 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.826 1.25 . . . . 0.0 112.416 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -150.87 163.3 38.98 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.144 1.778 . . . . 0.0 109.755 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -89.76 151.85 21.61 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 169.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.2 154.42 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.232 1.013 . . . . 0.0 110.923 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -75.77 162.97 70.05 Favored Pre-proline 0 CA--C 1.552 1.047 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.26 -23.38 23.09 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.878 3.052 . . . . 0.0 116.508 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -82.79 -11.88 57.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.624 1.97 . . . . 0.0 114.691 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.42 49.19 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.457 1.503 . . . . 0.0 115.826 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 m -69.64 119.24 13.58 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.762 1.781 . . . . 0.0 109.575 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -57.01 138.5 54.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.914 0.886 . . . . 0.0 112.942 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.3 t -83.73 107.66 11.01 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.18 152.93 77.2 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -169.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 71.42 -3.62 2.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 128.438 2.695 . . . . 0.0 114.396 -173.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.2 p -79.24 -19.98 49.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.222 1.374 . . . . 0.0 112.072 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.1 97.46 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.26 1.424 . . . . 0.0 110.293 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.9 t -137.66 168.78 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.129 1.372 . . . . 0.0 113.217 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -7.73 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 129.324 3.05 . . . . 0.0 115.084 -173.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.21 -169.18 40.3 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.654 1.121 . . . . 0.0 113.422 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -51.99 150.66 4.13 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.999 2.52 . . . . 0.0 114.777 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.96 164.63 38.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.794 1.238 . . . . 0.0 110.92 170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -95.54 66.61 2.79 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.871 1.268 . . . . 0.0 111.602 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.5 m -60.12 134.86 57.45 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.055 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.6 m 49.81 27.09 2.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.312 1.045 . . . . 0.0 113.406 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 62.97 20.54 12.33 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.748 2.419 . . . . 0.0 114.462 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 125.9 1.68 . . . . 0.0 112.549 177.259 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -83.26 167.7 17.41 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.39 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -52.94 -39.21 62.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.298 0.639 . . . . 0.0 112.099 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 t -59.57 -59.68 5.05 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.599 0.759 . . . . 0.0 110.9 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.75 -37.13 78.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.632 0.773 . . . . 0.0 112.537 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.11 -58.66 7.43 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.152 1.381 . . . . 0.0 110.841 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -56.94 -41.04 77.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.488 0.585 . . . . 0.0 112.108 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.04 -29.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.333 1.053 . . . . 0.0 112.365 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 m -72.59 -42.83 64.12 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.762 0.825 . . . . 0.0 112.274 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -78.85 -37.3 40.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.809 1.244 . . . . 0.0 113.265 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.4 mt -90.75 104.33 9.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -71.24 169.13 21.45 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.186 1.924 . . . . 0.0 111.294 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.91 -24.55 38.25 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.44 68.48 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 0.0 108.873 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -104.34 8.81 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -41.96 136.67 3.4 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.452 2.768 . . . . 0.0 115.234 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.07 -18.56 35.41 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.888 1.708 . . . . 0.0 113.494 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.4 p -130.34 166.69 19.87 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.177 1.488 . . . . 0.0 114.362 -169.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -82.78 145.05 29.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.613 1.565 . . . . 0.0 110.733 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -133.7 123.95 17.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.944 1.698 . . . . 0.0 107.96 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.98 175.61 4.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.848 1.699 . . . . 0.0 114.569 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -136.83 146.36 45.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.826 2.05 . . . . 0.0 109.206 171.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 m -135.17 153.42 51.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.102 0.865 . . . . 0.0 112.301 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -95.48 -176.38 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.524 1.129 . . . . 0.0 114.03 -173.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -61.14 -24.3 66.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -86.56 8.69 21.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.236 1.414 . . . . 0.0 112.667 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.15 2.08 12.38 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.472 1.511 . . . . 0.0 114.833 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -82.87 169.59 15.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.523 1.529 . . . . 0.0 108.553 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -61.29 133.63 56.09 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.651 -0.656 . . . . 0.0 109.6 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.14 145.59 72.94 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.75 -14.28 38.81 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.881 1.72 . . . . 0.0 114.144 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.6 tp -110.63 135.51 51.15 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.172 2.189 . . . . 0.0 107.978 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -128.7 150.11 50.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.444 1.098 . . . . 0.0 109.491 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 71.9 m -140.68 134.83 30.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.269 0.628 . . . . 0.0 112.216 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.69 73.61 9.71 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.39 15.79 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.685 1.612 . . . . 0.0 114.598 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -63.68 -11.67 27.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.86 -5.28 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.481 1.513 . . . . 0.0 112.421 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.45 8.29 83.71 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.88 1.705 . . . . 0.0 115.629 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -83.91 148.1 27.13 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.093 1.447 . . . . 0.0 110.733 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.5 m -135.34 164.02 28.69 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.224 1.01 . . . . 0.0 113.037 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -149.35 163.58 37.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.689 1.996 . . . . 0.0 109.038 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.5 m -88.86 155.14 19.71 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.43 156.38 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.381 1.072 . . . . 0.0 111.796 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -76.46 164.81 57.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 166.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -51.83 -29.96 36.51 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.474 2.783 . . . . 0.0 115.893 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.61 -6.34 56.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.131 2.172 . . . . 0.0 114.643 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.12 0.93 65.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.626 1.108 . . . . 0.0 115.189 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.7 m -70.99 126.49 29.71 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.733 1.766 . . . . 0.0 108.588 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -68.82 161.86 27.65 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.25 95.13 3.15 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.16 23.62 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.916 1 C-N-CA 125.836 4.357 . . . . 0.0 117.82 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -125.04 -3.66 7.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.426 1.891 . . . . 0.0 112.398 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.6 p -86.4 -19.94 28.96 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.056 0.942 . . . . 0.0 113.192 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.93 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.511 1.525 . . . . 0.0 111.351 -169.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.0 m -132.22 165.49 24.0 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.154 1.382 . . . . 0.0 113.177 -168.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -5.13 1.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.399 3.08 . . . . 0.0 115.02 176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.13 -173.1 39.93 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.093 1.806 . . . . 0.0 112.355 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -59.29 164.85 2.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.375 1.87 . . . . 0.0 114.41 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 167.98 28.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.454 1.501 . . . . 0.0 110.547 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -84.25 57.43 4.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.523 1.929 . . . . 0.0 112.458 -168.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.9 m -66.92 159.34 28.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.97 -0.456 . . . . 0.0 111.286 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.1 m -154.98 20.76 0.44 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.23 -1.544 . . . . 0.0 114.991 172.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -70.52 21.44 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.811 2.445 . . . . 0.0 115.11 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 128.219 2.608 . . . . 0.0 110.328 -178.25 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.0 p -82.76 167.7 17.9 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.785 0.834 . . . . 0.0 111.32 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -54.28 -40.04 67.49 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.436 -0.79 . . . . 0.0 111.761 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -56.86 -60.28 3.8 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.737 0.815 . . . . 0.0 110.939 171.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -59.57 -36.66 76.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.252 0.621 . . . . 0.0 112.477 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.75 -57.56 11.41 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.689 1.196 . . . . 0.0 110.875 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -52.69 -47.74 67.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.95 0.796 . . . . 0.0 111.459 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.95 -24.9 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.328 1.451 . . . . 0.0 112.426 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -91.01 3.93 53.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.235 1.814 . . . . 0.0 115.102 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -130.51 -33.16 1.67 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.187 1.358 . . . . 0.0 113.426 -174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.9 mt -75.17 138.56 72.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.99 158.52 53.78 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 111.357 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.56 84.74 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.838 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.62 66.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.769 1.227 . . . . 0.0 109.135 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -85.54 -6.64 0.11 Allowed Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -43.72 107.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 123.881 3.054 . . . . 0.0 114.554 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.89 -20.48 6.0 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.619 2.057 . . . . 0.0 112.909 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 t -138.83 178.0 7.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.625 1.57 . . . . 0.0 112.215 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -80.68 159.07 25.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.245 1.818 . . . . 0.0 111.035 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttt-85 -148.86 117.64 3.95 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.336 1.455 . . . . 0.0 109.34 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 174.68 4.57 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.17 1.913 . . . . 0.0 114.221 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -138.78 147.77 43.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.033 2.133 . . . . 0.0 108.905 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -132.75 157.67 44.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.254 0.934 . . . . 0.0 113.043 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -103.29 -178.27 3.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.751 1.621 . . . . 0.0 114.721 -169.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -15.56 27.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.968 1.707 . . . . 0.0 115.044 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -102.01 13.53 34.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.922 1.689 . . . . 0.0 111.886 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.19 3.94 20.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.328 1.442 . . . . 0.0 114.561 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -85.34 167.12 15.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.667 1.587 . . . . 0.0 109.343 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -61.0 124.1 19.51 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -53.83 128.71 55.13 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 117.394 -1.289 . . . . 0.0 108.697 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.39 -9.51 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.074 3.183 . . . . 0.0 117.915 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.43 127.85 54.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.772 2.429 . . . . 0.0 107.622 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.15 150.62 41.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.082 0.953 . . . . 0.0 109.721 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.3 m -138.12 153.83 49.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.893 0.854 . . . . 0.0 112.641 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.37 70.02 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.266 2.226 . . . . 0.0 107.668 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -50.84 -34.39 29.64 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.088 1.328 . . . . 0.0 113.991 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 m -53.13 -22.62 6.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.862 2.065 . . . . 0.0 115.191 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -121.39 -0.33 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.444 1.498 . . . . 0.0 112.615 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.27 6.3 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.354 0.978 . . . . 0.0 111.339 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -143.3 158.62 43.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.0 m -141.23 161.57 37.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 127.177 2.191 . . . . 0.0 110.077 167.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -150.21 161.64 42.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.74 1.616 . . . . 0.0 109.366 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.1 m -85.98 153.73 21.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.85 159.28 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.38 1.072 . . . . 0.0 111.708 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -82.01 160.54 63.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.62 -26.21 22.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.785 2.99 . . . . 0.0 116.664 -172.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.1 -5.16 55.44 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.4 0.59 50.36 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.697 1.618 . . . . 0.0 114.806 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.8 m -67.9 108.62 3.09 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.165 1.482 . . . . 0.0 110.686 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -56.62 129.89 42.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.263 1.025 . . . . 0.0 112.979 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.48 110.69 26.17 Favored Pre-proline 0 C--O 1.241 0.617 0 C-N-CA 125.465 1.506 . . . . 0.0 107.97 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.8 161.2 33.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.595 2.197 . . . . 0.0 111.758 -173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 62.47 -5.23 0.19 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.948 2.099 . . . . 0.0 115.445 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 p -76.69 -24.89 53.17 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.345 1.429 . . . . 0.0 111.339 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -50.23 102.95 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.525 1.93 . . . . 0.0 111.106 -174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -144.33 167.74 21.74 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.448 1.099 . . . . 0.0 111.127 -170.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 -74.79 4.56 6.18 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.79 43.82 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.684 1.611 . . . . 0.0 112.252 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -58.18 161.77 3.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.956 1.702 . . . . 0.0 114.439 -171.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.55 165.73 34.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 110.589 172.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -86.4 62.85 7.67 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.274 1.83 . . . . 0.0 111.223 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.6 m -65.14 164.1 13.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.5 m -70.25 63.53 0.24 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.828 1.651 . . . . 0.0 111.852 174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -52.07 22.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.438 4.295 . . . . 0.0 121.375 -167.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.8 p . . . . . 0 N--CA 1.474 0.738 0 O-C-N 119.9 -1.75 . . . . 0.0 113.649 170.002 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.3 p -82.88 166.98 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.882 0.873 . . . . 0.0 111.525 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -54.41 -37.99 65.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.513 -0.742 . . . . 0.0 112.406 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 t -60.84 -59.77 4.85 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.727 0.811 . . . . 0.0 110.9 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -58.54 -39.11 79.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.286 0.634 . . . . 0.0 112.7 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -60.55 -56.2 24.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.293 1.437 . . . . 0.0 110.986 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -56.61 -44.04 80.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.766 0.426 . . . . 0.0 111.587 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.57 -28.11 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.235 1.014 . . . . 0.0 112.277 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 m -83.49 3.85 30.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.016 1.727 . . . . 0.0 114.03 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -124.78 -35.66 2.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.528 1.131 . . . . 0.0 111.805 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -94.08 105.95 19.98 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.51 171.33 18.44 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.614 2.209 . . . . 0.0 111.822 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.56 39.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.082 0.953 . . . . 0.0 113.403 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.98 76.7 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.983 1.313 . . . . 0.0 108.051 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.45 46.7 0.46 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.42 129.03 25.33 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.699 2.266 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.04 -7.51 66.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.158 1.361 . . . . 0.0 114.323 -173.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.2 t -123.28 161.26 24.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.629 1.714 . . . . 0.0 113.56 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -78.1 160.41 28.08 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.477 1.511 . . . . 0.0 107.708 165.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -147.79 127.32 6.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.497 2.319 . . . . 0.0 107.098 169.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.73 171.37 9.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.493 1.462 . . . . 0.0 114.111 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -135.28 137.44 42.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.595 2.358 . . . . 0.0 108.82 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.92 154.86 49.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.652 0.781 . . . . 0.0 111.216 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -79.86 173.56 12.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.937 0.895 . . . . 0.0 112.267 171.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -61.79 -16.74 52.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.76 -5.71 59.33 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.364 1.865 . . . . 0.0 111.523 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.43 2.07 89.14 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 125.532 1.539 . . . . 0.0 114.627 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -78.47 147.29 33.99 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.124 1.462 . . . . 0.0 109.106 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -54.84 123.77 14.47 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.915 0.886 . . . . 0.0 110.104 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.2 mt -57.06 145.03 67.16 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.65 -18.58 59.11 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.508 2.138 . . . . 0.0 114.291 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -109.91 131.67 54.85 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.795 2.438 . . . . 0.0 108.541 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -119.64 146.94 45.1 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.871 1.269 . . . . 0.0 109.417 171.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.64 128.88 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.35 71.31 10.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.681 1.592 . . . . 0.0 106.991 169.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -49.63 -37.2 26.54 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.513 1.53 . . . . 0.0 114.401 -170.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -63.31 -10.41 16.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.0 pt -125.01 -0.47 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 112.453 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.7 -5.05 76.51 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.667 1.603 . . . . 0.0 115.498 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -81.83 151.23 27.46 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.028 1.414 . . . . 0.0 111.493 -172.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.2 m -137.38 164.99 27.28 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.255 1.022 . . . . 0.0 112.518 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -148.4 163.96 35.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.8 2.04 . . . . 0.0 109.227 169.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.8 157.03 18.61 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.668 -0.645 . . . . 0.0 109.771 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.45 161.4 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.87 162.66 46.44 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.715 1.606 . . . . 0.0 108.697 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.81 -15.28 9.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.995 3.13 . . . . 0.0 118.027 -172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -95.55 0.78 53.39 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.103 1.361 . . . . 0.0 114.083 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 2.47 62.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.197 1.38 . . . . 0.0 114.804 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.3 m -71.23 130.38 41.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.122 1.461 . . . . 0.0 109.624 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -60.53 137.94 58.1 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.4 t -83.42 109.15 15.97 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.01 155.95 47.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.832 2.354 . . . . 0.0 113.141 -168.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 61.68 -0.24 0.43 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.135 2.174 . . . . 0.0 115.818 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 p -72.79 -32.01 65.27 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.106 1.321 . . . . 0.0 110.77 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.76 106.38 0.11 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.934 1.694 . . . . 0.0 111.967 -169.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -137.21 165.82 25.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.013 1.325 . . . . 0.0 113.103 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.84 -6.27 2.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.734 2.814 . . . . 0.0 114.216 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.89 -175.66 39.04 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.219 1.866 . . . . 0.0 112.559 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -58.04 161.97 3.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.823 2.049 . . . . 0.0 114.067 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.13 167.11 31.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.611 1.164 . . . . 0.0 111.771 172.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -82.61 61.53 5.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.448 2.299 . . . . 0.0 112.023 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.7 m -58.4 111.28 1.17 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.4 p -72.69 69.94 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.062 1.745 . . . . 0.0 112.281 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 57.44 11.11 1.09 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.645 2.378 . . . . 0.0 115.783 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 C--N 1.329 -0.286 0 C-N-CA 128.128 2.571 . . . . 0.0 110.32 169.678 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 120.555 0.217 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -145.98 -178.83 6.32 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.149 1.38 . . . . 0.0 110.16 169.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -47.32 -33.02 5.25 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 0.0 112.369 169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.9 t -57.47 -68.5 0.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.235 0.614 . . . . 0.0 111.191 171.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -54.55 -39.77 68.06 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.44 1.096 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.94 -60.34 3.6 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.679 1.192 . . . . 0.0 110.282 173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -54.32 -48.2 71.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.272 0.629 . . . . 0.0 111.908 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.06 -34.32 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.699 0.4 . . . . 0.0 111.261 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.6 p -80.97 -2.1 46.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -130.22 -23.58 2.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -67.33 137.74 93.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 165.15 27.08 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.007 1.805 . . . . 0.0 111.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.0 -33.76 72.45 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.523 -0.736 . . . . 0.0 111.564 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -83.79 77.81 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 125.388 1.475 . . . . 0.0 107.927 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -118.68 53.2 1.83 Allowed Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.383 1.073 . . . . 0.0 113.542 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -61.83 139.05 77.94 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.885 2.39 . . . . 0.0 110.853 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.48 11.51 0.78 Allowed Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.266 1.412 . . . . 0.0 115.544 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -120.41 136.92 54.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.436 1.495 . . . . 0.0 110.928 -168.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -66.05 154.68 38.86 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -169.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -148.83 125.33 5.31 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.864 2.066 . . . . 0.0 108.523 168.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 178.3 7.04 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.274 1.983 . . . . 0.0 112.66 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -139.17 151.53 46.68 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.876 2.071 . . . . 0.0 109.764 170.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.77 154.46 51.22 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -86.25 175.36 8.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.304 1.442 . . . . 0.0 113.206 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.53 -21.06 59.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -84.9 6.31 25.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.348 1.859 . . . . 0.0 111.862 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.34 4.93 39.88 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.955 1.74 . . . . 0.0 114.889 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -90.5 164.73 14.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.831 2.052 . . . . 0.0 109.759 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.65 127.87 33.3 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.917 -0.489 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.35 141.2 62.96 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.826 175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.5 -30.94 12.73 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.339 3.359 . . . . 0.0 116.251 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.2 tp -107.93 129.99 55.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.445 1.898 . . . . 0.0 108.855 169.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -112.52 140.09 47.56 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.681 1.193 . . . . 0.0 108.609 169.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.1 m -130.56 119.7 22.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 122.069 0.938 . . . . 0.0 110.669 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.25 66.59 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.24 1.816 . . . . 0.0 106.501 172.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.23 -27.12 64.78 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.564 1.554 . . . . 0.0 114.402 -169.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.5 p -61.97 -11.99 16.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.66 1.584 . . . . 0.0 114.267 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 pt -127.48 -3.54 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.643 1.977 . . . . 0.0 111.705 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.69 20.32 79.56 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 126.412 1.958 . . . . 0.0 115.749 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -95.48 158.95 15.23 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.842 1.821 . . . . 0.0 111.28 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.37 164.88 29.03 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.383 0.673 . . . . 0.0 112.746 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -149.51 164.18 35.78 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.785 2.034 . . . . 0.0 109.277 168.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.83 150.67 22.79 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.45 156.48 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.519 0.728 . . . . 0.0 111.737 172.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.5 158.59 81.05 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.121 -1.436 . . . . 0.0 107.121 165.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.55 -22.3 16.41 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.655 2.903 . . . . 0.0 117.091 -171.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -82.24 -5.46 58.53 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.421 1.489 . . . . 0.0 114.694 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.74 -0.47 48.88 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.679 1.609 . . . . 0.0 114.968 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.1 m -69.88 114.54 8.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.124 1.462 . . . . 0.0 110.539 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.92 136.81 55.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.729 0.812 . . . . 0.0 112.676 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.01 114.3 51.7 Favored Pre-proline 0 C--O 1.24 0.572 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -45.14 137.45 10.05 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.487 3.458 . . . . 0.0 115.58 -169.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.25 9.66 4.13 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.756 2.023 . . . . 0.0 114.843 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -78.11 -22.38 48.99 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.01 1.277 . . . . 0.0 111.604 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 105.17 0.11 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.197 0.999 . . . . 0.0 111.724 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -144.74 171.1 14.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.086 1.354 . . . . 0.0 112.999 -169.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -0.06 2.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 129.87 3.268 . . . . 0.0 114.922 -174.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.64 -176.58 48.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.218 1.389 . . . . 0.0 113.01 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -56.54 159.06 3.99 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.216 2.207 . . . . 0.0 114.174 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.51 166.29 33.99 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.479 1.111 . . . . 0.0 111.906 174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.75 67.44 9.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.028 1.731 . . . . 0.0 111.535 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 84.4 m -59.05 111.48 1.33 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.9 p -70.36 76.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 112.079 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.274 10.5 pt-20 48.91 19.15 0.24 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 128.511 2.724 . . . . 0.0 116.413 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 127.345 2.258 . . . . 0.0 110.374 169.931 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.996 0.427 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 p -83.72 167.92 16.73 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.32 1.048 . . . . 0.0 110.754 171.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -55.15 -39.24 69.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.443 -0.786 . . . . 0.0 112.239 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.1 t -62.18 -59.81 4.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.67 0.788 . . . . 0.0 111.03 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -58.0 -36.54 72.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.58 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.47 -59.23 5.74 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.366 1.066 . . . . 0.0 110.631 172.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.29 -42.1 81.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.414 0.552 . . . . 0.0 112.079 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.65 -32.27 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.262 1.025 . . . . 0.0 111.908 174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 m -86.51 7.93 24.04 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.178 1.791 . . . . 0.0 114.063 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -124.94 -38.77 2.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.449 1.1 . . . . 0.0 111.376 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.41 108.03 20.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 168.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -70.4 160.08 50.75 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.148 1.899 . . . . 0.0 111.47 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.63 61.08 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.89 67.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 108.927 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -99.11 5.31 0.07 OUTLIER Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -41.91 112.69 0.24 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.506 2.804 . . . . 0.0 115.609 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.99 28.44 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.118 1.818 . . . . 0.0 113.318 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.2 t -117.44 159.16 23.25 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.214 1.806 . . . . 0.0 111.972 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -71.38 157.87 37.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -148.54 130.14 7.35 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.499 1.919 . . . . 0.0 107.597 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.91 170.99 17.5 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.19 1.927 . . . . 0.0 112.509 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -144.14 150.5 38.17 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.18 1.792 . . . . 0.0 110.073 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -133.11 158.39 42.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.95 1.3 . . . . 0.0 111.208 -173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -89.38 179.64 6.04 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.282 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -16.82 49.07 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -173.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -84.64 -3.28 58.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.167 0.987 . . . . 0.0 112.61 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 8.93 82.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.215 0.912 . . . . 0.0 113.74 -171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.46 HD21 ' HB3' ' A' ' 65' ' ' SER . 4.0 t30 -80.34 147.97 30.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.72 1.208 . . . . 0.0 109.008 172.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -51.98 126.97 19.89 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.089 0.956 . . . . 0.0 111.403 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.86 131.63 82.99 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.08 -30.05 30.35 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.24 2.627 . . . . 0.0 115.543 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.4 140.37 34.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.604 1.961 . . . . 0.0 109.482 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -131.72 149.82 52.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.087 1.355 . . . . 0.0 109.004 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 79.4 m -142.28 132.33 24.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -172.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.92 72.0 9.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 168.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.93 -39.14 17.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.215 1.388 . . . . 0.0 114.784 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -60.9 -16.11 38.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 pt -119.66 1.88 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.191 1.396 . . . . 0.0 112.435 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.94 69.26 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.811 1.672 . . . . 0.0 115.224 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -83.31 143.4 30.4 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.71 1.255 . . . . 0.0 111.974 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.7 m -131.18 164.81 24.7 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.645 1.178 . . . . 0.0 112.12 170.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.9 p90 -153.15 165.4 35.75 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.233 1.813 . . . . 0.0 109.376 170.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.9 m -89.66 154.16 20.17 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 122.027 -0.421 . . . . 0.0 110.241 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.81 160.29 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.874 0.87 . . . . 0.0 113.122 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.47 167.22 17.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.675 1.59 . . . . 0.0 110.714 167.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -58.82 -2.21 1.03 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 124.845 3.696 . . . . 0.0 118.614 -170.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -111.31 2.32 17.6 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.45 1.9 . . . . 0.0 113.562 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.69 2.34 61.48 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.227 1.394 . . . . 0.0 114.352 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.5 m -67.13 111.62 4.0 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.183 1.491 . . . . 0.0 110.108 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -56.09 138.34 49.73 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.705 1.602 . . . . 0.0 113.06 174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.68 100.1 1.01 Allowed Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.946 1.698 . . . . 0.0 106.826 168.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.17 19.32 0.3 Allowed 'Trans proline' 0 C--N 1.354 0.868 1 C-N-CA 125.506 4.137 . . . . 0.0 117.127 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -123.73 -1.28 8.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.847 2.059 . . . . 0.0 112.875 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 p -96.3 -15.08 22.13 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.359 1.064 . . . . 0.0 112.843 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.616 HH22 ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.24 111.46 0.78 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.416 1.086 . . . . 0.0 109.877 -173.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 t -148.23 167.39 25.23 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.616 ' NH1' HH22 ' A' ' 55' ' ' ARG . 5.4 mpt_? -77.2 12.06 1.62 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.626 2.77 . . . . 0.0 113.598 -173.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.65 176.99 47.54 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.904 1.24 . . . . 0.0 112.747 175.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -57.6 157.98 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.61 1.964 . . . . 0.0 113.28 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.1 168.11 28.12 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.124 0.97 . . . . 0.0 111.821 176.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -87.76 65.74 8.53 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.771 1.628 . . . . 0.0 111.795 -168.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.4 m -66.69 161.11 24.14 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.4 m -157.72 19.01 0.26 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.833 1.253 . . . . 0.0 114.171 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.51 25.18 0.19 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.303 1.841 . . . . 0.0 113.812 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.46 ' HB3' HD21 ' A' ' 28' ' ' ASN . 57.7 m . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.481 1.512 . . . . 0.0 111.565 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.4 p -83.42 168.24 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.403 0.681 . . . . 0.0 111.661 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -51.06 -42.64 60.68 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 0.0 112.207 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.65 -58.91 6.49 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.954 0.343 . . . . 0.0 111.45 171.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -59.27 -34.41 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.072 -0.49 . . . . 0.0 111.97 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.74 -61.83 2.23 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.579 1.152 . . . . 0.0 110.359 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -51.41 -49.66 61.2 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.182 0.993 . . . . 0.0 111.59 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.57 -27.39 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.067 0.947 . . . . 0.0 111.357 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -86.2 2.77 45.72 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.224 1.81 . . . . 0.0 114.602 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -128.86 -25.62 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.192 1.36 . . . . 0.0 113.838 -174.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.65 136.15 92.51 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 169.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.4 169.39 15.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.947 1.765 . . . . 0.0 112.074 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.81 -40.18 72.64 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.609 -0.682 . . . . 0.0 110.868 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.15 74.36 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.07 1.348 . . . . 0.0 108.498 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.47 15.85 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.49 110.36 1.22 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 CA-C-N 123.636 2.334 . . . . 0.0 110.734 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.96 -15.37 8.92 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.567 1.556 . . . . 0.0 113.134 -169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.0 t -124.87 148.81 48.08 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.474 1.509 . . . . 0.0 110.756 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -77.27 165.25 24.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.961 0.904 . . . . 0.0 112.624 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttt85 -138.85 106.97 7.51 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.122 1.769 . . . . 0.0 109.864 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -55.51 155.67 20.33 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.29 2.66 . . . . 0.0 115.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -122.27 128.81 51.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 127.995 2.518 . . . . 0.0 108.809 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 29' ' ' TYR . 76.0 m -143.19 157.74 44.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 122.012 0.91 . . . . 0.0 111.885 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -79.24 176.93 9.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.326 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.2 -24.64 63.29 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -84.61 7.98 18.35 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.977 1.711 . . . . 0.0 111.668 174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.27 15.4 51.26 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.044 1.783 . . . . 0.0 114.634 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.86 149.77 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.728 1.211 . . . . 0.0 109.252 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 66.1 m-85 -69.0 120.69 15.26 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.715 0.806 . . . . 0.0 110.01 -170.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.31 128.87 83.0 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.638 -1.172 . . . . 0.0 108.898 -175.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.77 -22.45 9.8 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.773 2.982 . . . . 0.0 116.594 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.59 136.11 50.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.431 1.893 . . . . 0.0 109.228 169.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -123.69 148.92 46.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.475 1.51 . . . . 0.0 109.073 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -140.82 152.85 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.335 1.054 . . . . 0.0 110.1 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -127.09 88.2 2.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.325 1.06 . . . . 0.0 110.688 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.66 -12.93 36.42 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.841 1.686 . . . . 0.0 116.84 -169.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.2 p -66.25 -25.68 67.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.263 1.532 . . . . 0.0 112.833 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.6 pt -119.89 -17.09 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 112.515 173.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.29 9.25 85.27 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.515 1.531 . . . . 0.0 114.683 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -83.2 158.06 22.47 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.571 1.185 . . . . 0.0 110.95 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.1 m -133.82 164.97 26.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.618 1.167 . . . . 0.0 112.067 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.2 p90 -154.42 163.87 39.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.904 1.681 . . . . 0.0 109.498 169.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 71.4 m -90.64 150.42 21.7 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.693 0.797 . . . . 0.0 109.639 169.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.46 151.29 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.575 1.15 . . . . 0.0 110.208 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.3 155.4 91.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 166.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -54.9 -16.89 12.62 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.737 2.958 . . . . 0.0 117.372 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -83.23 -4.7 58.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.125 2.17 . . . . 0.0 114.996 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.29 -3.26 54.54 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.733 1.635 . . . . 0.0 114.873 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 m -73.83 111.6 9.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.628 1.214 . . . . 0.0 110.067 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -55.52 143.08 30.75 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.773 1.229 . . . . 0.0 113.804 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.94 89.04 0.7 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 168.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.18 -15.23 48.3 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.761 2.308 . . . . 0.0 117.435 -166.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -66.43 -12.96 59.92 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 127.217 2.207 . . . . 0.0 113.134 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.7 p -102.9 -2.62 27.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.923 1.689 . . . . 0.0 112.65 174.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 104.83 0.6 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.572 1.078 . . . . 0.0 109.447 -176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 t -141.39 162.04 36.45 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -168.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -7.84 3.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.847 3.259 . . . . 0.0 114.945 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.39 -174.53 42.96 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.107 0.86 . . . . 0.0 114.165 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -55.72 149.92 13.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.346 2.258 . . . . 0.0 113.982 -170.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -155.46 -176.51 5.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.833 1.653 . . . . 0.0 110.024 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -130.88 91.03 2.99 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.527 1.531 . . . . 0.0 110.201 -170.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.3 m -68.12 -176.2 0.68 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.625 2.37 . . . . 0.0 112.916 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -65.64 74.19 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.35 1.46 . . . . 0.0 111.126 169.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -122.51 18.64 10.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.13 1.772 . . . . 0.0 114.285 -168.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 126.101 1.76 . . . . 0.0 111.709 -177.321 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.3 p -83.09 167.19 18.07 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.706 0.803 . . . . 0.0 111.498 171.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -52.25 -39.66 60.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 112.382 171.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 t -59.59 -60.74 3.36 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.581 0.752 . . . . 0.0 110.949 171.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -58.88 -36.53 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.498 0.719 . . . . 0.0 112.458 -176.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.86 -58.03 10.34 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.876 1.271 . . . . 0.0 110.749 171.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -57.81 -43.17 85.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.233 0.47 . . . . 0.0 112.016 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.9 t -61.55 -34.55 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.309 0.643 . . . . 0.0 111.628 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.0 m -82.46 3.19 29.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.736 1.615 . . . . 0.0 114.338 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -127.59 -34.02 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.439 1.018 . . . . 0.0 112.416 -177.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.8 mt -87.27 114.25 57.7 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.2 161.28 40.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.33 2.02 . . . . 0.0 111.705 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.74 -18.43 42.87 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 175.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.02 78.9 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.302 1.441 . . . . 0.0 107.775 169.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -113.52 63.2 0.98 Allowed Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.025 1.33 . . . . 0.0 112.763 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.16 136.65 57.13 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.366 2.71 . . . . 0.0 111.255 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.96 11.76 1.05 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.376 1.465 . . . . 0.0 115.183 -173.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -125.97 162.89 24.21 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.661 1.585 . . . . 0.0 112.007 -168.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -88.79 155.02 19.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.781 1.632 . . . . 0.0 111.675 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.61 126.34 8.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.796 1.639 . . . . 0.0 108.65 168.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.54 174.03 12.86 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.191 1.928 . . . . 0.0 113.507 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 151.34 44.86 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.822 2.049 . . . . 0.0 110.015 173.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -132.63 157.38 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.625 -173.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -99.41 -175.64 3.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.564 1.146 . . . . 0.0 113.946 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -60.63 -24.97 65.94 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 177.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.14 8.65 20.1 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.238 1.415 . . . . 0.0 112.71 171.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.35 3.05 17.18 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.49 1.519 . . . . 0.0 114.794 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.19 170.68 11.92 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.682 1.593 . . . . 0.0 109.118 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -60.31 129.93 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 177.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.92 137.49 79.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.776 -1.106 . . . . 0.0 108.635 173.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.75 -22.78 10.27 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.495 2.796 . . . . 0.0 116.369 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.91 132.09 53.83 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.737 2.015 . . . . 0.0 109.319 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -122.8 147.78 46.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.628 1.171 . . . . 0.0 109.684 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -139.24 116.84 11.4 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -170.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 63.25 7.43 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.942 2.097 . . . . 0.0 106.531 168.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.63 -21.74 63.14 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.936 1.255 . . . . 0.0 114.945 -169.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.0 p -62.15 -15.0 42.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.87 1.268 . . . . 0.0 114.12 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -123.5 8.9 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 127.139 2.176 . . . . 0.0 111.724 169.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.18 5.05 89.16 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.963 1.744 . . . . 0.0 115.218 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -84.73 150.64 24.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.202 1.501 . . . . 0.0 114.142 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.9 m -143.77 163.37 33.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.897 1.679 . . . . 0.0 111.16 168.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.9 p90 -150.84 163.38 38.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.484 1.914 . . . . 0.0 108.731 169.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.4 m -86.88 154.31 20.95 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 169.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.29 157.88 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.203 1.001 . . . . 0.0 111.645 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -75.66 158.81 82.6 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 165.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.98 -13.68 38.89 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.386 2.057 . . . . 0.0 114.949 -169.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -79.8 -7.33 58.61 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.136 2.174 . . . . 0.0 115.103 169.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.69 -2.65 49.12 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 126.073 1.797 . . . . 0.0 115.132 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.9 m -73.33 116.78 14.28 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 1.408 . . . . 0.0 110.701 -175.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -57.32 133.38 55.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.025 1.33 . . . . 0.0 113.635 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -84.17 111.7 35.48 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 126.718 2.007 . . . . 0.0 108.557 172.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.14 156.62 4.99 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.875 3.05 . . . . 0.0 114.285 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 59.99 -2.88 0.13 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.864 2.066 . . . . 0.0 116.04 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 p -76.01 -26.43 56.66 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.115 1.325 . . . . 0.0 111.524 169.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -46.94 106.36 0.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.941 2.097 . . . . 0.0 111.783 -174.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.6 t -148.08 161.29 41.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.729 0.812 . . . . 0.0 111.714 -172.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -89.69 36.23 0.84 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.214 1.405 . . . . 0.0 113.087 174.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.68 170.74 41.33 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 127.028 2.251 . . . . 0.0 112.218 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -67.71 167.89 12.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.052 1.341 . . . . 0.0 112.85 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 166.9 32.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.724 1.21 . . . . 0.0 110.981 174.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -83.99 61.3 6.35 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.795 2.038 . . . . 0.0 111.627 -168.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 33.7 m -64.36 158.89 22.38 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.496 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.1 m -159.62 24.63 0.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -70.97 34.9 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.309 2.244 . . . . 0.0 113.412 177.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 126.313 1.845 . . . . 0.0 110.145 174.721 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 p -130.96 176.14 8.49 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.756 1.222 . . . . 0.0 112.777 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -48.57 -35.98 14.57 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.202 1.401 . . . . 0.0 112.446 169.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.7 t -62.22 -57.69 10.51 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.453 0.57 . . . . 0.0 110.884 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -57.46 -40.41 78.45 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.279 0.632 . . . . 0.0 112.637 177.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.96 -57.59 12.21 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.044 0.937 . . . . 0.0 110.578 174.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -54.53 -46.79 73.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.703 0.801 . . . . 0.0 111.672 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -67.34 -29.58 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 0.0 112.014 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 m -76.95 -36.04 56.82 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.266 1.026 . . . . 0.0 113.167 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -80.08 -32.66 39.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.311 1.044 . . . . 0.0 113.365 -175.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.48 131.4 95.07 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.45 167.84 24.17 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.276 1.984 . . . . 0.0 112.678 -176.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.32 -39.41 78.22 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.582 -0.699 . . . . 0.0 110.682 169.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -79.68 70.93 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.736 1.215 . . . . 0.0 108.914 171.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -114.29 -3.08 0.1 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -43.23 112.49 0.3 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 CA-C-N 124.458 2.628 . . . . 0.0 113.904 174.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.82 6.67 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.154 1.835 . . . . 0.0 111.667 -169.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.5 t -125.32 162.54 24.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.397 1.879 . . . . 0.0 112.729 178.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -70.0 159.16 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.169 2.188 . . . . 0.0 112.938 -176.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -142.0 113.99 6.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 127.589 2.355 . . . . 0.0 107.723 168.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -62.46 168.81 9.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.367 2.044 . . . . 0.0 114.245 176.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.96 142.04 51.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.849 2.46 . . . . 0.0 108.442 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -136.13 156.77 48.21 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.289 0.95 . . . . 0.0 112.071 -176.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.08 -177.28 3.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.12 -32.34 64.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.035 1.334 . . . . 0.0 113.462 176.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -84.5 11.39 8.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.869 1.268 . . . . 0.0 112.404 176.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.44 4.47 24.45 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.184 1.374 . . . . 0.0 114.371 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.22 169.88 11.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.814 1.307 . . . . 0.0 109.071 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -62.56 130.67 46.11 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -57.89 134.07 83.41 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 117.77 -1.109 . . . . 0.0 108.546 174.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -50.33 -26.07 15.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.037 2.492 . . . . 0.0 115.893 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.35 133.94 48.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.06 1.744 . . . . 0.0 109.142 168.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -121.76 149.28 43.51 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.632 169.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.27 148.43 43.01 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.496 0.665 . . . . 0.0 112.332 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.22 77.51 1.05 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.643 1.977 . . . . 0.0 107.81 -178.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -37.1 -54.54 1.53 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 127.6 2.524 . . . . 0.0 115.619 -169.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.6 p -63.79 -12.35 34.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -116.76 -5.6 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.343 1.057 . . . . 0.0 112.278 169.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.55 10.43 70.92 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.286 1.898 . . . . 0.0 115.246 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -83.41 155.7 23.34 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.621 1.21 . . . . 0.0 111.293 -179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.1 m -138.25 164.84 28.22 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.033 0.933 . . . . 0.0 112.423 170.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -148.94 164.03 35.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.595 1.958 . . . . 0.0 109.229 169.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.06 153.62 20.85 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.49 157.83 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 124.33 1.052 . . . . 0.0 111.595 173.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -77.81 160.77 73.56 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 165.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.28 -21.25 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.844 3.029 . . . . 0.0 117.358 -170.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -86.65 -3.0 58.97 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.792 1.637 . . . . 0.0 114.716 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.97 1.36 56.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.301 1.429 . . . . 0.0 114.899 -179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -71.31 117.45 12.86 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.134 1.467 . . . . 0.0 110.146 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -56.15 137.16 52.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.7 110.38 24.62 Favored Pre-proline 0 C--O 1.242 0.669 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 168.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.27 150.26 11.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.863 3.042 . . . . 0.0 114.408 -171.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.93 3.6 0.5 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.283 1.833 . . . . 0.0 115.585 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.0 p -73.71 -28.04 61.51 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.171 1.351 . . . . 0.0 110.926 169.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.88 102.83 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.695 1.998 . . . . 0.0 111.774 -176.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.5 m -136.13 164.22 28.55 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.079 1.352 . . . . 0.0 112.999 -168.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -4.75 0.81 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 130.03 3.332 . . . . 0.0 115.295 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.07 -175.77 41.12 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.592 1.567 . . . . 0.0 112.986 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -56.19 161.15 2.58 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.091 2.156 . . . . 0.0 113.698 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.09 171.03 20.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.751 1.221 . . . . 0.0 111.294 174.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -89.31 68.78 8.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.396 1.878 . . . . 0.0 110.488 -168.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 32.8 m -68.92 -178.66 1.27 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.803 0.811 . . . . 0.0 112.003 174.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.1 m -66.95 35.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.162 2.185 . . . . 0.0 116.682 -173.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -69.51 66.17 0.2 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 110.514 169.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.468 0.426 0 C-N-CA 126.063 1.745 . . . . 0.0 112.477 -172.344 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.556 0.694 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -142.31 168.11 20.51 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.844 2.858 . . . . 0.0 108.695 177.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -52.17 -39.53 60.19 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 0.0 112.734 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 t -59.62 -61.46 2.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.603 0.761 . . . . 0.0 111.518 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.45 -31.22 71.16 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -61.24 -58.58 7.69 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.701 1.6 . . . . 0.0 110.517 170.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.79 -43.87 81.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.45 0.568 . . . . 0.0 111.954 177.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.29 -36.39 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.617 0.644 . . . . 0.0 111.712 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -68.68 -45.35 71.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.884 0.874 . . . . 0.0 112.353 173.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -77.81 -26.24 49.42 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.581 1.152 . . . . 0.0 113.47 -176.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.98 94.98 19.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.975 1.71 . . . . 0.0 108.06 179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.89 154.06 58.38 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.055 1.836 . . . . 0.0 109.994 169.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.51 -36.04 66.26 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.45 73.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 109.059 178.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.633 ' CE1' ' H ' ' A' ' 19' ' ' PHE . 7.0 p80 -132.67 151.09 77.51 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.932 0.893 . . . . 0.0 112.826 175.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.9 155.19 69.35 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.382 2.721 . . . . 0.0 110.94 171.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 54.8 40.66 72.73 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -169.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 107.99 0.17 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.2 2.6 . . . . 0.0 114.487 -168.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.633 ' H ' ' CE1' ' A' ' 15' ' ' HIS . 2.4 t80 -152.64 89.1 1.38 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 130.654 3.582 . . . . 0.0 108.084 172.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -84.56 124.52 73.23 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 169.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.04 175.0 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.578 1.518 . . . . 0.0 111.118 169.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.08 153.67 36.83 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.688 1.195 . . . . 0.0 111.759 177.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.8 m -132.84 158.59 42.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 113.021 -169.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -95.76 -178.93 4.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.263 1.425 . . . . 0.0 113.698 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pm0 -62.43 -10.38 11.36 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -100.68 8.24 43.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.408 1.883 . . . . 0.0 111.619 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.62 6.07 27.14 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.963 1.268 . . . . 0.0 114.434 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -90.23 164.75 14.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.543 1.537 . . . . 0.0 108.876 178.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -61.35 132.62 54.11 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.851 -0.53 . . . . 0.0 110.082 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -58.43 139.36 85.0 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.873 175.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.45 -21.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.292 3.328 . . . . 0.0 117.374 -175.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -113.98 135.63 53.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.656 1.982 . . . . 0.0 109.37 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.81 151.74 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.654 1.181 . . . . 0.0 109.11 169.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 76.2 m -140.65 120.42 13.45 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.342 1.057 . . . . 0.0 113.238 -172.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.38 72.92 9.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.427 1.108 . . . . 0.0 108.416 172.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -42.49 -47.95 5.79 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.708 2.099 . . . . 0.0 115.133 -169.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 p -60.95 -14.44 22.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.7 pt -118.7 -6.91 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 120.016 1.28 . . . . 0.0 113.083 170.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.8 -3.74 86.74 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.194 1.854 . . . . 0.0 115.342 176.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -83.55 117.66 23.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.363 1.581 . . . . 0.0 112.083 -173.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.9 m -102.18 158.54 16.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.424 1.089 . . . . 0.0 110.262 168.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.19 162.37 39.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.513 1.525 . . . . 0.0 109.499 171.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.1 m -86.39 154.38 21.23 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 169.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.3 157.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.118 0.961 . . . . 0.0 113.298 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -80.12 163.29 58.27 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.97 -24.13 46.77 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.495 2.797 . . . . 0.0 115.829 -169.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -81.45 -7.84 59.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.266 2.226 . . . . 0.0 114.766 176.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.65 -0.22 59.45 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.2 1.381 . . . . 0.0 115.438 -178.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.0 m -70.91 132.31 45.04 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.907 1.854 . . . . 0.0 109.937 177.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.1 141.93 57.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.274 1.029 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -82.34 115.37 57.53 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -44.08 133.44 8.63 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.779 3.652 . . . . 0.0 116.262 -169.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 59.5 15.15 4.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.731 2.013 . . . . 0.0 115.719 179.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.4 p -74.57 -24.14 58.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.197 170.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . 0.363 0.0 OUTLIER -57.99 110.73 0.98 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.027 1.285 . . . . 0.0 113.232 -170.503 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.3 t -148.65 153.54 38.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.792 1.637 . . . . 0.0 110.398 -170.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -80.31 28.12 0.32 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.166 1.386 . . . . 0.0 114.333 -171.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.35 169.05 35.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.387 1.946 . . . . 0.0 112.598 171.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -63.92 165.3 8.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.734 1.214 . . . . 0.0 112.781 179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 164.12 38.65 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.017 0.927 . . . . 0.0 111.333 172.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -83.45 62.88 7.01 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.159 1.784 . . . . 0.0 111.976 -168.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.45 108.4 0.94 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -173.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.7 t -139.45 27.92 2.26 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.214 1.806 . . . . 0.0 112.56 -177.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.02 15.9 3.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.347 1.459 . . . . 0.0 114.606 -169.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.331 -0.235 0 C-N-CA 125.426 1.49 . . . . 0.0 109.559 175.493 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.543 0.673 0 CA-C-O 120.607 0.241 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.8 p -144.89 167.69 22.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.516 1.927 . . . . 0.0 110.971 -174.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -50.23 -42.39 51.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.785 1.234 . . . . 0.0 113.418 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.08 -61.77 2.16 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.201 0.6 . . . . 0.0 111.127 173.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -58.66 -40.39 83.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.716 1.606 . . . . 0.0 112.265 -177.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.24 -55.86 26.57 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 125.793 1.637 . . . . 0.0 110.344 172.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.68 -44.61 81.6 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.557 0.617 . . . . 0.0 111.432 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.85 -34.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 118.629 0.65 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -84.97 3.94 36.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.016 1.726 . . . . 0.0 115.231 175.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.8 -24.96 1.9 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.276 1.398 . . . . 0.0 114.265 -174.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.14 122.49 75.65 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.31 0.959 . . . . 0.0 109.166 176.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.54 172.48 15.01 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.302 2.002 . . . . 0.0 111.657 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -22.14 66.69 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.653 -0.654 . . . . 0.0 112.278 169.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 t -77.09 67.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.164 1.386 . . . . 0.0 109.184 169.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.5 92.65 44.13 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.102 1.361 . . . . 0.0 110.28 175.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.58 115.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 124.771 3.647 . . . . 0.0 114.994 -173.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.9 51.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.174 1.368 . . . . 0.0 114.86 -177.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.261 92.0 p 69.16 107.08 0.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.274 3.029 . . . . 0.0 116.097 -176.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -138.44 136.21 35.99 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.968 1.707 . . . . 0.0 109.392 168.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -144.47 135.35 12.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 126.406 1.882 . . . . 0.0 106.086 169.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.9 163.57 38.72 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 CA-C-N 120.63 1.261 . . . . 0.0 111.224 177.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -122.82 147.05 46.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.954 1.702 . . . . 0.0 109.469 177.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.4 m -136.61 156.53 48.43 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.19 0.996 . . . . 0.0 111.848 -171.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -102.8 179.25 4.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.732 1.213 . . . . 0.0 114.162 -174.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 -62.21 -12.04 17.97 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 177.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -97.04 8.27 44.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.239 1.816 . . . . 0.0 111.696 175.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.7 8.81 35.38 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.706 1.146 . . . . 0.0 114.034 -176.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.33 165.6 13.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.582 1.553 . . . . 0.0 108.85 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -62.17 132.52 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 173.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.09 135.74 87.88 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.8 -1.095 . . . . 0.0 108.258 174.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.07 -15.44 7.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.332 2.688 . . . . 0.0 116.887 -176.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.26 137.59 51.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.951 2.1 . . . . 0.0 109.891 171.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -131.9 152.42 51.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.853 1.261 . . . . 0.0 109.471 170.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.2 m -143.59 158.12 43.9 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.39 1.076 . . . . 0.0 112.353 -178.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 113.46 12.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.997 2.119 . . . . 0.0 108.93 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -47.04 -80.91 0.05 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 127.562 2.506 . . . . 0.0 117.274 -168.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.6 m -64.43 -18.73 65.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -168.34 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.0 pt -92.61 -3.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.0 10.83 59.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.597 1.57 . . . . 0.0 114.948 174.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -94.78 146.6 24.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.231 1.015 . . . . 0.0 113.445 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.9 m -130.86 156.45 45.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.509 1.523 . . . . 0.0 108.53 165.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -147.39 161.33 41.24 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.49 1.516 . . . . 0.0 108.781 172.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.8 m -86.8 152.69 22.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.82 156.66 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.736 1.214 . . . . 0.0 110.019 170.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -73.68 161.19 79.92 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 166.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.54 -26.55 22.47 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.329 2.686 . . . . 0.0 115.389 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -76.46 -8.12 56.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.296 1.839 . . . . 0.0 115.374 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.69 -3.86 56.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.745 1.641 . . . . 0.0 115.266 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.9 m -73.56 119.79 18.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.059 1.43 . . . . 0.0 110.439 -177.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -56.82 132.14 51.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.719 1.207 . . . . 0.0 113.758 176.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -84.39 109.33 18.84 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.92 1.688 . . . . 0.0 107.639 169.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.44 163.51 26.6 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.556 2.171 . . . . 0.0 111.871 -175.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 61.2 -3.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.772 2.029 . . . . 0.0 115.74 -175.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.2 p -72.38 -28.84 63.27 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.994 1.27 . . . . 0.0 110.989 169.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -40.35 102.91 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.603 2.361 . . . . 0.0 113.103 -173.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.7 m -133.51 161.79 33.63 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.118 0.967 . . . . 0.0 111.627 -172.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -71.95 17.55 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 130.17 3.388 . . . . 0.0 113.777 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.31 -178.82 40.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.669 2.081 . . . . 0.0 112.178 -171.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -61.21 162.45 7.5 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.654 1.581 . . . . 0.0 114.193 -172.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 163.75 36.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.066 1.346 . . . . 0.0 110.827 171.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.06 57.69 3.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.17 2.188 . . . . 0.0 112.496 -168.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.7 m -60.41 95.39 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 122.845 1.307 . . . . 0.0 112.078 -173.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.8 m -83.65 63.29 7.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.053 1.741 . . . . 0.0 111.571 -167.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 56.44 19.58 4.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.44 1.896 . . . . 0.0 114.509 -171.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 127.368 2.267 . . . . 0.0 112.512 179.35 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 p -129.77 175.07 9.13 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.778 1.231 . . . . 0.0 112.717 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -51.02 -33.44 25.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.661 1.184 . . . . 0.0 112.31 172.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.1 t -61.33 -60.2 4.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.307 0.503 . . . . 0.0 110.653 172.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -55.68 -38.7 69.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -60.53 -58.22 9.42 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.087 0.955 . . . . 0.0 110.654 173.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.59 -40.84 88.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.385 0.539 . . . . 0.0 112.41 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -69.03 -28.26 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.036 0.934 . . . . 0.0 112.243 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -73.43 -48.44 33.7 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.69 0.796 . . . . 0.0 111.955 169.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -73.62 -33.75 64.7 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.846 1.259 . . . . 0.0 113.251 -175.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.8 mt -97.43 101.06 9.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.42 173.54 14.07 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.698 2.265 . . . . 0.0 111.902 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.22 -20.26 17.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.408 1.083 . . . . 0.0 113.808 173.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.41 76.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.124 1.37 . . . . 0.0 107.987 169.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -111.67 71.87 0.98 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.135 1.374 . . . . 0.0 111.354 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.78 119.44 6.7 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.833 3.022 . . . . 0.0 112.391 -169.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 53.37 8.62 0.81 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.444 1.974 . . . . 0.0 115.313 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -108.57 159.89 16.35 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.649 1.579 . . . . 0.0 112.39 -167.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -77.61 148.39 35.14 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.842 0.457 . . . . 0.0 110.751 173.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -138.28 125.03 13.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.318 1.847 . . . . 0.0 107.723 169.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -70.33 174.34 10.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.103 1.868 . . . . 0.0 113.427 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -135.41 143.88 46.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.016 2.126 . . . . 0.0 110.236 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.77 164.24 29.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.433 1.893 . . . . 0.0 110.643 -177.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -120.99 178.38 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.041 0.936 . . . . 0.0 113.068 169.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -62.93 -11.95 22.07 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.571 1.548 . . . . 0.0 114.682 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -87.49 1.3 53.89 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.231 0.469 . . . . 0.0 111.901 173.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.45 -1.01 88.55 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.857 1.694 . . . . 0.0 114.353 173.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -86.71 165.18 16.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.481 1.113 . . . . 0.0 110.629 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -64.85 130.31 42.98 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 167.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mt -55.2 135.35 68.59 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.63 -7.01 16.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.153 1.902 . . . . 0.0 114.854 -168.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.12 135.97 53.62 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.555 1.942 . . . . 0.0 108.135 168.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -130.8 153.11 49.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.469 1.107 . . . . 0.0 108.977 170.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.7 m -140.53 156.88 46.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.145 0.978 . . . . 0.0 112.008 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.02 102.38 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.383 1.073 . . . . 0.0 111.24 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.44 -41.0 62.7 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.99 1.281 . . . . 0.0 114.946 -175.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 m -62.32 -17.88 59.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.004 1.402 . . . . 0.0 114.652 -176.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -112.83 -2.47 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.171 1.389 . . . . 0.0 112.313 171.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.58 20.72 74.13 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.9 1.238 . . . . 0.0 114.438 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -118.54 161.41 20.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.939 1.369 . . . . 0.0 113.724 -170.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 64.2 m -132.36 159.15 40.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.993 2.117 . . . . 0.0 109.742 167.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -145.71 160.93 41.01 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 125.169 1.387 . . . . 0.0 109.248 171.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.6 m -88.34 152.9 21.61 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 169.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.65 154.59 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 124.752 1.221 . . . . 0.0 110.942 172.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -74.82 164.82 58.79 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 167.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -50.86 -28.54 23.84 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.473 2.782 . . . . 0.0 115.758 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -78.59 -6.93 56.93 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.236 2.215 . . . . 0.0 115.459 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.28 -3.27 63.85 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.914 1.245 . . . . 0.0 115.458 177.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.2 m -73.4 131.73 42.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.929 1.365 . . . . 0.0 109.402 177.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -59.18 142.54 51.41 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.03 110.1 21.25 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 168.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -47.67 142.96 13.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.011 3.141 . . . . 0.0 115.334 -169.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 61.09 8.65 2.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.56 1.944 . . . . 0.0 115.225 177.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.5 p -71.56 -27.58 63.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.037 1.29 . . . . 0.0 110.919 172.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.549 HH21 ' NH2' ' A' ' 57' ' ' ARG . 1.7 ptm180 -41.17 93.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.343 2.257 . . . . 0.0 114.363 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 m -127.78 163.44 24.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.17 1.788 . . . . 0.0 112.083 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' NH2' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -69.2 9.05 0.48 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 128.577 2.751 . . . . 0.0 113.318 176.654 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.37 -179.83 47.03 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.979 1.752 . . . . 0.0 112.658 -176.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -65.19 167.31 8.37 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.156 1.782 . . . . 0.0 114.008 -174.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.02 167.08 31.54 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.074 1.35 . . . . 0.0 111.359 176.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -78.63 53.63 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.129 2.571 . . . . 0.0 113.196 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 56.9 m -60.68 95.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.916 1.341 . . . . 0.0 114.576 -169.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 m -89.05 34.43 0.79 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.248 2.219 . . . . 0.0 112.033 -169.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -119.88 23.7 10.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.615 1.566 . . . . 0.0 112.962 -169.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 125.285 1.434 . . . . 0.0 111.451 -179.603 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.29 0.09 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 p -83.53 170.08 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -173.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.9 -39.26 62.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.705 1.202 . . . . 0.0 112.684 170.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.9 t -61.22 -59.2 5.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.722 0.809 . . . . 0.0 110.677 171.231 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -59.95 -34.82 73.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.6 0.76 . . . . 0.0 112.595 -176.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.26 -59.29 5.64 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.765 1.626 . . . . 0.0 110.774 170.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.36 -44.99 76.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.183 0.447 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.63 -28.85 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.134 0.974 . . . . 0.0 112.136 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -83.0 3.02 31.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.664 1.586 . . . . 0.0 114.231 169.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -124.17 -33.66 3.05 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.689 1.131 . . . . 0.0 111.976 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.73 102.78 8.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 168.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.34 166.38 29.47 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.545 2.164 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.0 56.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.21 63.57 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.512 1.125 . . . . 0.0 109.272 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -93.52 -5.94 0.11 Allowed Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -178.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -42.39 126.8 4.05 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.726 2.951 . . . . 0.0 115.305 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.99 -23.75 33.57 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.106 1.813 . . . . 0.0 112.401 -169.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.0 p -123.02 159.44 28.4 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.594 1.558 . . . . 0.0 113.086 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -87.72 106.27 17.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.277 1.031 . . . . 0.0 111.291 175.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -91.76 118.39 68.27 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.97 174.75 2.23 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.356 2.037 . . . . 0.0 114.032 175.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -134.55 142.38 46.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.252 1.821 . . . . 0.0 109.94 175.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.1 m -137.54 157.67 46.03 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.802 1.641 . . . . 0.0 109.668 -177.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.24 -177.4 3.39 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 171.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -58.03 -22.94 52.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.478 1.511 . . . . 0.0 113.704 -174.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -84.96 -1.14 56.36 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.473 0.579 . . . . 0.0 111.916 176.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.02 -0.87 86.6 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.892 1.711 . . . . 0.0 114.521 178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -77.85 160.74 28.11 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.628 1.714 . . . . 0.0 109.538 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.67 130.42 46.8 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.83 143.07 77.69 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.75 -17.3 52.18 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.02 1.814 . . . . 0.0 113.575 -169.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.07 137.63 44.77 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.705 2.002 . . . . 0.0 108.63 169.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -128.4 150.36 50.14 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.667 1.187 . . . . 0.0 109.414 169.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.4 m -140.99 151.98 44.56 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.972 0.909 . . . . 0.0 111.959 -177.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.36 78.46 1.81 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.795 2.038 . . . . 0.0 107.865 177.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.96 -34.86 58.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.228 0.918 . . . . 0.0 114.334 -170.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.5 m -63.72 -15.23 57.97 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -114.31 -0.25 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.646 1.178 . . . . 0.0 111.974 169.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.4 58.23 13.33 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.585 1.088 . . . . 0.0 111.351 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -140.7 154.31 46.3 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 176.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.6 m -142.28 160.19 40.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.4 1.88 . . . . 0.0 110.166 167.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -150.08 163.13 38.98 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.881 1.672 . . . . 0.0 109.113 173.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 74.8 m -89.28 153.09 21.17 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.54 152.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.307 1.043 . . . . 0.0 110.543 171.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.86 162.52 73.71 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 166.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -56.14 -20.1 29.73 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.586 2.857 . . . . 0.0 116.167 -170.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -83.57 -8.79 59.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.485 2.314 . . . . 0.0 114.67 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.06 -0.93 54.8 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.471 1.51 . . . . 0.0 115.269 -177.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -70.88 115.79 10.42 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.856 1.828 . . . . 0.0 110.342 178.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -54.83 135.3 47.94 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.836 1.254 . . . . 0.0 112.863 175.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.49 111.7 33.65 Favored Pre-proline 0 C--O 1.242 0.709 0 C-N-CA 125.509 1.524 . . . . 0.0 108.075 172.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -50.97 150.58 12.94 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.647 2.898 . . . . 0.0 113.653 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 59.86 2.24 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.404 1.882 . . . . 0.0 115.933 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p -72.85 -32.4 65.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.297 1.408 . . . . 0.0 110.565 169.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -45.27 103.86 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.335 1.854 . . . . 0.0 112.41 -172.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m -135.48 167.86 20.3 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.553 1.541 . . . . 0.0 110.14 -171.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -79.67 13.35 2.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.462 1.105 . . . . 0.0 113.717 -178.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.98 -178.16 47.27 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.744 2.116 . . . . 0.0 112.476 -172.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -62.69 162.94 9.9 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.466 1.506 . . . . 0.0 114.227 -172.002 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 169.12 22.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.135 1.774 . . . . 0.0 110.332 171.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -74.0 39.88 0.12 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.776 2.83 . . . . 0.0 114.747 -168.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -55.8 110.93 0.8 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -116.96 22.58 12.49 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.774 1.63 . . . . 0.0 111.658 -171.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.79 14.83 0.33 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.431 2.292 . . . . 0.0 115.539 -168.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 C--N 1.328 -0.326 0 C-N-CA 125.768 1.627 . . . . 0.0 110.75 -171.853 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 120.746 0.307 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 p -82.73 167.15 18.46 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.976 0.91 . . . . 0.0 111.235 170.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -53.47 -42.38 67.18 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.721 -0.612 . . . . 0.0 112.168 171.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.8 t -55.88 -61.4 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.444 0.697 . . . . 0.0 110.688 172.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -56.42 -43.19 79.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.682 1.193 . . . . 0.0 112.744 -178.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -56.43 -53.92 51.75 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.63 1.172 . . . . 0.0 110.706 172.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.15 -41.49 83.85 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.616 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 4' ' ' CYS . 1.6 t -63.84 -35.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.563 1.074 . . . . 0.0 111.365 175.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -83.28 6.3 20.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.362 1.865 . . . . 0.0 114.733 176.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.44 -37.39 1.62 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.704 1.202 . . . . 0.0 112.051 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.61 118.72 67.53 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.691 1.596 . . . . 0.0 106.76 172.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.54 168.02 23.34 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.672 2.248 . . . . 0.0 111.849 177.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.78 -23.63 53.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.277 1.031 . . . . 0.0 113.723 173.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.97 75.39 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.037 1.335 . . . . 0.0 108.549 172.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -118.73 62.04 5.16 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.333 1.053 . . . . 0.0 113.737 176.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.28 119.42 6.4 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.068 2.512 . . . . 0.0 110.575 172.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.53 7.91 88.07 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.389 -0.673 . . . . 0.0 114.465 -177.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -138.38 -179.4 5.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.376 1.47 . . . . 0.0 110.275 174.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -131.39 145.72 51.95 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.102 -0.999 . . . . 0.0 113.008 -176.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -123.92 113.59 28.35 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 127.234 2.214 . . . . 0.0 108.295 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.65 161.33 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 121.694 1.596 . . . . 0.0 112.629 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -118.67 152.72 35.58 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.894 1.678 . . . . 0.0 109.747 169.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -131.27 151.57 51.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.762 1.225 . . . . 0.0 111.681 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.92 179.59 7.77 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.047 1.339 . . . . 0.0 112.362 173.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -61.37 -17.51 54.34 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -173.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.01 -2.03 58.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.51 1.124 . . . . 0.0 112.464 174.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.87 1.66 84.85 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.608 1.099 . . . . 0.0 113.853 -171.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -77.57 151.52 34.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.132 1.466 . . . . 0.0 109.072 175.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -51.28 129.92 25.7 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 111.281 175.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.62 131.18 77.64 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 117.888 -1.053 . . . . 0.0 108.368 171.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.43 -35.75 36.92 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.677 2.918 . . . . 0.0 114.53 -177.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.91 140.45 33.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.769 1.628 . . . . 0.0 109.898 169.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -126.52 143.52 51.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.226 1.41 . . . . 0.0 108.695 169.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.3 m -139.35 144.98 38.47 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.082 0.953 . . . . 0.0 110.923 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -113.07 93.27 4.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.656 1.183 . . . . 0.0 110.712 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.97 -9.22 26.89 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -169.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 97.2 p -68.65 -26.33 65.27 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.77 1.785 . . . . 0.0 112.538 169.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -125.56 -16.07 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 125.948 1.699 . . . . 0.0 112.853 -178.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.12 89.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.497 1.046 . . . . 0.0 114.578 176.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -81.93 154.4 25.79 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.21 1.005 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.4 m -134.55 165.34 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.018 1.327 . . . . 0.0 112.512 178.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -153.26 165.0 37.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.125 1.77 . . . . 0.0 109.415 169.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 83.3 m -91.86 152.38 20.12 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 169.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.38 159.62 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.142 0.977 . . . . 0.0 113.377 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -92.68 164.85 20.68 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 127.059 2.143 . . . . 0.0 110.389 168.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -57.72 -5.83 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.749 3.633 . . . . 0.0 118.545 -172.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -103.59 -5.48 22.64 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.129 1.371 . . . . 0.0 113.865 172.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 100.46 0.58 55.59 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.797 1.665 . . . . 0.0 114.663 -177.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 m -69.77 128.08 35.18 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.886 1.343 . . . . 0.0 108.497 178.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.84 163.4 27.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.48 100.49 2.76 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 167.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.31 22.57 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.858 1 C-N-CA 125.895 4.396 . . . . 0.0 118.054 -166.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.85 -3.21 7.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.409 1.884 . . . . 0.0 112.398 168.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.5 p -92.98 -10.98 34.38 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.441 1.096 . . . . 0.0 113.246 178.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.51 96.5 0.08 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.157 0.983 . . . . 0.0 110.224 -173.424 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.0 t -134.57 163.07 30.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -168.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -1.9 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.727 2.811 . . . . 0.0 114.017 -169.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.82 -171.04 40.04 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.071 1.796 . . . . 0.0 112.75 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.91 152.22 13.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.494 1.917 . . . . 0.0 114.505 -170.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -155.43 171.76 19.37 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.012 1.725 . . . . 0.0 109.502 169.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -116.43 78.12 1.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 0.0 110.824 -168.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.1 m -56.97 119.3 6.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.25 1.82 . . . . 0.0 113.066 -179.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.5 m -67.87 60.41 0.07 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.887 2.075 . . . . 0.0 113.64 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 53.98 29.47 10.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.613 1.965 . . . . 0.0 114.785 177.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.468 0.433 0 C-N-CA 126.202 1.801 . . . . 0.0 112.954 -175.639 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.648 0.737 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.2 p -142.13 169.15 18.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.576 2.75 . . . . 0.0 108.823 176.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -51.59 -40.14 59.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.862 0.865 . . . . 0.0 112.87 179.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.2 t -59.1 -62.36 1.94 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.598 0.759 . . . . 0.0 111.517 170.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -59.93 -31.03 69.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.673 0.789 . . . . 0.0 113.006 -176.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -62.11 -58.17 8.82 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.264 1.426 . . . . 0.0 110.509 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -58.31 -38.94 78.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.875 0.762 . . . . 0.0 112.623 177.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.97 -31.22 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.772 0.829 . . . . 0.0 112.223 175.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 m -72.55 -43.99 62.73 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.926 0.89 . . . . 0.0 112.233 171.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.05 -33.71 57.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 113.413 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.9 mt -99.55 101.56 13.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.75 1.62 . . . . 0.0 106.889 172.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.16 172.59 16.06 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 122.742 2.295 . . . . 0.0 112.148 -177.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.07 -23.15 31.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.309 1.043 . . . . 0.0 113.355 171.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.1 t -76.19 70.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.198 1.399 . . . . 0.0 109.29 169.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -122.36 24.93 0.11 Allowed Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -62.22 114.69 2.44 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.754 2.303 . . . . 0.0 112.13 -173.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.64 -17.2 30.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.013 1.768 . . . . 0.0 112.956 -172.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.1 t -119.71 177.98 4.75 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.635 1.974 . . . . 0.0 111.646 177.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -94.24 157.69 15.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.252 2.621 . . . . 0.0 110.865 176.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -143.24 129.95 10.56 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 0.0 108.378 169.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.67 170.53 18.42 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.9 1.734 . . . . 0.0 113.221 177.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -137.7 145.63 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.477 3.111 . . . . 0.0 110.368 -178.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -134.07 157.62 45.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.962 0.905 . . . . 0.0 112.504 -174.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -95.52 173.22 7.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.446 1.499 . . . . 0.0 112.798 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -62.43 -13.99 35.91 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.21 6.41 40.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.105 2.162 . . . . 0.0 111.379 175.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.55 5.78 38.69 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.643 1.592 . . . . 0.0 114.416 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -91.18 164.68 13.82 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.431 1.492 . . . . 0.0 109.289 178.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -64.7 130.74 44.71 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.7 138.61 77.25 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 117.787 -1.102 . . . . 0.0 108.988 176.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -48.12 -31.88 17.49 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.158 3.239 . . . . 0.0 116.13 -177.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.67 139.6 39.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.449 1.9 . . . . 0.0 110.09 171.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -129.36 147.26 51.17 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.218 1.407 . . . . 0.0 108.871 169.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.1 m -139.15 125.48 20.28 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.4 68.17 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.941 1.696 . . . . 0.0 107.3 168.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.21 -30.21 47.08 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.312 1.434 . . . . 0.0 114.409 -172.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 m -53.34 -24.87 13.16 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 114.477 173.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -122.03 10.16 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 125.963 1.705 . . . . 0.0 111.934 173.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.78 3.64 68.39 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.505 1.526 . . . . 0.0 115.006 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -81.59 149.51 28.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.206 1.503 . . . . 0.0 112.128 -169.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.2 m -138.42 160.6 39.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.913 0.885 . . . . 0.0 111.43 168.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -150.71 163.5 38.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.154 1.782 . . . . 0.0 108.831 169.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.1 m -90.45 154.78 19.39 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 169.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.28 159.82 42.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.129 0.972 . . . . 0.0 111.363 175.366 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.77 159.98 72.81 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 165.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -53.98 -24.32 31.7 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.627 2.884 . . . . 0.0 115.824 -173.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -78.22 -6.74 55.8 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.182 2.193 . . . . 0.0 115.289 174.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.89 -1.92 56.75 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.594 1.569 . . . . 0.0 115.237 178.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 m -72.25 119.3 16.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.893 1.346 . . . . 0.0 109.984 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -59.28 144.88 45.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.739 1.215 . . . . 0.0 113.662 177.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.25 96.55 0.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.73 2.012 . . . . 0.0 106.239 168.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -71.81 24.01 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.853 1 C-N-CA 125.789 4.326 . . . . 0.0 117.26 -166.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -125.04 -1.25 7.78 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.149 1.78 . . . . 0.0 112.594 169.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.0 p -92.96 -14.41 27.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.047 0.939 . . . . 0.0 113.171 176.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -57.1 107.88 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.069 0.948 . . . . 0.0 112.102 -171.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 t -132.81 158.94 41.2 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.83 1.252 . . . . 0.0 112.374 -171.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 7.72 0.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 128.339 2.656 . . . . 0.0 113.408 169.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.65 -172.42 43.72 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.817 1.199 . . . . 0.0 114.099 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -58.11 154.11 13.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.67 2.388 . . . . 0.0 115.353 -169.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.87 158.39 37.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.063 1.345 . . . . 0.0 110.494 168.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.45 69.65 3.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.592 1.157 . . . . 0.0 110.577 -169.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.2 m -46.3 106.95 0.09 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.928 1.691 . . . . 0.0 113.938 -173.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.3 m -130.28 24.23 5.19 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.477 1.911 . . . . 0.0 112.15 -170.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.09 10.93 2.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 115.066 -169.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.328 -0.368 0 C-N-CA 125.518 1.527 . . . . 0.0 109.439 177.349 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.4 tp . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 123.245 1.498 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.6 p -142.76 172.19 13.03 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 130.675 3.59 . . . . 0.0 112.483 -172.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.33 -39.71 32.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 0.0 111.991 169.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.5 t -58.71 -62.97 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.434 0.561 . . . . 0.0 110.949 175.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -62.45 -30.54 71.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.62 -58.59 7.49 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.118 1.367 . . . . 0.0 110.764 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -53.31 -48.14 68.67 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.639 0.775 . . . . 0.0 111.136 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.86 -26.3 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.412 1.085 . . . . 0.0 112.639 177.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -89.32 3.22 52.83 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.417 1.487 . . . . 0.0 114.652 171.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -130.93 -29.95 1.84 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.888 1.222 . . . . 0.0 113.905 -173.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -79.78 116.85 64.0 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.632 0.773 . . . . 0.0 109.105 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -70.16 162.92 40.5 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.877 1.718 . . . . 0.0 111.147 176.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -27.13 67.67 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.675 -0.641 . . . . 0.0 112.248 170.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -76.81 71.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.277 1.431 . . . . 0.0 109.15 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -114.73 30.19 0.12 Allowed Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 170.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.13 113.48 2.05 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.491 2.794 . . . . 0.0 112.173 -170.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.99 -16.34 27.92 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.093 1.806 . . . . 0.0 112.765 -174.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -115.93 171.93 7.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.67 1.588 . . . . 0.0 112.443 178.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -88.42 160.33 17.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.86 2.864 . . . . 0.0 111.611 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -141.96 123.16 8.7 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.08 0.952 . . . . 0.0 110.638 169.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.97 174.83 12.21 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.96 2.44 . . . . 0.0 113.525 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -140.2 149.46 42.96 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.335 2.254 . . . . 0.0 109.835 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -144.25 160.76 40.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.563 0.745 . . . . 0.0 112.437 -175.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -85.22 176.06 8.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.552 168.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.52 -29.49 66.33 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.319 1.047 . . . . 0.0 112.469 174.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -83.58 14.15 4.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.265 2.226 . . . . 0.0 111.92 -175.046 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.94 8.53 49.43 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.309 1.433 . . . . 0.0 114.43 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -91.42 146.65 23.63 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.562 1.181 . . . . 0.0 109.214 179.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -62.43 126.13 26.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.056 0.942 . . . . 0.0 108.919 177.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.3 143.73 79.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.386 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -50.22 -22.5 8.37 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.2 3.267 . . . . 0.0 117.489 -174.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.26 137.24 52.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.47 1.908 . . . . 0.0 109.598 174.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -130.68 147.2 52.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.846 1.259 . . . . 0.0 109.63 173.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 70.8 m -135.77 122.43 20.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -172.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -85.13 70.56 10.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.749 1.619 . . . . 0.0 108.057 169.034 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.31 -33.35 31.41 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.343 1.449 . . . . 0.0 114.562 -172.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m -54.73 -24.61 23.0 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 175.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -118.62 6.46 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.301 1.44 . . . . 0.0 112.022 174.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.94 67.05 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.299 1.428 . . . . 0.0 114.665 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -90.6 150.22 21.8 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.124 1.462 . . . . 0.0 112.121 -174.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.9 m -134.44 160.51 37.76 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.427 1.491 . . . . 0.0 110.078 168.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -144.45 163.21 34.47 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.169 1.787 . . . . 0.0 109.284 169.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.75 151.71 23.63 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 169.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.25 155.43 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.061 0.945 . . . . 0.0 111.307 172.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -77.57 159.91 76.01 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 166.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.3 -24.44 15.69 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.935 3.09 . . . . 0.0 117.102 -172.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -82.68 -4.77 58.29 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 175.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.77 -0.08 52.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.632 1.587 . . . . 0.0 114.772 -178.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.6 m -70.66 113.93 8.25 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.152 1.476 . . . . 0.0 110.222 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -55.61 136.7 50.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.06 109.76 19.21 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.3 156.48 50.73 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.729 2.286 . . . . 0.0 112.109 -169.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 m120 59.5 2.0 0.3 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.114 1.765 . . . . 0.0 115.52 -175.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -71.35 -30.95 66.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.639 1.563 . . . . 0.0 110.699 169.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.664 ' NH2' HH12 ' A' ' 57' ' ' ARG 0.279 0.0 OUTLIER -46.65 120.62 3.04 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 123.524 0.729 . . . . 0.0 111.98 -172.506 . . . . . . . . 4 4 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.9 m -151.87 164.73 36.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.784 1.233 . . . . 0.0 111.134 -170.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.664 HH12 ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -76.98 17.29 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.337 2.655 . . . . 0.0 112.717 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.91 179.78 45.98 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.756 1.646 . . . . 0.0 112.745 -178.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -67.0 167.04 12.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.759 1.623 . . . . 0.0 113.417 -176.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.7 166.69 32.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.789 1.236 . . . . 0.0 111.353 174.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.36 61.25 4.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.831 2.452 . . . . 0.0 112.289 -168.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -65.85 98.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -77.13 23.81 0.18 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.868 2.067 . . . . 0.0 114.895 -175.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.21 25.67 3.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.008 1.323 . . . . 0.0 113.47 -169.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.469 0.512 0 C-N-CA 126.432 1.893 . . . . 0.0 110.543 169.759 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 120.8 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.4 p -84.69 165.73 17.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.359 1.064 . . . . 0.0 112.71 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -51.6 -40.66 60.25 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.726 1.211 . . . . 0.0 113.029 172.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.01 -56.49 16.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.041 -0.412 . . . . 0.0 111.142 172.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -59.66 -31.24 69.36 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.41 -61.79 2.29 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.016 1.326 . . . . 0.0 110.082 169.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.67 -37.77 82.67 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.416 0.553 . . . . 0.0 112.461 -176.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.54 -27.44 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.568 1.147 . . . . 0.0 112.296 175.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -74.43 -41.39 60.95 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.587 -0.696 . . . . 0.0 111.47 168.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -69.29 -41.92 76.16 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.977 1.311 . . . . 0.0 112.8 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -85.71 108.95 18.55 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.61 167.29 27.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.915 1.744 . . . . 0.0 111.716 177.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.74 -20.55 35.57 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 172.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.17 74.52 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.347 1.459 . . . . 0.0 108.272 169.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -112.98 65.53 0.92 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.965 1.306 . . . . 0.0 111.774 176.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -60.23 121.11 9.27 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.702 2.934 . . . . 0.0 111.734 -171.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.95 13.51 2.25 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.623 1.583 . . . . 0.0 114.98 -174.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.1 m -115.43 161.57 18.37 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.677 1.991 . . . . 0.0 112.373 -167.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -79.55 149.2 31.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.315 0.646 . . . . 0.0 111.513 179.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -144.79 127.64 8.39 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.241 1.816 . . . . 0.0 108.624 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.45 168.52 17.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 121.581 1.52 . . . . 0.0 113.928 178.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -130.85 150.62 51.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.076 2.55 . . . . 0.0 110.867 173.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -128.93 155.54 45.15 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.552 1.141 . . . . 0.0 112.238 -175.202 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -90.76 176.84 6.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.59 1.556 . . . . 0.0 113.272 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.33 -16.13 31.97 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 177.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.86 9.56 38.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.186 1.795 . . . . 0.0 111.697 175.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 5.57 33.0 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.475 1.512 . . . . 0.0 114.432 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.63 166.17 13.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.839 1.256 . . . . 0.0 108.88 178.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -59.81 130.58 47.48 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.817 -0.552 . . . . 0.0 109.976 178.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.3 125.87 59.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.555 173.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.62 -18.57 6.19 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.641 2.894 . . . . 0.0 116.982 -175.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 tp -111.48 135.31 52.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.655 1.982 . . . . 0.0 108.976 169.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -129.69 154.02 47.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.531 1.133 . . . . 0.0 109.127 169.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 73.6 m -141.22 159.35 42.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.939 0.895 . . . . 0.0 111.528 178.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.68 90.17 2.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.789 1.236 . . . . 0.0 109.904 175.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -48.11 -48.02 26.2 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.286 1.898 . . . . 0.0 116.052 -169.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -64.91 -13.41 56.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.095 1.447 . . . . 0.0 114.616 -175.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 pt -116.36 -0.45 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 112.812 170.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.01 4.43 55.4 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.867 1.699 . . . . 0.0 115.399 175.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -84.76 148.56 26.29 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.227 1.013 . . . . 0.0 112.811 -176.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 60.6 m -132.13 159.27 39.41 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.03 1.332 . . . . 0.0 109.75 166.629 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 48.1 p90 -151.76 160.92 43.41 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.318 1.447 . . . . 0.0 109.228 173.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 80.2 m -88.86 153.13 21.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 169.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.76 149.6 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.669 1.188 . . . . 0.0 110.587 175.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -70.22 155.96 92.6 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 165.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -14.56 38.27 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.796 2.331 . . . . 0.0 115.743 -169.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -78.34 -10.97 59.9 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.9 1.68 . . . . 0.0 114.204 171.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.21 -1.35 47.09 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.049 1.785 . . . . 0.0 115.183 -177.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.3 m -73.85 116.16 14.14 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.556 1.678 . . . . 0.0 109.72 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -57.11 145.02 32.44 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.699 1.2 . . . . 0.0 113.652 175.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.72 87.52 0.71 Allowed Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 168.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -64.27 -17.32 59.25 Favored 'Trans proline' 0 C--N 1.351 0.704 0 N-CA-C 118.169 2.334 . . . . 0.0 118.169 -165.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -68.23 -11.44 59.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.455 1.502 . . . . 0.0 113.184 172.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.2 p -90.83 -14.0 32.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.215 172.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -55.64 105.08 0.15 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.32 1.418 . . . . 0.0 112.151 -169.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m -133.63 166.19 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.79 1.236 . . . . 0.0 112.96 -168.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -70.12 12.14 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 130.105 3.362 . . . . 0.0 114.547 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.68 -176.64 41.14 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.38 1.943 . . . . 0.0 112.625 -172.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -61.27 163.13 6.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.338 1.855 . . . . 0.0 114.425 -171.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.19 165.21 37.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.256 1.422 . . . . 0.0 111.175 174.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -82.11 63.76 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.084 2.154 . . . . 0.0 111.667 -168.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m -57.14 98.5 0.03 OUTLIER 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.903 1.335 . . . . 0.0 112.129 -174.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.9 m -76.6 31.62 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.857 2.463 . . . . 0.0 115.168 -167.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.67 13.2 14.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.311 1.844 . . . . 0.0 111.068 169.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 CA--C 1.53 0.177 0 C-N-CA 127.61 2.364 . . . . 0.0 110.734 -175.723 . . . . . . . . 0 0 . 1 stop_ save_